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001 [003]
Functional Effects Of Pachyonychia Congenita Type I Mutations on Keratinocyte Migration 
and the Actin Cytoskeleton
Van Koningsveld R1, Fitchett CJ1, Rugg EL2 and O’Toole EA1
1Centre for Cutaneous Research, ICMS, Queen Mary, University of London (United Kingdom)
2Department of Dermatology, University of California, Irvine (USA)
Keratins are the largest group of cytoskeletal proteins forming the intermediate fi lament cy-
toskeleton within epithelial cells. Keratins K6a and K16 are expressed in wound healing, skin 
cancer and psoriasis and mutations in these genes cause type I pachyonychia congenita (PC1). 
The aim of this study was to investigate the effect of over-expression of wild-type or mutant K6a 
(K6aN171del) and K16 (K16R127C) on human keratinocyte (HK) migration, and study the sig-
nalling pathways involved. Phoenix cells (HEK293 cells modifi ed to express retroviral packag-
ing proteins) were transfected with target genes and the supernatant was used to infect primary 
HK. Migration was assessed using the colloidal gold and in vitro scratch assays. Expression of 
signalling molecules was investigated using Western blotting and differentially expressed genes 
using Afymmetrix chip technology. All cells migrated further in the presence of 10nM EGF, 
however, the K16R127C-transduced HKs displayed maximal hypermotility in response to EGF 
in the colloidal gold assay (p<0.0001). Both K16 and K16R127C-expressing cells displayed hy-
permotility in the in vitro scratch assay. Maximal p38 phosphorylation in response to EGF was 
seen in the K16R127C-transduced HKs. The K16R127C-transduced keratinocytes displayed 
decreased basal expression of cofi lin, an actin-binding protein. Data-mining of the Afymmetrix 
chip data using Genespring identifi ed altered expression of several genes involved in actin 
remodelling in the transduced cells suggesting that the PC type I mutation, R127C, signifi cantly 
alters keratinocyte migration by affecting actin cytoskeletal dynamics. These changes may play 
a role in the stress-induced clinical phenotype seen in PC1. 
002 [011]
Serpin Squamous Cell Carcinoma Antigen-1 Suppresses UV-induced Cell Death In Vivo and 
In Vitro
Hibino T, Katagiri C and Nakanishi J
Shiseido Life Science Research Center (Japan)
Recently we have demonstrated that serpin squamous cell carcinoma antigen 1 (SCCA1) plays 
a critical role in UV-induced apoptosis in human keratinocytes. This reaction was mediated via 
specifi c suppression of c-Jun N-terminal kinase-1 (JNK1). In the present study, we generated 
transgenic mice that overexpressed SCCA1 driven from the involucrin promoter and examined 
the effect of UV irradiation. In addition, we established various cell lines, in which SCCA1 was 
overexpressed or downregulated. Using these cell lines we further analyzed the roles of SCCA1 
in cell death and proliferation. 
 Since SCCA1 was strongly upregulated in the upper epidermis of sun-exposed skin, we gener-
ated involucrin promoter-driven SCCA1 transgenic mice. In order to obtain hairless phenotype, 
the involucrin-SCCA1 transgenic mice were crossed with HR-1 mice and SCCA1+/+ mice were 
obtained after three passages. Immunostaining of skin sections revealed strong expression of 
SCCA1 in the upper epidermis of the transgenic mice but not in the skin of wild HR-1 mice. 
When 200 mJ/cm2 of UV was irradiated twice on the back of mice, the epidermis of wild 
type mice was seriously damaged, showing spongiosis in the suprabasal layer. In contrast, the 
mutant mice demonstrated remarkable resistance against UV irradiation. We transfected hu-
man SCCA1 cDNA into 3T3/J2 cells and established 20 individual clones that stably express 
SCCA1. SCCA1-expressing clones showed a strong correlation between the expression levels 
and the suppression of UV-induced apoptosis. In SCCA knockdown HaCaT cells using siRNA, 
UV-induced apoptosis dramatically increased. Interestingly downregualtion of SCCA1 resulted 
in marked increase of phospho-c-Jun and UV irradiation further enhanced the levels of c-Jun 
phosphorylation. Our data suggest that the up-regulation of SCCA1 is enough to suppress UV-
induced apoptosis and reveal a novel UV protection mechanism in the human skin.
003 [021]
Functional Study of the Dermokine σ, an Intracellular Isoform Encoded by an Epidermal Gene 
with a Complex Splicing
Leclerc E, Jonca N, Toulza E, Gazeilles L, Serre G and Guerrin M
“Epidermal Differentiation and Rheumatoïd Autoimmunity”, UMR 5165 CNRS-Toulouse III 
University (France)
In order to better understand the molecular mechanism underlying the cohesion/desquama-
tion processes which are essential for the barrier function, we have analyzed the granular 
keratinocyte transcriptome. As part of this project, a new gene with unknown function, called 
dermokine, has been identifi ed. This gene undergoes numerous alternative splicings, leading 
to the production of four groups of proteins: α, β and γ are secreted isoforms with epidermis 
restricted expression, whereas the σ one is intracellular and ubiquitous.
To characterize further the dermokine σ function, we have carried out the screening of a cDNA 
keratinocyte library by a yeast two-hybrid system. We have thus identifi ed two potential part-
ners of the dermokine σ: Rab5, a member of the Ras-GTPases superfamily, involved in the early 
endocytic pathway, and Arfaptin-2 (or POR1) which interacts with the two Ras-GTPases, Rac 
and Arf, leading to activation of Rac signalling pathways. Another two-hybrid assay refi ned the 
interaction with the two partners through the N-terminal region of the dermokine sy
. Subsequently, we confi rmed the Rab5 / dermokine σ interaction in vitro by GST-pull down 
and their co-localisation in vivo will be analysed further. Moreover, Rab5 protein function is 
based on its nucleotide state, bound to GTP (active) or GDP (inactive). During this cycle, Rab5 
interacts with many regulator and effector proteins. Dermokine σ could thus be one of those 
proteins and it will be of interest to determine with which Rab5GTP or Rab5GDP it interacts.
This work leads us to assume a potential role for dermokine σ in the intracellular traffi c and 
in particular it may constitute a functional coupling between the Rab and Arf/Rac signalling 
pathways.
004 [022]
P120-catenin is a New Member of Desmosome to Recruit desmoglein3 (Dsg3) to Desmosomes 
by Binding to its Cytoplasmic Membrane-proximal Domain
Kanno M, Aoyama Y, Nagai M, Yamamoto Y and Kitajima Y
Department of dermatology, Gifu University School of Medicine (Japan)
p120-catenin (p120-ctn) is armadillo family protein, which binds to classical cadherins at 
the juxtata membrane domain (JMD) of cytoplasmic domain through its arm repeat domain. 
Recently several lines of evidence indicate that p120-ctn stabilizes cadherins and regulates 
the cell adhesion positively . We have already shown the association of endogeneous Dsg 1 
and 3 associated with p120ctn by immunoprecipitation study and the localization of p120-
ctn at desmosome by immuno-electron microscopy. To investigate the association manner of 
Dsg3 and p120-ctn, we constructed expression vectors containing Flag tagged mutant forms of 
mouse Dsg3 with increasing truncations eliminating various cytoplasmic subdomain from the 
carboxy-terminus, which is ∆ICS:AA1-810, AA1-761,∆IA:AA1-714, 1-641, respectively. These 
constructs and HA tagged mouse p120-ctn were co-transfected into HEK293 cell. Extracts 
were subjected to immunoprecipitation with anti-HA antibody. Recoverd p120-ctn contained 
all Dsg3 mutants but not 1-641. The result suggests that the cytoplasmic membrane-proximal 
domain including IA region (641-714AA) of Dsg3 is the binding site for p120-ctn. To confi rm 
the role of p120-ctn, we generated another mutant form of mouse Dsg3, ∆641-714. We deter-
mined the localization of these recombinant proteins in DJM-1 cells by immunofl uorescence. 
P120-ctn was found to co-localize with ∆ICS:AA1-810, AA1-761, ∆IA:AA1-714, but neither 
∆IA:AA1-641 nor AA641-714, immunocytochemicaly. Interestingly, ∆IA:AA1-641 and AA641-
714 which lack the cytoplasmic membrane-proximal region, were localized in the cytoplasm 
but not localized at the plasma membrane. These results suggest that p120-ctn can associate 
not only with classical cadherin, but also with desmosomal cadherin as a new member of 
desmosomal constituents, and that p120-ctn might be involved in stabilization of Dsg3 at the 
plasma membrane. 
005 [048]
Novel Targets for Cystatin M/E: A New Route in Epidermal Differentiation
Cheng T1, Hitomi K2, Ishida-Yamamoto A3, van Vlijmen-Willems IM1, de Jongh GJ1, Bergers M1, 
Schalkwijk J1 and Zeeuwen PL1
1Department of Dermatology, Radboud University Nijmegen Medical Centre (Netherlands)
2Department of Applied Molecular Biosciences, Nagoya University (Japan)
3Department of Dermatology, Asahikawa Medical College (Japan)
Cystatin M/E is a high affi nity inhibitor of the asparaginyl endopeptidase legumain. Although 
cystatin M/E also contains a predicted binding site for papain-like cysteine proteases, no high 
affi nity binding for any member of this family has been demonstrated so far. The present study 
aims on fi nding these unknown target proteins of cystatin M/E. Furthermore, we investigated 
the possible role of cystatin M/E and its physiological target proteases in epidermal differentia-
tion and desquamation. We report that human cathepsin V (CTSV) and human cathepsin L 
(CTSL) are strongly inhibited by human cystatin M/E. Kinetic studies show that Ki values of 
cystatin M/E for the interaction with CTSV and CTSL are 0.47 nM and 1.78 nM, respectively. 
Site-directed mutagenesis was used to identify the binding sites of cystatin M/E. We found that 
legumain and the papain-like cysteine proteases CTSV and CTSL are inhibited by two distinct 
non-overlapping sites. Localization studies in normal human skin show that cystatin M/E co-
localizes with CTSV and CTSL in the upper layers of the epidermis. Furthermore, we show that 
CTSL is the elusive enzyme that processes and activates epidermal transglutaminase 3, an en-
zyme responsible for crosslinking during epidermal cornifi cation. Compartmentalization stud-
ies using immunoelectron microscopy revealed that both cystatin M/E and CTSV are found in 
the extracellular space in the stratum corneum associated with corneodesmosomes, suggesting 
an important role for these molecules in epidermal desquamation. The identifi cation of CTSV 
and CTSL as novel targets for cystatin M/E, their co-expression in human skin, and the activity 
of CTSL towards transglutaminase 3, strongly implies an important role for these molecules in 
the differentiation process of human epidermis.
006 [049]
The activity of PI3K-Akt-mTOR Survival Pathway in Keratinocytes is Critically Dependent on 
the Integrity of Lipid Rafts in the Membrane 
Calay D and Gniadecki R
Department of Dermatology, Bispebjerg Hospital, University of Copenhagen (Denmark)
Lipid rafts are nanometer-large, cholesterol- and shingolipid-rich plasma membrane microdo-
mains, regulating signal transduction and protein traffi cking. Since our earlier work indicated 
that raft disruption caused cell death, we investigated here the involvement of these microdo-
mains in the regulation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway, which signals 
to a range of survival promoting enzymes, such as mTOR (mammalian target of rapamycin) 
and Forkhead family of transcription factor (FoxO). Raft disruption was achieved in normal 
human keratinocytes and HaCaT cell line by cholesterol extraction from the membrane with 
methyl-beta cyclodextrin or by replacement of membrane cholesterol with its oxidized deriva-
tive 5-cholestene 5-beta-ol, which destabilizes lipid domains. Lipid raft disruption caused an 
abrupt dephosphorylation of Akt at its two main activation sites (Thr 308 and Ser 473) within 5 
minutes, and subsequently reduced phosphorylation of its downstream target proteins, includ-
ing mTOR, the translation-regulating protein p70S6K and FoxO3a. Dephosphorylated FoxO3a 
was translocated to the nucleus. Lipid raft disruption did not affect PI3K binding to membrane 
growth factor receptors, but caused PI3K deactivation, probably by sequestering of the enzyme 
away from its substrate PIP2 in the rafts. As a consequence of Akt/mTOR inhibition, HaCaT 
keratinocytes initiated the macroautophagic programme and exhibited higher sensitivity to 
apoptosis-inducers TRAIL and FasL. This report highlights the importance of lipid rafts in the 
regulation of keratinocyte survival and may have implications for the understanding of epider-
mal carcinogenesis. Since Akt pathway is upregulated in most types of malignancies, lipid raft 
disruption may be an emerging strategy in anticancer treatment. 
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007 [050]
DNase1L2 Degrades Nuclear DNA During Corneocyte Formation
Fischer H1, Eckhart L1, Mildner M1, Jaeger K1, Buchberger M1, Ghannadan M1 and Tschachler E2
1Department of Dermatology, Medical University of Vienna (Austria)
2Department of Dermatology, Medical University of Vienna; CE.R.I.E.S. (Austria)
The removal of keratinocyte (KC) nuclear DNA by deoxyribonucleases (DNases) is an impor-
tant step in the formation of normal stratum corneum (SC). However, the molecular identity of 
the DNA degrading enzymes has so far remained elusive. Here we show that the endonucle-
ase DNase1-like 2 (DNase1L2) is preferentially expressed in epidermis and that its expression 
correlates with terminal differentiation of KC in vitro and in vivo. In biopsies of normal skin 
DNase1L2 mRNA was regularly found in suprabasal KC and DNase1L2 protein was highly 
abundant in the stratum granulosum. In contrast to normal skin, DNase1L2 expression was 
down-regulated in parakeratotic epidermis such as in psoriatic lesions. When DNase1L2 gene 
expression was knocked down by siRNA in a human skin equivalent model, nuclei were main-
tained through all layers of the stratum corneum. Taken together, our data demonstrate that 
DNase1L2 plays an essential role in DNA degradation during terminal differentiation of epi-
dermal KC.
008 [051]
In situ Identifi cation of Candidate Keratinocyte Stem Cells by Multi Epitope Ligand 
Kartography (MELK) Robot Technology
Böckelmann R1, Pommer AJ2, Philipsen L3, Schubert W4, Gollnick H1 and Bonnekoh B1
1Clinics for Dermatology & Venereology, Otto-von-Guericke-University Magdeburg (Germany)
2SkinSysTec GmbH, Magdeburg (Germany)
3MelTec GmbH & Co. KG, Magdeburg (Germany)
4Institute for Medical Neurobiology, Otto-von-Guericke-University Magdeburg (Germany)
As reported by others, candidate keratinocyte stem cells (KSC) are characterized by up-regula-
tion of beta1-integrin (CD29), alpha-integrins (CD49), cytokeratins 14, 15 and 19, hemopoietic 
progenitor cell antigen 1 (CD34), transcription factor p63, melanoma associated chondroitin 
sulphate, and thymus cell antigen 1 (CD90). Moreover KSC are assumed to show down-regula-
tion of the transferrin receptor (CD71), cytokeratins 10 and 18, psoriasis-associated fatty acid 
binding protein, with negativity for transglutaminase 1, desmoglein 3, involucrin, and Ki67. 
However, it has not so far been possible to identify cells defi ned by such a complex marker 
combination in situ and to map their distribution in a single skin tissue section.
We hereby demonstrate in a series of proof-of-principle experiments that candidate KSC may 
be readily identifi ed by Multi Epitope Ligand Kartography (MELK) robot technology. This in-
novative methodology relies on a core process comprising an iterative sequel of I) incubation 
of a skin tissue section with fl uorochrome-tagged antibodies II) fl uorescence imaging and III) 
fl uorescence bleaching. Biomathematical postprocessing allows pixel-precise overlay of cor-
responding images in order to generate so-called epitope co-location maps.
Using this approach we analyzed the occurrence of candidate KSC of the phenotype Ki67-/
CD71-/pan-cytokeratin+/CD29+/CD49d+ in biopsies from involved skin of psoriasis and at-
opic dermatitis as compared to healthy control skin. Under these conditions the number of KSC 
was signifi cantly reduced in psoriasis (11±7% of basal epidermal cells) and somewhat reduced 
in atopic dermatitis (24±12%) compared to healthy controls (34±7%). Thus, the keratinocyte 
hyperproliferation in psoriasis is accompanied by a reduced number of resting KSC. 
Overall, we hereby present a novel strategy for the future identifi cation of distinct cell types 
characterized by a combinatorial variety of epitopes, such as rare epidermal stem cells in skin 
sections, by advanced MELK robot technology.
009 [052]
Proteomic Characterization of the Lamellar Bodies by High-throughput Mass Spectrometry
Raymond AA1, Gonzalez De Peredo A2, Stella A2, Serre G1, Monsarrat B2 and Simon M1
1UMR 5165 CNRS - University of Toulouse III (France)
2Institut de Pharmacologie et de Biologie Structurale, UMR 5089 CNRS-University of Toulouse 
III (France)
 
Tubulo-vesicular structures, called lamellar bodies (LB) or keratinosomes are present in the 
cytoplasm of granular keratinocytes and play a major role in stratum corneum homeostasis, 
secreting their content at the stratum granulosum/stratum corneum interface.
We describe the fi rst systematic characterization of the proteome of a fraction enriched in LB, 
obtained from human epidermis using sub-cellular fractionation, density gradient sedimenta-
tion and fi ltration. Both soluble (S100 supernatant) and LB-enriched fractions were analyzed 
by mass spectrometry: 100μg of proteins from each sample were separated by mono-dimen-
sional electrophoresis, the entire gel lanes were cut into a series of bands, proteins were in-gel 
digested with trypsin and characterized by nanoLC-MS/MS. 
From the S100 fraction we identifi ed 740 proteins, more than half being known to be cytosolu-
ble. From the LB-enriched fraction, we identifi ed 601 proteins among which several markers of 
these organelles such as beta-glucocerebrosidase and acid ceramidase. Almost half of the 601 
proteins were specifi c of the LB fraction. A few of them corresponded to mitochondria (3%), 
endosomes (<1%) and peroxysomes (<1%). From the 601 proteins, 459 had a gene ontology 
annotation for cellular component, and 65 were purely hypothetical. Among the annotated 
proteins, 75 (14%) were assigned as integral membrane proteins and several are known to be 
involved in vesicular traffi cking. A dozen of lysosomal proteins were identifi ed further support-
ing a close relationship between lysosomes and LB. We then separated 200μg of LB proteins on 
a longer gel, which was cut in a higher number of bands, and were able to identify more than 
1500 proteins which are currently analyzed.
This analysis evidences nanoLC-MS/MS associated with mono-dimensional separation as a 
powerful method for identifying proteins in a complex mixture. This approach will allow char-
acterizing constitutive proteins of LB, to understand their genesis and traffi cking. 
010 [054]
Regulation Of Epidermal Proliferation And Wound Re-epithelialization By Syndecan-1 And 
CASK
Ojeh N1, Hiilesvuo K2, Salmivirta M2, Henttinen T2, Jahoda C1, Maatta A1
1School of Biological and Biomedical Sciences, University of Durham (United Kingdom)
2Centre for Biotechnology, University of Turku (Finland)
Syndecan-1 (Sdc1) is a cell surface heparan-sulphate proteoglycan that is strongly expressed 
in suprabasal keratinocytes and transiently up-regulated in all layers of the epidermis during 
wound healing. To address the role of Sdc1 in the regulation of keratinocyte proliferation and 
differentiation, we generated transgenic mice that over-express syndecan-1 in the stem and 
transit amplifying keratinocyte populations. To this end, we used K14 keratin promoter to drive 
the transgene expression in the basal cell layer of the epidermis. We observed epidermal hy-
perproliferation in newborn transgenic mice in two independent transgenic lines as evidenced 
by increased number of suprabasal cell layers, by increased number of PCNA positive nuclei 
in the basal and suprabasal cell layers and by expression of keratin 6 in the interfollicular 
epidermis. Notably, the transgene expression interfered with skin wound healing by decreasing 
epidermal thickness and cell proliferation in the re-epithelialised epidermis at day 7 of wound 
healing. We observed re-epithelialisation defect also in syndecan-1 null animals, although the 
phenotype was not as severe as in the Sdc1 over-expressing transgenic mice. To study the role 
of cytoplasmic proteins interacting with syndecans during epidermal differentiation, we have, 
furthermore, investigated the expression and subcellular localization of CASK during keratino-
cyte differentiation, hair follicle development and wound healing. We have found that CASK 
protein is frequently located in the nucleus during hair follicle development and lost from 
nuclei of differentiating keratinocytes. In summary, Sdc1 can regulate keratinocyte proliferation 
differentially during skin development and wound healing. Moreover, CASK, a PDZ protein 
interacting with syndecans is a translocated to nucleus in defi ned epidermal cell populations.
011
Study Of The In Vitro Effects Of Lithium On Normal And Stimulated Keratinocytes
Ballanger F1, Tenaud I2, Quereux G3, Brocard A3, Khammari A3 and Dreno B3
1Inserm U601, Nantes (France)
2UTCG, Nantes (France)
3Clinique Dermatologique, Nantes (France)
In contrast to oral lithium used in psychiatry, topical lithium gluconate has a benefi cal effect in 
seborrhoeic dermatitis (SD). SD is an infl ammatory dermatitis associated with excessive prolif-
eration of a lipophilic yeast: Malassezia Furfur (MF), which may have an immunogenic action. 
However, the exact mechanism of action of lithium gluconate in SD still remains unknown.The 
aim of the study was to investigate lithium (Li)-induced modulation on proliferation, differen-
tiation, cytokines production and Toll-like receptor (TLR)2 and 4 expression by unstimulated 
and stimulated keratinocytes.Two differents skin models were used : cultured keratinocytes 
in monolayer and explants. In some of them, infl ammation was induced with LPS (1μg/ml) 
or zymosan (2mg/ml). Then skin models were incubated with Li gluconate (Labcatal*, Mon-
trouge, France) at 3 different concentrations (1,6 ;3 ;5mM) determined according to viability 
MTT test. Expression of Ki67, Keratine 10, Filaggrine, TNFα, IL6, IL8, IL10, TGFβ, TLR2, TLR4 
was detected by immunohistochemistry (IHC). Cytokines were quantifi ed by Elisa methods. 
Detection of proliferating cells by Ki67 IHC showed a dependent-dose decreasing of prolifera-
tion in keratinocyte monolayer. On skin explants, there was increased number of Ki67 positive 
keratinocytes with Li 1,6mM. Concerning differentiation markers, Li 5mM was associated with 
enhancement of K10 expression in keratinocytes monolayer and extension to spinous layer 
of fi laggrin expression in explants. Li 5mM signifi cantly enhanced TNF and IL10 production 
by unstimulated and stimulated keratinocytes. Li down regulated TLR2 and TLR4 expression 
especially on zymosan-stimulated keratinocytes. To our knowledge, this is the fi rst study con-
cerning Li effect on proliferation, differentiation and cytokines production by unstimulated and 
stimulated keratinocytes. The experimental model of zymosan-induced infl ammation has never 
been used on keratinocytes before. Li 5mM down regulates keratinocyte proliferation, induces 
differentiation, enhances expression and production of IL10 and TNFα by stimulated keratino-
cytes. Li down regulates TLR2 expression which is required for cell response to MF.
These results suggest that lithium has signifi cant immunomodulatory effect. Topical Li may 
restore cutaneous desequilibrium in DS probably due to MF.
012
Gene-specifi c Silencing Experiments In HaCat Keratinocytes Reveal A Functional Redundancy 
Among The Different Subtypes Of D Type Cyclins During Cell Cycle Regulation
Belso; N, Széll M, Kohajda M, Dobozy A, Kemény L and Bata-Csörgo Zs
Department of Dermatology and Allergology, University of Szeged (Hungary)
Previously we have shown that the G0 phase of the cell cycle can be characterized with the ap-
pearance of cyclin D1, while during the rapid proliferation (G1/S phase) of cells cyclin D2 and 
D3 dominate in HaCaT keratinocytes. To address the function(s) and possible redundancy of D-
type cyclins in cell proliferation, we used an RNA interference method in HaCaT keratinocytes. 
Real-time RT-PCR results revealed a successful silencing for D1 (n=2) and D3 (n=2) cyclins. 
Morphological and proliferation changes of the D1 and D3 silenced HaCaT keratinocytes were 
detected by microscopy and by MTT assay, respectively. The morphology and the prolifera-
tion of the cells showed no difference within the 96-hour period following the transfection. 
Further real-time RT-PCR experiments revealed no expression changes in cyclin D2 and D3 
mRNA expression in the D1-silenced HaCaT keratinocytes, cyclin D2 mRNA was substantially 
up-regulated, while cyclin D1 was not in the D3-silenced cells. Our results suggest a functional 
redundancy among the different subtypes of D cyclins during cell cycle regulation.
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013
CYP450 and GST are Induced by Xenobiotics in Normal Human Keratinocytes and Play a 
Different Role in UVB-Mediated Apoptosis.
Benassi L, Magnoni C, Bertazzoni G, Giudice S, Gualdi G, Bernardi C, Seidenari S and 
Giannetti A
Department of Dermatology, University of Modena and Reggio Emilia (Italy)
Skin enzymatic detoxifi cation systems may provide a barrier for protection against the external 
environment. UVB is the major cause for cutaneous malignancies in the human population. 
The skin is able to activate anti-oxidants and enzymatic detoxifi cation reactions to neutralize 
reactive photochemical products. Very little is known about the behaviour of cutaneous me-
tabolizing enzymes after ultraviolet B exposure. 
In the fi rst part of the present study we analysed the induction and expression of cytocrome 
P450 (CYP450) phase I and gluthatione S transferase (GST) phase II enzymes in normal human 
keratinocytes in culture after exposure to classical inducers such as: β-naphthofl avone (BNF), 
3-methylcholanthrene (MC), phenobarbital (PB) and also to ultraviolet B (UVB) radiation. Phase 
I enzymes (CYP450 1A1, 1A2, 1B2 and 2B1, 2B2) were investigated through 7-ethoxyresorufìn 
O-deethylase (EROD) and 7-pentoxyresorufìn O-depenthylase activities (PROD), while GST 
was analysed throught the coniugation of 1-chloro-2,4 dinitrobenzene with reduced glutha-
tione.
MC, BNF and UVB exposures resulted in a dose-dependent and time dependent induction 
of CYP450 confi rmed by immunoblotting assay. GST was induced by PB and inhibited by 
UVB. According to these results in the second part of this study we analysed the role of these 
enzymes in UVB induced apoptotic process. Apoptosis is a key mechanism in the cellular 
homeostasis and can be triggered by exogenous insults and in particular by genotoxic agents. 
The exact function of these enzymes in carcinogenesis remains unclear.
Western blot analysis of Bcl2 expression showed that inhibition of CYP450 prevented UVB 
induced apoptotic cell death. On the contrary inhibition of GST, by ethacrynic acid, showed to 
improve UVB induced apoptosis.
These experimental fìndings stress the value that CYP450 and GST enzymes may play an im-
portant role in keratinocytes apoptosis.
014
Survivin Identifi es Keratinocyte Stem Cells And It Is Down-regulated By Anti β1 Integrin 
During Anoikis
Dallaglio K1, Lotti R1, Marconi A1, Truzzi F,1 Dumas M2, Bonté F2 and Pincelli C1
1Department of Dermatology, University of Modena and Reggio Emilia (Italy)
2LVMH Recherche, Saint Jean de Braye (France)
Survivin belongs to the family of inhibitor of apoptosis proteins (IAP) and it is involved in regu-
lation of cell death as well as cell division. We have shown previously that survivin is expressed 
in the basal layer of adult normal human epidermis. Here we show that survivin is expressed in 
a subpopulation of basal keratinocytes in normal human skin, at the cytoplasmic level. Survivin 
is highly expressed in keratinocyte stem cells (KSC), while its mRNA level decreases in transit 
amplifying (TA) cells and disappears in postmitotic (PM) cells. Similarly, survivin protein is ex-
pressed in KSC, almost undetectable in TA and absent in PM cells. Real Time PCR demonstrates 
that the putative anti-apoptotic isoforms survivin-2B and survivin-∆Ex3 are expressed at highest 
levels in KSC, while they tend to decrease in TA cells and disappear in PM. On the contrary, 
the putative pro-apoptotic variants of survivin, survivin-3B and survivin-2β tend to be high in 
PM and TA and almost absent in KSC. By confocal microscopy, survivin is predominantly ex-
pressed at the nuclear level in KSC, that proliferate signifi cantly better than TA, which, in turn, 
express mostly cytosolic survivin. Blocking β1 integrin signal down-regulates survivin mRNA 
and protein expression and induces apoptosis (anoikis) in KSC, indicating that the anti-apop-
totic function of survivin involved in the survival signal mediated by integrins. On the other 
hand, inhibition of β1 integrin up-regulates mRNA expression of survivin-2β. While psoriasis 
is characterized by a reduced rate of apoptosis, survivin is expressed throughout the epidermal 
layers. Taken together, these results indicate that survivin identifi es human KSC. Expression of 
nuclear survivin could refl ect the different behavior between KSC in vitro and in vivo, in terms 
of proliferation. 
015
Control of Glycolysis in Keratinocytes, A New Aspect of Epidermal Growth and Differentiation
De Potter IY1, Rathman-Josserand M2, Breton M2 and Hue L1
1Hormones And Metabolic Research Unit, Institute Of Cellular Pathology, Brussels (Belgium)
2L’Oréal Recherche (France)
The high anaerobic glycolytic rate of proliferating cells results from the increased activity of the 
fi rst control steps in this pathway. A characteristic feature of the skin is the proliferative state 
of keratinocytes. In these cells, the rate of glycolysis is correlated with the state of prolifera-
tion-differentiation. In the present work we studied how glycolysis is controlled in a model of 
autocrine cultured human keratinocytes. In this model, proliferating keratinocytes underwent 
the differentiation process within 10 days of culture. We confi rmed that, in both proliferative 
and differentiated keratinocytes, glycolysis remained anaerobic, with 2 lactate produced per 
glucose consumed. However, glucose uptake and glycolysis decreased 3-4 fold during this 
process. The decrease correlated with the expression of differentiation markers (keratin 10 and 
transglutaminase-1). To explain these quantitative changes we analyzed the control steps of 
glycolysis, namely glucose transport and phosphorylation, and the phosphofructokinase and 
pyruvate kinase steps. We fi rst studied the expression of glucose transporters (GLUT). Glucose 
transport across the plasma membrane depends on the type of GLUT expressed at the cell 
surface. In normal human epidermis, GLUT1 is mainly expressed in non-differentiated kerati-
nocytes of the basal layer, whereas GLUT2 expression increases with differentiation. A similar 
pattern was observed in cultured keratinocytes and correlated with the kinetics of glucose 
uptake. The concentration of fructose-2,6-bisphosphate, the most potent activator of PFK, was 
more than 10-fold higher in proliferating than in differentiated cells. There was no change in the 
activity of hexokinase and pyruvate kinase. These results suggest that GLUT1 and fructose-2,6-
bisphosphate are the main control steps of glycolysis in keratinocytes. Finally, we studied the 
possible links between glycolysis and proliferation/differentiation states. Keratinocytes treated 
for 3 days with 0.01-1 micromolar retinoic acid displayed a downregulation of differentiation, 
as evidenced by a decreased expression of keratin 10, and a doubling of a glycolytic rate. This 
illustrates the inverse relationship between glycolysis and differentiation.
016
Physiological LEKTI Fragments Inhibit Epidermal Kallikreins
Deraison C1, Bonnart C2, Lopez F3, Besson C1, Robinson R4, Jayakumar A5, Wagberg F6, Hachem 
JP7, Bratssand M8 and Hovnanian A9
1INSERM, U.563, Toulouse (France)
2INSERM, U.563, Univ Paul-Sabatier, Toulouse (France) 3IFR31, INSERM, Toulouse (France)
4Wellcome Trust Centre for Human Genetics, Oxford (United Kingdom)
5Department of Head and Neck surgery, Houston (USA)
6Arexis AB, Gothenburg (Sweden) 7Vrije Universiteit, Brussels (Belgium)
8Dermatology and Venereology, Umea (Sweden)
9INSERM, U.563, Department of Medical Genetics, Purpan Hospital, Toulouse (France)
LEKTI is a 15-domain (D1-D15) serine protease inhibitor that is defective in the severe auto-
somal recessive ichthyosiform skin condition, Netherton syndrome (NS). Secretion of LEKTI 
fragments follows the rapid cleavage of pro-LEKTI by proprotein convertases. Using transfection 
of CHO and furin-defi cient CHO cells with a LEKTI cDNA, we demonstrate a key role of furin 
in pro-LEKTI processing. This is consistent with colocalization of LEKTI and furin in the granu-
lar layer of the epidermis. Subsets of LEKTI proteolytic fragments sharing a similar molecular 
weight, ranging from 10 to 65 kDa, were detected in the conditioned medium of transfected 
CHO cells and human keratinocytes, as well as in human epidermis. Consequently, these prob-
ably correspond to biologically active LEKTI domains. We identifi ed a new proteolytic cleavage 
site by directed mutagenesis between D8 and D9. Several LEKTI fragments were produced in 
heterologous systems: D1, D5, D6, D8-D11, D9-D15. Their inhibitory activity was determined 
against a large panel of serine proteinases involved in skin desquamation and infl ammation. 
D8-D11 showed the most potent inhibitory activity, with a Ki < 10 nM for kallikreins hK5 and 
hK14. The kinetics of the interaction between D8-D11 and hK5 revealed a rapid and irrevers-
ible inhibition (kD = 1.1x10-12 M). In contrast, D5, D6 and D9-D15 were less potent inhibitors 
of hK5 (30 nM < Ki < 120 nM). D5 and D8-D11 but not D9-D15 inhibited hK7 with a Ki of 60 
nM. This inhibition profi le of LEKTI fragments confi rms that LEKTI is a key regulator of enzymes 
involved in desquamation (hK5, hK7 and hK14). Our results demonstrate the high specifi city 





Nanoscale BIAcore Fishing for Desmosealin
Duhieu S1, Le Bitoux MA2, Estève JP3, Monsarrat B4 and Haftek M2
11Université Lyon 1, EA3732,Laboratoire de Dermatologie, Hôpital E. Herriot, Lyon (France)
2Laboratoire de Dermatologie, Hôpital E. Herriot, Lyon (France)
3INSERM U.531, Toulouse (France)
4Institut de Pharmacologie et de Biologie Structurale, CNRS, Toulouse (France)
Desmosealin is a chondroitin sulfate proteoglycan expressed in the stratifying epithelia, includ-
ing human epidermis. We have previously reported its incorporation into desmosome cores 
in a manner dependent on the degree of keratinocyte differentiation. The presence of such a 
highly glycosylated molecule in the extracellular spaces of desmosomes may be of functional 
importance, especially in regard of the protection against endogenous proteolysis.
The KM48 monoclonal antibody used for desmosealin detection is a mouse IgM which does 
not allow effi cient immunoprecipitation or screening of cDNA libraries. Therefore, we have 
used a “ligand fi shing” approach with plasmon surface resonance (BIAcore) followed by micro-
recovery and mass spectrometry in an attempt to defi nitely characterize the antigen.
The antibody could be successfully grafted onto activated dextran CM5 microchips and al-
lowed for immobilisation followed by elution of approximately 600 RU of the antigen applied 
in a proteinaceous extract of normal human epidermis. Pooled microrecovery samples were 
digested with trypsin and analysed with QSTAR mass spectrometer. Among the recognizable 
mass spectrometry profi les, only one peptide belonged to a proteoglycan: the invariable por-
tion of CD44. The calculated molecular mass of the v3-10 form of CD44 (72 kDa) is compat-
ible with the one observed on Western blots of the entirely deglycosylated epidermal extracts 
detected with KM48 antibody. Further experiments focused on this chondroitin sulphate prote-
oglycan variant should allow us to confi rm the identity of desmosealin.
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Role Of Glycogen Synthase Kinase 3β In Regulating Keratinocyte Proliferation And Lithium-
provoked Psoriasis
Hampton PJ, Parker G and Reynolds NJ
Dermatological Sciences, University of Newcastle Upon Tyne (United Kingdom)
The aim of this study was to investigate the molecular signalling pathways underlying lithium-
provoked psoriasis. Lithium is used to treat bipolar disorder and is known to induce or ex-
acerbate psoriasis. Lithium does not exacerbate other T cell mediated chronic infl ammatory 
diseases such as rheumatoid arthritis or ulcerative colitis. Lithium inhibits glycogen synthase 
kinase 3β (GSK-3β) at therapeutically relevant concentrations. GSK-3β is a constitutively ac-
tive kinase which negatively regulates cell proliferation both directly via phosphorylation of 
cyclins and also indirectly via phosphorylation of transcription factors such as β-catenin. We 
hypothesised that lithium may induce keratinocyte proliferation via inhibition of GSK-3β. We 
used immunohistochemistry to confi rm expression of GSK-3β in normal skin and in involved 
and uninvolved psoriatic epidermis (n=6). Using sulphorhodamine B (SRB) assays, we found 
that lithium induced a 2 fold increase in keratinocyte proliferation at 7 days (n=6) at therapeu-
tic doses (1-2mM). Flow cytometry studies showed an increase in cells in S-phase following 
treatment with lithium (mean % cells in S phase: control 34.8%, 2mM lithium 50.4%, n=3, 
p=0.045). By western blotting, lithium (2, 5 and 10mM) induced increased phosphorylation of 
GSK-3β at ser-9, the inhibitory phosphorylation site of GSK-3β, indicating that lithium inhibits 
GSK-3β in keratinocytes. The GSK-3β binding protein (GSKBP) inhibits GSK-3β activity. We 
made a retroviral GFP-GSKBP vector and showed that over expression of GSKBP increased 
proliferation of SV-k14 keratinocytes by 40% (p<0.005), compared with transduction with 
empty vector, as assessed by SRB assay at 7 days. We also showed that the pharmacological 
GSK-3β inhibitor 6-bromoindirubin-3’-oxime (BIO) (0.5, 5, 50 nM) induced a dose dependent 
increase in proliferation of SV-k14 keratinocytes (n=3x6 per dose, p<0.005) as assessed by 
SRB assay at 7 days. In summary, both lithium and inhibition of GSK-3β induced proliferation 
of keratinocytes suggesting that GSK-3β may be an important enzyme involved in lithium-
induced psoriasis.
020
Real-time Measurement Of Oxidative Species Release After Stress On A Single Keratinocyte 
With A Microelectrode
Tapsoba I1, Moreau M2, Heusèle C2, Lachmann-Weber N2, Amatore C1, Nizard C2 and
Arbault S1
1ENS, UMR CNRS-ENS-UPMC 8640 “PASTEUR”, Département de Chimie, Paris (France)
2LVMH-Recherche. Département Sciences du Vivant, St Jean de Braye (France)
Biological damages created by stress are mainly mediated through free radical reaction and 
reactive species production. We previously developed a method for the quantifi cation of each 
reactive species released by a single cell after stress. Using a modifi ed microelectrode (10 μm 
tip diameter) the amount of superoxide and nitric oxide derivatives (H2O2, ONOO-, NO2-, ...), 
is detected in the atto- to femtomolar range at the vicinity of a single cell in culture. Previous 
work demonstrated that the release of oxidative bursts by single skin fi broblasts was easily in-
ducible by a mechanical depolarization of their cell membrane with a microcapillary. Involve-
ment of NADPHoxidase and constitutive NOsynthase (NOS-III) was also shown.
Using this sensitive electrochemical method, we quantifi ed the amount of reactive species 
(H2O2, ONOO-, NO2- and NO°) produced by HaCaT cells. The environment of the cell was 
shown to affect the kinetic of the species release. Particularly a longer duration of NO deriva-
tive species was observed when the stressed cell was in contact with others HaCaT cells show-
ing the putative role of cell-cell interactions for the oxidative stress into the tissue. Pre-irradia-
tion of the cells with UVA (2J/cm2) and UVB (0,01J/cm2) was also shown to strongly increase 
the mechanically induced oxidative bursts 24 to 72 h after irradiation. 
This electrochemical technique will allow us to investigate quantitatively and qualitatively at 
the single keratinocyte level the effect of protective molecules on reactive species production. 
021
Distinct Intracellular Transport For Three Epidermal Lamellar Granule Molecules: Lekti, 
Cathepsin D, and Glucosylceramide
Ishida-Yamamoto A, Kishibe M, Mizukoshi K and Iizuka H
Department of Dermatology, Asahikawa Medical College (Japan)
Epidermal lamellar granules (LGs) contain various molecules, including lipids, proteases, and 
protease inhibitors, whose transport mechanisms are not well understood. We compared the 
localization of three LG molecules, LEKTI (lymphoepithelial Kazal-type related inhibitor), 
cathepsin D, and glucosylceramide (GlcCer), in epidermal equivalents and cultured keratino-
cytes. The three components reacted differently to monensin, an ionophore known to interfere 
with the transport of secretory products. On immunofl uorescence microscopy of the epidermal 
equivalents, all three molecules were detected in differentiated keratinocytes; cathepsin D was 
also found in basal cells. Staining was concentrated on the apical side of the cells. Immuno-
electron microscopy showed that, LGs containing the three components were well developed 
and secreted the contents into the extracellular space, as in normal epidermis. After 1 hour of 
incubation with monensin (10-20 μM), the Golgi-apparatus was swollen; the LGs were still 
detectable; LEKTI staining proximal to the nuclei became stronger; and there were no changes 
in cathepsin D and GlcCer staining. After 24 hours of incubation with monensin, LGs were 
severely vacuolated; LEKTI and GlcCer staining was found in the cytoplasm; and there was no 
apical accumulation. Cathepsin D staining was lost in differentiated cells, but was retained in 
basal cells. In the cultured keratinocytes that were induced to differentiate, a reticular pattern 
of LEKTI colocalizing with a trans-Golgi network marker, TGN46, was noted. In cultured kerati-
nocytes, after 1 hour of incubation with monensin, both LEKTI and TGN46 staining developed 
a peri-nuclear fi brillar pattern, and GlcCer and cathepsin D staining showed a coarse granular 
pattern that was distinct from that of LEKTI staining and was not changed by incubation with 
monensin. The different expression patterns and sensitivities to monensin suggest that there are 
distinct transport mechanisms for each LG molecule.
022
Zinc Gluconate Inhibits Toll-like Receptor 2 Expression Induced By Propionibacterium Acnes 
Extracts
Jarrousse V1, Castex-Rizzi N2, Khammari A3, Charveron M2 and Dreno B3
1Inserm U601, Nantes (France)
2Pierre Fabre, Toulouse (France)
3Clinique Dermatologique, Nantes (France)
Acne vulgaris is a skin disorder of the pilosebaceous follicles. Propionibacterium acnes 
(P.acnes) plays an important role in the pathogenesis of acne and it is now well established 
that P.acnes is involved in the induction and maintenance of the infl ammatory phase of acne. 
Zinc salts have a benefi cial effect in mild to moderate infl ammatory acne lesions. The precise 
mechanism that induces the development and progression of acne and the mechanisms by 
which zinc salts act on infl ammatory are still partially known. Activation of Toll-like Receptors 
(TLRs) leads to NF-κB translocation and production of infl ammatory cytokines (Interleukine 
(IL)-8). The aim of this work was to determine if benefi cial zinc effect on infl ammatory le-
sions in acne is related to an inhibition of TLR2 expression by keratinocytes by zinc. We have 
investigated by immunohistochemistry (TLR2), by ELISA (IL8) and by Western-blot (NF-κB) the 
effects of zinc gluconate capsule (Rubozinc®, Labcatal) on cutaneous explants incubated with 
P.acnes extracts (Pierre Fabre, Toulouse, France). Recently we have shown that P.acnes is able 
to stimulate TLR2 expression by keratinocytes in the presence of three different bacterial ex-
tracts (membrane fractions: FM, surpernatant A: SA and B: SB). After incubation (3h) with zinc 
gluconate (1μg/ml), the expression of TLR2 induced by FM fractions was signifi cantly lower 
than control expression on normal skin. Using our infl ammatory model, we observed by ELISA 
that zinc had no effect on IL-8 secretion by keratinocytes and by western-blot that zinc had no 
effect on NF-κB expression after stimulation by P.acnes extract. It has been previously shown 
that TLR2 activation by P.acnes triggers NF-κB activation and IL8 secretion. We have shown 
that anti-infl ammatory effect observed with zinc could be partially explained by TLR2 inhibi-
tion. Thus this effect does not seems not to be mediated by a modulation of IL-8 secretion or 
modifi cations of NF-κB expression. Further investigations are necessary to determine if NF-κB 
activation is modulated by zinc gluconate.
023
TLR9 is Not Expressed Constitutively But Is Inducible In Murine Keratinocytes
Panzer R, Proksch E and Jensen JM
Department of Dermatology, University of Kiel (Germany)
Human keratinocytes constitutively express various members of the toll-like receptor (TLR) 
family, which are important for innate immunity. TLR9 is known to recognize unmethylated 
CpG motifs which are very frequently found in bacterial DNA. TLR9 expression differs signifi -
cantly in human and murine tissues. We investigated murine TLR9 mRNA expression in vitro in 
PAM212 cell line and primary keratinocytes and in vivo in SKH1 mice using realtime PCR with 
intron spanning primers verifi ed by subsequent gel electrophoresis. Expression of human TLR9 
in HaCaT cells and human primary keratinocytes served as control. In addition we analyzed 
the infl uence of potential stimuli, particularly interferon-beta and in vivo epidermal barrier dis-
ruption, on murine TLR9 expression. HaCaT cells and human primary keratinocytes expressed 
TLR9 constitutively. In contrast, TLR9 expression was not consistently found in PAM212 cell 
line, murine primary keratinocytes, or mouse epidermis. However, TLR9 expression was found 
in some murine cell lines, suggesting that the expression may be inducible. However, stimuli 
effective in human systems like interferon-beta did not stimulate murine TLR9 and permeability 
barrier disruption was also not successful. Keratinocyte TLR9 expression was signifi cantly lower 
than in murine spleen or brain tissue in vivo, which served as control. In summary, we found 
that TLR9 is not constitutively expressed in murine keratinocytes in contrast to human kerati-
nocytes. The expression of TLR9 in murine keratinocytes is inducible, but an inductor of TLR9 
expression has not yet been identifi ed.
024
A Novel 3D-Organotypic Mouse Model To Study The Role Of Connexins In Epidermal 
Organisation
Kandyba E, Hodgins MB and Martin PE
Dept of Biological & Biomedical Sciences, Glasgow Caledonian University (United Kingdom)
At least 5 Connexin subtypes, the constituent proteins of gap junctions, are differentially ex-
pressed within normal epidermis and are believed to be critical for the coordination of cellular 
behaviour and activity. Although evidence exists that gap junctional intercellular communica-
tion has an important role in the coordination of cellular events leading to the formation of a 
fully stratifi ed epidermis, the exact function of specifi c connexins during keratinocyte migra-
tion, proliferation and differentiation has yet to be determined.
In vitro models of epidermal morphogenesis have been largely based on conventional 2D 
cultures, however these systems lack the cellular interactions found within an intact complex 
tissue environment. 3D-organotypic in vitro skin models permit valuable investigations into ep-
idermal differentiation events but there presently lacks a robust murine organotypic model. We 
have optimised the isolation and culture of primary mouse keratinocytes from perinatal mice 
and have developed a novel and robust Transwell in vitro organotypic skin model. Once raised 
to the air-liquid interface, in the presence or absence of dermal fi broblasts, these cells are 
induced to stratify and differentiate. The transparent nature of the semi permeable membranes 
permits visualisation of the complex 3D multilayered regions by dual immunofl uorescent la-
belling with proliferation and differentiation markers by whole mount laser scanning confocal 
microscopy, negating the need for standard histology procedures. The tissue architecture pos-
sesses morphological and differentiation characteristics typical of those observed in vivo.
The connexin expression profi les and gap junctional permeability properties of these cultures 
have been characterised via dual label immunofl uorescence and dye transfer studies using a 
variety of low molecular weight gap junction permeable tracers. This novel Transwell organo-
typic mouse skin model provides an excellent system to probe the role different connexins play 
in epidermal organisation.
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RUNX1 Transcription Factor Is Involved In The Regulation Of Keratinocyte Proliferation And 
Differentiation In Human Epidermis
Lamartine J1, Chaligné R2, Gaudry M3 and Martin M2
1Centre de Génétique Moléculaire et Cellulaire, CNRS UMR 5534, Université Claude Bernard 
Lyon I (France)
2CEA, Service de Génomique Fonctionnelle. Evry (France)
3Institut Cochin, Département d’hématologie, Paris (France)
RUNX1 transcription factor is involved in the regulation of keratinocytes proliferation and dif-
ferentiation in human epidermis.
RUNX1 is a member of the Runt/Runx family of transcription factors, a particular group of 
proteins important for the regulation of cell proliferation and differentiation in various tissues. 
RUNX1 is well known as a key regulator of haematopoiesis and neurogenesis, but its role in 
epidermal homeostasis has never been investigated. The main purpose of the present work 
was to identify the expression pattern of RUNX1 in epidermis, and to study the functional 
consequences of RUNX1 silencing in cultured keratinocytes. Expression study was done using 
real-time PCR and immunohistochemistry. The silencing of RUNX1 was obtained by transient 
siRNA or stable lentiviral shRNA transfection in primary human keratinocytes.
We observed that RUNX1 transcript is strongly expressed both in proliferating and differenti-
ated cultured keratinocytes. Theses results were confi rmed at the protein level in skin sections: 
RUNX1 expression is restricted to the basal and granular layers of human epidermis. RUNX1 
down-regulation by siRNA transfection in cycling keratinocytes leads to an increase of cell 
number 48h after transfection with an induction of proliferation markers (PCNA, Cdc2). In sub-
confl uent keratinocytes, after RUNX1 silencing by lentiviral shRNA transfection, we observed a 
particular phenotype of small, immature keratinocytes, exhibiting a potential of sub-cultivation 
up to passage 7 whereas control cells are cultured only to up passage 5. This undifferentiated 
phenotype was confi rmed by an induction of basal markers (KRT5, KRT14) and a repression 
of differentiation markers (involucrin, KRT10). Altogether, these preliminary results indicate 
that RUNX1 acts as a negative regulator of cell proliferation in cycling keratinocytes and as a 
positive regulator of cell differentiation in quiescent sub-confl uent keratinocytes. RUNX1 could 
therefore be involved in the control of the switch between proliferation and differentiation in 
basal keratinocytes.
026
Disruption of keratinocytes’ lipid rafts causes p38-dependent actin cytoskeleton remodelling
Lambert S, Hérin M and Poumay Y
Department of Medecine, University of Namur (Belgium)
The keratinocyte is the major cell type in the epidermis. Keratinocyte-keratinocyte interac-
tions as well as keratinocyte-basal membrane interactions are due to several kinds of junc-
tions whose regulation is important during keratinocyte migration leading to the renewal of 
the epidermis. It has been shown that the plasma membrane of different cell types includ-
ing keratinocytes contains large aggregates of lipid rafts, which are microdomains enriched in 
cholesterol known to contain receptors such as the EGF receptor (EGFR) but also anchoring 
protein like the integrin α6β4. Cholesterol depletion by methyl-β-cyclodextrin (MβCD) disor-
ganizes lipid rafts and thereby causes activation of signalling pathways leading to keratinocyte 
differentiation. We have shown that EGFR activation by cholesterol depletion in keratinocyte 
leads to induction of MAPKs Erk and p38 phosphorylation (which is implicated in epidermal 
differentiation). In this work, we are studying the effects of lipid raft disruption on keratinocyte 
morphology and adhesion. We show here that lipid raft disruption by cholesterol depletion 
in normal keratinocyte induces changes in the actin cytoskeleton and formation of fi lopodia. 
Those changes are dependent upon p38 activation, as we show that inhibition of this MAPK by 
the pharmacological inhibitor PD169316 reduces the morphological changes observed after 
cholesterol depletion. 
027
Connexin 30, A New Marker Of Hyperproliferative Epidermis
Lemaitre G1, Sivan V1, Lamartine J1, Cosset JM2, Cavelier-Balloy B3, Salomon D4, Waksman G1 
and Martin MT1
1SGF/CEA Evry - EA2541 Université Evry (France)
2Oncologie/Radiothérapie Inst. Curie, Paris (France)
3Anatomie Pathologique et Dermatologique, Paris (France)
4Service de Dermatologie, HUG, Geneve (Switzerland)
Background Cellular alterations that lead to chronic hyperproliferation of epidermis are still 
poorly understood. Gap junctions play important roles in keratinocyte growth and differentia-
tion as well as in wound healing, and a marked up-regulation of several connexins has previ-
ously been described in psoriatic lesions. 
Objectives and Methods To describe the expression of connexin 30 (Cx30) in three different 
types of hyperplasia: radiation-induced hyperplasia, psoriasis and Mibelli’s porokeratosis, Cx30 
protein expression was studied by immunohistochemistry for 13 patient samples. Western-blot-
ting and in situ hybridization were performed on irradiated samples and the induction of Cx 30 
transcript by ionizing radiation was studied by quantitative PCR in cultured keratinocytes.
Results Cx30 was not expressed in the normal interfollicular epidermis. It was consistently 
expressed in the three types of hyperproliferative epidermis, from the spinous to the granular 
layer, whereas no expression was detected in the basal layer. Moreover, Cx30 mRNA was 
directly induced by radiation exposure. 
Conclusions This study reports for the fi rst time on Cx30 expression in hyperproliferative dis-
eases of human epidermis. High expression was detected in the three types of hyperplasic 
epidermis. Cx30 could represent a new marker of keratinocyte hyperproliferation and play a 
role in the chronic cellular alterations observed in these diseases. 
028
β1b Cooperates With The Cytoplasmic Domain Of β1a And Induces Anoikis In Human 
Keratinocytes By Binding To Procaspase-8
Lotti R, Marconi A, Dallaglio K, Truzzi K, Pignatti M and Pincelli C
Department of Dermatology, University of Modena and Reggio Emilia (Italy)
Anoikis is a mode of cell death that occurs after detachment from the extracellular matrix 
(ECM). The anchorage of cells to the ECM is mainly mediated by integrins. We have shown pre-
viously that blockade of β1 integrin signal induces apoptosis through the caspase-8 triggered 
apoptotic pathway. Anti-β1 integrin activates procaspase-8 at 1 hr in human keratinocytes. As 
blockade of β1 integrin fails to up-regulate either Fas or Fas ligand, and FADD shRNA does 
not prevent anoikis in keratinocytes, we hypotesized a direct correlation between β1 integrin 
and caspase-8. To this purpose, we have immunoprecipitated β1 integrin in suspended cells 
and immunoprecipitates were blotted against procaspase-8. Pro-caspase-8 co-immuneprecipi-
tates with β1 integrin and is cleaved starting at 1hr. On the other hand, β1 integrin does not 
precipitate with FADD. By confocal microscopy, pro-caspase-8 co-localizes with β1 integrin. 
During anoikis, extracellular domain of β1 integrin is degraded at 1-2 hrs. Moreover, β1 in-
tegrin internalizes cells starting at 30 minutes. Human keratinocytes express both β1A and 
β1B integrin variants, as shown by western blotting. By confocal microscopy, β1A integrin is 
mostly localized in the membrane, while β1 B is detected in the cytoplasm. Moreover, during 
anoikis, procaspase-8 co-immunoprecipitates with the cytoplasmic domain of either β1A or β1 
B integrins. These results seem to indicate that β1A and B integrins cooperate in the activation 
of caspase-8 leading to anoikis.
029
Effect of UVB irradiation on Proteasome in Keratinocytes
Marque M1, Meunier L1, Baldin V2 and Coux O2
1Department of Dermatology, University Hospital of Montpellier (France)
2CRBM, CNRS FRE 2593 (France)
UVB cause direct or indirect DNA damages, major agents of the skin photo-carcinogenesis. 
The 26S proteasome, a proteolytic complex composed of the 20S core and the 19S regulatory 
complex, is involved in many steps of cell cycle regulation and repair processes induced in re-
sponse of UV radiations. 19S proteins also play a nonproteolytic role in repair and transcription 
processes. However, the effects of UV-irradiation on proteasome itself are still unclear.
The project of the present study was to determine the direct effects of UVB on the proteasome 
by analyzing specifi cally: 1) its proteolytic activity using a fl uorigenic substrate, 2) the distribu-
tion of the different forms of proteasome (26S and 20S) by in gel activity staining and immuno-
blot analysis, 3) sub-cellular localization by Western blot analysis, after nuclear and cytosolic 
fractionated extraction, and indirect immucytochemistry. Human immortalized keratinocytes 
(HaCat cells), irradiated or not with increasing doses of UVB, were used and analysis were 
performed at different times after UVB-irradiation.
Our results suggest that after UVB irradiation: i) the global proteolytic activity of the protea-
some is not signifi cantly affected, ii) a partial dissociation of the 26S proteasome occurs and 
iii) there is a partial relocalization of 20S and 19S complexes : both types of complexes tend 
to accumulate into the nuclei, with a clearly more pronounced effect for the subunits of the 
19S complex. As judged for the Sug1 ATPase of the 19S complex, the nuclear accumulation is 
transient. Based on these results we propose the hypothesis that a dissociation of the 26S pro-
teasome occurs in the cytoplasm to facilitate the import into the nucleus of primarily the 19S 
complex, most likely to favor processes involved in the cell response to genotoxic stress.
030
Azelaic Acid Counteracts The Peroxide-induced Infl ammatory Response In HaCaT Cells
Mastrofrancesco A, Ottaviani M, Camera E and Picardo M
San Gallicano Dermatological Institute (Italy)
Recent clinical studies have outlined the effi cacy of azelaic acid (AZA) even in the treatment of 
rosacea, in particular in reducing the infl ammation and erythema severity. On the basis of early 
investigations, an anti-infl ammatory activity of AZA could be envisioned partially ascribable 
to its reactive oxy-species (ROS) scavenging properties. To elucidate the mechanisms through 
which azelaic acid interfere with the infl ammatory cascade, we have tested this compound in 
a cell model of infl ammation. A human stabilized keratinocytes cell line (HaCaT) was treated 
with H2O2 (200 μM) for 1h as pro-oxidant stimulus and, typically, an incretion of intracellular 
ROS levels, and activation of NF-κB were detected by fl ow-cytometric analysis. Azelaic acid 
added at sub-toxic concentrations (1-20 mM) either 24h before or contemporaneously to the 
pro-oxidant challenge was able to contrast the above H2O2-induced effects. In order to inves-
tigate, a specifi c action of AZA on lipoxygenase (LOX) an enzyme involved in the formation 
of infl ammatory mediators, such as leukotrienes and eicosanoids, we assayed the LOX activity 
of the purifi ed enzyme or of supernatants of stimulated HaCaT cells by spectrophotometric 
and LC-MS analyses. The decrease of peroxidated products of linoleic acid, which is a LOX 
substrate, demonstrated that AZA was able to dose-dependently inhibit the LOX. Overall, our 
fi ndings support the hypothesis that azelaic acid may be benefi cial in the modulation of the 
infl ammatory response as it provided an effective inhibition of the infl ammatory cascade by 
counteracting the elevation of ROS, the activation of NF-κB and the generation of LOX prod-
ucts and consequently the production of pro-infl ammatory mediators.
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Analysis Of Cytokine Production By Human Keratinocytes Grown In Monolayer As Compared 
To Skin Equivalent Cultures
Mildner M1, Ballaun C1, Gruber F1, Buchberger M1 and Tschachler E2
1Department of Dermatology, Medical University of Vienna (Austria)
2Department of Dermatology, Medical University of Vienna; CE.R.I.E.S. (Austria)
Human epidermal keratinocytes (KC) are a rich source for cytokines and growth factors that 
modulate pathologic as well as physiologic processes in the skin. To determine the infl uence 
of the differentiation state of KC on the production of secreted signalling proteins, we inves-
tigated differences in their expression between preconfl uent KC in monolayer cultures and 
KC in a fully differentiated three dimensional epidermal equivalent model. Using microarray 
gene expression analysis (Human Genome U133 Plus 2.0 Affymetrix DNA chip) we found, 
as expected, signifi cant differences in a wide variety of genes. Examples for sustained expres-
sion in both monolayer and skin equivalent culture of primary KC included VEGF, PDGFA, 
PDGFB, CCL20, CXCL16, and IL18, whereas other infl ammatory cytokines such as CXCL1, 
GROα, CXCL3, IL1α and -β, IL6 and IL8 were down-regulated in differentiated KC. The group 
of soluble mediators which were up-regulated in differentiated keratinocytes included HBEGF, 
PDGFC, PDGFD,FGF11 and antagonists of the IL-1 receptor IL1RN and IL1F5, and most nota-
bly CXCL14, recently characterized as a chemotactic factor for immature dendritic cells. Our 
results confi rm that the cytokine expression profi le of human KC in vitro is strongly infl uenced 
by their differentiation state. Since skin equivalent cultures mimic the late phase of wound 
healing in vivo, our approach will help to identify cytokines relevant for epithelisation and re-
establishment of the epidermal barrier. 
032
Reverse Transcriptase Activity in Psoriatic Lesions: Effects of Reverse Transcriptase Inhibitors 
on Keratinocyte Proliferation and Differentiation
Molès JP1, Tesniere A1, Dumas M2, Bonté F2 and Guilhou JJ1
1Lab Molecular Dermatology, University of Montpellier (France)
2LVMH Recherche, Saint Jean de Braye (France)
About half of the human genome is composed of ancient transposable elements that integrated 
the genome through out the evolution. In order to evaluate whether retroelements could be 
active in the psoriatic lesion, we 1/ quantifi ed endogenous reverse transcriptase (RT) activity, 2/ 
localised RT-expressing cells 3/ evaluated the effects of RT inhibitors on keratinocyte prolifera-
tion and differentiation in a skin culture model.
An increased RT activity was detected in protein extracts from lesional psoriatic skin when 
compared to normal skin (mean Mn2+-dependent RT activity 191 ± 118 μU/ml (n= 24) vs 71 
± 78 μU/ml (n = 17) and mean Mg2+-dependent RT activity 7.3 ± 4.3 mg/ml (n=15) vs 2.3 ± 
1.93 mg/ml (n = 15); p = 0.0048 and p = 0.0009, respectively). Sera and plasma from healthy 
and psoriatic individuals were all negative.
By anti-RT antibody staining, we detected few dermal positive cells in normal skin sections 
(n=10) as in non-lesional psoriatic skin (n=10). In contrast, in the lesional skin (n=20), the 
granular layer was intensely stained as were Munro’s abscesses. In addition, a subset of infl am-
matory cells was also positive. 
In order to evaluate the effects of two RT inhibitors, AZT and Efavirenz, on keratinocyte pro-
liferation and differentiation, we fi rst confi rmed the expression of RT proteins in the granular 
layer of in vitro skin culture. We observed that Efavirenz, a non-nucleosidic RT inhibitor, at 
10-5M potently reduced cell proliferation and hyperkeratosis while AZT had little or no effect 
on keratinocyte differentiation. 
These results support that endogenous retroelements are active in the psoriatic lesion and that 
they also participate in the control of keratinocyte proliferation and differentiation.
033
Notch Ligand, Jagged-1 Expression in Psoriatic Skin
Nakanishi G, Suzuki N and Iwatsuki K
Department of Dermatology, Okayama University Medical School (Japan)
The Notch signaling pathway is a well-recognized network that plays a pivotal role on keratino-
cytes growth and differentiation. Notch, transmembrane receptors, are cleaved after binding to 
their ligands and then cleaved intracellular domain enters the nucleus and activates transcrip-
tion. Jagged-1 was originally isolated as a mammalian ligand that activates Notch-1 and was 
suffi cient to trigger keratinocytes differentiation. In addition, it has been reported that mRNA 
expression of Jagged-1 is down-regulated in psoriatic skin when compared to normal skin. 
These observations prompted us to conduct an investigation of Notch ligand, Jagged-1 in skin 
and cultured keratinocytes. At fi rst, we confi rmed mRNA expression of Jagged-1 in psoriatic 
skin by real-time PCR. Jagged-1 mRNA was very slightly down-regulated in psoriatic skin when 
compared to uninvolved lesions. However, despite the expectations, Jagged-1 protein expres-
sion was highly up-regulated in involved lesions of psoriasis patients by western blot analysis. 
Immunohistochemical analysis demonstrated that in normal skin, Jagged-1 was diffusely and 
weekly expressed throughout epidermis, but in psoriasis, Jagged-1 was highly expressed in 
lower spinous layers and abolished in upper spinous layers. Next, we investigated Jagged-
1 protein expression in normal human epidermal keratinocytes (NHEK), HPV-immortalized 
keratinocyte cell line (HPV-NHEK), and some squamous cell carcinoma cell lines. Western 
blot analysis showed Jagged-1 was highly expressed in all the cell types including squamous 
cell carcinoma cell lines. Neither Confl uent condition nor high calcium concentrations alter 
the expression level of Jagged-1, while, TPA treatment down-regulated Jagged-1 expression in 
NHEK. The TPA treatment did not alter the Jagged-1 expression in HPV-NHEK and squamous 
cell carcinoma cell lines. In conclusion, the alteration of Jagged-1 expression in psoriatic epi-
dermis may associate with abnormal cornifi cation in psoriasis.
034
Differentiation-Specifi c Factors Modulate TGM1 and CYP1-4 Gene Expression In Human 
Keratinocytes In Response To Retinoic Acid And Classical Aryl Hydrocarbon Receptor 
Ligands
Neis MM1, Du L2, Ladd PA3 and Keeney DS4
1Department of Dermatology and Allergology, RWTH Aachen (Germany)
2Department of Biochemistry3, Vanderbilt University School of Medicine, Nashville, TN (USA)
3Department of Medicine/Dermatology, Vanderbilt University School of Medicine, Nashville, 
TN (USA)
4VA Tennessee Valley Healthc. Syst. and the Departments of Med./Dermatol. and Biochem., 
Vanderbilt U. (USA)
Our previous studies identifi ed subsets of CYP1-4 genes expressed in human epidermal kerati-
nocytes that are strongly regulated, not regulated (<2-fold change), or down-regulated during 
terminal differentiation in vitro. In this study, we investigated how CYP1-4 mRNA expression 
levels are altered by treatment with drugs that modulate epidermal differentiation or have thera-
peutic effects on human skin. Epidermal keratinocytes were differentiated six days in the pres-
ence of DMSO vehicle or drugs. Quantitative real-time PCR assays measured mRNA levels, 
which were normalized for 18S rRNA. Signifi cant results were corroborated by western blot 
analysis. The spinous phenotype was confi rmed by cellular morphology and up-regulation of 
keratin 10 and transglutaminase mRNA levels in day 6 differentiating keratinocyte cultures. 
Treatment with retinoic acid and aryl hydrocarbon receptor ligands (dioxin, ß-naphthofl avone) 
inhibited the differentiation-induced up-regulation of CYP genes expressed preferentially in 
differentiating keratinocytes (CYP2C18, 2C19, 2C9, 2W1, 3A4, 4B1). These same drugs up-
regulated or had no effects (<2-fold change) on the subset of CYPs expressed at similarly in both 
proliferating and differentiating cells (CYP2S1, 2J2, 1B1, 1A1, 1A2, 2E1, 2D6, 2U1) and the 
single CYP (CYP2U1) expressed preferentially in proliferating cells. Statistical signifi cance was 
not achieved for other drug treatments (miconazole, dexamethasone, rifampicin, dapsone). 
Suprisingly, dioxin specifi cally up-regulated transglutaminase I mRNA and protein levels and 
cross-linking activities measured in situ (vs. vehicle controls). Data suggest the aryl hydrocar-
bon receptor might be involved in the dioxin-induced transglutaminase expression and func-
tion, but this would likely occur via an indirect mechanism rather than direct transcriptional 
regulation of the TGM1 gene.
035
New Role of Vitamin B6 on Skin Moisturization through Filaggrin Upregulation in Human 
Keratinocytes and Development of its Derivative
Ochiai Y, Fujishiro M, Okano Y and Masaki H
Cosmos Technical Center Co., Ltd. (Japan)
Vitamin B6 (VB6) plays an important role in epidermal homeostasis, because VB6 depletion 
causes skin roughness, scaling and ultimately seborrheic dermatitis. However, the precise con-
tribution of VB6 in the epidermis has not been clear. Thus, we attempted to clarify the effects 
of VB6 on the epidermal function. We also developed a novel VB6 derivative, because VB6 is 
not stable against heat and oxidation, and does not penetrate the skin due to its hydrophilic 
property. At fi rst, we examined effects of VB6 focusing on the differentiation of keratinocytes. 
The expressions of keratinocyte-specifi c markers, such as involucrin, serine palmitoyltrans-
ferase and profi laggrin, in cultured human keratinocytes treated with VB6 were measured using 
RT-PCR. We found that VB6 excellently up-regulated both of mRNA expression and protein 
of profi laggrin. Since fi laggrin is thought as a precursor of a natural moisturizing factor, the 
upregulation of fi laggrin was expected to improve skin moisturization. Then, we tried to de-
velop a more stable and more effective VB6 derivative. We newly synthesized lipophilic VB6 
derivative, VB6 tri-isopalmitate (VB6IP) and evaluated its potential focusing on profi laggrin as 
a marker. VB6IP showed upregulations of profi laggrin on both aspects of mRNA and protein 
in cultured keratinocytes and 3D epidermal model, and the abilities were superior to those of 
VB6. The results indicated that VB6IP remained the function of VB6. We next examined the 
alteration of water content in the stratum corneum by the topical application of VB6IP. The 4 
week treatment with VB6IP signifi cantly increased the water content. We concluded the fol-
lowings; 1) VB6 contributed to the epidermal homeostasis through upregulation of profi laggrin. 
2) VB6IP, improved skin surface water contents.
This is a fi rst report which demonstrated the relationship between VB6 and profi laggrin.
036
Constitutive expression of the membrane bound chemokine CXCL16 in keratinocytes and 
stimulated cleavage mediated by the disintegrin-like metalloproteinase ADAM 10
Scholz F1, Schulte A2, Adamski F2, Hundhausen C1, Schwartz A1, Ludwig A1 and Proksch E1
1Department of Dermatology, University of Kiel (Germany)
2Department of Biochemistry, University of Kiel (Germany)
Constitutive expression of the membrane bound chemokine CXCL16 in keratinocytes and 
stimulated cleavage mediated by the disintegrin-like metalloproteinase ADAM 10
Chemokines are a large family of small proteins with a size about 10 kDa and are released 
upon stimulation. In the skin they are involved in particular in infl ammation and wound heal-
ing. CXCL 16 is one of two special chemokines. It is a membrane bound Chemokine and 
consists of a short cyctoplasmatic tail, a single membrane bound α-helix, a high glycosylated 
mucin like stalk and a 10 kDa chemokine domain. We were able to show that CXCL16 is 
constitutively expressed by keratinocytes. Normal human and murine skin expressed CXCL16 
without stimulation as shown by immunhistochemical staining. Murine and human primary ke-
ratinocytes, HaCaT and PAM212 cells express CXCL16 constitutively, too. We showed that the 
chemokine domain of CXCL16 is released in the supernatants of the cell cultures of the used 
celltypes and that this release is time dependent. To analyse the proteolytic cleavage of CXCL16 
we used the metalloproteinase inhibitors marimastat (broad spectrum inhibitor), GW280264X 
(preferentially blocking ADAM 17) and GI254023X (preferentially blocking ADAM 10). These 
inhibitor experiments showed that the release of the CXCL16 chemokine domain is dependent 
of ADAM10 activity. To confi rm our results we used stealth siRNA to knock down the ADAM 
10 and ADAM 17 expression. In the ADAM10 knock down proteolytic cleavage of CXCL16 was 
completely blocked. In contrast, ionomycin or UVB radiation stimulated the ADAM10 mediat-
ed proteolytical cleavage of CXCL16 in HaCaT cells. Our data show that ADAM 10 but not the 
related ADAM 17 is responsible for the proteolytic cleavage of CXCL16 in keratinocytes. ADAM 
10 dependent cleavage is enhanced by cell activation with iomomycin or UV-B radiation.
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037
Transcriptional Regulation of the Peptidylarginine Deiminase 2 and 3 Genes Driven by Sp1/3 
Factors in Human Keratinocytes.
Dong S1, Chavanas S2, Kojima T1, Méchin MC2, Kanno T1, Adoue V2, Shiraiwa M1, Serre G2, 
Simon M2 and Takahara H1
1Department of Applied Biological Resource Sciences, School of Agriculture, University of Iba-
raki (Japan)
2UMR5165, CNRS-University of Toulouse III (France)
Peptidylarginine deiminases (PAD) convert protein-bound arginine residues into citrulline in 
a Ca2+-dependent manner. The fi ve mammalian isoforms (PAD1- 4, 6) are encoded by the 
genes PADI1-4 and 6 clustered on human chromosome 1p35-36.Three of them are expressed 
in the epidermis. PAD1 is detected in all the epidermis, PAD2 in the stratum spinosum and 
granulosum. The expression of PAD3 is restricted to the granular and the lower cornifi ed layers. 
Moreover, PAD1 and 3 are detected in the inner root sheath of hair follicles. PAD1 and 3 are 
involved in terminal processing of fi laggrin and trichohyalin. 
We investigate the molecular mechanisms that control the transcription of the PADI genes in 
human keratinocytes. Unlike the other PADI paralogs, the 5’ fl anking region of PADI2 spans a 
CpG island and does not exhibit any TATA or CAAT box. Reporter gene experiments in primary 
keratinocytes suggested that as few as 132 and 129 bp upstream from the transcription start 
site of PADI2 and PADI3, respectively, are suffi cient to direct transcription. Deletion mutant 
analyses, gel shift assays and chromatin immunoprecipitation revealed that binding of the tran-
scription factors Sp1 and Sp3 is required for the activity of both the promoter regions of PADI2 
and PADI3. Conversely, binding of the factor NF-Y was required for activity of the promoter of 
PADI3 but not PADI2. Sp1, NF-Y but not Sp3 small interfering RNAs impaired PADI3 expres-
sion in keratinocytes.
These results suggest that Sp1/Sp3 cooperation drives the transcription of PADI2 and PADI3 in 
the epidermis. Functional analysis of the putative Sp1/Sp3 binding sequences present in the 
promoter region of the genes PADI1, 4 and 6 will help to decipher if Sp1/Sp3 could be a pos-
sible general PADI gene regulation system in the epidermis.
038
The Diverse Infl ammatory Responses Of Body Site-specifi c Keratinocytes Might Explain The 
Clinical Distribution Of Psoriatic Skin Lesions
Takahashi K and Miyachi Y
Department of Dermatology, Kyoto University (Japan)
Infl ammatory skin diseases, such psoriasis vulgaris and atopic dermatitis, can involve all over 
the human body, but they tend to be distributed in the specifi c favorite sites. Psoriatic skin 
plaques occur commonly in the extensor surfaces of the lower extremities and the lumbar back 
skin, while atopic skin lesions are seen in the fl exor surfaces of extremities and neck. These fre-
quently observed regions are also diffi cult to treat and poorly respond to the various treatments. 
In order to elucidate this spatial distinction, we investigated the biological and infl ammatory 
characteristics of regional epidermal keratinocytes. Keratinocytes from healthy individual were 
collected and cultured from different parts of the body. After several hours’ stimulations with 
TNF-α, INF-γ or IL-1β, mRNA expressions of various genes for cytokines, adhesion factors and 
extracellular matrix were determined by fi lm type micro array analysis. For instances, the ke-
ratinocytes derived from the lower extremity showed the different expression profi les of genes 
which are known to be involved in the onset of psoriatic rash, such as IL-1, IL-8, IL-11, VEGF, 
GM-CSF and ICAM-1, compared to those obtained from other areas. These results suggest that 
the combined differences in biochemical and infl ammatory responses observed in the various 
body sites, especially the lower leg skin, might explain the differences of the psoriatic clinical 
phenotypes and their responses to the treatment regimens at least in part.
039
Brk Promotes Primary Keratinocyte Survival And Migration
Tupper J, Harvey A and Crompton M
School of Biological Sciences, Royal Holloway, University of London (United Kingdom)
Breast tumour kinase (Brk), is a non-receptor tyrosine kinase with sequence similarity to the Src 
family kinases. Its normal pattern of expression, and that of the mouse orthologue Sik, appears 
to be restricted to the differentiating layers of epithelia. Brk is also found in a variety of tumour 
types; it is expressed in approximately 60% of breast tumours, but is not detectable in normal 
breast epithelium.
The aim of this study was to examine the role of Brk in human keratinocytes. Neonatal keratino-
cytes were transfected with short interfering RNAs directed towards Brk. Two siRNA sequences 
were used to target Brk, both of which resulted in a signifi cant decrease in protein levels 24 
and 48 hours after transfection. The survival of cells was examined using trypan blue exclusion 
and a cell death ELISA which measures free histone-associated DNA, a chromatin degrada-
tion phenotype characteristic of apoptosis. The effect of Brk targeting on the ability of cells to 
migrate and close wounds was assessed using a scratch test.
Using both siRNA sequences, it was found that decreased Brk expression led to a signifi cant 
increase in the number of trypan blue including cells. This was corroborated by the detection 
of chromatin degradation, which was not affected by treatment with a pan-caspase inhibitor. 
Cells induced to differentiate by suspension culture in methylcellulose also exhibited increased 
trypan inclusion and increased cell death as measured by the ELISA, but this was caspase de-
pendent. Cells with decreased Brk protein levels also displayed a marked impairment of their 
ability to migrate at wound edges.
The results support a role for Brk in the survival of keratinocytes; however, the cell death path-
way induced upon Brk suppression may be mechanistically distinct from that initiated by cell 
suspension. Additionally, Brk potentiates wound-induced keratinocyte migration.
040 [007]
Mesenchymal Stem Cells Differentiate Into Multiple Skin Cell Types And Contribute To 
Wound Repair
Sasaki M, Abe R, Inokuma D, Ando S and Shimizu H
Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
Mesenchymal stem cells (MSCs) differentiate not only into mesenchymal lineage cells such as 
adipocytes, osteocytes, chondrocytes but also into various cell lineage including hepatocytes 
and neural cells. As MSCs can easily be established from bone marrow, MSCs are expect-
ed to be applied to various tissue engineering strategies. However, it is currently not known 
whether MSCs can differentiate into keratinocytes. To clarify this question, we isolated MSCs 
from mouse bone marrow and cultured in various conditioned media containing human epi-
dermal growth factor and stained with a keratinocyte marker (keratin 14). We found K14(+) 
cells (0.4%), namely keratinocytes that transdifferentiated from MSCs. Secondary, we assessed 
whether MSCs can differentiate into keratinocytes and/or other skin cells in vivo. GFP transgen-
ic mouse-derived MSCs were intravenously injected, then skin wound sites were biopsied and 
stained with cell specifi c markers. We detected various GFP+ that also expressed other cell spe-
cifi c markers for macrophages (CD11b+), myelogenic cells (CD45+), endothelial cells (CD31+) 
or keratinocytes (keratin+), suggesting that MSCs can differentiate into multiple skin cell types 
in vivo. Next, we investigated the contribution of MSCs to wound repair. MSCs injected-mice 
repaired wounds more rapidly than control mice (P< 0.05). Furthermore, we determined MSCs 
that express several chemokine receptors, particularly SLC/CCR7 and their interaction medi-
ated the accumulation of MSCs at wounded sites. Local application of SLC accelerated wound 
repair. Taken together, we have demonstrated that MSCs can differentiate into keratinocytes, 
and contribute to wound repair via MSCs differentiation into various skin cell types.
041 [008]
Expression And Function Of Thyroid Specifi c Genes In Human Skin
Cianfarani F1, Marchioni E2, Baldini E2, Cavalli A1, Teson M1, Zambruno G1, D’Armiento M2, 
Odorisio T1 and Ulisse S3
1Molecular and Cell Biology Laboratory, IDI-IRCCS, Rome (Italy)
2Department of Experimental Medicine and Pathology, University of Rome La Sapienza (Italy)
3Experimental Medicine Department, University of l’Aquila (Italy)
Patients affected by autoimmune thyroid diseases (AITD) are characterized by several altera-
tions of skin function. Although skin is considered a target tissue for thyroid hormones (TH), 
very little is known on the molecular mechanisms involved in cutaneous manifestations dur-
ing AITD. Recent data show the presence of the transcripts for the thyroid specifi c genes TSH 
receptor (TSH-R) and thyroglobulin (Tg) in immortalized keratinocytes and melanoma cells. 
This fi nding suggests that during AITD the skin could be a target of autoantibodies directed 
against thyroid specifi c antigens. To get insight into the expression and function of thyroid 
specifi c genes in skin cells, in the present study we analyzed the expression of TSH-R, Tg, 
sodium iodide symporter (NIS) and thyroperoxidase (TPO) genes in primary cultures of normal 
human keratinocytes and dermal fi broblasts by quantitative RT-PCR, in comparison with that 
of normal human thyrocytes (NHT). The results revealed the presence of TSH-R, Tg and NIS 
transcripts in both human keratinocytes and fi broblasts, while TPO mRNA was found only in 
keratinocytes. Immunohistochemical analysis of human healthy skin specimens confi rmed the 
presence of TSH-R and Tg protein in keratinocytes and dermal fi broblasts. Cultured normal 
human keratinocytes and dermal fi broblasts were then treated with TSH (10 μUI/ml) for 72 h 
and the effect on cell proliferation evaluated by BrdU incorporation. The results indicated the 
ability of TSH to signifi cantly increase proliferation in both cell types. Moreover, TSH treatment 
for 2 h induced a signifi cant increase in intracellular cAMP levels. However, differently from 
its action on thyrocytes, TSH did not stimulate the expression or the secretion of Tg in cultured 
keratinocytes and dermal fi broblasts. 
In conclusion, our data demonstrate that keratinocytes and fi broblasts express thyroid specifi c 
genes which may be involved in the pathogenesis of skin alterations during AITD.
042 [009]
Towards Defi ning The Role Of The Mineralocorticoid Receptor In The Skin: A Transgenesis 
Approach
Sainte-Marie Y1, Toulon A1, Maubec E2, Cherfa A1, Cluzeaud F1, Grossin M3, Descamps V2, 
Peuchmaur M4, Farman N1 and Jaisser F1
1INSERM U 772, Collège de France, Paris (France) 2Hospital Bichat, APHP, Université Paris VII 
(France) 3Hospital Louis Mourier, APHP, Université Paris VII (France)
4Hospital Debré, APHP, Université Paris VII (France)
The mineralocorticoid receptor (MR) is a transcription factor belonging to the nuclear receptor 
family. In the kidney, its activation by aldosterone leads to enhanced renal salt reabsorption 
and regulation of blood pressure. MR is also expressed in non classical aldosterone target cells 
where its function is not yet full understood (brain, heart) or totally ignored as in skin keratinoc-
ytes. Keratinocytes express the MR and its downstream effector, the epithelial sodium channel, 
but it is not known whether the receptor (or its ligands) plays a role in keratinocyte biology and 
pathophysiology in vivo.
To address the question of in vivo MR relevance, its overexpression in the epidermis was 
achieved by using a tissue specifi c (keratin K5-transactivator mouse strain) transgenic ap-
proach, with the conditional tetracyclin (doxyxyclin)–inductible system, to target the human 
MR (tetO-hMR) specifi cally in keratinocytes of the basal layer of epidermis in mice. 
Double-transgenic (DT) mice (K5-rtTa/ tetO-hMR) exhibited 2 different phenotypes, depending 
on the moment of the transgene induction. When MR expression was induced throughout ges-
tation, it resulted in an early open-eye phenotype with abnormal shiny skin; histologicaly, there 
was a fl attening of the basal layer with an effacement of the rete ridge pattern and at TUNEL 
study an increased apoptosis. The toluidine blue permeability test showed a premature estab-
lishment of the cutaneous barrier. Post natal survival of pups was severely compromized. When 
MR expression was initiated only after birth, DT mice developed progressive alopecia and loss 
of vibrissae. Histological analysis showed follicular cysts. The hair cycle was abnormal, with 
delayed entry into the fi rst post natal anagen phase.
This model should help to dissect the pathway downstream of MR and glucocorticoid receptors 
in skin. This is particularly important in view of side-effects of topical administration of gluco-
corticoid hormones, which may depend on their binding to cutaneous MR. It is proposed that 
such side-effects could be prevented by blocking MR function at the level of the skin.
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043 [023]
Kindlin-1 regulates polarity and motility of epidermal keratinocytes
Herz C1, Aumailley M2, Schulte C2, Schloetzer-Schrehard U3, Bruckner-Tuderman L1 and Has C1
1Department of Dermatology, University of Freiburg (Germany)
2Department of Biochemistry, University of Cologne (Germany)
3Department of Ophtalmology, University of Erlangen (Germany)
A novel family of focal contact proteins, the kindlins, is involved in attachment of the actin 
cytoskeleton to the plasma membrane and in integrin mediated cellular processes. Defi ciency 
of kindlin-1, as a result of loss-of-function mutations in the KIND1 gene, causes Kindler syn-
drome (KS) characterized by skin blistering, progressive skin atrophy, photosensitivity and, oc-
casionally, carcinogenesis. Here we investigated consequences of kindlin-1 defi ciency in skin 
and keratinocytes from KS patients. Reduced proliferation of basal keratinocytes in KS skin 
correlated with the slow dividing potential of the cells in culture. Apoptotic basal keratinocytes 
were present in the upper dermis, but no apoptosis was detected in cultivated KS keratinocytes. 
In the epidermis, collagen XVII and α6 integrin were distributed at the entire circumference of 
the cell membrane, indicative for loss of polarization of basal keratinocytes. In culture, 40% 
of the KS keratinocytes exhibited multiple leading edges instead of polarized lamellipodia. No 
wound healing problems were described in KS patients, but in vitro wound closure assays and 
videomicroscopy demonstrated that KS keratinocytes migrated slower than controls and in 
an undirected manner. Actin cytoskeleton, visualized by phalloidin staining, showed reduced 
circumferential cortical actin and concentration of actin to multiple leading edges in KS cells. 
Focal adhesions, assessed by vinculin staining, were diffuse and abnormally distributed to the 
leading edges in KS cells. In 82% of controls, microtubuli were bundled at the edge of the 
cells, while microtubuli remained individual in 50% of KS cells. These fi ndings suggest that 
kindlin-1 is pivotal for the polarity and shape of epithelial cells and for the formation of polar-
ized lamellipodium in keratinocytes during directed migration. Vice versa, kindlin-1 defi ciency 
leads to reduced proliferation and enhanced apoptosis in keratinocytes, correlating with the 
severe epidermal atrophy in KS.
044 [045]
Soluble Vascular Endothelial Growth Factor-1 Could Represent A Positive Mediator In The 
Angiogenic Process
Orecchia A1, Soro S2, Arcelli D3, Lacal PM3, Morea V4, Mettouchi A5, Strinati G1, Tramontano A2, 
Zambruno G1 and Failla CM1
1Molecular and Cell Biology Laboratory , IDI-IRCCS, Rome (Italy)
2Depart of Biochemical Sciences “A. Rossi Fanelli” , University “La Sapienza”, Rome (Italy)
3Molecular Oncology Laboratory, IDI-IRCCS, Rome (Italy)
4CNR Institute of Molecular Biology and Pathology, University “La Sapienza”, Rome (Italy)
5U634 Inserm, Nice (France)
Angiogenesis represents one of the main events in wound healing. In fact, the development of 
granulation tissue requires the formation of new vessels and reduced angiogenesis contributes 
to cutaneous wound healing impairment as it occurs in diabetes. Vascular endothelial growth 
factor receptor-1 (VEGFR-1) is a tyrosine kinase receptor for growth factors of the VEGF family. 
Endothelial cells express both a membrane-bound and a soluble variant of this protein, the lat-
ter being mainly considered as a negative regulator of angiogenesis. Soluble VEGFR-1 (sVEG-
FR-1) was isolated in wound fl uid and appears highly expressed in non-healing wounds.
We previously reported that sVEGFR-1 is deposited in the extracellular matrix produced by en-
dothelial cells and promotes cell adhesion and migration through interaction with the α5β1 in-
tegrin. The key role of this integrin in sustaining angiogenesis has been previously highlighted. 
As none of the classic α5β1 integrin binding motifs is present in the sequence of sVEGFR-1, we 
tried to identify the molecular determinants responsible for receptor-integrin interaction. We 
found that a peptide mapping on Ig-like domain II of sVEGFR-1 directly interacts with α5β1 
integrin, supports EC adhesion, and displays in vitro proangiogenic activity.
To identify those pathways specifi cally activated by sVEGFR-1 through α5β1 integrin, large-
scale gene expression analysis in endothelial cells adhering on sVEGFR-1 or fi bronectin, as 
the distinctive α5β1 ligand, was carried out by Affi metrix microarrays HU133A. In respect of 
non-adherent cells, endothelial cells adherent on either sVEGFR-1 or fi bronectin vary both the 
MAP kinase and the apoptotic pathway, and affect the formation of focal adhesion.
Taken together, our studies suggest that sVEGFR-1 could positively act on angiogenesis and 
thus play a role in the wound healing process.
045 [046]
Expression And Regulation Of Nrf1-3 In Human Skin Cells
Kokot A, Schiller M, Metze D, Luger TA and Bohm M
Department of Dermatology, University Hospital Münster (Germany)
Nrf1-3 are members of the Cap’ n’ collar family of transcription factors and play a crucial role in 
regulation of protective genes and therefore in the cellular stress response. Surprisingly little is 
known about Nrf1-3 in human skin which is constantly exposed to various stressors, especially 
ultraviolet (UV) light. RT-PCR analysis revealed constitutive expression of all Nrf members at 
the RNA level in the majority of epidermal and dermal human cell types with highest amounts 
in epidermal melanocytes. Western blotting confi rmed expression of Nrf1 and 2 at protein 
level in all tested cell types. Immunohistochemistry of healthy skin disclosed the presence of 
Nrf1 in nuclei of epidermal cells, dermal fi broblasts and distinct epithelia of adnexal structures 
while Nrf2 was found only in the latter within the cytoplasm. Functional studies using various 
stressors including UVB, H202 and chemical oxidants revealed time-dependent and subtype-
specifi c regulation of Nrf1-3 in epidermal melanocytes, keratinocytes and dermal fi broblasts. 
Moreover, exposure to oxidants resulted in a time-dependent nuclear translocation of Nrf2 
and 3 but not Nrf1 as shown by immunofl uorescence. Our data present a fi rst insight into the 
expression and regulation of Nrf members in human skin cells and will be the base for further 
studies of Nrf function in skin cells under physiologic and pathophysiologic conditions.
046 [047]
Connexins Have Isoform And Tissue Specifi c Functions And Are Critical For Skin 
Differentiation, Migration, Wound Healing And Bacterial Invasion
Man S1, Unsworth H1, Aasen T1, Trolove C1, Tattersall D1, Thomas A1, O’Toole E1, Navsaria H1, 
Curtis MA2, Kelsell DP1
1Centre for Cutaneous Research, ICMS, Queen Mary University of London, (United Kingdom) 
2Inst of Cell and Molecular Science, Queen Mary University of London, (United Kingdom)
Up to ten connexins (gap junction subunits) are expressed in human skin and several have 
been associated with disease including keratitis ichthyosis deafness (KID - Cx26 and Cx30) 
and erythrokeratodermia variabilis (EKV - Cx30.3 and Cx31). Upon performing a number of 
molecular and cellular investigations using retroviral expression of wild type and mutant Cx26, 
30 and 31 in keratinocytes and non-keratinocyte cell types, two striking functional observa-
tions were made. Cx31 expression is induced during both keratinocyte and neuronal cell dif-
ferentiation. We observed that ectopic expression of wild type Cx31 and Cx31 EKV mutants 
induced a differentiation-like phenotype in neuronal cells. Wild type Cx31 had no dramatic 
effect in keratinocytes although the EKV mutants caused cell death as previously described. No 
dramatic changes were observed using wild type Cx26 and Cx30 in either cell types. We thus 
demonstrate both cell and connexin specifi c effects upon ectopic expression, some of which 
may be unrelated to gap junctional communication as the EKV mutants failed to translocate 
to the membrane yet induced neurite outgrowth. Microarray analysis has been performed in 
order to elucidate in more detail the molecular changes associated with these observations. 
Secondly, we observed increased migration and proliferation in cells expressing the R143W-
Cx26 deafness mutation compared to wild type Cx26. In addition, R143W-Cx26 expressing 
keratinocytes formed a signifi cantly thicker epidermis in organotypic co-culture skin models. 
Cells expressing this mutant Cx26 were also signifi cantly less susceptible to cellular invasion 
by the enteric pathogen Shigella fl exneri when compared to wild type Cx26, Cx30 and Cx31. 
Recessive non-syndromic deafness Cx26 mutations have a carrier frequency of between 1-3 % 
suggesting a possibility of heterozygous advantage. The reason why Cx26 deafness mutations 
are so prevalent may relate to their benefi cial effects on epidermal wound repair and protec-
tion from infection.
047
Sebocyte Commitment of Murine Embryonic Stem Cells
Aberdam E, Storelli G, Rouleau M and Aberdam D
INSERM U634, University of Nice Sophia Antipolis (France, Metropolitan)
Sebocytes play crucial function in acnea vulgaris. To date, much of our understanding of the 
physiopathology of the sebaceous gland derives either from animal models or from the pat-
ented immortalized sebocyte cell line SZ95. Reproducible culture conditions for the cultivation 
of human sebocytes in vitro are well established but the primary cells can only be grown for 
few passages to eventually differentiate and die. 
Embryonic stem (ES) cells are derived from the pluripotent cells of the early mouse embryo. 
They can be expanded infi nitely in vitro while maintaining their potential to spontaneously 
differentiate into any cell type of the three germ layers, including epidermal cells. We have 
recently determined the experimental conditions under which murine embryonic stem cells 
can recapitulate in vitro the main steps of embryonic skin development. In the course of that 
commitment, an ectodermal stable line expressing the cytokeratins K8/K18 has been isolated 
and characterized. It represents the cellular precursor of both epidermis and skin appendage 
cells (unpublished data). Stimulation of the ES-derived ectodermal cell line with both PPARγ 
ligand (BRL) and cis-retinoic acid resulted in the appearance of prominent cytoplasmic lipid 
droplets as detected by nile red fl uorescence. Molecular studies using RT-PCR showed after 
treatment a substantial gene expression increase of a key enzyme in lipid metabolism SCD3 
and the melanocortin receptor MC5-R, both specifi c of the sebocyte. Moreover, we observed 
an increase in the enzymatic activity of GPDH, the fi rst enzyme of the lipogenesis pathway. 
This model should allow us to study the molecular mechanism governing sebocyte commit-
ment. In addition, this approach might allow the identifi cation of molecules that guide the mi-
gration of epidermal stem cells and turn their differentiation into sebaceous glands, a research 
topic of critical importance for transplantation/grafting procedures and cosmetic/pharmaceuti-
cal applications
048
Mechanisms of Apoptosis Induced By Melanoma Gangliosides On Human Monocyte-derived 
Dendritic Cells
Bennaceur K, Popa I, Berthier-Vergnes O, Peguet-Navarro J and Portoukalian J
EA 37-32 Laboratoire de Recherche Dermatologique (France)
Tumor escape is linked to multiple mechanisms, notably the liberation, by tumour cells, of sol-
uble factors that inhibit the function of dendritic cells (DC). We have shown that gangliosides 
purifi ed from human melanoma tumours impair DC differentiation from human monocytes 
and induce their apoptosis. The present study was aimed to analyse the mechanisms of GM3 
and GD3 ganglioside-induced apoptosis. After purifi cation from human blood, monocytes 
were cultured with GM-CSF and IL-4 in presence or not of GM3 (50μg/ml) or GD3 (50μg/ml). 
Enzymatic inhibitors were added at different times of the culture and apoptosis was quantifi ed 
by double staining with annexin-FITC/propidium iodide and FACS analysis. Results showed 
that GM3 and GD3-induced apoptosis is caspase-dependent, since it can be reversed by Z-
Vad, a specifi c inhibitor. Moreover, kinetic studies showed that ganglioside-induced apoptosis 
was only detected 3 or 4 days after their addition to the DC, suggesting that it is caused by 
accumulation of certain substances. Since gangliosides are catabolized into ceramides, we 
analysed their implication in the apoptotic process. Addition of lactosyl-ceramide (50μg/ml), 
the direct precursor of gangliosides, to MoDC did not induce apoptosis, suggesting that it did 
not merely result from the ganglioside catabolism. Glutathion or trimipramine did not reverse 
the apoptosis induced by gangliosides, thus ruling out the onset of ceramides hydrolyzed from 
sphingomyelin. Apoptosis induced by GM3, but not with GD3, is totally reversed by addition 
of L-cycloserine, but myriocine and fumonisine FB1, which also intervene in the de novo 
synthesis of ceramides, had no effect. By contrast, N-oleoylethanolamine (NOE), sphingosine 
1-phosphate (S1P) and ceramide 1-phosphate (C1P) which counterbalanced the effect of cera-
mides, partly or completely reversed GM3 and GD3-induced apoptosis, suggesting that cera-
mides play a role in the apoptotic process.
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Expression of Cannbinoid Receptor 1 Protein in Human Scalp Skin
Bhogal R1, Meldrum H2 and Burry J3
1Unilever R&D Colworth House, Life Science, Sharnbrook, Bedford,  (United Kingdom)
2Unilever HPC NA, Trumbull, CT (USA)
3Unilever R&D Port Sunlight, Bebington, Wirral, (United Kingdom)
Three cannabinoid (CB) receptors have been identifi ed to date, including the recently de-
scribed CB receptor, GPR55. The distribution of these receptors varies from tissue to tissue in 
both humans and animals. The sensitivity of these receptors to CB agonists and antagonists also 
varies in different body sites. 
Recent experiments have implicated cannabinoid receptors in nociception and infl ammation 
in the peripheral tissues. Administration of the CB1 receptor agonist, HU210, has been demon-
strated to have anti-itch properties in human forearm skin. On the scalp the symptoms of dan-
druff include not only the presence of loose fl akes but also itch and infl ammation. Although, 
research activities have confi rmed the presence of CB1 and CB2 receptor protein in normal 
facial skin in humans in this study we have extended investigations to examine the presence of 
CB 1 receptor (CB1R) in human scalp skin. 
Here, we report evidence indicating the presence of the CB1R in human scalp skin and within 
regions of the hair follicle and eccrine sweat gland. Indirect immuno-fl uorescence using an-
tibodies directed against human CB1R was carried out on fi xed scalp skin sections. Binding 
was specifi c and blocked using a peptide to compete with the primary antibody. These fi ndings 
demonstrate the presence of the CB1R in human scalp skin and its appendages and confi rm 
and extend some of the fi ndings observed by [reference removed]. Further investigations will 
pinpoint the role of this receptor in these sites.
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Human Skin and Hair Follicles Are Targets and Sources of Erythropoietin
Kromminga A1, Bodó E2, Laugsch M3, Duske U1, Funk W4, Jelkmann W3 and Paus R2
1Institute for Immunology, Clinical Pathology, Molecular Medicine, Hamburg (Germany)
2Department of Dermatology, University of Lübeck, Lübeck (Germany)
3Department of Physiology, University of Lübeck, Lübeck (Germany)
4Klinik Dr. Kozslowski & Dr. Funk, Munich (Germany)
The glycosylated hormone erythropoietin (EPO), which is primarily synthesized in kidney and 
liver and regulated by hypoxia, activates its specifi c receptor (EPO-R). However, the expression 
and function of the EPO/EPO-R signaling system are not limited to the hematopoietic sytem. 
This system has recently been found to be expressed in multiple non-hematopoietic tissues, but 
the expression of EPO/EPO-R has not yet been reported in normal mammalian skin. By real 
time RT-PCR, we detected specifi c PCR products for both EPO (132 bp) and EPOR (315 bp) in 
human scalp skin and isolated hair follicles. By immunohistology (EnVision-AP method), spe-
cifi c EPO immunoreactivity was confi ned to the skin epithelium. EPO immunoreactivity was 
most prominent in the central outer root sheath of anagen VI hair follicles. By ELISA, we were 
able to detect EPO secretion by microdissected, organ-cultured human scalp hair follicles into 
the culture medium. Under hypoxic conditions cultured hair follicles up-regulate EPO mRNA 
expression, while the expression of EPOR and HIF-alpha1 mRNA remains largely unaltered. 
The up-regulated expression of Glut1, as analyzed by RT-PCR, was used as a positive control 
for the demonstration of the hypoxic conditions. EPO treatment did not infl uence hair shaft 
elongation signifi cantly. Preliminary evidence, furthermore, suggests that EPO reduces experi-
mentally induced apoptosis in the hair follicle epithelium. These data provide the fi rst evidence 
that normal human skin expresses both EPO and functionally active EPO-R, and suggest that 
hair follicles are the predominant sources and targets of EPO/EPO-R signaling in human skin, 
and employ EPO as a novel auto-/paracrine regulator of hair follicle biology.
051
Indications That Normal Human Hair Follicles Have Established a Hypothalamic-Pituitary-
Thyroid (HPT) Axis
Bodó E4, Kromminga A2, Gáspár E1, Duske U2, Funk W3, Wenzel BE1 and Paus R4
1Cell and Immunbiological Laboratory, Department of Med. I., University of Lübeck, Lübeck 
(Germany)
2Institute for Immunology, Clinical Pathology, Molecular Medicine, Hamburg (Germany)
3Klinik Dr. Kozlowski & Dr. Funk, Munich (Germany)
4Department of Dermatology, University of Lübeck, Lübeck (Germany)
Hair follicles (HF) are among the most thyroid hormone-sensitive tissues of mammals. Thyroid 
hormone synthesis and release are under the control of pituitary thyroid-stimulating hormone 
(TSH), for which thyroid epithelial cells express a cognate receptor (TSH-R). Pituitary TSH 
release, in turn, is under control of the hypothalamic hormone, thyroid-releasing hormone 
(TRH), which stimulates pituitary TRH receptors (TRH-R). Recent research has indicated that 
the expression of TRH and TSH is not confi ned to hypothalamus and pituitary gland, and tran-
scripts for several elements of the hypothalamic-pituitary-thyroid (HPT) axis have recently been 
identifi ed, e.g. in cultured human skin cells. Therefore, we intended to clarify whether normal 
human scalp HF express elements of the HPT axis. Total RNA extracted from microdissected 
normal human anagen VI hair bulbs was analyzed by reverse transcription PCR. Specifi c PCR 
products with a size of 348 bp (=TSH), 264 bp (=TSH-R), 501 bp (=TRH) and 582 bp (=TRH-R) 
were identifi ed. Cryostat sections of normal human scalp skin were stained for TRH, TSH and 
TSH-R. Immune reactivity of the member of the HPT axis was localized to several compart-
ments of human skin and (HF). Activation of TRH-R in organ-cultured human scalp HF resulted 
in increased TSH production and in a moderate stimulation of hair shaft elongation, while 
the melanin production, proliferation/apoptosis of matrix keratinocytes and the cytokeratin-
6 immunoreactivity were not signifi cantly altered. However, by Agilent microarray, keratin-6 
and keratin-1 was signifi cantly down-regulated and neurofi lament 3 was up-regulated after 
TRH treatment. TSH treatment evoked signifi cant cAMP-release from cultured HF. These data 
provide the fi rst evidence that normal human scalp hair follicles express all key hypothalamic 
and pituitary elements of the HPT, and demonstrate for the fi rst time that these elements are 
functionally active and linked in human hair follicles.
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Role Of The Class 3 Semaphorin Guiding Molecules In Skin Wound Healing
Bian B1, Fitsialos G1, Turchi L1, Pascual M2, Odorisio T3, Meneguzzi G1, Ponzio G1 and Buscà R1
1INSERM U 634 Faculté de Médecine. Nice (France)
2Dpt. of Cell Biology, Faculty of Biology, University of Barcelona /Barcelona Science Park, Bar-
celona (Spain)
3Istituto Dermopatico dell’Immacolata (IDI – IRCCS). Rome (Italy)
Skin wound healing is a complex process involving multiple cell types and features such as 
proliferation, differentiation, adhesion and migration of epidermal keratinocytes and dermal 
fi broblasts and also involving endothelial cells, neurons and cells implicated in the immuno-
logical response. The crosstalk signals between all these cell types ensures a proper wound 
closure . In our work we focused on epidermal keratinocytes and dermal fi broblasts migration 
during in vitro wound healing.
We performed a DNA array analysis of genes induced at different times after injury by using an 
original technical device that highly increases the surface of wounded cells.
We interestingly observed an up-regulation of some class 3 semaphorin secreted molecules 
which play a role in cell guidance and migration in other contexts, notably during the develop-
ment of the nervous and vascular systems.
We next analyzed the putative role of these molecules using our in vitro wound healing model.
By using classical biochemical techniques as well as cell migration assays and time-lapse 
video microscopy, we have obtained promising results suggesting the existence of a crosstalk 
between epidermal keratinocytes and dermal fi broblasts, through class 3 semaphorins, to pro-
mote migration signals that are crucial for the proper closure of the wound bed.
 
053
GTP Cyclohydrolase I Feedback Regulatory Protein is Functional in the Human Epidermis 
regulating Catecholamine and Serotonin Synthesis as well as Melanogenesis
Chavan B1 and Schallreuter KU2
1Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of 
Bradford (United Kingdom)
2Institute for Pigmentary Disorders, Greifswald/Germany and Bradford/UK (United Kingdom)
Previously it has been documented that the human epidermis holds the full capacity for auto-
crine (6R)-L-erythro 5,6,7,8 tetrahydrobiopterin (6BH4) synthesis and recycling. GTP Cyclohy-
drolase I (GTPCHI) is the rate limiting enzyme in the de novo synthesis of 6BH4. This crucial 
co-factor is involved in the hydroxylation of L-phenylalanine, L-tyrosine and L-tryptophan regu-
lating catecholamine and serotonin synthesis as well as tyrosinase in melanogenesis and nitric 
oxide synthases. De novo synthesis via GTPCHI is under the regulation of GTP Cyclohydrolase 
I Feedback Regulatory Protein (GFRP). Binding of L-phenylalanine to GFRP increases GTPCHI 
activity, while 6BH4 exerts the opposite effect. Apart from the expression of epidermal mRNA 
for GFRP, the presence of a functioning GFRP feedback has never been shown. Therefore we 
asked the question whether the human epidermis exercises this important feedback regulation. 
For this purpose we used in situ and in vitro immunolabeling, electron microscopy, Western 
blot and HPLC-analysis. Our results showed a functional GFRP/GTPCHI axis in the cytosol of 
primary epidermal melanocytes and keratinocytes completing the missing link for 6BH4 de 
novo synthesis regulation in the epidermal compartment. Importantly, we also detected GFRP 
expression and GTPCHI activities in the nucleus of both cell types underlining the importance 
of this signal in this organelle. 
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Dermal Lattice Use Provides an Alternative to Animal Testing
Marchand T, Bauza E, Dal Farra C and Domloge N
Vincience Research Center (France)
Alternative methods to animal testing have received increasing attention in recent years. Ac-
companying this growing interest is a search for new in vitro approaches that enable toxic-
ity testing of cosmetic products. At present, most alternative methods cannot be used to test 
oil-soluble active ingredients or cosmetic products. Furthermore, the experimental conditions 
of these alternative tests are, for the most part, very different from the human skin. For these 
reasons, we were interested in developing a 3D dermal lattice model that approximates skin 
dermal structure and that can be used to test oil-soluble active ingredients. To develop this 
model, it was necessary to determine the adequate quantity of each of its components, includ-
ing collagen I and primary fi broblasts. To arrive at a reproducible and easy-to-handle structure, 
it was also necessary to determine the appropriate time of culture. Porosity studies on the lattice 
revealed the necessity to add mixed solvents, which allowed for a good diffusion of the prod-
ucts throughout the lattice, similar to the controls. MTT viability studies were performed on the 
lattice in order to evaluate toxicity, after application of the oil-soluble active ingredients for 24 
hours. Parallel studies using the Het-Cam test were also performed. Comparison with Het-Cam 
revealed the lattice to be a reliable model for testing oil-soluble active ingredients. Findings 
from the lattice model yielded conclusions similar to those of the Het-Cam method and were 
reproducible when the same experiments were repeated under the same conditions. 
These studies reveal that this dermal lattice offers an interesting alternative to animal testing for 
the evaluation of oil-soluble active ingredients, and presents experimental conditions that are 
close to those found in organisms. 
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Enhanced Cell Viability and Decreased Expression of a Senescence Marker Exhibited in SIRT1-
Induced Human Skin Cells
Dal Farra C, Bauza E, Marchand T and Domloge N
Vincience Research Center (France)
The expression of SIRT1, the human homologue to yeast Sir2, has been associated with a 
number of cellular processes, including lifespan extension. In our previous studies, we ob-
served that SIRT1 is expressed in human skin keratinocytes and fi broblasts, and is physiologi-
cally induced to prevent stress and aging. In this study, we investigated cell viability and se-
nescence in order to evaluate the correlation between SIRT1 expression, induced specifi cally 
in human skin cells by an active ingredient, and the modulation of cell aging. Immunostaining 
and immunoblotting studies were performed in order to evaluate induced-SIRT1 expression 
level in in vitro aged human keratinocytes and fi broblasts. Cell viability studies were performed 
using the MTT method, and cell senescence studies were performed using beta-galactosidase, 
a specifi c biomarker that is absent from quiescent and differentiated cells. The results revealed 
a net increase in nuclear protein SIRT1 expression in in vitro-aged cells (cells up to P16 for 
fi broblasts and P6 for keratinocytes) treated with the SIRT1-inducing active ingredient for 24 
h. This increase reached 73% in immunoblotting studies. In parallel, MTT studies revealed an 
increase in cell viability in the SIRT1-induced cells, compared to control cells where SIRT1 was 
not induced. Moreover, the results revealed a considerably decreased expression of the senes-
cent biomarker beta-galactosidase in SIRT1-induced cells. The aged SIRT1-induced cells exhib-
ited a decrease in number of stained cells and in staining intensity, compared to the control.
These results demonstrate a correlation between SIRT1 induction in aged human skin cells and 
a decrease in the expression of a senescence marker as well as an extension of the lifespan of 
these cells. This method can thus be of great use in anti-aging skin research and in the develop-
ment of skin care products.
056
FOXO3 Expression and Cell Viability Increased by Inducing SIRT1 in Human Fibroblasts
Domloge N, Bauza E and Dal Farra C
Vincience Research Center (France)
 
Studies have shown that in nematodes, the role of Sir2 in increasing lifespan depends on the 
presence of DAF-16, a member of the FOXO family of Forkhead transcription factors. Recent 
studies have also demonstrated that FOXO3, together with the deacetylase SIRT1, plays an 
important role in human cell biology and stress management. In its active state, FOXO is local-
ized in the nuclei where it preferentially induces pro-apoptotic genes, such as FasL and BIM. At 
the same time, FOXO also activates antioxidant genes, depending on the stress level and needs 
of the cell. In previous studies, we demonstrated that SIRT1, the human homologue to Sir2, is 
expressed in human skin cells. In this study, we evaluated SIRT1 and FOXO3 expression in the 
aging process of skin cells. Immunostaining and immunoblotting studies were performed in or-
der to evaluate the effect of SIRT1 induction on FOXO3 expression and cell viability in normal 
and in vitro aged human fi broblasts. SIRT1 induction in young human fi broblasts was shown to 
slightly increase cell viability, compared to control cells where SIRT1 was not induced. FOXO3 
level remained similar to the control in SIRT1-induced young human fi broblasts. In in vitro 
aged cells, SIRT1 induction correlated with a signifi cant increase in cell viability and FOXO3 
expression. Interestingly, this increased expression of FOXO3 was predominantly cytoplasmic. 
Furthermore, an increase in apoptosis did not accompany this increase in FOXO3 (parallel 
studies). These fi ndings confi rm that this augmentation of FOXO3 expression is modulated by 
its desacetylation by SIRT1 (which also increased). 
These results demonstrate the essential physiological role that SIRT1 plays, especially in cell 
aging and apoptosis. These fi ndings highlight the interest of increasing SIRT1 expression in the 
skin, an activity that can be of great use in anti-aging skin care products.
057
Melanin Level and Tyrosinase Activity Reduced in Skin Treated with Brassicaceae Extract
Portolan F, Bressier G, Dal Farra C, Peyronel D and Domloge N
Vincience Research Center (France)
Melanin synthesis reduction has become an increasingly important dimension of dermatologi-
cal research in recent years. In an effort to contribute to the research and formulation of new 
lightening compounds for the skin, we developed an extract of fermented and hydrolyzed pro-
teins from Brassicaceae, and conducted a variety of studies on its effect on melanin synthesis in 
cultured melanocytes and on human skin. In our fi rst set of studies, we observed that melanin 
intensity decreased in a dose-dependent manner in cultured mouse melanoma B16F10 cells 
treated with Brassicaceae extract. Colorimetric assay of tyrosinase enzyme activity revealed 
a corresponding dose-dependent decrease in tyrosinase activity after Brassicaceae extract 
administration. Moreover, melanin level reduction was also observed in studies on ex vivo 
samples of different types of caucasian skin treated with Brassicaceae extract, and this effect 
was seen with different doses. Further studies showed that, in contrast to UV control skin, the 
application of Brassicaceae extract restrained UVB-induced melanin synthesis in skin samples 
exposed to UVB irradiation. In addition, a simple blind clinical study was conducted on fi fteen 
healthy volunteers who applied a cream formula with 3% of the extract on the forearm, twice 
a day, for four weeks. Clinical observation was performed using a scoring method, instrumental 
analysis of skin color, and subjective evaluation. After four weeks of extract application, a clear 
reduction in melanin level in the skin and in pigmented lesions was observed. According to the 
Wilcoxon test, this reduction was statistically highly signifi cant (p=0.00235).
These series of studies reveal that Brassicaceae extract can play an important role in melanin 
synthesis reduction, and thus can be of great use in skin care products and cosmetics designed 
for lightening purposes, for the treatment of pigmentation disorders, and for the moderation of 
UV-induced tanning. 
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Oligodeoxynucleotide Uptake In In Vitro Cultured HaCaT Keratinocytes And In A Full-
Thickness Skin Model
Dorn A1, Bock A1, Mewes K1, Zöller N1, Bernd A2, Bereiter-Hahn J3, Kaufmann R2 and 
Kippenberger S2
1Phenion GmbH & Co. KG, Frankfurt/Main (Germany)
2Dept. of Dermatology and Venerology, University Hospital, Frankfurt/Main (Germany)
3Kinematic Cell Research Group, J. W. Goethe University, Frankfurt/Main (Germany)
CpG oligodeoxynucleotides (ODN) are intensively studied as bioactive molecules in immune 
cells where they are taken up via endocytosis, followed by an accumulation in the endosomal 
compartment. Consecutively, they bind to and activate the Toll-like receptor 9 (TLR-9) evoking 
an immune stimulatory effect. Recently, it was shown that TLR-9 is also expressed in epidermal 
keratinocytes suggesting a relevance of CpG-ODN in epithelial cells.
In the present study, the uptake of fl uorescent labelled CpG-ODN of different lengths was 
tested in HaCaT keratinocytes. We could demonstrate by confocal laser scanning microscopy 
that a 20-mer CpG-ODN as well as a 6-mer ODN enters HaCaT cells instantly after a few min-
utes. After 30 minutes the 20-mer CpG-ODN was detected in perinuclear aggregates, whereas 
the 6-mer CpG-ODN accumulates in the nucleus.
Penetration studies of CpG-ODN into a full-thickness skin model (Phenion® FT skin model) 
were analysed using immunohistochemistry. The Phenion® FT skin model comprises stratifi ed 
keratinocyte layers grown on a fi broblast containing matrix. After topical application of fl uores-
cent labelled CpG-ODN of different length onto the Phenion® FT skin model, the majority of 
fl uorescence was detected within the stratum corneum. Nevertheless, after 4 hours a consider-
able amount of a 6-mer approximates to the stratum basale whereas a 20-mer accumulates in 
more superfi cial skin layers.
In conclusion our fi ndings show that CpG-ODN of different lengths are able to enter epithe-
lial cells. The subcellular distribution of both CpG-ODN tested differed, suggesting a different 
biological activity. Experiments using the Phenion® FT skin model showed that penetration 
of CpG-ODN after topical application is possible and particularly short molecules are able to 
reach the proliferative cell layer. These fi ndings suggest CpG-ODN as pharmacological active 
molecules also in skin keratinocytes.
059
Different Stages Of Bax Expression During Keratinocyte Differentiation And Apoptosis In The 
Human Epidermis
Zuliani Th1, Obriot H2, Tual Ma2, Lachman-Weber N3, Dumas Ma3, Polakowska R2 and 
Ratinaud M1
1EA 3842, Faculte de Medecine, Limoges (France)
2INSERM U814, Lille (France)
3LVMH-Recherche, Saint Jean de Braye (France)
Skin that is in continual contact with the external environment is exposed to numerous chemi-
cal and physical agents, inducing damage responsible of cell death. A tight control of cell 
death process is essential for the maintenance of cellular homeostasis in healthy tissue. Among 
regulators of the execution phase of death, one of the most documented pro-apoptotic proteins 
is Bax, a member of the Bcl-2 family. Bax, is predominantly located in the cytoplasm of healthy 
living cells. In dying cells, Bax is translocated to mitochondria and mediates the release of 
apoptogenic factors into the cytosol. It seems that in normal skin, the spatial and temporal pat-
tern of Bax expression remains controversial. The contradictory observations prompted us to 
re-exam Bax expression. We investigated by immunohistofl uorescence the in vivo expression 
of Bax in normal human epidermis before and 24 hours after irradiation with solar-simulated 
radiations (SSR). Bax expression was correlated to keratinocytes differentiation and apoptosis 
using anti-1 integrin and anti-active caspase-3 antibodies, respectively. Our data highlight the 
differentiation-associated changes in the pattern of Bax subcellular and cellular distribution 
uncovered by those different anti-Bax antibodies in the human epidermis. Hence, using anti-
Bax N20 and A3533 polyclonal antibodies, respectively, we found that whereas undifferenti-
ated keratinocytes of the basal proliferative compartment contained Bax in the cytosol, the 
differentiated suprabasal cells had mainly Bax in the nucleus. Interestingly, the well known 
apoptosis-related Bax redistribution to mitochondria following cell death induction could be 
detected only with the 2D2 monoclonal antibody. This relocalization occurs essentially in ac-
tive caspase-3 positive cells of irradiated epidermis. These results suggest that each antibody 
recognizes different stages of Bax activation that progresses in parallel with keratinocytes dif-
ferentiation and apoptosis.
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Transcriptomal Signature During Keratinocytes Wound Healing: Characterisation of the 
Selective Role ERK, p38 and PI3K Signalling Pathways
Fitsialos G1, Turchi L1, Chassot AA1, A Dayem M2, Moreilhon C2, Meneguzzi G1, Busca R1,
Mari B2, Barbry P2 and Ponzio G1
1Inserm U634 (France) 2CNRS/UNSA UMR 6097 (France)
Reepithelization is a crucial step of cutaneous wound healing. Covering the denuded dermal 
surface requires migration, proliferation and differentiation of keratinocytes. We have surveyed 
at a RNA level the modifi cations occurring in human keratinocytes during the course of a 
wound healing, and we have characterized the major signalling pathways controlling this proc-
ess. For that DNA microarray approach was performed. We report here the identifi cation of 158 
relevant transcripts that. Most of them have never been reported so far during wound healing. 
Expression data were combined with functional results obtained with specifi c inhibitors of 
ERK, p38[MAPK] and PI3 kinases (U0126, SB203580 and LY 294002, respectively). Thus, we 
demonstrate that ERK, p38 and PI3 kinases pathways exert very specifi c functions and con-
trol the expression of highly specifi c groups of genes. Inactivation of the ERK pathway totally 
blocks the wound closure and inactivates a very specifi c set of gene including a great number 
of transcription factors and a majority of growth factor of the EGF family. A different effect was 
noticed after P38[MAPK] inhibition, which only delays the healing process. Inhibition of the PI3 
kinase pathway strongly accelerates wound closure and, in parallel, strongly potentiates the 
injury-dependent stimulation of HAS3, DTR and Ets1, suggesting that, in normal healing condi-
tion, PI3 kinase pathway acts as a fi ne negative regulator of wound healing. In conclusion our 
results open many new interesting fi elds of investigation in physiological and physiopathologi-
cal wound healing.
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061
Expression of Prohibitin and Glucose-regulated Protein 58 In Kaposi’s Sarcoma
Cuccuru MA1, Carta F2, Pirodda C1, Turrini F2 and Cottoni F1
1Institute of Dermatology, University of Sassari (Italy)
2Depart of Genetic, Biological and Medical Chemistry, Sect of Medical Chemistry, University 
of Torino (Italy)
Kaposi’s sarcoma (KS) is a multicentric angioproliferative process with multifactorial etio-
pathogenesis. In addition to the skin, KS may affect oral, genital and conjuntival mucosa, and 
also the gastroenteral tract, although this is rare. In most cases, disease course is slow and 
rarely presents aggressivity. In this study, expression of prohibitin and glucose-regulated protein 
58kDa (GRP-58) were investigated in indolent and anaplastic KS lesions. Two-dimensional gel 
electrophoresis (2-DE) and Western blotting techniques were used for qualitative and quantita-
tive analysis. Proteins extracted from 9 skin biopsies obtained from patients affected by KS 
(7 with indolent KS and 2 with anaplastic KS) were separated by two-dimensional gel elec-
trophoresis (2-DE). The protein spots exhibiting statistical alterations between the two groups 
through computerized image analysis were then identifi ed by mass spectrometry. Western blot-
ting was performed to confi rm the different expression of candidate proteins between the two 
groups. This analysis showed that prohibitin, characterized as an anti-proliferative protein, was 
signifi cantly downregulated in anaplastic KS; GRP-58, a molecular chaperone, was signifi -
cantly upregulated in anaplastic KS. 
062
The Truncation Of The Distal C-terminus Of Collagen XVII /BP180 Impairs Glycolylation And 
Leads To Intracellular Accumulation
Franzke CW1, Has C1, Schulte C2, Huilaja L3, Tasanen K3, Aumailley M2 and Bruckner-Tuderman L1
1Department of Dermatology, University of Freiburg (Germany)
2Department of Biochemistry, University of Cologne (Germany)
3Department of Dermatology, University of Oulu (Finland)
Collagen XVII, a type II transmembrane protein in hemidesmosomes, is involved in the an-
chorage of stratifi ed epithelia to the underlying mesenchyme. Its functions are regulated by 
ectodomain shedding and its genetic defects lead to epidermal detachment in junctional 
epidermolysis bullosa (JEB), a heritable skin fragility syndrome, but the molecular disease 
mechanisms remain elusive. Here we used a spontaneously occurring homozygous COL17A1 
deletion mutant in JEB to discern glycosylation of collagen XVII. The mutation truncated the 
distal ectodomain and positioned the only N-glycosylation site 34 amino acids from the newly 
formed C-terminus, which impaired effi cient N-glycosylation. Immunofl uorescence staining 
of authentic JEB keratinocytes and of COS-7 cells transfected with the mutant indicated in-
tracellular accumulation of collagen XVII precursor molecules. Cell surface biotinylation and 
quantifi cation of ectodomain shedding demonstrated that only about 15% of the truncated 
collagen XVII reached the cell surface. The cell surface associated molecules were N-glyco-
sylated in a normal manner, in contrast to the molecules retained within the cells, indicating 
that N-glycosylation of the ectodomain is required for targeting of collagen XVII to the plasma 
membrane and that reduced accessibility of the N-glycosylation site negatively regulates this 
process. Functional consequences of the strong reduction of collagen XVII on the cell surface 
included scattered deposition of cell adhesion molecule laminin 5 into the extracellular envi-
ronment and, as a consequence of faulty collagen XVII-laminin ligand interactions, aberrant 
motility of the mutant cells.
063
Anti-aging Activities On Ex Vivo Living Skin Explants
Gasser P, Peno-Mazzarino L, Doremus S and Lati E
1Histo-biology department, BIO-EC (France)
Ex vivo living skin explant is a very good tool for the highlighting activities of anti-aging prod-
ucts.
Capable to be maintained in survival during 12 days with a good morphology conservation in 
the BIO-EC Medium, this model shows, after some products applications, results comparable 
to those observed on biopsies after in vivo studies and after some weeks of applications.
With this model, we are able to evaluate the epidermal thickness increase, the GAGs, collagen 
l or lll synthesis, the dermal-epidermal junction restructuration visualized after immunostain-
ing, the UV protection by sun burn cells induction, the P53 or caspase cells counting, the 
anti-free radicals effi cacy by MDA quantifi cation.
With this model, it is possible to show the activity of many cosmetic and derma-cosmetic 
products.
064
High expression of neuropeptide Y in human lip keratinocytes
Sallette J1, Al-Sayed N2, Adem C3, Laboureau J4, Soussaline F1 and Breton L4
1IMSTAR S.A. 60 rue Notre Dame des Champs PARIS (France)
2Cabinet de Pathologie Dr Hammou et Dr Gerard 1 rue Barety NICE, (France)
3Cabinet de Pathologie, 49 rue du Ranelagh, PARIS (France)
4L’OREAL RECHERCHE , CLICHY (France)
The presence of nervous fi bers in human epidermis is well-established. They play a major role 
in sensitivity and immune response. In this paper, we demonstrate a differential expression of 
neuronal markers among different facial locations. In particular, strong expression of NPY in 
lip keratinocytes is shown for the fi rst time, thus suggesting a possible control of skin plasticity 
by autonomous system in response to stress or ageing.
065
Identifi cation of Ifapsoriasin as a Novel and Putative New Member of the ”S100 Fused Type 
Protein” Family
Wu ZH, Hansmann B andSchröder JM
Dept of Dermatology, University Hospital of Schleswig-Holstein, Campus Kiel (Germany)
S100 fusion type proteins (SFTPs) are a family comprised of proteins involved in keratinocyte 
terminal differentiation. They show a protein structure similar to the S100 protein family like 
psoriasin and the calgranulins with an S100 domain and an EF hand domain at the N- terminus 
as well as to the Cornifi ed Envelope (CE) precursor proteins like involucrin and loricrin at the 
C-Terminus. Five members of the human SFTP genes have been identifi ed so far: trichohyalin, 
profi laggrin, hornerin, c1orf10, and repetin. They all localize to a region known as the “Epi-
dermal Differentiation Complex” (EDC) on human chromosome 1q21.3, and share a highly 
conserved structure on mRNA level. To seek for potential new members of the SFTP family 
in silico data analyses of the EDC was performed. We could identify a putative novel SFTP 
gene termed ifapsoriasin. The full-length cDNA was determined by RACE PCR and PCR walk-
ing. The deduced protein sequence is composed of an S100 domain, an EF hand domain, a 
spacer sequence and internal tandem repeats. Whereas on amino acid level the S100 domain, 
the EF hand domain, and putative calcium binding sites show high similarity among all SFTP 
members, the repeat number and sequences differ in each protein. Among the tested 23 differ-
ent human tissue samples, ifapsoriasin mRNA was detected only in healthy skin and in small 
intestine. Real time PCR-analyses revealed a strong up-regulation of ifapsoriasin expression 
in cultured human keratinocytes in response to calcium stimulation. Our results indicate that 
ifapsoriasin is a putative new member of the S100 fused type protein family similar to the 
prototypical members as profi laggrin and trichohyalin, which interestingly as yet has not been 
identifi ed upon sequencing of chromosome 1.
066
Lipases of Staphylococcal Epidermidis - Are they Important for Skin Colonisation?
Holland DB, Wright JD, Longshaw CM, Bojar RA, Ingham E and Holland KT
Skin Research Centre, University of Leeds (United Kingdom)
Staphylococcus epidermidis is a major resident of the lipid-rich regions of human skin and 
the factors required for its colonisation and persistence have not been identifi ed. Previously, 
we reported that S. epidermidis had two lipases, GehC and GehD. Since the gehC gene was 
located adjacent to the ica operon, which is involved in the formation of biofi lms, this study ex-
amined whether lipases, as well as having a nutritional function, played a role in colonisation. 
To determine the regulation of expression of the lipase genes, plasmid-based transcriptional 
luciferase reporter gene fusions were constructed. Batch cultures in chemically defi ned me-
dium showed that gehC and gehD were upregulated in the late exponential phase of growth. 
Isogenic single and double mutants were constructed and tested for their capacity to colonise 
an in vitro human skin equivalent (SE) model. The wild type and all mutant strains colonised 
the SEs. However, the gehD- mutant did not affect the integrity of the stratum corneum like the 
other strains. Also, this was associated with a 60% statistically signifi cant reduction in colonisa-
tion by this mutant. Further, in vitro substrate specifi city tests demonstrated that the mutants still 
had some lipase activity, which indicated the existence of more lipase genes in S.epidermidis. 
A genome search using gehC and gehD sequences confi rmed the presence of two extra lipase 
genes. The multiplicity of lipase genes shows their importance to the survival of this organism. 
Taken together these results suggest a role for lipases in the later stages of colonisation of S. 
epidermidis on human skin. 
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The S143F Lamin A/C Mutation Is Associated With Structural And Functional Changes Of 
The Nuclear Envelope
Lüke Y1, Kandert S2, Munck M1, Wehnert M3, Dabauvalle M2, Noegel A1 and Karakesisoglou I1
1Institute for Biochemistry I, Medical Faculty, University of Cologne (Germany)
2Department of Cell and Developmental Biology, University of Würzburg (Germany)
3Institute of Human Genetics, Ernst-Moritz-Arndt-University Greifswald (Germany)
Nesprin-1 and Nesprin-2 belong to a novel family of vertebrate α-actinin type actin-binding 
proteins residing at the nuclear membrane. We demonstrated recently that Nesprin-2 binds 
directly to emerin and the C-terminal common region of the nuclear envelope protein lamin 
A/C. In addition, lamin A/C is necessary for the proper nuclear envelope localization of Ne-
sprin-2. These data suggest that lamin A/C mutations may disrupt the localization and function 
of Nesprin-2 at the nuclear envelope. Mutations in human lamins cause a variety of disorders 
like Hutchinson-Gilford Progeria syndrome and several types of muscular dystrophies. Here we 
analysed dermal fi broblasts from a patient combining features of progeria and muscular dystro-
phy due a single missense mutation in LMNA (S143F) and we found that in early-passage cells 
20,9 % of the cells showed nuclear shape deformations (lobulations). Interestingly, the amount 
of nuclear defects progressively increased as cells aged in culture. Deformed nuclei often dis-
played a mislocalization of Nesprin-2, whereas the localization of Nesprin-1 remained unaf-
fected. In addition, we found that emerin, an inner nuclear envelope integral protein, formed 
aggregates at the nuclear envelope in the mutant cells. An altered distribution of nuclear pores 
could also be detected. Furthermore, western blot analysis showed a very weak expression of 
LAP2 compared to its expression in wild-type cells. These data were confi rmed by transfecting 
a GFP-S143F lamin A fusion protein into mouse and human dermal wild-type fi broblasts. We 
observed a mislocalization and the formation of aggregates of both LAP2 and emerin only in 
transfected cells. In summary our data suggest that the lamin A/C S143F mutation can affect the 
function of Nesprin-2 at the nuclear membrane and support profound roles for Nesprin-2 in the 
nuclear architecture and function.
068
Engagement of Killer Cell Ig-like Receptors Expressed by Malignant CD4+ Sezary Cells 
Increases their CD3-induced Proliferation
Huet D1, Ortonne N1, Le Gouvello S2, Tessier-Marteau A3, Berrehar F2, Marie-Cardine A1,
Bagot M4 and Bensussan A4
1INSERM U659, Faculté de Médecine de Créteil (France)
2Department of Biological Immunology, Henri Mondor Hospital (France)
3INSERM U659, Faculté de Médecine and Dept of Biological Immunology, Henri Mondor Hos-
pital (France)
4INSERM U659, Faculté de Médecine and Dept of Dermatology, Henri Mondor Hospital 
(France)
Sezary Syndrome (SS) is a CD4+CD45RO+ leukemic variant of cutaneous T cell lymphomas 
(CTCL). In previous studies we found that malignant SS cells expressed KIR3DL2/CD158k re-
ceptors and thus could be distinguished from normal lymphocytes. Here, we investigated in 
these tumor lymphocytes the expression of different killer cell Iγ-like receptor (KIR) transcripts. 
The function of the KIRs was further studied in circulating cells, and in a long-term derived ma-
lignant T cell line established from an SS patient and expressing signifi cant amount of CD158a, 
CD158b and CD158k membrane receptors. CDR3 TCRVβ-chain sequencing revealed the 
clonality and the identity of the circulating malignant cell population and the derived-cell 
line. While transcript expression and biochemical analysis demonstrated that the CD4+ tumor 
cells expressed both KIR2D-S and KIR2D-L molecules, triggering by specifi c anti-CD158a or 
-CD158b mAbs, that recognized both isoforms of each receptor, resulted in an increase of 
the CD3-induced malignant cell proliferation. We demonstrated that CD158a, CD158b and 
CD158k inhibitory molecules did not become phosphorylated on their ITIM tyrosine residues 
upon pervanadate treatment, and that SHP-1, while expressed, was not recruited. This suggests 
that KIR expression may favor Sezary cell expansion. Finally, although Sezary cells can lack 
FoxP3 expression they still produce immunoregulatory cytokine IL-10, thus escaping the im-
mune surveillance. 
069
Culture of Merkel Cells
Boulais N1, Pereira U1, Rougier N2, Dorange G3, Chesné C2 and Misery L1
1Department of Dermatology, University Hospital, Brest (France)
2BIOPREDIC International, Rennes (France)
3Department of Cell culture, University of Western Brittany, Brest (France)
Merkel cells (MC) are the least known cell type of the epidermis. This poor knowledge is mainly 
due to their scarcity and their post-mitotic state which makes their culture very diffi cult. How-
ever, their connexion with the nervous system and the number of neurohormones they secrete 
let us to think they play an essential role in the skin homeostasis. With the aim to gain further 
insight into MC, we performed a new model of culture of enriched-MC epidermal cells.
First, epidermal cells of several anatomical sites from different species were dissociated and 
then tested by immunocytochemistry for the expression of cytokeratin 20, a general marker of 
cutaneous MC. Pig snout allowed to obtain numerous easily reachable MC, whereas it was 
more diffi cult from the outer root sheath of rat vibrissae
Hence, epidermal sheets were taken off the pig snouts and enzymatically-isolated cells of the 
basal layer were recovered. We used specifi c cell surface marker to positively select magnetic-
labelled MC by MiniMACS separation columns
Results were analysed by immunocytochemistry and transmission electron microscopy to con-
fi rm the presence of MC. Flow cytometer analysis are under way to precisely quantify the 
enrichment in MC in our culture.
Using this technique, we were able to obtain a culture of epidermal cells in which MC often 
represent more than 50% of the whole sample. Our model provides a new tool to study MC 
and their infl uence upon other epidermal cells; and it might further allow performing molecu-
lar biology analysis for a better understanding of the intimate mechanisms of these cells.
070
The Role Of Cholesterol In Microdomain Structure Of Erythrocytes, Lymphocytes And 
Granulocytes Membranes In Psoriasis. A Spin Label Study
Nowak J1, Nedoszytko B2, Wozniak M3, Syta E1 and Siedlecka K3
1Department of Biophysics, Medical University of Gdansk (Poland)
2Department of Dermatology, Medical University of Gdansk (Poland)
3Department of Medical Chemistry, Medical University of Gdansk (Poland)
Psoriasis is a chronic infl ammatory skin disorder characterized by a focal dense infi ltration 
of neutrophils, T lymphocytes and macrophages that migrate from the vascular system to the 
skin. Oxygen metabolites and proteases released by activated infl ammatory cells may induce 
oxidative and proteolytic damage in the skin and blood cells. Patients with psoriasis showed 
changes in blood cell count: reduced red blood cells (RBC) number, and increased number of 
leukocytes, mainly neutrophils and basophils. RBC have reduced antioxidant defense, osmotic 
fragility and elevated membrane lipid peroxidation.
The aim of our study was to analyze the differences in a microdomain structure of erythrocytes, 
lymphocytes and granulocytes cell membranes in psoriatic patients and healthy controls. The 
study was performed in 10 psoriatic patients and in 10 control healthy donors. From each 
person the erythrocytes, lymphocytes and granulocytes were isolated from peripheral blood. 
The cells were incubated with different concentration of methylcyclodexstrin (MCD) to deplete 
the membrane cholesterol. Next, the cells were labeled with spin label 5-doxyl-stearic acid 
(5DS) and electron spin resonance spectra (EPR) were analyzed. The changes in microdomain 
structure of the membrane were determined by using mathematical model based on linear 
regression method.
We have found that a decrease in the membrane cholesterol content strongly affects the mem-
brane organization by decreasing the number or size of microdomains. This effect was signifi -
cantly stronger in the membranes of cells derived from psoriatic patients.
Our results indicate the differences in microdomain membrane structure in the cells of psori-
atic patients in comparison to control group. This effect could be related to different membrane 
cholesterol content and its distribution.
071
In Vitro Model For Studies On Cutaneous Neurogenics Infl ammation
Pereira U1, Boulais N1, Lefeuvre L2, Dorange G3, Gougerot A2 and Misery L1
1Department of Dermatology, University of Brest (France)
2Laboratoires Dermatologiques d’Uriages (France)
3Laboratory of Physiology, Faculty of Medecine Brest (France)
Neurogenic infl ammation is due to the release of neuropeptides like subtance P (SP), from the 
sensory endings. It induces edema, erythema, pain or pruritus and participates in the patho-
physiology of various skin disease. Until now, there is non in vitro model of neurogenic infl am-
mation. We have performed a co-culture of neurons and epidermal assays associated with an 
enzyme immunoassay (EIA).
Neurons from dorsal root ganglia and epidermal cell were extracted from a piglet between 3 
and 10 days old, by differents enzymatic traitements: dispase and trypsin for keratinocytes, and 
collagenase IV and trypsin for neurons. Then, they were seeded in 96 well-microplates. After 
one week of culture, neurons developped neurites towards keratinocytes and SP- EIA was car-
ried out in the culture medium.
A basal amount of SP release was detected. This baseline can be considerably increased in a 
dose-dependent response by compounds involved in the neurogenic infl ammation like cap-
saicine. Some molecules were able to attenuate or to enhance this stimulation. Interesteingly, 
tacrolimus increased SP levels as well as capsaicin. 
In conclusion, this model will be a valuable tool to screen news agents for dermatologic or 
cosmetics industries. The next step of this research is a screening on compartmented co-cul-
ture. This new stage is made possible by the development of microsystems with or without 
integrated microelectrode.
072
Differentiation-dependent Apoptotic Response of the Human Epidermis Exposed to H202, 
UV-B and a Full Solar Spectrum
Nicol Ma1, Zuliani Th1, Juan Mi2, Noblesse E2, Stenger Ch1, Lachman-Weber Na2, Schnebert Sy2, 
Dumas Ma2 and Ratinaud M1
1EA 3842, Faculte de Medecine, Limoges (France)
2LVMH-Recherche, Saint Jean de Braye (France)
More than other tissues, epidermis is continuously exposed to numerous stresses leading to 
alterations of keratinocytes. Among them the sunlight is the main cause of skin ageing and car-
cinogenesis through its UV-A and UV-B wavelengths, the harmful effects of UV-A being mainly 
triggered by ROS and H2O2 in particular. Damaged cells are actively removed by apoptosis, 
which contributes to the maintenance of epidermal integrity and functions. Recent studies sug-
gest that epidermal cell susceptibly to apoptosis is differentiation-dependent. To explore this 
hypothesis normal human skin was submitted ex vivo to H2O2 (from 500 m to 5 mM) or UV-B 
(from 50 to 5000 mJ/cm2) and in vivo to a full solar spectrum (3-Minimal Erythema Dose). After 
stress exposures, skin cryosections were double stained for apoptotic cells (active caspase-3 
or Bax antibodies) and β1-integrin expression, a marker of basal keratinocytes. 24hrs after 
solar irradiation, apoptosis was easily detectable in the epidermis (66% in the differentiated 
suprabasal and 34% in basal layers respectively). Whereas UV-B induced apoptotic responses 
were restricted to the spinous layer; phenomenon was accompanied by a relocalization of 
Bax, a pro-apoptotic regulator of the Bcl-2 family, from nucleus to mitochondria, according to 
UV-B intensity. With H2O2 exposure, apoptotic cells were only located in the basal layer of 
the epidermis. Results indicate that epidermal cells exhibit a differentiation-dependent respon-
siveness to the full solar spectrum, specifi c wavelengths and oxidative stress. They suggest that 
suprabasal keratinocytes are the most sensitive to UV-B induced apoptosis since basal cells, 
resistant to UV-B, could mainly be responsive to reactive oxygen species generated by UV-A. 
Finally this strengthens the close relation between UV-A mediating photoaging and the specifi c 
sensitivity of the basal epidermal layer to ROS. 
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Mechanisms of Internalization and Recycling of Somatostatin-Receptor 1
Roosterman D and Steinhoff M
Department of Dermatology, University of Münster (Germany)
Endocytosis of somatostatin receptors regulate cellular responses to the two natural peptides, 
somatostatin-14 (SST-14) and somatostatin-28 (SST-28), and to synthetic ligands used in the 
clinical diagnosis and symptomatic therapy of neuroendocrine tumours. Thus it is of impor-
tance to understand the mechanism and function of receptor-subtype specifi c internalization 
and traffi cking. We investigated SST-14 induced internalization and traffi cking of stably ex-
pressed rat somatostatin-receptor 1 (sst1) in rat insulinoma 1046-38 cells and determined the 
localization and function of intracellular resident sst1. During the fi rst 2-5 min of stimulation, 
50% of surface located receptors are internalized, cotransporting 50% of surface-bound SST-
14 into acidic wash resistant cell compartments. Chronic stimulation with SST-14 induced 
a sst1-mediated accumulation of SST-14. After 75 min of stimulation, 2.2 times the amount 
specifi cally bound SST-14 were found cell-associated. The amount of accumulated SST-14 di-
rectly depends on the KD-value of sst1. Refreshing the medium induced recycling of intact and 
biological active SST-14. The biochemical data indicate a dynamic process of sst1-mediated 
endocytosis, recycling, and re-endocytosis of SST-14. Receptor and FITC-SST-14 were initially 
internalized within superfi cial cell compartments. Intracellular resident sst1 was located within 
Rab5a- and Rab11a-positive compartments, indicating receptor distribution within the endo-
cytoic and recycling pathway of the cell. SST-14 activated translocation of resident sst1 to the 
cell surface. In summary, our results identifi ed the pathway of SST-14 induced traffi cking of 
sst1 and demonstrate that sst1 mediates dynamic process of endocytosis, recycling and re-
endocytosis of SST-14 
074
The BMP-4 Dependent Epidermal Commitment Of Mouse Embryonic Stem (ES) Cells Is 
Associated With Apoptosis Of Developping Neural Precursors
Gambaro K, Aberdam E, Virolle T, Aberdam D and Rouleau M
INSERM U634 (France)
The BMP-4 dependent epidermal commitment of mouse embryonic stem (ES) cells is associ-
ated with apoptosis of developing neural precursors.
It has been stated that the embryonic development of the epidermis requires inductive signals 
and proceeds from the inhibition of the dorsal ectoderm neuralization. The BMP-4, a key regu-
lator of this commitment, can directly induce the epidermal cell fate and inhibit the forma-
tion of the neural tissue. Using ES cell technology to study the initial molecular mechanisms 
underlaying these lineage differentiations, we focused our work on the precise role of BMP-4 
in the early choice between the neural and the epidermal commitment. We show that BMP-4 
treatment induces a severe inhibition of the neural differentiation process leading to epider-
mal commitment. A high proportion of ES cells, engaged in differentiation towards neural cell 
types, undergoes a dose dependent apoptotic cell death early after treatment with BMP-4. This 
apoptotic cell death, involving mitochondrial damages leading to the cleavage of caspase-3, 
targets early neural Sox-1 positive precursor cells. The overexpression (by adenoviral infection) 
of the Smad-6 protein (a specifi c endogeneous inhibitor of the Smad pathway) prevented, as 
expected, the BMP-4 inhibition of the neural differentiation. Focusing on the remaining live 
cells, we observed an upregulation of mRNA transcripts known to be involved in the epider-
mal commitment. Among them, the deltaN isoform of the p63 nuclear factor was transcribed, 
starting 24 h after the BMP-4 treatment, associated with the onset of the epidermal precursor 
differentiation. Altogether, our results suggest that, in mammals, BMP-4, as an active inducer of 
the epidermal commitment, directely interferes with the survival of the neural precursors. This 
cellular model of early development will further allow to defi ne the crucial molecular events 
involved in the normal epidermal differentiation and those associated with developmental re-
lated pathologies.
075
RNase 7, an Important Member of the Cutaneous Defense System
Rudolph B and Harder J
Dept of Dermatology, University Hospital of Schleswig-Holstein, Campus Kiel (Germany)
Human skin protects itself by the release of various antimicrobial proteins like beta-defensins 
and ribonucleases such as RNase 7. RNase 7 is a broad spectrum antimicrobial protein with 
high antimicrobial activity against different bacteria and fungi. To gain more insight into the 
role of RNase 7 in the defense system of human skin, we analyzed its expression in primary 
keratinocytes and compared it to the expression levels of the antimicrobial proteins hBD-2, 
hBD-3 and Psoriasin. Using real-time PCR we observed highest constitutive gene expression 
of RNase 7 which was upregulated in cells grown at higher confl uence. This observation was 
in concordance with ELISA-experiments showing a high RNase 7 protein expression and an 
upregulation during differentiation of the keratinocytes. Immunohistochemistry analyses con-
fi rmed high expression levels of RNase 7 in the more differentiated upper layers of human 
epidermis. To elucidate the antimicrobial signifi cance of RNase 7 we generated RNase 7-spe-
cifi c antibodies which neutralized the antimicrobial activity of RNase 7 in an antimicrobial 
microdilution assay. Supernatants of cultured primary keratinocytes showed high antimicrobial 
activity against microorganisms such as E. coli. Treatment of these supernatants with the neu-
tralizing anti-RNase 7 antibodies resulted in a signifi cant decrease of killing activity against 
E. coli. In summary these fi ndings demonstrate the important biological role of RNase 7 as 
an antimicrobial factor produced by human keratinocytes and indicate that RNase 7 may be 
signifi cant involved in cutaneous innate immunity.
076
Skin Stress Response to Exposure to GSM-1800 Mobile Phone Signal
Sanchez S, Lagroye I, Billaudel B and Veyret B
PIOM Laboratory, CNRS 5501 UMR, University of Bordeaux 1 (France)
Stress response is a common process in skin against environmental injuries. Numerous mecha-
nisms are involved from an increase of stress proteins to the cellular death. Our goal was to 
determine if radiofrequency radiation (RFR) emitted by mobile phone signals could act as a 
stressor. Indeed, the frequency of these signals ranges from 900 to 2000 MHz with an energy 
absorbed in the skin increasing with the frequency. This energy absorption is expressed as the 
specifi c absorption rate, SAR in W/kg. Therefore, the skin represents a good model to inves-
tigate the effect of a mobile phone exposure. GSM-1800 is the signal tested on two models: 
(i) normal human primary keratinocytes and fi broblasts were exposed to a GSM-1800 signal ( 
2W/kg SAR) for 48 hours and (ii) Hairless female rats were submitted to a single (2 hours to a 
4W/kg SAR) or a repetitive (2h/day, 5 d/week, 12 weeks to a 2 or 4W/kg SAR) exposure. Follow-
ing exposure, the cellular stress response was measured in vitro and in vivo as the expression of 
three heat-shock proteins (HSPs: Hsc70, Hsp27 or 25 and Hsp70) by using immunochemistry. 
Additional parameters were investigated: apoptosis in vitro (fl ow cytometry) and epidermal 
overproliferation in vivo (Ki-67 immunodetection). The results showed that an exposure to the 
GSM-1800 signal induced apoptosis neither in human keratinocytes nor in dermal cells (n=8 
independent experiments). Moreover, no changes in the HSPs expression were observed what-
ever the cell type used. The in vivo study showed that a single or a repeated exposure did not 
induce any overproliferation of the epidermal cells or HSPs expression alteration (n=8 animals 
/ group). There is no evidence, under the conditions tested, that RFR emitted by mobile phones 
could act as a stressor agent for the skin.
077
Hydrogen Peroxide Mediated Oxidation Severely Compromises The Methionine Sulfoxide 
A/thioredoxin Reductase Antioxidant Defence System
Schallreuter KU1, Gibbons CJ2, Rokos H3, Ruebsam K3 and Wood JM1
1Clinical and Experimental Derrmatology, Department of Biomedical Sciences, University of 
Bradford (United Kingdom)
2Institute for Pigmentary Disorders, Greifswald/Germany and Bradford/ UK (United Kingdom)
3Institute for Pigmentary Disorders, Greifswald/Germany and Bradford/ UK (Germany)
Methionine sulfoxide reductase A (MSRA) and thioredoxin reductase (TR) have been shown 
to be present in the human epidermis providing a powerful antioxidant defence and repair 
mechanism. One of the most important reactive oxygen species (ROS), is hydrogen peroxide 
(H2O2), as it can damage the structure of proteins by oxidising methionine (Met) residues to 
methionine sulfoxide (MetSO), tryptophan (Trp) to 5-hydroxytryptophan (5-OH-Trp), cysteine 
(Cys) to cysteic acid and seleno cysteine (Sec) to its selenolate. MSRA specifi cally reduces 
MetSO back to Met. This process requires TR, which assists in the thiol-disulfi de exchange 
reactions that occur between the catalytic Cys residues to regenerate the enzyme. Since abnor-
mally high levels of H2O2 are found in patients with vitiligo, we asked the question whether 
this ROS could affect these two important proteins. To address this, we used in situ and in vitro 
immunolabelling, Westernblot, in vivo and in vitro FT-Raman spectroscopy, enzyme kinetics 
and structural computer modelling. Our results showed that oxidation of Met, Cys and Sec 
severely affects the function of both enzymes. Several Met and Trp residues exist either in or 
around the MSRA active site, and oxidation of these by H2O2 causes changes in the position 
of the active site Cys, supporting decreased enzyme activity. Likewise, H2O2 mediated oxida-
tion of Met/Trp/Cys/Sec residues in TR decreases its enzyme activity. Several Met residues exist 
around the binding site for the essential cofactor NADPH. Oxidation of these residues results 
in a severe decrease or complete loss in affi nity for NADPH, leading to complete deactivation 
of the enzyme. In conclusion, our results show that the redox balance is severely compromised 
by H2O2 affecting also these two important antioxidant protein repair mechanisms.
078
Towards The Development Of A Pragmatic Technique For Isolating And Differentiating 
Nestin+ Cells From Human Scalp Skin Into Neuronal And Glial Cell Populations: Generating 
Neurons From Human Skin?
Kruse C1, Bodó E2, Petschnik AE1, Danner S1, Tiede S2 and Paus R2
1Fraunhofer-Inst of Biomedical Engineering, Group of Cell Differentiation & Cell Technology 
(Germany)
2Univ Hospital Schleswig-Holstein, Univ of Lübeck, Dept of Dermatology (Germany)
Although human skin is one of the most highly innervated organs of the mammalian organism, 
skin is generally accepted to be free of neuronal cells. Instead, sensory neurons are located far 
outside of the skin organ, i.e. in dorsal root ganglia or in sympathetic tracts. Based on previous 
reports that nestin+, keratin 15-hair follicle-associated cells of murine skin can be isolated and 
differentiated in vitro into neuronal and glial cells.
Human scalp skin is an easily accessible tissue source of the human organism and has been 
shown to be source of adult stem cell populations. Therefore, we were interested in studying, 
whether nestin+ cells can be detected in human scalp skin in situ, and whether these can be 
isolated, cultured, propagated and differentiated into neuronal and/or glial cell populations. 
For practical purposes, we were interested in techniques that do not require microdissection 
of stringently defi ned cell populations. Instead, we wished to explore only techniques that 
require crude isolation techniques, simple mechanical manipulations and enzymatic digestion 
and that would, thus, be widely applicable in clinical practise. We show that normal human 
scalp skin displays numerous, non-randomly distributed nestin+ cells in defi ned cutaneous 
compartments which were neurofi lament-negative. This shows that in vivo nestin+ cells of 
scalp skin do not represent neuronal cells. But in vitro we were able to differentiate them into 
neuronal (PGP9.5+, CD44+, Pax6+) and/or glial (GFAP+, MBP+) cells. In contrast to previous 
fi ndings in murine the human scalp skin showed the largest number of nestin+ cells in defi ned 
mesenchymal compartments: the immediate mesenchymal vicinity of sweat glands, sebaceous 
glands, and the hair follicle epithelium. 
2006 ESDR ABSTRACTS
 www.jidonline.org s15
2006 ESDR abstracts.1.indd   s15 7/6/06   3:06:06 PM
079
Use Of The Human Keratin15-promotor For Targeting Epithelial Stem Cell Populations In The 
Human Hair Follicle
Tiede S and Paus R
Dept of Dermatology, Univ Hospital Schleswig-Holstein, Univ of Lübeck (Germany)
Previous work has shown the utility of the keratin15-promotor for targeting epithelial hair fol-
licle stem cells (eHFSC) in mice. The murine keratin15-(K15)-promotor preferentially identifi es 
hair follicle bulge cells in adult mice, and K15-mRNA is overrepresented in bulge outer-root-
sheath cells, consistent with the increase in K15-protein detected in the Tdr-label retaining 
region that could be defi ned as the counterpart of the human anagen hair follicle bulge. Since 
K15-promoter-driven GFP-expression in transgenic mice has successfully been employed for 
cell-sorting and gene profi ling of murine eHFSCs, it would be highly desirable to utilize this 
promoter also for demarcating eHFSC in the human system. However, it remains to be dem-
onstrated that this is feasible.
To attempt this, we have cloned the human K15-promotor into a GFP-expression system and 
have transiently transfected microdissected whole, organ-cultured human anagen-VI hair fol-
licles from normal scalp skin in vitro, using modifi ed pEGFP-N1. 
Preliminary results with this technique indicate that a K15-promoter-driven expression of GFP 
can indeed be seen in the bulge region of human hair follicle. This has not been achieved 
before in an intact human organ. However, since GFP expression can also be seen in unex-
pected human hair follicle regions not previously recognized to show K15-promoter activity, 
this method requires further controls, better characterization, and stringent controls. 
Nevertheless, this in vitro method already holds substantial promise as an experimental tool 
for demarcating human eHFSC and for distiguishing these from other hair follicle stem cells 
populations as well as from epidermal keratinocyte stem cells. In addition, targeting the human 
K15-promoter may become exploitable for gene and stem cell therapeutic purposes in human 
skin, and may be recruited as a powerful new therapeutic tool for the management of selected 
hair growth disorders.
080
The Impact of Aging on the Expression of Selected Genes (Heat Shock Proteins, Elastin, 
Fibrillin, and Steroid Hormone Receptors) in Human Skin
Klosner G1, Matsui M2, Muizzuddin N2, Kokesch C1, Grabner R1, Hofstatter E1, Binder M1 and 
Trautinger F3
1Department of Dermatology, Medical University of Vienna (Austria)
2Estee Lauder Research, Melville, NY (USA)
3Department of Dermatology, Landesklinikum St. Poelten (Austria)
Changes in steroid hormones and their receptors, extracellular matrix proteins, and heat shock 
proteins (HSP) have been discussed as causes and/or consequences of intrinsic skin aging. 
Thus, in the present study mRNA expression of estrogen receptors 1 and 2 (ESR1, ESR2), pro-
gesterone receptor (PGR), elastin (ELN), fi brillin 1 (FBN1), and heat shock proteins 27, 72, and 
90 (HSP27, HSP72, HSP90) were quantifi ed in the skin of healthy female volunteers. 44 vol-
unteers (phototypes II and III) were included in the study; ages were between 19 and 28 (group 
I, n=22) and between 55 and 65 (group II, n=22). Punch biopsies were taken from the upper 
inner arms and the expression of the genes of interest was quantifi ed by real-time RT-PCR. Im-
munohistochemistry was used to investigate HSP27 and HSP72 before and after heat stress. We 
found that expression of ESR1, ESR2, PGR, HSP27, HSP72, and HSP90 did not show signifi cant 
differences between age groups. Expression of ELN and FBN1 was signifi cantly higher in group 
II (ages 55 to 65yrs) (p=0.037 and 0.001, respectively; U-test). Ex vivo heat shock induced an 
identically strong increase in the intensity of hsp72 immunostaining in both groups. For hsp27 
a less pronounced but statistically signifi cant induction was only observed in group I, but not 
in group II. These results demonstrate that in sun protected healthy female skin the expression 
of steroid receptors and HSP remains remarkably stable between 19 and 65 years indicating 
that these factors are essential for skin physiology. The reduced ability to respond to stress with 
induction of hsp27 and the increased expression of the major components of elastic fi bers 
might correspond to an impaired adaptive capacity and to a dysregulation of extracellular 
matrix formation that contribute to the phenotype of aged skin. 
081
In Vitro Activity Of Dermal Fibroblasts Cultivated On Human Amniotic Membrane
Viennet C1, Goydadin AC1, Saguet T1, Binda D1, Gounand M1, Lapierre V2, Tiberghien P2 and 
Humbert P1
1Lab d’Ingénierie et Biologie Cutanées, EA 3183, IFR 133, UFR Médecine, Besançon (France)
2Etablissement Français du Sang Bourgogne-Franche-Comté, Besançon (France)
Human amniotic membrane (AM) is an excellent biological dressing and its clinical applica-
tion has been under study for many years (ocular surface disorders, skin ulcers...). The main 
purpose of this in vitro study was to investigate the effects of AM on the wound healing func-
tions of human dermal fi broblasts: migration, proliferation, collagen synthesis and differentia-
tion into myofi broblasts. Fibroblast cultures were established by outgrowth from abdominal 
skin biopsies of fi ve healthy women (aged 45±10 years). They were covered with cryopreserved 
AM. Cell proliferation was measured by MTT colorimetric assay (n=20 for each cell line). Col-
lagen I was determined by Elisa assay (n=8). Alpha-smooth muscle actin (α-SMA) was detected 
by immunostaining (n=2). Fibroblasts were embedded in type I collagen gel to assess migration 
(n=8). Data analysis showed a good reproductibility among the fi ve cell lines. We found that 
AM stimulates fi broblast proliferation (+24%), while it inhibits migration (-32%). AM has no 
effect on collagen I synthesis and α-SMA expression. This in vitro study reports that AM modu-
lates some fi broblast functions such as proliferation and migration. These effects may contribute 
to AM as an ideal dressing. The mechanism by which AM changes cell growth and migration 
remains to be established.
082
Tensile Properties of NGF in Reconstituted Human Dermis
Dumas M1, Viennet C2, Bonté F1 and Humbert P2
1L.V.M.H. Recherche, Saint Jean de Braye (France)
2LIBC, UFR Médecine-Pharmacie, Besançon (France)
Nerve growth factor (NGF), is a polypeptide secreted by neurons and skin, both from ectoder-
mal origin. NGF belongs to the neurotrophin family also composed of brain-derived neuro-
trophic factor (BDNF) and neurotrophin-3 and -4 exerting their effects through transmembrane 
receptors p75 and the trk family. We previously demonstrated that human epidermal kerati-
nocytes and dermal fi broblasts and myofi broblasts synthesized and released all neurotrophins 
and expressed their receptors. In the skin these molecules act like neurotrophic molecules for 
innervation as well as growth and survival factors for keratinocytes under stress and for dermal 
fi broblasts regulators of collagen and metalloproteases synthesis. The present work investigates 
new functions of these molecules i.e. isometric tensile strengths developed by tightened der-
mal equivalents composed of normal human dermal fi broblasts and type I collagen. Real-time 
measurement of isometric forces was done using GlaSbox® with and without addition of these 
polypeptides (10 – 100 ng/ml). After 7 h, NGF and to a lesser extent BDNF stimulated isometric 
strengths in a dose dependant manner to a maximum of 2929 mN (+30.2 %) and 2500 mN 
(+12.6 %) respectively. This effect was noted both during the exponential phase of the strengths 
development corresponding to vigorous matrix remodelling, and during the equilibrium phase 
when strengths reach their maximum. In the same time TGF-beta (2.5 ng/ml) known as a posi-
tive tension inductor, increased the strengths to 3177 mN (+55%) but no effect was observed 
with neurotrophin 3 and 4. Since we demonstrated that keratinocytes, and fi broblasts release 
NGF and BDNF, that fi broblasts express their receptors and respond to those soluble factors by 
increasing their tensile properties, we conclude that NGF and to a lesser extent BDNF partici-
pate actively to the regulation of biomechanical properties of the dermis and can be therefore 
considered as key dermal tensotrophins.
083
NOD2/CARD15 Mediates Induction of Human Beta-Defensin-2 (hBD-2) in Primary 
Keratinocytes
Voss E, Schröder JM and Harder J
Dept of Dermatology, University Hospital of Schleswig-Holstein, Campus Kiel (Germany)
A fi rst and rapid defense reaction of skin and other epithelia against invading microbes of-
fers the production of inducible antimicrobial peptides. Human beta-defensin-2 (hBD-2) is 
an antimicrobial peptide induced in various epithelia upon extracellular as well as intracel-
lular bacterial challenge. The cytosolic nucleotide-binding oligomerization domain protein 2 
(NOD2/CARD15) is involved in intracellular recognition of microbes by sensing peptidoglycan 
fragments (e.g. muramyl dipeptide) through its LRR region leading to proinfl ammatory respons-
es through activation of NF-κB. The aim of this study was to gain more insight into the biologi-
cal signifi cance of NOD2 regarding the induction of hBD-2 in primary keratinocytes. We were 
able to detect NOD2 gene and protein expression in primary keratinocytes by using RT-PCR 
and Western-blot analyses. Stimulation of primary keratinocytes with MDP led to an induction 
of hBD-2 gene expression as well as hBD-2 peptide release. We used a siRNA approach to 
downregulate NOD2 expression in the primary keratinocytes to verify that activation of NOD2 
was responsible for the MDP-mediated hBD-2. The siRNA-mediated downregulation of NOD2 
expression in primary keratinocytes resulted in a defective induction of hBD-2 upon MDP 
treatment. Together, these data suggest that NOD2 serves as an intracellular pattern recognition 
receptor (PRR) in keratinocytes to enhance cutaneous defense by inducing the production of 
antimicrobial peptides such as hBD-2. 
084
Retinoid Receptor Expression Infl uences Cell Growth Kinetics In Vitro
Lamonnier E1, Blackburn A2, O’Neill CA3, Griffi ths CE2 and Watson RE2
1Universite Pierre et Marie Curie (Paris 6) (France)
2Dermatological Sciences, The University of Manchester (United Kingdom)
3GI Sciences, The University of Manchester (United Kingdom)
Alterations in retinoid receptor expression have been observed during ageing of a variety of 
organs: in skin, ageing is characterised by increased retinoic acid receptor α (RARα) expres-
sion. However, its role in this process is yet to be fully elucidated. We have modelled the effect 
of increased retinoid receptor expression in vitro to ascertain the effect of receptor load on 
growth kinetics.
The fi broblast IIC9 cell line was chosen as our model system as it has low endogenous retinoid 
receptor expression. Cells were stably transfected with cDNA encoding RARα or retinoid X 
receptor α (RXRα); mock transfection (empty vector; pCDNA3.1) and wild-type cultures were 
used as controls. Clones were screened for retinoid receptor protein expression by Western 
blot prior to assessment of growth kinetics using the trypan blue exclusion assay (initial density, 
1x104 cells; time in vitro, 9 days; n = 3 per clone). Differences in growth characteristics were 
assessed statistically by ANOVA, with signifi cance taken at the 95% level.
Wild-type IIC9 cells exhibited typical fi broblast morphology and standard growth character-
istics, with cultures reaching plateau phase at 7 days post-seeding. Mock transfected cultures 
behaved in a similar manner to wild-type cultures. Cells transfected with genes encoding RARα 
and RXRα showed alterations in growth kinetics and morphology; cells reached plateau phase 
at 4 days (RARα; p < 0.01) and 5 days (RXRα; p < 0.05) post-seeding and took on a ‘cobble-
stone’ appearance similar to epithelial cells in vitro. At no time did cell numbers in transfected 
cultures reach those observed in wild-type cultures (p < 0.001). At 7 days post-seeding, retinoid 
receptor-transfected cells were in decline.
This study identifi es that increased retinoid receptor load results in altered cellular growth 
kinetics and morphology. It is possible that alterations in retinoid receptor expression may 
contribute to the phenotype observed in aged skin.
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085
The Establishment and Characterization of the Immortalized Human Dermal Papilla cell
Won CH, Choi, Kwon HJ, Kim Hs, Cho and Eun
Dept of Dermatology, Seoul National University, College of Medicine (Republic of Korea)
The dermal papilla is a condensed structure of specialized mesenchymal cells at the base of the 
hair follicle and known to play a critical role in the induction and growth of the hair follicle. 
We performed this study to immortalize the human dermal papilla cells maintaining the pri-
mary property of the dermal papilla. We established immortalized human dermal papilla cell 
lines by transfection of simian virus 40 T and c-myc gene. The established cell lines had been 
cultured over 30 passages and retained the primary phenotype and aggregation pattern. These 
cells showed the stable expression of alpha smooth muscle actin and alkaline phosphotase, 
which are known to be specifi c marker of dermal papilla cell. These cells showed no tumor 
formation when inoculated subcutaneously into SCID mice. We studied the gene expression 
profi le of these cells by cDNA microarray analysis. This study showed that the established cell 
lines maintain most of the original characteristics of the human dermal papilla cells. These cell 
lines will be useful tools for studying hair biology and various hair diseases.
086
Expression of Ephrin-A and EphA Family in the Hair Cycle
Yamada Y1, Oura H2, Yoshino T1, Ohdera M1 and Arase S2
1Biological Science Research Laboratiories, Lion (Japan)
2Department of Dermatology, University of Tokushima (Japan)
Ephrins are cell-membrane-bound ligands for Eph receptor tyrosine kinases. Although ephrins 
are known to regulate a variety of developmental processes, little is known of their role in 
hair development. In our previous study on the gene expression profi le of dermal papilla cells 
(DPCs) from androgenetic alopecia (AGA) patients, it was found that ephrin-A3 was downregu-
lated to a greater extent compared to its expression in DPCs obtained from non-AGA subjects. 
 To further investigate the role of ephrins-Ephs signals in hair development, we studied the 
mRNA expression of ephrin-As and EphAs in C3H/He mice from the day of birth to the sec-
ond anagen phase by means of quantitative PCR. Ephrin-As and EphAs were found to express 
synchronously with the hair cycle. Simultaneously, we also investigated the localization of 
ephrin-As and EphAs in the same specimens immunohistochemically. Although ephrin-A1, A3, 
A5, and EphA4 were more or less positive in epidermal basal cells and outer root sheath cells 
throughout the hair cycle, they became more strongly expressed in the cells of the bulge region 
particularly during the telogen and early anagen phases. Furthermore, intracutaneous injection 
of ephrin-A3 to neonatal mice surprisingly raised the increase in hair follicle number. These 
results indicate that ephrin-As and EphAs are expressed in a hair cycle-dependent manner, and 
it was suggested that ephrin-As-EphAs signals play an important role in the hair development.
087
Melanoma Cell-derived VEGF Induces Formation Of Tube-like Structure By Endothelial Cells 
Cultured Within Fibrin Gels By A Matrix Metalloproteinases Mediated Mechanism
Zigrino P1, Löffek S1, Steiger J1, Smola H2 andMauch C1
1Department of Dermatology, University of Cologne (Germany)
2Paul Hartmann AG, Heidenheim (Germany)
Melanoma cell-derived VEGF induces formation of tube-like structure by endothelial cells cul-
tured within fi brin gels by a matrix metalloproteinases mediated mechanism
Angiogenesis is a process required not only for embryonic development but encountered in 
wound healing and in pathological situations such as in tumour growth. Important event of an-
giogenesis is the endothelial cell sprouting from parental vessels whose migration, proliferation 
and alignment lead to the formation of tubular structures. All these processes involve a tightly 
controlled degradation of extracellular matrix by the activity of several classes of proteases such 
as members of the families of MMPs, serine proteases and ADAM proteinases. 
The in vivo formation of capillary structures can be mimicked in vitro by culturing endothelial 
cells on top of a three-dimensional fi brin matrix. Using this assay, we have observed forma-
tion of tube-like structures by microvascular endothelial cells stimulated with supernatants 
collected from high invasive melanoma cells, while no tubes were seen upon stimulation with 
low invasive melanoma cells. 
Analysis of the cytokines/growth factors released from high but not from low invasive melanoma 
cells suggested VEGF as an important factor involved in endothelial cell activation. Neutraliza-
tion of VEGF could reduce the melanoma-induced tube formation, thus suggesting a primary 
role for this growth factor in the pathologically induced neo-angiogenesis. In addition, VEGF 
stimulation of endothelial cells monocultures led to the induction of several metalloprotein-
ases whose inhibition, by 1,10-phenanthroline, completely abolished the melanoma-induced 
formation of tube-like structures. Stimulation of endothelial cells with conditioned medium 
from high, but not low, invasive melanoma cells strongly induced ADAM-15 expression. Inter-
estingly, neutralisation of VEGF resulted in reduced induction of this protease. In conclusion, 
these results show that VEGF is an important mediator of melanoma cells induced pathological 
neo-vascularisation and ADAM-15 is involved in this process.
088 [016]
Major Translocation Of Calcium Upon Barrier Insult: Calcium Dynamics Visualized By -
fl uorescence Lifetime Imaging
Behne MJ1, Sanchez S2, Moll I1 and Gratton E2
1Dept of Dermatology and Venerology, Univ Medical Center Hamburg-Eppendorf (Germany)
2Laboratory for Fluorescence Dynamics, University of California Irvine (USA)
Calcium controls an array of key events in keratinocytes and epidermis: Localized changes in 
Ca2+ concentrations and their regulation are therefore especially important to assess in epider-
mal barrier homeostasis and repair, neonatal barrier establishment, in differentiation, signaling, 
cell adhesion, and in various pathologic states. Yet, tissue- and cellular Ca2+ concentrations 
in physiologic and diseased states are only partially known, and diffi cult to measure. Here we 
report a method using Calcium Green as the calcium sensor and the phasor-plot approach to 
separate raw lifetime components. This enables us to quantitatively assess and visualize dynam-
ic changes of Ca2+ in ex vivo biopsies of unfi xed epidermis, exploiting fl uorescence lifetime 
imaging. Our fi rst results comparing undisturbed epidermis with epidermis following a barrier 
insult revealed major shifts from intra- to extracellular, and, more importantly, a mobilization 
of high amounts of Ca2+ shortly following barrier disruption, presumably from intracellular 
stores. These results partially contradict the conventional view, where barrier insults abrogate 
a Ca2+ -gradient towards the SG. Methodologically, the latter is based on Ca2+-precipitation 
followed by electron microscopy, or proton-induced x-ray emission. Both techniques require 
fi xed tissue, for electron microscopy also a chemical precipitation and are limited in that they 
can determine Ca2+ in only very small sample volumes, at or below light microscopic resolu-
tion levels, or, in the case of PIXE, determine only total Calcium, irrespective of ionization or 
binding. So far, neither cellular and/or subcellular localization can be determined through 
these approaches. We believe that our approach will overcome these limitations in the obser-
vation of epidermal Ca2+ dynamics, and contribute to elucidating basic physiology as well as 
various pathologic situations in epidermis.
089 [072]
De Novo Synthesis Of Ceramides In Keratinocytes Is Essential For Maintenance Of 
Permeability Barrier And Prevention Of Skin Infl ammation
Sano S1, Itami S1, Sakamoto F2, Ito M2, Takeda J3 and Katayama I1
1Department of Dermatology, Osaka University Graduate School of Medicine (Japan)
2Department of Dermatology, Niigata University Graduate School of Medical and Dental Sci-
ences (Japan)
3Department of Social and Environmental Medicine, Osaka University Graduate School of 
Medicine (Japan)
We have previously reported the generation of keratinocyte-specifi c ceramide knockout mice 
(referred to as K5.lcb2-/-), whose epidermis was devoid of serine palmitoyl-CoA transferase 
(SPT), the key enzyme for the de novo synthesis of ceramides. These mice exhibited a reduction 
in water retention of the stratum corneum (SC), and ultrastructural study revealed an aberrant 
alignment of lamella structure in lamellar bodies (LBs). Although the epidermal permeability 
barrier was normal at birth, recovery from the tape stripping-induced barrier disruption was 
signifi cantly delayed in K5.lcb2-/- mice compared with controls. Delay in repair of their bar-
rier was attributed to retarded secretion of LBs to intercellular space in SC. From two weeks of 
age, K5.lcb2-/- mice exhibited alteration in permeability barrier, which became worse as age 
with a decrease in number of LBs. At the same time, they developed histological abnormalities 
including hyperkeratosis, acanthosis, follicular keratosis, follicular cysts, and fi nally alopecia. 
Simultaneously, K5.lcb2-/- mice developed infl ammatory reaction in the dermis, including cell 
infi ltrates and vascular proliferation. Taken together, the biosynthesis of ceramides in epidermal 
keratinocytes is essential for structural integrity of LBs to maintain and repair of permeability 
barrier following acute disruption. Furthermore, the primary defect in barrier function of SC 
resulted in skin infl ammation, suggesting a direct relationship between disrupted skin barrier 
and infl ammatory dermatoses such as atopic dermatitis.
090 [073]
Keratinocyte Lipid Transporter ABCA12 Is Highly Expressed In The Late Stages Of Human 
Epidermal Development
Yamanaka Y, Akiyama M, Sakai K, Sugiyama-Nakagiri Y, Goto M, Sawamura D, McMillan JR, 
Ota M and Shimizu H
Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
We recently reported that ABCA12 works as an epidermal keratinocyte lipid transporter, and 
that defective ABCA12 results in a loss of the skin lipid barrier, leading to harlequin ichthyosis 
(HI), one of the most devastating genodermatoses. In the present study, precise expression 
pattern of ABCA12 was studied in human embryonic and fetal skin of 7-22 weeks estimated 
gestational age (EGA) and newborn skin samples. For controls, we also studied the expression 
of transglutaminase 1 (TGase1) that is known to cross-link several precursor proteins in the 
formation of the cornifi ed cell envelope during keratinocyte terminal differentiation. In two-
layered epidermis (about 6-9 weeks EGA), both ABCA12 and TGase1 were only expressed 
in periderm cells. In three-layered epidermis (10-13 weeks EGA), ABCA12 staining was seen 
not only in periderm, but also throughout the entire epidermis, while TGase1 staining was re-
stricted to the periderm. A similar pattern was observed during four- or more-layered epidermal 
development (14-22 weeks EGA). In newborn skin, ABCA12 and TGase1 were seen only in 
the upper epidermal layers, mainly the granular layer. These staining patterns were similar to 
those in normal adult skin. Next, we studied ABCA12 mRNA expression in extracts of the fetal 
skin (at 10, 14, 15 weeks EGA). In 15 weeks EGA, the expression level of ABCA12 mRNA was 
signifi cantly increased compared with that in the early development (10 and 14 weeks EGA). 
This increasing pattern of ABCA12 mRNA expression is consistent with ABCA12 immunofl uo-
rescent staining during human epidermal development. The unique pattern of ABCA12 expres-
sion during human epidermal development might imply severe symptoms of HI patients with 
ABCA12 mutations around the birth. 
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091
Nail Penetration Of AN2690: Effi cacy Coeffi cient And Effect Of Formulation
Baker S1, Hui X2, Sanders V1, Hold K1, Plattner J1, Wester R2, Barbadillo S2, Cashmore A2 and 
Maibach H2
1Anacor Pharmaceuticals, Inc. (USA)
2Department of Dermatology, UCSF (USA)
AN2690, a novel oxaborole antifungal agent in clinical development to treat onychomycosis 
topically, has been studied for it’s ability to penetrate human nail plates. The fi rst study com-
pares the in vitro nail penetration effi cacy coeffi cient of AN2690 to ciclopirox, and the second 
study was to determine the effect of vehicle on nail penetration of AN2690. First, AN2690 
(10% w/v in ethanol, propylene glycol 4:1) and ciclopirox (8% in commercial lacquer) were 
applied daily for 14 days to the top of cadaver fi nger nails, mounted on top of a wetted cotton 
ball support in a one cell diffusion chamber. The cotton balls were replaced every three days. At 
study end the micro-dissected nail plates, cotton balls and surface washings were analyzed for 
AN2690 or ciclopirox. This data and MIC90 values against T. rubrum for AN2690 (8 μg/mL) and 
ciclopirox (0.5 μg/mL) were used to determine the effi cacy coeffi cient of each drug. Second, 
AN2690 was formulated into four vehicles, including lacquer formulations, at 10% w/w and 
tested for nail penetration in the same assay. 
The fi rst study showed ciclopirox had a low effi cacy coeffi cient: fl ux through the nail reached 
only 4.5x it’s MIC90 (2.25 μg/cm2/day) and had reached a plateau. By contrast, the steady-state 
fl ux of AN2690 reached 81x it’s MIC90 (652 μg/cm2/day) at the end of the study and was in-
creasing at a rate of 8x MIC90 per day (64.5 μg/cm2/day). The second study showed no statisti-
cal difference between any of the vehicles in penetration of AN2690. The high penetration of 
AN2690 is thus directly related to it’s physicochemical properties and is vehicle independent.
In conclusion, AN2690 showed an intrinsic ability to penetration human nails that was inde-
pendent of vehicle and in quantities that far exceed it’s MIC against T. rubrum.
092
Regulation of Tight Junctions by Somatostatin Receptor 3
Vockel M1, Liew CW2, Kreienkamp HJ3 and Brandner JM4
1Dept of Dermatology & Venerology, Dept of Human Genetics, Univ Hospital Hamburg
(Germany)
2Joslin Diabetes Center, Boston (USA)
3Department of Human Genetics, University Hospital Hamburg (Germany)
4Department of Dermatology and Venerology, University Hospital Hamburg (Germany)
Tight Junctions (TJ) are occluding cell-cell junctions that are located in the uppermost living 
layers of the epidermis. It has been demonstrated that they play a role in barrier function of the 
skin. Heterotrimeric G-proteins have been shown to regulate the formation and permeability 
of tight junctions in simple epithelia, yet hormone/receptor systems which might control these 
junctional G-proteins have so far been elusive. Here we show that the human somatostatin 
receptor 3 (SSTR3) is present in the stratum granulosum of human epidermis, in a staining 
pattern which is consistent with a localization at tight junctions. By yeast two hybrid screening 
we identify the multiple PDZ protein MUPP1, a tight junction associated protein which is also 
present in the epidermis, as an interaction partner for the C-terminus of the receptor. Interaction 
between both proteins in vivo can be demonstrated in epithelial cell lines such as MDCK-II 
and MCF-7. As a result of the interaction with MUPP1, the hSSTR3 is targeted to a large pro-
tein complex at tight junctions in MDCK-II cells. On a functional level, the activation of the 
receptor by agonists leads to an increase in transepithelial resistance (TER). Our data raise the 
possibility that hSSTR3, due to its interaction with MUPP1, can modulate the permeability 
characteristics of epidermal TJs.
093
Differential Expression of Caspase 14 and Caspase 3 during Human Hair Follicle 
Morphogenesis
Chang CH1 and Tsai RK2
1Department of Dermatology, Tzu Chi University (Taiwan)
2Department of Ophthalmology, Tzu Chi University (Taiwan)
Background: Caspases are a large family of proteinases, many of which play a key role in apop-
tosis. Apoptosis occurs temporally and spatially in shaping the growth zone, creating the hair 
canal, separating tissue layers, and accompanying terminal differentiation during human hair 
follicle morphogenesis . Objective: We investigated the developmental expression of caspase 
14 and caspase 3 on human fetal skins to delineate the different apoptotic mechanism. Meth-
ods: We used immunohistochemistry to examine caspase 14 and caspase 3 expression. Results: 
Caspase 14 does not appear in human scalp skin until 15 wks EGA and is restrictedly expressed 
in the suprabasal layers with most prominently in the outermost layer. In bulbous peg, caspase 
14 is expressed in the sebaceous gland, inner root sheath and companion layer. Epidermal and 
subepidermal hair canal are lined by caspase 14-positive keratinocytes. Caspase 3 appears 
early in fetal skin since 13 wks EGA, and is homogeneously expressed in the suparbasal layers 
of epidermis and periderm. In bulbous peg, caspase 3 is not expressed in sebaceous gland or 
inner root sheath, but expressed in the outer root sheath below the bulge. In epidermal hair 
canal, caspase 3 is prominent in the roof and faint in the bottom. In subepidermal hair canal, 
there is no caspase 3 expression. Conclusion: Taken together, caspase 14 is strongly involved 
in the apoptotic events of the epidermal and subepidermal hair canal formation, hair follicle 
terminal differentiation, and interfollicular stratum corneum formation. Caspase 3 is mainly 
involved in the homeostasis of early fetal epidermis and outer root sheath below the bulge, and 
in the permanent loss of hair canal roof and periderm.
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New AN0128 Formulations Improve Skin Penetration And In Vivo Effi cacy
Ip E, Baker S, Hold K and Maples K
Anacor Pharmaceuticals, Inc. (USA)
The purpose of this investigation was to determine if new AN0128 formulations could improve 
skin penetration and in vivo effi cacy in an animal model of infl ammation. AN0128, a novel 
compound with antibacterial and anti-infl ammatory activity, is in development for the topical 
treatment of acne, atopic dermatitis, and psoriasis. The original cream formulations contain 
AN0128 at 1% w/w solution and 5% w/w suspension. New ointments and creams were suc-
cessfully manufactured with AN0128 at 5% w/w solution. A percutaneous absorption study 
was performed using human cadaver skin mounted in Franz diffusion cells. Samples were 
collected at 5 time points from the receiver well and at 48 hours from tape strip, epidermis, 
dermis, and surface wash following a 5 μL/cm2 dose. The ONT-0001 and CRM-0005 formula-
tions demonstrated high penetration (4.7-6.3% of applied dose) through the skin and good 
deposition in the dermis and epidermis (0.03-0.44% and 2.0-2.7%, respectively). Male CD-1 
mice were treated on the anterior and posterior surfaces of the ear (20 mg/ear) at 30 minutes 
before and 15 minutes after topical challenge with phorbol 12-myristate 13-acetate. Ear swell-
ing was measured with a micrometer at 6 hours after challenge. Whereas the original 1% and 
5% cream formulations reduced ear edema by 2-10%, the ONT-0001 and CRM-0005 formula-
tions reduced ear edema by 50% and 35%, respectively. AN0128 original cream formulation 
has demonstrated effi cacy in early phase acne and atopic dermatitis clinical trials. ONT-0001 
and CRM-0005 will be evaluated in a psoriasis microplaque assay to determine if these new 
formulations with greater skin penetration and in vivo effi cacy demonstrate improved clinical 
effi cacy. In conclusion, new AN0128 formulations demonstrated increased fl ux and increased 
dermal, epidermal, and tape strip concentrations and also demonstrated good effi cacy in a 
mouse infl ammation model.
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Loss of Skin Barrier Function in 12R-lipoxygenase-defi cient Mice is Associated with Alterations 
in Skin Lipid Composition
Epp N1, Fuerstenberger G1, Hausser I2, Schmitz G3, Liebisch G3, Thieme F3  and Krieg P1
1Department of Eicosanoids and Tumor Development, Deutsches Krebsforschungszentrum, 
Heidelberg (Germany)
2EM Laboratory, Dermatological Department, University Clinic Heidelberg (Germany)
3Inst for Clinical Chemistry and Laboratory Medicine, University of Regensburg (Germany)
Lipoxygenases (LOX) represent a widespread enzyme family of non-heme iron dioxygenases. 
They insert molecular oxygen into polyunsaturated fatty acids thus synthesising highly active 
lipid mediators. 12R-LOX and eLOX-3 differ from all other LOX by unusual structural and 
enzymatic features. Furthermore, they act in sequence to form hepoxilin-like metabolites. Mu-
tational inactivation of 12R-LOX and eLOX-3 is associated with the development of a severe 
keratinisation disorder, autosomal recessive congenital ichthyosis (ARCI), indicating an essen-
tial role of this novel LOX pathway in terminal skin differentiation.
In order to determine the role of this pathway in terminal differentiation of the skin we estab-
lished a 12R-LOX knockout model using the Cre/loxP-system. 12R-LOX-defi cient mice show 
a severe skin phenotype resulting in early neonatal lethality. They die of a tremendous tran-
sepidermal water loss indicating a severely impaired skin barrier function. Morphological and 
ultrastructural analysis showed a compact cornifi ed layer and collapsed lamellar bodies in the 
upper granular layer of 12R-LOX-/- skin indicating perturbations in the synthesis/processing of 
lipids that are required for proper skin barrier formation.
Here, we present data on the analysis of the skin lipid composition of 12R-LOX-defi cient mice 
indicating that alterations in the bound lipid fraction may be associated with the lethal phe-
notype.
096
Non-invasive Measurement of the Epidermal Balance Between Proliferation and 
Differentiation
Hellemans L1, Van Overloop L1, Neven A1, Declercq L1 and Maes D2
1Estée Lauder Companies, Oevel (Belgium)
2Estée Lauder Companies, Melville, NY (USA)
In order to ensure a continuous renewal of the epidermal barrier, a proper balance between 
the processes of proliferation, differentiation and desquamation needs to be maintained. These 
processes can be monitored in human skin in a non-invasive way. 
The autofl uorescence of Tryptophan can be used as a marker for epidermal proliferation. Dur-
ing the differentiation process precursor proteins like involucrin (INV), loricrin, small prolin-
rich proteins and keratins are sequentially cross-linked and anchored into the cornifi ed enve-
lope (CE) by transglutaminases. The resulting degree of cross-linking can be determined on 
tape strippings from the stratum corneum (SC) and is used as a marker for the fi nal steps of 
differentiation. This process is called SC maturation and relates to a structural property of the 
skin barrier. The amount of residual free INV which has not been anchored into the CE refl ects 
incomplete CE formation.
Using the above approach we evaluated the skin on the inner forearm, face and psoriatic le-
sions. The degree of SC maturation in psoriatic lesions was low, high on the inner forearms and 
intermediate on the face. There was an inverse correlation between the amount of residual free 
INV and the degree of SC maturation. Psoriatic lesions contained a higher amount of residual 
free INV than non-lesional skin on the inner forearms, with intermediate levels on the face.
High Tryptophan fl uorescence was found in psoriatic skin, consistent with the hyperprolifera-
tive state of this disease, lower levels were found on the face and lowest on the inner forearms. 
Hyperproliferation is believed to result in shorter epidermal turnover times, with incomplete 
SC maturation and a higher amount of residual free INV. We found that also in the face of 
healthy subjects an increased proliferation and less complete differentiation/maturation is tak-
ing place.
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Seasonal Variations Of Stratum Corneum Characteristics And Lipid Profi le In Relation To Skin 
Dryness
Lachmann-Weber N1, Lotzing M2, Bernois A1, Bachot N3, Schnebert S1, Dumas M1, Thielitz A2 
and Heusèle C1
1LVMH-Recherche, Saint-Jean de Braye (France)
2Klinik für Dermatologie Otto-von-Guericke Universität, Magdeburg (Germany)
3Dermexpert, Paris (France)
Stratum corneum provides an essential barrier to water loss, exogenous substances penetration 
and environmental insults. Its variations in relation to environmental conditions such as those 
inducing winter xerosis are not fully understood although a visible change of skin aspect is 
commonly observed.
Stratum corneum characteristics on the outer lower leg were investigated by clinical and instru-
mental evaluation and lipid analysis carried on 33 healthy Caucasian women aged 30-40 in 
winter (February) and spring (May). Subjects had either clinically normal or dry skin in winter.
Hydration was evaluated by electrical capacitance, trans-epidermal water loss (TEWL) by an 
open chamber system, skin barrier resistance by number of strips leading to initial TEWL dou-
bling and skin pH with a circular electrode. Skin surface lipids were collected by a cyanoacr-
ylate stripping and analyzed by sequential HPTLC. Total lipids and lipid classes were expressed 
upon stratum corneum mass measured by gravimetry. 
Among the 21 women presenting a visible dry skin condition in winter, 6 showed a diminu-
tion of skin dry score in spring. On the whole panel, an increase of hydration and a decrease 
of pH were observed from winter to spring. Basal TEWL and number of strips to double TEWL 
did not statistically vary between the two seasons. Total lipids content did not vary signifi cantly 
between winter and spring but sebum lipids content (squalene + triglycerides + wax esters) and 
ceramides 1 to 3 were signifi cantly lower in the spring samples. These results indicate that the 
balance between skin hydration, barrier function and sebum excretion might be infl uenced by 
seasonal factors.
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Identifi cation and Characterization of Caspase-14 Substrates
Hoste E1, Denecker G1, Van Damme P2, Ovaere P1, Gevaert K2, Vandekerckhove J2, Vandena-
beele P1 and Declercq W1
1Department of Molecular and Biomedical Research, University of Ghent (Belgium)
2Department of Medical Protien Research, University of Ghent (Belgium)
Caspase-14 is the most recently discovered member of the caspase-family. Although caspases 
are normally ubiquitously expressed, the expression profi le of caspase-14 appeared to be re-
stricted to the differentiating keratinocytes in skin, the Hassall’s bodies in the thymus and kerati-
nizing cells of the forestomach in mice. Active cleaved caspase-14 has been shown in skin, but 
so far no in vivo substrates of caspase-14 have been reported.
By means of different proteomic approaches we want to identify caspase-14 substrates, in order 
to unravel the physiological role of caspase-14 during terminal keratinocyte differentiation. 
Preferentially we made use of the non-gel COFRADIC technology (combined fractional diago-
nal chromatography). Epidermal lysates derived from wild-type mice and caspase-14 knock-
out mice are compared differentially. After a tryptic digest the epidermal proteins isolated from 
caspase-14 wild-type skin are labelled with light isotopes (O16) and the epidermal extract de-
rived from caspase-14 knock-out skin is labelled with heavy isotopes (O18). After this step both 
preparations are mixed and the N-terminal peptides of the highly complex peptide mixture are 
isolated by diagonal chromatography and analysed by LC-MS/MS. Caspase-14 substrates, only 
present in wild-type samples, will appear as single O16 peaks. This technology enabled us to 
identify some potential caspase-14 substrates that need to be confi rmed in in vitro assays using 
recombinant caspase-14. 
Discovery of substrates of caspase-14 will give us insight into the role of caspase-14 in terminal 
keratinocyte differentiation.
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Augmentation of Sebaceous Lipogenesis by Propionibacterium acnes in Hamsters In Vivo and 
In Vitro
Ito A1, Iinuma K1, Akimoto N1, Noguchi N2, Sasatsu M2, Sato T1
1Department of Biochemistry and Molecular Biology, Tokyo University of Pharmacy and Life 
Sciences (Japan)
2Department of Microbiology, Tokyo University of Pharmacy and Life Sciences (Japan)
Propionibacterium acnes (P. acnes) has been reported to be involved in the development and 
aggravation of acne vulgaris. Acne vulgaris is characterized as a morphological and functional 
disorder of sebaceous glands and pilosebaceous units and symptoms include: excess sebum 
production, hyperkeratinization, and infl ammatory reactions. Since P. acnes has directly or 
indirectly causes the hyperproliferation of keratinocytes in follicles, and the induction of proin-
fl ammatory cytokines, it remains unclear whether P. acnes may directly infl uence lipogenesis 
in sebaceous glands. In the present study, we investigated the effects of P. acnes culture me-
dium (PaCM) and formalin-killed P. acnes (FkPa) on lipogenesis in hamster sebaceous glands in 
vivo and in vitro. When poorly differentiated and insulin-differentiated hamster sebocytes were 
treated with PaCM or FkPa, an increase in intracellular lipid droplet formation was observed 
along with the augmentation of triacylglycerol (TG) synthesis. The augmentation of TG produc-
tion was resulted from an increase in diacylglycerol acyltransferase activity. Furthermore, when 
the auricles of hamsters were treated every day with PaCM for 4 weeks, oil red O staining 
showed that sebum accumulation in sebaceous glands was augmented 1.8-fold as compared 
with vehicle-treated hamsters. However, there was no signifi cant change in epidermal thick-
ness in the skin of auricles in the PaCM-treated hamsters. On the other hand, both PaCM and 
FkPa increased the level of interleukin 6 (IL-6) in cultured macrophages, but not in sebocytes. In 
addition, IL-6 dose-dependently augmented TG production in hamster sebocytes. Thus, these 
results provide novel evidence that P. acnes directly participates in the augmentation of seba-
ceous lipogenesis via itself and/or P. acnes-derived soluble factor(s). Moreover, P. acnes may 
exacerbate acne vulgaris in concert with IL-6 derived from macrophages that have invaded into 
the infl ammatory lesions of the disease.
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Improvement In The Skin Barrier And Induction Of Epidermal Differentiation After Treatment 
With Pimecrolimus Versus Betamethasone In Atopic Dermatitis
Jensen JM1, Pfeiffer S2, Witt M1, Neumann C1, Fölster-Holst R1 and Proksch E1
1Department of Dermatology, University of Kiel (Germany)
2Central Microscopy, Department of Biology, University of Kiel (Germany)
An impaired skin barrier leading to penetration of allergens (e.g. house dust mite or grass pol-
len) is a well-accepted feature of atopic dermatitis (AD). A compromised skin barrier can facili-
tate the invasion of allergens that induce immunological reactions and aggravate the disease. 
Recently, evidence for a disturbed epidermal differentiation and mutations in the fi laggrin gene, 
contributing to the barrier defect, have been found in patients with AD. Here we investigated 
whether treatment with pimecrolimus or betamethasone may improve the skin barrier and epi-
dermal differentiation in AD. In a randomized, double blinded left-right comparison study, 15 
patients with mild to moderate AD were treated on one upper limb with pimecrolimus cream 
1% and on the other with 0.1% betamethasone cream twice daily for three weeks. The greatest 
reduction in Eczema Area and Severity Index (pEASI), lesion size, and pruritus was seen after 
the fi rst week of treatment in both groups. Transepidermal water loss (TEWL), as a marker of 
the inside-out barrier, improved in both groups. However, barrier structure, which also refl ects 
the outside-in barrier, showed a more ordered stratum corneum lipid layer and lamellar body 
extrusion by electron microscopy after treatment with pimecrolimus than with betamethasone. 
Enhanced epidermal proliferation in AD, possibly as a consequence of infl ammation, was re-
duced 49% by pimecrolimus. The 74% reduction of proliferation by betamethasone may be 
considered a suppression exceeding the normal level, leading to thinning of the epidermis. Im-
munohistochemistry showed that both treatments induced the differentiation markers involu-
crin, loricrin and water-binding fi laggrin. In summary, both pimecrolimus and betamethasone 
improved AD regarding the clinical score and the expression of cornifi ed envelope proteins. 
However, the side effect of epidermal thinning became apparent already after three weeks of 
treatment with betamethasone but not with pimecrolimus. Restoration of the skin barrier in AD 
was more complete with pimecrolimus than with betamethasone.
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Defects in Skin Barrier Structure and Function, Impaired Epidermal Differentiation and 
Pronounced Expression of Human Beta-defensin-2 (HBD2) Despite Lack of Antimycotic 
Activity in Tinea Corporis
Proksch E1, Brasch J1, Neumann C1, Akaki T1, Schröder JM1, Pfeiffer S2 and Jensen JM1
1Department of Dermatology, University of Kiel (Germany)
2Central Microscopy, Department of Biology, University of Kiel (Germany)
Tinea corporis mainly caused by Trichophyton (T.) rubrum may clinically resemble eczema 
or even psoriasis. These diseases are characterized by infl ammation, a disrupted skin barrier 
and changes in epidermal differentiation. Here we determined skin barrier function and struc-
ture by transepidermal water loss (TEWL) and electron microscopy in lesional compared to 
non-lesional skin in tinea corporis. In addition, we investigated stratum corneum hydration, 
epidermal proliferation and differentiation, including antimicrobial peptide HBD2 expression. 
HBD2’s antimycotic activity was analyzed by a microdilution array using recombinant and 
native HBD2. In tinea corporis we found a signifi cant increase in TEWL as a marker of the in-
side-out barrier, additionally refl ected in a severely disturbed stratum corneum lipid structure. 
Lamellar bodies were empty and lipid layers were incompletely fused. A reduction in stratum 
corneum hydration in tinea corporis correlates with reduced water-binding fi laggrin expression 
in the epidermis. Cornifi ed envelope proteins involucrin and loricrin were reduced. We found 
a pronounced expression of HBD2 in tinea corporis even exceeding that in psoriasis. However, 
we could not identify an antimycotic effect of HBD2 against T. rubrum. HBD2 is known to be 
effective in innate immunity against bacterial pathogens and in high concentrations against 
candida albicans. Therefore, we suggest that HBD2 expression is related to the disturbed epi-
dermal differentiation in tinea corporis. A relationship between HBD-2 expression and the 
degree of epidermal differentiation has been shown previously in keratinocyte culture. HBD2 
expression might protect the skin against secondary infections by bacteria. In conclusion, we 
found disturbed skin barrier structure and function as well as impaired differentiation in tinea. 
Pronounced HBD2 expression is related to changes in differentiation and may protect against 
secondary bacterial infection.
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Cell Penetrable Peptoid Based Transdermal Penetration
Kumar P1, Fara MA2, Bradley M2, Friedmann PS1 and Healy E1
1Dermatopharmacology, University of Southampton (United Kingdom)
2Department of Chemistry, University of Edinburgh (United Kingdom)
The availability of topical therapeutic agents to treat skin diseases is fairly limited due to poor 
absorption of many drugs through the stratum corneum. Techniques to enhance skin penetra-
tion, including the use of chemical penetration enhancers and iontophoresis, are not suffi -
ciently effi cient to deliver a vast range of drugs into skin. Cell penetrable peptide (CPP) based 
carrier molecules such as penetratin, Tat and transportan can deliver a range of compounds 
into cells in vitro but to date very few CPPs capable of transporting molecules into skin have 
been identifi ed. 
We have developed a novel polycationic carrier molecule, polypseudolysine (PPL), and have 
investigated whether this compound allows penetration of alpha-melanocyte stimulating hor-
mone (αMSH) into cells and skin. αMSH is a tridecapeptide which acts through a family of 
melanocortin receptors to have effects on pigmentation, immune function, and infl ammation. 
Competitive ligand binding experiments and pigmentation assays demonstrate that αMSH-PPL 
can bind to MC1R and stimulate melanin synthesis. LDH assays and fl uorescence activated 
cell sorting (FACS) analysis with propidium iodide show no signifi cant toxicity or effects on 
cell viability. Fluorescence and confocal microscopy at a range of time points indicate that 10-
5M fl uorescein labeled αMSH-PPL readily enters into a variety of cell types in culture, which 
contrasts with the poor penetration of fl uorescein labeled αMSH in the absence of the carrier. 
Ex vivo skin penetration assays on mouse, pig and human skin mounted in a Franz diffusion 
chamber indicate that the PPL carrier can transport fl uorescein labeled αMSH into skin at a 
concentration of 10-3M whereas fl uorescein labeled αMSH fails to penetrate into the skin.
The results suggest that PPL may have the potential to act as a molecular carrier for cargo-based 
delivery of therapeutic compounds into human skin.
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IGF-I is the Most Potent Regulator of Lipid Synthesis During Aging in Human Sebocytes
Makrantonaki E1, Fimmel S2, Seltmann H2 and Zouboulis C1
1Depts of Dermatology and Immunology, Dessau Medical Center, Dessau (Germany)
2Lab for Biogerontology, Dermato-Pharmacology and Dermato-Endocrinology, Charité
University Berlin (Germany)
Morphological changes of sebocytes and alteration of their activity play a distinct role in the 
aging phenotype of the skin. The size of sebocytes tends to decrease with advancing age, while 
their number remains approximately the same throughout life. In addition, sebocytes exhibit an 
age-related reduced secretory output, which results in decreased surface lipid levels and skin 
xerosis - a major characteristic of aged skin. The goal of our study was to evaluate the extent to 
which lipid synthesis in sebocytes is a hormone-dependent function. Human sebocytes were 
maintained in vitro under GH, IGF-I, 17β-estradiol, DHEA and progesterone as single agents 
in concentrations corresponding to those circulating in young (f20) and postmenopausal (f60) 
women. Subsequently, cell proliferation and lipid synthesis were measured by means of the 4-
MUH fl uorescence assay and nile red microassay/fl uorescence microscopy, accordingly. While 
progesterone and DHEA showed no effect on lipid synthesis, after treatment with IGF-I for 48 
h at f20 and f60 concentrations a signifi cant dose-dependent increase of neutral (p<0.001) and 
polar lipids (p<0.001) was observed at both concentrations tested. Furthermore, IGF-I could 
signifi cantly increase the cell size. On the other hand, GH at f20 and f60 enhanced signifi -
cantly the production of neutral (p<0.01 and p<0.05, accordingly) and polar lipids (p<0.05 and 
p<0.01) in sebocytes but not in such an extent as IGF-I. 17β-estradiol only induced polar lipid 
synthesis (p<0.01) and increased cell size. Sebocyte proliferation remained unchanged under 
any treatment. In conclusion, sebocyte differentiation and lipid synthesis are signifi cantly af-
fected by hormone fl uctuation occurring with advanced age and IGF-I plays among circulating 
hormones a key role in the skin aging process. 
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Claudin-5 is Expressed in Human Epidermis
Peltonen S1, Riehokainen J1, Pummi K1 and Peltonen J2
1Department of Dermatology, University of Turku (Finland)
2Institute of Biomedicine, University of Turku (Finland)
Cells of the granular layer are interconnected by tight junctions in normal epidermis. The struc-
tural proteins of epidermal tight junctions include occludin, ZO-1, and claudins-1 and -4. 
Claudin-5 has previously detected in the dermal blood vessel walls but the epidermis has been 
reported to be negative. In the present study, the distribution of tight junction proteins was 
evaluated in the skin of nine psoriasis patients using indirect immunofl uorescence labeling. 
Punch biopsies were taken from perilesional skin, from active psoriasis plaques, and from 
healed, previously lesional locations. Unexpectedly, all samples from psoriasis patients, both 
lesional and perilesional, displayed fi ne intercellular labelling for claudin-5 in the cell-cell con-
tact zones of the granular cell layer. The presence of claudin-5 in psoriatic epidermis prompted 
us to perform further labelling for skin samples of healthy patients with mono- and polyclonal 
antibodies for claudin-5. Confocal laser scanning microscopy revealed thin lines of positive 
labelling for claudin-5 in the granular cell layer. Claudin-5 was expressed more intensely in the 
upper epidermis of the psoriasis plaque than in the normal epidermis. Specifi cally, most intense 
labelling was detected in and near the vicinity of the parakeratotic foci in psoriatic epidermis. 
In perilesional and healed epidermis claudin-5 was strictly restricted to the granular cell layer, 
the distribution resembling that of occludin. Since the amount of claudin-5 in epidermis was 
very low compared to claudins-1 and - 4, it is understandable that epidermis has previously 
been considered to be negative for claudin-5. The localisation of claudin-5 to the cell-cell con-
tact sites of the granular cells suggests that claudin-5 can be a component of the epidermal tight 
junctions in epidermis. It is feasible to speculate that the up-regulation of claudin-5 in psoriatic 
epidermis may serve to compensate the dysfunction of the lipid barrier by adding the tightness 
of the barrier against small molecules. 
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Analysis of Epidermal Lipids in Dogs. A Preparative Study for Validation of an Animal Model 
of Atopic Dermatitis
Popa I1, Piekutowska A1, Chapman J1, Gatto H2, Pin D3, Haftek M1 and Portoukalian J1
1EA 37-32 , Univ. Lyon I, Pavillon R, Lyon (France)
2Virbac Laboratory, Carros (France)
3Ecole Nationale Vétérinaire de Lyon, Marcy l’Etoile, (France)
Atopic dermatitis (AD) is a well characterized clinical entity in dogs. We have observed ul-
trastructural changes in stratum corneum (SC) morphology and lamellar lipid organization in 
the non-lesional skin of atopic dogs using osmium and ruthenium tetroxide postfi xation. 
Because of the observed clinical and morphological similarities between the human and dog 
atopic skin, we speculated that biochemical modifi cations concerning SC lipid expression de-
scribed in man could also underlie AD in dogs. 
Dog SC was taken using strips. Ten consecutive strips were needed to reach the viable epider-
mis. We purifi ed and analyzed individually for each strip the different classes of free lipids (free 
fatty acids, ceramides, phospholipids, glycolipids, gangliosides) and protein-bound lipids (ce-
ramides and fatty acids) and compare to the lipid profi le of human epidermis. This comparison 
showed us that dog epidermis contain similar ceramides species as in humans with the same 
three sphingoid bases coupled to long-chain fatty acids, especially to omega-hydroxylated 
fatty acids. 
In the case of human AD, it has been reported that the defi ciency in acylceramides was cor-
related to the defects in skin barrier. We have compared the lipid profi les of normal dog epi-
dermis with those of atopic dermatitis dogs, and found that the epidermis of atopic dogs have 
a much lower lipid content with a marked defi cit in ceramides. 
A detailed knowledge about the lipid composition of normal SC in dogs is an indispensable 
step towards the biochemical characterization of canine AD and should help to defi ne an 
animal model of this disease.
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Analysis of Ammonium Levels on Skin Surface and Relation to Parameters of Skin Barrier 
Physiology
Reuther T1, Neugebauer O1, Schröder S1 and Kerscher M1
1Division of Cosmetic Sciences, Department of Chemistry, University of Hamburg (Germany)
The present study aims at comparing ammonium levels on the skin surface at various skin sites 
and at investigating their relation to skin barrier physiology parameters such as pH, hydration 
and transepidermal water loss (TEWL). Overall 44 healthy volunteers (aged 18 to 58) were 
included. Sites of investigation were the forearm, the forehead and the palms. Ammonium 
levels were determined in a water extract of 6 ml using a spectrophotometric assay (Spectro-
quant® Ammonium-Test, Merck). Futhermore in all volunteers skin pH (skin-pH-meter® pH 
900), hydration (Corneometer® CM 825) and TEWL (Tewameter® TM 210) was measured (all 
instruments Courage + Khazaka, Cologne, Germany). Data was calculated as mean±SEM. The 
average ammonium levels were 1.86±0.98 μg on the forearm, 1.58±0.11 μg on the forehead 
and 3.94±0,25 μg on the palms. The values on the palms were signifi cantly higher than in the 
other locations (p<0.001; p<0.001). No signifi cant difference could be assessed between fore-
arm and forehead (p>0.05). The correlation analysis revealed a signifi cant negative correlation 
between the ammonium content and pH on the forearm (r=-0.376, p=0.012) and the forehead 
(r=-0.341, p=0.023). On the palms a negative but not signifi cant correlation was found (r=-
0.147, p=0.341). The signifi cant correlation found between ammonium levels and skin surface 
pH on the forearm and the forehead indicate that ammonium levels in these areas are to a large 
extent due to pH dependent conversion of ammonia to ammonium after passive diffusion of 
ammonia through the skin. The fact that the correlation between ammonium levels and pH on 
the palms was not signifi cant indicate that other factors like for example water deriving from 
emotional sweating that is very hard to rule out even after good acclimatisation infl uence am-
monium levels on the skin surface.
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ABCA12 Is Involved in Lipid Transport from the Golgi Apparatus to Cell Periphery in 
Epidermal Keratinocytes
Sakai K, Akiyama M, Sugiyama-Nakagiri Y, Yamanaka Y, McMillan JR and Shimizu H
Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
Mutations in ABCA12 lead to harlequin ichthyosis and lamellar ichthyosis. The keratinocyte 
lipid transporter ABCA12 is a member of the ATP-binding cassette transporter family, and mem-
bers of the ABCA subfamily have closely related functions as lipid transporters. Previously, we 
reported that the pathomechanism of harlequin ichthyosis involves the defective function of 
the lipid transporter ABCA12.To further elucidate the precise distribution pattern and function 
of ABCA12, we performed double-labeling immunofl uorescence staining for ABCA12 and for 
Golgi-associated or lamellar granule-associated molecules both on normal human epidermis 
and cultured normal human keratinocytes. We studied the precise localization of ABCA12 
and other molecules using confocal laser scanning microscope. In normal human epidermis, 
ABCA12 was observed mainly in the granular layers with glucosylceramide (one of the ma-
jor lamellar granule contents) and transglutaminase 1 (a cornifi ed cell envelope-associated 
keratinization marker), but not always colocalized with GM130 and TGN46 (Golgi-related 
molecules) that were expressed from the lower epidermis. In normal human keratinocytes 
cultured in high Ca++ concentration medium, ABCA12 colocalized with GM130 (a cis-Gol-
gi-associated molecule), TGN46 (a trans-Golgi-associated molecule) and glucosylceramide. 
Transglutaminase 1 was restricted to the cell membrane and ABCA12 localization was within 
the cytoplasm distinct from transglutaminase 1 localization. The present results suggest that 
ABCA12 is mainly expressed in differentiated, granular layer keratinocytes with glucosylcera-
mide and transglutaminase 1, and, at the subcellular level, ABCA12 is distributed from the cis-
side of the Golgi apparatus to trans-Golgi network, lamellar granules at the cell periphery. Our 
results suggest that ABCA12 may play an important role in lipid transport from the cis-side of 
the Golgi apparatus through the trans-Golgi network, to the cell periphery via lamellar granules 
in human epidermal granular layer keratinocytes.
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A Citrus Polymethoxy Flavonoid, Nobiletin, Is a Novel Anti-acne Agent by Inhibition of Sebum 
Production and Augmentation of Sebum Excretion in Hamsters In Vivo and In Vitro
Sato T1, Akimoto N1, Takahashi A1, Kojima M1, Yano M2 and Ito A1
1Department of Biochemistry and Molecular Biology, Tokyo University of Pharmacy and Life 
Sciences (Japan)
2Department of Citriculture, Okitsu, National Institute of Fruit Tree Science (Japan)
Acne, the chronic infl ammatory skin disease, is characteristic of excess sebum production, 
and there are few effective agents of acne therapy that directly decrease sebaceous lipogenesis 
apart from tretinoin (all-trans retinoic acid, atRA) or isotretinoin (13-cis retinoic acid, 13-cisRA). 
In the present study, we investigated the effects of a citrus polymethoxy fl avonoid, nobiletin 
on sebum production in hamster in vivo and in vitro. The topical application of nobiletin or 
atRA to auricles of hamsters decreased the skin surface lipids such as triacylglycerols (TGs), 
free-fatty acids (FFAs), cholesterol (Ch), as well as the size of sebaceous glands. Although atRA 
augmented the cornifi cation of the epidermis, there was no signifi cant change in epidermal 
thickness in the nobiletin-treated skin. Furthermore, in the case of ultraviolet B (5.4 kJ/m2)-irra-
diated hamsters, excess sebum accumulation in sebaceous glands, an increase in level of skin 
surface TGs, sebaceous enlargement, and abnormal epidermis cornifi cation, which partially 
mimicked acne pathology in vivo, were suppressed by nobiletin. In hamster sebocytes, on the 
other hand, TG production was dose-dependently inhibited by nobiletin, atRA, and 13-cisRA 
in the presence or absence of insulin. The suppression of TG production was resulted from the 
inhibition of diacylglycerol acyltransferase (DGAT) activity in these three agent-treated cells. 
Furthermore, nobiletin, but not 13-cisRA, augmented the excretion of accumulated TGs into 
culture medium in a cAMP-dependent mechanism. Taken together with our previous report 
that nobiletin exerts in vivo and in vitro anti-infl ammatory actions, these results provide novel 
evidence that nobiletin is effective for acne therapy since its mechanisms inhibit not only 
DGAT-dependent TGs synthesis and sebaceous enlargement, but also augment the excretion 
of accumulated sebum.
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LEDGF/DFS70, a Major Autoantigen of Atopic Dermatitis, is a Component of Keratohyalin 
Granules
Sugiura K1, Muro Y1, Nishizawa Y2, Okamoto M1, Shinohara T3, Usukura J2 and Tomita Y1
1Department of Dermatology, Nagoya University Graduate School of Medicine (Japan)
2Department of Anatomy, Nagoya University Graduate School of Medicine (Japan)
3Dept of Ophthalmology and Visual Sciences, University of Nebraska Medical Center (USA)
LEDGF/DFS70 is known to be a transcriptional cofactor, a transcriptional activator, a survival 
factor, and a HIV-1 transporter. We have clarifi ed that LEDGF/DFS70 is a major autoantigen in 
patients with atopic dermatitis (AD), because autoantibodies to this protein are found in ap-
proximately 30% of AD patients, and they appear to play an important role in the pathogenesis 
of AD. To know how the autoantibodies and autoantigens are involved in the pathogenesis of 
AD, we tried to determine the localization of LEDGF/DFS70 in the epidermis of normal hu-
man skin by light and electron microscopic immunocytochemistry. Light microscopic studies 
showed that LEDGF/DFS70 were located highly in the nuclei of cells in the basal layer of the 
epidermis, but were found to deposit highly in the cytoplasm of cells in the granular layer 
and the stratum corneum. Immunoelectron microscopy showed that a signifi cant amount of 
LEDGF/DFS70 was accumulated in keratohyalin granules (KG) in the cytoplasm of cells in the 
granular layer. In addition, profi laggrin, a KG specifi c protein, and Bip/GRP78, a stress sensing 
protein in the endoplasmic reticulum, were co-localized with LEDGF/DFS70 in the KG. These 
results suggest that the LEDGF/DFS70 is predominantly located in the nucleus of the basal 
epidermal cells and translocates into the cytoplasm during differentiation. In the cytoplasm, 
it accumulates in the KG and eventually in the epidermal cells after they have completed 
keratinization and enucleation. These results suggest that LEDGF/DFS70 has a functional role 
in the KG, and this implies a new role of ‘nuclear’ autoantigen of LEDGF/DFS70 in the patho-
genesis of AD.
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Detergents with Different Chemical Properties Induce Variable Degree of Cytotoxicity and 
the mRNA Expression of Lipid-metabolizing Enzymes and Differentiation Markers in Cultured 
Keratinocytes
Wei T, Geijer S, Lindberg M, Berne B and Törmä H
Department of Medical Sciences/Dermatology, University of Uppsala (Sweden)
The knowledge how detergents with different chemical properties infl uence epidermal kerati-
nocytes is sparse. In the present study, the effects of fi ve detergents were examined with respect 
to cell-toxicity using the XTT assay and mRNA expression of key-enzymes in barrier lipid 
production and keratinocyte differentiation markers using real-time-PCR. First, the LD50 for 
each detergent were determined. Secondly, keratinocytes were exposed for 24 h. to sub-toxic 
concentrations of detergents and the mRNA expression was analysed by real-time PCR. SLS 
and CAPB induced a concentration-dependent increase in the expression of enzymes pro-
ducing cholesterol (HMG-CoA reductase) and ceramides (SMPD-1, β-glucocerebrosidase and 
SPT-2), while transcripts of enzymes involved in producing fatty acids (ACAC-B and Fatty acid 
synthase) were unaffected. SLES and cocoglucoside increased the expression of certain en-
zymes involved in cholesterol and fatty acid synthesis while sodium cocoamphoacetate (SCAA) 
stimulated expression of transcripts involved in fatty acid synthesis but not the other enzymes. 
The expression of differentiation markers (fi laggrin, transglutaminase 1 and involucrin) were 
increased by SLS, SLES and CAPB, while SCAA and cocoglucoside exhibited no effect. 
The present fi ndings show that detergents have variable effects on lipid synthesis and keratinoc-
yte differentiation, which could partly explain their barrier destruction potential in vivo. 
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Collagen XVII/BP180 Knockout Mouse and its Transgenic Rescue Using Human Collagen XVII 
cDNA
Nishie W1, Sawamura D1, Goto M1, Shibaki A1, McMillan JR1, Nakamura H1, Olasz E2,
Yancey KB2, Akiyama M1 and Shimizu H1
1Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
2Department of Dermatology, Medical College of Wisconsin (USA)
Collagen XVII (COL17, BP180, BPAG2) is a type II transmembrane protein associated with the 
hemidesmosome-anchoring fi lament complex in basal keratinocytes, which plays a pivotal role 
in dermal-epidermal adhesion. COL17 is defective in non-Herlitz junctional epidermolysis bul-
losa (EB) patients (nH-JEB), and is targeted by autoantibodies in patients with bullous pemphig-
oid (BP). To date, no animal models exist to explore the correction of this genetic skin disease, 
and direct evidence of the pathogenicity of autoantibodies of BP patients has yet to be verifi ed. 
To address these goals, we fi rst engineered COL17 knockout (KO) mice. The COL17 KO mice 
survived and showed a similar phenotype to nH-JEB, the human disease equivalent. Next, we 
performed a transgenic rescue experiment with COL17 KO mice using transgenic mice with a 
human COL17 cDNA driven under the K14 promoter. This experiment demonstrated that the 
rescued COL17 KO mice (now COL17-humanized mice) overcame the nH-JEB-like phenotype 
seen in COL17 KO mice. This indicates that genetic diseases with defective genes such as EB 
are treatable using gene therapy and an appropriate transgene. To clarify whether human BP 
autoantibodies can directly induce blister formation, we passively transferred IgG from hu-
man BP patients into COL17-humanized mice. The treated mice clearly showed subepidermal 
blisters that displayed the clinical, histological, and immunopathologic features of BP. Finally, 
we developed an experiment to test the effi cacy of a novel therapeutic treatment using this 
BP model system. Injection of short, recombinant decoy peptides including the pathogenic 
BP NC16a domain, signifi cantly suppressed blister formation by binding to and neutralizing 
pathogenic BP-IgG. In conclusion, these novel COL17 KO and COL17-humanized model mice 
highlight the pathomechanisms of BP and nH-JEB and allow valuable therapeutic insights into 
the treatment of both inherited and autoimmune blistering diseases.
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The Alternative Pathway of Complement Activation is Critical for the Induction of Experimental 
Epidermolysis Bullosa Acquisita
Mihai S1, Chiriac MT1, Takahashi K2, Thurman JM3, Holers VM3, Botto M4, Zillikens D1 and 
Sitaru C1
1Department of Dermatology, University of Luebeck (Germany)
2Department of Pediatrics, Harvard Medical School, Boston (USA)
3Deps of Medicine and Immunology, Univ of Colorado Health Sciences Center, Denver (USA)
4Rheumatology Section, Imperial College School of Medicine, Hammersmith Campus, London 
(United Kingdom)
Epidermolysis bullosa acquisita (EBA) is a subepidermal blistering disease associated with 
tissue-bound and circulating autoantibodies to type VII collagen, a major constituent of the 
dermal-epidermal junction. We have recently demonstrated that antibodies generated against 
murine type VII collagen induce a subepidermal blistering disease closely resembling human 
EBA when passively transferred into mice of different strains. When injected into C5-defi cient 
mice, antibodies to type VII collagen failed to induce the disease, demonstrating that activation 
of terminal complement components is required for blister induction in experimental EBA. To 
further dissect the role of the complement system in this model, we injected mice unable to 
activate complement by the classical (C1q-defi cient), the mannan binding lectin (MBL-null), 
and the alternative (factor B-defi cient) pathways, and their control littermates (n=10/group) 
with rabbit antibodies against murine type VII collagen. Direct immunofl uorescence micro-
scopy revealed deposition of rabbit IgG in the skin of all injected mice, independent of their 
strain. Staining for murine C3 was bright in the skin of control mice and less intense in the 
skin of C1qa-/-, factor B (fB)-/-, and MBL-null mice. The development and evolution of blistering 
had a similar pattern in C1qa-/-, MBL-null, and control mice. Interestingly, fB-defi cient mice 
developed a delayed and signifi cantly less severe blistering disease compared with fB-suffi cient 
mice. Histopathological examination revealed extensive dermal-epidermal separation and a 
rich infl ammatory infi ltrate in the skin of C1qa-/-, MBL-null and control mice, but not in the skin 
of fB-/- mice. Our study provides the fi rst direct evidence for the involvement of the alternative 
pathway in an autoantibody-induced subepidermal blistering disease and should facilitate the 
development of new therapeutic strategies for this disease.
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Induction of Bullous Pemphigoid and Pemphigoid Gestationis in Humanized BP180NC16A 
Mice by Passive Transfer of Autoantibodies from Patients
Liu Z1, Sui W1, Zhao M1, Li N1, Giudice G2, Fairley J2, Sitaru C3, Zillikens D3, Marinkovich P4 
and Diaz L1
1Dermatology, University of North Carolina (USA)
2Dermatology, Medical College of Wisconsin (USA)
3Dermatology, University of Lubeck (Germany)
4Dermatology, Stanford University (USA)
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with 
autoantibodies against the hemidesmosomal components BP180 and BP230. Pemphigoid ges-
tationis (PG) shows similar skin lesions associated with pregnancy and autoantibodies against 
BP180. Due to the lack of cross-reactivity between human and murine BP180, direct evidence 
for a pathogenic role of BP and PG autoantibodies has been lacking to date. In this study, 
we generated a mouse strain in which the mouse BP180NC14A is replaced with the human 
BP180NC16A, a domain harboring BP and PG dominant epitopes and investigated the role 
of these autoantibodies in the disease pathogenesis by passive transfer of patients’ autoanti-
bodies into the humanized BP180NC16A mice. The humanized BP180NC16A mice injected 
with BP180NC16A-specifi c BP and PG autoantibodies developed clinical and histological 
subepidermal blisters. Lesional/perilesional skin showed human IgG and mouse C3 deposi-
tion at the BMZ, mast cell degranulation and neutrophil infi ltration. However, the humanized 
BP180NC16A mice injected with F(ab’)2 fragments of the pathogenic IgG or pretreated with 
an inhibitor of mast cell degranulation failed to develop blisters. The skin of the mice exhib-
ited a signifi cant reduction of neutrophil infi ltration as compared to the diseased mouse skin. 
We provide the fi rst direct evidence that autoantibodies to BP180NC16A in BP and PG are 
pathogenic. Subepidermal blistering triggered by anti-BP180NC16A antibodies depends on 
complement activation, mast cells and neutrophils. 
114 [085]
Fas Ligand and Pemphigus Sera Induce Cleavage of Desmogleins and Apoptosis in Human 
Keratinocytes
Marconi A, Truzzi F, Lotti R, Vaschieri C, Dallaglio K, Giannetti A and Pincelli C
Department of Dermatology, University of Modena and Reggio Emilia (Italy)
Pemphigus is an autoimmune bullous disease characterized by loss of adhesion of keratino-
cytes that round up in a process known as acantholysis. While the molecular mechanisms 
underlying acantholysis are still unclear, it is well known that cell detachment is often as-
sociated with apoptosis. We have previously detected apoptotic keratinocytes in perilesional, 
yet undetached, pemphigus skin. Moreover, Fas ligand (FasL) levels are signifi cantly higher in 
untreated pemphigus sera than in controls. The aim of the present study was to analyze the 
apoptotic mechanisms in pemphigus. We fi rst demonstrated that sera from patients with both 
pemphigus vulgaris (PV) and foliaceus (PF), not yet under steroid treatment, induce apoptosis 
in cultured keratinocytes. Pemphigus sera-induced keratinocyte apoptosis is partially prevented 
by pretreatment with either caspase-8 inhibitor or anti-FasL neutralizing antibody. Moreover, 
caspase-8 activation induced by untreated pemphigus sera is partially inhibited by anti-FasL 
antibody. Finally, untreated pemphigus sera or rFasL induce the cleavage of desmoglein 1 and 3 
(dsg 1, 3). These results strongly suggest that PV and PF immunoglobulins, through the up-regu-
lation of FasL, exert a dual activity, by both inducing keratinocyte apoptosis and dsg cleavage. 
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Changes in Antibody Profi les in Pemphigus Vulgaris and Pemphigus Foliaceus
Pigozzi B, Amici MP, Cavallini F and Alaibac M
Unit of Dermatology, University of Padua (Italy)
Pemphigus vulgaris (PV) and foliaceus (PF) are characterized by antibodies to the desmosomal 
proteins desmoglein 3 (Dsg3) and desmoglein 1 (Dsg1), respectively. Commercially available 
enzyme-linked immunosorbent assay (ELISA) tests have recently become available for the de-
tection of antibodies to Dsg1 and Dsg3. The aim of the study was to compare Dsg1 and 3 
antibody levels with disease severity and to investigate the change in antibody profi les in a 
series of pemphigus cases. Sera were obtained from 15 cases with active PV and PF and 30 
controls with other dermatologic disorders. The severity of oral and cutaneous involvement 
was assessed and recorded. ELISA tests were performed using recombinant Dsg1 and Dsg3 to 
detect IgG autoantibodies. Of the 15 patients, 15 were ELISA positive for anti-Dsg1 antibodies 
and/or anti-Dsg3 antibodies. Of the controls, 1 was positive for anti-Dsg3. The different mor-
phologic types of PV and PF could be generally differentiated on the basis of antibody profi les. 
Moreover these tests were particularly useful in demonstranting the transition from one subtype 
of pemghigus to another, notably PF into PV. However, the assays were not particularly useful 
for monitoring disease activity in a subgroup of patients as we could not detect a correlation 
between antibodies titres and disease severity. 
In conclusion, Dsg1 and Dsg3 ELISA tests are a useful and specifi c tool for diagnosing the 
different subtypes of pemphigus and demonstrating changes from one clinical phenotype into 
another. However, specifi c antibodies titers did not always correlate with disease severity.
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Detection of Torque Teno Virus in Patients with Autoimmune Bullous Skin Disorders
Blazsek A1, Kornséé Z1, Lepesi-Benko R1, Ishii N2, Csikós M1, Hashimoto T2 and Karpati S1
1SU, Dept. of Dermatology, Venerology and Dermatooncology, Budapest (Hungary)
2Department of Dermatology, Kurume University, School of Medicine (Japan)
The Torque Teno virus (TTV), a member of the single stranded DNA virus family Circoviridae 
has been shown to commonly infect humans, yet with no detectable pathogenicity. Recent 
studies showed that the virus genome is more often detectable in the sera of patients with 
systemic lupus erythematosus, and that its presence in patients with idiopathic infl ammatory 
myopathies is linked to a more severe disease progression, which requires immunosuppressive 
therapy measures. These results imply, that TTV may contribute to building up autoimmune 
progresses in the pathogenesis of systemic lupus erythematosus, and idiopathic infl ammatory 
myopathies 
Viruses have been also considered to contribute to disease pathogenesis in autoimmune bul-
lous skin disorders, including bullous pemphigoid and pemphigus vulgaris but not dermatitis 
herpetiformis Duhring. We assessed the prevalence of TTV infection in these disorders, and 
compared these to results from healthy blood donors. Detection of TTV was carried out by 
nested and real-time PCR in the sera of 95 patients with autoimmune bullous skin disorders, 
and 95 healthy blood donors age and sex matched for the whole bullous disease group, and 50 
healthy blood donors matched fort he bullous pemphigoid group. Identity of the PCR products 
was confi rmed by cycle-sequencing.
TTV DNA was detected in 74/95 (77,89%) patients with bullous skin disorders and in 62/95 
(65,26%) of the healthy individuals. The collective group of autoimmune bullous disorders 
showed a slight, but not signifi cant elevation (p=0,076). However patients with bullous pem-
phigoid had a signifi cantly higher rate of TTV infection 38/42 (90,47%, p=0,017) than pem-
phigus vulgaris, dermatitis herpetiformis patients, or both healthy control groups. Gender and 
presence of autoantibodies of the diseases had no infl uence on TTV positivity in either group. 
Our data suggest that TTV infection may contribute to the pathogenesis of bullous pemphigoid. 
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Multicenter Prospective Study of the Humoral Autoimmune Response in a large Cohort of 
Bullous Pemphigoid Patients
Di Zenzo G1, Thoma-Uszynski S2, Fontao L3, Calabresi V1, Hofmann SC4, Lacour JP5, Bruckner-
Tuderman L4, Borradori L3, Zambruno G1 and Hertl M6
1Molecular and Cell Biology Laboratory, IDI-IRCCS, Rome (Italy)
2Department of Dermatology, University of Erlangen (Germany)
3Clinic of Dermatology, University Medical Hospital, Geneva (Switzerland)
4Department of Dermatology, University of Freiburg (Germany)
5Department of Dermatology, Hopital de l’Archet 2, Nice (France)
6Department of Dermatology and Allergology, Philipps University, Marburg (Germany)
Bullous pemphigoid (BP) is a subepidermal bullous disease, associated with autoantibodies 
directed against distinct domains of two hemidesmosomal components, BP180 and BP230. 
To defi ne the molecular specifi city of the humoral immune response to BP180 and BP230 and 
to compare the sensitivity of different diagnostic assays, we studied 51 sera from untreated BP 
patients, by immunoblotting (IB) and ELISA analysis utilizing defi ned eukaryotic and prokaryo-
tic recombinant proteins, and correlated the immunological fi ndings with disease activity and 
extent. 
The results show that: 1) the NC16A domain of the BP180 ectodomain was recognized by the 
majority of BP sera using both prokaryotic (88%) and eukaryotic (86%) recombinant proteins; 
2) additional portions of the BP180 ectodomain (mid-portion, COOH-terminus etc.) were rec-
ognized by 86% of the BP sera; 3) ELISA with prokaryotic and eukaryotic BP180 recombinants 
showed similar sensitivity (94% and 96%, respectively) suggesting that IgG autoantibodies in 
the BP sera preferentially recognized non-glycosylated epitopes; 4) 41% of the BP sera recog-
nized three BP180 intracellular epitopes by ELISA using prokaryotic expressed recombinant 
proteins; 5) and the majority (72%) of the BP sera reacted also with a subdomain of BP230 in 
an ELISA with different BP230 eukaryotic recombinants. Thus, ELISA analysis utilizing both, 
BP180 ectodomain and BP230 recombinants allowed to detect circulating IgG autoantibod-
ies in all BP sera tested. The present data suggest that advanced technology with recombinant 
autoantigens is a highly sensitive approach not only to establish the diagnosis of BP but also 
to better understand the relative relevance of distinct autoantigenic epitopes in the immune 
pathogenesis of this severe autoimmune bullous disorder.
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Bullous Pemphigoid and Psoriasis – Autoantibody Reactivity in a Series of Six Patients
Drenovska K1, Vassileva S1, Gilbert D2, Tron F2 and Tsankov N1
1Department of Dermatology and Venereology, Faculty of Medicine, Sofi a (Bulgaria)
2Laboratoire d’Immunopathologie Clinique et Expérimentale, CHU, Rouen (France)
The occurrence of bullous diseases in patients suffering from psoriasis was often reported in the 
literature. The aim of the present investigation was to study the autoantibody reactivity in the 
sera of six patients (one woman and fi ve men) with history of long lasting plaque type psoriasis 
who developed an autoimmune subepidermal blistering eruption. All patients had active psori-
atic lesions at the onset of the bullous disease, and one patient was erythrodermic. All patients 
showed clinical and histological features of bullous pemphigoid. Direct immunofl uorescence 
on perilesional skin revealed linear deposits of IgG and C3 complement along the basement 
membrane zone (BMZ) in all six patients, anti-BMZ antibody titers on indirect immunofl uores-
cence varied from negative in one patient to strongly positive (1:640), binding to the epidermal 
side of 1M-NaCl - split skin in all positive cases. In order to determine the true nature of the 
blistering disease, the autoantibody profi le of psoriasis patients’ sera was additionally studied 
by immunoblotting (Western blot) using epidermal extracts and ELISA with commercial BP180 
(NC16A) kit. Immunoblotting showed serum binding to BP180 in three patients, BP230 in one 
patient, to both BP180 and BP230 in another patient and was negative in one patient. ELISA 
BP180 revealed three negative and three positive sera. Our fi ndings support the previously 
reported data that bullous pemphigoid is the subepidermal bullous disease most commonly 
associated with psoriasis. The anti-psoriatic treatment and the changes at the basement mem-
brane zone due to psoriasis may be both responsible for the observed heterogeneous antibody 
response and may trigger the bullous disease. Further investigations should be carried out in 
order to precise the suspected common immunological mechanisms of this association.
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Treatment with Rituximab (anti-CD20) Affects Both Autoreactive T and B Lymphocytes in 
Pemphigus Vulgaris
Eming R, Nagel A, Wolff-Franke S, Podstawa E and Hertl M
Department of Dermatology, Philipps University Marburg (Germany)
Pemphigus vulgaris (PV) represents a severe autoimmune bullous skin disorder primarily as-
sociated with autoantibodies (auto-ab) against desmoglein 3 (dsg3). The interaction between 
autoreactive, dsg3-specifi c B and T cell seems to be crucial for both the initiation and per-
petuation of PV. Treatment with the monoclonal anti-CD20 ab, rituximab, leads to a rapid and 
prolonged B cell depletion, followed by a good clinical response. Aim of the present study is, to 
investigate the effect of rituximab-induced B cell depletion on the modulation of dsg3-specifi c 
T cell activation. Prior to rituximab treatment and during a 12 month’ follow-up period, three 
subtypes of dsg3-reactive T cells were analysed in eight PV patients with extensive and recalci-
trant PV using the MACS secretion assay. T cells were characterized by their cytokine profi les as 
Th1 (IFNγ), Th2 (IL4) and type 1 regulatory-like (Tr1) T cells (IL10). Prior to rituximab treatment 
on average 23 ± 13.5 IFNγ-producing, 27 ± 18 IL4-secreting and 33 ± 31 IL10-positive T cells 
per 105 peripheral blood mononuclear cells were detected which dropped to 61% IFNγ-, 37% 
IL4- and 33% IL10-secreting T cells one month after the last rituximab infusion. Three months 
after rituximab the numbers of IFNγ- and IL4-producing T cells remained unchanged while the 
frequency of IL10-positive T cells slightly increased. Six months after rituximab treatment four 
PV patients showed on average 17% IFNγ-, 41% IL4- and 21% IL10-producing, dsg3-reactive T 
cells compared to pretreatment frequencies. Noteworthy, the effect of rituximab seemed to be 
specifi c for dsg3-specifi c T cells since the frequency of tetanus toxoid-specifi c IFNγ-producing 
T cells was not affected. Titers of dsg3-reactive IgG remained unchanged or slightly increased 
at one month after rituximab and dropped signifi cantly three months after rituximab. Thus, 
despite persisting autoantibody titers rituximab might exert its clinical effect through immu-
nomodulatory effects on dsg3-specifi c T cells. 
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IgE Autoantibodies from Bullous Pemphigoid Patients Target Multiple Antigenic Regions of 
Type XVII Collagen
Dresow S1, Sitaru C1, Oostingh GJ2, Zillikens D1 and Gibbs BF1
1Department of Dermatology, University of Lübeck (Germany)
2Department of Dermatology, University of Würzburg (Germany)
Bullous pemphigoid (BP) is an autoimmune skin disease associated with IgE autoantibodies 
against the dermal-epidermal junction and FcεRI-positive effector cell involvement, including 
mast cells and basophils. However, the role of IgE autoantibodies in BP pathogenesis is not 
fully understood. In the present study, we analyzed IgE reactivity in serum of patients with BP 
(n=20), together with controls (n=10), which included both healthy donors and pemphigus 
patients, using various recombinant fragments of the transmembrane hemidesmosomal protein 
type XVII collagen/BP180 by immunoblotting. Pronounced elevation of total serum IgE levels 
were observed in 90% of BP sera. IgE autoantibodies from 65% of BP donors displayed IgE 
reactivity to BP180 NC16A. Interestingly, although the NC16A region has been proposed to 
be a major antigenic site also for IgE autoantibodies, we discovered substantial IgE reactivity 
to the N-terminal intracellular domain (ICD) of BP180, with up to 75% of BP sera reacting to 
at least one of these regions. Fine mapping of antigenic sites within the ICD revealed similar 
reactivity patterns for IgE and IgG. In addition, we found IgE autoantibodies against the C-ter-
minal domain of BP180 in 50 % of BP patients. Sera from healthy donors or pemphigus vulgaris 
patients failed to display IgE reactivity to any of these antigens. The results indicate that NC16A 
is not the only antigenic determinant of IgE autoantibodies in BP and that additional, novel 
epitopes exist on different regions of the intracellular domain as well as C-terminal regions of 
the extracellular domain. The heterogeneous autoimmune response against BP180 suggests 
intramolecular epitope spreading during disease progression. IgE autoantibodies may contrib-
ute to the pathogenesis of this disease by triggering FcεRI-dependent activation of leukocytes 
and mast cells.
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Toxic Epidermal Necrolysis in Association with Mycoplasma Pneumoniae Infection
Grosber M1, Carsin H2 and Leclerc F3
1Service de dermatologie, Hôpital Henri Mondor, Créteil (France)
2Centre de traitement des Brûlés, Hôpital d’ instruction des armées Percy, Clamart (France)
3Service de réanimation pédiatrique, Hôpital Jeanne de Flandre, Lille (France)
Toxic epidermal necrolysis (TEN) is a mucocutaneous disorder with mucosal erosions and large 
areas of epidermal detachment. It is considered to be drug related. However in only 2/3 of the 
cases clear responsibility of a drug is established and in 5 % of the cases there is no drug intake. 
Our aim is to point out the possible role of Mycoplasma pneumoniae (MP) in the aetiology of 
SJS/TEN by reporting 3 patients who developed SJS/TEN in association with MP infection and 
without patent drug cause.
Patient 1(eight years) presented a SJS/TEN overlap form (15-20 % of body surface area (BSA)) 
with no drug intake before onset. MP serology showed highly positive IgM titers and positive 
IgG titers in the acute phase.
Patient 2 (19 years) presented TEN (58% of BSA) without prior drug intake. MP serology was 
negative in IgM, but showed a fourfold IgG titer increase after 3 weeks.
Patient 3 (fi ve years) presented TEN (80% of BSA). The only drug administered 5 days before 
onset was Imocur®, an orally administered bacterial lysate. However Imocur® had been ad-
ministered several times during the 2 years preceding TEN without any side effects. Serology for 
MP was negative in IgM, but showed a fi vefold increase in IgG titer after 15 days.
In our 3 patients MP infection was serologically proven. 2 patients had not been exposed to 
any drug. The imputability of Imocur® in case 3 is doubtful, as it had been taken on several 
occasions, without adverse reaction. Our observations suggest that MP may rarely be associ-
ated with TEN, especially in children and young adults. As TEN is generally considered to be 
drug-related, MP serology is not always performed. This may have led to an underestimation 
of MP infection in TEN.
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The Shed Ectodomain of Collagen XVII is Present in Blister Fluids of Autoimmune and Non-
autoimmune Bullous Dermatoses
Hofmann SC1, Schönau V1, Franzke CW1, Sorokin LM1, Bruckner-Tuderman L2
1Institute of Physiological Chemistry and Pathobiochemistry, University of Münster (Germany)
2Department of Dermatology, University of Freiburg (Germany)
Bullous pemphigoid is a blistering disorder characterized by autoantibodies against collagen 
XVII / BP180, a hemidesmosomal 180 kDa transmembrane protein. Its ectodomain is consti-
tutively shed from the cell surface by ADAMs leading to a soluble 120 kDa fragment, which 
represents the autoantigen of linear IgA-dermatosis. In order to determine the relevance of 
collagen XVII shedding under different pathological conditions, we generated a mouse IgG2a 
monoclonal antibody (mAb NC16a-2) directed against an epitope spanning amino acid resi-
dues 513-525 of the NC16a domain. NC16a-2 recognizes both full-length collagen XVII and its 
shed ectodomain by immunoprecipitation, immunofl uorescence, immunoblotting and ELISA. 
In this study, NC16a-2 was employed for immunoprecipitation of blister fl uids in bullous pem-
phigoid, other infl ammatory skin conditions and in vacuum induced bullae on normal skin. 
These assays revealed the presence of the shed collagen XVII ectodomain in 9/10 pemphigoid 
blister fl uids and 5/6 infl ammatory blisters of non-autoimmune origin such as bullous vasculitis 
or bullous drug reactions. Very low amounts of the ectodomain were detected in 2/5 freshly 
induced suction blisters. Furthermore, we assessed the proteinase profi les of blister fl uids by 
chromographic activity assays and found a signifi cantly higher activity of serine proteases in 
bullous pemphigoid blisters than in suction blisters. These results suggest that different protei-
nases contribute to enhanced shedding and blister formation in infl ammatory skin diseases. In 
contrast, mechanically induced blistering appears not to be associated with increased release 
of the ectodomain from cell surface. Thus, it seems conceivable that different proteinases may 
be involved, directly or indirectly, in ectodomain shedding, depending on the prevailing bio-
logical and pathological context. 
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Immunolocalization of Target Autoantigens in IgG/IgA Pemphigus -ELISA, cDNA Transfection 
and Immunoelectron Microscopic Studies
Ishii N1, Ishida-Yamamoto A2, Amagai M3 and Hashimoto T1
1Department of Dermatology, Kurume University School of Medicine (Japan)
2Department of Dermatology, Asahikawa Medical College (Japan)
3Department of Dermatology, Keio University School of Medicine (Japan)
Pemphigus is an autoimmume bullous disease with two major subtypes, pemphigus vulgaris 
(PV) and pemphigus foliaceus (PF). Pemphigus is characterized by IgG autoantibodies aganist 
keratinocyte cell surfaces, and the autoantigens of PV and PF have been identifi ed as desmo-
glein 3 (Dsg3) and Dsg1, respecively. IgA pemphigus is a rare autoimmune bullous disease 
characterized by deposition of IgA autoantibodies at keratinocyte cell surfaces. IgA pemphigus 
is divided into two major subtypes based on clinical and histological features: subcorneal pus-
tular dermatosis (SPD) type and intraepidermal neutrophilic IgA dermatosis (IEN) type. Using 
cDNA transfection and living cell immunofl uorescence, we previously showed that desmocol-
lin 1 (Dsc1), one of desmosomal cadherins, is the autoantigen in SPD type of IgA pemphigus, 
but the autoantigen in IEN type is still unknown. A very rare form of pemphigus, in which both 
IgG and IgA autoantibodies to keratinocyte cell surfaces are found by indirect
immunofl uorescence, is called IgG/A pemphigus. Generally, relationship between the anti-
gen profi le and the clinical features is not clearly characterized in IgG/IgA pemphigus. In the 
present study, we investigated autoantigens in 5 cases of IgG/IgA pemphigus by using enzyme-
linked immunosorbent assay (ELISA), cDNA transfection and living cell immunofl uorescence 
and post-embedding immunoelectron microscopy. This study revealed that the autoantigens 
bound by IgG and IgA antibodies of IgG/IgA pemphigus were identifi ed as Dsg and/or Dsc, the 
adhesion molecules of desmosomes. Immunoelectron microscopy clearly showed immuno-
localization to desmosomes.
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Spatial Expression of Matrilysin-1 in Epidermolysis Bullosa-associated and Sporadic Cutaneous 
Squamous Cell Carcinomas
Kivisaari AK1, Kallajoki M2, McGrath J3, Bauer JW4, Weber F5, Shimizu H6, Csikós M7, Königová R8, 
Sinemus K9 and Kähäri VM1
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(Finland) 3Inst of Dermatology, St Thomas Hospital, London (United Kingdom) 4Dept of Der-
matology, General Hospital, Salzburg (Austria) 5Dept of Dermatology and Venereology, Univ of 
Innsbruck (Austria) 6Hokkaido Univ Graduate School of Medicine, Sapporo (Japan) 7Dept of 
Dermatology, Semmelweis University Budapest (Hungary) 8Burn Centre, Charles Univ Hospital 
Královské Vinohrady, Prague (Czech Republic) 9Helios Klinikum Wuppertal (Germany)
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe hereditary mechano-bullous disease 
resulting from mutations in COL7A1. Cutaneous squamous cell carcinoma (SCC) is a frequent com-
plication in chronic ulcers in RDEB patients. Cutaneous SCCs in RDEB are characterized by rapid in-
vasion and development of metastases resulting in poor prognosis. In this study, we have investigated 
the role of matrilysin-1 (matrix metalloproteinase-7, MMP-7) in SCCs arising in patients with RDEB, 
and for comparison in sporadic SCCs and Bowen’s disease. Immunohistochemical analysis of MMP-7 
in 25 SCCs complicating RDEB, 61 sporadic SCCs and 28 sporadic lesions of Bowen’s disease was 
carried out using monoclonal antibodies for MMP-7 and its substrates E-cadherin and syndecan-1. Im-
munohistochemical fi ndings were evaluated semiquantitatively. Expression of MMP-7 was detected 
in 100 % of SCCs arising in patients with RDEB. In the tumor areas where MMP-7 immunoreactiv-
ity was strongest, E-cadherin and syndecan-1 were markedly diminished or absent. Most abundant 
MMP-7 staining was noted in the invasive edge of the tumors. MMP-7 expression was also observed 
in 98% of sporadic SCCs and in 68% of Bowen’s diseases. In 76% of RDEB-associated SCCs MMP-7 
staining was moderate or strong while in sporadic SCCs, 43% of tumors had moderate or strong im-
munopositivity. Our results imply that up-regulation of MMP-7 expression in malignantly transformed 
keratinocytes can at least in part explain the aggressive behavior of the RDEB-associated cutaneous 
SCCs. According to our spatial immunohistochemical observations, MMP-7 has an important role 
in the invasiveness of both RDEB-associated and sporadic cutaneous SCCs. In conclusion, MMP-7 
should be considered as a potential therapeutic target to inhibit the growth and invasion of cutaneous 
squamous cell carcinomas.
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Paraneoplastic Pemphigus in a Child without Malignancy
Marinovic B1, Husar K2, Lakos Jukic I1, Lipozencic J1 and Hashimoto T3
1Univ Dept of Dermatology & Venereology, Zagreb University Hospital Center (Croatia)
2Univ Dept of Dermatology & Venereology, Zareb University Hospital Center (Croatia)
3Dept of Dermatology, Kurume Univ School of Medicine (Japan)
Paraneoplastic pemphigus (PNP) is an autoimmune mucocutaneous disease mostly associated with 
specifi c B-cell lymphoproliferative neoplasm. A 11-year-old boy presented to our department fi ve 
years ago with erosions on oral mucosa, on the lips and with changes on the conjunctiva. His 
skin was brownish-gray as it is seen in graft-versus-host disease – lichenoid type. Pathohistological 
fi nding revealed satellite cell necrosis. In direct immunofl uorescence deposits of C3 were found 
along basement membrane zone. In indirect immunofl uorescence anti-cell surface antibodies of 
IgG class were positive on human skin section as well as on rat bladder section. On immunoblot-
ting of human epidermal extracts envoplakin and periplakin were highly positive. Serum was also 
tested with ELISA of desmoglein 1 and 3 , and showed postivity of Dsg3. Evaluation of underlying 
malignancy was done repeatedly but no malignancy was detected untill today. Since demonstration 
of underlying, mostly lymphoproliferative, neoplasm is one of the minimal criteria for diagnosis of 
PNP there is a question is this case paraneoplastic pemphigus or a new entity.
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Study of the B- and T-lymphocyte Responses in Pemphigus Patients Treated by anti-CD20 
Immunotherapy (Rituximab)
Musette P1, Mouquet H2, Jacquot S2, Gilbert D2, Gougeon ML3, Roujeau JC4, D’Incan M5, 
Bedane C6, Tron F2 and Joly P7
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(France) 5Service de Dermatologie, CHU Clermont Ferrand (France) 6Service de Dermatologie, 
Hôpital Dupuytre, Limoges (France) 7Service de Dermatologie, CHU Rouen (France)
Rituximab (Mabthera®) is a chimeric mAb directed against the human CD20 molecule that is ex-
pressed by pre-B cells and B lymphocytes but not by plasma cells. Rituximab induces the destruction 
of CD20+ lymphocyte populations and represents an effective treatment for non-Hodgkin’s lympho-
ma and for several autoimmune diseases. Pemphigus is a specifi c autoimmune disease mediated by 
pathogenic autoAbs directed against desmogleins (Dsg). We have treated pemphigus patients (n=20) 
by anti-CD20 immunotherapy (Rituximab) in a prospective study and analyzed the immunological 
modifi cations. Forty patients presenting pemphigus vulgaris (PV) (n=13), foliaceus (PF) (n=6), or para-
neoplastic pemphigus (PNP) (n=1) were included in the study. At D90, 18 patients were in complete 
remission (CR) and 2 in partial remission (RP). Three PF patients relapsed at 8-10 months. During the 
monitoring, rate and phenotype of B lymphocytes, CD4+ and CD8+ T lymphocytes as well as anti-
epidermis, anti-Dsg1 and anti-Dsg3 Ab titers were determined from D0 to D360. Moreover, the B-cell 
repertoire was analysed at D0 by a B-cell immunoscope method.
Treatment by Rituximab (375 mg/m2/week) induced the complete depletion of circulating B lym-
phocytes from D21. We observed 3 types of autoAb responses: (i) decreases of anti-Dsg Ab titers that 
were associated with CR started at D21 to reach the negative threshold at D120 for anti-Dsg1 (15/17 
patients) and anti-Dsg3 Abs (7/14 patients), (ii) in 2 PF patients that relapsed at 8 months, we observed 
a persistence of anti-Dsg1 Abs (iii) anti-Dsg3 Abs persisted in 7 PV patients with CR. Between the 6th 
and 9th month following the fi rst Rituximab perfusion, a highly diverse B-cell repertoire is reconsti-
tuted. Moreover, B cells presented a naïve phenotype (CD5+, CD27-) and expressed CD38 and CD24 
that characterize transitional B-cells. Study of the B-cell repertoire diversity before treatment showed 
B-cell oligoclonal expansions. Moreover, B-cell depletion did not induce any changes of number or 
distribution of NK cells, CD4+ and CD8+ T lymphocytes as well as in theirs phenotypes (activation, 
IL2, INFγ and TNFα secretions). Treatment by Rituximab induced the complete depletion of circulat-
ing B lymphocytes that led to elimination of anti-Dsg autoAbs in respondent patients. Nevertheless, 
in 7 PV patients, loss of anti-Dsg3 Abs did not seem necessary to CR. Thus, in these patients, disease 
could result of pathogenic effect of anti-Dsg1rather than anti-Dsg3 Abs. Absence of CR is associated 
with persistence of anti-Dsg1 Abs in 2 cases of PF. In these patients, it can be hypothesized that 
Rituximab-resistant plasma cells continue to secrete autoAbs, because of a low turn-over. Treatment 
by anti-CD20 immunotherapy Rituximab induced a complete depletion of circulating B lymphocytes 
leading to elimination of anti-Dsg autoAbs that allow a CR in respondent patients.
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A Truncated Alternative Spliced Isoform of Human Desmoglein 1 Contains a Specifi c T-Cell 
Epitope Binding to the Pemphigus Foliaceus-Associated HLA Class II DRβ1*0102 Molecule
Mouquet H4, Farci S1, Drouot L4, Joly P7, Leblond J4, Leprince J2, Charron D3, Maillère B1, Tron 
F4 and Gilbert D4
1Dép d’Ingénierie et d’Etudes des Protéines, Commiss à l’Energie Atomique-Saclay (France)
2INSERM U413 (France)
3Laboratoire d’Immunologie et d’Histocompatibilite, Paris, INSERM U396 (France)
4INSERM U519 (France)
Desmogleins (Dsg) are transmembrane glycoproteins of the desmosome that allow a cell-cell 
adhesion between keratinocytes and comprise 4 different isoforms (Dsg1 to Dsg4). Dsg1 is 
targeted by pathogenic autoantibodies in the course of pemphigus foliaceus (PF), an autoim-
mune bullous skin disease. The genetic susceptibility to PF is associated with certain HLA class 
II alleles which are thought to participate in disease pathogenesis through their capacity to 
accommodate autoantigen-derived peptides and present them to autoreactive T cells. So far a 
unique isoform of Dsg1 has been described in human which includes several immunodomi-
nant T-cell epitopes.
We describe an alternative transcript of DSG1 which contains a 101 bp insertion corresponding 
to the 3´ end of DSG1-intron 6 and introducing a stop codon in the nucleotide sequence. The 
2 DSG1 transcripts were detected in the epiderm of all healthy subjects (n=9), and alternative 
transcripts containing the intronic insertion represent 10 to 30% of the total DSG1 mRNAs. This 
alternative transcript leads to the synthesis of a truncated isoform of Dsg1 that was detected in 
normal human epidermis by IIF assay and immunoblot analysis using specifi c antibodies. HLA-
DR peptide binding assay showed that this isoform bears a specifi c peptide sequence which 
binds to PF-associated HLA class II DRβ1*0102 molecule. Moreover, this peptide induces the 
proliferation of PBMC from 4 PF patients (n=9). 
These data provide an illustration of an autoantigen encoded by alternative spliced transcript 
which may participate in the pathogenesis of the disease by bearing PF-associated HLA class 
II restricted epitope.
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Desmoglein 3 (Dsg3) Autoantibody Profi le of Pemphigus Vulgaris (PV) Patients in Correlation 
with their Disease Activity and Clinical Phenotype
Müller R1, Svoboda V1, Wenzel E1, Müller H-H2 and Hertl M1
1Department of Dermatology and Allergology and 2Department of Medical Biometrics and Epi-
demiology, University of Marburg (Germany)
In PV, autoantibodies against the desmosomal adhesion molecule Dsg3 cause blisters due 
to loss of adhesion in keratinocyte cell-cell contact. The purpose of the present study was to 
relate IgG reactivity of PV sera against defi ned regions of the extracellular domain of Dsg3 with 
disease activity and the clinical phenotype of PV. We established an ELISA with baculovirus-en-
coded recombinant proteins representing the fi ve extracellular domains (EC1 to EC5) of Dsg3 
and a recently described immunodominant epitope within the NH2-terminal region of EC1. 
IgG autoantibody profi les of sera from 94 individual PV patients were examined with regard to 
disease activity and clinical phenotype. Because IgG reactivity against the entire Dsg3 ectodo-
main, Dsg3(1-566), is conformation dependent, we denatured the proteins in the ELISA to ad-
dress the question whether the short recombinant proteins of Dsg3 contained conformational 
and/or non-conformational epitopes. 
Our data suggest, that 1) there is a prevalence of IgG reactive with the NH2-terminus (EC1) of 
Dsg3 in active PV, 2) IgG reactivity against EC2, EC3, and EC4 tends to decrease during the 
course of the disease, 3) the presence of IgG against the EC1-4 of Dsg3 seems to decrease upon 
transition of mucosal and mucocutaneous PV to cutaneous PV, and 4) autoantibodies of PV 
patients also react with non-conformational epitopes of Dsg3. These fi ndings may be very use-
ful in understanding the relative contribution of domain-specifi c IgG autoantibodies in PV and 
may help to defi ne predictive disease markers.
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Conformational Epitope Analysis of IgG autoantibodies Against Desmoglein 3 in Pemphigus 
Vulgaris using Dsg3/Dsg2 Domain-swapped Molecules
Ohyama B1, Nishifuji K2, Hashimoto T1 and Amagai M2
1Department of Dermatology Kurume University School of Medicine (Japan)
2Department of Dermatology Keio University School of Medicine (Japan)
Pemphigus vulgaris (PV) is an autoimmune blistering disease that is caused by IgG autoantibod-
ies against desmoglein (Dsg) 3. We previously examined the epitopes of Dsg3 for PV autoan-
tibodies by competition ELISA against Dsg3 using Dsg3/Dsg1 domain-swapped molecules as 
competitors. The major epitopes of anti-Dsg3 IgG were mapped on the N-terminal domains of 
Dsg3. One of the limitation using the Dsg3/Dsg1 molecules is the diffi culty in analyzing Dsg3 
epitopes with PV sera containing both anti-Dsg3 and anti-Dsg1 IgG autoantibodies. To over-
come this problem we produced a new set of domain-swapped molecules of Dsg3 with Dsg2 
as a backbone, because PV patients do not have anti-Dsg2 IgG autoantibodies. Five Dsg3/Dsg2 
domain-swapped molecules were constructed by substitution of the each extracellular (EC) 
domain of Dsg2 with the corresponding EC domain of Dsg3, by baculovirus expression sys-
tem. To analyze the epitopes for anti-Dsg3 IgG in PV, we performed the immunoprecipitation 
and immunoblotting analysis using the Dsg3/Dsg2 molecules as substrates. Among 134 serum 
samples obtained from 33 cases in various clinical stages, 112 samples (84%) recognized mul-
tiple EC domains of Dsg3; 123 samples (92%) reacted with EC1 domain of Dsg3, 110 samples 
(82%) reacted with EC2, 71 samples (53%) reacted with EC3, 30 samples (22%) reacted with 
EC4, and only15 samples (11%) reacted with EC5. We also analyzed the epitope shift along the 
time course and found that no epitope shift was recognized in 30 of 33 cases (91%), and only 
3 cases (9%) showed changes in epitopes. This study confi rmed that the major conformational 
epitopes resides on the N-terminal EC1 domain of Dsg3, and the epitope shift is only rarely 
seen. These Dsg3/Dsg2 domain-swapped molecules are useful to study the epitope-phenotype 
correlation to clarify the pathophysiology in pemphigus.
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Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS)
Pfütze M, Niedermeier A, Hertl M and Eming R
1Department of Dermatology, Univerity Hospital Giessen and Marburg (Germany)
At present, there is no consensus about clinical criteria that defi ne disease severity of autoim-
mune bullous skin disorders. During the last years several scoring systems have been intro-
duced but it remains a challenging problem to refl ect disease activity of individual patients 
accurately by a standardised scoring system as these scores mainly compare interindividual 
disease activities. Due to phenotypical varieties and the remarkable clinical variability of 
autoimmune bullous skin disorders, several parameters are needed to refl ect intraindividual 
changes in disease activity. Especially in view of the evaluation of different therapeutic options 
a scoring system sensitive enough to refl ect gradual changes in individual disease activity seems 
more appropriate than classifi cation for interindividual comparison. Taking this challenge into 
account we introduce a newly developed autoimmune bullous skin disorder intensity score 
(ABSIS). As a major improvement of cutaneous scoring we developed a lesion-quality based 
weighting factor. For improved intraindividual comparability of disease acitvity ABSIS consists 
of separate components representing the clinically most relevant areas of involvement: skin, 
oral and genital mucosa. At present 26 patients with autoimmune bullous diseases including 16 
pemphigus vulgaris and 1 pemphigus foliaceus patients, 2 patients with bullous pemphigoid, 
2 epidermolysis bullosa aquisita patients, 4 patients with mucous membrane pemphigoid and 
1 patient with linear IgA bullous dermatosis were investigated with regard to ABSIS. In these 
patients the clinical course was well represented by ABSIS.
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Possible Involvement of Exon 31 Alternative Splicing in Marked Different Clinical 
Manifestation Caused by Mutations in the Plectin Gene (PLEC1)
Sawamura D1, Goto M1, Nakamura H1, Oyama N2, Satoh M2, Kaneko F2, Takahashi T3,
Konno H3 and Shimizu H1
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Epidermolysis bullosa (EB) is an inherited mechano-bullous disorder of the skin. Mutations in 
the plectin gene (PLEC1) are known to cause EB simplex associated with muscular dystrophy. 
However, we and the other group have recently demonstrated that some cases with EB simplex 
associated with pyloric atresia are also resulted from mutations in the PLEC1 gene. To fur-
ther elucidate the pathomechanisms of heterogeneous EB phenotype caused by PLEC1 muta-
tions, we have studied probands from two distinct EB families, one associated with muscular 
dystrophy and the other associated with pyloric atresia. Electron microscopy detected blister 
formation within the basal keratinocytes leading to the diagnosis of EB simplex, and immuno-
histochemical studies showed that the expression of plectin was absent or markedly attenu-
ated in both cases. Sequence analysis demonstrated the proband-1 with muscular dystrophy 
harbored heterogeneous novel premature stop codon mutations of Q2466X and Q2545X. In 
proband-2 with pyloric atresia homozygous novel premature stop codon mutation of Q1450X 
was identifi ed. Our examination of mutation database suggested possible involvement of exon 
31 alternative splicing in marked different clinical manifestations of EBS with muscular dystro-
phy and pyloric atresia. 
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Treatment of Severe Pemphigus with the Combined use of Immunoadsorption and 
Rituximab
Shimanovich I1, Nietschke M2, Rose C1, Grabbe J1 and Zillikens D1
1Department of Dermatology, University of Lübeck (Germany)
2Department of Medicine, University of Lübeck (Germany)
Treatment of severe pemphigus with the combined use of immunoadsorption and rituximab
Pemphigus is a life-threatening autoimmune disease commonly treated with high-dose sys-
temic corticosteroids in combination with other immunosuppressants. While this therapy 
usually does not cure pemphigus, it may result in serious side-effects and sometimes fails to 
control disease activity. Rituximab is a monoclonal antibody against human CD20, leading 
to complete long-term remission in about 1/3 of patients with pemphigus several weeks or 
months after its administration. On the other hand, protein A immunoadsorption (PAIA) has 
been shown to induce a rapid clearance of skin lesions even in most severe pemphigus by 
selectively removing IgG antibodies from the circulation. The aim of the present study was to 
combine the rapid improvement of skin lesions induced by PAIA with the favourable long-term 
outcome following the use of rituximab. Six patients with severe treatment-resistant pemphigus 
received a combination of PAIA (on days 1, 2, 3, 7, 14, 21 and 28), rituximab (375 mg/sqm on 
days 8, 15, 22 and 29), and conventional immunosuppressants (prednisolone [initial dose 2 
mg/kg] plus azathioprine). All patients demonstrated a dramatic clinical improvement within 
the fi rst 4 weeks of therapy, paralleled by a rapid decline in circulating desmoglein-specifi c 
antibody levels. After 9-15 months of follow-up, one patient remained in complete remission 
and all immunosuppressants could be discontinued. Three patients developed a relapse after 
PAIA treatment was stopped and conventional immunosuppression was tapered. Two further 
patients experienced a prolonged improvement of pemphigus, but could not be completely 
weaned off low-dose immunosuppression thus far. These data suggest that on longer follow-up, 
results of the combined use of rituximab and PAIA are similar to those observed with rituximab 
alone. The present combination protocol, however, appears to be advantageous for patients 
with severe pemphigus by combining a rapid clearance of skin lesions with the benefi cial 
long-term effects of rituximab.
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Autoantibodies from Patients with Bullous Systemic Lupus Erythematosus Recognize Type VII 
Collagen and Induce In Vitro Dermal-epidermal Separation
Herrero-González JE1, Mascaró Jr. JM2, Herrero C2, Dilling A3, Zillikens D3 and Sitaru C3
1Department of Dermatology, Hospital del Mar, Barcelona (Spain)
2Department of Dermatology, Hospital Clínic, Barcelona (Spain)
3Department of Dermatology, University of Lübeck (Germany)
Bullous systemic lupus erythematosus (BSLE) and epidermolysis bullosa acquisita (EBA) are 
acquired subepidermal blistering diseases associated with autoimmunity against type VII col-
lagen, the major component of anchoring fi brils at the dermal-epidermal junction (DEJ). The 
aims of this study were to characterize the IgG subclasses distribution and the blister-inducing 
potential of circulating autoantibodies in sera of BSLE patients. For the latter, we used an in 
vitro model of leukocyte-dependent autoantibody-mediated dermal-epidermal separation on 
cryosections of normal human skin. We report two SLE patients who developed an acquired 
generalized blistering eruption, with subepidermal blisters and rich granulocyte infi ltration by 
histopathology, and deposits of multiple immunoreactants at the DEJ by direct immunofl uores-
cence study. Circulating IgG antibodies of both patients bound to the dermal side of salt-split 
skin as detected by indirect immunofl uorescence, and these autoantibodies were shown to spe-
cifi cally recognize type VII collagen by immunoblot analysis. Patients’ serum autoantibodies 
predominantly belonged to the IgG2 subclass and did not fi x complement to the dermal side 
of the artifi cial blister in salt-split skin. Autoantibodies from BSLE patients, in contrast to SLE 
controls without blistering eruption, induced leukocyte attachment to the dermal-epidermal 
junction resulting in subepidermal cleavage in frozen sections of human skin when co-incu-
bated with leukocytes from healthy donors. In conclusion, we demonstrate that autoantibodies 
against type VII collagen in our BSLE patients belong to the IgG2 subclass and induce leuko-
cyte-dependent dermal-epidermal separation in cryosections of human skin. 
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Epidermolysis Bullosa with Muscular Dystrophy Due to Impaired Recruitment of BP180 and 
BP230 at the Dermal-epidermal Junction Caused by Novel Plectin Mutations
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Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) is an autosomal recessive 
disorder caused by mutations in PLEC1 encoding plectin. Most EBS-MD cases reported result 
from mutations leading to loss of plectin expression. We describe 2 affected kindred with con-
trasting EBS-MD severity and persistent plectin expression. The 30-year-old patient presented 
since birth with mild skin blistering and developed progressive, disabling muscular dystrophy 
of the upper limbs. Her 24-year-old sister presented skin blistering during infancy with no 
muscular manifestations. Both patients were compound heterozygotes for 2 novel mutations: 
p.Q2602X and p.L1486P. p.L1486P co-segregated with p.R2859H (a known SNP), p.H1349R 
(a novel SNP) and p.E2798K substitutions. In silico-modelling showed p.E2798K to introduce 
only subtle changes in the position of C-α atoms with very high secondary structure conser-
vation. In contrast p.L1486P is predicted to disrupt the α-helical plectin rod domain, and is 
likely to be a causative mutation. Electron microscopy of skin sections revealed the absence of 
hemidesmosomal inner plaques. β4 integrin expression was normal and plectin showed posi-
tive but reduced staining at the dermal-epidermal junction, while both BP180 and BP230 stain-
ing were negative. Western-blot analysis revealed reduced BP230 expression and absence of 
the 120 kDa shed ectodomain of BP180. These results suggest that the mutant plectin prevents 
the recruitment of BP180, and therefore of BP230, at the dermal-epidermal junction. A pos-
sible mechanism is that the mutant plectin is unable to unfold the intracytoplasmic C-terminal 
β4-integrin which is requested for the recruitment of these molecules in the hemisdesmosomes. 
These results further document the role of plectin in hemidesmosomes assembly, and suggest 
that modifying genes underlie the variability of the disease severity in this family.
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Assessment of Pemphigus Autoantibodies Pathogennicity in Culture of Immortalized Human 
HaCaT Keratinocytes
Krajewski M1, Torzecka JD2, Narbutt J3, Wozniak K1, Waszczykowska E2 and Kowalewski C1
1Department of Dermatology, Medical University of Warsaw (Poland)
2Lab of Immunodermatology, Dept of Dermatology, Medical University of Lodz (Poland)
3Department of Dermatology and Venereology, Medical University of Lodz (Poland)
We examined pathogennicity of sera collected from 17 patients with pemphigus vulgaris (9 
M, 8 F; mean age 51.2 y.o.). Six sera were taken from the patients before treatment began, 4 
ones – from the individuals at active stage of PV (at a 4th week of immunosuppressive therapy) 
and 5 sera - from the subjects in clinical remission. Besides, 2 sera were collected from the 
patients in whom treatment was ceased at least 6 months earlier. Additionally we examined 
sera obtained from 4 healthy relatives of PV patients in whom indirect immunofl uorescence 
test revealed the presence of circulating pemphigus autoantibodies (titer 1:20-1:40). The sera 
were diluted in DMEM and incubated with culture of immortalized HaCaT keratinocytes for 
24-48 h. The presence of acantholysis was studied by Radiance 2000 laser scanning confocal 
microscopy. The study revealed that all sera collected from the patients at active stage of the 
disease were able to cause loss of cell to cell contact in the keratinocyte culture after a 24 h 
incubation. 4 out of 5 sera taken from the patients being in clinical remission did not cause 
this phenomenon either after 24 or 48 h of incubation. However, in one case acantholysis was 
noted (after 48 h). None of the sera collected from the patients after cessation of the treatment 
and from healthy relatives induced loss of cell to cell contact in the examined model. Laser 
scanning confocal microscopy method may be used for experimental assessment of acantholy-
sis. It allows to monitor any alterations in keratinocyte culture as well to study pathogenicity of 
pemphigus autoantibodies obtained from sera of the patients at different immunological and 
clinical stages of the disease. 
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Detection of Low Avidity Desmoglein 3-Reactive T Cells in Pemphigus Vulgaris using HLA- 
DRβ1*0402-Tetramers
Veldman C1, Eming R1, Wolff-Franke S1, Sonderstrup G2, Kwok W3, Hertl M1
1Department of Dermatology and Allergology, University of Marburg (Germany)
2Department of Microbiology and Immunology, Medical School, Stanford University (USA)
3Benaroya Research Institute, Virginia Mason, Seattle (USA)
Pemphigus vulgaris (PV) is a severe autoimmune bullous skin disorder associated with T cell-
dependent IgG-autoantibodies against desmoglein 3 (Dsg3). CD4+ T cell epitopes of Dsg3 have 
been shown to be restricted by distinct HLA class II alleles, i.e. DRβ1*0402 and DQβ1*0503, 
which are prevalent in PV. The goal of this study was to directly analyse ex vivo functionally 
relevant autoreactive T helper cells in patients with PV. We thus developed a HLA class II te-
tramer-based detection system utilizing DRβ1*0402 tetramers loaded with recently identifi ed 
Dsg3 peptides known to be DRβ1*0402 restricted epitopes. Initial experiments demonstrated 
staining of a Dsg3-reactive T cell hybridoma which was derived from HLA-DR0402-transgenic 
mice with PE-labelled DRβ1*0402-tetramers complexed with specifi c Dsg3 peptide. However, 
staining of autoreactive T cell clones (TCC) derived from PV patients was negative. Addition 
of exogenous peptides to the staining reactions in an antigen specifi c fashion resulted in posi-
tive staining. To demonstrate specifi city of tetramer Dsg3-peptide binding, Dsg3-response TCC 
were incubated with tetramers complexed with their nominal Dsg3 peptide and varying con-
centrations of an exogenously added irrelevant Dsg3 peptide. There was a dose-dependent spe-
cifi c binding of TCC to the tetramers with the agonistic Dsg3 peptide which was not altered by 
exogenous unrelated Dsg3 peptide. Noteworthy, the TCC did not stain with HLA-DR4 tetramers 
complexed with unrelated Dsg3 peptides. The preliminary fi ndings of this study suggest that 
HLA class II tetramers may provide a highly specifi c approach to monitor ex vivo the T cellular 
autoimmune response against Dsg3 in patients with PV.
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Bullous Pemphigoid Induced by lisinopril - A New Angiotensin Ii Converting Enzyme Inhibitor 
Lacking Thiol Group
Wozniak K, Rogozinski T, Kalinska-Bienias A and Kowalewski C
Department of Dermatology, Medical University of Warsaw (Poland)
Bullous pemphigoid (BP) is the most frequent autoimmune disease observed in the older pa-
tients. The etiology of this disease is unknown, but in some cases drugs have been claimed re-
sponsible for development of pemphigoid. A list of the drugs consists of approximately 30 med-
ications differing in their chemical structure. BP appears in the different time from introduction 
of medicine (on average 2 months). So far single cases of pemphigoid induced by angiotensin 
II converting enzyme inhibitors (ACE-i) containing the thiol group, such as captopril, have been 
reported. We report a 75-years-old male with arterial hypertension, at whom BP developed 30 
days after introducing lisinopril (ACE-i) lacking the thiol group. Direct immunofl uorescence 
revealed the presence of linear IgG and C3 deposits in the basement membrane zone (BMZ) 
and laser scanning confocal microscopy study showed that IgG deposits are localized above 
laminin-5 and co-localized with β4-integrin characteristically for BP. Indirect immunofl uores-
cence examination on salt split skin revealed the presence of the circulating anti-BMZ antibody 
reacting with the epidermal side of artifi cial blister and by ELISA with recombined protein 
NC16a of antigen of BP 180 kD. After withdrawal of lisinopril and introduction of prednisolon 
(0,4 mg/kg/day) rapid healing of the cutaneous lesions was observed. To our knowledge we 
report the fi rst case of BP probably induced by lisinopril.
138
Pemphigus Foliaceus with Circulating Antibodies Directed Against Desmoglein-1 and BP 230 
Antigen
Wozniak K2, Rogozinski T2, Hashimoto T1 and Kowalewski C2
1Department of Dermatology, University of Kurume (Japan)
2Department of Dermatology, Medical University of Warsaw (Poland)
We present 79-year-old male with superfi cial erosions accompanied by several crusts affecting 
forehead, ears, scalp and focally the left cheek. Erosions and multiple postinfl ammatory hy-
perpigmentations were also present on the trunk, lower legs and buttocks. Neither genital nor 
oral mucous membranes were involved. Direct immunofl uorescence (IF) showed the presence 
of in vivo bound IgG in intercellular space of the upper part of epidermis and at the basement 
membrane zone (BMZ). Indirect IF revealed pemphigus IgG in a titer of 80 on human esopha-
gus and in a titer of 320 on guinea pig esophagus as well as anti-BMZ antibody. Laser scanning 
confocal examination showed the localization of in vivo bound IgG at the BMZ above the lam-
inin-5 and collagen IV typically for bullous pemphigoid (BP). To confi rm the coexistence of PF 
with BP we performed ELISA tests which was strongly positive for desmoglein-1 and for BP230 
but was negative for desmoglein-3 and NC16a epitop of BP180. Histopathology disclosed the 
presence of subcorneal blisters with acantholytic cells, whereas subepidermal blister was not 
found. Patient initially received tetracycline 2g and nicotinamide 1,2g daily for two weeks, but 
improvement was not achieved. Then, prednisone in a dose of 0.5mg/kg was introduced with 
success. Patient has been in clinical remission for 7 months. However indirect IF performed 
after 7 months of the treatment showed the presence of circulating IgG anti-BMZ antibody 
but not pemphigus antibody. In conclusion, we speculate that the treatment of pemphigus 
prevented the development of clinical features of BP at its early course.
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Expression of Selected Integrins and Selectins in Skin Lesions of Dermatitis Herpetiformis
Zebrowska A1, Sysa-Jedrzejowska A1, Torzecka JD2, Wagrowska-Danilewicz M3, 
Waszczykowska E4
1Dept of Dermatology and Venerology (Poland) 2Laboratory of Immunodermatology (Poland) 
3Dept of Nephropathology (Poland) 4Laboratory of Immunodermatology (Saint Lucia)
Pathogenesis of skin lesions in dermatitis herpetiformis is associated with destruction of basement 
membrane components, leading to formation of bullous lesions. Basement membrane is a complex 
structure providing integrity of dermo-epidermal junction. Antibodies binding to autoantigens local-
ized in the basement membrane activate a series of immunological and enzymatic phenomena that 
lead to destruction of anchoring fi bers. Blister formation is initiated by accumulation of neutrophils, 
attracted by CD4+ T cells forming Pierrard’s microabscesses. They are quickly transformed by oede-
ma and infl ammation into microvesicles and later into subepidermal blisters. Adhesive molecules 
have an important role in processes of adhesion and interaction between individual cells as well 
as between cells and components of extracellular matrix. Selected integrins and selectins are cell 
surface transmembrane glycoproteins that function as adhesion receptors transmitting biochemical 
and mechanical signals in a bidirectional manner across the plasma membrane and thus infl uence 
most cellular functions such as proliferation, differentiation, apoptosis and cell migration during 
infl ammation. The aim of the study was to investigate whether selected integrins and selectins, are 
involved in pathogenesis of DH. Skin biopsies were taken from 13 patients with DH in an active 
stage of the disease and from 10 healthy subjects.The localization and expression of beta1, beta3, 
beta4 integrins, L-selectin and E-selectin were examined by immunohistochemistry (Novocastra).
Signals for beta1 and beta4 integrins were detected in basal keratinocytes in all the DH samples 
and it was moderate or intensive. Expression of beta4 integrin in samples with blister was irregular 
and focal. Neutrophils in microabscesses, in blister fl uid and perivascular infi ltrations gave positive 
staining for beta1 integrin and L- selectin. Expression of E-selectin was assessed as strong or moder-
ate in vascular wall in all examined DH biopsies. Signals for beta3 integrin were detected in single 
basal keratinocytes, platelets and collagen fi bres. In all samples obtained from healthy volunteers 
weak expression of the examined molecules was detected in basal keratinocytes. Expresion of beta4 
integrin in basal keratinocytes was regular in all controls samples. Our results allow us to conclude 
that integrins and selectins play an important role in the pathogenesis of skin lesions of DH.
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Overexpression of Manganese Superoxide Dismutase in a Human Dermal Fibroblast Cell Line 
Enhances Contraction of the Free Floating Collagen Lattice 
Treiber N1, Peters T1, Menke A2, Sulyok S1, Keist AF1, Wlaschek M1 and ScharffetterKochanek K1
1Dermatology, Univ Ulm (Germany) 2Dept of Internal Medicine I, Univ Ulm (Germany)
Manganese superoxide dismutase (MnSOD), a mitochondrially localized antioxidative enzyme, 
exerts its antioxidative defense by dismutation of superoxide anions to hydrogen peroxide. ROS 
like superoxide anions and hydrogen peroxides play an important role in the physiology of 
wound healing. However, prolonged generation of toxic concentrations of ROS by infl ammatory 
cells may contribute to the pathophysiology of chronic wounds. Here we adressed the question 
whether overexpression of MnSOD plays a role in wound contraction. For this purpose, we used 
stably transfected MnSOD overexpressing human dermal fi broblasts in the collagen lattice as an 
in vitro wound contraction assay. Using the scopoletin assay we showed that the concentration 
of hydrogen peroxide is increased in MnSOD overexpressing fi broblasts due to an imbalanced 
overexpression of MnSOD, while hydrogen peroxide detoxifying enzymes (catalase, glutathione 
peroxidase) have unchanged activities. MnSOD overexpressing fi broblasts lead to a substantially 
increased contraction, whereas MnSOD defi cient fi broblasts showed a signifi cant delay in the 
contraction compared to controls. Among other effectors, Transforming Growth Factor-β1 (TGF-
β1) is known to stimulate collagen lattice contraction. Collagen lattices seeded with MnSOD 
overexpressing cells showed high secretion levels of TGF-β1 compared to controls. Inhibition of 
the TGF-β1-receptor signal transduction pathways, by means of an inhibitor of TGF-β1-receptor 
kinases, resulted in a reduced contraction of the MnSOD overexpressing fi broblasts. Incubation 
of vector transfected control fi broblasts with recombinant TGF-β1 led to an enhanced contraction 
at late time points. Exogenously added H2O2 stimulated the contraction of vector control cells 
at early time points. Incubation of MnSOD overexpressing cells with the antioxidant N-acetyl-
cysteine strongly reduced the enhanced contraction at early as well at late time points. Collec-
tively, these data show that the imbalance of MnSOD expression with an increase in hydrogen 
peroxide and subsequent TGF-β1 release promote collagen lattice contraction dramatically.
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Cell-extracellular Matrix Interactions in the Skin – Is the Collagen Receptor Integrin α2β1 
Dispensable?
Zhang ZG1, Zweers MC2, Bothe I1, Hirche F2, Krieg T2, Aumailley M1 and Eckes B2
1Biochemistry, Univ of Cologne (Germany) 2Dermatology, Univ of Cologne (Germany)
Numerous studies suggested pivotal roles for integrin α2β1 in cell attachment to collagens and 
other extracellular matrix (ECM) components, migration, matrix contraction, protease induction 
and cell differentiation. Therefore the ‘normal’ phenotype of integrin α2-defi cient mice was unex-
pected. We hypothesized that interactions of cells with surrounding collagens may be maintained 
by compensatory action of other collagen integrin receptors, e.g. α1β1 or α11β1, and that func-
tional defi cits would be uncovered in situations which challenge the cell-collagen interactions.
To address this, we subjected primary keratinocytes and fi broblasts from skin of α2-knockout mice 
and controls to functional assays. These demonstrated that integrin α2β1 is absolutely required for 
keratinocyte adhesion to collagens, while fi broblast adhesion was impaired, not abolished. These 
results were confi rmed by silencing α2 and by applying antibodies blocking integrin function. 
However, fi broblasts revealed severe impairment of mechanical properties in a complex colla-
gen environment: lack of α2β1 resulted in impaired contraction of freely fl oating collagen lattices 
and reduced force-generation in tethered lattices. These defi cits were concomitant to alterations 
in force-bearing focal adhesions and de-regulated Rho GTPase activation. Altogether, our in vitro 
analysis indicates that the extent of functional defi cits depends on the repertoire of collagen recep-
tors expressed by individual cell types.
To address the question whether challenges to the skin may uncover functional defi cits in vivo 
in α2-defi cient mice, we studied the healing of full-thickness wounds. Surprisingly, re-epitheli-
alization and granulation tissue contraction by myofi broblasts were normal in knockout mice, 
demonstrating that integrin α2β1-collagen contacts are dispensable for correct wound healing 
and scar contraction. However, absence of α2β1 resulted in altered wound vascularization and 
scar properties. These results shed new light integrin α2β1functions in skin biology and underscore 
the complex interactions between different cell types and the dynamic ECM environment.
142
Two Selected Active Ingredients Improve Skin Elasticity by Increasing the Lysyl Oxidase-Like 
Expression
Cenizo V1, André V1, Reymermier C1, Orly I1, Elsheikh A2, Damour O3 and Sommer P4
1Engelhard-Lyon (France)
2Division of Civil Engineering, University of Dundee (France)
3Hospices Civils de Lyon, Lab des Substituts Cutanés, Hôpital Edouard Herriot, Lyon (France)
4Inst de Biologie et Chimie des Protéines, CNRS/Universite Lyon 1 UMR-5086, Lyon (France)
The synthesis and organization of elastic fi bers, elastogenesis, mainly occurs during embryo-
genesis and growth. In the adult skin, elastic fi bers repair and renewal are not effi cient despite 
an active tropoelastin synthesis. Thus, another elastic fi bers component, or a protein involved 
in their formation, might be lacking in adult skin. The lysyl oxidases LOX and LOXL, responsi-
ble for the elastin cross-linking, could be one of the lacking components. The goal of this study 
was to induce elastogenesis in adult skin. We fi rst showed that the LOX and LOXL mRNA level, 
quantifi ed by quantitative RT-PCR decreased in fi broblasts from adult skin (by 41 % and 66 
% respectively) compared to those from children. Therefore, both enzymes, and in particular 
LOXL, of which expression is the most affected by age, could be considered as targets to rein-
duce functional elastogenesis.
We thus screened a library of about 1,000 active ingredients to fi nd activators capable to 
stimulate particularly the LOXL gene expression in adult dermal fi broblasts. The positive effect 
of two selected active ingredients was then analyzed on dermal and skin equivalents. The skin 
equivalent model allows the formation of elastic fi bers in vitro and thus the detection of the 
components involved in their formation. The selected active ingredients increase the LOXL 
mRNA level in fi broblasts. At the same time, the elastin detection observed by immunohistol-
ogy is increased in this model and below the dermal-epidermal junction of skin equivalents, 
without any increase of the elastin mRNA. Finally, treated dermal equivalents present increased 
strength and elasticity compared to control, as measured by mechanical tests.
In conclusion, LOXL can be considered as a new target to induce de novo elastogenesis. Its 
stimulation by the selected compounds is correlated with an increased elastin detection and 
skin elasticity, suggesting an improved elastogenesis.
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High Body Weight is Associated with Increased Glycation Associated Fluorescence in Human 
Skin
Corstjens H1, Neven A1, Declercq L1 and Maes D2
1Estée Lauder Companies, Oevel (Belgium)
2Estée Lauder Companies, Melville, NY (USA)
Although excessive weight gain is a complex, multi-factorial chronic condition involving ge-
netic, physiologic, metabolic and psychological components, a dramatic increase in energy 
rich food intake accompanied by a signifi cant reduction in physical activity are major contribu-
tors to obesity. Skin problems like itchiness and dry skin have already been associated with 
obesity. In this study we investigated whether in vivo skin fl uorescence, used as a marker for 
Advance Glycation Endproduct (AGE) accumulation in human skin, was associated with body 
weight in a data set of healthy volunteers. Sixty six female Caucasian non-smoking healthy 
volunteers living in Belgium with an age of 21 to 59 years (median age 42 years) were enrolled 
in this study. Weight, height and percentage of body fat was measured and the Body Mass Index 
ranged from 18.3 to 32.0 (median BMI 24.2). We gathered in vivo fl uorescence intensity data 
on the thigh of each panellist. Fluorescence intensity at λex/λem 370/440nm was attributed to 
the AGEs. Skin colour was measured on the same test site. Multiple linear regression techniques 
were used to simultaneously evaluate in vivo fl uorescence as a function of skin colour, panellist 
age and percentage of body fat. Taking into account differences in individual skin colour, the 
fl uorescence intensity attributed to AGEs increased as a function of panellist age (p=0.008), 
which confi rms former results. We also observed a positive correlation between the glycation 
associated fl uorescence and percentage of body fat (p=0.04) (independent of the age effect). 
These data suggest that within a population of healthy women heavy weighted panellists seem 
to have higher AGE levels in their skin.
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Glycotoxins from Tobacco Smoke May Impair Bioenergetic Capacity of Skin in Smokers
Corstjens H1, Eyckmans G1, Declercq L1 and Maes D2
1Estée Lauder Companies, Oevel (Belgium)
2Estée Lauder Companies, Melville, NY (USA)
Glycation is a non-enzymatic chemical process in which proteins are damaged by the at-
tachment of reducing sugars, ultimately leading to the formation of Advanced Glycation End-
products (AGEs). During the fi rst steps of glycation propagators like methylglyoxal and glyco-
laldehyde are formed as intermediate reaction products. In addition to those endogenously 
formed, AGEs can also be introduced in the body from exogenous sources. Tobacco smoke is 
suspected to be an exogenous source of AGE-inducing compounds and we already showed 
that in vivo skin glycation, measured as in vivo fl uorescence, is increased in smokers. Many 
adverse consequences of glycation are reported. Cross-linking of long-lived proteins like col-
lagen and elastin may contribute to the loss of elasticity in aging skin. Enzymes are susceptible 
to deactivation when modifi cations in functional groups are introduced by reaction with gly-
cation propagators. In this study we evaluated the in vitro glycation properties of a cigarette 
smoke condensate. The cigarette smoke condensate caused an increase in the glycation as-
sociated fl uorescence of the model protein bovine serum albumin, which could be completely 
prevented by the glycation inhibitor aminoguanidine. Cigarette smoke condensate also caused 
a concentration dependent decrease of the in vitro creatine kinase enzyme activity. Creatine 
kinase is an enzyme that plays a critical role in the cellular energy metabolism by regulat-
ing free ATP levels. The enzyme is crucial under conditions of high-energy demand and the 
creatine kinase system helps protecting against cellular stress conditions like oxidative and UV 
damage. In this case aminoguanidine partially protected against the cigarette smoke induced 
deactivation of creatine kinase, which suggests the involvement of glycation reactions. We 
hypothesize that the process of glycation may compromise the bioenergetic capacity of aging 
skin, especially in smokers.
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Serum Levels of Metalloproteinases -2 and -9 (MMP-2, MMP-9) and their Expression in Skin 
Lesions in Systemic Sclerosis Patients – Preliminary Examination
Dziankowska-Bartkowi B1, Joss-Wichmann E2, Zebrowska A2, Waszczykowska E1
1Division of Immunodermatology (Poland)
2Department of Dermatology Medical University of Lodz, Poland (Poland)
The role of extracellular matrix metalloproteinases (MMPs) is implicated in pathogenesis of 
systemic sclerosis (SSc). The aim of present study was a comparison of serum levels of two 
metalloproteinases – gelatinases MMP-2 and MMP-9 with their expression in lesional skin 
biopsies from patients with SSc. 
10 patients with systemic sclerosis (6 with limited SSc and 4 with diffuse SSc) and 10 healthy 
volunteers without any skin disease were examined. 
Evaluation of serum levels of MMP-2 and MMP-9 was performed by ELISA method using R&D 
Systems kits. Expression of MMPs was determined by immunohistochemistry with DAKO EnVi-
sion detection system using immunoperoxidase method with mouse monoclonal antibodies. 
Levels of MMP-2 were not statistically different between SSc patients and control group (179.3-
321.7 ng/ml vs. 117-410 ng/ml), neither between both clinical types of the disease (lSSc – 
179.3-304.7 ng/ml vs. dSSc 181.2-321.7 ng/ml).
Concentration of MMP-9 in the examined group of patients was 116-2306 ng/ml vs. 169-705 
ng/ml in the control group. There were no signifi cant differences between two clinical types of 
sclerosis – lSSc 116-2306 ng/ml vs. dSSc – 569-1328 ng/ml. 
Expression of MMP-2 in skin biopsies from SSc patients was high around blood vessels and 
in dermis, while medium expression of MMP-9 was observed around blood vessels, in basal 
keratinocytes and in dermis. Expression of both metalloproteinases was higher in lesional skin 
in comparison to control group. 
Obtained results confi rm the important role of MMPs in pathogenesis of systemic sclerosis. 
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L-carnitine-L-tartrate Promotes Human Hair Growth In Vitro
Foitzik K1, Hoting E2, Förster T2, Pertile P3 and Paus R4
1Department of Dermatology, University Hospital Hamburg-Eppendorf (Germany)
2Schwarzkopf & Henkel GmbH & Co. KG (Germany)
3Cutech (Germany)
4Dept. of Dermatology, 2 University Hospital Schleswig-Holstein (Germany)
The trimethylated amino acid L-carnitine plays a key role in the intramitochondrial transport of 
fatty acids for β-oxidation and thus serves important functions in energy metabolism. Here, we 
have tested the hypothesis that L-carnitine may also stimulate hair growth by increasing energy 
supply to the massively proliferating and energy-consuming anagen hair matrix. Hair follicles 
(HFs) in the anagen VI stage of the hair cycle were cultured in the presence of 0.5-50μM L-
carnitine-L-tartrate (CT) for nine days. At day 9, HFs treated with 5μM or 0.5μM CT showed 
a moderate, but signifi cant stimulation of hair shaft elongation compared to vehicle controls 
(p <0.05). Also, CT prolonged the duration of anagen VI, down regulated apoptosis and up 
regulated proliferation of hair matrix keratinocytes (p<0.5). By immunohistology, intrafollicular 
immunoreactivity for TGFβ 2, a key catagen-promoting growth factor, in the dermal papilla 
and TGF-β II receptor protein in the outer root sheath and dermal papilla were down regulated. 
Shown by Caspase activity essay, Caspase 3 and 7,which are known to initiate apoptosis, are 
down regulated at day 2 and day 4 after treatment of HFs with CT compared to vehicle treated 
control indicating that CT has an immediate protective effect on HFs to undergo programmed 
cell death. Our fi ndings suggest that L-carnitine stimulates human scalp hair growth by up 
regulation of proliferation and down regulation of apoptosis in follicular keratinocytes in vitro. 
They further encourage one to explore administration of L-carnitine as an adjuvant treatment in 
the management of androgenetic alopecia and other forms of hair loss.
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TGF β1 Induces Myofi broblastic Differentiation of Subcutaneous Human Adipose Tissue-
derived Stromal Cells
Franchi J1, Zakaroff-Girard A2, Pellicier F1, Schnebert S1, Lafontan M2, Dumas M1 and Galitzky J2
1LVMH Research P&C (France)
2Inserm U586 Recherche Obésités (France)
Adipose tissue development is the result of adipocyte hypertrophy and the recruitment and 
differentiation of regenerative precursors located in the stromal-vascular fraction. This fraction 
represents a heterogeneous cell population surrounding mature adipocytes. Several groups 
have demonstrated that mesenchymal cells within the stromal-vascular fraction of the sub-
cutaneous adipose tissue display multilineage developmental plasticity in vitro and in vivo. 
In this study, transdifferentiation of these human adipose tissue-derived stromal cells (ATSC) 
into myofi broblasts was assessed by the quantifi cation of alpha-smooth muscle actin (α SMA) 
using immunocytochemistry and real-time PCR. In the dermis, myofi broblasts are derived from 
fi broblasts through a differentiation process controlled by various cytokines, especially trans-
forming growth factor β1 (TGF β1) a potent inducer of this process. Results showed that α-SMA 
expressing cells are particularly abundant in the ATSC fraction after 10 days in a medium 
adapted for fi broblast culture. It is revealed that upon the stimulation of TGF β1 (1 and 5 
ng/mL), the expression of α-SMA mRNA increases signifi cantly, more than 2 fold, depending 
on the culture conditions. In addition, we found a negative correlation between the expres-
sion of α-SMA and the activity of MMP-9, possibly explained by the critical role of TGF β1 in 
modulating the infl ammatory response through its regulation of the production of MMPs as 
in macrophage. It is well established through in vitro and in vivo investigations that there are 
regional variations in particular in the lipolytic activity. No regional differences were noticed 
after a preliminary examination of the response of the ATSC cells extracted from abdominal or 
thigh adipose tissues in terms of α-SMA expression and MMP-9 activity. In conclusion, ATSC 
fraction may contain a cell population which is sensitive like dermal fi broblasts to the TGF β1 
and can acquire myofi broblast phenotype. Yet Again, the trans differentiation in contractile 
cells illustrates the plasticity of the adipose tissue progenitor cells.
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Characterization and Biological Interest of the Different Cell Populations Present in the 
Stroma Vascular Fraction of Human Subcutaneous Adipose Tissue
Galitsky J1, Sengenès C1, Miranville A1, Curat C1, Bouloumié A1, Pellicier F2, Schnebert S2, 
Dumas M2 and Franchi J2
1Inserm U586, Recherches Obésités (France)
2LVMH Research P&C (France)
Mature adipocytes are the metabolically active cellular component of adipose tissue. The imbal-
ance between lipolysis and lipogenesis is thought to be responsible for the adipocyte hypertrophy 
causing the growth of fat mass during the settlement of obesity. Moreover, when the maximal stor-
age capacity of the adipocytes is reached, a phase of apparent hyperplasia is observed. Given that 
mature adipocytes have no proliferative ability, the hyperplasia phase is supported by the non-adi-
pose fraction of adipose tissue, the so-called stoma-vascular fraction (SVF). Although extensively 
used to investigate the adipocyte differentiation process, little data is available concerning the cel-
lular fractions present in the adipose tissue SVF, as well as the identity of the adipocyte precursors.
Using fl ow cytometry analysis and an immuno-selection approach, we isolated and characterized 
different cell populations present in the SVF from human adipose tissue. This approach is based on 
the cell surface expression of various cell surface markers, i.e. CD34 (human hematopoietic stem 
and capillary endothelial cells), CD31 (marker for endothelial cells, monocyte/macrophage lineage) 
and CD14 (marker for the monocyte/macrophage lineage). We identifi ed three main cell popula-
tions: the CD34+/CD31- cells, characterized as adult progenitor cells since under appropriate cul-
ture conditions the cells differentiate into adipocytes or into endothelial cells, the CD34+/CD31+, 
identifi ed as capillary endothelial cells as well as CD14+/CD31+ defi ned as macrophages, the 
proportion of which increases with the fat mass growth. 
Such an approach allowed a fi ne characterization of the cell populations that constitute the non-
adipose fraction of the fat mass and revealed two major fi ndings: the development of the adipose 
tissue in obesity is associated with an increased infi ltration of infl ammatory cells and the human 
adipose tissue contains a population of cells that exhibit a relative plasticity relating to their fate. 
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Extracellular Processing of the Laminin Gamma2 Chain Controls Basement Membrane 
Formation and Regulates its Turnover
Delteil F, Saldo J, Meneguzzi G, Gagnoux-Palacios L
Inserm, U634, Faculty of Medicine, Nice (France)
Laminin 5 is one of the major components of the extracellular matrix proteins secreted by ke-
ratinocytes. Under physiological conditions, laminin 5 undergoes extracellular proteolysis of the 
gamma2 chain that removes the NH2-terminal short arm of the polypeptide and reduces the size 
of this molecule from 155 to 105 kDa. Our previous in vitro studies demonstrate that the short arm 
of the gamma2 chain is necessary for the incorporation of the laminin 5 into the basement mem-
brane and in cell adhesion. In order to understand the molecular mechanisms associated with this 
specifi c domain and to isolate molecular partners, we generated Fc fusion proteins corresponding 
to the uncleaved entire short arm (Fc-gamma2NC) or the short N-terminal domain III remaining 
after processing (Fc-gamma2C). Expression of Fc-gamma2 chimeras and the 50 kDa (gamma2-Nt), 
corresponding to the released N-terminal domain of gamma2 chain, in gamma2-null keratinocytes 
(Ker gamma2-/-) revealed that the Fc-gamma2NC is actively deposited in the ECM and increased 
signifi cantly the adhesion capacity of the Ker gamma2-/- compare to the two other fusion proteins. 
Our results suggest that this effect is indirect and is caused by an increased deposition of several 
ECM proteins including collagens and fi bronectin. These results are in agreement with our observa-
tions made in knock-in mice which exclusively express an unprocessed gamma2 chain. Indeed, 
these animals present an accumulation of laminin 5 and other components of the ECM in the 
basement membrane that is associated with a lamina densa thickening. We were also able to dem-
onstrate that in these animals ECM accumulation was not due to higher levels of protein expression 
but is rather caused by an increased stability in the ECM of the unprocessed form of laminin 5 which 
results in the reduction of the ECM turn over.
In conclusion, our studies suggest that the proteolytic cleavage of the short arm of the laminin 5 
not only controls the deposition of the laminin 5 into the ECM, but also the basement membrane 
formation and its turn over. 
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Conception In Vitro of a Skin Substitute made from the Combination of Bioresorbable poly(α-
hydroxy acid)s and Human Skin Cells
Garric X1, Molès JP2, Garreau H3, Casellas D4, Guilhou JJ2 and Vert M1
1Centre de Recherche sur les Biopolymères Artifi ciels, University of Montpellier (France)
2Laboratory of Molecular Dermatology, University of Montpellier (France)
3Centre de Recherche sur les Biopolymères Artifi ciels, Universityt of Montpellier (France)
4Laoboratory of kidney and hypertension, University of Montpellier (France)
Patients with large skin defects have been treated with cultured epithelial autografts (CEA) for many 
years. This technique has shown its limits due to the fragility of the epidermal sheet and the lack 
of dermal replacement. One of the approaches consists in making skin substitutes composed of a 
dermal equivalent (bioresorbable polymer and dermal fi broblasts) and an epidermal layer.
The various properties of poly(α-hydroxy-acid)s derived from lactic (LA) and glycolic acids (GA) 
appear to be of great interest in tissue engineering, including skin reconstruction.
In order to further evaluate whether three poly(α-hydroxy-acid)s (PLA37.5GA25, PLA50, PLA50-
PEG-PLA50) fi lms could be considered as skin cell culture supports, we fi rst synthesized and char-
acterized these polymers. Second, we determined by MTT assay the adhesion and the proliferation 
of human skin cells (human dermal fi broblasts and human keratinocytes) on these supports. Third, 
we prepared a porous matrix by the salt leaching method and we fi lled pores with type I collagen 
and human dermal fi broblasts in order to obtain a dermal equivalent. The last step was to cultivate 
human keratinocytes on this dermal scaffold in physiological conditions to obtain a skin substitute 
with a well-differentiated epidermis as assess by keratin and adhesion molecules (integrin, cad-
herin,…) immunodetection.
All in all, this work highlighted that two poly(α-hydroxy-acid)s tested could be considered as skin 
cell culture supports. These supports allowed the adhesion and the proliferation of human keratino-
cytes and human dermal fi broblasts until the formation of a confl uent layer of cells. One of these 
polymers (PLA50-PEG-PLA50) was used as a dermal scaffold and a culture support for the forma-
tion of a stratifi ed epidermis. These results confi rm that poly(α-hydroxy-acid)s are good candidates 
for skin tissue engineering.
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The Effect of Glycine Substitution Mutations to the Cellular Localization and the Post-
Translational Modifi cations of the Transmembrane Collagen XVII
Huilaja L1, Hurskainen T1, Tu H2, Franzke CW3, Pihlajaniemi T2, Autio-Harmainen H4, Bruck-
ner-Tuderman L3 and Tasanen K1
1Dept of Dermatology, University of Oulu and Clinical Research Center, Oulu University Hos-
pital (Finland)
2Dept of Medical Biochemistry, University of Oulu and Biocenter Oulu (Finland)
3Dept of Dermatology, University of Freiburg (Germany)
4Dept of Pathology, University of Oulu (Finland)
Mutations in transmembrane collagen XVII are associated to junctional epidermolysis bul-
losa. Most COL17A1 mutations lead to premature termination codon. Missense mutations or 
deletions of COL17A1 are more rare and their consequences at the molecular level are poorly 
understood. Recently, we have shown in four different cases that single glycine substitutions 
decrease the thermal stability of the collagen XVII.
Here we analyzed the effect of mutations G609D, G612R, G627V, G633D and the nine amino 
acid deletion (∆779-787) to the cellular localization of recombinant collagen XVII. The immun-
ofl uorescence staining of COS-7 cells with collagen XVII specifi c antibody showed a patchy 
cytoplasmic expression of glycine substituted collagen XVII, whereas the deleted form of col-
lagen XVII was clearly detected in the cell membrane similarly to the wild type. 
As a member of the collagen superfamily, collagen XVII is subjected to post-translational modi-
fi cations such as glycosylation and hydroxylation of proline and lysine residues. SDS-PAGE 
analysis revealed that glycine substituted collagen XVII migrated slower than the wild type, in-
dicating that these mutated proteins are post-translationally over-glycosylated or -hydroxylated. 
In contrast, the deletion mutant showed no molecular weight shift. In glycosidase digestions all 
glycine substituted forms of collagen XVII were sensitive to N-glycosidase F, but not to Endo-H. 
However, the collagen XVII with nine amino acid deletion was resistant to both N-glycosidase 
and Endo-H treatments. 
Thus, collagen XVII with glycine substitutions is properly N-glycosylated followed by normal 
trans-Golgi-passage, while deletion of amino acids 779-787 seems to prevent N-glycosylation. 
By disturbing the correct triple-helix formation, glycine substitution mutations expose collagen 
XVII to post-translational overmodifi cations and may cause proteolytical degradation or abnor-
mal accumulation of mutated molecules. 
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Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and 
Results in Clinical Improvement in a Patient with Pretibial Myxedema
Kaya G, Tran C, Stucki L, Grand D, Salomon D and Saurat JH
Department of Dermatology, University Hospital of Geneva (Switzerland)
Hyaluronidases are endoglycosidases essential for the breakdown of hyaluronate (HA) in tis-
sues. To explore the activity of hyaluronidase on an exogenous HA, we fi rst incubated HA fi llers 
(Restylane®, Perlane®) with different concentrations of hyaluronidase (Lido-Hyal®) in vitro. 
Hyaluronidase showed a progressive degrading effect on high molecular weight HA with in-
creasing concentrations. We then injected hyaluronidase into the papules generated by subcu-
taneous injections of HA fi llers in SKH1 hairless mouse skin. Administration of hyaluronidase 4 
hours after the injection of exogenous HA showed a 100% reduction of the size of the papules 
by 18 hours as compared to Lidocain (the anesthetic component of Lido-Hyal®; 16%) and no 
injection (46%) as monitored by ultrasonography. Histological examination of the injected 
sites revealed the disappearance of HA, confi rmed by colloidal iron and hyaluronate binding 
protein stainings. We then investigated the effect of injected hyaluronidase on the mucinous 
nodules of pretibial myxedema in a 51 year-old patient. Intralesional injections of hyaluroni-
dase also resulted in complete dissolution of nodules within three days with no recurrence 
during 3 months. These results show that the injection of hyaluronidase is capable of degrading 
exogenous HA in mouse skin in vivo and may be a therapeutic option for skin diseases charac-
terized by abnormal accumulation of HA.
153
Immunoglobulin A deposits in Lesional Skin of a Patient With Acral Acquired Cutis Laxa 
Associated with Multiple Myeloma
Kluger N1, Bessis D1, Guillot B1 and Molès JP2
1Dept of Dermatology, University of Montpellier I, Montpellier University Hospital (France)
2Laboratoire de Dermatologie Moléculaire, Institut Universitaire de Recherche clinique, Univer-
sity of Montpellier (France)
A 40-year-old man presented for laxity of the skin of his fi ngers and toes after repeated episodes 
of itching and swelling of the upper and lower extremities since 2001. Medical data included 
chronic urticaria of the extremities and the trunk since 1996 and monoclonal immunoglobulin 
A (IgA) gammapathy since 2002. In addition, examination revealed urticaria on the extremities 
and severe painless hyperlaxity of the distal interphalangeal joints. Laboratory tests showed IgA 
peak with normal serum level (3,49 g/l) and hypogammaglobulinemia (4,9 g/l). Bone marrow 
aspiration revealed 13% of plasma cells with dystrophy, consistent with IgA myeloma. His-
topathology revealed urticarial vasculitis with neutrophilic infi ltrate between collagen fi bers 
on an urticarial lesion and decreased, fragmented and clumped elastic fi bers in the dermis 
of acquired cutis laxa (ACL) lesion. Amyloid stain was negative. Electron microscopy showed 
conspicuous diminution of the elastic fi bers with normal appearing collagen fi bers and mac-
rophages were found phagocyting the elastic fi bers. Direct immunofl uorescence investigation 
and immunoelectron microscopy of lesional skin revealed abundant IgA deposits in the papil-
lary dermis. Controls from non-lesional forearm skin showed only a faint staining.
Acral ACL is a rare disorder (only 6 cases reported) characterized by loose pendulous skin and 
loss of dermal elastic tissue restricted to extremities. ACL pathogenesis remains unknown with 
various hypothesis including decreased synthesis of serum elastase inhibitor like alpha1-antit-
rypsin, presence of neutrophil-derived elastase and lysyl-oxidase defi ciency. Reports of immu-
noglobulin deposits on elastic fi bers during plasma cell dyscrasia or myeloma are anectodal. 
An underlying genetic susceptibility of elastic fi bers to infl ammatory destruction could explain 
ACL after common infl ammatory diseases. IgA deposits in the acral ACL skin of a patient with 
chronic urticaria and IgA myeloma is reported for the fi rst time. Immunopathogenic mecha-
nisms could participate to acral elastolytic process in a predisposed patient, although reasons 
for such a specifi c localization remain unknown.
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Serum Concentrations of Matrix Metalloproteinase-2, -9 (MMP-2, -9) and Tissue Inhibitors of 
Metalloproteinases-1, -2 (Timp-1, -2) In Patients With Systemic Sclerosis
Krasowska D1, Bogaczewicz J1, Chodorowska G1, Ostrowski S2, Myslinski W2, Makaruk B2 
and Ignatowicz A2
1Department of Dermatology, Medical University of Lublin (Poland)
2Department of Internal Medicine, Medical University of Lublin (Poland)
Systemic sclerosis (SSc) is characterized by alterations of the microvasculature, disturbances of 
the immune system and excessive deposition of extracellular matrix (ECM) components, in par-
ticular collagen, in the skin and internal organs. The enzymes classifi ed as matrix metalloprotein-
ases (MMP) and their tissue inhibitors (TIMP) play a key role in ECM turnover. 
The objective of the study was to examine concentrations of matrix metalloproteinase-2, -9 
(MMP-2, -9) and tissue inhibitor of metalloproteinases-1, -2 (TIMP-1, -2) in serum of 53 female 
patients with SSc (with ELISA technique), to calculate serum ratio of MMP-9/TIMP-1 and MMP-
2/TIMP-2, and to determine whether there exists a relationship between these parameters and the 
involvement of internal organs. The control group consisted of 35 healthy, age-matched women. 
In our study, no statistically signifi cant difference in serum concentration of MMP-2 between pa-
tients with SSc and the controls was found. Serum concentration of MMP-9 was elevated in patients 
with SSc compared to the controls (p<0.002). Serum concentration of TIMP-1 was found to be el-
evated in SSc patients (p<0.0001). There was no difference in serum TIMP-2 concentration between 
SSc patients and the controls. Serum ratio of MMP-9/TIMP-1 and MMP-2/TIMP-2 in patients with 
SSc did not statistically differ from those of the controls. 
The serum ratio of MMP-9/TIMP-1 was correlated with ejection fraction (EF) in patients with SSc
(r = 0.57; p< 0.05). Correlation between serum ratio of MMP-2/TIMP-2 and total lung capacity 
(TLC) in patients with SSc was found (r = 0.35; p< 0.05). 
Although no difference in serum ratio of MMP-9/TIMP-1 and MMP-2/TIMP-2 between SSc patients 
and controls was found, the relationship of serum ratio of MMP-2/TIMP-2 with total lung capacity 
and MMP-9/TIMP-1 with ejection fraction suggest that development of organ involvement may 
be due to increased TIMP and decreased MMP. Further studies determining this interrelation are 
required to enhance knowledge on pathological mechanisms underlying organ fi brosis in SSc. 
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Sprouting Of Endothelial Progenitor Cells In Spheroid Cultures Is Resistant To Inhibition By 
Stromal Cells: Potential Use In Tissue Engineering
Kurschat P1, Stahl A2, Wu X2 and Klagsbrun M2
1Department of Dermatology, University of Cologne (Germany)
2Department of Surgery, Childrens Hospital Boston (USA)
After embryonic development the regenerative capacity of human tissues is generally limited. 
To repair congenital defects or to replace tissues destroyed by disease or injury, various tech-
niques of tissue engineering are being developed to provide graft material for reconstructive 
surgery. One of the main problems for the successful application of ex vivo generated human 
tissue for transplantation purposes is the slow ingrowth of blood vessels, leading to cell loss 
through hypoxic cell death during the early postimplantational stage. A method to enhance 
graft vascularization is to establish a primitive vascular plexus within the graft prior to trans-
plantation. Endothelial cells cultured as multicellular spheroids within a collagen matrix form 
sprouts resembling angiogenesis in vitro. However, stromal cells like osteoblasts or fi broblasts 
integrated into the graft suppress endothelial cell sprouting. This inhibition depends on direct 
cell-cell-interactions and is characteristic of mature endothelial cells isolated from preexisting 
vessels. In order to generate transplantable composite grafts with stromal cells benefi tting from 
pre-formed capillaries, endothelial precursor cells were analyzed. In contrast to the results 
obtained with mature endothelial cells, the sprouting of endothelial precursor cell spheroids 
was not inhibited by the presence of stromal cells. We conclude that endothelial precursor cells 
provide a more promising source for the generation of vascularized tissue-engineered grafts 
than other endothelial cells.
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Integrins and Tetraspanins in Angiogenesis
Cailleteau L1, Domange B1, Thyss R1, Duvivier A1, Johnsson N2, Rubinstein E3, Boucheix C3, 
Meneguzzi G1 and Mettouchi A1
1INSERM U634 (France) 2Institute of Toxicology and Genetics (Germany) 
3INSERM U268 (France)
Angiogenesis is defi ned as the outgrowth of new blood vessels from the pre-existing vasculature. 
This complex process involves steps of proliferation and migration of endothelial cells, together 
with their three dimension organization into mature blood vessels. Our aim is to study the mo-
lecular basis of the control of neo-angiogenesis mediated by the extracellular matrix and its 
integrin receptors.
For this purpose, we use HUVECs in culture, which harbor either a proliferative or sprouting phe-
notype, depending on the extracellular matrix protein they contact and we observed that laminin 
induces a growth arrest signal that overcomes the proliferative effect of fi bronectin present in 
provisional matrices, and induces cells to organize into network. These two proteins recruit re-
spectively the alpha2-beta1 and alpha5-beta1 integrin receptors. In order to defi ne the signaling 
pathways involved in this dominant cell growth suppression /morphogenesis signal triggered by 
alpha2 integrins, and assess the eventual occurrence of specifi c cytosolic partners of this integrin 
receptor, we have adapted a yeast genetic screen for transmembrane proteins interaction named 
“Split-Ubiquitin”. The screening of an endothelial cDNA library for alpha2 integrin partners has 
allowed us to isolate several proteins, among which the tetraspanin CD9 protein.
Functional approaches demonstrate that this interaction is central for the adhesion dependent 
control of cell cycle progression and the three dimensional organization of blood vessels in our 
in vitro model of angiogenesis. In vivo adult angiogenesis assays in the CD9 knockout animals 
confi rmed the central role of the CD9 tetraspanin in angiogenesis processes.
Our work places the CD9 protein as a key regulator of proximal events of integrins signaling, 
including the nucleation and stability of focal adhesions and the nature of downstream signals. 
Moreover, this approach represents the fi rst attempt to genetically screen for integrins partners 
in an integral membrane setting. Altogether, this approach will bring some knowledge on yet 
uncharted integrin partners and will help understand the molecular basis of integrin-mediated 
angiogenesis control, potentially leading to the defi nition of new/specifi c targets for anti-ang-
iogenic drugs in cancer treatment.
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Differential Expression of Fibrillin and Factor XIIIA on Chinese Skin With Aging and 
Photoaging
Noblesse E1, Juan M1, Bonnet-Duquennoy M1, Lachmann N1, Bernois A1, Adhoute H2, Sun J3, 
Kurfurst R1, Schnebert S1 amd Bonte F1
1LVMH Recherche (France)
2Dermexpert (France)
3Chinese Academy of Medical Sciences (China)
Differential expression of Fibrillin and Factor XIIIa on Chinese skin with aging and photoaging
The extent of changes with aging depends largely on the skin exposure to sunlight and also on 
the genetic disposition of the individual. There are two main processes, extrinsic aging because 
of environmental stress, and intrinsic genetically programmed aging. The present study investi-
gates the infl uence of age and exposure to sunlight on fi brillin and factor XIIIa expression on 30 
healthy Chinese Women (from 21 to 68 years). The study is carried out starting from cutaneous 
biopsies taken from photoexposed zones and photoprotected zones of the arm. Fibrillin is a 
glycoprotein present in the reticular and papillary dermis which takes part in the formation of 
elastic fi bers. A decrease in the expression of this protein is characteristic of photoaging. Factor 
XIIIa is a marker of the transglutaminases family, which is expressed by the dermic dendrocytes 
and would be controlled negatively by the intrinsic tensions of the skin. These markers expres-
sions were studied by immunohistochemistry on frozen sections. The results show us that the 
dermis expression of factor XIIIa was interindividually variable and that this expression was 
signifi cantly decreased with age in photoexposed and photoprotected zones (- 65,7% and 
– 39,2% respectively). In the same way, we noticed a signifi cant decrease of the factor XIIIa 
expression with photoexposure (-24,2%). As we expected, the results showed us a signifi cant 
decrease of fi brillin expression with photoexposure (- 22,7%), mainly on oxytalan fi bers from 
the papillary dermis. These results also showed that respective expressions of factor XIIIa and 
fi brillin were statistically negatively correlated in the photoexposed zone and not in the photo-
protected zone. In conclusion, this study permit us to better characterize the Chinese skin like 
its markers of photoaging and chronological aging.
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Subcellular Localization of Type XVII Collagen Synthesis is Mediated through the 
3’Untranslated Region of the mRNA
van Zalen S, Nijenhuis AM, Jonkman MF and Pas HH
Dept of Dermatology, Univ Medical Centre Groningen, Univ of Groningen (Netherlands)
The COL17A1 gene codes for the hemidesmosomal protein type XVII collagen. Alternative 
splicing of the gene leads to two major mRNA populations that differ in length of the 3’un-
translated region (3’UTR). The shorter 3’UTR variant misses a stretch of 610 nucleotides (nt 
4631-5240) compared to the long UTR variant. In the study here we investigated if these UTRs 
are involved in localization of the type XVII collagen mRNA in the cell, using green fl uores-
cent protein (GFP) reporter assays and fl uorescent in situ hybridization (FISH). Transfection of 
keratinocytes with a GFP-vector that had the long variant 3’UTR cloned behind the GFP cod-
ing region, led to GFP-expression that was largely found in the perinuclear compartment. In 
contrast, transfection with the short 3’UTR vector led to a more random expression. FISH was 
performed with two different probes. The fi rst probe was unique to the 610 nt stretch of the 
long variant only, while the second probe was complementary to part of the coding sequence 
and thus recognized both mRNA variants. FISH on keratinocytes showed that the long variant 
mRNA localized close to the nucleus, in line with the GFP reporter assays. The second probe 
distributed more randomly, indicating that the short transcript is found throughout the cyto-
plasm. This study shows that the subcellular site of type XVII collagen synthesis is determined 
by the 3’UTR type of the mRNA.
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Galectin 7 In Skin Homeostasis
Gendronneau G1, Sidhu S1, Calonne C1, Houzelstein D1, Magnaldo T2 and Poirier F1
1Institut Jacques Monod, CNRS UMR7592, Paris (France)
2Institut Gustave Roussy, CNRS, FRE2939, Villejuif (France)
Galectin 7 is a marker of stratifi ed epithelia that belongs to a family of small, evolutionarily 
conserved proteins, characterized by their specifi c affi nity for beta-galactosides and their vari-
able subcellular localisation. Galectin 7 is abundantly expressed in normal adult epidermis but 
is absent from several squamous cell carcinoma lines such as TR146, A431 and SV-40-trans-
formed keratinocytes. Galectin 7 overexpression has been associated with the apoptotic proc-
ess taking place in sunburn keratinocytes that appear after UV-B exposure of reconstructed hu-
man epidermis. In addition, indirect evidence suggests a role for galectin 7 in wound healing.
We have generated a galectin 7 null mutation in mice in order to assess the biological role(s) 
of this protein in vivo. Homozygous mutants are viable and fertile, they do not display any 
obvious phenotype in animal house conditions. In a detailed in vivo analysis of the effects 
of UV-B irradiation on wt and mutant animals, we found that galectin 7 is implicated (i) in 
the appearance/elimination of sunburn cells and (ii) in the subsequent dynamics of epidermal 
cell proliferation which ensures the maintenance of tissue integrity. We are also exploring the 
potential importance of galectin 7 in wound healing by comparing the properties of wild-type 
and mutant skin explants in culture. Taken together, our results establish galectin 7 as a key 
player in epidermal homeostasis.
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Serum Concentrations of Total and Active MMP-9 and TIMP-1 in Patients with systemic Lupus 
Erythematosus with and without Skin Symptoms
Robak E, Kulczycka L, Tomczak J and Sysa-Jedrzejowska A
Departament of Dermalogy, University of Lodz (Poland)
Matrix metaloproteinases (MMP) are extracellular matrix components implicated in angiogen-
esis. Among them MMP-9, also called gelatinase B is involved in infl ammation and immune 
sytem dysfunction. The tissue ihibitor of MMP-1 (TIMP-1) is one of the natural inhibitors of 
MMPs. We investigated the serum concentrations of total MMP-9 (tMMP-9), active MMP-9 
(aMMP-9) and TIMP-1 in a group of 41 patients with SLE including 32 with skin symptoms , and 
20 healthy controls. The levels of tMM-9 and TIMP-1 were assessed by an enzyme-linked im-
munosorbent assay (ELISA), and aMMP-9 by fl uorometric assay. Additionally, we measured the 
serum level of proangiogenic factors- VEGF and angiogenin. The tMMP-9 concentration was 
lower in SLE patients (mean 262 ng/ml) than in healthy volunteers (mean 325 ng/ml)(P=0,023). 
The concentration of tMMP-9 was lower in active SLE (mean 182,9 ng/ml) than in inactive 
disease (mean 333 ng/ml)(P=0,048). TIMP-1 level was lover in SLE patients (mean 181 ng/ml) 
than in control group (mean 233 ng/ml) (P=0,004). The concenrtations of tMMP-9, aMMP-
9 and TIMP-1 were similar in SLE patients with and without skin symptoms. However, we 
found higher level of tMMP-9 in the patients without antinuclear antibodies(ANA) (mean 440 
ng/ml), than in patients with titer of ANA>1/160 (145ng/ml)(p=0,003). A poitive correlation 
was obserwed between tMMP-9 and aMMP-9 in SLE patients (?=0,568;P=0,001), but cor-
relation of aMMP-9 with TIMP-1 and tMMP-9 with TIMP-1 were not statistically signifi cant. 
However, we found possitive correlation of VEGF with tMMP-9 (p=0,450; P=0,005) and TIMP-
1 (?=0,387;P=0,018), and no correlation of these proteins with angiogenin concentration in 
patients with SLE. Lower concenrtations of MMP-9 and TIMP-1 in patients with SLE can result 
from the accumulation of those factors in the inffl ammed blood vassels and tissues. 
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Bacterial Killing by Heparin-binding Peptides from PRELP and Thrombospondin
Malmsten M1, Davoudi M2 and Schmidtchen A2
1Dept. of Pharmacy, Uppsala University (Sweden)
2Section of Dermatology, Lund University (Sweden)
Antimicrobial peptides (AMP) are effector molecules of the innate immune system. A cross-
functionality exists between AMPs and heparin-binding peptides. Here, we show that the 
peptides QPTRRPRPGTGPGRRPRPRPRP (QPT22), derived from proline arginine-rich end 
leucine-rich repeat protein (PRELP) and KRFKQDGGWSHWSPWSS (KRF17) from throm-
bospondin exert antimicrobial activities against the Gram-negative bacteria Escherichia coli 
and Pseudomonas aeruginosa, as well as against the Gram-positive Bacillus subtilis. Analy-
sis by fl uorescence microscopy demonstrated that that QPT22 and KRF17 bind to bacterial 
membranes. Particularly QPT22 was found to induce membrane leakage of liposomes. The 
peptides displayed no hemolytic activities, nor did they exert membrane permeabilising ef-
fects on human epithelial cells. Additional peptides derived from heparin-binding regions of 
laminin, vitronectin, and fi bronectin exerted similar antibacterial effects. Several peptides also 
showed activity against Staphylococcus aureus. Thus, the data disclose a novel antimicrobial 
activity of heparin binding regions of matrix glycoproteins. The fi ndings can be utilized in the 
development of novel AMPs for therapeutic use.
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Further Consideration on the Measurement of Skin Elasticity: The Prospective Role of 
Corneocyte
Min-Youl Ch1, Jin-Jun K1, Chun-Goo L1 and Seong-Gin K2
1LG Household & Health Care, (Republic of Korea)
2Dept of Dermatology, Chonnam National Univ Medical School, Kwangju (Republic of Korea)
Skin elasticity has been known to be infl uenced by the change of dermal components such 
as collagen, elastic fi ber, glycosaminoglycans. However, it is unclear whether the uppermost 
epidermis may affect the mechanical characteristics of elasticity. In present study we tried to 
fi nd the role of corneocytes when determining the elastic property under skin bioengineering 
measurement with Cutometer®.
A total of 20 healthy volunteers aged 25–40 years were investigated by the parameters re-
fl ecting the skin elasticity from cheek and volar forearm. Within a range of suction pressure, 
R0(=Uf), R7(=Ur/Uf) and R8(=Ua) were obtained to explore the depth-associated elasticity. The 
parameters revealed as signifi cantly lower value from cheek than those from forearm. Suction 
pressure-dependent slope derived from elasticity parameters was also lower at the cheek when 
compare to forearm. Stratum corneum of each area was fully hydrated to see any change of 
elastic property, where the parameters showed slightly increased values in R0, R8, but no 
changes in R7 as well as pressure-dependent slope. Interestingly, measured data from the cheek 
before and after the hydration manifested relatively higher variation than from the forearm. 
Stripped corneocytes were examined under atomic force microscope with parameters of Rq 
and Ra (nm) revealed fl at surface and easily detachable characteristics from the cheek skin. 
These results suggest the characteristics of elasticity between cheek and forearm could be dif-
ferent. Regardless of tensile strength determined by dermal components, the status of upper-
most epidermis should be considered while collecting the sensitive bioengineering parameters 
toward skin elasticity. 
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Fibroblast Growth Factor-6 Reduces the Motile Activity of Human Melanoma Cells
Kawashima M, Takahashi T, Fujisawa Y and Otsuka F
1Department of Dermatology, University of Tsukuba (Japan)
Fibroblast growth factor (FGF) –6, a protooncogene product, is expressed in both epithelial and 
mesenchymal derivatives and has autocrine and/or paracrine roles. The FGF-6 function has not 
fully been explored although FGF-6 is thought to play a role in tumor progression like other 
members of FGF family. We previously evaluated FGF-6 action on melanoma cell proliferation 
and apoptosis via activation of MEK/ERK and AKT pathway. The present study showed that 
FGF-6 elicited the integrin-associated protein (IAP, CD47) expression on human melanoma 
cell surface and suppressed the motogenic activity of melanoma cells without modulation of 
integrin molecules. FGF-6 also augmented the cohesion of melanoma cells. IAP is a member of 
the immunoglobulin superfamily and binds to its receptor, SHPS-1, which is widely expressed 
and is particularly abundant in neural and myeloid tissues. Recent studies suggest that the IAP-
SHPS-1 interaction leads to the dephosphorylation of SHPS-1 and dissociation of SHP-2 from 
intracellular SHPS-1 region, resulting in the inhibition of cell migration. Thus, IAP and SHPS-1 
may be important molecules for the malignant behavior of certain cell types. Although the 
regulation of SHPS-1 expression has been shown in several tissues and cells including breast 
cancer, the regulation of IAP expression has hardly been reported. Our results might imply the 
participation of FGF-6 in the invasive action of melanoma cells.
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Study of the Role of α2β1 Integrin and Jak2 in the Regulation of Angiogenesis
Thyss R, Cailleteau L, Meneguzzi G and Mettouchi A
INSERM U634 Faculté de Medecine, Nice (France)
In addition to the genetic and epigenetic changes that occur during transformation, the induc-
tion of a tumor vasculature, in a process termed the angiogenic switch, is another step required 
to allow tumor progression.Angiogenesis is a complex process that depends on a balance 
between pro- and anti- angiogenic soluble factors. It also depends on the extracellular matrix 
remodelling in the tumor stroma.
Our project is focused on the regulation of neo-angiogenesis by extracellular matrix compo-
nents and its cellular receptors: integrins.
In our in vitro model, primary human endothelial cells are exposed to different matrix proteins. 
We have demonstrated the existence of a growth arrest signal when endothelial cells are ex-
posed to the basement membrane protein Laminin1. This signal is transduced in cells by the 
α2β1 integrin.
To understand the molecular basis of this growth arrest signal, a genetic screen has been devel-
opped to discover new partners of the α2 integrin.
Among the clones we obtained, we could isolate the Jak2 kinase. This kinase has been exten-
sively described in its association whith cytokines/hematopoietins receptors. 
In endothelial cells, Jak2 is particularily implicated in the transmission of proliferation signals, 
by its assoctiation whith IL3-, IL6-, or GM-CSF-receptors.
Our results show that the activation of α2β1 induces a change in the localisation of Jak2, and 
a decrease of its activity. 
Moreover, endothelial cells transfected whith a shRNA designed against Jak2 were signifi cantly 
affected: the α2β1 suported signals, ie growth arrest and vascular morphogenesis, were ampli-
fi ed in these cells. These results suggest that the interaction of the α2β1 integrin whith Jak2 
interferes whith its kinase activity.
Understanding the mechanisms by witch the quiescence is maintained in endothelial cells can 
be a promising complementary approach for the development of anti-angiogenic durgs.
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Immunohistological Phenotyping of Human Hair Follicle Compartments as Potential Stem 
Cell Niches
Klöpper J, Tiede S and Paus R
Dept of Dermatology, Univ Hospital Schleswig-Holstein, University of Lübeck (Germany)
Since the discovery of epithelial hair follicle stem cells (eHFSC) in the bulge region of mouse 
hair follicles and the identifi cation of equivalent cells in the hair follicles of other species 
(including human), a biologically and clinically important debate has unfolded: How many 
eHFSC populations are there actually, where are they localized, which are the best immuno-
histological markers for identifying them, and what are the characteristics of the individual 
stem cell niches these propulations reside in? In the current study, we attempt to contribute to 
this ongoing debate by summarizing published markers of murine eHFSC and by comparing 
selected ones by immunhistochemical analysis of normal human scalp skin. 
We show that, in addition to keratin 15 and β1-integrin, extra cellular matrix proteins such 
as tenascin-C, fi bronectin and fi brillin-2 are upregulated in the bulge region of human scalp 
hair follicles. Similar to what has previously reported in murine hair follicles, these may be 
contribute to defi ning the – as yet obscure - stem cell niche conditions of human hair follicles. 
Whereas α6-integrin, nidogen and LTBP-1 show no upregulation in the human bulge region. 
Additionally, in most human hair follicles examined, contrary to what has been reported in 
mice, prominent nestin immunoreactivity was not seen in the bulge region of the outer root 
sheath. 
Thus, the key challenge to identify defi nitive immunohistological markers that allow one to 
distinguish human bulge stem cells from their progeny (transient amplifying cells), and that 
reliably refl ect the functionally most important elements of the corresponding epithelial and 
mesenchymal components of the stem cell niche in the human hair follicle is still unmet.
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Transcriptional Upregulation of MMP1 via JNK/AP-1 and Decreased Type I Collagen Gene 
Expression via mRNA Destabilization by Rapamycin: An Explanation for its Anti-Fibrotic 
Activities?
Poulalhon N, Farge D, Michel L, Mauviel A and Verrecchia F
INSERM U697 (France)
We have examined whether rapamycin, an immunosuppressive drug used for the treatment of 
systemic sclerosis patients (SSc), may exert a direct anti-fi brotic activity by targeting fi broblasts. 
Incubation of human lung fi broblast (WI-26) cultures with rapamycin lead to dose- and time-de-
pendent reduction in the expression of types I and III collagens, both at the protein and mRNA 
levels. Inversely, expression of interstitial collagenase (MMP1) was increased. Transient cell 
transfection experiments with collagen promoter/reporter constructs indicated an absence of 
transcriptional response. On the other hand, experiments in which RNA synthesis was blocked 
with actinomycin D indicated that rapamycin reduces collagen mRNA steady-state levels via 
a direct action on mRNA stability. Thus, COL1A1 mRNA half-life dropped from 14h in control 
cells to 9.5h in rapamycin-treated fi broblast cultures. Since MMP1 is a classical AP-1-depend-
ent gene, we examined the regulation of the AP-1 cascade in rapamycin-treated fi broiblasts. 
We determined that rapamycin induced a rapid activation of c-jun/AP-1 gene expression, phos-
phorylation of JNK and c-Jun, transactivation of an MMP1/AP-1 promoter/reporter construct, 
and binding of AP-1 complexes to a radio-labeled AP-1 oligonucleotide (EMSA experiments). 
On the other hand, a Jun-N-terminal kinase inhibitor, SP600125, inhibited MMP1 gene acti-
vation, AP-1/DNA interactions, and c-Jun phosphorylation, induced by rapamycin. Likewise, 
transfection of a c-jun antisense expression vector prevented rapamycin-induced MMP1 gene 
expression. Pharmacologic inhibition of either ERK or p38/MAPK pathways was without effect 
on rapamycin-induced MMP1 gene expression. Together, these results provide defi nitive evi-
dence for a direct role for the JNK/AP-1 pathway in mediating rapamycin-induced MMP1 gene 
expression in fi broblasts. It thus appears that rapamycin may exert direct antifi brotic activities 
by various molecular mechanisms affecting both matrix production and degradation by fi brob-
lasts, independent from its immunosuppressive activity.
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Small Fragments of Hyaluronic Acid (HA) Induce Metalloprotease- and Cytokine Upregulation 
in Human Melanoma Cells
Voelcker V, Gebhardt C, Averbeck M, Anderegg U and Simon JC
Department of Dermatology, University of Leipzig (Germany)
Hyaluronic Acid (HA) is a major component of the extracellular matrix (ECM). HA turnover oc-
curs constantly but is enhanced in areas of infl ammation. During infl ammation, high molecular 
weight HA is degraded into small molecular fragments (sHA) by activated hyaluronidases or 
reactive oxygen species. These fragments have been shown to induce metalloproteases and 
cytokines in dendritic and endothelial cells. Additionally, sHA is probably associated with 
tumour invasiveness and metastasis. Therefore, we investigated whether sHA also induces met-
alloprotease- and cytokine upregulation in human melanoma cells.
We report here that exposure of different human melanoma cell lines to sHA leads to en-
hanced expression of matrix metalloproteinase (MMP)2 and IL-8, factors that can contribute to 
melanoma progression e.g. by inducing angiogenesis or spreading of tumour cells. We suggest 
Toll like receptor (TLR)4 to be involved in this signalling pathway, similar to effects shown in 
dendritic and endothelial cells. We detected TLR4 on the surface of melanoma cells in vivo 
and in vitro. In vitro, TLR4 expression is upregulated following sHA stimulation. Small HA 
fragments induce IL-8 and TLR4-expression on melanoma cells independently from the HA 
receptor CD44 since these effects were found also in the CD44 defi cient cell line RPM-MC. In 
addition, sHA stimulation leads to an increase of detectable bioactive NFk-B, a key component 
of the TLR pathway in the melanoma cells. 
This further confi rms our hypothesis of TLR4 to be involved in the sHA signalling pathway in 
human melanoma cells. 
Our results suggest that small fragments of HA in melanoma might promote tumour invasivness 
by inducing metalloprotease- and cytokine expression.
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Does Chloroquine Phosphate have Photoprotective Activity?
Wozniacka A1, Lesiak A1, McCauliffe P2 and Sysa-Jedrzejowska A1
1Department of Dermatology Medical University of Lodz (Poland)
2Department of Medicine, Rutland Regional Medical Center, Rutland, Vermont (USA)
Antimalarials have been used in rheumatological treatment for decades, but the mechanisms 
by which they provide therapeutic benefi t are not fully understood. Benefi t may be derived 
from their anti-infl ammatory and immunosuppressive properties. However there are controver-
sies regarding their photoprotective effects, and some authors suspect that they may cause light 
sensitivity, while others claim the converse. Therefore the aim of our study was to investigate 
whether chloroquine can infl uence the minimal erythema dose (MED) of UVB irradiation and 
the duration of UVB-induced erythema in systemic lupus erythematosus patients. The study 
group consisted of 43 patients with mild to moderate disease and 32 sex- and age- matched 
healthy volunteers. Chloroquine phosphate was administered at a dose of 125 mg twice daily 
in all examined patients, for 3 months. The mean MED value in SLE patients before treatment 
was 0.1J/cm2 and after therapy a signifi cant increase of this parameter (mean 0.128J/cm2) was 
observed. In healthy volunteers erythema provoked by 3 MED of UVB lasted from 1-4 days 
(mean 2,6 days). In SLE group, before chloroquine treatment, it persisted from 2 to 62 days 
(mean 11.3 days), but after therapy from 1 to 20 days (mean 6.1 days). Our results indicate that 
chloroquine reduces UVB-induced photosensitivity reactions.
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169 [004]
Development of Therapeutic siRNAs for Treatment of Pachyonychia Congenita
Smith FJ1, Hickerson RP2, Liao H1, Sayers J1, Leachman SA3, Leake D4, Kaspar RL2 and McLean WH1
1Human Genetics Unit, University of Dundee (United Kingdom)
2Transderm, Santa Cruz, CA (USA)
3Dermatology, University of Utah, Salt Lake City, UT (USA)
4Dharmacon Inc., Lafayette, CO (USA)
Pachyonychia congenita (PC) is a rare autosomal dominant keratin disorder characterised by 
hypertrophic nail dystrophy, palmoplantar keratoderma, and oral leukokeratosis. PC is subdi-
vided into two major variants, PC-1 due to mutations in keratin K6a or K16 and PC-2 by muta-
tions in K6b or K17. Here, we report 8 recurrent and 2 novel mutations in K6a, and present 
preliminary studies for a therapeutic approach. Currently there is no treatment for PC and the 
most painful aspect of the disorder is the plantar keratoderma which can result in wheelchair 
use. RNAi offers a novel approach for treating genetic disorders such as PC. We have designed 
four siRNAs against the unique 3’UTR region of K6a to target K6a in patients with mutations 
in K6a. We predict that treatment with K6a siRNA resulting in reduction/knockout of both K6a 
alleles (mutant and wildtype) could alleviate the symptoms of PC at treated sites. We propose 
that loss of K6a would be compensated for by other keratins, such as K6b, as demonstrated 
by transgenic mouse models. Here, in a tissue culture model, we were able to knockdown 
endogenous K6a in the HaCaT keratinocyte cell line by transient transfection of the four inde-
pendent K6a siRNA, resulting in almost 100% reduction of K6a as visualised on protein gels 
and by immunoblotting. Other keratins present in HaCaT cells were unaffected. These siRNAs 
were shown to be specifi c for K6a and not for K6b in a cell culture model. Previously, we have 
shown that specifi c siRNAs (but not non-specifi c controls) strongly inhibit reporter gene expres-
sion in vivo (intradermal injection into mouse footpads). These 3’UTR K6a siRNAs are being 
tested in similar animal studies.
170 [017]
Prevalent Mutations in the Filaggrin Gene are a Major Genetic Factor in Atopic Disease
McLean WH2, Sandilands A2, Smith FJ2, Terron-Kwiatkowski A2, Palmer CN1, Lee SP1, Zhao Y2, 
Liao H2, O’Regan G3 and Irvine AD3
1Biomedical Research Centre, University of Dundee (United Kingdom)
2Human Genetics Unit, University of Dundee (United Kingdom)
3Department of Paediatric Dermatology, Our Lady’s Children’s Hospital, Dublin (Ireland)
The aim of this study was to analyse the fi laggrin gene (FLG) in atopic dermatitis (AD). Profi lag-
grin is the major protein in keratohyalin granules and consists of 10-12 repeats of the fi laggrin 
peptide which is essential for skin barrier formation. We recently reported the fi rst FLG muta-
tions, R501X and 2282del4, leading to premature termination codons in fi laggrin repeat 1. 
These mutations, carried by up to 10% of European-origin populations, cause mild or severe 
ichthyosis vulgaris (IV) and importantly, are a genetic predisposing factor for AD and related 
atopic phenotypes. We ascertained a cohort of 150 Irish children with AD and identifi ed further 
loss-of-function mutations, 3702delG in fi laggrin repeat 3, R2447X in repeat 7 and S3247X in 
repeat 9, all of which are carried by <1% of the population. These variants allow synthesis of 3-
9 repeats but biochemical analysis showed that these truncated profi laggrin molecules cannot 
be processed into mature fi laggrin and so act as null-alleles. Consistent with this, homozygosity 
for these mutations, or compound heterozygosity with R501X or 2282del4, causes severe IV 
accompanied by AD. In this cohort with moderate-severe AD, ~48% carried one or more of 
these 5 FLG variants. Comparing our cohort to the Irish population gave a Chi-square p value 
of <10-50 and Fisher’s exact test OR 7.13 with 95%CI 4.9-10.6. We have also replicated the as-
sociation of FLG null-alleles with AD and other atopic phenotypes in a total of 10 independent 
studies within 6 different European populations. In addition to association studies, we used ge-
netic linkage analysis, transmission disequilibrium testing and a longitudinal association study, 
all of which gave highly statistically signifi cant correlations. These data demonstrate that in 
European populations at least, FLG mutations are the major genetic factor in atopy. 
171 [019]
A High Density Human Whole Genome Scan Identifi es SLC24A5 SNPs Strongly Associated 
with Natural Human Skin Colour Variation
Green MR1, Ginger R1, Dadd T1, Fereday A1, Fisell W1, Jarman C1, Schnetkamp P2, Hinds D3, 
Cox DR3 and van der Ouderaa F1
1Unilever Corporate Research, Colworth Park, Sharnbrook, Bedfordshire (United Kingdom)
2University of Calgary (Canada)
3Perlegen Sciences Inc, Mountain View, California (USA)
A very high density (ca 1SNP per 2kb) whole genome analysis of human SNPs has been com-
pleted to discover genes associated with natural variation in human skin colour. Genotype 
analysis of 915 volunteers of South Asian ancestry, with lighter or darker skin tones, identifi ed 
an ‘intergenic’ SNP (rs1834640) 21kb upstream of the SLC24A5 gene signifi cantly associated 
with skin colour variation. A more detailed genotype analysis of a subset of volunteers (n=230) 
revealed that the ancestral allele of a nearby non-synonymous (ns) SNP (rs1426654; pA111T) 
in SLC24A5 is associated with dark skin (allele frequency difference = 38.7%; FDR = ~ 10-12). 
The SLC24A5 SNPs are in high linkage disequilibrium (R2≈0.9, D’≈1). Data from the human 
Hap-Map and African-American and African-Caribbean populations (Lamason et al 2005) to-
gether with our results indicate that SLC24A5 has a key role in human skin pigmentation. In-
dependent from SLC24A5, TYR (rs1042602) and MATP (rs16891982) nsSNPs were also found 
associated with skin colour variation in South Asians. 
Transcript analysis of SLC24A5 in human skin biopsies and cultured melanocytes representing 
a range of skin colours shows that SLC24A5 is the predominantly expressed member of the 
SLC24A family in skin. Using affi nity purifi ed polyclonal antibodies against synthetic pep-
tides selected from the SLC24A5 sequence, the protein has a putative non-plasma membrane, 
intracellular location in melanocytes. The nsSNP pA111T encodes an amino acid change in 
a region of SLC24A5 that is highly conserved in SLC24A family members. Site-directed muta-
genesis in heterologously expressed SLC24A2 suggests that this residue is important for Na+/
Ca2+exchange function in SLC24A2, though the effect of this residue on SLC24A5 function and 
the mechanism by which SLC24A5 affects human skin colour remain to be elucidated.
172 [065]
Filaggrin Mutations are a Major Predisposing Factor in Childhood-Onset Adult-Persistent 
Atopic Dermatitis
Barker JN1, Palmer CN2, Lee SP2, Allen MH1, Zhao Y3, Liao H3, Meggit SJ4, Reynolds NJ4, 
Trembath RC5 and McLean WH3
1St John’s Institute of Dermatology, King’s College London (United Kingdom)
2Biomedical Research Centre, University of Dundee (United Kingdom)
3Human Genetics Unit, University of Dundee (United Kingdom)
4Department of Dermatology, University of Newcastle (United Kingdom)
5Department of Medical Genetics, King’s College London (United Kingdom)
Atopic diseases including allergy, atopic dermatitis (AD) and asthma have complex aetiologies 
in childhood and adult life. Recently, two prevalent mutations in the FLG gene, R501X and 
2282del4, both of which lead to loss of epidermal fi laggrin expression, have been strongly as-
sociated with AD in childhood. However, the role of these mutations in adult AD has not been 
investigated. Profi laggrin is a major component of keratohyalin granules and upon terminal 
differentiation, it is cleaved into multiple copies of fi laggrin, which is essential for normal skin 
barrier formation. The aim of this study was to examine the role of these FLG mutations in a 
cohort of patients with moderate-severe childhood AD that has persisted into adulthood. In this 
cohort of 150 patients of English ethnicity, the combined carrier frequency of the two FLG null 
alleles was ~48% (cf. population frequency ~10%, n=1400). This represents an odds ratio of 
7.7 with 95CI of 5.3-10.9 and a Chi-square p value of 1.7x10-53, conclusively demonstrating 
that FLG null variants predispose to a form of eczema that starts in early infancy and persists 
into adulthood. Interestingly, there was a noticeable male gender bias amongst the fi laggrin 
null carriers, which was statistically signifi cant (p=0.02) and replicable in AD cohorts from 
other populations. This is in keeping with an emerging trend in complex trait genetics that link-
age to autosomal genes may be subject to gender-specifi c skewing by an unknown mechanism. 
This study highlights the importance of determining an intervention based on barrier function 
defects in young children to prevent persistence of disease and starts to shed light on the genet-
ics underlying the recognised gender differences in AD. 
173 [066]
Kindlin-1 is Important in Human Keratinocyte-substrate Focal Contact Adhesion and Cell 
Survival In Vitro
McMillan JR1, Qiao H1, Akiyama M2, Yasukawa K2, Goto M2, Sawamura D2, Miyamura Y1,
Abe R2, Shibaki A2 and Shimizu H2
1Dept of Dermatology & Creative Research Initiative Sousei, Hokkaido University (Japan)
2Department of Dermatology, Hokkaido University (Japan)
Kindler syndrome (KS) is a rare, autosomal recessive skin disorder leading to erosions at sites 
of trauma, keratinocyte fragility, poikiloderma, palmar hyperkeratosis and nail dystrophy 
(OMIM173650). Defects in the actin/focal contact linker protein kindlin-1 (also known as 
kinderlin) encoded by the gene KIND1 have been shown to underlie this disease. We have 
assessed the function of kindlin-1 in human keratinocyte and fi broblast cells using RNAi knock-
down technology. RNAi signifi cantly reduced KIND1 message by more than 72% and 63% in 
cultured keratinocyte and fi broblast cells respectively. In vitro RNAi treatment reduced kerati-
nocyte but not fi broblast cell adhesion on plastic within 2 hours after plating. Furthermore, 
RNAi treatment reduced keratinocyte but not fi broblast cell survival in culture and increased 
rates of keratinocyte (not fi broblast) apoptotic cell death, as visualized by TUNEL and carboxy-
dichlorofl uorescein diacetate cell vital staining. In RNAi treated cells, loss of cell adhesion and 
survival was concomitant with a reduction in the number of kindlin-1-containing focal contacts 
per keratinocyte (but not in fi broblast cells). Confocal and scanning electron microscopy dem-
onstrated that these keratinocytes showed a reduction in fi lopodia numbers and some disrup-
tion of adjacent keratinocyte cell-cell interactions. Keratinocyte migration was not affected by 
KIND1 RNAi treatment. Taken together our data suggest that kindlin-1 plays important roles in 
keratinocyte: cell-substrate adhesion via focal contacts; fi lopodia/focal contact formation and 
assembly; maintenance of keratinocyte survival in vitro. Our observations in keratinocytes in 
vitro help to explain the pathogenesis of KS, specifi cally the loss of cell-substrate adhesion that 
leads to loss of normal basement membrane architecture. Additionally, reductions in keratino-
cyte adhesion, cell survival and increased rates of cell death may underlie epidermal thinning 
(poikiloderma) and skin fragility seen in KS.
174 [067]
R-spondin 4 (RSPO4), a Novel Secreted Protein Implicated in Wnt Signalling, is Mutated in 
Inherited Anonychia
Blaydon DC1, Ishii Y2, O’Toole EA1, Teh MT1, Hopsu-Havu VK3, Moss C4, Ruschendorf F5, Wajid 
M2, Christiano AM2 and Kelsell DP1
1Cutaneous Research, Inst of Cell and Molecular Science, Queen Mary University of London 
(United Kingdom)
2Departments of Dermatology and Genetics & Development, Columbia University (USA)
3Department of Dermatology, University of Turku (Finland)
4Dermatology Department, Birmingham Children’s Hospital (United Kingdom)
5Bioinformatics and Gene Mapping Centre, Max Delbruck (Germany)
Anonychia/hyponychia congenita (OMIM 206800), a rare condition in which the only presenting 
phenotype is the absence or severe hypoplasia of all fi ngernails and toenails, is inherited in an au-
tosomal recessive manner. To identify the underlying gene, homozygosity mapping was performed 
on individuals from three consanguineous families. An initial genome screen of 400 microsatellite 
markers did not yield any signifi cant regions of linkage and was followed up by an Affymetrix 10K 
SNP chip analysis. Statistical analysis of the SNP data revealed a region of linkage on chromosome 
20p13 with a LOD score of 4 in a family of Pakistani origin. This region, found to lie only 135 kb 
downstream of the microsatellite marker D20S117 in the original genome scan set, was confi rmed 
in a second Pakistani family. Data from Finnish, Irish and British families were also consistent with 
linkage to the region on chromosome 20p13. Additional affected Pakistani families were genotyped 
and informative recombinations further narrowed the minimal region of linkage down to approxi-
mately 300 kb, which included the genes ANGPT4, RSPO4 and PSMF1. Homozygous mutations 
were identifi ed in RSPO4 which included a 26 bp deletion, a conserved missense mutation and a 
splice site change. RSPO4 is a member of the R-spondin family of secreted proteins that appear to 
act as novel frizzled ligands and activate the Wnt/beta-catenin pathway. This study highlights a criti-
cal role for RSPO4 and the Wnt signalling pathway in human nail development.
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175 [068]
Revertant Mosaicism in Epidermolysis Bullosa due to Different Second-site Mutations in 
LAMB3
Pasmooij AM, Pas HH and Jonkman MF
Department of Dermatology, University Medical Center Groningen (Netherlands)
Revertant mosaicism due to in vivo reversion of an inherited mutation has been described in 
the genetic disease epidermolysis bullosa (EB) for the genes KRT14 and COL17A1. Here, we 
demonstrate the presence of several different second-site mutations, all correcting the germ-
line LAMB3 mutation 628G→A, in two unrelated mosaic nH-JEB patients. Both patients had a 
severe reduction of laminin-332 expression in their affected skin. Remarkably, patient EB 078-
01 (628G→A/R635X) obtained clinically healthy skin on his lower leg with normal expression 
of laminin-332 on previously affected skin. In the other proband, EB 029-01 (628G→A/628G→
A), the revertant patches were located at his arms, shoulder and chest. Unfortunately the pa-
tient could not remember how long these patches had been present and if they had expanded 
in time. DNA-analysis showed in revertant keratinocytes of distinct biopsy specimens different 
second-site mutations: 565-3T→C, 596G→C (G199A), 619A→C (K207Q), 628+42G→A and 
629-1G→A, implying that there is not a single preferred mechanism for the correction of a 
specifi c mutation. The two compensatory intron mutations - 628+42G→A and 629-1G→A - af-
fected splicing, by giving rise to aberrant in-frame mRNA transcripts that resulted in functional 
protein. The two second-site mutations in exon 7 – 596G→C (G199A) and 619A→C (K207Q) 
– most likely compensate the effect of the inherited amino acid change on a protein level. Both 
patients thus had multiple correcting mutations in LAMB3. Our data offer prospects for EB 
treatment, since revertant mosaicism seems to occur at a higher frequency than expected, and 
most importantly, the healthy skin of EB 078-01 expanded over time. This opens the possibility 
of applying revertant gene therapy in mosaic EB of the LAMB3 gene using the patient’s own 
naturally corrected keratinocytes.
176 [069]
Intradermal Injection of Allogeneic Human Fibroblasts Promotes Type VII Collagen Deposition 
at the Dermal-epidermal Junction in Recessive Dystrophic Epidermolysis Bullosa
Wong T1, Gammon L2, Liu L1, Ozoemena L1, Dopping-Hepenstal PJ1, Jones C1, Leigh IM2, 
Navsaria H2 and McGrath JA1
1St. John’s Institute of Dermatology (United Kingdom)
2Institute of Cell and Molecular Science, Queen Mary University of London (United Kingdom)
The inherited blistering skin disorder recessive dystrophic epidermolysis bullosa (RDEB) results 
from loss-of-function mutations in the COL7A1 gene encoding type VII collagen, the major 
component of anchoring fi brils at the dermal-epidermal junction (DEJ). In RDEB skin, there is 
reduced or absent type VII collagen expression at the DEJ and anchoring fi brils are rudimentary. 
Recent studies, using mouse models of human RDEB, have shown that intradermal injections of 
either normal human fi broblasts or COL7A1 gene-corrected RDEB fi broblasts can lead to type 
VII collagen deposition at the DEJ and anchoring fi bril formation. To assess whether fi broblast 
cell therapy might be of benefi t to patients, we gave intradermal injections of low passage 
(P2) autologous and allogeneic fi broblasts (different sites, each 5 x 106 cells in 350-500μl of 
phosphate buffered saline) to fi ve individuals with RDEB (4M, 1F; aged 19-39 years). Biopsies 
were taken two weeks after the injections. For the allogeneic fi broblast-treated sites, immun-
ofl uorescence microscopy revealed an increase in type VII collagen at the DEJ in four of the 
fi ve RDEB subjects; no increase was seen for autologous fi broblasts. In one individual, whose 
underlying COL7A1 pathology included a recessive glycine substitution mutation, there was 
also increased intra-epidermal type VII collagen at the allogeneic fi broblast site suggesting a 
paracrine benefi t from the fi broblasts in inducing keratinocyte neosynthesis of type VII colla-
gen. This subject also had transient erythema at the allogeneic cell injection site but no clinical 
evidence of infl ammation or rejection was seen in any of the other RDEB patients. Clearly, it 
will be necessary to perform biopsies at later time-points as well as assessing ultrastructural 
changes at the DEJ and investigating host immunological responses, but our preliminary analy-
sis shows that allogeneic fi broblasts have the potential to increase type VII collagen at the DEJ 
in individuals with RDEB and that this approach may have clinical benefi ts. 
177 [070]
Targeted Skipping of a Single Exon Harboring a Premature Termination Codon Mutation by 
Antisense Oligoribonucleotide for Dystrophic Epidermolysis Bullosa
Goto M, Sawamura D, Nishie W, Sakai K, McMillan JR, Akiyama M and Shimizu H
Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
The transfer of normal genes into somatic cells is one strategy to treat patients with genetic 
diseases. However, this strategy has still encounters technical problems including effi cacy of 
gene transfer rate and practical clinical safety. Thus, other strategies including pharmacologi-
cal therapy or gene correction, are receiving increasing attention. Dystrophic epidermolysis 
bullosa (DEB) is caused by mutations in the COL7A1 encoding type VII collagen. This study 
examined the feasibility of antisense oligoribonucleotide (AON) therapy for DEB. AON was 
designed to induce skipping of a targeted exon containing a premature termination codon 
mutation, resulting in restoration of the open reading frame. We targeted exon 70 of COL7A1 
since a recurrent mutation 5818delC was localized to exon 70 in Japanese DEB patients. We 
initially designed and synthesized two AONs to modulate splicing of exon 70 and found that 
one AON induced effective skipping of normal exon 70 containing the 16 amino acids. At-
tachment and migration analyses showed that recombinant collagen without contribution of 
exon 70 had similar effect to normal type VII collagen. Next, we synthesized mutation-specifi c 
AON by deleting cytosine at 5818. Introduction of this AON into DEB keratinocytes harboring 
5818delC without expression of type VII collagen showed that the AON induced skipping of 
exon 70 in the abnormal 5818delC allele. Furthermore, 6.2 % of the DEB keratinocytes started 
to express type VII collagen in vitro after application of the mutation-specifi c AON. Injection 
of the AON into rat model grafted the DEB keratinocytes and fi broblasts induced detectable 
of type VII collagen expression at the basement membrane zone. We conclude that skipping 
of targeted exons using mutation-specifi c AON may show potential for future gene therapy for 
DEB patients.
178 [071]
Spliceosome Mediated RNA Trans-Splicing (SMaRT) is a Novel Method to Treat Autosomal 
Dominant Diseases
Wally V1, Klausegger A1, Koller U1, Lochmüller H2, Krause S2, Wiche G3, Mitchell LG4, Hintner 
H1 and Bauer JW1
1Div of MolDermat and eb house Austria, Dep of Dermatology, Paracelsus Private Medical 
University (Austria)
2Friedrich-Baur-Institute, Dept of Neurology, Ludwig-Maximilians-Univ of Munich (Germany)
3Inst of Biochem & Molecular Cell Biol, Univ of Vienna, Max F. Perutz Laboratories (Austria)
4Intronn Inc., Gaithersburg, MD (USA)
Dominant negative genetic disorders can be treated by allele-specifi c silencing therapies. Con-
ventional therapeutic strategies including ribozymes and siRNA carry the risk of reducing the 
expression of the normal gene. Spliceosome mediated RNA trans-splicing replaces segments 
of pre-mRNA in an exonwise manner, thus correcting mutant genes. We used SMaRT for the 
correction of a three basepair insertion in exon 9 of the PLEC1 gene (1287ins3), leading to 
aggregation of plectin peptide chains and consecutive protein degradation. Clinically this mu-
tation, together with Q1518X, results in the blistering skin disease epidermolysis bullosa with 
muscular dystrophy (EB-MD). Patient fi broblasts were used to correct the 1287ins3 mutation 
in vitro. A 5’ pre-trans-splicing molecule (PTM) containing the coding region for wild-type 
exons 2 through 9 plus a binding domain complementary to intron 9 of PLEC1 pre-mRNA was 
engineered to specifi cally replace the mutant 5’ portion of the plectin gene by trans-splicing. 
We detected a 73% reduction of the mutant allele by semiquantitative RT-PCR and a two-fold 
increase of full-length plectin protein by western blot analysis. Furthermore, immunofl uores-
cence analysis revealed the reversion to wildtype morphology of plectin expression in treated 
patient fi broblasts, thus confi rming the reversion of the degradation process. These results pave 
the way for allele-specifi c repair by trans-splicing.
179 [086]
Patients with recessive dystrophic epidermolysis bullosa develop squamous cell carcinoma 
regardless of type VII collagen NC1 domain expression.
Pourreyron C1, Jones C2, Volz A3, O’Toole EA1, Chen M4, Hart IR5, Bruckner-Tuderman L3, Salis-
Alanis JC6, McGrath JA2 and Leigh IM1
1Centre for Cutaneous Research, Barts & London Queen Marys School of Medicine & Dentistry 
(United Kingdom)
2St John’s Institute of Dermatology, Kings College London (United Kingdom)
3Universitäts-Hautklinik, Freiburg (Germany)
4USC Laboratory for Investigative Dermatology, University of Southern California Keck School 
of Medic (USA)
5Tumour Biology Lab, Barts & London Queen Marys School of Med & Dentistry (United Kingdom)
6Servicios Medicos de la Universidad Autonoma de Nuevo Leon, Monterrey (Mexico)
Recent data suggest that individuals with recessive dystrophic epidermolysis bullosa (RDEB) only 
develop Squamous cell carcinoma (SCC) in the presence of the NC1 domain of type VII collagen. 
This conclusion was based on experimental work in which cryosections of SCCs from 10 people 
with RDEB all showed positive type VII collagen immunostaining and also observations in a murine 
model of SCC development in which tumours only occurred in keratinocytes from RDEB subjects 
that expressed detectable levels of the NC1 domain of the type VII collagen protein. To assess 
whether the clinical interpretation was valid in another cohort of RDEB patients, we examined 
expression of the NC1 domain of type VII collagen in 10 SCC tumours excised from 10 patients. We 
assessed presence of type VII collagen by indirect immunofl uorescence (9 separate tumour biop-
sies, from 9 patients) and by Western blotting of cultured SCC keratinocyte lysates (6 tumours from 
6 patients). In 7 of 9 tumours available for indirect immunofl uorescence we were able to detect type 
VII collagen expression in cryosections using polyclonal antibodies raised against the NC1 domain. 
Using an affi nity purifi ed polyclonal antibody, Western blotting confi rmed the immunofl uorescence 
data: 4/6 RDEB patient keratinocytes expressed the NC1 domain of type VII collagen while 2/6 did 
not. Western blotting using commercially available antibodies against type VII collagen was unsuc-
cessful in detecting endogenous type VII collagen in these samples. Thus two of the tumours had no 
detectable type VII collagen by both assessment methods. These data suggest that individuals with 
RDEB can develop SCC regardless of type VII collagen NC1 domain expression and that additional 
factors have a role in explaining the high incidence of tumours complicating this genodermatosis.
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Correlation Between Triple Helix Stability of Collagen VII and Clinical Phenotype in 
Dystrophic EB
Schmid SC1, Fritsch A1, Meneguzzi G2 and Bruckner-Tuderman L1
1Department of Dermatology, University of Freiburg (Germany)
2INSERM U634, Faculty of Medicine, Nice (France)
Dystrophic epidermolysis bullosa (DEB) is a hereditary blistering skin disorder caused by abnormal-
ities of collagen VII, the major anchoring fi bril protein. In addition to null mutations, glycine sub-
stitutions within the collagenous domain are frequent in DEB. These may exert dominant negative 
effects on fi bril function, but very little is known about genotype-phenotype correlations underlying 
different degrees of skin fragility. Triple helix stability is likely to be a key factor in determining the 
phenotype of a mutation. Therefore, we used recombinant expression and site directed mutagen-
esis to generate wild type and mutant collagen VII and measured their helix-to-coil transition (Tm, 
or melting temperature) using resistance to limited proteolysis as a probe. Wild-type collagen VII 
had a Tm of 40,5 °C, similar to endogenous collagen VII in keratinocytes. Glycine substitutions 
causing homozygous recessive DEB decreased the Tm to 32°C (G1854R) and to 36°C (G2316R). 
Three other glycine substitutions, known to occur in dominant DEB, reduced the Tm to 25°C 
(G1776R), 32°C (G2006D), and 34°C (G2015E), when expressed alone. However, coexpression 
of the mutants with wild-type collagen VII, mimicking equal expression of both COL7A1 alleles in 
dominant DEB, increased the Tm of the G1776R/WT hybrid collagen to 36°C and of the G2006D/
WT hybrid to 40°C. Interestingly, mutations associated with minimal DEB phenotypes, such as 
nail dystrophy, reduced the Tm only to 36°C (G1815R) and 37°C (G2251E), even in homozygous 
state. Our results demonstrate signifi cant differences in triple helix stability of collagen VII mutants 
associated with recessive and dominant DEB and that the phenotype correlates with the Tm of 
the mutant. Therefore, determination of Tm of recombinant mutants provides a tool for precise 
analysis of COL7A1 mutation consequences and a test system for gene and protein therapeutic
approaches for DEB.
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DNA-based Prenatal Diagnosis of Harlequin Ichthyosis with Residual ABCA12 Expression
Akiyama M1, Titeux M2, Sakai K1, McMillan JR1, Tonasso L2, Calvas P3, Jossic F4, Hovnanian A2 
and Shimizu H1
1Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
2Inserm, U563 and University Paul Sabatier (France) 3Department of Medical Genetics, Purpan 
Hospital (France) 4Nantes Hospital (France)
Harlequin ichthyosis (HI) is a devastating genodermatosis that is often fatal during the neona-
tal period. Until the identifi cation of ABCA12-encoding a keratinocyte lipid transporter, as the 
causative gene for HI, prenatal diagnosis (PNDx) had been performed for more than 20 years 
by electron microscopic examination of fetal skin biopsy samples. We report here the fi rst case 
of DNA-based PNDx for HI. The proband, the fi rst child of healthy non-consanguineous French 
parents, showed a typical HI phenotype and died soon after birth. ABCA12 immunostaining was 
markedly reduced in the proband’s skin. Direct sequence analysis of ABCA12 revealed that the 
proband was a compound heterozygote for two novel mutations: a maternal nonsense mutation 
p.Ser1249X in exon 26 and a paternal missense mutation p.Arg2479Lys occurring at the last 
codon of exon 50. p.Ser1249X leads to an approximate 52 % truncation of the ABCA12 protein 
losing both ATP-binding cassette active sites. p.Arg2479Lys involves a highly conserved codon 
among diverse species in the second ABCA12 ATP-binding cassette. For their third pregnancy, 
the parents requested PNDx. Direct sequence analysis using fetal genomic DNA from amniotic 
fl uid cells at 17 weeks of pregnancy revealed that the fetus was a compound heterozygote for 
both mutations. The fetus was predicted to be affected and the parents requested the pregnancy 
to be terminated. The aborted fetus showed typical signs of HI. Analysis of ABCA12 transcripts of 
cultured keratinocytes from the abortus showed the presence of six abnormally spliced products 
arising from the allele carrying the missense mutation. Four of them lead to premature termina-
tion codons while the two others produced deleted proteins missing 21 and 31 amino acids in the 
second ATP-binding cassette. These results indicated residual expression of ABCA12. The present 
report paves the way for molecular PNDx of HI in the earlier stages of pregnancy.
*The fi rst and the second authors contributed equally to this work.
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The South African “Bathing Suit Ichthyosis” is a Form of Lamellar Ichthyosis Caused by a 
Homozygous Missense Mutation, p.R315L, in Transglutaminase 1
Arita K1, Jacyk WK2, Moosa L3, Modi D3, Schulz EJ3, van Rensburg EJ4, Chaplin T5, Mein C6, 
Happle R7, Wessagowit V1, McGrath JA1, Akiyama M8 and Shimizu H8
1Genetic Skin Disease Group, St. John’s Inst of Derm, St. Thomas’ Hospital (United Kingdom)
2Dept of Dermatology, University of Pretoria (South Africa) 3Dept of Dermatology, Unversity 
of Witwatersrand (South Africa) 4Department of Genetics, University of Pretoria (South Africa) 
5CRUK Medical Oncology (United Kingdom) 6Barts and the London, Queen Mary’s School of 
Medicine and Dentistry (United Kingdom) 7University of Marburg (Germany)
8Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
Bathing-suit, or “badpak”, ichthyosis (BSI) is an autosomal recessive disorder that occurs in 
certain communities in South Africa. The name refl ects the striking distribution of the skin 
scaling which is confi ned to the trunk and scalp but which spares the extremities and face. 
There is minimal intra- and inter-familial variability and a common ancestral allele has been 
postulated. To determine the molecular basis of BSI, we performed homozygosity mapping us-
ing a SNP (single nucleotide polymorphism) chip approach on genomic DNA from 8 affected 
individuals (3M, 5F; aged 7-17 years). Seven regions of the genome were found to have large 
blocks of homozygosity in all subjects. These included a 1.2mB interval (22757380-23916597) 
on chromosome 14q11, which contains the TGM1 gene that encodes transglutaminase 1, a 
key enzyme involved in formation of the cornifi ed cell envelope and which is mutated in some 
cases of lamellar ichthyosis. The TGM1 gene was sequenced and a homozygous G>T trans-
version at nucleotide c.944 (GenBank No. NM_000359) in exon 6 was identifi ed in all DNA 
samples. This mutation converts a highly conserved arginine residue to leucine, designated 
p.R315L, and occurs within the core domain of transglutaminase 1, a site involved in stabiliz-
ing the structural conformation of the enzyme through salt bridge and hydrogen bonds linked 
to neighboring amino acids No other sequence variations were identifi ed in the coding or 
splice site regions, nor was this missense mutation identifi ed as a polymorphism in ethnically-
matched control samples. Thus we have determined that BSI is actually a variant of lamellar 
ichthyosis associated with TGM1 gene pathology. While the exact mechanism that causes the 
distinct clinical phenotype has yet to be elucidated, knowledge of the molecular basis of BSI 
will be helpful in improving genetic counselling within this South African population.
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Silencing of JunB Alters Differentiation of Human Keratinocytes in Skin Equivalent Cultures
Ballaun C1, Buchberger M1, Mildner M1, Gruber F1 and Tschachler E2
1Dep of Dermatology, Medical Univ of Vienna (Austria)
2Dep of Dermatology, Med Univ of Vienna, CE.R.I.E.S (Austria)
The differential expression of the jun family members of the transcription factor AP1 in human 
epidermis and their potential role in the pathogenesis of psoriasis led us to examine the role of 
JunB during keratinocyte differentiation in vitro. JunB was successfully knocked down in kerati-
nocytes used to establish skin equivalent cultures by JunB-specifi c stealth siRNA. JunB knock 
down led to an altered epidermal architecture with an irregular stratifi cation, a strongly reduced 
stratum corneum, a reduced or absent granular layer, and the appearance of foamy cells and 
vacuoles in the suprabasal layers. No such changes were observed when instead of JunB siRNA 
either scrambled siRNA or siRNA against CD4 were used. Immunohistochemistry showed a 
reduction of loricrin, fi laggrin, cytokeratin1/10 and caspase-14 expression compatible with a 
disturbed keratinocyte terminal differentiation. Expression of involucrin and cytokeratin 5/14 
remained unaffected. JunB silencing had no infl uence on the proliferation rate of keratinocytes 
in monolayer culture. Human Genome U133 Plus 2.0 Affymetrix DNA chips that contained 
oligonucleotide arrays of ~38500 well-characterised human genes were used to compare gene 
expression in skin equivalent cultures of keratinocytes treated with either scrambled or JunB-
specifi c siRNA. The majority of genes affected by JunB knock down in skin equivalent cultures 
were such involved in signal transduction (MAPK, JAK/STAT, calcium signalling), cell adhesion 
(ß-catenin), cytoskeleton restructuring (keratins), and cell cycle (p53, SMAD). In conclusion our 
results indicate that silencing of JunB in a human skin equivalent model leads to alteration of 
the regular keratinocyte differentiation in vitro. 
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Involment of PATCHED Mutations in the Development of Basal Cell Carcinomas
Barnay-Verdier S1, Valin A1, Gorry P2, Brellier F3, Avril MF4 and Magnaldo T1
1Laboratoire Genomes et Cancers, CNRS-FRE 2939, Institut Gustave Roussy, Villejuif (France)
2Laboratoire de Génétique Oncologique, Institut Bergonié, Bordeaux (France)
3Friedrich Miescher Institute for Biomedical Research, Basel (Switzerland)
4Department of Dermatology, Hopital Cochin-Tarnier , Paris (France)
Human PATCHED (PTC) is a tumor suppressor gene encoding the transmembrane receptor for 
the diffusible SONIC-HEDGEHOG (SHH) factor. Germinal mutations of PTC are responsible 
for the nevoid basal cell carcinoma syndrome (NBCC) or Gorlin syndrome, a rare autosomal 
dominant disorder. NBCC patients present developmental defects and a predisposition to cer-
tain tumors, mostly basal cell carcinomas (BCC). PTC mutations have also been detected in at 
least 40-50% of sporadic BCCs. The PTC/SHH pathway is altered in all BCCs analysed. These 
observations have suggested an essential role of PTC in skin homeostasis and BCC develop-
ment. However, the status of PTC/SHH pathway in human skin cells has remained poorly 
documented. To characterize the expression of PTC, SHH and GLI effectors in normal and 
Gorlin genetic backgrounds, we established a collection of primary cutaneous fi broblasts and 
keratinocytes. PTC mutations were determined in all Gorlin cells used in this study. Gorlin 
fi broblasts displayed a decrease (30%) in the amount of PTC mRNA compared to normal cells. 
In contrast, no difference was observed between normal and Gorlin keratinocytes. Moreover, 
the expression of SHH was only detected in both types of fi broblasts. These results indicated 
a cell specifi c expression of PTC and SHH genes, maybe infl uenced by the status of PTC gene 
in skin. To further document the implication of PTC/SHH pathway in skin homeostasis, expres-
sion of its target genes (GLI, PTC) was measured in normal keratinocytes cultivated in normal 
or Gorlin fi broblasts supernatants. In presence of Gorlin fi broblasts supernatants, PTC and GLI 
mRNA levels were increased by about 30% and 50%, respectively. These observations strongly 
suggest an activation of PTC/SHH pathway by Gorlin fi broblasts and its implication in the 
mesenchyme-epithelium interactions. Taken together these results may contribute to precise 
the role of major cutaneous cell types in physiological and molecular mechanisms leading to 
BCC development.
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Proopiomelanocortin Gene: A New Susceptibility Gene for Cutaneous T-cell Lymphoma
Bienertova-Vasku JA1, Vasku V2 and Vasku A1
1Inst of Pathological Physiology, Faculty of Medicine, Masaryk Univ, Brno (Czech Republic)
2Department of Dermatovenerology, St Ann’s Faculty Hospital, Brno (Czech Republic)
Recently, it has been demonstrated that proopiomelanocortin (POMC) is widely expressed and 
produced within the keratinocytes, melanocytes and dermal microvascular endothelial cells 
suggesting the possibility of its auto/paracrine role in controlling skin metabolism. Aim of the 
study was to investigate possible associations of two common POMC gene polymorphisms 
(rs3754860=RsaI and rs1009388=AvaI) and cutaneous T-cell lymphomas (CTCL), with respect 
to treatment responsiveness.
95 patients with CTCL, diagnosed and treated at the 1st Department of Dermatology of St Ann’s 
Faculty Hospital Brno (65 men and 30 women, median age 62, range 26-101 years) plus 198 
controls (133 men and 65 women, median age 58, age range 26-80) without personal or family 
history of skin diseases and without personal history of malignancy were tested for association 
of RsaI and AvaI polymorphisms of POMC gene.
Signifi cant differences in genotype distributions as well as allelic frequencies of AvaI polymor-
phism between CTCL cases and controls were observed (pg= 0.016, pa= 0.008). Moreover, 
there is half a risk for CTCL in CC genotype carriers (OR= 0.558, 95% CI=0.339-0.918, pcorr= 
0.03). Furthermore, when investigating the double genotype distributions of RsaI and AvaI 
polymorphisms, a signifi cant decrease in ++CC associated genotype frequency was observed 
in CTCL cases (OR= 0.560, 95% CI=0.29-1.11, p=0.06). No associations of investigated poly-
morphisms and patients’ baseline characteristics, such as age, gender and family history of 
severe skin disorders were proved. 
Based on our results, POMC seems to be a strong genetic factor in CTCL and thus we suggest 
it might be considered a CTCL susceptibility gene. Presented data support the hypothesis of 
possible involvement of POMC gene variability in CTCL ethiopathogenesis; however, more 
research is necessary to provide the precise insight into POMC role in CTCL development. 
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Phorbol Ester induced Phosphorylation of Heat Shock Protein 27 in Cultured Keratinocytes
Jehani M and Bowden PE
Dermatology, Cardiff Univeristy (United Kingdom)
Heat shock protein 27 (Hsp27) is expressed in human epidermis and cellular stress induces 
phosphorylation at three amino acid residues (serine 15, serine 78 and serine 82). In normal 
epidermis, phosphorylation at serine 82 is limited to the granular layer but this dramatically 
increases throughout the whole epidermis in some genodermatoses caused by keratin muta-
tions. In cultured HaCaT cells, calcium-induced differentiation leads to phosphorylation of 
Hsp27 at serine 78 and serine 82. Furthermore, the phorbol ester, 12-O-tetradecanoylphorbol 
13-actetate (TPA) causes growth arrest of keratinocytes, induces protein kinase C (PKC) and 
reduces keratin (K1 and K10) expression. We have now examined the effect of TPA on Hsp27 
phosphorylation and K10 expression in cultured keratinocytes. HaCaT cells were grown in 
low calcium medium until 80% confl uence was reached. Cells were then treated for different 
times (1 hour, 3 hours, 1 day and 3 days) with either 1.8mM calcium plus TPA (100nM) or 
with calcium alone (control). Cell extracts were examined by SDS-PAGE and immunoblotting 
with K10, K14 and Hsp27 (general and different phosphoserine specifi c) antibodies. Western 
blotting analysis showed that TPA prevented induction of K10 expression but had no effect 
on K14 expression. Hsp27 expression remained constant but treatment with TPA dramatically 
increased Hsp27 phosphorylation at serine 78 and serine 82. This was observed as soon as 
1 hour after adding TPA. No phosphorylation of Hsp27 was observed at these early times in 
the absence of TPA. These results demonstrate that the growth arrest induced by TPA rapidly 
induces phosphorylation of Hsp27 at serine 78 and 82. Thus, the increased phosphorylation 
of Hsp27 in keratin genodermatoses could be due to PKC induced growth arrest which con-
tributes to the phenotype.
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Trisomies 8 and 9 Detected by FISH in Cutaneous Lesions of Patients with Mastocytosis
Hunold S, Brönnimann M and Braathen LR
Department of Dermatology, University of Berne (Switzerland)
Mastocytosis is a rare disease characterized by proliferation of mast cells in one or several 
organs. Cytogenetic studies with conventional techniques on bone marrow cells revealed ab-
normal clones in one third of the patients with systemic mastocytosis. Trisomies of chromo-
somes 8 and 9 have been reported in myeloproliferative disorders and have been discussed in 
systemic mastocytosis. The aim of the present study was to examine the presence of numerical 
aberrations of chromosomes 8 and 9 in skin biopsies of patients with cutaneous or systemic 
mastocytosis.
Numerical chromosomal aberrations for chromosomes 8 and 9 were analyzed using a com-
bined FISH- and immunofl uorescence staining technique with specifi c probes for the centro-
mere region of chromosomes 8 or 9 and an anti-human mast cell tryptase antibody in skin 
biopsies of 20 patients with mastocytosis, including 16 cutaneous and 4 systemic cases. 2 
of 18 patients examined had trisomy 8. Both cases (2 of 14, 14 %) suffered from cutaneous 
mastocytosis. 7 of 12 patients examined had trisomy 9. These included 1 of 4 cases (25 %) with 
systemic and 6 of 8 cases (75 %) with cutaneous mastocytosis.
Our study demonstrates the feasibility of the double-staining technique with FISH and a cell 
specifi c marker for the detection of numerical chromosomal aberrations in a specifc cell popu-
lation in paraffi n-embedded tissue samples. It further shows that numerical chromosomal aber-
rations are a frequent fi nding not only in systemic but also in cutaneous mastocytosis.
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A Novel Mutation of CGI-58 in Dorfman-Chanarin Syndrome
Ben Selma Z1, Yilmaz S2, Schischmanoff PO3, Blom A1, Laroche L1 and Caux F1
1Dpt of Dermatology and ERI-18, University Paris XIII, Bobigny (France)
2Dpt of Pediatric Hematology, Dokuz Eylul University,Izmir (Turkey)
3Dpt of Biochemistry, Avicenne Hospital, Bobigny (France)
Dorfman-Chanarin syndrome (DCS) is a recessive disease characterized by an ichthyosiform 
erythroderma associated with a diffuse tissular accumulation of triacylglycerol. In 2001 we 
have identifi ed 8 distinct mutations in a new gene, CGI-58, in 9 families with DCS. To date only 
7 additional mutations have been reported. In this study we searched for CGI-58 mutation in a 
new patient with DCS from Turkish origin.
A 1.5-year-old girl presented with ichthyosis, hepatic steatosis and fi brosis, increase of muscle 
enzymes, vacuoles in blood and marrow smears and in skin biopsy observed by electron mi-
croscopy. Her consanguineous parents, two sisters and one brother were normal. Sequencing 
of CGI-58 coding regions in the propositus leucocyte DNA revealed a homozygous A-to-G 
transition in exon 3 at position 343 substituting serine-115 (polar) for glycine (apolar). This 
point mutation was present at a heterozygous state in both parents and her brother but was not 
found in 49 Turkish normal subjects (98 alleles) excluding the likeliness of a polymorphism. 
Although, in silico splice site analysis (https://splice.cmh.edu) predicted the appearance of a 
cryptic splice site one nucleotide after the mutation, RT-PCR experiment showed a normal size 
for the CGI-58 transcript.
Nevertheless, this novel mutation may be pathological from the following reasons: i) serine at 
codon 115 is highly conserved among all studied species, ii) conversion of serine-115 to gly-
cine is predicted to induce a structural change of leucine-110 from coil to sheet, iii) functional 
analyses recently demonstrated that a close mutation (Q130P) results in a loss of adipose trig-
lyceride lipase-activating function, recruitment to lipid droplets and affi nity for perilipin.
In conclusion, the novel S115G missense mutation of CGI-58 in DCS, may affect the function(s) 
of this protein and explain the diffuse excess of lipid storage.
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Are Keratoacanthomas Variants of Squamous Cell Carcinomas? A Comparison of Chromosomal 
Aberrations by Comparative Genomic Hybridization
Clausen OP1, Aass HC1, Beigi M1, Purdie K2, Proby CM2, Mattingsdal M3, Micci F4, Kolvraa S5, 
Bolund L6 and DeAngelis PM1
1Institute of Pathology, Rikshospitalet,University of Oslo (Norway)
2Centre for Cutaneous Research, University of London (United Kingdom)
3Department of medical Genetics, Ullevaal University Hospital, Oslo (Norway)
4Department of Cancer Genetics, The Norwegian Radium Hospital, Oslo (Norway)
5Department of Clinical Genetics, Vejle Hospital, Vejle (Denmark)
6Institute of Human Genetics, University of Aarhus, Aarhus (Denmark)
Keratoacanthoma (KA) is a benign keratinocytic neoplasm that usually presents as a solitary 
nodule on sun exposed areas, develops within 6-8 weeks and spontaneously regresses after 
3-6 months. KAs share features such as infi ltration and cytological atypia with squamous cell 
carcinomas (SCCs). Furthermore, there are reports of KAs that have metastasized, invoking the 
question of whether or not KA is a variant of SCC. To date no reported criteria are sensitive 
enough to discriminate reliably between KA and SCC, and consequently there is a clinical 
need for discriminating markers. 
We screened fresh frozen material from 132 KAs and 37 SCCs for gross chromosomal aberra-
tions by using comparative genomic hybridization (CGH), the largest material of either lesion 
so far analyzed by this method. Forty-nine KAs (37.1%) and 31 SCCs (83.7%) showed genomic 
aberrations, indicating a higher degree of chromosomal instability (CIN) in SCCs compared to 
KAs. Gains of chromosomal material from 1p, 14q, 16q, 20q and losses from 4p were seen 
signifi cantly more frequently in SCCs, (p- values 0.0033, 0.0198, 0,0301, 0.0017 and 0.0070), 
whereas loss from 9p was seen signifi cantly more frequently in KAs (p-value 0.0434). The de-
gree of CIN as well as patterns of recurrent aberrations were thus different in the two types of 
neoplasms, pointing to different genetic mechanisms involved in their developments.
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Gene Expression Studies in Monocyte-Derived Dendritic Cells using OLISA™ Low Density 
Array
Cluzel-Tailhardat M1, Bonnet-Duquennoy M2, Kurfürst R1, Courtellemont P1, Nicolas JF3 and 
Le Varlet B1
1LVMH Recherche - LVMH Parfums et Cosmétiques (France) 2LINKS Ingénierie (France)
3IFR 128 Biosciences, INSERM U503 (France)
Chemical-induced allergy is an important occupational health problem and undergo the devel-
opment of in vitro models to identify sensitizing chemicals. A critical step in the induction of 
contact hypersensitivity is the activation, maturation and migration of dendritic cells from the 
epidermis to the draining lymph nodes to sensitize naïve T lymphocytes. To explore the concept 
of chemical allergen-induced dendritic cell maturation and to identify genes that are differentially 
regulated by exposure to allergens, we developed a low density cDNA-array using colorimet-
ric revelation (OLISA – bioMérieux) and studied 75 genes on monocyte-derived dendritic cells 
(MDDC). Monocytes are negatively isolated from human blood using magnetic microbeads and 
cultured for 6 days in GM-CSF and IL-4 supplemented medium. The phenotypic characterization 
of the isolated cells was assessed by fl ow cytometry using specifi c markers. The effects of expo-
sure to chemicals were performed on immature (IDC), LPS-induced mature (MDC) and chemical-
stimulated MDDC. Using the specifi c microarray, we showed that monocytes, IDC and MDC sig-
nifi cantly expressed transcripts for 31/71 genes (44%), 46/71 (65%) and 51/71 (72%) respectively. 
After differentiation, 1 gene was up-regulated, 4 genes down-regulated and 27 were unchanged 
in IDC. Upon stimulation with LPS, and in samples from 19 different donors, whereas expression 
profi les were unchanged for 30 genes, 10 were up-regulated and 8 down-regulated in MDC. The 
variation in gene expression was confi rmed by real-time quantitative RT-PCR assay for some of 
them. Then, to develop an in vitro alternative method for predicting the sensitizing potential of 
chemicals, we performed expression profi les analysis on MDDCs exposed to chemical allergens 
as DNBS, eugenol, isoeugenol and hydroxycitronellal and qRT-PCR is used to confi rm microarray 
data. Preliminary results show that the discrimination between the different allergens and irritants 
requires the use of gene markers hapten specifi c.
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Early Prenatal Diagnosis of Inherited Epidermolysis Bullosa with Pyloric Atresia by Villous 
Trophoblast Immunofl uorescence
D’Alessio M1, Zambruno G1, Charlesworth A2, Lacour JP3 and Meneguzzi G2
1Laboratory of Molecular and Cell Biology, IDI-IRCCS (Italy) 2INSERM U634, University of 
Nice-Sophia Antipolis Nice (France) 3Department of Dermatology, Nice (France)
Junctional and simplex epidermolysis bullosa with pyloric atresia (PA-JEB and PA-EBS) are two 
clinically indistinguishable genodermatoses caused by mutations in integrin α6β4 and its interac-
tor plectin, respectively. Prenatal diagnosis for these life-threatening conditions relies on either 
microscopic examination of foetal skin biopsies or genetic analysis of fi rst-trimester chorionic vil-
li. Since cytotrophoblasts express integrin α6β4, we investigated the feasibility of PA-EB prenatal 
diagnosis by placental villi immunolabelling. First-trimester villous trophoblasts from 19 pregnant 
women at recurrent risk of PA-EB, and a placenta sample from a PA-JEB terminated pregnancy 
were used for molecular and immunofl uorescence studies. The genetic mutations were already 
known in 7 kindred, and in 7 more identifi ed during this study. By immunofl uorescence, all 19 
villus cytotrophoblasts exhibited a normal immunolabelling for both α6β4 and plectin, when 
compared to the controls. Accordingly, the genetic studies disclosed either healthy carriers or 
wild type foetuses in the 14 molecularly characterized kindred. In the remaining 5, periodical 
follow-up failed to detect any sign of PA. As expected, at delivery all 19 newborns were healthy. 
By contrast, but in agreement with the clinical diagnosis and the identifi cation of two nonsense 
mutations in the β4 gene, the PA-JEB placenta showed a marked reduction of integrin β4 expres-
sion while maintaining a strong plectin immunoreactivity.
Our study demonstrates the feasibility of PA-EB prenatal diagnosis by α6β4 and plectin immuno-
detection in chorionic villi, and suggests the strong likelihood that plectin immunolabelling can 
be extended to EB-with muscular dystrophy prenatal testing. Specifi cally, this simple technique 
is extremely useful for early prenatal diagnosis in kindred affected by PA-EB in which the genetic 
mutations are unidentifi ed or in pregnancies presenting polyhydramnios, elevated α-fetoprotein 
and positive acetylcholinesterase. Besides disclosing the foetus phenotype, this procedure identi-
fi es the defective polypeptide, facilitating mutation screening. 
192
Comparative Studies of B16F10 and B16Bl6 Protein Profi les in Cell Culture and Mouse Sera
Rondepierre F1, Defay C1, Bouchon B1, Papon J1, Arlotto M2, Beger F2, Miot-Noirault E1, Moins N1, 
D’Incan M1 and Degoul F1
1UMR 484,INSERM, UdA, CJP , Clermont-Fd (France)
2INSERM U318, Grenoble (France)
Melanoma dissemination may result from the intrinsic nature of the tumor itself and from the host 
reaction capacity towards tumoral cell invasion. In a syngenic model, mouse melanoma B16F10 
and B16Bl6 cell lines differ in their capacity to induce pulmonary colonies from a subcutaneous 
tumor. In our hands, no metastasis was observed in the B16F10 inoculated mice while 50% of the 
B16Bl6 injected mice developed pulmonary metastasis. Potential intrinsic tumoral proteins were 
searched on cell culture extracts by 2D electrophoresis in a 5 to 8 pI separation range. Statistical 
analyses showed seven differently expressed proteins, 6 of them were identifi ed by MALDI-TOF 
mass spectrometry. Heat-shock protein 60 (HSP60) and sepiapterin reductase (SPR) were present 
in larger amount in B16F10 cells while two endoplasmic reticulum proteins (ERP57 and ERP29), 
creatin kinase B (CKB), and annexin A1 (ANXA1) were overexpressed in B16Bl6 cells. Further 
immunoblotting studies validated HSP60, ERP57, ERP29 and ANXA1 expression profi les on B16 
cellular extracts as well as in mouse tumoural tissues. ANXA1 (implicated in apoptosis and in-
fl ammation) and CKB (implicated in metabolism) proteins have been found to increase in parallel 
with malignacy for other cancers. HSP 60 expression was found to be associated with melanoma 
chemoresistance. Both ERP57 and ERP29 play a role in protein folding, ERP57 being implicated 
in the major histocompatibility complex class I folding and assembly. In the same animal model, 
SELDI-TOF-MS analyses were performed on sera from mice inoculated with B16F10 or B16Bl6 
cells. The analyses indicated forty proteins present in statistically different amounts in the two 
groups. Furthermore clustering between B16Bl6 mice with or without pulmonary metastasis dis-
played three differential proteins. Further studies are ongoing to characterize these lastest markers 
which may participate in the host tumor relationship or in the dissemination process.
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A Novel Complex Insertion/Deletion Mutation in the XPC DNA Repair Gene Leads to Skin 
Cancer in an Iraqi Family
Emmert S1, Wetzig T2, Imoto K3, Khan SG3, Oh KS3, Laspe P1, Zachmann K1, Simon JC2 and 
Kraemer KH3
1Department of Dermatology, University of Goettingen (Germany)
2Department of Dermatology, University of Leipzig (Germany)
3Basic Research Laboratory, National Cancer Institute, NIH (USA)
We examined the clinical, molecular, and genetic features of a newly diagnosed Iraqi family 
with xeroderma pigmentosum (XP). Both parents are consanguine (cousins) and have two clini-
cally affected children. Their son, XP6GO, is 9 years old and exhibits sun-sensitivity as well as 
freckling in the sun-exposed areas of his skin. He already developed one squamous cell and 
two basal cell carcinomas. His sister, XP5GO, is 6 years old and also exhibits sun-sensitivity 
and freckling that was noted since her fi rst year of life. She developed one squamous cell can-
cer so far. Neurological symptoms are absent in both siblings. Primary fi broblast strains were 
established from punch biopsies of both patients. XP5GO and XP6GO fi broblasts showed a 
reduced nucleotide excision DNA repair capability as refl ected by reduced host cell reactiva-
tion of a UV-treated luciferase gene-containing reporter plasmid. Cotransfection of different 
wild-type XP cDNA containing plasmids assigned both strains to the XP complementation 
group C. Additionally, both strains exhibited a reduced post-UVC cell survival. Using quantita-
tive real-time RT-PCR we found a reduced XPC mRNA expression in XP5GO and XP6GO cells 
(~33% of normal) as well as no measurable XPC protein expression by Western blot analysis. 
Mutational analysis of the XPC gene revealed a novel homozygous insertion/deletion mutation 
within exon 9 in both patients. We found a deletion of 12 bases (2028-2039) that was replaced 
by a 25 bp insertion. Interestingly, the insertion is similar to the duplicated inversion of the 
deleted 12 bp sequence. Seventeen of the 25 bases in the insertion are 100% identical to a 
portion of the human X chromosome Xq25-26.2 which might be the source of a part of the 
insertion. This mutation leads to a frameshift at codon 641 in the XPC gene (641fs-661ter) and a 
truncated and potentially non-functional XPC protein resulting in a reduced capability to repair 
UV-induced DNA damage and a skin cancer prone phenotype.
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Development and Application of Preimplantation Genetic Diagnosis for Inherited Skin 
Disorders in the UK
Fassihi H1, Renwick PJ2, Black C2, Pickering S2, Braude P2 and McGrath JA1
1St John’s Inst of Dermatology, King’s College London School of Medicine,  (United Kingdom)
2Centre for Preimplantation Genetic Diagnosis, Guy’s and St Thomas’ NHS Trust, London 
(United Kingdom)
At present there is no effective gene, protein or cell therapy in clinical use for patients with 
inherited skin diseases. As such, one of the most signifi cant translational benefi ts of recent 
research has been the development of DNA-based prenatal testing. One approach, that obvi-
ates the need for a fi rst trimester termination of pregnancy, is preimplantation genetic diag-
nosis (PGD), based on DNA analysis of single blastomeres extracted from late cleavage stage 
embryos following in vitro fertilization. Here, we present our experience of developing PGD 
for severe genodermatoses over the last 4 years. First, we successfully designed and applied a 
nested-polymerase chain reaction (PCR) for mutations in the plakophilin 1 gene in a couple at 
risk for skin fragility-ectodermal dysplasia syndrome. Secondly, we designed and optimized a 
sensitive single cell semi-duplex PCR assay for recessive dystrophic epidermolysis bullosa that 
involved two highly polymorphic dinucleotide repeat microsatellite markers close to the type 
VII collagen gene. Thirdly, we established two PGD tests for Herlitz junctional epidermolysis 
bullosa (for the LAMB3 and LAMA3 genes) based on whole genome amplifi cation of DNA 
from single blastomeres by multiple displacement amplifi cation (MDA). The MDA products 
were tested using fl uorescent multiplex PCR assays to generate extended haplotypes spanning 
the disease loci. The successful application of MDA as part of the PGD protocol now means 
that we will be able to rapidly develop robust PGD tests for several other severe inherited skin 
diseases. However, the PGD assays for epidermolysis bullosa have already been licensed by the 
UK Human Fertilization and Embryology Authority and are now available for clinical use. PGD 
is becoming a real rather than a theoretical option and one which broadens the personal choice 
for couples at reproductive risk of a broad range of severe genetic skin diseases.
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The Transcription Factor PPAR delta is Active in Psoriasis
al Yacoub N1, Romanowska M1, Seidel H2, Artuc M1, Phillip S1, Gerken H1, Donandt S1 and 
Foerster J1
1Department of Dermatology, Charité Hospital, Berlin (Germany)
2Schering AG, Berlin (Germany)
We performed microarray analysis of lesional versus non-lesional psoriatic skin. 3.6 % of all 
genes exhibited > 2-fold up- and 2.0 % > down-regulation. Surprisingly, when dysregulated 
transcripts were compared to genes previously shown to be altered in psoriasis, a concordance 
of 90 % of up- and 70 % of down-regulated genes was found, indicating that the vast majority 
of transcriptional changes in lesional psoriatic skin are not random, as might have been as-
sumed, but part of a highly reproducible disease-associated pattern. When grouping altered 
transcripts according to function, the largest group of genes unexpectedly where related to 
fatty-acid signalling, adipocyte differentiation, and redox activity. All of these functions are 
critically dependent on the acitivity of PPAR delta, a transcription known to regulate keratino-
cyte differentiation, which was one of the most highly upregulated transcripts itself (10-fold). 
PPAR delta was found to be constitutively expressed and localized to the nucleus in primary ke-
ratinocytes in vitro by western blot. Activation of PPAR delta by the specifi c ligand LD-160541 
in primary keratinocytes reproduced numerous transcriptional changes affecting keratinocyte 
differentiation seen in vivo and identifi ed putative novel target genes of relevance to psoriasis 
(p63, SPINK5). Lentivirus – mediated knock-down of PPAR delta in keratinocytes inhibited 
cellular proliferation. Finally, PPAR delta was found to be expressed in primary T cells and the 
T cell line Jurkat. Lentivirus-mediated knock-down of PPAR delta in T cells caused apoptosis 
upon serum withdrawel and CD95 ligation.As a transcriptional target of TFN alpha, PPAR delta 
appears to be a major factor inducing and / or maintaining the regenerative phenotype char-
acteristic for psoriasis.
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Functional Analysis of Epigenetic Regulation on Normal Skin and Skin Cancers
Fujiwara H and Ito M
Department of Dermatology, Niigata University (Japan)
Differentiation and carcinogenesis of the skin are closely regulated by the epigenetic mecha-
nisms, especially through DNA methylation and histone acetylation. We reported suppressed 
expression of E-cadherin and other tumor suppressor genes in squamous cell carcinoma 
through DNA methylation by means of methylation-specifi c PCR and in situ detection of E-
cadherin mRNA and protein, previously. Although those are the established techniques in 
researching the effect of DNA methylation, they cannot show if the protein/ mRNA are truly 
regulated via DNA methylation in vivo. Herein we report the function of DNA methylation and 
histone acetylation in normal skin and skin neoplasms with the novel technique, the combina-
tion of tissue culture and DNA array analysis.
Normal skin taken in plastic surgery was cut into several pieces, and subjected for primary tis-
sue culture. They were incubated in DMEM supplemented with fetal bovine serum, with /with-
out 5-aza-cytidine of 5uM, trichostatin A of 300nM, or both; 5-aza-cytidine is a DNA methyla-
tion inhibitor; trichostatin A is a histone deacetylase inhibitor. The cultured tissue pieaces in 
each of the culture medium were collected in several time points up to 72hrs, processed for 
RNA extraction with RNA later (Ambion) or formalin fi xation. The extracted RNA was amplifi ed 
with TargetAmp Aminoallyl-aRNA Amplifi cation kit (Epicentre), biotinylated, and hybridized 
on Human 1A Oligo Microarray Kit (Agilent). Basal cell carcinoma, squamous cell carcinoma, 
and malignant melanoma tissues were also cultured under the conditions mentioned above, 
and harvested for analyses.
DNA de-methylation with 5-aza-cytidine, and histone acetylation with trichostatin A activated 
mRNA expression within 24hrs in normal skin. Of skin neoplasms 5-aza-cytidine and trichosta-
tin A treatment lead the expression of several tumor suppressor mRNA including E-cadherin.
The present technique was very useful in fi nding candidate gene to study for epigenetic regula-
tion.
197
Is Systemic Sclerosis a Laminopathy?
Gaudy-Marqueste C1, Navarro C2, Boyer A3, Desandre-Giovannoli A3, Bocaccio I2, Grob JJ1 
and Levy N3
1Department of Dermatology, Ste Marguerite Hospital, Marseille (France)
2Inserm U491, University Aix-Marseille II (France)
3Department of Molecular Genetics, Timone Hospital, Marseille (France)
Lamins are proteins of the nuclear envelope involved in pathologies called “laminopathies”. 
As clinical similarities exist between Systemic Sclerosis and some laminopathies (e.g., Hutch-
inson Gilford progeria, restrictive dermopathy), we hypothesized that Systemic Sclerosis could 
be due to lamins mutations. Our purpose was to identify, in a cohort of patients (18 systemic 
diseases and 2 localized scleroderma), mutations in three genes involved in nuclear lamina 
constitution: LMNA, encoding lamins A/C; FACE1, encoding a protease involved in lamin A 
processing; and LBR, encoding the lamin B receptor. Molecular analyses were performed on 
DNA extracted from peripheral blood. DHPLC was use for sequence variations detection, and 
sequencing for variations characterisation. Transcriptional analyses (RT-PCR) were performed 
on RNA extracted from subject’s lymphocytes. Sixteen sequence variations were identifi ed (6 in 
LMNA, 2 in FACE 1 and 8 in LBR), all but one were identifi ed in patients suffering from systemic 
form of disease. Five of these variations have never been reported: c.651 T>C, p.Asp217Asp 
(FACE1), g.474+83A>C (FACE1), c.1870A>C p.His266Gln (LBR), c.1071 G>A p. Ser357Ser 
(LBR), and g.165+74C>T (LBR). Transcriptional analyses allowed us to eliminate an impact 
on splicing of FACE1 variations, analysis are ongoing for LBR variations. Up to date, we have 
identifi ed only polymorphisms in these 3 genes. Even if we can not assume that these varia-
tions are suffi cient to explain the phenotype, we can hypothesize that they may act as genetic 
predisposing factors in conjunction with other environmental or genetics factors. As molecu-
lar mechanisms involved in laminopathie’s pathophysiology are complexes, complementary 
analyses of other genes encoding LMNA partner’s proteins and functional cellular analysis 
must be performed.
198
Anti-Angiogenic Tumor Therapy by Endothelium-specifi c Suicide Gene Expression
Heidenreich R1, Weidemann S1, Brill C1, Muschter A2, Röcken M1 and Breier G2
1Department of Dermatology, Eberhard Karls University Tuebingen (Germany)
2Institute of Pathology, University Clinic Carl Gustav Carus, Dresden (Germany)
Angiogenesis, the formation of new blood vessels from pre-existing vessels, is a prerequisite 
for the growth of tumors beyond a minimal size in order to supply the tumor with oxygen 
and nutrients. Therefore, anti-angiogenic strategies are promising therapeutical approaches 
to inhibit solid tumor growth. Vascular endothelial growth factor (VEGF) and its high affi nity 
endothelial receptor VEGFR-2 are key regulators of tumor angiogenesis. In contrast to most 
adult blood vessels VEGFR-2 expression is strongly and specifi cally upregulated in the tumor 
endothelium. Therefore, gene regulatory elements of the VEGFR-2 gene are ideally suited to 
deliver therapeutic genes specifi cally to the tumor vasculature, minimizing the risk of systemic 
side effects. In transgenic mice, expressing the LacZ reporter gene under the control of previ-
ously identifi ed promotor/enhancer sequences of the murine VEGFR-2 gene, we observed a 
strong tumor endothelium-specifi c reporter gene expression in different experimental tumors. 
These sequences were used to develop an endothelium-specifi c anti-angiogenic tumor therapy 
based on a gene-directed enzyme prodrug strategy, in which the transgenes used encode en-
zymes that activate specifi c non-toxic prodrugs to cytotoxic products. We established trans-
genic mouse lines expressing the potent chimeric suicide gene yeast super-cytosine deaminase 
(super-yCD) under the control of the VEGFR-2 promoter/enhancer sequences (VEGFR-2/super-
yCD transgene). The non-toxic 5-Fluorocytosine will be converted to cytotoxic 5-Fluorouracil 
by super-yCD, leading to cell death of super-yCD expressing endothelial cells and, due to the 
strong bystander effect, of neighbouring tumor cells. In vitro, the expression and functionality 
of the transgene in endothelial cells was proven. In vivo, super-yCD expression was verifi ed by 
RT-PCR of transgenic embryos. Analysis of experimental tumor growth in VEGFR-2/super-yCD 
transgenic mice after 5-Fluorocytosine treatment will be performed. The established transgenic 
mice represent a powerful tool to investigate the effi cacy of endothelium-specifi c gene-directed 
prodrug strategies for tumor therapy in vivo.
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Identifi cation of Functional Genes During Fas-Mediated Apoptosis Using Randomly 
Fragmented cDNA Libraries
Hassan M1, Mirmohammadsadegh A1, Selimovic D2, Nambiar S1 and Hengge UR1
1Dept of Dermatology, Heinrich-Heine-University of Duesseldorf (Germany)
2Dept of Dentistry, University of Homburg/Saar (Germany)
Up to date, genomic information has been used mainly to develop expression array technolo-
gies. However, the general weakness of this approach is that expression profi ling gives no indi-
cation of gene function and is, therefore, not suited for the functional annotation of the human 
genome. Here, we describe a general strategy for the identifi cation of functional genes whose 
downregulation results in a selectable phenotype. This strategy is based on expression selec-
tion of cDNA fragments that counteract their cognate genes. MTT assay, TUNEL assay, RT-PCR, 
Western blot. By transfection of different tumor cell types including melanoma cell lineA375 
using a cDNA library containing random fragments, we identifi ed functional genes whose inhi-
bition conferred resistance to Fas-induced apoptosis. Thirty-fi ve clones were isolated, twenty-
eight of which were derived from unknown genes that tag 19 individual genes and seven of 
which were derived from known genes that tag apoptosis-related protein-1,-2 (APR-1,-2) and 
indoleamine-pyrrole 2,3, dioxygenase (IDO). The ability of APR-1, 2- and IDO-derived anti-
sense RNAs to induce resistance to Fas in HepG2, A375, CLS-354 suggesting that APR-1,-2 and 
IDO genes are involved in the mechansim of Fas-mediated apoptosis as confi rmed by Western 
blot analysis. Our gene discovery strategy provides a generally applicable procedure to identify 
functional genes that might be clinically relevant for tumor therapy.
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Expression and Properties of the Ten LY6/PLAUR Genes Encoded on Chromosome 8q24.3
Favre B, Plantard L and Hohl D
Department of Dermatology, University Hospital of Lausanne, CHUV (Switzerland)
Some members of the LY6/PLAUR family clustered on chromosome 8q24.3 were shown to be 
either associated with the genodermatose Mal de Meleda (SLURP1) or potential markers for 
head-and-neck squamous cell carcinoma (LY6D and LY6K). The LY6/PLAUR family regroups 
glycosyl-phosphatidylinositol (GPI)-anchored and secreted proteins with a common specifi c 
pattern of cysteine residues forming disulfi de bonds, resulting in a characteristic three-fi nger 
folding also found in some snake toxins. Chromosome 8q24.3 encodes 10 LY6/PLAUR genes: 
PSCA, LY6K, SLURP1, LYPD2, LYNX1, LY6D, GML, LY6E, LY6H, and HDLBP1, although the 
membership of LY6K to this family, based on its primary protein structure, is not clear as yet. Ac-
cording to Genbank LYNX1 is transcribed into 5 mRNA variants coding for 3 different proteins, 
secreted LYNX1-A (1 variant), secreted LYNX1-B (1 variant), and GPI-anchored LYNX1-C (3 
variants). We have identifi ed in several tissues a 6th variant encoding a putative fourth protein, 
LYNX1-D, with a consensus signal sequence and no GPI anchoring sequence, like LYNX1-A 
and -B. Among the 10 tissues tested SLURP1 and LY6D were exclusively expressed in the 
skin and foetal bladder. A similar but not as restricted expression was also observed for PSCA, 
LYPD2 and LYNX1-B. LY6E was ubiquitously expressed, whereas HDLBP1 mRNA was found in 
all tissues except the skin. Among the LY6/PLAUR genes expressed in cultured keratinocytes, 
SLURP1 and LYNX1-B transcription was dependent or stimulated by calcium-induced differ-
entiation. In situ hybridization confi rmed that these two genes in contrast to the others were 
predominantly transcribed in the upper layers of the epidermis. The function of most of these 
LY6/PLAUR proteins remains to be established.
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A Molecular Survey of 97 Families with Recessive and Dominant Dystrophic Epidermolysis 
Bullosa in French Reference Centres
Titeux M1, Mejia JE1, Hadj-Rabia S2, Mazereeuw-Hautier J3, Lacaze-Buzy L4, Mazarguil AM5, 
Taïeb A6, de Prost Y7, Bodemer C7 and Hovnanian A8
1Inserm, U.563, Univ Paul-Sabatier, Toulouse (France)
2Department of Dermatology, Necker Hospital, Reference Centre for Genodermatosis 
(MAGEC), APHP, Paris (France)
3Inserm U.563, CHU Purpan, Department of Dermatology, Toulouse (France)
4Inserm, U.563, CHU Purpan, Reference Centre for Orphan Skin Diseases, Toulouse (France)
5CHU Purpan, Department of Medical Genetics, Toulouse (France)
6Department of Dermatology, St Andre Hospital, Bordeaux, Reference Centre for Orphan Skin
Diseases (France)
7Department of Dermatology, Necker Hospital, Reference Centre for Genodermatosis, APHP, 
Paris (France)
8Inserm U563, CHU Purpan, Department of Genetics, Reference Centre for Orphan Skin
Diseases, Toulouse (France)
Dystrophic epidermolysis bullosa (DEB) are severe recessively (RDEB), or dominantly (DDEB) 
inherited skin disorders characterized by skin and mucosal blistering, scarring and nail dystro-
phy. DEB are caused by mutations in COL7A1 encoding type VII collagen. Here we report a 
mutation survey of 83 RDEB and 14 DDEB families mainly of European origin. A total of 106 
patients (88 RDEB and 18 DDEB), were analysed. 68 RDEB patients were affected with the 
most severe form (Hallopeau-Siemens, HS), 11 with generalized non-HS RDEB, 6 patients with 
inversed RDEB and 3 patients had a localised form. A total of 93 different recessive mutations, 
56 of which are novel, were identifi ed. Both mutations were found in 77% of RDEB patients. 
A majority of RDEB mutations led to PTCs through nonsense (19) or frameshift mutations (40, 
including one large deletion). In addition, 20 missense and 13 consensus splice-site mutations 
were identifi ed. Eight mutations were recurrent, including c.6527insC which was predominant-
ly found (6/11) in families of Spanish origin, and p.Arg2063Trp in families of Tunisian origin 
(4/5). Ten prenatal diagnosis were performed on the basis of these results. Nine different DDEB 
mutations were identifi ed, including 6 glycine substitutions and 3 inframe defects. Five of these 
mutations are novel (p.Gly1332Asp, p.Gly2707Asn, c.6008delGCTGAinsAG, c.6854del27, 
c.6932-5del5). DDEB mutations were located in exon 73, but also in exons 33, 75, 87 and 
110. One patient had a more severe DDEB phenotype due to compound heterozygosity for a 
dominant and recessive mutation. These data confi rm the prevalence of truncating mutations in 
HS-RDEB, and combinations of truncating and missense/splicing mutations in non-HS RDEB. 
Glycine substitutions in exon 73 were predominant but not exclusive defects in DDEB. This 
study further documents the large variety and complexity of COL7A1 mutations and is relevant 
for genetic counselling and prenatal diagnosis. 
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Genetic Study of Netherton Syndrome in a Large International Cohort
Deraison C1, Descargues P1, Lacaze-Buzy L2, Besson C1, Mazarguil AM3, Mazereeuw-Hautier J4, 
Bourdon-Lanoy E5, de Prost Y5, Bodemer C5 and Hovnanian A3
1INSERM, U.563,Purpan Hospital, Toulouse (France)
2Reference Center for Orphan Skin Diseases, Purpan Hospital, Toulouse (France)
3INSERM, U.563, Department of Medical Genetics, Purpan Hospital, Toulouse (France)
4Dept of Dermatology, Reference Center for Orphan Skin Diseases, Purpan Hospital, Toulouse 
(France)
5Department of Dermatology, Necker Hospital, Reference Center for Genodermatoses, APHP, 
Paris (France)
Netherton syndrome (NS) is one of the most severe keratinizing diseases of children and young 
adults. NS is a rare (1 in 100,000 newborns) autosomal recessive genodermatosis characterized 
by exfoliative erythroderma, trichorrhexis invaginata and atopic manifestations (the classical 
clinical triad), as well as ichthyosis linearis circumfl exa and failure to thrive. NS is caused by 
mutations in SPINK5 encoding the serine protease inhibitor, LEKTI. We report the molecu-
lar characterization of an international cohort of 47 NS families. 36 different mutations were 
identifi ed, 23 of which were novel. The causal mutations were identifi ed in both alleles in 
66% of the families. Sequencing is in progress to detect the second, unidentifi ed mutations 
in the remaining, heterozygous patients. Most patients presented with the classical clinical 
triad, while some patients displayed only a subset of these manifestations. In 40% of patients, 
immunohistochemical staining was performed, which showed in all cases a complete loss of 
LEKTI expression in the epidermal granular layer. All changes were nonsense or frameshift mu-
tations leading to premature termination codons (61%), or to abnormal splicing (39%). 36% of 
the mutations are deletions removing one to eleven nucleotides, including 9 new mutations. 
The remainder are either nonsense mutations (11%) including two new mutations (R350X and 
R853X) or insertions (13%), including two new insertions of 4 bp and 11 bp. Five recurrent 
mutations were identifi ed in patients of different geographical origins, including 153delT (7, 
Turkey, the Balkans), 238insG (5, Italy, Greece), 316delGA (3, Germany, France), 2240+G>A 
(3, The Netherlands, Chile) and R853X (3, France). 81% of mutations determined in this cohort 
localized to exons 3, 4, 5 and to exons 22-27. This study contributes to the fi rst database of 
worlwide SPINK5 mutations by the French reference centers.
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Functional Analysis of CDSN Haplotypes Associated with Familial Psoriasis
Jonca N, Caubet C, Gallinaro H, Simon M, Guerrin M and Serre G
Epidermal Differentiation and Rheumatoid Autoimmunity, UMR 5165 CNRS-Toulouse III
University (France)
Association of HLA-C and CDSN alleles with familial psoriasis is very strong and highly sig-
nifi cant. HLA-C and CDSN are indeed the only PSORS1 genes that yield protein alleles unique 
to risk haplotypes. The CDSN gene is specifi cally expressed in terminally differentiated ke-
ratinocytes. It encodes for corneodesmosin (CDSN), a secreted protein which is involved in 
corneocyte cohesion and is progressively degraded as desquamation occurs. 
The aim of our study is to assess the putative consequence of the psoriasis-associated SNPs of 
CDSN on the proteolysis of the corresponding proteins. The CDSN gene is highly polymor-
phic, six of the more common haplotypes being distinguished according to 6 non-synonymous 
SNPs. Among them, genetic studies defi ned 1.11, 1.21 and 1.41 as risk-haplotypes, whereas 
1.52 and 2.11 were under-transmitted or neutral. After transfection of COS cells, CDSN cor-
responding to the reference haplotype 1.11, or to each of the 6 haplotypes carrying a single 
substitution with respect to 1.11, were produced. We also produced the neutral haplotype 2.21 
carrying 3 substitutions as compared to 1.11. The CDSN variants were incubated with vari-
ous proteases, some of them supposed to be involved in desquamation (trypsin, kallikrein 5, 
alpha-chymotrypsin, kallikrein 7, cathepsin D). Proteolytic fragments were detected by western 
blotting using a panel of antibodies directed against different domains of CDSN. We observed 
that only one variant (Ser202/Phe202) produces a proteolysis profi le different from the others after 
incubation with kallikrein 7, whereas all of them show the same pattern of digestion with the 
other proteases.
Our results add new data on the impact of psoriasis-associated amino acid exchanges of CDSN 
on the properties of the protein. However, they do not clearly demonstrate an association 
between protease sensitivity and risk haplotypes.
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Carbonic Anhydrase II is Upregulated in Atopic Dermatitis
Kamsteeg M, Zeeuwen PL, Olthuis D, de Jongh GJ, Zeeuwen-Franssen ME, van Erp PE and 
Schalkwijk J
Department of Dermatology, Radboud University Nijmegen Medical Centre (Netherlands)
Atopic Dermatitis (AD) and psoriasis are two common infl ammatory skin disorders of unknown 
etiology. There is increasing evidence that in addition to the immune system, the epidermal kerat-
inocytes are intimately involved in the disease process. The aim of the present study was to reveal 
disease specifi c differences in gene expression between keratinocytes in lesions from psoriasis 
and AD patients. Therefore, microarray analyses were performed on isolated epidermal sheets 
from biopsies of lesional skin of psoriasis and AD patients. Among a large number of genes that 
showed disease-specifi c differential expression, a striking upregulation of Carbonic Anhydrase 
II (CAII) mRNA was found in AD patients, compared to psoriasis patients and healthy controls. 
Microarray results were validated by qPCR. To determine the cellular localisation of CAII in the 
epidermis, keratinocytes were sorted in β1-integrin positive (basal cells) and negative fractions 
(differentiated cells) using fl owcytometry. qPCR showed that CAII mRNA levels were higher in 
differentiated cells present in the upper epidermis. Immunohistochemistry showed a cytoplasmic 
localization of CAII protein in the upper epidermis. CAII expression in cultured normal human 
keratinocytes was investigated in monolayer cultures and in 3-D reconstructed skin. To mimic AD 
and psoriasis in vitro, keratinocytes were stimulated with Th2 cytokines (IL-4 and IL-13) and Th1 
cytokines (IL-1α, TNF-α and IFN-γ), respectively. We found that stimulation by Th2 cytokines (but 
not by Th1 cytokines), caused enhanced expression of the CAII gene, as determined by qPCR, 
western blotting and ELISA. This suggests that Th2 cytokines, which are characteristic for the cy-
tokine microenvironment in lesional skin of AD patients, are likely to contribute to the upregula-
tion of CAII observed in AD in vivo. The pathophysiological consequences of high cellular levels 
of CAII require further investigation, but could involve pH regulation and water transport.
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A Case of Bullous Congenital Ichthyosiform Erythroderma and Palmoplatar Hyperkeratosis 
Due to Mutation N188K in the Gene KRT1 Encoding Keratin 1
Kowalewski C1, Wozniak K1 and Ishiko A2
1Department of Dermatology, Medical University of Warsaw, (Poland)
2Department of Dermatology, Keio University, Tokyo (Japan)
We report 16-months-old girl born in time from non-consanguineous healthy parents who 
presented at the birth generalized blisters and erosions accompanied by Nicolsky’s sign. Mu-
cous membranes were not involved. In second month of the live new blisters were present 
mainly on fl exural surfaces. On the beginning of third month of the live patient developed 
slight hyperkeratotic plaques on erythematous base localized on extensor surfaces of the fore-
arms and calves and on the lower abdomen. While patient was 6-months-old she developed 
hyperkeratotic plaques and prominent palmoplantar keratoma whereas blisters appeared oc-
casionally. After 15-months of the live blisters stopped to appear and hyperkeratotic scales 
dominated in the clinical picture. Histopathology performed in third month of the live showed 
hyperkeratosis, acanthosis and the presence of numerous cells in the upper part of stratum 
spinosum with a large keratohyaline granules, whereas electron microscopic study disclosed 
keratin clumps refl ecting the disturbances in keratin assembly process. Molecular analysis in 
the proband showed a mutation N188K in the gene KRT1 encoding keratin 1 resulting in an 
asparagine-to-lysine substitution. Our study confi rms previous observations concerning strong 
association between mutations in the KRT1 gene and palmoplantar keratoma in patients with 
bullous congenital ichthyosiform erythroderma.
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Novel and Recurrent KIND1 Gene Mutations in Five Patients with Kindler Syndrome
Lai-Cheong JE1, Liu L1, Wessagowit V2, Pather S3, Jessop S3, Sethuraman G4, Reddy S5, Hovnanian A6, 
Vahlquist A7 and McGrath JA1
1Genetic Skin Disease Group, St John’s Institute of Dermatology (United Kingdom)
2Genetic Skin Disease Group, St John’s Institute and Inst of Dermatology, Bangkok,  (Thailand)
3Division of Dermatology, G23 New Groote Schuur Hospital (South Africa)
4Department of Dermatology, AIIMS (India)
5Department of Dermatology, Hyderabad (India)
6Department of Functional Genetics, Hopital Purpan, Toulouse (France)
7Department of Medical Sciences, Uppsala University Hospital (Sweden)
Kindler syndrome is a rare autosomal recessive genodermatosis characterised by skin fragil-
ity, photosensitivity and poikiloderma. The disorder results from loss-of-function mutations in 
the KIND1 gene which encodes kindlin-1, an actin fi lament-associated component of focal 
contacts. In this study, we screened genomic DNA from fi ve unrelated individuals with Kindler 
syndrome for KIND1 mutations; all subjects were from consanguineous families. Nucleotide 
sequencing disclosed different homozygous mutations in each case: p.S114X (South African), 
p.E168X (Indian), p.E304X (French), IVS13+1G>A (Somalian) and IVS14-1G>C (Indian). Of 
these mutations, E304X has been previously shown to be a recurrent mutation in Kindler syn-
drome; the other mutations are all new. Clinically, no major phenotypic differences were noted 
between the individuals with the amino-terminal nonsense mutations and those with the c-ter-
minal splice site mutations, confi rming a previous lack of genotype-phenotype correlation for 
KIND1 mutations in Kindler syndrome. When added to the global KIND1 mutation database, 
28 different mutations (11 nonsense, 10 frameshift, 6 splice site and one internal deletion) have 
now been identifi ed. Although the precise mechanisms through which these KIND1 muta-
tions lead to the Kindler syndrome phenotype is yet to be explained, the discovery of new 
pathogenic mutations in KIND1 helps optimise overall mutation detection strategies as well as 
highlight specifi c mutations in patients from particular geographical origins.
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A European Genetic Study of Stevens-Johnson and Toxic Epidermal Necrolysis: HLA-B 
Association with Specifi c High-Risk Drugs
Lonjou C1, Sekula P2, Ledger N1, Borot N1, de Toma C3, Halevi S4, Schumacher M2, Roujeau JC5, 
Hovnanian A1 and Mockenhaupt M6
1Départment de Génétique fonctionnelle des maladies des épitheliums, INSERM U563, Tou-
louse (France)
2Institute of Med. Biometry and Informatics, University Hospital of Freiburg (Germany)
3Fondation Jean Dausset - CEPH, Paris (France)
4Department of Dermatology, Ben-Gurion University of the Negev, Beer-Sheva (Israel)
5Department of Dermatology, Hopital Mondor, Créteil (France)
6Department of Dermatology, University Hospital Freiburg (Germany)
We have undertaken a genetic study of Stevens-Johnson syndrome (SJS) and toxic epidermal 
necrolysis (TEN) focussing on the HLA region. SJS and TEN are rare but severe cutaneous 
adverse drug reactions, which can be caused by many drugs. Among them are “high-risk” 
drugs including allopurinol, carbamazepine, lamotrigine, phenobarbital, phenytoine, sulfam-
ethoxazole, oxicam and nevirapine. We report results from a European study (RegiSCAR) of 
150 cases including 31 allopurinol, 30 sulfamethoxazole, 14 oxicam, 12 carbamazepine, 18 
lamotrigine, 8 phenytoin, and 8 nevirapine –induced cases. After a strong association of car-
bamazepine and allopurinol induced cases of SJS has been described with HLA-B*1502 and 
HLA-B*5801, respectively, in a Han Chinese population, we initially studied the HLA region 
using 17 microsatellites in a cohort of 70 French retrospective cases and 106 French controls. A 
signifi cant association was observed with 3 microsatellites. The critical region defi ned by these 
microsatellites spans 500-600 kb, which includes HLA-B. We still observed an association in 
the HLA region with microsatellite D6S2793, when the cases associated with allopurinol and 
carbamazepine were removed. Therefore, we further investigated this region by HLA-B geno-
typing all 150 cases. We found an association between HLA-B*5801 and allopurinol-induced 
cases in 61% of the European SJS/TEN cases studied (p<10-8), but none of the European car-
bamazepine-induced cases had allele B*1502. These results confi rm the association of B*5801 
in the majority of the allopurinol-induced cases of SJS and TEN. In Europe no allele reach the 
100% association as observed in Taiwan. The importance of some HLA-B alleles appears more 
clearly, thus sustaining a drug-specifi c gene effect in SJS/TEN caused by specifi c drugs.
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Quantifi cation of Circulating Cell-Free DNA: An Exploratory Analysis in Melanoma Patients
Mallet S1, Levy-Mozziconacci A2, Bouvenot J3, Richard MA1, Gabert J2 and Grob JJ1
1Department of Dermatology, Universite de la Mediterranee, Marseille (France)
2Lab of Biochemistry and Molecular Biology, Univ de la Mediterranee, Marseille  (France)
3Departement of Public Health, Universite de la Mediterranee, Marseille  (France)
Recently, attention was raised on the potential role of free circulating DNA (FCDNA) in a variety 
of disorders. Increased levels of FCDNA have been found in cancer patients and they have been 
proposed as potential tumor marker, although the meaning of such an increase is not yet clear. 
The purpose of this study was to develop a standardized quantifi cation of FCDNA, in order to ex-
plore whether FCDNA could have some diagnostic or prognostic value in melanoma patients.
We developed a real time quantitative PCR assay, using the B-globin gene, based on the use 
of standardized plasmid calibrator. This assay was used in a 59 prospectively collected plasma 
samples of melanoma (MM) patients: 15 stage I (AJCC), 14 II, 15 III and 15 IV.
FCDNA plasma concentration was signifi cantly higher in MM patients stage I-II-IIIA than in stage 
IIIB-C-IV (median: 932 and 1659 copies/ml, respectively, P0,05 M-W test). The plasma FCDNA 
level was higher in case of disease progression within 6 month (P0,05 M-W test).
However, in this limited sample of patients, no clear relation was observed with clinico-patho-
logical parameters, or positivity of sentinel node. This new standardized quantitative real time 
PCR permits a reliable assessment of FCDNA, which seems to have some relation with prognos-
tic variables in MM. Further testing of FCDNA as a non-invasive prognostic or monitoring tool 
in a larger population is warranted.
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Analysis of Gene Regulation During In Vivo Granular Keratinocyte Differentiation using 
Pangenomic Microarrays
Mattiuzzo N, Toulza E, Serre G and Guerrin M
UMR 5165 CNRS-Toulouse III University, France (France)
Extensive identifi cation of genes specifi cally expressed in granular keratinocyte in vivo is a key 
step to get a global view of the transcriptional program required for cornifi cation and establish-
ment of the epidermal barrier function.
By repeated trypsin incubations of human epidermis fragments, we obtained cell batches en-
riched in basal or granular keratinocytes. After total RNA extraction, enrichment was checked 
by quantitative RT-PCR. cDNA from the two batches were labelled with Cy3 alternatively with 
Cy5 and hybridized on pangenomic oligonucleotide microarrays (22 395 genes) produced by 
the Réseau National des Génopoles.
Independent RNA samples extracted from four healthy individuals were analyzed. After back-
ground subtraction, ratios were log transformed and normalized according to LOWESS method. 
The expression of 5400 genes was detected on microarrays. Among these genes, 700 appeared 
to be overexpressed in granular keratinocytes (ratio > 1,5 with p-value < 0,05 ; Student’s t-test), 
including known markers of differentiation (fi llaggrin, loricrin, dermokine, kallikrein 5 and 
7...). Above all, our approach allows to greatly extend the list of genes regulated in the course 
of epidermal differentiation. Various genes were not described as epidermal, and their ratio will 
be checked by Q RT-PCR, especially those encoding transcription factors.
Pooled with Q RT-PCR and ORESTEs data produced in our lab, these results should allow 
us to describe the global regulation of gene expression in granular keratinocytes, and more 
especially, to decrypt which combinations of transcription factors might activate or repress the 
transcription of the differentially expressed genes.
210
KLN-47: An Effi cient Gene Reagent to Transfect Primary Melanocytes Cultures Inducing Cell-
Death after Addition of GCV
Montier T1, Denizot M1, Pereira U2, Delépine P1, Lehn P1, Misery L3 and Férec C1
1Unité INSERM 613, Université de Bretagne Occidentale, Faculté de Médecine et des Sciences 
de la Sant (France)
2EA 3879, Université de Bretagne Occidentale (France)
3Service de Dermatologie, CHU de Brest, Hôpital Morvan (France)
New approaches are necessary to treat melanoma. Considering the easy cellular access of the 
skin, gene therapy is a realistic possibility. Although viral vectors are mainly used in clinical 
trials due to their high transduction effi ciency, they are responsible of major drawbacks (im-
munogenicity, oncogenicity…). Consequently, non-viral gene delivery systems represent an 
interesting alternative. Among the strategies, the “pro-drug / suicide gene” approach is one of 
the most promising. On this line, we decided to use some of the synthetic transfection agents 
to carry out a plasmid encoding the HSV thymidine kinase, enzyme which phosphorylate the 
ganciclovir blocking fi nally the cell division. 
We fi rstly transfected some cell lines (A-375 and SK-Mel-28) to evaluate the effi ciency of KLN-
47 in comparison with a commercial reagent (DOTAP/DOPE). 48h following transfection and 
whatever the cell lines, we showed that KLN-47 led to approximately 50% of GFP+ cells 
(DOTAP/DOPE ~20%). Moreover, we noticed that the cytotoxicity was largely correlated to 
the formulation. To go further, we develop a model of primary healthy melanocytes cultures 
to evaluate the ex vivo potential of these synthetic DNA carriers. The fi rst observation was 
melanocytes were transfectable. Then, as previously observed on cell lines, we demonstrated 
that KLN-47 is much more effi cient than the commercial reagent (KLN-47: 1.2 106 total RLU 
/ mg of total protein vs DOTAP/DOPE: 5.2 105 total RLU / mg of total protein). Finally, we 
transfected a plasmid encoding the HSV/TK in the primary culture. Twenty-four hours later, 
we added some ganciclovir (GCV - 10 μg) and we followed the viability of melanocytes dur-
ing the next 12 following days. Up to 8 days, we mainly observed the toxicity induced by the 
complexes DNA / cationic lipids. Then, 8 and 12 days following GCV addition, we showed 
that the number of viable cells is largely decreased, leading to less than 22% of viable cells 
after transfection with KLN-47. Hence, KLN-47 could be an interesting effi cient gene reagent 
to transfect melanoma cells.
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Filaggrin Mutations in Atopic Dermatitis
Morar N1, Harper JI2, Cookson WO3 and Moffatt MF3
1Dept of Molec Genetics & Chelsea & Westminster Hospital, Imperial College (United Kingdom)
2Great Ormond Street Hospital and Institute of Child Health (United Kingdom)
3Department of Molecular Genetics, Imperial College (United Kingdom)
Atopic dermatitis (AD) results from the interplay between strong genetic and environmental factors. 
Genome screens have identifi ed several chromosomal regions linked to AD. One of these contains 
the epidermal differentiation complex (EDC) on chromosome 1q21. The EDC contains several gene 
families and single copy genes such as FILAGGRIN (FLG) which is expressed late during terminal 
differentiation of the epidermis. Recently, loss of function mutations, R510X and 2282del4 in FLG 
were reported to be strongly associated with AD and with icthyosis vulgaris. We tested these asso-
ciations in a set of families ascertained through probands with severe AD. The 278 nuclear families 
contained 403 children with AD. The children’s mean age was 6.7 years. 55.3% were males and 
57.8% had asthma. Their mean IgE was 521.5 IU/L. Genotyping was performed using a Taqman 
based allelic discrimination assay forR510X and sequencing for 2282del4. Signifi cant associations 
for the single nucleotide polymorphism R510X were seen with AD (T v NT 46 v 19; P= 0.001), doc-
tor diagnosed asthma (DDAST)( T v NT 34 v 16 ; P= 0.011) and atopy (T v NT 50 v 23; P=0.0016) 
using the transmission disequilibrium test (TDT). Weaker associations were seen between 2282del4 
and AD (T v NT 29 v 16; P=0.052), DDAST (T v NT 25 v 12; P= 0.033) and atopy (T v NT 34 v 
19; P=0.039). However, the R510X allele was also transmitted to 28 unaffected children and the 
2282del4 allele to 15 unaffected children, indicating that the mutations were only partially pen-
etrant. Similar levels of transmission distortion have been previously observed with polymorphisms 
in the FCERIß and SPINK5 genes, so that FLG mutations do not represent an exceptional risk for AD. 
Previous genetic mapping studies have shown genetic linkage of EDC markers to AD, but we found 
no evidence of genetic linkage of FLG variants to disease in these families. This suggests that other 
EDC genes will need to be tested systematically for their role in the pathogenesis of AD
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Homozygosity for an Intragenic Deletion in the Gene Encoding Collagen XVII, COL17A1: 
823delA Results in Lethality in a Family with Non-Herlitz Junctional Epidermolysis Bullosa
Pasmooij M1, Jonkman MF1, Pas HH1, Klingberg S2, Pfendner E3, Uitto J3, Collins F4, Widmer 
R5 and Murrell DF6
1Dept Dermatology, UMC Groningen (Netherlands) 2Biochemistry Lab, Royal Brisbane Hospi-
tal (Australia) 3Dept Dermatology, Jefferson Medical College, Philadelphia (USA)
4Dept Genetics, Westmead Hospital, Sydney (Australia) 5Dept Dentistry, Westmead Hospital, 
Sydney (Australia) 6Dept Dermatology, St George Hospital, UNSW, Sydney (Australia)
Background: Two children born to a consanguineous Iraqi couple developed blistering from 
birth. The fi rst had died at age 9 months and the second after 4 weeks, both in hospital. Both 
had widespread erosions but no hoarse cry. The parents and an older son were phenotypically 
normal except that they all had pitting/ridging of their teeth. The father and mother had some 
vertical ridging and pigmentation of their 5th toenails. The type of EB was not known. Methods: 
Skin biopsies of rubbed areas of skin from the parents were processed for IF mapping and electron 
microscopy. The LAMA3, LAMB3, LAMC2, and COL17A1 genes were screened for mutations. 
Keratinocytes were cultured from a skin biopsy for COL17A1 mRNA expression studies and im-
munoblotting of collagen XVII. Prenatal diagnosis was performed from CVS tissue at 10 weeks’ 
gestation. Results: IF mapping identifi ed reduced expression of type XVII collagen (1D1). Muta-
tion analysis of COL17A1 identifi ed the heterozygous presence of a novel COL17A1 mutation 
823delA in both parents and the brother. This mutation causes a frameshift and leads to a pre-
mature termination codon downstream. Digenic mutations in other genes involved in JEB were 
excluded by screening of the LAMA3, LAMB3, LAMC2 and ITGA6 and ITGB4 genes. RT-PCR of 
cultured keratinocytes showed no aberrant mRNA transcripts of the mutated allele. Immunoblot 
revealed only the wild-type type XVII collagen protein. The fetus was a carrier of the COL17A1 
mutation and a normal baby was born whose primary teeth erupted at 12 months and at that 
stage had no enamel defects. Conclusions: Homozygotes for COL17A1 intragenic deletions do 
not usually have a shortened life expectancy. This is the second intragenic deletion in COL17A1 
reported to result in death in infancy. Heterozygous carriers of COL17A1 mutations usually show 
a normal skin phenotype and have no teeth problems, although in a few cases minor dental 
problems have been reported due to missense mutations (G609D, G612R, G627V & G633D) and 
in one instance a PTC mutation, R1226X, in carriers. This study provides further evidence that an 
intragenic COL17A1 deletion may result in lethality in infancy. Furthermore, our data show that 
not only carriers of heterozygous COL17A1 missense mutations may display dental abnormalities 
as mini-symptom, but also carriers of a COL17A1 intragenic deletion. 
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New Therapeutic Approach Targeting T-bet for Alopecia Areata Mouse Model c3h/hej Mice
Nakamura M1, Jo J2, Tabata Y2 and Ishikawa O1
1Department of Dermatology, Gunma University (Japan)
2Department of Biomaterials, Kyoto University (Japan)
Alopecia areata is considered to be triggered by a collapse of immune privilege in hair follicles. 
The immunohistochemical study revealed that infi ltrating lymphocytes around the hair follicles 
of alopecia areata were mostly CD4,CCR5 positive with few CD4,CCR4 positive cells. The fi nd-
ings indicate that Th1 cells are dominant in the alopecic lesion. Moreover, local injection of IL-4 
was effective for alopecia in C3H/HeJ mice, a mouse model for alopecia areata. Semiquantitative 
RT-PCR assay demonstrated that there was signifi cantly higher expression of IFN-γ in an alopecic 
skin than in a non-affected skin. Intralesional injection of IL-4 suppressed the enhanced IFN-γ ex-
pression in the alopecic skin. To elucidate whether or not IFN-γ plays an indispensable role in the 
pathogenesis of alopecia areata, we injected neutralizing antibodies against IFN-γ into C3H/HeJ 
mice. The neutralizing antibodies were signifi cantly more effective for alopecia than control rat 
IgG. T-bet, a transcription factor expressed in Th1 cells, is important for IFN-γ transcription and 
Th1 differentiation. Antisense T-bet oligonucleotide injections restored the hair elongation in alo-
pecia of C3H/HeJ mice more effectively than a control nonsense oligonucleotide. Furthermore, 
T-bet siRNA applications conjugated with gelatin showed restoring effects on alopecia in C3H/
HeJ mice. The diminished T-bet protein expression after the T-bet siRNA injections was confi rmed 
by western blotting. MHC class I and II molecules expression in the follicular epithelium was 
diminished by the T-bet siRNA injections, indicating a restoration of immune privilege. Taken 
together, new drug delivery system for siRNA conjugated with gelatin can be a novel candidate 
for promising therapeutic approaches to various human skin diseases and cancers.
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Associations of Promoter Region Polymorphisms in the TNF-alpha Gene and Juvenile Psoriasis 
Vulgaris
Nedoszytko B1, Szczerkowska-Dobosz A1, Zablotna M1, Glen J1, Rebala K2 and Roszkiewicz J1
1Department of Dermatology, Medical University of Gdansk (Poland)
2Institute of Forensic Medicine, Medical University of Gdansk (Poland)
Exaggerated production of TNF-α may play an important role in the pathogenesis of psoriasis. 
Increased levels of this pro-infl ammatory cytokine have been detected in blood and psoriatic 
lesions of patients with psoriasis vulgaris (PV), whereas anti TNF-α therapy has produced dra-
matic improvements. Since certain allelic variants of TNF-α gene are associated with increased 
or decreased production of the TNF-α, the disturbed cytokine balance may be under genetic 
control. 
In our study we evaluated the frequency of TNF-α –238 G/A and –308 G/A promoter polymor-
phisms in psoriasis vulgaris patients and in healthy controls.
We analyzed 166 patients with psoriasis vulgaris (134 with type I and 32 with type II ) and 65 
healthy controls. The polymorphism -238 G/A and 308 G/A in the promoter region of TNF-α 
gene was typed using ARMS-PCR method. 
We have found that the TNF-α –308A allele frequency was signifi cantly decreased among 
patients with PV with early onset in comparison with control subjects (7.5% vs. 15.4%; p= 
0.022), whereas in the same patients, the frequency of the TNF-α –238 A allele was signifi -
cantly increased as compared with the controls (16.8 % vs. 1 %, p= 0.000017, OR= 8.79 [95% 
CI = 2.606–29.678]). Early onset PV patients with genotype -238 GA or AA were found more 
often among those with age of onset before 25 y in comparison to those with genotype GG 
(31.7% vs. 9.1%, p=0.0312). We also found that the mean age of onset among –238 A carriers 
was signifi cantly lower in comparison to that associated with the –238 GG genotype (13.5 ± 
7.4 vs. 19.2±9.9, p=0.0132)
In conclusion, our study confi rming the association between –238 G/A TNF-α promoter poly-
morphism and psoriasis vulgaris with the early onset in the northern Polish population suggests 
that the variant may contribute not only to a predisposition to psoriasis vulgaris but also to the 
disease phenotype.
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Lack of Association Between Vascular Endothelial Growth Factor Gene Promoter 
Polymorphism and Psoriasis Vulgaris
Zablotna M, Nedoszytko B, Szczerkowska-Dobosz A and Roszkiewicz J
Department of Dermatology, University of Gdansk (Poland)
Neoangiogenesis and abnormalities in microvessels formation, are the prominent feature in the 
histogenesis of psoriatic skin. One of the major factor, which promotes angiogenesis is vascular 
endothelial growth factor (VEGF). Elevated levels of such cytokine are found in plaques of pso-
riasis and in the plasma of erythrodermic patients. VEGF gene is located in 6p21, and several 
single nucleotide polymorphisms in the promotor region have been identifi ed. Recently, substi-
tution of adenine to guanine at the position -1154 of promoter region of VEGF, which enhance 
production in vitro, has been described. 
The aim of our study was to verify the hypothesis that increased synthesis of VEGF observed in 
the psoriatic patients was associated with the presence of high-producer genotype. 
We analyzed 151 patients with psoriasis vulgaris (114 with type I and 32 with type II ) and 
65 healthy controls. The polymorphism -1154 A/G in the promoter region of VEGF was typed 
using ARMS-PCR method. 
In both compared groups the genotype AG (50,3% in psoriasis and 58,5% in the controls), 
and allele T ( 64% in psoriasis and 70% in the control) the most frequently was observed. No 
signifi cant differences in alleles and genotypes frequency between investigated groups were 
observed.
In conclusion, results of our study indicate lack of association between psoriasis and polymor-
phism -1154 A/G in promotor region of VEGF gene.
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Association of Interleukine 13 Promotor Gene Polymorphism with Atopic Dermatitis
Glen J, Nedoszytko B, Jasiel-Walikowska E and Roszkiewicz J
Department of Dermatology, Medical University of Gdansk, (Poland)
Interleukin 13 (IL-13) is a major cytokine involved in IgE synthesis, which increased level are 
obserwed in majority of atopic dermatitis patients. IL-13 gene has been mapped to the cytokine 
cluster on chromosome 5q31-33, which has been associated with atopic conditions. Numer-
ous single-nucleotide polymorphisms (SNP) have been identifi ed in the IL-13 gene and have 
been found to be associated with IgE levels and/or allergic diseases. Recently, polymorphism (C 
to T exchange) at position -1024 of promotor region in IL-13 gene have been described. Some 
reports indicates that this polymorphisms is associated with allergic asthma, altered regulation 
of IL-13 production, and increased binding of nuclear proteins to this region. The aim of this 
study was to analyse the association of IL-13 gene polymorphisms at positions −1024 (C → T) 
with atopic dermatitis. In our study we analyzed 111 patients with atopic dermatitis and 65 
healthy controls. The polymorphism -1024 C/T in the promoter region of IL-13 gene was typed 
using ARMS-PCR method. We have found that -1024 T allele and CT genotypes frequency 
were signifi cantly increased among patients with atopic dermatitis in comparison with control 
subjects (55% vs. 32%; OR, 2,1, p<0,028).
In conclusion, our results indicates that presence of -1024 C/T polymorphism of IL-13 gene 
may predisposes to the development of atopic dermatitis in the northern Polish population.
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Manipulating Transcriptional Control of ECM Homeostasis: A Novel Strategy to Rejuvenate 
Skin
Maloverjan A, Kazantseva A, Liik A, Palm K and Neuman T
FibroTx, LLC (Estonia)
Development of skin wrinkles is related to the defects in the synthesis and assembly of extracel-
lular matrix (ECM). Formation and homeostasis of skin ECM requires coordinated expression 
of fi brillar components, modifying enzymes, proteinases and proteinase inhibitors in dermal 
fi broblasts. Gene expression analysis data clearly show that aging of skin is related to altered 
gene expression of ECM components in fi broblasts. Also, aging results in altered expression of 
components of transcriptional machinery including TAF, GTF2, MED, SWI/SNF and POLII com-
plexes. Both expression level and isoforms of components of transcription complexes is altered 
in aged fi broblasts that translates into functional differences of transcriptional machinery and 
altered expression of target genes. Manipulating transcriptional machinery using activators and 
inhibitors of signaling pathways and molecules that interact with components of transcriptional 
complexes enabled us to modify ECM of dermal fi broblasts and “rejuvenate“ gene expression 
pattern characteristic for old fi broblasts. 
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Filaggrin Mutations in German Patients with Ichthyosis Vulgaris and Concomitant Atopic 
Diseases
Oji V1, Seller N1, Aufenvenne K1, Walker T1, Höwel M1, Schulz P1, Küster W2, Hausser I3 and 
Traupe H1
1Department of Dermatology, University of Muenster (Germany)
2Tomesa Hospital Bad Salzschlirf (Germany)
3Department of Dermatology, University of Heidelberg (Germany)
Ichthyosis vulgaris (IV) has a world-wide occurrence with a prevalence of 1:250-1,000 and can 
be regarded an autosomal dominant cornifi cation disorder with incomplete penetrance. There 
has been biochemical/genetic evidence for ~20 years that the fi laggrin gene (FGL) is the IV 
gene. Only recently a genetic study in the UK demonstrated two causative FGL mutations.
We wanted to know, whether these data can be confi rmed in a German cohort with moderate 
to severe IV (29 individuals of 26 families), and performed a histological and/or ultrastructural 
work-up with a mutation screening for R501X and 2282del4. 15 patients concomitantly suf-
fered from atopic dermatitis (AD), allergic rhinoconjunctivitis or asthma. Genotypes of parents 
and/or other family members were analysed in nine families. Genetic analysis was performed 
making use of the published NlaIII and DraIII restriction enzyme sites.
For R501X 7.7% (n=2), 34.6% (n=9) and 57.7% (n=15) of all index patients (n=26) showed 
an homozygous, heterozygous or negative genotype, respectively. 2282del4 was homozygous 
in 3.9% (n=1) of the cases and heterozygous or absent with the same percentage of 46.2% 
(n=12 each). 10.7% (n=3) of the 26 IV index patients were R504X/2282del4 compound het-
erozygous. 57.7% (n=15) were heterozygous for one of the alleles – either R504X or 2282del4. 
80.8% (n=21) of all index patients showed at least one or two mutation alleles. However, 
four IV patients (15.4%) (two with concomitant AD) did not display any of the mutations. 
Heterozygous parents displayed a less severe IV phenotype than their likewise compound 
heterozygous offspring or were healthy even though their affected offspring carried the same 
heterozygous allele. 
We thus can confi rm that fi laggrin mutations underlie IV and at the same time predispose to 
AD. Future work focussing on the CE formation in IV may therefore provide valuable clues for 
the understanding of atopic diseases.
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Assessing the Complexity of Normal Human Skin – Results of a Comprehensive Gene 
Expression Profi ling Study
Peters B1, Tomiuk S1, Wenzel J2, Mauch C3, Baron JM4, Bieber T2, Krieg T3, Merk H4 and Bosio A1
1MACSmolecular Business Unit, Miltenyi Biotec GmbH (Germany)
2Department of Dermatology, University of Bonn (Germany)
3Department of Dermatology, University of Cologne (Germany)
4Department of Dermatology, University of Aachen (Germany)
In a large-scale study, the feasibility of establishing a microarray-based system for the molecular 
classifi cation of human skin diseases was analysed. A central aim of the study was the identi-
fi cation of disease-specifi c, common gene expression signatures that can eventually be used 
for classifi cation and that are not regulated in a donor- or biopsy-dependent way. To establish 
these signatures, it was important to understand the gene expression pattern of normal skin. For 
this reason, the gene expression of 90 normal human skin biopsies was analysed by microarray 
analysis. Normal skin samples were collected from non-affected skin of skin cancer patients or 
from skin-disease-free donors, while no samples were collected from patients with infl amma-
tory skin diseases. All samples were accompanied by donor-specifi c clinical data as well as a 
haematoxylin-eosin-based histological evaluation of the biopsy. The gene expression profi les of 
the biopsies were established using PIQOR™ Skin Microarrays, followed by a comprehensive 
bioinformatics analysis. Gene expression profi ling revealed a high variability of gene expres-
sion in normal human skin. Cluster analyses revealed the formation of several subgroups of 
donors based on the expression profi les. Correlation of subgroups to clinical data identifi ed 
factors that seemingly infl uenced the gene expression and had led to subgroup formation. Not 
surprisingly, subgroup formation was highly infl uenced e.g. by the biopsy excision site and UV-
exposition. In addition, the clinical data was used to identify gene expression changes that are 
related to collected parameters. In conclusion, normal skin showed a high variability in gene 
expression that has to be taken into account when disease- or treatment-specifi c expression 
changes in the skin are analysed in comparison to normal skin, and when disease-specifi c gene 
expression signatures or marker genes are to be developed.
220
Improved Protocol for Isolation of RNA from Pigmented Skin Lesions after Laser Capture 
Microdissection
Correa R, Abraham S, Jaunin F and Piguet V
Dept of Dermatology & Venereology, Univ Hospital & Med School of Geneva (Switzerland)
Melanoma displays very heterogeneous clinical behaviour. New methods based on the study 
of global gene expression are needed in order to understand the events underlying melanoma 
carcinogenesis. Since skin is an inherently heterogeneous tissue, the purifi cation of pure cell 
populations such as melanocytes using Laser Capture Microdissection is a progress for the 
accurate correlation of a molecular profi le to a particular cell type or histological location. 
However obtaining suffi cient quantities of RNA after Laser Capture Microdissection in the skin 
is a challenge.
A prerequisite to perform gene profi ling studies to identify the molecular events governing 
the transitions between benign nevus and melanoma is to extract high quality RNA from pig-
mented skin lesions, preferably isolating melanocytes from skin. Therefore, we compared and 
tested several protocols designed to extract highly preserved RNA from isolated melanocytes 
from benign nevus, atypical nevus and melanoma after Laser Capture Microdissection (LCM). 
LCM permits the effi cient isolation of melanocytes from histologically prepared samples. We 
are able to obtain high quality RNA from melanocytes from benign and atypical nevus after 
LCM after adjusting conditions, modifying RNA extraction methods as well as times to process 
samples. Test microarrays were successfully performed using RNA after LCM, indicating that 
the quality and quantity of RNA obtained with this procedure is largely adequate to perform 
microarrays. 
RNA isolation after Laser Capture Microdissection in the skin is still an obstacle and our im-
proved method should be applicable to melanocytes as well as other cell types in the skin, 
thereby representing a valuable technique for genetic studies on skin. 
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Mutation Analysis of Patients with Comel-Netherton Syndrome in Hungary
Lepesi-Benko R, Medvecz-Csikos M, Becker K, Sardy M, Bona A, Blazsek A, Sajo R,
Hatvani Zs, Kornsee Z and Karpati S
Department of Dermatology, Semmelweis University, Budapest (Hungary)
The Comèl-Netherton syndrome (MIM256500, CNS) is a rare, severe autosomal recessively 
inherited skin disease. Symptoms of CNS are ichthyosis linearis circumfl exa ILC or congenital 
ichthyosiform erythroderma, trichorrhexis invaginata (TI, bamboo hair) and atopic diathesis. 
The pathognomic changes of TI or the characteristic ILC do not usually manifest before the age 
of 2 years. Mutations in the SPINK5 gene had been identifi ed in the background of the disorder. 
CNS patients from different populations were screened for SPINK5 mutations, and several dis-
ease specifi c mutations or polymorphisms with yet unknown effects have been described. 
Our aim was to analyse Hungarian patients with CNS for mutations in the SPINK5 gene and 
to relate our data to previous genotype - phenotype correlations. Genomic DNA extracts of 3 
Hungarian patients were analysed. Mutation pre-screening was performed with conformation 
sensitive gel electrophoresis (CSGE) and heteroduplex analysis. SPINK5 exons forming heter-
oduplexes with control DNA were submitted to direct sequencing.
All the verifi ed mutations (238insG in exon 4 and 2468delA ) had been previously described in 
international publications. We additionally identifi ed 19 previously described polymorphisms 
in the SPINK5 gene. Identifi ed SPINK5 mutations are of signifi cant clinical value, because a 
defi nitive diagnosis of CNS is usually diffi cult in the fi rst years of life. Detection of SPINK5 
mutations contributes to a correct differential diagnosis. 
222
Comprehensive Diagnostic Analysis of the Filaggrin Gene: Identifi cation of Allelic Size 
Variants and New Recurrent Mutations
Sandilands A1, Smith FJ1, Terron-Kwiatkowski A1, Zhao Y1, Liao H1, O’Regan G2, Irvine AD2 
and McLean WH1
1Human Genetics Unit, University of Dundee (United Kingdom)
2Dept of Paediatric Dermatology, Our Lady’s Children’s Hospital, Dublin (United Kingdom)
Two prevalent mutations in fi laggrin gene (FLG) cause ichthyosis vulgaris (IV) and are a major 
genetic factor in atopic dermatitis (AD) within European populations. The aim of this study was 
to devise a mutation detection strategy for the entire gene to identify mutations in all ethnic 
groups worldwide. Exon 3 of the profi laggrin gene contains multiple fi laggrin repeat units 
arranged in tandem. These highly repetitive DNA sequences make PCR amplifi cation and di-
agnostic re-sequencing of this gene problematic. Furthermore, the number of repeats has been 
shown to vary from 10-12 in the population. By designing repeat-specifi c primers we were able 
to develop a range of overlapping PCR fragments each of which spans several fi laggrin repeats. 
Using this methodology we have identifi ed four distinct allelic size variants where there is du-
plication of one or more fi laggrin repeats near the 3’ end of exon 3. We also used our strategy to 
analyse the FLG gene from two unrelated individuals with IV, both of whom already carried one 
of the common mutations (R501X or 2282del4) but whose severe IV phenotype suggested the 
existence of another mutation. Sequencing of PCR products from these individuals identifi ed 
two new mutations: a C>T transition at position 7339 (R2447X) and a C>T transition at posi-
tion 9740 (S3247X). These mutations give rise to premature termination codons within repeats 
7 and 9, respectively, which are predicted to result in expression of truncated profi laggrin. Both 
mutations were present in several unrelated IV families and are carried by <1% of the European 
population. Our strategy currently permits routine sequencing of ~90% of the FLG gene, allow-
ing the identifi cation of IV- and AD-related mutations in all human populations.
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Filaggrin Mutations in Ichthyosis Vulgaris
Gruber R1, Terron-Kwiatkowski A2, Sandilands A2, Utermann G3, Fritsch F1, Janecke A3, McLean I2 
and Schmuth M1
1Department of Dermatology, Innsbruck Medical University (Austria)
2Human Genetics Unit, Div of Pathology & Neuroscience, Univ of Dundee (United Kingdom)
3Department of Medical Genetics, Innsbruck Medical University (Austria)
Ichthyosis vulgaris (IV) is the most common hereditary disorder of cornifi cation in humans, 
characterized by generalized fi ne scaling of the skin associated with palmar hyperlinearity 
and atopy. Recently, the molecular basis of IV was ascribed to loss-of-function mutations in 
the gene encoding fi laggrin (FLG), namely p.R501X and c.2282del4 in the fi rst of the 10-12 
fi laggrin repeats encoded by this gene. We here confi rm the presence of these FLG mutations 
in 15 of 21 IV patients, including a four-generation family comprising 8 affected individuals 
that exhibited heterozygosity for p.R501X or c.2282del4 despite marked disease expression. 
An extended search for additional mutations in the distal portions of exon 3 of the FLG gene, 
uncovered compound heterozygosity due to R2447X in fi laggrin repeat 7 in 3 of the family 
members. Notably, two asymptomatic members of this four-generation family were p.R501X 
heterozygotes. Moreover, compound heterozygosity due to a 2 bp deletion in fi laggrin repeat 6, 
6867delAG, was present in an isolated case of severe IV who interestingly, had a histologically 
apparent stratum granulosum. Taken together, these novel FLG mutations confi rm that FLG is a 
major IV gene and point to the existence of modifi ers of the disease.
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Filaggrin Mutation is not a Genetic Risk Factor for Atopic Dermatitis in the Bangladeshi 
Population
Sinclair C1, O’Toole E1, Leigh I1, Paige D2, Elbashir H3, Stevens H4, Booy R5, Mein C6 and 
Kelsell DP1
1Centre for Cutaneous Research, ICMS, Queen Mary, University of London (United Kingdom)
2Departments of Dermatology, Barts and the London NHS Trust (United Kingdom)
3Development Centre, St Ann’s Hospital, London (United Kingdom)
4Department of Dermatology, Barnet General Hospital, Hertfordshire (United Kingdom)
5Centre for Child Health, Barts and the London NHS Trust (United Kingdom)
6Genome Centre, Queen Mary, University of London (United Kingdom)
Atopic Dermatitis (AD) is a common skin disease of childhood and, like many common com-
plex disorders it has a multi-factorial genetic component. Recently mutations in a gene encod-
ing the protein fi laggrin have been reported to cause Ichthyosis Vulgaris (IV) and be a major pre-
disposing factor for AD. These studies were done in a predominantly white Northern European 
population. Here we investigated the link with AD and fi laggrin in an Asian population residing 
in the UK. We have carried out a genetic investigation into the Bangladeshi population of East 
London in 80 families with 2 or more siblings with AD. Polymorphic DNA markers fl anking the 
fi laggrin gene in addition to known fi laggrin mutations were genotyped in these families. The 
results were analysed by non-parametric analysis as to whether specifi c alleles are shared in 
excess among affected family members. No evidence for linkage with AD to 1q21 was identi-
fi ed. A LOD score of 0 was found in the Bangladeshi families with AD suggesting no linkage 
between AD and FLG. Allele segregation analysis within families indicated no co-segregation 
of AD with specifi c alleles of D1S498. Even though the known fi laggrin mutations are present 
within this population, they are very rare. R501X had an allele frequency of 0.011 with no 
homozygotes, whereas 2282del4 had an allele frequency of 0.042 with four homozygotes for 
this mutation. In addition, 5 SNPs selected showed no association in the Bangladeshi popula-
tion with either affected status or total serum IgE level. The results indicate that fi laggrin is not 
the major predisposing gene for AD in the Bangladeshi population. We are now carrying out a 
major 40 candidate gene scan to try and identify genes which have a genetic effect in AD.
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Matrix Metalloproteinase-21 is Induced by Activin A and Retinoic Acid in HaCaT 
Keratinocytes
Skoog T1, Tiala I2, Jeskanen L3, Elomaa O2 and Saarialho-Kere U1
1Department of Dermatology, Karolinska Institutet, Stockholm Söder Hospital (Sweden)
2Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki (Finland)
3Department of Pathology, Helsinki University Central Hospital (Finland)
Human matrix metalloproteinase-21 (MMP-21) is the newest member of the MMP enzyme 
family, recently cloned by our group. It has been implicated in embryogenesis, tumor progres-
sion and apoptosis, being expressed by developing skin and invasive tumor cells of basal and 
squamous cell cancers. Furthermore, also neutrophils, fi broblasts and macrophages can pro-
duce MMP-21 in certain skin disorders. We have earlier shown, that MMP-21 mRNA is induced 
by TGF-β1 in HaCaT cells. In this work, we have further characterized the biology on MMP-21 
both on tissue level and in HaCaT cell cultures using TaqMan real-time PCR. In HaCaT cells 
retinoic acid (RA, 10-6M) induced MMP-21 expression, a phenomenon previously detected 
also in U937 monocytic cells. As MMP-21 may play role in embryogenesis and has been found 
in placenta and several hormone-related cancers, we wanted to see if its expression is hormo-
nally regulated: neither estrogen, progesterone, testosterone, thyronine nor insulin infl uenced 
expression of this gene. Activin A (18 ng/ml), a member of the TGF-β superfamily, upregulated 
MMP-21 mRNA expression. 1α,25-dihydroxyvitamin D3 (10-7M) and staurosporine (25 nM), 
two agents able to induce apoptosis in keratinocytes, induced expression of MMP-21 in HaCaT 
cells. However, apoptotic keratinocytes in graft-versus-host and SLE samples did not stain for 
MMP-21. Anisomycin, an activator of MAPK-pathways, had no effect on MMP-21 expression, 
while the tumor promoter okadaic acid (30 ng/ml) downregulated MMP-21 mRNA expression. 
Our tissue data indicate that MMP-21 expression is not only related to tumorigenesis, as supra-
basal keratinocytes in lichen planus, actinic keratoses, Bowen’s disease and keratoacanthoma 
occasionally express MMP-21. However, in vivo mere migration, proliferation or acantholysis 
of keratinocytes are not enough to induce this protein. In summary, TGF-β1 and related factors 
seem to be important in the regulation of MMP-21 expression in HaCaT cells.
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Polymorphisms in the PTPN22 Region are Associated with Psoriasis of Early Onset
Smith RL1, Warren RB2, Eyre S1, Young HS2, Griffi ths CE2 and Worthington J1
1ARC Epidemiology Unit, University of Manchester (United Kingdom)
2The Dermatology Centre, University of Manchester (United Kingdom)
T-cell recruitment and activation at the site of new psoriasis lesions are considered to be of 
primary importance in the pathogenesis of the disease. A functional polymorphism (R620W) in 
the haematopoietic-specifi c protein tyrosine phosphatase (PTPN22) gene, a negative regulator 
of T-cell activity, is associated with a number of autoimmune diseases including rheumatoid ar-
thritis and Type I diabetes but not psoriasis. The purpose of this study was to investigate further 
the role of the PTPN22 gene region in susceptibility to chronic plaque psoriasis of onset on or 
before age 40yr (Type I psoriasis). 
Using Sequenom MassArray technology we genotyped 13 single nucleotide polymorphisms 
(SNPs), including R620W, in the PTPN22 region in 647 unrelated Type I psoriasis patients and 
566 population based controls. 
Two SNPs demonstrated signifi cant association with Type I psoriasis: - SNP rs1217414, which 
resides in intron 1 of PTPN22, conferred risk by carriage of two copies of the minor allele with 
OR = 2.39 (95% CI 1.43 - 4.11, p=0.0005); and - SNP rs3789604, located downstream of the 
gene- under a dominant model for the major allele (OR = 1.43; 95% CI 1.13-1.80, p = 0.0017). 
The rs2476601 (R620W) SNP showed no evidence of association with Type I psoriasis (p=0.67) 
susceptibility, thereby replicating existing literature. 
This study suggests that association does exist between Type I psoriasis and 2 SNPs in the 
region of the PTPN22 gene. SNP rs1217414 has not been identifi ed previously as associated 
with antibody-associated autoimmune diseases and its exact function is unknown. rs3789604, 
located in a predicted transcription factor binding site, has been associated with rheumatoid 
arthritis but only when independent of R620W. Further investigation and replication is required 
in other psoriasis cohorts as well as other autoimmune diseases un-associated with the R620W 
polymorphism. 
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Oculocutaneous Albinism Type 4: Three Novel Mutations in the MATP Gene and their 
Genotype-Phenotype Correlation
Suzuki T1, Inagaki K1, Ito S1, Suzuki N1, Adachi K2, Oono T3 and Tomita Y1
1Department of Dermatology, Nagoya University Graduate School of Medicine (Japan)
2Department of Dermatology, Tottori University Faculty of Medicine (Japan)
3Department of Dermatology, Okayama University Graduate School of Medicine (Japan)
Oculocutaneous albinism (OCA) is a group of autosomal recessive hypopigmentary disorders 
of the skin, hair and eyes. OCA is classifi ed into 4 types according to 4 different responsible 
genes. OCA4, one of the 4 types, is caused by mutations in the Membrane-Associated Trans-
porter Protein (MATP) gene. The human MATP protein is a 530-amino-acid polypeptide that 
contains 12 putative transmembrane domains, and appears to be a transporter that mediates 
melanin synthesis. Clinical phenotypes of OCA4 vary from complete absence to some pig-
mentation with brown hair and irides, and some patients showed improvement during the 
fi rst decade of life. Eighteen different mutations in Turkish, German, Korean and Japanese pa-
tients with OCA4 have been reported so far. Additionally, we reported 3 novel mutations, 
p.Y49C, p.T440A, and p.G473D, detected in 3 patients at the 35th ESDR last year. Here, we 
report different 3 novel mutations, p.G89R (c.265G>A), p.C229Y (c.686G>A), and p.T437A 
(c.1309A>G), recently found in 5 Japanese patients with various clinical phenotypes. All of 
these 8 patients were classifi ed into three categories of severe, moderate, and mild phenotypes 
according to the presence of nystagmus and the degree of their hair and iris pigmentation. 
Furthermore, their genotype-phenotype correlations were examined. The phenotypes of OCA4 
were as various as the other types of OCA and depended on the mutation site in the MATP 
gene. Each of the 6 mutated alleles could be conjectured to have no function, little activity, or 
some activity in melanogenesis according to the patient’s phenotypes.
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Studying the Role and the Expression of β-Defensins in Human Keratinocytes
Szabó K, Nagy I and Kemeny L
Department of Dermatology and Allergology, University of Szeged (Hungary)
In our laboratory we use an in vitro model system to study the interaction of the skin commen-
sal Propionibacterium acnes (P. acnes) and human primary keratinocytes. Epidermal keratino-
cytes secrete several factors playing an important role in cutaneous defence, e.g.members of 
the β-defensin family that are very effective against various offending microorganisms. In order 
to have a better understanding the exact role of the different defensins in host defence, we 
are using the in vitro keratinocyte model to analyze the expression of these genes in cultured 
keratinocytes and in skin samples.
We have shown that the gene expression level of DEFB4 (hBD2) increases in keratinocytes 
when they are treated with various P. acnes clinical isolates. This is followed by increased 
protein expression too. DEFB4 protein, however, does not seem to have a signifi cant effect on 
the viability of the bacteria, but might play an important role in the initiation and regulation of 
the adaptive immune responses.
Many new members of the β-defensin family has been predicted based on conserved structural 
properties using in silico computational methods recently, but their pattern of expression and 
exact function has not been investigated in detail. In order to study the function of these newly 
predicted defensin genes we are currently analyzing their expression in keratinocytes and in 
skin samples, and also whether their expression is changing in response to P. acnes treatment.
P. acnes have been shown to play an important role in the etiology of acne vulgaris. By study-
ing the host pathogen interactions and the role of the different β-defensin family members in 
host defence might help to fi nd proteins with natural antibacterial properties that could be 
used to treat acne.
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HLA-C Locus Alleles Distribution in Patients from Northern Poland with Late Onset Psoriasis
Szczerkowska Dobosz A1, Niespodzianka K2, Rebala K2, Gastecka J3, Nedoszytko B1, Baranska 
Rybak V1 and Sobjanek M1
1Department of Dermatology, Medical University, Gdansk (Poland)
2Department of Forensic Medicine, Medical University, Gdansk (Poland)
3Dermatology Department, Mikolaj Kopernik Hospital, Gdansk (Poland)
Data from different cohorts have indicated the Cw*06 allele to be the most signifi cant marker 
for psoriasis risk, especially of the early-onset type. Late onset psoriasis, which represent vast 
minority of psoriatic population demonstrates only week association with Cw*06 and other 
candidate genes of PSORS-1, suggesting that this type of psoriasis may represent a distinct 
entity, different from the early onset psoriasis. 
The aim of the study was to compare the frequency of human leukocyte antigen – C (HLA-C) 
locus alleles in patients with late type psoriasis and in healthy controls in the same ethnic group 
in Poland. HLA-C locus alleles of 89 patients with psoriasis with onset after 40 y of age and 80 
controls were determined by a polymerase chain reaction (PCR) low-resolution method. The 
differences between HLA-C alleles frequencies in the populations were assessed using χ2 test 
with Yates’s correction. 
There was no signifi cant difference in the frequency of carriage of HLA-C locus alleles in popu-
lation of patients with late onset psoriasis and in control population. 
Our results confi rm no association between HLA-C alleles and late onset psoriasis in the north-
ern Poland population. The lack of this association may support the thesis of different genetic 
basis of early and late psoriasis.
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Functional Analysis of a Psoriasis Susceptibility Related Non-Coding RNA Gene, PRINS by 
Gene Specifi c Silencing and cDNA Microarray
Szegedi K1, Sonkoly E1, Nagy N1, Bata-Csörgo Zs1, Kemény L1, Dobozy A1 and Széll M2
1Department of Dermatology and Allergology, University of Szeged (Hungary)
2Dermatological Research Group, Hungarian Academy of Sciences (Hungary)
Expression of the non-coding RNA gene PRINS (Psoriasis Susceptibility-Related RNA Gene 
Induced by Stress) identifi ed and characterized by our working group suggests a role for PRINS 
in psoriasis susceptibility and in cellular stress response. We addressed the question whether 
PRINS has any functional role in cellular stress response. To this end, we silenced the expres-
sion of PRINS in HeLa cells using a vector-based RNA interference method to see whether 
silencing of the gene affects the viability of the transfected cells and/or the expression of other 
genes. According to our results, the silencing of PRINS diminished the viability of HeLa cells 
upon serum starvation suggesting a protective role for PRINS in cells exposed to stress. In-
terestingly, while examining the morphology of cells, we observed that PRINS depletion by 
RNA interference results in altered cell morphology: HeLa cells transfected with PRINS siRNA 
showed an elongated, spindle-like morphology and formed less colonies as compared to con-
trol HeLa cell cultures. In order to reveal gene expression changes causing these morphological 
changes, we have performed a cDNA microarray experiment. 66 transcripts were differentially 
expressed in the PRINS siRNA transfected cells compared to control HeLa cells: 24 genes were 
down-regulated and 42 were up-regulated. Gene expression differences were validated by real 
time RT-PCR, than the expression of the validated genes was compared in healthy, psoriatic un-
involved and involved epidermis. Our current investigations focus on transcripts that showed 
notable differences in psoriatic samples: we hypothesize that they might play a role in psoriasis 
susceptibility and/or development of psoriatic lesions.
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Integrated Genomic Analysis Classify CD4+CD56+ Hematodermic Neoplasm and Cutaneous 
Myelomonocytic Leukemia as Distinct Disease Entities and Reveal Novel Diagnostic and 
Therapeutic Targets
Dijkman R1, van Doorn R1, Szuhai K2, Willemze R1, Vermeer MH1 and Tensen CP1
1Department of Dermatology, LUMC (Netherlands)
2Department of Mol. Cell. Biology, LUMC (Netherlands)
CD4+CD56+ hematodermic neoplasm (CD4+CD56+HN) is an aggressive hematopoietic 
malignancy with distinct clinicopathologic and immunophenotypical features that commonly 
involves the skin, bone marrow and blood. Differentiation from cutaneous myelomonocytic 
leukemia (c-AML) may be exceedingly diffi cult and requires extensive phenotyping. 
The molecular mechanisms involved in the development of CD4+CD56+HN are largely un-
resolved. Moreover, recurrent chromosomal alterations have not yet been precisely defi ned in 
CD4+CD56+HN and c-AML. 
In the present study an integrated genomic analysis using expression profi ling and array-based 
CGH was performed on lesional skin biopsy samples of patients with CD4+CD56+HN and 
c-AML. 
Our results demonstrate that CD4+CD56+HN and c-AML show distinct gene expression pro-
fi les and distinct patterns of chromosomal aberrations. CD4+CD56+HN is characterized by 
recurrent deletion of regions on chromosome 4 (4q34), chromosome 9 (9p13-p11 and 9q12-
q34) and chromosome 13 (13q12-q31), that contain several tumor suppressor genes with di-
minished expression (Rb1, LATS2). Elevated expression of the oncogenes HES6, RUNX2 and 
FLT3 was found, but was not associated with genomic amplifi cation. We noted high expres-
sion of various plasmacytoid dendritic cell (pDC)-related genes, pointing to the cell of origin 
of this malignancy. The membrane-bound sialoadhesin SIGLEC6 was selectively expressed in 
CD4+CD56+HN and may represent a novel diagnostic and therapeutic target. 
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Harmless Selection of Genetically Manipulated Human Keratinocytes
Bergoglio V, Del Rio M, Larcher F, Chevallier-Lagente O and Magnaldo T
CNRS FRE 29 39, Institut Gustave Roussy (France)
Primary epidermal keratinocyte can readily be grown under apropriate culture conditions 
and submitted to corrective gene transfer after retroviral infection. Prospects for ex vivo gene 
therapy of monogenic and recessively inherited genodermatoses have thus been encouraged. 
As for severe burns, epithelial sheets generated from genetically corrected keratinocytes can be 
produced and grafted onto candidate patients. A major challenge is the selection of transduced 
epidermal keratinocytes in a manner compatible with graft perspectives. We have set up a 
selection system which aims at: i-preserving growth and differentiation potentials of transduced 
keratinocytes, ii-reduce the risk of immune response in grafted patients, iii-maintain sustained 
expression of the corrective gene. In this system, selection is based on ectopic expression of 
the small cell surface marker CD24 in proliferative keratinocytes. In human epidermis, CD24 is 
normally expressed in post mitotic, differentiated keratinocytes. Several primary strains of nor-
mal keratinocytes could be successfully transduced using a CD24-IRES-GFP MoMLV retroviral 
viral vector. CD24-selected cells could be passaged serially over more than one year, attesting 
the conservation of stem cell growth potential. Reconstruction of organotypic skin cultures 
using transduced cells, indicated normal differentiation and proliferation capacity, as shown 
by the normal amount and distribution of markers such as Ki67, Laminin 5, beta-1 Integrin, 
Keratins, Loricrin, Filaggrin. Transduced cells could be grafted onto the nu/nu athymic mouse 
and demonstrated their ability to regenerate a full thickness, normally differentiated epidermis, 
over a period of 20 weeks. Under these circumstances, expression of the GFP reporter gene 
was maintained without attenuation. The encouraging results strongly stimulate our prospects 
of genetic correction of epidermal keratinocytes from patients suffering from the DNA repair 
defi cient / cancer prone disease, xeroderma pigmentosum. Our progresses could also be ap-
plied to other genodermatoses candidate for ex vivo cutaneous gene therapy. 
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Genetic Mechanisms of ABCA12 Mutation in Harlequin Ichthyosis
Thomas A, Cullup T, Sinclair C, Mein C, O’Toole E and Kelsell D
Queen Mary, University of London (United Kingdom)
Harlequin ichthyosis (HI) is the most severe form of recessive congenital ichthyosis. Infants 
born with this autosomal recessive skin condition have hard, thick skin covering most of their 
body as well as distortion of the lips, eyelids, ears and nose. Due to the impaired barrier func-
tion of the skin neonates struggle to control water loss, regulate temperature and are more sus-
ceptible to infection. Previously, we have shown that mutations in the ABCA12 [(ATP)-binding 
cassette transporter gene underlie the skin disease HI. To date, we have analysed 36 HI patients 
for mutations in this gene. Sequencing of the ABCA12 gene has greatly aided pre-natal diagno-
sis for families with a history of HI. However due to the wide variety in the type and location 
of mutations found often all 53 exons need to be sequenced. An additional complexity arises 
when no mutations are detected in a patient that is clearly confi rmed as HI. In many cases there 
is no tissue available for immunohistochemical analysis of ABCA12 protein. For this reason we 
have devised 2 molecular methods to look for complex heterozygous deletions which cannot 
be detected via standard sequencing, namely CGH oligo-array and multiplex PCR followed by 
non-denaturing HPLC. These methods have not only detected heterozygous deletions in two 
patients but have also uncovered multiple complex duplications in two parental samples. We 
are also manipulating ABCA12 expression in 3D in vitro skin models towards understanding 
the mechanism in which loss of ABCA12 expression can cause such a devastating effect on the 
epidermis. It is now possible to carry out pre-natal testing in families with a history of HI. The 
discovery of more complex mutations has shown the need to look beyond standard sequencing 
when offering such testing.
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The CCHCR1 Gene is Relevant for Skin Steroidogenesis: Possible Involvement in Psoriasis?
Tiala I1, Suomela S2, Ikonen E3, Kere J4, Saarialho-Kere U2 and Elomaa O1
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The CCHCR1 gene (earlier name: HCR) is a plausible psoriasis candidate gene due to its ge-
nomic location in PSORS1, psoriasis associated allele (HCR*WWCC) in different populations, 
and different expression pattern in psoriatic and healthy skin. Overexpression of the human 
CCHCR1 risk allele in mouse skin resulted in altered mRNA expression profi les of several 
genes relevant in psoriasis. CCHCR1 has been shown to interact with the steroidogenic acute 
regulatory protein (StAR), which plays a key role in the transport of cholesterol from the outer 
mitochondrial membrane to the inner membrane where P450scc resides. P450scc may also 
metabolize vitamin D3 and its precursor localizing in basal epidermal keratinocytes, which, in 
turn, are capable of producing the active form of vitamin D and bear vitamin D receptor (VDR). 
In skin, steroid hormones are required for epidermal barrier homeostasis, differentiation, cell 
proliferation, and modulation of immune response, all processes altered in psoriasis as well. 
We hypothetized that abnormal cholesterol/steroid metabolism might be an essential underly-
ing defect in psoriasis and investigated the role of CCHCR1 in cutaneous steroidogenesis. 
Expression of CCHCR1 and StAR overlapped partially in psoriatic and healthy epidermis by im-
munohistochemistry. In a steroidogenesis assay, CCHCR1 risk protein was functional, enhanc-
ing pregnenolone production. Both VDR and CCHCR1 expression were altered in non-lesional 
keratinocytes as shown by quantitative PCR. Also in transgenic CCHCR1 mice, the expression 
of VDR showed dysregulation by Affymetrix and Taqman assays. We showed also that factors 
relevant to the regulation of steroidogenesis infl uence CCHCR1 expression in keratinocytes. 
We conclude that CCHCR1 might be involved in steroidogenesis in the skin, possibly contrib-
uting to the formation of psoriatic lesions.
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Identifi cation of 3500 Genes Expressed by the Human Granular Keratinocyte
Toulza E, Mattiuzzo N, Galliano F, Jonca N, Serre G and Guerrin M
Epidermal Differentiation & Rheumatoid Autoimmunity, UMR 5165 CNRS-Toulouse III
University (France)
Investigation of the late transcriptional events taking place in the course of epidermis terminal 
differentiation is critical to the comprehension of cornifi cation and barrier function. Transcrip-
tome analysis of granular keratinocytes is the fi rst step towards such goals. 
We isolated four cell populations, from the basal to the most superfi cial epidermal layers, by re-
peated trypsin incubations of human epidermis fragments. The analysis of BPAG2 (specifi cally 
expressed in the basal layer) and SCCE (specifi cally expressed in the granular layer) mRNA by 
quantitative RT-PCR in each cell batch, and comparison with the level of these genes in the 
entire epidermis, confi rmed the progressive enrichment in granular keratinocytes. Starting with 
mRNA extracted from the most superfi cial layers, we produced EST minilibraries using a PCR-
derived method. 20000 sequences were clustered with public databases to produce an index 
of approximately 3500 genes that includes 100 genes encoding hypothetical proteins. Among 
these genes, Dermokine and A2ML1, a new protease inhibitor, have already been character-
ized further on in the laboratory. We showed also specifi c granular keratinocyte expression for 
dozen of potential protein-coding genes. As an example, we identifi ed a new gene, completely 
unknown, in the Epidermal Differentiation Complex on 1q21, which actually corresponds to 
a new member of the LCE (Late Cornifi ed Envelope) family and may represent a new marker 
of cornifi cation. 
A complete analysis of expression of this set of genes in the course of epidermis differentiation 
will allow us to distinguish the genes expressed in all epidermis layers that might correspond to 
housekeeping genes, from the late expressed genes that are likely to encode proteins candidate 
for being involved in barrier function. The EST generated in this work will provide a compre-
hensive resource for genes functioning in establishment of the epidermis barrier function.
236
Keratin 1 Gene Mutation Leads to Epidermal Nevus with Epidermolytic Hyperkeratosis
Tsubota A, Akiyama M, Sakai K, Nomura Y, Abe M and Shimizu H
Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
Epidermal nevus with epidermolytic hyperkeratosis (EH) is a rare subgroup of epidermal nevi 
showing characteristic granular degeneration. It had been hypothesized that mutations in kera-
tin 1 (K1) and keratin 10 (K10) genes underlie epidermal nevus with EH as is the case with bul-
lous congenital ichtyosiform erythroderma (BCIE). However, no case of K1 mutation that leads 
to epidermal nevus with EH has been reported, although 4 cases of epidermal nevus with EH 
caused by K10 gene mutations have been reported. We detected a K1 mutation in epidermal 
nevus with EH of a ten-year-old Japanese boy. His clinical features were well-demarcated ver-
rucous, hyperkeratotic plaques mainly on the trunk, covering 15 % of the entire body surface. 
They distributed along the lines of Blaschko. No hyperkeratosis was seen on the palms and 
soles. The other family members including his parents and elder brother had neither BCIE nor 
epidermal nevus. Histologically, the lesional skin showed typical granular degeneration with 
large keratohyalin granules in the upper epidermis. Electron microscopic observation showed 
clumped keratin fi laments in the upper epidermal keratinocytes. Direct sequence analysis of 
genomic DNA extracted from lesional skin revealed heterozygous 5’ donor splice site muta-
tion IVS1+2T>A in K1 gene. This mutation was not detected in genomic DNA samples form 
patient’s peripheral leukocytes or those of other family members. No other mutation was found 
in entire exons and exon/intron borders of K1 and K10 genes. The splice mutation IVS1+2T>A 
was previously reported to lead to a 22 amino acid deletion in the H1 and 1A domains of K1, 
resulting in palmoplantar keratoderma (PPK) and mild ichthyosis. The present patient, a mosaic 
of the PPK and mild ichthyosis, is the fi rst reported case of epidermal nevus with EH caused 
by a K1 gene mutation.
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Type I Interferon Innate Response to Adenoviral Vector Plays a Role in Regression of 
Cutaneous Lymphoma Lesions Treated with Adenovirus-Mediated IFN-γ Gene Delivery
Urosevic M1, Calmels B2, Laine E1, Fujii K1, Acres B2 and Dummer R1
1Department of Dermatology, University Hospital Zurich (Switzerland)
2Transgene SA (France)
Adenoviral vectors belong to commonly used gene delivery systems, particularly where tran-
sient expression of the delivered gene is required, as in cytokine gene therapy. 
Gene transfer strategies have long overlooked the fact that adenoviral vectors also activate in-
nate immunity and thus induce type I interferons (IFNs), such as IFN-α and β. Broad effects of 
type I IFNs infl uencing different steps of human immune response are believed to be crucial in 
mounting effi cient antiviral and antitumor immunity. Looking at gene expression profi les (Af-
fymetrix™) of 19 cutaneous lymphoma patients before and after treatment with an adenoviral 
vector encoding for human IFN-γ gene (TG1042), we observed a very distinct IFN-signature 
in treated lesions containing, in addition to IFN-γ (type II IFN)-inducible, numerous type I 
IFN-stimulated genes (ISGs). Additional in vitro experiments with an empty adenoviral vector 
(TG-adeno-null) versus TG1042 revealed that this IFN-signature is vector dependent and that 
its magnitude and complexity, in terms of immune activation, is potentiated by the IFN-γ gene 
insert. Mounting of combined type I/II IFN response to the TG1042 vector in the treated lesions 
of cutaneous lymphoma patients may be important for this type of treatment. The display of 
combined type I/II IFN-signature in the treated lesions is associated with objective (measurable) 
clinical response later in the course of the treatment. Biological effects of type I IFNs seem to 
enhance those set in motion by the transgene, in our case IFN-γ. It is conceivable that com-
bined effects of transgene expression and the innately induced type I IFNs are of therapeutic 
importance in cytokine gene delivery using adenoviruses.
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Birt-Hogg-Dubé, an Under-Recognized Cancer Syndrome
van Geel M, Verstraeten V, Frank J, Bladergroen R, Steijlen P and van Steensel M
Department of Dermatology, University Hospital Maastricht (Netherlands)
Birt-Hogg-Dubé (BHD) is an autosomal dominantly inherited cancer syndrome characterized 
by fi brofolliculomas, lung cysts leading to pneumothorax, and chromophobic/oncocytic renal 
cell carcinoma. Fibrofolliculomas, which are benign skin-colored papules occurring usually in 
the second to third decade of life, may be the fi rst signs of the disease and can often be misdiag-
nosed as acne. Histological evaluation of a papule is necessary to confi rm BHD syndrome and 
consequently makes precautious clinical screening needed to detect possible malignancies. 
The disease is caused by heterozygous mutations in the BHD gene encoding folliculin and all 
mutations reported putatively lead to protein truncation. Although the function of folliculin is 
unknown, it is thought to be a tumour suppressor, with loss of heterozygosity (LOH) initiating 
tumour formation.
Here, we report on four novel BHD gene mutations, including two splice-site mutations, in 
patients presenting with skin lesions only. We further show that LOH can not be detected in fi -
brofolliculomas from three patients, suggesting that for the manifestation of cutaneous tumours 
in BHD syndrome haplo-insuffi ciency of folliculin is suffi cient to initiate uncontrolled growth. 
Whether this applies to renal carcinogenesis, too, remains unclear.
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Novel and Prevalent Filaggrin Mutations Causing Ichthyosis Vulgaris in The Netherlands
van Geel M2, Terron-Kwiatkowski A1, Sandilands A1, Smith FJ1, van Steensel MA2 and McLean WH1
1Human Genetics Unit, University of Dundee (United Kingdom)
2Department of Dermatology, University Hospital Maastricht (Netherlands)
The aim of this study was to determine the spectrum of fi laggrin (FLG) mutations in the Dutch 
population causing ichthyosis vulgaris (IV). The 400 kDa polyprotein profi laggrin is the major 
protein of keratohyalin granules and its proteolytically processed end-product, fi laggrin, is es-
sential for formation of the stratum corneum and skin barrier function. Prevalent loss-of-expres-
sion mutations in FLG were recently shown to cause IV and predispose to atopic dermatitis 
(AD) in European populations. Here we analysed the FLG gene in several Dutch families with 
IV and found that mildly affected patients were heterozygous for the previously reported muta-
tions R501X or 2282del4, whereas severely affected individuals were homozygous for either 
mutation, consistent with the suggested semidominant inheritance model. Interestingly, three 
individuals with the marked IV presentation were found to be heterozygous for R501X or 
2282del4. Further sequencing in these cases revealed three novel compound heterozygous 
mutations: E2422X and 7267delCA, both at the end of fi laggrin repeat 6; and 11033del4 in 
fi laggrin repeat 10. All of the novel mutations lead to premature termination codons within 
exon 3 of the FLG gene. Immunohistochemical and biochemical analysis suggested that al-
though these more distal mutations allow synthesis of several fi laggrin repeats, they disrupt 
profi laggrin processing and therefore act as null-alleles. This strongly suggests that sequences 
near the C-terminus of profi laggrin are required for correct processing to occur. These data 
confi rm the role of the FLG gene in IV and suggest that other family-specifi c or population-
specifi c mutations should be sought in IV. These FLG defects are also likely to contribute to 
the genetic basis of AD.
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Compound Heterozygosity for Mutations in LMNA Causes a Progeria Syndrome without 
Prelamin A Accumulation
Verstraeten V3, Broers J1, van Steensel M3, Zinn-Justin S2, Ramaekers F1, Steijlen P3, Smeets H4, 
Hennekam R5, Marcelis C6 and van den Wijngaard A4
1Department of Cell Biology, University of Maastricht (Netherlands)
2Département d’Ingénierie et d’Etudes des Protéines, CEA Saclay (France)
3Department of Dermatology, University Hospital Maastricht (Netherlands)
4Department of Clinical Genetics, University Hospital Maastricht (Netherlands)
5Department of Pediatrics, Academic Medical Center, Univeristy of Amsterdam (Netherlands)
6Dept of Clinical Genetics, Radboud University Nijmegen Medical Centre (Netherlands)
LMNA-associated progeroid syndromes have been reported with both recessive and dominant 
inheritance. We report a two-year-old boy with an apparently typical Hutchinson-Gilford pro-
geria syndrome (HGPS) due to compound heterozygous missense mutations (p.T528M and 
p.M540T) in LMNA. 
Because of the specifi c phenotype and the interesting mutation constellation, we studied pa-
tient fi broblasts for nuclear abnormalities and evaluated the effect of farnesylation inhibition.
Both mutations affect a conserved region within the C-terminal globular domain of A-type lam-
ins, defi ning a progeria hot spot. The nuclei of the patient showed no prelamin A accumulation. 
In general, the nuclear phenotype did not correspond to that previously described for HGPS. 
Instead, honeycomb fi gures predominated and nuclear blebs with reduced/absent expression 
of B-type lamins could be detected. The healthy heterozygous parents showed similar nuclear 
changes, although in a smaller percentage of nuclei. Treatment with a farnesylation inhibitor 
resulted in accumulation of prelamin A at the nuclear periphery, in annular nuclear membrane 
plaques and in intra/trans-nuclear membrane invaginations. 
In conclusion, these fi ndings suggest a critical role for the C-terminal globular lamin A/C region 
in nuclear structure and support a major contribution of abnormal assembly to the progeroid 
phenotype. In contrast to earlier suggestions, we show that prelamin A accumulation is not the 
major determinant of the progeroid phenotype.
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Loss-of-Function Mutations within the Filaggrin Gene are Strong Risk Factors for Atopic 
Dermatitis with Allergic Sensitizations
Weidinger S1, Rodriguez E2, Baurecht HJ3, Ring J1, Irvine AD4, McLean I5, Klopp N6, Illig T6 
and Novak N7
1Department of Dermatology and Allergy, Technical University Munich (Germany)
2Division of Environmental Dermatology and Allergy GSF/TUM (Germany)
3Inst for Medical Statistics & Epidemiology IMSE, Technical University Munich (Germany)
4Dept of Pediatric Dermatology, Our Lady’s Hosp for Sick Children, Crumlin, Dublin (Ireland)
5Epithelial Genetics Group,Human Genetics Unit, University of Dundee (United Kingdom)
6Department of Epidemiology, GSF-National Research Center for Environment and Health, 
Neuherberg (Germany)
7Department of Dermatology, University of Bonn (Germany)
Atopic dermatitis (AD) is a chronic infl ammatory skin disease with a strong genetic back-
ground. One of its characteristic features is an impaired epidermal skin barrier based on a 
primary defect of epidermal differentiation. Recently, two loss-of-function mutations (R501X 
and 2282del4) in the fi laggrin (FLG) gene that cause ichthyosis vulgaris (IV) have been reported 
to be associated with AD. In the presented study we evaluated these mutations in a large collec-
tion of well-characterized 476 German-Caucasian AD families using the transmission-disequi-
librium test (TDT). Our family-based approach revealed prominent associations between the 
two loss-of-function FLG mutations and AD as previously observed in a traditional Mendelian 
linkage analysis and case/control cohort analysis approach. Thus, FLG is the fi rst really strong 
genetic factor identifi ed in a common complex disease. In addition, we observed associations 
in particular with the extrinsic subtype of AD, which is characterized by high total serum IgE 
levels and concomitant allergic sensitizations. Furthermore FLG mutations are signifi cantly 
associated with palmar hyperlinearity in AD patients, which represents a shared feature of AD 
and IV. Together, these data implicate that a genetically-determined disruption of the epidermal 
skin barrier should be regarded as key-event in the pathogenesis of AD, and as a considerable 
risk factor for the development of subsequent sensitizations. 
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Human p38α Gene Encodes Multiple Protein Isoforms Derived from Alternative RNA 
Splicing
Wu ZH and Schroeder JM
Universitaetsklinikum Schleswig-Holstein, Campus Kiel, Hautklinik (Germany)
The p38α gene plays an important role in regulating the development and proliferation of cells 
and in response to disease and tissue injury. Four alternatively spliced transcript variants of this 
gene encoding distinct isoforms have been reported. Here we report the identifi cation of two 
novel transcripts of p38α, namely p38α-v5 and p38α-v6, by RACE-PCR using mRNA derived 
from foreskin-derived human primary keratinocytes. The full-length mRNA of p38α-v5 differs 
from that of MAPK14 transcript variant 2 (or CSBP2) in the 5’ end portion transcripted from 
exon 1 and contains an open reading frame of 849 bp encoding a N-terminus-truncated CSBP2 
of 283 amino acids. The full-length mRNA of p38α-v6 contains an open reading frame of 1005 
bp which is predicted to encode an 335-amino-acid isoform that has a different N-terminus as 
compared to CSBP2. RT-PCR indicated that they showed different tissue distribution unlike the 
ubiquitous expression of p38α within the tested 18 human tissue samples. Both of p38α-v5 
and p38α-v6 are expressed in skin, spleen, thymus, small intestine, bone marrow, stomach, 
bronchial epithelial cells and lung, but not in tonsils, tongue, polyps, salivary gland, or nasal 
epithelial cells. Our fi ndings may help to elucidate in more detail its protein function and imply 
that it can be regulated through its transcription induction in addition to its protein activation 
by the MKKK-MKK- MAPK phosphorylation module. Differences in the distinct transcriptional 
starting sites (TSSs), which result from the distinct exon 1 among p38α-v5, p38α-v6 and the 
other four known isoforms, suggest that the p38α gene has at least three distinct promoter 
regions in response to different kinds of stress.
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A Case of Sporadic Cylindromatosis with a Novel Germline Mutation in CYLD gene
Zavattaro E1, Bertero M2, Colombo E1, Tiberio R1, Nasti S3, Bianchi-Scarrà G3, Cusano R3, 
Ghiorzo P3, Pastorino L3 and Leigheb G1
1Department of Dermatology, University of Piemonte Orientale, Novara (Italy)
2Department of Dermatology, Ospedale Santa Croce e Carle, Cuneo (Italy)
3DOBIG- Department of Oncology, Biology and Genetic, University of Genova (Italy)
Cylindromatosis is a rare genodermatosis involving skin appendages. It is usually genetically 
inherited in the so called Brooke-Spiegler syndrome.
Mutations in the CYLD gene (16q12-13) were identifi ed to be responsible for both sporadic and 
familial cylindromatosis, but germline mutations have been found only in families with familial 
cylindromatosis (MIM 132700). The CYLD gene, a tumor suppressor gene, spans over 56 kb of 
genomic DNA and contains 20 exons. The CYLD protein, a member of the family of deubiqui-
tinating enzymes, plays an indispensible role in the NF-κB negatively regulation. 
We have studied a 42 year-old Italian man presenting numerous nodules on his scalp and chest 
arised few years ago and histologically diagnosed as cylindromas. His parents did not show any 
cutaneous lesions and the proband has no offspring. 
DNA from the proband whole blood, was tested by direct sequencing for mutations in all 17 
coding exons of the CYLD gene. 
We identifi ed a novel single nucleotide duplication, c.561dupT in exon 5. The duplication is 
predicted to change the reading frame after codon 188 resulting in a premature stop codon after 
two amino acids (p.Gln188SerfsX2). The parents were tested negative for the same mutation. 
To our knowledge this is the fi rst report of de-novo germline mutation in a sporadic case of 
cylindromatosis.
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Switch of Syndecan-1 and Syndecan-4 Expression Controls Maturation associated Dendritic 
Cell motility
Averbeck M1, Gebhardt C1, Anderegg U1, Temeer C1, Sleeman JP2 and Simon JC1
1Department of Dermatology, Leipzig University (Germany)
2Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe (Germany)
Dendritic cells need to mobilize within the extracellular matrix during their maturation and 
concomitant migration from peripheral sites to lymphoid organs. Syndecans are cell surface 
proteoglycans that mediate the interaction of dendritic cells with the extracellular matrix. Here 
we investigated the infl uence of syndecans on dendritic cell motility and morphology. Lang-
erhans cells of the epidermis and monocyte-derived dendritic cells, their in vitro counterparts, 
were found to undergo a switch in syndecan expression during maturation. Syndecan-1 was 
downregulated and syndecan-4 was strongly upregulated within the fi rst hours of lipopolysac-
charide induced dendritic cell maturation and during Langerhans cell emigration from human 
skin, as shown by fl ow cytometry and qRT-PCR. Syndecan-1 downregulation was inhibited by 
syndecan-4 siRNA knock-down, indicating a functional interconnection between enhanced 
syndecan-4 expression and syndecan-1 downregulation. Syndecan-4 upregulation is func-
tionally involved in dendritic cell motility, as inhibition of syndecan-4 function by means of 
blocking antibodies or through siRNA knock-down decreased dendritic cell motility. In other 
experiments, the cytoskeletal component alpha-actinin was observed to be upregulated in den-
dritic cells as a consequence of the induction of maturation, and was found to colocalize with 
syndecan-4. Furthermore, lammellopodial spreading by dendritic cells on fi bronectin-coated 
surfaces was dependent on syndecan-4. This binding of syndecan-4 to fi bronectin and its asso-
ciation with the cytoskeleton may be relevant for syndecan-4-dependent dendritic cell motility. 
We conclude that the switch in syndecan expression during dendritic cell maturation controls 
the motility of dendritic cells in a way that appears to be crucial for their mobilization from 
peripheral sites and subsequent migration to lymphoid tissues.
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CD4+CD25+ Regulatory T Cells Suppress the Elicitation Phase of Contact Hypersensitivity 
(CHS) Reaction in an IL-10 Dependent Pathway
Ring S, Mahnke K, Schallenberg S, Schönfeld K and Enk A
Department of Dermatology, University of Heidelberg (Germany)
We previously demonstrated that adoptively transferred CD4+CD25+ T cells suppressed an CHS 
reaction in a murine model. Using intravital fl uorescence microscopy in the skinfold chamber, 
we could show that injection of CD4+CD25+ T cells, or tissue culture supernatant thereof, into 
TNCB sensitized mice at the time of local hapten challenge signifi cantly inhibited rolling and 
adhesion of endogenous leukocytes to the endothelium of postcapillary venules. Further analy-
sis revealed that this suppressive activity of Tregs or respective supernatant was associated with 
a reduction of the hapten induced edema and a decrease of infi ltrating CD8+ T cells into the 
hapten treated ear. However, we did not detect any of the injected Tregs at the site of infl amma-
tion. Instead, the injected Tregs accumulated in the draining lymph nodes within few minutes 
after injection. Notably, suppression only occurred when Tregs were injected at least 6 min 
before challenging, indicating that Treg need at least 6 min, to exert their regulatory properties 
in vivo. Moreover, the comparable suppressive effects of Treg derived tissue culture supernatant 
suggests an important role of soluble factors in the regulation mediated by Tregs.
Accordingly we found that IL-10, but not TGF-beta, was produced by Treg upon stimulation 
and that addition of anti-IL-10 antibodies abrogated the suppressive effects of Treg and tissue 
culture supernatant in CHS reactions. Moreover, CD4+CD25+ T cells isolated from IL-10-/- 
mice failed to suppress the immune response induced by hapten treatment.
Thus, these data show that Tregs suppress CHS reactions in vivo by blocking the infi ltration 
of CD8+ effector T cells and the leukocyte-endothelium interaction in infl amed tissues by an 
IL-10 dependent pathway.
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A New Strategy for Antigen-Specifi c Tolerance by Induction of Tolerogenic Dendritic Cells
Morita A, Isomura I and Shintani Y
Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical 
Sciences (Japan)
The induction of antigen-specifi c immune tolerance has long been targeted to control aller-
gic or autoimmune disease activity without immunosuppressive reagents. Recently, increasing 
number of reports demonstrated that peripheral tolerance had been induced by modulating 
dendritic cells (DC). Tolerogenic DC, which can induce peripheral tolerance, are characterized 
by inhibitory co-stimulatory molecules and IL-10 production. Recently, nuclear factor kappa B 
(NF-κB) decoy oligodeoxynucleotides (ODN) has been used for heart graft transplantation by 
inhibiting NF-κB-related gene expression. NF-κB plays signifi cant roles in upregulation of co-
stimulatory molecules and immunostimulatory cytokines. We previously have demonstrated 
that NF-κB decoy ODN could induce antigen-specifi c peripheral tolerance in DTH through 
the induction of regulatory T cells (Treg). In this study, we investigated the underlying mecha-
nisms of peripheral tolerance in DC. By topical NF-κB decoy ODN, more LC were observed 
in the epidermis by 38% with morphologically active characteristics and high expression of 
MHC class II until 2 days after OVA sensitization. In addition, migration of DC into draining 
lymph nodes was decreased by 40%. Even after migration of DC, the expression of B7-1, B7-2 
were slightly downregulated, and PD-L1 and PD-L2 were signifi cantly upregulated, suggesting 
NF-κB decoy ODN treatment induces tolerogenic DC. The antigen-specifi c tolerance could 
be transferable by isolating CD11c+ DC from the tolerant mice. These fi ndings indicate that 
the induced tolerance could be mediated by the delay of DC migration and modulation of the 
surface molecules on DC. Topical application of NF-κB decoy ODN might be a new strategy 
for inducing tolerogenic DC that contribute to the induction of peripheral tolerance.
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Differences in Toll-like Receptor Expression on Langerhans Cells and Dermal Dendritic Cells 
Lead to Differential Pathogen Recognition
van der Aar A1, Sylva-Steenland R1, Bos J1, Kapsenberg M2, de Jong E2 and Teunissen M1
1Dept of Dermatology, Academic Medical Centre, University of Amsterdam (Netherlands)
2Dept of Cell Biol & Histology, Academic Medical Centre, Univ of Amsterdam (Netherlands)
The characteristic dendritic cell (DC) of the epidermis is the Langerhans cell (LC), whereas in 
the dermis another DC subset is present, the dermal dendritic cell (DDC). It is unknown why 
different DC subsets are present in the skin and their functional differences are enigmatic. DC 
can recognize highly-conserved pathogen-associated molecular patterns by means of so-called 
pattern recognition receptors, of which the Toll-like receptors comprise an important family. 
The aim of this study was to analyze functional differences between DDC and LC. We used 
freshly isolated LC and DDC, as well as in vitro generated LC (moLC) and DDC (moDC), which 
were generated by culturing monocytes in the presence or absence of transforming growth 
factor (TGF)-β1, respectively. We examined the expression of TLR1 through TLR10 on both DC 
subsets by quantitative PCR and analyzed their reactivity to bacteria and viruses. DDC showed 
constitutive expression of most TLR. In contrast, both cultured and fresh LC showed a notice-
able low or absent expression of TLR2, TLR4, and TLR5, which selectively recognize bacterial 
components. TLR involved in virus recognition were expressed at a comparable level on LC 
and DDC. Corresponding to their TLR expression, LC responded to purifi ed viral components 
or whole viruses by secreting cytokines, but showed very low or no responsiveness to puri-
fi ed bacterial components and whole Gram-positive and Gram-negative bacteria compared to 
DDC. Presence of TGF-β1 during stimulation of DC had no effect on pathogen recognition. 
These results show an important role for TGF-β1 in phenotypical development of LC, leading to 
functional differences in pathogen recognition between LC and DDC. The low reactivity of LC 
to bacteria may to a certain degree result in tolerance for the bacterial skin fl ora. 
248 [076]
Cytotoxic Potential of Toll-like Receptor 7/8 Activated Infl ammatory Dendritic Cells in 
Anticancer Immunity
Stary G1, Bangert C1, Altrichter S1, Strohal R2, Kopp T1 and Stingl G1
1Department of Dermatology, DIAID, Medical University of Vienna (Austria)
2Department of Dermatology, Federal Academic Hospital Feldkirch (Austria)
Immunotherapy becomes an interesting approach to specifi cally target tumors by the immune 
system. As a synthetic agonist to toll-like receptor (TLR) 7/8, imiquimod acts as an immune 
response modifi er and has been successfully used for the treatment of certain skin neoplasms. 
In order to get an insight into the underlying mechanisms of tumor clearance, we analyzed lytic 
molecules expressed by the local cellular imiquimod-induced infl ammatory infi ltrate of basal 
cell carcinomas (BCC) at particular clinical time points of tumor regression. In addition, we ex-
amined the TLR7/8-induced expression and secretion of lytic molecules of different peripheral 
blood-derived cell populations.
Upon 2 weeks of imiquimod treatment, we observed a massive increase of the infi ltrate that 
correlated with the upregulation of perforin, granzyme B and TRAIL, but not of Fas ligand. 
Somewhat to our surprise, we found that CD11c+HLA-DR+CD14-TNF+iNOS+ myeloid den-
dritic cells, and not NK-cells or CD8+ T-cells, were the main source of these lytic proteins. After 
6 weeks of therapy, the tumors had resolved and the cellular infi ltrate as well as the expression 
of lytic molecules had returned to baseline levels. 
In peripheral blood, TLR7/8 ligand-stimulated, but not freshly isolated CD11c+ mDCs displayed 
perforin and granzyme B within their cytoplasm, while both molecules decreased in T-cells 
upon TLR7/8 stimulation. Furthermore we demonstrate the release of perforin and granzyme B 
by CD11c+ mDCs after TLR7/8 stimulation. These results suggest a cytotoxic potential of DCs 
using the perforin/granzyme B pathway upon specifi c stimulation by TLR ligands.
We entertain the possibility that CD11c+HLA-DR+CD14-TNF+iNOS+ myeloid dendritic cells,  
referred to as Tip-DCs (TNF-iNOS-producing dendritic cells), are directly involved in imiqui-
mod-induced tumor destruction.
249 [077]
CD25+/CD4+ Regulatory T Cells Suppress the Maturation of Dendritic Cells and Induce 
Surface Expression of Inhibitory B7-H3 Molecules
Mahnke K, Johnson T, Ring S, Schallenberg S and Enk A
Department of Dermatology, University of Heidelberg (Germany)
Previous results have shown that immature dendritic cells (DC) play a crucial role in the activa-
tion of regulatory T cells (Treg). Vice versa, only few reports suggest that Treg affect DC develop-
ment. Therefore we set out to investigate the effects of Treg on DC maturation, activation and 
phenotype in vitro and in vivo. To determine whether Tregs interfere with DC maturation, we 
cultured immature bone marrow derived DC as well as magnetic-bead separated lymph node 
DC in the presence of isolated CD4+/CD25+ Treg and assessed their maturation status by FACS 
and mixed lymphocyte reactions. In these assays it became evident that DC after co-culture 
with Treg retained their immature status as indicated by low expression of CD80, CD86 and 
inferior T cell stimulatory capacity. Parallel to this downregulation of activation markers, in-
hibitory molecules were upregulated. I.e. co-culture with Treg induced surface expression of 
B7-H3 and induced IL-10 expression in DCs. These effects required largely cell - cell contact, 
since supernatant of cultivated Treg did not affected DC maturation. Using MHC-class II – HEL 
peptide specifi c antibodies (C4H3), we could show that MHC - peptide complex formation by 
DCs was impaired after contact to Treg. This also resulted in functional consequences since 
DCs that had been pulsed with peptide (OVA) or haptens (TNBS) were inferior in priming mice 
against the respective antigens. Thus this data indicate that Treg can impair the maturation of 
developing DC. In a “feedback-loop” immature DC may stimulate generation of Treg, which 
in turn then further affect DC maturation keeping them immature and thus ensuring their Treg- 
activating properties. 
250 [078]
Alteration of the Migratory Behaviour of UV-Induced Regulatory T Cells by Tissue-specifi c 
Dendritic Cells
Schwarz A, Maeda A and Schwarz T
Department of Dermatology, University of Kiel (Germany)
UV-induced regulatory T cells (UV-Treg) inhibit the sensitization but not the elicitation of con-
tact hypersensitivity when injected intravenously (i.v.). However, upon injection into the ears 
of sensitized mice the ear swelling response upon elicitation with the specifi c antigen is sup-
pressed. I.v. injected UV-Treg migrate into the lymph nodes and therefore inhibit the sensitiza-
tion (taking place in the lymph nodes) but do not go into the periphery and therefore do not 
inhibit the elicitation (taking place in the ears). We tried to modify the migratory behaviour 
of Treg with the aim to get them into the periphery and thereby to suppress the elicitation. 
Since the tissue selective homing of T effector cells is determined by tissue-specifi c dendritic 
cells (DC) we asked whether the migratory behaviour of UV-Treg can be modifi ed by tissue-
specifi c DC. DNFB-specifi c UV-Treg were coincubated with epidermal Langerhans cells (LC) 
and DNBS. Upon i.v. injection into DNFB-sensitized mice UV-Treg stimulated with LC blocked 
the elicitation. In contrast, i.v. injection of UV-Treg not incubated with LC did not inhibit the 
ear challenge. The same was observed for UV-Treg coincubated with DC from bone marrow, 
from spleen or from lymph nodes, implying that DC from peripheral organs may reprogram the 
migratory behaviour of UV-Treg into the periphery, while DC obtained from lymphoid organs 
do not. This was not due to different maturation stages of the DC as checked by MHC class II 
expression of the different DC types. UV-Treg express the lymph node homing receptor CD62L 
which was downregulated upon incubation with LC but not with bone marrow-derived DC. 
These data show that the migratory behaviour can be altered by tissue-specifi c DC. This may 
have input on strategies trying to utilize Treg not only for the prevention but also for the treat-
ment of immune-mediated diseases. 
251 [079]
Defi ciency in beta2 Integrins Results in Appearance of Increased Numbers of Antigen-
Experienced Double-Negative CD3+CD4-CD8- T Cells
Oreshkova T1, Wang H1, Seier A1, Sindrilaru A1, Renkl A1, Kess D1, Varga G2, Grabbe S3, 
ScharffetterKochanek K1 and Peters T1
1Dept of Dermatology, University of Ulm (Germany)
2Dept of Dermatology, University of Münster (Germany)
3Dept of Dermatology, University of Essen (Germany)
Beta2 integrin adhesion receptors (CD11/CD18) are known to importantly participate in blood 
vessels wall transmigration of leukocyte and lymphocyte activation providing fi rm intracellu-
lar adhesion and co-stimulatory signaling during antigen presentation. Lymphocytes obtained 
from CD18-defi cient (CD18-/-) mice showed defective homing to secondary lymphoid organs 
and an aberrant localization in non-lymphoid tissues (lungs and liver) in comparison to their 
wild type counterparts when transferred in wild type recipients.
To investigate the reasons underlying an aberrant homing of lymphocytes, we now analyzed 
phenotypic and functional changes of re-circulating T lymphocytes in primary and secondary 
lymphoid tissues of CD18-/- mice using in vivo adoptive cell transfers, and in vitro proliferation 
assays. We found that a decrease in mature CD4+ and CD8+ T cells, was contrasted by high 
numbers of T cell receptor αβ or γδ CD3+CD4-CD8- double-negative (DN) T lymphocytes in 
the peripheral lymphoid organs of CD18-/- mice. Interestingly, these cells showed an antigen-
experienced phenotype, which was also confi rmed by vigorous in vitro proliferation upon IL-2. 
However, an anergic behavior was observed when DN T cells were cultured in the presence of 
even potent mitogens. Despite the expression of CD25, response to low-dose IL-2, and anergic 
behavior, TCRαβ DN cells did not express the transcription factor Foxp3, thus widely ruling out 
that they were natural thymus-derived regulatory T cells. But interestingly, functional studies 
revealed a dose-dependent suppressive effect of TCRαβ DN cells on in vitro proliferation of 
wild type T lymphocytes in co-culture experiments. It will now be of central interest, whether 
these particular properties are cell contact-dependent or mediated by soluble factors 
We here show that β2 integrins not only guide transmigration and re-circulation but also criti-
cally infl uence T-lymphocyte maturation and differentiation.
252 [080]
Neutrophils are Key Cellular Effectors in Experimental Epidermolysis Bullosa Acquisita
Chiriac MT, Zillikens D and Sitaru C
Department of Dermatology, University of Lübeck (Germany)
To determine weather neutrophils contribute to the effector phase of the autoimmune response 
in an in vivo model of epidermolysis bullosa acquisita (EBA), we examined in this study the ef-
fects of neutrophil depletion on tissue damage induced by antibodies against type VII collagen. 
Epidermolysis bullosa acquisita is an autoimmune subepidermal blistering disease associated 
with tissue-bound and circulating autoantibodies directed against type VII collagen. Our group 
has recently shown that antibodies to type VII collagen induce in vitro dermal-epidermal sepa-
ration in cryosections of human skin when co-incubated with human granulocytes and cause a 
blistering skin disease that reproduces human EBA at the clinical, histological, ultrastructural, 
and immunopathological levels when passively transferred into mice. Using the passive trans-
fer mouse model, we demonstrate here that neutrophil recruitment and activation is critical 
for the in vivo subepidermal blistering. BALB/c mice were injected i.p. with either a mono-
clonal rat anti mouse antibody (RB6-8C5) that selectively binds to the Gr-1 receptor on mature 
murine neutrophils and depletes these cells in vivo or with a mock antibody. In contrast to 
animals treated with the mock antibody, administration of RB6-8C5 depleted mice neutrophils 
in the peripheral blood as revealed by fl ow cytometry analysis. Subsequent injection of the 
pathogenic rabbit antibody against murine type VII collagen resulted in binding of IgG to the 
dermal-epidermal junction and local activation of complement in all animals. Interestingly, 
neutrophil-depleted mice (n=12) failed to develop a blistering phenotype, both clinically and 
histologically. As expected, IgG against type VII collagen induced infi ltration of neutrophils and 
subepidermal blisters in mock antibody control animals (n=12). Our fi ndings identify granu-
locytes as key cellular effectors engaged by pathogenic autoantibodies in experimental EBA 
and should facilitate the development of novel prevention and treatment strategies for tissue 
damage in granulocyte-dependent autoimmune diseases. 
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Maternal Skin Infl ammation During Pregnancy Recruits Fetal Endothelial and Infl ammatory 
Cells
Nguyen Huu S1, Aractingi S2, Oster M1, Espié MJ1, Chareyre F3 and Khosrotehrani K2
1EA4053 Université Pierre et Marie Curie, Paris 6 (France)
2EA4053 Université Pierre et Marie Curie, Paris 6; AP-HP, Hôpital Tenon, Service de Derma-
tologie (France)
3Centre d’Etude du Polymorphisme Humain, INSERM U434 (France)
Purpose: Fetal cells enter the maternal circulation during pregnancy. The presence of fetal cells 
has been demonstrated in lesional skin of pregnant women affected with polymorphic erup-
tions of pregnancy. We aimed to determine in mouse models the role of maternal infl ammation 
in attracting microchimeric cells.
Methods: Wild type (WT) female mice were mated to transgenic males for various reporter genes 
or WT male. We used males transgenic for the luciferase gene under the control of the VEGFR2 
(V-Luc) promoter or for the EGFP under the control of the β-actin promoter. On day 16, on previ-
ously sensitized pregnant mice, contact hypersensitivity reaction (CHR) was revealed by painting 
the right ear with oxazolone, the left ear receiving the vehicle. Fetal cells were analysed using (a) 
in vivo imaging to detect luciferase expressing fetal cells; (b) immunohistochemistry anti GFP as 
well as double labelling, (c) real time quantitative amplifi cation of the EGFP transgene (RT-PCR) , 
(d) Y chromosome in situ hybridization (FISH) to detect male cells. 
Results: Quantitative PCR disclosed fetal cells in 17/17 oxazolone ears (n = 220 cells) as com-
pared with 3/17 control ears (n= 76) (p = 0.01). GFP positive cells were detected in all studied 
slides in infl amed ears. Y positive cells were found by FISH in the analysed right ears speci-
mens. Double labelling showed that these were either CD31/GFP positive cells or CD45/GFP 
cells. On 8 female mice bearing V-Luc fetuses, the infl amed ear bioluminescent signal was 
higher than controls (3362 versus 1507 photons/s/cm2, p=0.02) using in vivo imaging.
Discussion: Using various techniques in different reporting mice, we demonstrated that mater-
nal skin can recruit fetal endothelial cells as well as fetal leucocytes in CHR. Fetal cells may 
therefore participate and possibly infl uence maternal angiogenesis and infl ammation.
254 [082]
Knockout Mice Reveal Novel Activities of Interleukin-10 in Wound Repair
Eming SA1, Werner S2, Bugnon P2, Wickenhauser C3, Siewe L1, Uthermoelen O4, Davidson JM5, 
Krieg T1 and Roers A1
1Department of Dermatology, University of Cologne (Germany)
2Department of Biology, ETH Zurich (Switzerland)
3Institute for Pathology, University of Cologne (Germany)
4Inst of Medical Microbiology, Immunology and Hygiene, University of Cologne (Germany)
5Department of Pathology, Vanderbilt University School of Medicine, Nashville (USA)
The impact of the local infl ammatory response on the process of wound healing has been 
debated for decades. In particular the question whether infi ltrating macrophages and granu-
locytes promote or impede tissue repair has received much attention. Interleukin-10 (IL-10), 
one of the most potent immunoregulatory cytokines, limits innate as well as adaptive immune 
responses and is thought to protect the host from immune-mediated tissue damage. The role 
of Il-10 during tissue repair is not well understood. In the present study, we show that wound 
healing is accelerated in mice defi cient for the anti-infl ammatory cytokine IL-10. IL-10-/- mice 
closed excisional wounds signifi cantly earlier as compared with IL-10 competent control lit-
termates. This effect was due to accelerated epithelialization as well as enhanced contraction 
of the wound tissue in the mutant animals. Increased α-smooth muscle actin expression in 
IL-10 defi cient mice suggests that augmented myofi broblast differentiation is responsible for 
the enhanced contraction of wounds in mutant mice. The number of macrophages infi ltrating 
the wound tissue was signifi cantly increased in IL-10-/- mice compared with control littermates 
suggesting that this cell type mediates the accelerated tissue repair. Functional analysis of tis-
sue breaking strength revealed a decreased biomechanical strength of wound tissue in IL-10 
defi cient mice during the early phase of repair, refl ecting the increased proportion of cells and 
provisional wound matrix versus collagen at the wound site. However, during later stages of 
repair, microscopic analysis of collagen fi brils and quantifi cation of collagen content indicated 
signifi cantly increased deposition of extracellular matrix in mutant mice. These results show for 
the fi rst time that IL-10 is a negative regulator of wound repair and support the view that activa-
tion of the innate immune response is a central event during wound healing.
255 [095]
Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in Lpr Mutation-
Induced Murine Lupus
Lartigue A1, Courville P2, Auquit I2, François A2, Arnoult C1, Tron F1, Gilbert D1 and Musette P1
1INSERM U519 (France)
2CHU, C. Nicolle (France)
Lpr/Lpr mice are widely used as an animal model for human systemic lupus (SLE). SLE is 
characterized by nephritis and vasculitis associated with the production of antibodies directed 
against nucleosome and DNA which correlate with the disease activity. Toll-like receptors 9 
(TLR9) which bind DNA via unmethylated CpG sequences is thought to play a role in the 
production of these autoantibodies through the capacity of nuclear immunogenic particles to 
interact both with BCR and TLR9. We sought to determine this role by creating C57BL/6-lpr/lpr-
TLR9-/- mice and analyzing their phenotype. We show that TLR9-/- and TLR9+/+ mice presented 
a massive lymphadenopathy and splenomegaly, associated with the expansion of CD4-CD8- 
double negative T cells. Concerning lupus-like autoimmunity, the TLR9-/- seroprofi le was very 
different compared with TLR9+/+ since anti-nucleosome antibodies remained negative until 6-
month-old in TLR9-/- mice while no difference was observed in the frequency of anti-dsDNA 
autoantibodies whose titer was strikingly higher in TLR9-/- mice. Thus in B6-lpr/lpr mice, TLR9 
defi ciency dissociates the anti-dsDNA from the anti-nucleosome antibody response. The as-
sessment of the renal disease showed that glomerular IgG deposits were more intense in TLR9 
defi cient mice and a higher rate of mesangial proliferation was also observed. 
All these results clearly demonstrate that TLR9 receptors are absolutely required for the anti-
nucleosome antibody response but not for anti-DNA antibody production which is involved 
in mesangial proliferation. Moreover, this study provide clear evidence for a protective role 
of TLR9 in the development of the lupus disease since TLR9-/- mice present more important 
renal lesions. 
256 [096]
Transcutaneous Immunization Following Epicutaneous Application of the Vitamin D Analogue 
Calcipotriol to Induce T Cell Tolerance
Ghoreishi M, Obst J and Dutz JP
Department of Dermatology, University of British Columbia (Canada)
In a murine model, 1, 25-Dihydroxyvitamin D3 (Vitamin D) induces tolerance in vitro and in 
vivo when administered either orally or intraperitoneally in combination with other immune 
suppressive drugs. We investigated whether topical application of a vitamin D analogue (cal-
cipotriol) affects subsequent T cell responses to ovalbumin (OVA) immunization. Mice were 
treated with topical calcipotriol and then were immunized transcutaneously (transcutaneous 
immunization – TCI) to OVA. Topical calcipotriol application prior to TCI induced suppression 
of subsequent antigen-specifi c CD8+ cytotoxic T cell (CTL) proliferation and IFNγ production 
in C57Bl/6 mice. Antigen-specifi c tolerance was also induced. This effect was mediated by 
CD4+/CD25+ T regulatory cells (Treg cells) expressing high levels of FoxP3 and was antigen-
specifi c, since transfer of these cells from calcipotriol- treated and OVA- immunized, but not 
irrelevant antigen immunized mice, resulted in suppression of OVA-specifi c CTL responses in 
naïve recipients. The suppressive and tolerance-inducing effect of the topical calcipotriol was 
local as contra-lateral OVA-TCI was not inhibited. The biologic relevance of this observation 
was confi rmed as calcipotriol and OVA-TCI induced Treg cells inhibited both the induction 
and elicitation phases of OVA dependent protein contact hypersensitivity (CHS). F4/80 is a 
molecule expressed by tolerance inducing macrophages. In our study F4/80+ cells were in-
creased in draining lymph nodes and skin of mice treated with calcipotriol. These studies thus 
describe a new method for antigen specifi c tolerance induction and imply a participatory role 
for F4/80+ cells in this phenomenon.
257 [097]
Th2 Immune Responses are not Inhibited by Interleukin-10-Treated Dendritic Cells in a 
Murine Model of Allergy
Bellinghausen I, Sudowe S, König B, Reske-Kunz AB, Knop J and Saloga J
Department of Dermatology, University of Mainz (Germany)
It is well known that the immunoregulatory cytokine interleukin-10 (IL-10) inhibits the ac-
cessory function of human dendritic cells (DC) in vitro. Recently, we have shown that these 
IL-10-DC inhibit the production of Th1 and Th2 cytokines by T cells from atopic individuals in 
vitro. The current study was set out to analyze whether IL-10-DC also exert inhibitory effects in 
vivo in a murine model of allergy to ovalbumin adsorbed to the adjuvant aluminium hydroxide 
(OVA/alum). OVA-pulsed or unpulsed bone marrow-derived DC, treated with IL-10 or left 
untreated during generation, were injected intravenously into BALB/c mice prior to and dur-
ing OVA/alum sensitization, and sera and immune responses of mesenterial lymph node cells 
were analyzed. Additionally, bronchoalveolar lavage was performed after intranasal challenge 
with OVA. Treatment of BALB/c mice with OVA-pulsed DC led to a signifi cantly enhanced 
proliferation as well as Th2 (IL-4, IL-5), Th1 (IFN-gamma), and IL-10 cytokine production after 
restimulation of lymph node cells with OVA in vitro as compared with OVA immunization 
alone. In contrast, using OVA-pulsed IL-10-DC for transfer, proliferation and cytokine produc-
tion by lymph node cells were not enhanced. OVA-specifi c IgG1 and IgG2a production were 
signifi cantly increased after transfer of OVA-pulsed DC and OVA-pulsed IL-10-DC, respective-
ly, whereas anti-OVA IgE production and airway eosinophilia remained unchanged. Our data 
indicate that IL-10-treatment of DC decreases the Th1- and Th2-cell stimulatory capacity of DC 
but does not actually inhibit systemic (IgE) and local (airway infl ammation) allergen-specifi c 
immune responses in a murine model of allergy.
258 [098]
Organ Preferential Leukocyte Recruitment through the Multifunctional Junctional Adhesion 
Molecule (JAM)-B
Ludwig RJ1, Hardt K2, Hatting M2, Bislian R3, Diehl S2, Kaufmann R2, Radeke HH4, Santoso S5, 
Henschler R3 and Boehncke WH2
1Dept of Dermatology & Pharmazentrum, Clinic of Johann Wolfgang Goethe Univ (Germany)
2Department of Dermatology, Clinic of the Johann Wolfgang Goethe University (Germany)
3Inst of Transfusion Medicine, German Red Cross Blood Donor Service, Frankfurt (Germany)
4Pharmazentrum / ZAFES, Clinic of the Johann Wolfgang Goehte University (Germany)
5Inst for Clinical Immunology & Transfusion Medicine, Justus-Liebig-Univ, Giessen, (Germany)
Junctional adhesion molecules (JAM)-A, -B and -C mediate leukocyte transmigration. More re-
cently JAM-C has been shown to additionally mediate fi rm adhesion of leukocytes, and JAM-B 
has been demonstrated to bind the leukocyte integrin VLA-4, which mediates rolling and fi rm 
adhesion in skin microvasculature through an interaction with VCAM-1. We therefore hypoth-
esized, that in addition to mediate transmigration JAM-B is also involved in leukocyte rolling 
and fi rm adhesion. To address this T-lymphocytes were perfused over JAM-B coated slides in a 
fl ow chamber, showing JAM-B dependent rolling and sticking interactions at low shear stress 
(0.3dyn/cm2 - 220±71 versus 165±88 rolling and 2.6±1.3 versus 1.0±0.7 sticking cells/mm-
2min-1 on JAM-B- versus BSA coated slides), but not higher shear forces (1.0dyn/cm2). We next 
used blocking antibodies in our fl ow chamber system showing a dependency of JAM-B medi-
ated rolling and sticking on T-lymphocyte α4- and β1-integrin, but not JAM-C expression. Using 
intravital microscopy of murine skin microvasculature, we also show, that rolling interactions 
of murine leukocytes is also affected by antibody blockade of JAM-B, reducing rolling interac-
tions from 9.1±2.6% to 3.2±1.2%. To test, if JAM-B mediated leukocyte-endothelium interac-
tions are functionally relevant, a contact hypersensitivity reaction (CHS) was elicited in mice 
using DNFB. Injection of a function blocking JAM-B antibody prior to challenge, consistently 
reduced the infl ammatory response evoked by DNFB in a dose dependent fashion. In contrast, 
using adoptive transfer experiments, an effect of JAM-B blockade is only observed using higher 
doses of function blocking antibody in the sensitization phase. Indicating, that JAM-B organ-
differentially governs leukocyte transmigration through multifunctional activities. As blockade 
of JAM-B leads to inhibition of leukocyte extravasation to the skin, and only slightly affects 
generation of immunity, targeting JAM-B seems an interesting approach for the treatment of 
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Array CGH and COBRA-FISH Reveal Recurrent Genetic Alterations in Sézary Syndrome
Vermeer MH1, Dijkman R1, Mao X2, Doorn R1, Whittaker S2, Gellrich S3, Geerts ML4,
Szuhai K5, Willemze R1 and Tensen CP1
1Department of Dermatology, Leiden University Medical Center (Netherlands)
2Department of Dermatology, St Thomas’ Hospital, King’s College, London, (United Kingdom)
3Department of Dermatology, Charité, Berlin (Germany)
4Department of Dermatology, Gent University Hospital, Gent (Belgium)
5Department Molecular Cell Biology, Leiden University Medical Center (Netherlands)
Sézary syndrome (SS) is a malignancy of CD4+ memory skin-homing T cells characterized by 
the presence of neoplastic T-cells in the skin, lymph nodes and peripheral blood. Previous stud-
ies demonstrated complex karyotypes and widespread chromosomal instability in SS patients. 
Despite the high number of reported chromosomal abnormalities there are few instances of 
recurrent chromosomal alterations. Deletion of the chromosomal region harboring the NAV3 
gene is one of the few recurrent chromosomal alterations identifi ed thus far in SS. In the present 
study we investigated chromosomal alterations in CD4+ T-cells isolated from peripheral blood 
lymphocytes of 21 SS patients using array-based comparative genomic hybridization (CGH) 
(n= 21) and multicolor COmbined Binary RAtio labeling Fluorescence In Situ Hybridization 
(COBRA-FISH) (n=6). COBRA-FISH analysis revealed abnormal karyotypes in 5 of 6 patients 
(83%). Recurring structural chromosomal alterations detected by COBRA-FISH involved dele-
tion of 10q24 (3 of 7 cases) and breakpoints at 17p11 (3 of 7 cases). Isochromosome 17 was 
detected in 1 patient. Recurrent translocations were not detected. The most frequent copy 
number alterations (CNA) detected by array-based CGH were amplifi cations at 5p15 (57%), 
8q11 (48%), 8q24 (71%), 17q11 (71%), 17q21 (86%), 17q25 (71%), 19q13 (29%) and 20q11 
(24%) and deletions at 4q31 (38%), 5q22 (43%), 6q24 (29%), 10q24 (52%) and 17p12 (67%). 
Candidate genes relevant to the pathogenesis of SS residing within these recurrent CNA include 
the proto-oncogenes MYC (8q24) and the tumor suppressor gene P53 (17p13). Quantitative 
PCR confi rmed the amplifi cation of MYC and deletion of P53 genes. The high frequency of 
detected amplifi cations of MYC and deletions of P53 suggest that deregulation of these genes 
could contribute in the pathogenesis of SS.
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Evidence for a Natural Killer (NK) Cell-Mediated Cytotoxic Activity Against Autologous 
Keratinocytes from the Anagen Hair Follicle: New Insights into the Pathogenesis of Alopecia 
Areata
Abecassis S1, Giustiniani J2, Kamoun A2, Bagot M1 and Bensussan A2
1Departement of Dermatology, Hôpital Henri Mondor, Créteil (France)
2INSERM U 659, Faculté de Médecine de Créteil, Université Paris XII, Créteil (France)
Keratinocytes from the anagen hair follicle are considered as an immunologically privileged tis-
sue, since they express low amounts of major histocompatibility complex class I (MHC-I) mol-
ecules. Thus, according to the non-revisited missing self theory of immunosurveillance, cells 
lacking or expressing low quantity of MHC-I molecules are potential targets for autologous NK 
mediated cytotoxicy. As NK cells are absent from the normal hair follicle, keratinocytes are 
usually spared from such a lethal interaction. In this study, we demonstrate that freshly iso-
lated peripheral blood NK cells exhibit cytotoxicity against autologous cultured keratinocytes 
from anagen hair follicles. We also show that this NK mediated lysis is mostly dependent on 
the CD160/MHC-I interaction. As expected, we found that interferon gamma (IFN-γ) induced 
up-regulation of MHC-I expression by keratinocytes abolished their sensibility to autologous 
NK mediated cytotoxicity. In conclusion, we discuss the possibility that the NK cell-medi-
ated cytotoxicity participates in the initial steps of hair follicle autoimmune disorders such as 
alopecia areata.
261
Identifi cation of a Unique CD160+CD4+ T Lymphocyte Subset in Peripheral Blood and within 
Infl ammatory Skin Lesions: A Possible Role for CD160 in Skin Infl ammation
Abecassis S1, Schiavon V2, Ortonne N3, Schmitt C2, Bagot M1 and Bensussan A2
1Departement of Dermatology, Hôpital Henri Mondor, Créteil (France)
2INSERM U 659, Faculté de Médecine de Créteil, Université Paris XII, Créteil (France)
3Departement of Pathology, Hôpital Henri Mondor, Créteil (France)
CD160 is a GPI-anchored cell surface molecule expressed by human circulating cytotoxic 
lymphocytes that correspond to the majority of natural killer cell expressing CD56dim, TCRγδ 
lymphocytes and to a minor CD8 T cell subset. CD160 engagement by MHC class I molecules 
triggers by itself both cytotoxic function and cytokines production in NK lymphocytes, whereas 
it provides co-activating signals to TCR-induced proliferation in T CD8+ lymphocytes. In the 
present study, we analyzed by immunohistochemistry the phenotype of lymphocytes infi ltrat-
ing normal skin and infl ammatory skin lesions of atopic dermatitis, contact dermatitis and 
psoriasis. We identifi ed a minor original subset of CD4+CD160+ T cells infi ltrating infl ammatory 
lesions. Furthermore, we demonstrated that this unique lymphocyte subset localization is not 
restricted to the skin, since CD4+CD160+ cells were isolated from 20 healthy donors peripheral 
blood lymphocytes, representing 0.01 to 0.6% of peripheral blood CD4+ T cells. Further phe-
notypical analysis identifi ed this original peripheral blood cell subset as CD4+CD160+CD25-
CD158a-CD158b-Granzyme+Perforine+, suggesting that CD4+CD160+ cells have cytotoxic 
properties. Lymphocyte proliferation assays revealed that CD4+CD160+ cells presented an 
increased response to IL2 and a decreased response to anti-CD3 monoclonal antibody and to 
allogeneic cells when compared to autologous CD4+CD160-cells. CD4+CD160- cells prolif-
eration was not inhibited when co-cultured with increased ratios of autologous CD4+CD160+ 
cells, indicating that CD4+CD160+ cells do not correspond to T regulatory cells. In conclusion, 
we described an original CD4+CD160+Granzyme+Perforine+ cells in healthy donors peripheral 
blood and infl ammatory skin. We hypothesize that these cells could play a role in the patho-
genesis of skin infl ammation.
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Intravenous Immunoglobulins Block TNF-α- and IL-12- Production by Activated 6-
sulfoLacNAc+ Dendritic Cells (slanDC)
Abraham S1, Meurer M1, Rieber P2 and Schäkel K1
1Dept of Dermatology, Med Faculty Carl-Gustav-Carus, Technical Univ of Dresden (Germany)
2Inst of Immunology, Med Faculty Carl-Gustav-Carus, Technical Univ of Dresden (Germany)
The application of intravenous immunoglobulins (IVIG) in the treatment of autoimmune diseases 
and systemic infl ammatory disorders is effective although the knowledge about their mode of ac-
tion is still insuffi cient. Possible targets of intravenously administered immunoglobulins are leuko-
cytes of the circulating blood pool. Among the blood leukocytes, a highly proinfl ammatory popula-
tion of mAb M-DC8 defi ned 6-sulfoLacNAc+ dendritic cells (now called slanDC) stand out by their 
strong capacity to produce tumor necrosis factor-α (TNF-α) and can be found in the infl ammatory 
infi ltrate of the dermis. In addition, slanDC are characterized by the production of ten times higher 
interleukin-12 (IL-12) levels than monocytes or CD1c+ / M-DC8- blood DC and are potent inducers 
of Th1 cells and may therefore be relevant for the pathogenesis of Th1-dominated skin diseases.
Here we explored the possibility to control the proinfl ammatory capacity of slanDC by therapeutic 
doses of IVIG. Native slanDC were isolated by magnetic cell sorting from buffy coats of healthy 
donors to a purity of >95% and treated with different doses of IVIG for a period of 6 hours. After 
washing the cells to remove IVIG, cytokine secretion of DC was induced by stimulating CD40, 
TLR-2, TLR-3 and TLR-4 with CD40L-transfected fi broblasts, PGN, Poly I:C and lipopolysaccharide 
(LPS), respectively. Regardless of the stimulus applied pretreating slanDC with IVIG led to a strong 
and dose-dependent reduction of IL-12p70 and TNF-α production. Eighty percent reduction of 
IL-12 and TNF-α secretion was observed after maximal stimulation with LPS (TLR-4 ligand) com-
bined with interferon-γ (IFN-γ). An inhibitory of immune complexes within the IVIG-preparation 
was excluded. Furthermore, IVIG impaired the capacity of slanDC to adhere on collagen type I 
(60% reduction after 1 h). 
Blood samples from IVIG-treated patients are currently studied to translate our fi ndings into in vivo 
setting.
In conclusion, we here describe the profound inhibitory effect of IVIG on the highly proinfl ammato-
ry population of slanDC and identify an important target for the anti-infl ammatory action of IVIG. 
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Cutaneous T-cell Lymphoma Cells Release Proapoptotic Fas Ligand in Lysosomal Secretory 
Vesicles
Michel L1, Chauvel C1, Jean-Louis F1, Raposo G2, Bachelez H1
1Inserm U697, Hopital Saint-Louis, Paris (France)
2Institut Curie (France)
Although the expression of the death promoting molecule CD95L/FasL by cutaneous T cell 
lymphomas (CTCL) has already been described, the subcellular localisation and the functional 
consequences of this expression remain unknown. We investigated herein the presence of FasL 
in the secretory vesicles of CTCL cells, and its proapoptotic properties in vitro. CTCL cell lines 
and peripheral blood lymphocytes (PBL) isolated from circulating blood of patients with CTCL 
were stimulated by PMA and ionomycine for 16h. Microvesicule fractions were obtained after 
ultracentrifugation of cell supernatants. The presence of microvesicle-associated FasL was studied 
by Western blots, blocking with anti-Fas reagents, and immunoelectron microscopy. Biological 
activities of microvesicles were tested including the ability to induce apoptosis of Jurkat cells.
RT-PCR studies and fl ow cytometric analysis allowed to detect intracellular expression of Fasl, 
but not at the cell membrane, in peripheral blood tumor cells from SS patients and in SeAx and 
Myla CTCL lines. Confocal microscopic anaysis of CD95L/CD63 double staining showed that in-
tracellular FasL colocalised with the lysosomal secretory vesicles. Immunoelectronic microscopy 
confi rmed lysosomal FasL expression and showed a staining under cell membrane. Western-blot 
analysis of ultracentrifugated supernatant from PMA/ionomycin-stimulated CTCL lines and PBLs 
from SS patients showed predominant expression of the 37KDa form of FasL in the exosomal 
fraction, while the soluble form was barely detected. Finally, exosomal fractions from CTCL lines 
and CTCL cells from patients were able to induce apoptosis of the Fas-expressing Jurkat cell line, 
as shown by fl ow cytometric analysis of annexin staining. 
These results show that bioactive FasL is expressed in the lysosomal secretory vesicles of CTCL 
but not at their cell surface, and induce apoptosis following extracellular release, a phenomenon 
which is likely to confer an immune privilege to CTCL through the delivery of a death signal to 
Fas-expressing T-lymphocytes.
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Apoptotic Cells and Their Infl uence on Dendritic Cells In Systemic Lupus Erythematosus
Berger B1, Dörner L1, Weyd H1, Tarner I2, Müller-Ladner U2, Krammer P1 and Kuhn A1
1Tumorimmunology Program, Div of Immunogenetics, German Cancer Research Ctr (Germany)
2Justus-Liebig-University of Giessen, Dpt. of Internal Medicine and Rheumatology (Germany)
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease associated with 
abnormal immune responses including production of autoantibodies and immune complexes. 
It has been proposed that the accumulation of apoptotic cells in the tissue and circulation of 
patients with this disease might be due to a defect in the clearance system. Furthermore, sev-
eral reports suggested that a complete and safe disposal of apoptotic remnants is crucial for the 
maintenance of peripheral tolerance, and it has been demonstrated that dendritic cells (DCs) 
co-cultivated with apoptotic cells are suppressed in their production of infl ammatory signals. 
The aim of this study was to investigate whether an impaired clearance of apoptotic cells or a 
defect in the apoptotic pathway itself is responsible for the manifestation of SLE. DCs derived 
from peripheral blood mononuclear cell samples were analyzed regarding their functionality in 
clearance of apoptotic cells. Preliminary data suggest that DCs of patients with SLE are highly 
sensitive to infl ammatory stimuli as measured by cytokine secretion in contrast to normal healthy 
donors. In addition, we observed that the activation of patients’ DCs could still be suppressed by 
apoptotic tumor cells. To determine if tolerance can be induced by apoptotic cells of SLE patients, 
we co-cultivated apoptotic neutrophils with U-937, a tumor cell line displaying DC qualities. 
Interestingly, we observed an increase of infl ammatory parameters in some of the patients in 
contrast to normal healthy donors when apoptotic neutrophils were used. These data support our 
hypothesis that there is a molecular defect in peripheral tolerance in SLE patients which might be 
due to impaired apoptosis. Further analysis is necessary to understand the mechanism and impact 
of these fi ndings and to allow therapeutic approaches in the future.
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TLR2 Ligands of Vitreoscilla Filiformis Induce Tolerogenic Dendritic Cells
Volz T1, Gueniche A2, Kaesler S1, Breton L2 and Biedermann T1
1Department of Dermatology, University of Tübingen (Germany)
2L’OREAL Recherche, Clichy (France)
Activation of T helper lymphocytes by dendritic cells (DC) leads to skin infl ammation in atopic 
dermatitis (AD) and a dysbalance of the immune system plays a key role in the induction and 
maintenance of AD. Consequently, correcting this immune dysbalance is a promising thera-
peutic strategy. Among other approaches, applying extracts of non-pathogenic bacteria such as 
the thermal water gram-negative bacteria V.fi liformis (Vf) to atopic patient skin proved effective 
compared to placebo but the underlying mechanism remained unknown. To shed light on it, 
different compounds derived from Vf were analyzed and their immunomodulatory effects on 
dendritic cells (DC) and T cells were tested. Several Vf preparations led to maturation of im-
mature DC as monitored by upregulation of CD80, CD86 and MHC class II. However, marked 
differences were seen in regard to cytokine production comparing the different compounds. 
IL-12 production by DC was the highest in pure lipopolysaccharide (LPS) or LPS containing Vf 
preparations and less detectable in LPS depleted preparations. DC-T cell co-cultures revealed 
a marked induction of IFN-γ producing Th1 cells by the former activated DC. In contrast to 
IL-12, IL-10 production by DC was the lowest in DC stimulated with pure LPS. The IL-10 to 
IL-12 ratio was the highest in preparations with little or no LPS and the lowest in pure LPS. 
To investigate the mechanism of Vf induced IL-10 production, immature TLR2 knock-out and 
wildtype DC were generated and incubated with the different preparations. IL-10 production 
was almost completely abolished in DC lacking functional TLR2 suggesting a hitherto unknown 
TLR2 ligand with tolerogenic activity. 
Our data demonstrate the immunomodulatory activity of TLR2 ligands in thermal water bacte-
ria Vf and suggest a new possible mode of action. Furthermore, these studies indicate that these 
types of bacteria have the potential to strengthen immune control and that new compounds 
derived thereof could be used to restore the immunological balance in atopic patients.
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Innate Immune Responses in Atopic Dermatitis Induce Interleukin 12 and Skin Homing of 
Th2 Cells
Volz T1, Lametschwandtner G2, Guenova E1, Kaesler S1, Röcken M1, Carballido J2 and 
Biedermann T1
1Department of Dermatology, University of Tuebingen (Germany)
2Novartis Research Institute, Vienna (Austria)
Infl ammation in atopic dermatitis (AD) is closely linked to skin infections with Staphylococ-
cus aureus. A major cell wall component of S. aureus is lipoteichoic acid (LTA) belonging to 
the class of “pathogen associated molecular pattern” (PAMP) that bind to Toll-like receptor 
(TLR) 2. The role of TLR2 ligands in initiating innate immune responses is still not clear and 
has not been investigated for AD. The present studies were carried out to understand TLR2 
mediated innate immune signals and the transition to adaptive immune responses in AD. In 
dendritic cells (DC), LTA induced TLR2 dependent maturation and Interleukin (IL) 12 produc-
tion. Extensive studies on the consequences of LTA mediated IL-12 production for AD revealed 
that IL-12 mediated “cutaneous imprinting” on human memory Th2 cells prior to a switch to 
Interferone (IFN) γ production. Immunological imprinting describes the induction of a tissue 
specifi c pattern of homing receptors that is achieved during T cell activation and determines T 
cell homing. We could show that IL-12 rapidly upregulated α(1-3)-fucosyltransferase VII and 
cutaneous lymphocyte antigen (CLA) even in former CLA- Th2 memory cells. This CLA expres-
sion was functionally relevant as it established Th2 cell rolling on E-Selectin and migrating into 
human skin of humanized SCID mice. Demonstrating that S. aureus derived LTA induced IL-12 
that consecutively initiated cutaneous imprinting in Th cells indicates an important new role 
of S. aureus in the pathogenesis of AD as well as a general pathway of the transition of innate 
immune signals to tissue specifi c immune responses. 
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The Severity of Allergic Contact Dermatitis Depends on the Numbers of Skin Dendritic Cells 
Able to Migrate to Draining Lymph Nodes During Sensitization
Bonneville M, Chavagnac C, Benetiere J, Tedone R, Vocanson M, Hennino A and Nicolas JF
INSERM U503, IFR128, Lyon (France)
Allergic contact dermatitis (ACD) is a frequent infl ammatory skin disease occuring in patients 
in contact with low MW chemicals called haptens. ACD is mediated by hapten-specifi c CD8+ 
T cells which are primed in lymph nodes upon hapten presentation by skin DC migrating from 
the skin during the sensitization phase. Upon challenge, primed CD8+ T cells infi ltrate the 
antigen-exposed site and induce the ACD infl ammatory reaction. Since the severity of ACD to 
a given hapten varies greatly among patients, the aim of the present study was to address the 
mechanisms which control the intensity of ACD to DNFB in two stains of mice which develop a 
severe (C57BL/6) and moderate (BALB/C) skin infl ammation, respectively. We used the primary 
allergic contact sensitivity model where mice develop a DNFB-specifi c ACD 5 days after a 
single hapten painting on the ear. Results show that the severity of ACD is proportional to the 
numbers of skin DC able to migrate from the skin to draining LNs during sensitization. C57BL/6 
mice displayed 2 to 3 times more skin derived DC than BALB/C mice in LNs 24 hours after 
DNFB immunization. This effect was responsible for: i) priming of enhanced numbers of specif-
ic CD8+ T cells in LNs during sensitization; ii) infi ltration of higher numbers of effectors CD8+ 
T cells in the DNFB painted skin site during elicitation. These data show that the outcome of an 
ACD reaction is dependant on early events involving innate immunity and that the severity of 
ACD correlates with the numbers of skin DC able to migrate to LNs during sensitization. 
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Evidence for Spontaneous Apoptosis of Mature Monocyte-Derived Dendritic Cells
Castera L1, Hatzfeld AS1, Delaporte E2, Piette F2, Velu T3, Formstecher P1, Mortier L4 and 
Marchetti P1
1INSERM U814 Lille (France)
2Clinique Dermatologie CHRU Lille (France)
3CH Erasme, Bruxelles (Belgium)
4INSERM U814 Lille, Clinique Dermatologie CHRU Lille (France)
Numerous clinical trials were initiated which used monocyte-derived dendritic cells (DCs) to 
treat cancer patients. Although the results of several clinical trials were quite optimistic, the 
presence of patients with limited or no responses indicates the actual need for the improve-
ment of modern DCs-based therapies. One of the reasons for the limited effi cacy of the immune 
responses in treated patients may be premature suppression and elimination of mature DCs by 
apoptosis. The purpose of this study was to analyze the capacity of monocyte-derived DCs to 
spontaneously undergo apoptosis following the maturation process. First, the expression of 96 
apoptosis-related genes has been analyzed by GEArray Q series Human ApoptosisΤΜ. Within 24 
hour post-maturation, only one gene was overexpressed (Bim) whereas 8 genes (c-Flip, Mcl-1, 
Bcl-X, Ripk2, Fas, Trail, Gadd45a, Check1) were downregulated. Secondly, real-time RT-PCR 
confi rmed the downregulation of c-Flip, a strong inhibitor of the extrinsic apoptotic pathway, as 
well as the commitment of the intrinsic mitochondrial pathway since Bim (pro-apoptotic) was 
increased and Bcl-x strongly decreased (anti-apoptotic). Third, the release of mitochondrial cy-
tochrome c accompanied by the activation of caspase-3 was detected within the 24 hour post-
maturation confi rming the pro-apoptotic gene expression pattern. In conclusion, we showed 
that monocyte-derived DCs in culture undergo spontaneous apoptosis through distinct signal-
ing cascades. These fi ndings provide a basis for future efforts to understand the mechanisms 
and the differences in the apoptotic execution machinery in DCs used in clinical trials.
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CD16-CD56+ NK Cells from Nickel Allergic Individuals are Recruited at the Skin Site of Nickel 
Exposure and Contribute to the Expression of Allergic Reaction by Inducing Keratinocyte 
Apoptosis
Nasorri F, Bedini C, Scarponi C, De Pità O and Cavani A
Laboratory of Immunology and Allergology, IDI (Italy)
Allergic contact dermatitis (ACD) is T cell mediated immune response to small chemicals, 
mostly mediated by cytotoxic CD8+ T lymphocytes. Immunohystochemical staining of positive 
patch tests to nickel revealed CD3-CD56+ NK cells distributed in the mid and papillary dermis. 
NK cells isolated from ACD skin were CD161+, NKG2A+, CD16- and CD158b-, as evidenced by 
FACS analysis. In addition, skin NK cells failed to express the cutaneous-lymphocyte associated 
antigen, and displayed a restricted chemokine receptor repertoire, with high CXCR3 and inter-
mediate levels of CCR5, CCR6 and CCR8. Accordingly, skin NK cells predominantly migrated 
to CXCL10, and to a lesser extent to CCL1, CCL3, CCL5 and CCL20. Skin NK cells from allergic 
patients strongly proliferated and release IFN-γ in the presence of nickel-loaded dendritic cells. 
Furthermore, NK cells killed autologous keratinocytes in the presence, but not in the absence, 
of nickel. These data indicate that NK cells contribute to the tissue damage in ACD, and are 
involved in the amplifi cation and maintenance of the allergic response by releasing IFN-γ.
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4-hydroxyisoleucin Extract Exhibits Anti-Infl ammatory Properties
Perrin A, Gondran C, Bauza E, Dal Farra C and Domloge N
Vincience Research Center (France)
 
Pathogenic elements and external aggressions often prompt the activation of the infl ammatory 
reaction within organisms. Although this reaction is a positive defensive mechanism, exces-
sive infl ammatory reaction can lead to cell damage, immune system dysfunctions, and other 
harmful effects. The pro-infl ammatory cytokines TNF-alpha and IL-1 alpha are important early 
infl ammatory mediators, as they are synthesized fi rst and induce the activation of the cytokine 
cascade. Moreover, during infl ammation, the enzyme iNOS is overexpressed in cells and its 
synthesis is controlled by the presence of cytokines. In this study, we investigated the anti-in-
fl ammatory properties of a 4-hydroxysioleucin (4-OH Ile) extract on epithelial cells. We irradi-
ated HaCaT keratinocytes with 30 mJ/cm² UVB and then applied the active ingredient for 24 h 
or 48 h. Total cellular TNF-alpha and IL-1 alpha levels were assessed by ELISA. Immunostaining 
studies were also performed in order to evaluate cell expression of the enzyme iNOS, and cell 
morphology was visualized by hematoxylin-eosin staining. When applied for 24 h or 48 h, 4-
OH Ile-extract improved UV-irradiated and morphologically damaged cells. Cells treated with 
4-OH Ile-extract exhibited decreased cytokine expression in a time-dependent manner. The 
expression of TNF-alpha and IL-1 alpha decreased slightly (-6.5% and –10.4%, respectively) 
after 24 h of treatment with 4-OH Ile-extract. Whereas, after 48 h of treatment, expression of 
these cytokines was clearly down-regulated. TNF-alpha decreased by 37.5%, and IL-1 alpha 
decreased by 45.7%. Similar results were observed in the immunostaining studies of iNOS 
expression. A slight decrease in expression was seen after 24 h of treatment, and a signifi cant 
decrease was observed within 48 h of application, demonstrating the net anti-infl ammatory 
effect of 4-OH Ile-extract on the cells. 
These results demonstrate that 4-OH Ile-extract possesses very interesting anti-infl ammatory 
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Free Radicals as Mediators of Multiple-organ Failure after Major Burns
De Luca C1, Mikhal’chik E2 and Korkina L1
1Lab. Tissue Engineering & Cutaneous Physiopathology, IDI-Istituto Dermopatico 
dell’Immacolata, IRCCS (Italy)
2Department of Molecular Biology, Russian State Medical University (Russian Federation)
We studied the dynamics/nature/source of free radical production and antioxidant enzyme defense 
induction in the pathogenesis of burn injury, to design appropriate antioxidant (AO) treatments for 
acceleration of wound-healing and lowering the incidence of multi-organ failure.
Eighteen children (4-14 years) with a mean body surface burned area > 40% (N=7, burn score III 
A and B to IV) or within 5% - 15% (N=11, IIIA and B) were treated with conventional intervention 
schedules. Five died of multiple organ failure (day 16-20). The study of blood free radical produc-
tion demonstrated a signifi cant increase in all children, more intense/persistent in the most severe 
cases. Superoxide anion/lipid radicals were the main species formed (lucigenin-dependent chemi-
luminescence - CL), whilst peroxynitrite (L-arginine-activated CL), hydroxyl radicals, hypochlorous 
acid (phorbol ester-activated luminol-dependent CL) were less relevant. Antioxidant defenses were 
induced precociously in the less severe injury, whilst delayed in the more severe, with stronger 
glutathione metabolism activation. Superoxide production by both isolated PNM and whole blood 
was 2-4-fold increased vs. normal values, with longer persistence in severe cases. Total ROS pro-
duction was increased 15-30-fold vs. normal in severe cases (peak at day 10), and 2-7-fold in 
mild burns (peak at day 7), due to hyperproduction of lipid peroxides formed enzymatically, wilst 
HO·, OCl-; peroxynitrite, NO2-/NO3-concentrations were in the normal range. Catalase induction 
(spectrophotometry) occurred on day 1, delayed to day 7 in critical burns. Glutathione-metaboliz-
ing enzymes were more induced in the more severe cases.
Experimental studies were performed on the skin burn model of the pre-heated (to C=85oC) alumi-
num bar, producing a IIIB grade burn of 20% of body surface. Twenty-four male Wistar rats were di-
vided into: a) control group (N=12), receiving intra-esophageally saline for 4 days before wounding; 
b) experimental group (N=12), pre-treated with AO and immuno-stimulating formulation (CoQ10, 
RRR-alpha-tocopherol, seleno-dl-aspartate, methionine). Results showed (12 days of observation), 
signifi cantly decreased whole blood ROS production in the AO group (vs. control), decreased MPO 
activity in the pulmonary epithelium, marked increase of blood AO and glutathione detoxifying 
enzyme activities. Infl ammation markers were reduced; total SOD, catalase, glutathione peroxidase 
were signifi cantly increased in the skin biopsies (10 mm from wound border).
These data offer a clue to clinicians for the selection of appropriate antioxidant protocols, to be 
tailored for individual cases, according to the severity and extension of burn injury.
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Immune-Regulatory Role of PPAR-alpha in the Epidermis
Dubrac S1, Stoitzner P1, Schoonjans K2, Auwerx J2, Fritsch P1, Romani N1 and Schmuth M1
1Department of Dermatology, Medical University of Innsbruck (Austria)
2Institut de Génétique et Biologie Cellulaire et Moléculaire (IGBMC) of Illkirch (France)
Previously, peroxisome proliferator activated receptor (PPAR)-alpha activation has been shown to 
exert anti-proliferative, pro-differentiating and anti-infl ammatory effects in the epidermis. How-
ever its immune-regulatory role in the epidermis was unknown. We here report an exaggerated 
ear swelling response to contact allergens in mice lacking PPAR-alpha. Whereas PPAR-alpha was 
detectable in keratinocytes and immature Langerhans cells isolated from wild-type epidermis, 
there was a decrease in PPAR-alpha during LC maturation. Pharmacologic PPAR-alpha activa-
tion delayed LC maturation. In contrast, this effect was not observed in PPAR-alpha knock out 
mice, indicating receptor specifi city. Nevertheless, LC maturation was normal in LC isolated from 
PPAR-alpha defi cient animals, presumably due to compensatory mechanisms. Furthermore, 
PPAR-alpha activation reduced the migratory capacity of LC, their production of cytokines and 
their ability to drive T cell proliferation. Moreover, activation of PPAR-alpha inhibited NF-kappaB 
but not SAPK/JNK, p38MAPK and ERK1/2. NF-kappaB inhibition was abolished in PPAR-alpha 
defi cient mice and decreased when DNA-binding of PPAR-alpha was blocked, indicating a tran-
scriptional effect. We conclude that PPAR-alpha activation by endogenous ligands may provide a 
molecular signal that allows LC to remain in an immature state within the epidermis for extended 
periods of time despite minor environmental stimuli. PPAR-alpha could be involved in the coun-
terbalance of ongoing immune responses, by preventing tissue destruction after ligand activation 
by arachidonic acids and derivatives released from damaged cells. 
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Targeting CD25 for T-Regulatory Cell Depletion in Cutaneous T-Cell Lymphoma
Geskin LJ1, Kwon SY1, Strauss L2, Whiteside T2, Watkins S3 and Falo, Jr LD1
1Department of Dermatology, University of Pittsburgh (USA) 2IMCPL, University of Pittsburgh 
Cancer Institute (USA) 3Center for Biological Imaging, University of Pittsburgh (USA)
We sought to evaluate T-regulatory (T-regs) cells and effects of denileukin diftitox (ONTAK) on Tregs 
in Cutaneous T cell Lymphoma (CTCL) patients. Using multicolor fl ow cytometry we found that pa-
tients with high tumor burden had higher numbers of cells co-expressing CD4, CD25 and FoxP3 in 
peripheral blood (mean 13%) than patients in remission (mean 6%) or normal volunteers (mean 3%). 
To determine if the cells with T-reg phenotype possessed T-reg function, we isolated CD4+CD25+ 
cells by cells sorting or using magnetic beads. We tested them for production of IL-10, TGF-beta and 
IFN-gamma by ELISA and for ability to suppress proliferation of the effectors using cell division track-
ing dye (CFSE) and analyzed it using ModFit software. We found that CD4+CD25+ cells produced 
high levels of IL-10, TFG-beta and low levels of IFN-gamma and suppressed proliferation of effectors 
in proliferation assays.
To evaluate the effects of denileukin diftitox in CTCL patients, peripheral blood was obtained before, 
immediately after the course of Denileukin diftitox (day 5), and 3 weeks after the course (day 19). We 
found that Denileukin diftitox signifi cantly but transiently (reversed in 3 weeks) depleted cells co-
expressing CD4, CD25, and FOXP3 in patients’ naïve to the drug. However, for patients on ongoing 
Denileukin diftitox therapy the Tregs numbers were consistently lower without signifi cant fl uctua-
tion. In lesional skin samples CD4+CD25+FoxP3+ cells were also depleted following Denileukin 
diftitox therapy.
In conclusion, we demonstrate that patients with high tumor burden have higher numbers of Tregs 
than patients in remission or normal volunteers. Denileukin diftitox (ONTAK) transiently depletes 
Tregs in CTCL patients. This study provides proof of principle that Tregs can be depleted from the pe-
ripheral blood of CTCL patients, and represents a clinically feasible strategy to accomplish this goal 
in conjunction with other immunotherapeutic approaches, including DC-based immunotherapy.
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Development of a Cellular Vaccine against Th1 Mediated Infl ammatory Autoimmune 
Disease
Brueck J, Weigert CM, Röcken M and Ghoreschi K
Department of Dermatology, University of Tuebingen (Germany)
Experimental autoimmune encephalomyelitis (EAE) is an infl ammatory demyelinating disease 
of the central nervous system that can be induced by interferon (IFN-)γ-producing CD4+ T 
helper (Th)1-cells recognizing myelin epitopes. Immune deviation of IFN-γ-producing Th1-cells 
into interleukin (IL-)4-producing Th2-like responses is one promising strategy that may improve 
this model disease of multiple sclerosis. To determine whether Th2-cells are merely associated 
with improved disease or whether Th2-cells themselves can be protective in immunocompe-
tent mice, we investigated whether in vitro differentiated autoreactive Th2 lymphocytes are able 
to protect mice from EAE.
After immunization of SJL mice with proteolipid protein peptide (PLP) in complete Freund’s 
adjuvant (CFA) and pertussis toxin (PT), we isolated CD4+ T-cells from lymph nodes and spleen 
and differentiated the cells into PLP-specifi c Th1- or Th2-cells in vitro. Adoptive transfer of PLP-
specifi c Th1-cells into naïve SJL mice resulted in severe encephalomyelitis, whereas transfer of 
PLP-specifi c Th2-cells did not induce any disease over a period of 90 days.
To determine whether PLP-specifi c Th2-cells may also protect against EAE, we transferred PLP-
specifi c Th2-cells into mice and challenged these mice with peptide, CFA and PT. Mice were 
assessed daily for clinical signs of EAE over 90 days. Following immunization control mice and 
mice receiving PLP-specifi c Th1-cells both developed severe EAE with high mortality. In sharp 
contrast, mice immunized with PLP, CFA and PT after the transfer of PLP-specifi c Th2-cells were 
protected as they developed no or only mild disease. 
Here we show that autoreactive myelin-specifi c Th2-cells have not only lost their capacity to 
induce infl ammatory autoimmune disease, but moreover the presence of antigen-specifi c Th2-
cells provided protection against induction of EAE, even under strong Th1-driving conditions. 
Thus, antigen-specifi c Th2-cells may be used for the development of a cellular vaccine protect-
ing from autoimmune disease.
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Organ-specifi c Antigen Exposure Directs Migration of GALT-Derived T cells
Glocova I, Yazdi AS, Röcken M and Ghoreschi K
Department of Dermatology, University of Tuebingen (Germany)
Epithelial surfaces of skin and intestine form barriers to the external environment and are per-
manently exposed to multiple potential antigens. Clinical observations suggest that oral antigen 
exposure may activate antigen specifi c T cells not only within the gut associated lymphoid 
tissue (GALT) but also to distant sites. As seen in patients with atopic dermatitis, food allergen-
reactive T cells could be isolated from the skin. Antigen-presenting dendritic cells from skin 
and gut have been shown to imprint specifi c T cells in vitro for selective homing to their cor-
responding organs after transfer in vivo. Therefore we investigated the potential of GALT-derived 
antigen-specifi c T cells to migrate to the site of antigen-exposure.
Ovalbumin (OVA)-specifi c T lymphocytes from OVA T cell-receptor transgenic mice fed with 
OVA-protein were transferred into naïve BALB/c mice exposed to OVA either by oral ad-
ministration or epicutaneous application. In parallel, skin primed OVA-specifi c T cells were 
transferred and migration was analyzed. After oral OVA challenge we observed specifi c en-
richment of OVA-reactive T cells in the GALT whereas random distribution of OVA-specifi c 
T lymphocytes was seen in control mice. Antigen-specifi c homing was associated with an 
upregulation of α4β7 integrin and concomitant downregulation of L-selectin and P-selectin lig-
and (PSGL-1) expression on OVA-specifi c T lymphocytes. Interestingly, epicutaneous OVA ex-
posure directed OVA-specifi c T lymphocytes predominantly into all skin draining lymph nodes 
accompanied by reduced L-selectin and PSGL-1 expression. In contrast to activation by feeding 
OVA, no α4β7 expression was detected after epicutaneous OVA application. Importantly, no 
clinical characteristics of protein-contact dermatitis could be observed, whereas skin-primed 
OVA-specifi c T cells were able to induce eczema after adoptive transfer and epicutaneous 
OVA challenge. Thus, epicutaneous antigen exposure directs GALT-derived antigen-specifi c T 
lymphocytes into the skin associated lymphoid tissue without causing eczema. 
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Reactive Oxygen Species Modulate Toll Like Receptor Signaling in Dendritic Cells
Ghoreschi K, Weigert CM, Respa A, Brueck J and Roecken M
Department of Dermatology, University of Tuebingen (Germany)
Activation of dendritic cells (DC) through Toll like receptor (TLR) ligands 4 or 9 leads to the 
differentiation of DC into either T helper (Th)1 cell-inducing DC1 or Th2 cell-inducing DC2. 
This may orchestrate the outcome of immune responses to self or foreign antigens resulting in 
autoimmune diseases or allergy. Activation of TLR4 by lipopolysaccharid or of TLR9 by un-
methylated CpG oligodeoxynucleotide induces a DC phenotype (DC1) that produces large 
amounts of IL-12 or IL-23 and induces interferon (IFN)-γ-producing Th1 cells or IL-17-produc-
ing Th17 cells. In contrast, IL-12- or IL-23-defi cient DC2 induce IL-4-producing Th2 cells. Yet, 
under physiological conditions, DC receive TLR-stimulation during infections, a condition that 
is frequently associated with the generation of large amounts of reactive oxygen species (ROS). 
As ROS strongly interfere with intracellular signaling, we analyzed the effects of ROS and ROS 
scavengers on IL-12 and IL-23, produced by DC and the development of Th1 or Th2 responses. 
H2O2 as well as depletion of intracellular ROS scavenger modulated the production of IL-12 
and IL-23 by DC following stimulation through TLR4 or TLR9. The capacity of DC to produce 
IL-12 or IL-23 was suppressed 10 to 100 fold after ROS induction or ROS scavenger-deple-
tion. These effects were compensated by exposure to ROS scavengers such as glutathione or 
N-acetylcysteine. Moreover, induction of higher ROS levels in DC enhanced IL-10 production 
after TLR activation. Functional analysis showed that TLR4- or TLR9-stimulated DC induce Th1 
and Th17 differentiation, whereas in the presence of ROS strong IL-4-dominated Th2 responses 
were observed. Thus, intracellular levels of ROS or ROS scavenger modulate TLR-signaling in 
DC that determines the differentiation of Th1 or Th2 responses.
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Increased Nitric Oxide Production by Perilesional Psoriatic Fibroblasts
Grabarczyk J1, Wyczolkowska J2, Sysa-Jedrzejowska A1 and Zalewska A1
1Department of Dermatology, Medical University of Lodz (Poland)
2Centre for Medical Biology, Polish Academy of Sciences, Lodz (Poland)
Nitric oxide (NO) has been considered as a strong candidate of psoriasis pathogenesis.
The aim of the study was to evaluate NO levels in plasma of psoriatic patients and supernatants 
of psoriatic fi broblasts.
The study comprised 106 patients with active psoriasis vulgaris. Severity of the disease was 
assessed by PASI score before treatment and after 3 weeks of in-patients treatment and plasma 
collected.The control group comprised 40 healthy individuals, age sex-matched. Fibroblast 
were obtained by punch biopsy from psoriatic lesions, immediate surroundings and healthy 
control skin. Human must cell line (HMC-1) was used for co-cultures. Interleukin 4 (IL-4) at 2 
ng/ml was used to stimulate the cells. Nitrite levels were determined by the Griess reaction.
Signifi cantly increased NO plasma levels were observed both before treatment and 3 weeks 
after treatment in comparison to the control group (mean ± SD: 5.6 ± 2.9, 4.1 ± 1.6, 1.0 
± 0.6 μM/L, respectively) (p<0.001). Also NO plasma levels were signifi cantly higher before 
treatment than after treatment (p<0.001). After treatment a positive correlation between PASI 
score and NO plasma levels was observed (r=0.31, p<0.05). Both in control and under IL-4 
stimulation, perilesional psoriatic fi broblasts and co-cultures of perilesional psoriatic fi brob-
lasts with HMC-1 line produced signifi cantly increased NO levels in comparison to HMC-1 
alone healthy control fi broblasts and co-cultures of HMC-1 with healthy control fi broblasts. 
IL-4 stimulation lead to increased NO production only by HMC-1 cells in comparison to the 
control (p<0.05).
In conclusion, NO plasma levels could serve as a maker of psoriatic lesion regression. IL-4 
seems not to be the key cytokine in NO suppresion by the examined cultures.
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A Novel Dermal Blood Vessel Phenotype in Skin Infl ammation
Gröger M1, Niederleithner H1, Kerjaschki D2 and Petzelbauer P1
1Department of Dermatology, Medical University of Vienna (Austria)
2Institute of Pathology, Medical University of Vienna (Austria)
Podoplanin and LYVE-1 are considered as lineage markers for lymphatic vessel endothelial 
cells (LEC). We have recently shown that IL-3 induces de novo expression of these genes in 
cultured blood vessel endothelial cells (BEC). To ask, if this is trans-differentiation or activation, 
we analyzed skin samples where the affi liation of EC to either blood or lymphatic capillary 
beds can also be determined by the presence of smooth muscle actin positive cells surround-
ing blood but not lymphatic capillaries. In infl amed skin samples and in cytokine-stimulated 
organ-cultured skin we found a subset of blood capillaries within the papillary dermis express-
ing low amounts of podoplanin and LYVE-1 as well as high amounts of cytokine-inducible 
adhesion molecules. In contrast, neighboring lymphatic capillaries express high amounts of 
podoplanin, LYVE-1 and low amounts of cytokine-inducible adhesion molecules. The different 
response patterns to infl ammatory stimuli were reproducible in cell culture, when cytokine-
stimulated BEC and LEC were analyzed. These fi ndings signify that expression of ‘lymphatic 
proteins’ on BEC corresponds to cell activation. Upregulation of podoplanin as a sialylated 
O-glycan and LYVE-1 as a receptor for glycosaminoglycan hyaluronan on blood vessels could 
serve as a modifi er of cell adhesion to blood capillaries in infl ammation. 
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Characterization of CD4+CD25+foxp3+ Regulatory T Cells in Psoriatic Skin
Gyulai R, Kocsis K, Varga B and Kemény L
Department of Dermatology and Allergology, University of Szeged (Hungary)
Previously we have demonstrated a profound proliferative and functional defi cit of CD4+CD25+ 
regulatory T cells in the chronic infl ammatory skin disease, psoriasis. The aim of the present 
work was to demonstrate the presence of CD4+CD25+foxp3+ T cells in situ, in psoriatic skin, 
and characterize their cytokine expression profi le and cellular marker expression. FoxP3, 
CD25, CTLA-4, glucocorticoid induced tumor necrosis factor receptor (GITR), interferon (IFN)- 
γ, interleukin (IL)-10, and transforming growth factor (TGF)-β mRNA expression was deter-
mined in normal, as well as involved and uninvolved psoriatic skin using quantitative real time 
RT-PCR technique. Foxp3 mRNA expression was present in normal epidermis, but remained 
below detection threshold in healthy dermis. In uninvolved psoriatic epidermis and dermis, 
foxp3, IFNγ, and IL-10 expression was found elevated as compared to corresponding normal 
skin values. In lesional psoriatic epidermis and dermis, foxp3, CD25, CTLA-4, IFNγ, and inter-
leukin IL-10 mRNA levels were markedly increased. The present experiments provide further 
evidence for the presence of foxp3+ regulatory T cells in normal and psoriatic skin.
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Papillomavirus-like Particles Presenting a Short Amyloid-beta Peptide are an Effective Vaccine 
Platform in Alzheimer’s Disease Mouse Model
Handisurya A1, Zamora E2, Shafti-Keramat S1, Borchelt D3, Rudow G2, Conant K2, Cox C4, 
Kirnbauer R1 and Troncoso JC2
1Laboratory of Viral Oncology, DIAID, Dermatology, Medical University Vienna (Austria)
2Neuropathology, Johns Hopkins University, Baltimore (USA)
3Santa Fe Health Alzheimer’s Disease Research Center, McKnight Brain Institute, University of 
Florida (USA)
4Bloomberg School of Public Health, Johns Hopkins University, Baltimore (USA)
Vaccination with amyloid-beta (A-beta) protein prevents the deposition of A-beta in the brain 
and memory defi cits in transgenic mouse models of Alzheimer’s disease (AD), opening the 
possibility for immunotherapy of AD in humans. Unfortunately, the fi rst human trial of A-beta 
vaccination was complicated by cell-mediated meningoencephalitis in a small number of 
vaccinees. In order to develop an A-beta immunogen that lacks the potential to induce au-
toimmune encephalitis, we have used papillomavirus-like particles (VLP) as an immunogenic 
vaccine platform, that display a small peptide of the A-beta protein, comprising amino acids 
(aa) 1-9, repetitively on the viral capsid surface (A-beta VLP). This A-beta peptide was chosen 
because it contains a functional B-cell epitope, but lacks known T-cell epitopes. Rabbit and 
mouse vaccinations with A-beta VLP were well tolerated and induced high-titer auto-antibod-
ies against A-beta that inhibited effectively assembly of A-beta 1-42 peptides into neurotoxic 
fi brils in vitro. Following A-beta VLP immunizations of APP/PS1 transgenic mice, a model for 
human AD, we observed trends for reduced A-beta deposits in the brain and increased num-
bers of activated microglia. Furthermore, vaccinated mice showed increased levels of A-beta in 
plasma, suggesting effl ux from the brain into the vascular compartment. These results indicate 
that the A-beta VLP vaccine induces an effective humoral immune response to A-beta, and may 
thus form a basis to develop a safe and effi cient immunotherapy for human AD.
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Infl uence of Heat Stress on Human Monocyte-Derived Dendritic Cell Functions with 
Immunotherapeutic Potential for Antitumor Vaccines
Hatzfeld-Charbonnier AS1, Lasek A1, Castera L1, Gosset P2, Velu T3, Formstecher P4, Mortier L5 
and Marchetti P4
1Unité de Thérapie Cellulaire, CHRU de Lille (France)
2INSERM U774, Institut Pasteur de Lille (France)
3Department of Medical Oncology, Erasme Hospital, Université Libre de Bruxelles (Belgium)
4INSERM U814, Faculté de Médecine de Lille (France)
5Département de Dermatologie, CHRU de Lille (France)
Mild heat stress can modulate activities of immune cells including dendritic cells (DC) and 
theoretically would constitute an innovative approach capable of enhancing the anti-tumor 
functions of DC. Therefore, we tested the effects of mild heat stress on physiology and viability 
of human monocyte-derived DC, the major type of DC used in tumor immunotherapy trials. 
We fi rst designed a heat stress protocol consisting on repetitive sublethal heat shocks through-
out the generation of DC. Using this protocol, we observed that heat stress did not perturb 
(1) morphology and phenotype of immature or mature DC; (2) capacities of immature DC to 
uptake antigens effi ciently. It is noteworthy that in response to heat stress mature DC produced 
higher levels of IL-12p70 and TNFα, which are two cytokines involved in the stimulation of 
infl ammatory reaction whereas IL-10 production remained low. After heat stress exposure, ma-
ture DC have the full ability to stimulate naive T cells with Th1 response polarization (high IFN-
γ and low IL-4 production) in a mixed allogeneic lymphocyte reaction. Interestingly, heat stress 
enhanced migratory capacities of DC in response to MIP3β/CCL19. Finally, heat stress partly 
protected DC from apoptosis induced by cytokine withdrawal. Overall, these fi ndings validate 
the feasibility of improving the immune response by heating of human monocyte-derived DC 
and provide a strong rationale for using mild heat stress in combination with DC vaccination 
to increase antitumor response.
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Cyclosporin A Impairs T Regulatory Cell Function in Atopic Dermatitis Patients
Hijnen DJ, Haeck I, Bruijnzeel-Koomen CA, Knol EF, Nijhuis E and Bruin-Weller MS
Department of Dermatology & Allergology, University Medical Center, Utrecht (Netherlands)
There is limited data on how calcineurin inhibitors might infl uence T regulatory cells (Tregs) in 
vivo. In vitro data have shown that cyclosporin A (CsA), in contrast to steroids, inhibits FOXP3 
expression. CsA is being increasingly used in the treatment of severe atopic dermatitis (AD). 
Impairment of Tregs by CsA treatment might represent a unwanted side effect.
The objective of this study was to investigate the effects of cyclosporin A (CsA) treatment on 
peripheral blood T cell populations and in particular Tregs in AD patients. 
In ten AD patients with severe AD, treated with CsA blood was obtained before onset of treat-
ment, after three and after six weeks of treatment. PBMCs were isolated for cell surface marker 
analysis using fl ow cytometry and CD4+ T cells were isolated using magnetic cell sorting. 
Using real-time RT PCR expression of genes previously found differentially expressed in AD 
patients, including FOXP3 and GADD45A was measured. Effi cacy of treatment was evaluated 
by using the scoring atopic dermatitis score (SCORAD). In addition, serum thymus and activa-
tion regulated chemokine (TARC/CCL17) was determined as a marker for disease severity.
All patients showed rapid improvement of disease severity as shown by signifi cant decreases 
of SCORAD and serum TARC levels. Although, FACS analysis revealed no signifi cant changes 
in the percentages of CD3+, CD4+, CD8+, CD19+, CD25+, CD45RA+ and CD45RO+ cells, 
there was a signifi cant decrease in the percentage of CD25high+ cells. In addition, there was 
a signifi cant decrease of FOXP3 and GADD45A expression in CD4+ T cells during CsA treat-
ment.
Although CsA treatment is highly effective, we suggest that impairment of the T regulatory cell 
population by CsA might represent an undesirable side effect. Severe exacerbations that fre-
quently occur when tapering CsA dosage or after discontinuation of treatment might be related 
to the impairment of Tregs described here.
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Increased Expression of Toll Like Receptor 2 in Active Lesions of Acne Inversa
Hunger RE, Surovy A, Braathen LR and Yawalkar N
Department of Dermatology, University of Bern, Inselspital, Bern (Switzerland)
Acne inversa is a chronic infl ammatory disease of the terminal hair follicles predominantly in 
skin folds that carry terminal hairs and apocrine glands. The disease is characterized by recur-
rent abscesses and draining sinuses mainly located in the axillae, groins and perineum. Healing 
occurs usually with substantial scarring. The pathogenesis of the disease is not well understood 
and the contribution of bacterial superinfection during disease progression is not clear. Toll like 
receptors expressed by infl ammatory cells are crucial players in the innate immune response 
to bacteria. In this study we investigated the contribution of TLR2 expressed on infl ammatory 
cells during disease progression. Using immunohistochemical markers we fi rst phenotypically 
characterized infi ltrating infl ammatory cells. In the dermis of chronic infl amed lesions the most 
abundant cells were macrophages (CD68), DC (CD209) and T cells (CD3). B cells (CD19) were 
only found in small numbers. In the epidermis Langerhans cells (CD1a) were not increased 
compared to normal skin, but a clearly increased number of T cells were found. Using real time 
PCR analysis and immunohistochemical staining we analyzed in situ expression of TLR2. Com-
pared to normal skin a highly increased in situ expression of TLR2 receptors in lesional skin 
was found on mRNA and protein level. Double stainings with fl uorescence-labelled antibodies 
showed that TLR2 was expressed by infi ltrating macrophages (CD68) and DC (CD209). These 
data indicate that chronic stimulation of TLR2 receptor expressed by infi ltrating monocytes and 
DC may contribute to disease progression.
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CCL19/21 as Survival Rather than Maturation Factors for DCs
Jalili A1, Pashenkov M1, Wagner C2, Nakano H3, Stingl G1, Wagner SN1
1DIAID, Department of Dermatology and CeMM, Center for Molecular Medicine (Austria)
2DIAID, Department of Dermatology (Austria)
3Division of Cardiology, Department of Medicine, Duke University Medical Center, NC (USA)
CCL19 and 21 are CC chemokines expressed predominantly in secondary lymphoid organs 
(SLO), to where they attract CCR7+ cells, including mature DCs. Most recently, it has been 
suggested that chemokines also induce maturation of DCs. The aim of our study was to evaluate 
whether CCL19 and 21 contribute to maturation and/or survival of DCs. 
Here, we took advantage of plt/plt mice, which lack expression of CCL19 and 21 in their 
SLO. 
Flow cytometric analysis of cells sorted from SLO of plt/plt mice revealed no evidence of matu-
ration difference to DCs from wild type mice, as indicated by comparable surface expression 
levels of CD80, CD86, CD40 and MHC class II.
In vitro, supernatants derived from CCL19- and 21- transfected cells as well as recombinant 
CCL19 and 21 induced: (i) chemotaxis, (ii) CD40 expression and (iii) FITC-dextran uptake in 
bone marrow-derived DCs (BMDCs) in both wild type as well as plt/plt mice. However, up-
regulation of expression of CD80, CD86, MHC class II, CCR7 and induction of morphological 
changes associated with maturation could be observed neither in wild type nor in plt/plt DCs. 
Our study show that, (i) numbers and maturation status of DCs in SLO independent of the 
presence of CCL19/21 in vivo, (ii) DCs may maturate even in the absence of CCL19/21, and 
(iii) CCL19/21 induce expression of CD40 on DCs. Our fi ndings argue for a contribution of 
CCL19/21 to survival rather than maturation of DCs and in this respect may help to identify 
mechanism underlying the impaired adaptive immune responses observed in the absence of 
CCL19 and 21 in vivo.
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Distorted Response of Lesional Psoriatic Fibroblasts to Infl ammatory Stimuli
Janowski P1, Glowacka E2, Tchorzewski H2, Sysa-Jedrzejowska A3, Zalewska A3
1Out-Patient Dermatological Department “PLMA” (Poland)
2Department of Clinical Immunology, Polish Mother’s Memorial Hospital, Lodz (Poland)
3Department of Dermatology, Medical University of Lodz (Poland)
Dynamic interplay between fi broblasts and their neighbouring cells including neutrophils 
seems to contribute to pathogenesis of psoriasis. The aim of the study was to evaluate inter-
leukin 8 (IL-8) production by psoriatic fi broblasts and neutrophils.
Fibroblasts were obtained by punch biopsy from lesional and perilesional psoriatic skin from 
ten psoriasis vulgaris in-patients and ten healthy control skin. Neutrophils were obtained from 
blood of both psoriatic patients and healthy controls. Cells were stimulated with either in-
terleukin 8 (IL-8) or tumor necrosis factor alpha (TNF-α). IL-8 levels both in plasma and cell 
supernatants were evaluated by ELISA method.
Normal healthy and lesional psoriatic fi broblasts produced signifi cantly higher levels of IL-8 
than perilesional skin fi broblasts (p<0.05). There was no signifi cant difference in IL-8 produc-
tion between normal healthy and psoriatic neutrophils (p>0.05). When stimulated with either 
IL-8 or TNF-α, addition of healthy normal neutrophils to either healthy normal fi broblasts or 
psoriatic lesional fi broblasts led to considerable IL-8 suppression (p<0.05).There was no how-
ever, any signifi cant difference between lesional and perilesional psoriatic fi broblasts (p>0.05). 
Suppression of IL-8 production by healthy normal neutrophils/healthy normal fi broblasts co-
cultures was signifi cantly stronger i.e. production of IL-8 lower than in healthy normal neu-
trophils/lesional psoriatic fi broblasts co-cultures (p<0.05). Healthy normal neutrophils and 
fi broblasts in vitro cooperate in suppression of IL-8 production, whereas lesional psoriatic fi -
broblasts in culture with normal healthy neutrophils produce signifi cantly higher amounts of 
IL-8 than normal healthy fi broblasts.
In conclusion, normal healthy fi broblasts and neutrophils interactions in vitro lead to suppres-
sion of IL-8 production and thus infl ammation. Lesional psoriatic fi broblasts in co-culture with 
healthy neutrophils seem to have a distorted response to infl ammatory stimuli in vitro thus 
probably adding in vivo to infl ammatory response maintenance.
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CD8+ T-lymphocytes Reactive against Epstein-Barr Virus Antigens in Skin Lesions of a Sezary 
Syndrome Patient
Knol AC1, Guilloux Y1, Pandolfi no MC2, Quereux G3, Brocard A3, Khammari A3, Dreno B3
1Inserm U601, Nantes (France)
2UTCG, Nantes (France)
3Clinique Dermatologique, Nantes (France)
Cutaneous T-cell lymphomas (CTCL) are characterized by an epidermal infi ltration of activated 
memory T lymphocytes of the CD4+ phenotype, and of unknown origin. Several studies have 
thus investigated the possible involvement of viral agents and among them herpes viruses in the 
development of CTCL. In a previous study, we observed that Langerhans cells of the epidermis 
expressed EBNA2 protein of EBV by immunohistochemistry on cutaneous sections of the lesional 
skin of a Sezary syndrome patient (histologically confi rmed with more than 80% circulating 
Sezary cells). In addition, we detected the presence of EBER1 mRNA by in situ hybridisation in 
Langerhans cells for the same patient. The aim of this new work to determine whether T-cells spe-
cifi c to EBV antigens were detectable among “TIL” infi ltrating cutaneous lesions. We used a tran-
sient COS transfection assay that permitted an estimation of CD8 T cell responses against a large 
number of HLA/viral protein combinations, to analyse responses to EBV, that were measured by 
TNF production of T-cells. This technique allowed the detection of EBV-specifi c T-lymphocytes 
mainly directed against epitopes generated during the lytic cycle in the cutaneous lesions: the 
strongest productions of TNF were observed with BHRF-1 and BRLF-1 in the HLA-A*0101 con-
text and with BZLF-1 in the HLA-B*0801 context. These results confi rm the presence of EBV 
in the lesional skin of a Sezary syndrome patient. The presence of the Pautrier microabscess, 
composed of large cluster of T cells surrounding Langerhans cells in the epidermis and in dermal 
infi ltrates, shows that there are tight interactions between these cells. Therefore such EBV infected 
Langerhans cells could attract T lymphocytes in the skin and induce their activation and prolifera-
tion. This is, to our knowledge, the fi rst description of the presence of EBV-specifi c T-lymphocytes 
among TIL infi ltrating the lesional skin of a Sezary syndrome patient.
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Anti-Infl ammatory and Wound Healing Activity of Verbascoside Derived from Cultured Plant 
Cells
Korkina L1, Mikhal’chik E2, Suprun M2, Pastore S1, Pressi G3 and Dal Toso R3
1Laboratory of Tissue Engineering, IDI IRCCS (Italy)
2Department of Molecular Biology, Russian State Medical University (Russian Federation)
3Istituto di Ricerca Biotecnologica, Altavilla Vicentina (Italy)
Plants contain a wide range of polyphenols possessing positive health effects such as anti-in-
fl ammatory, anti-thrombotic, anti-angiogenic, wound healing, UV-protective, and cancer pre-
ventive ones. Majority of these health effects was attributed to signifi cant antioxidant, free radi-
cal scavenging, and metal chelating properties of plant polyphenols. Verbascoside (VB) belongs 
to the family of phenylpropanoids containing two polyphenolic rings and three carbohydrates 
connected into an oligosaccharide chain. VB was found in aerial parts of a number of plants. 
The availability of VB from natural sources is very low, its extraction and purifi cation is diffi cult, 
and a fi nal product is poorly standardized. The plant cell line of Syringa vulgaris was developed 
to produce suffi cient amounts of standardized extracts enriched with VB. These VB-containing 
biotechnologically produced extracts were characterized physico-chemically and extensively 
evaluated for their free radical scavenging, antioxidant, chelating, anti-infl ammatory, and 
wound healing activity. They were found to be extremely effective in direct reactions with bio-
logically relevant oxygen centred free radicals and peroxynitrite; they chelated transition metal 
ions such as ferric, ferrous, copper, and nickel forming non-toxic redox inactive complexes 
thus, inhibiting lipid peroxidation and other free radical-driven damages to DNA and proteins. 
The VB extracts inhibited (IC50 = 20 μM) superoxide production by PMA-activated human 
granulocytes. They were more effi cient inhibitors of the infl ammatory protein formation by cul-
tured human keratinocytes stimulated by TNF-α and interferon-γ than hydrocortisone and tri-
amcinolone (IC50 for VB were equal to 50, 30, 10, 25 μM for GM-CSF, IL-8, IP-10, and MCP-1, 
respectively). The VB extracts, being applied topically, showed pronounced anti-infl ammatory 
and wound healing activity in three types of wounds in rats: burns, excision and scarifi cation. 
The results obtained allowed us to conclude that highly standardized biotechnologically pro-
duced VB is a new type of anti-infl ammatory and wound healing substances.
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Whole Body Irradiation Abrogates Anti-Tumor Effect of CpG Oligonucleotides in SCID Mice
Krepler C1, Strommer S2, Pehamberger H1 and Wacheck V2
1Department of Dermatology, Medical University Vienna (Austria)
2Department of Clinical Pharmacology, Medical University Vienna (Austria)
CpG oligonucleotides are a novel and promising approach to induce anti-tumor activity by stimula-
tion of the immune system. The anti-tumor potential of CpG oligos against human xenografts is well 
established, also in immune compromised SCID mice despite their lack of functional B- and T-cells. 
It is so far not known to which remaining part of the immune system this effect can be attributed to. 
In the current study we investigated whether ablation of the cellular immune system via whole body 
irradiation infl uences the immune stimulatory and anti-tumoral activity of CpG oligonucleotides. 
SCID mice were whole body irradiated (4 Gray) the day before s.c. inoculation of 518A2 human 
melanoma cells. After development of palpable tumors, SCID mice were treated with CpG oligos or 
saline three times per week. Non-irradiated SCID mice receiving the identical treatment were used 
as control. Tumor size was assessed twice weekly by calliper measurement.
After one week of CpG oligo treatment, the growth of established tumor xenografts in non-irradi-
ated SCID mice was inhibited by 45% relative to saline control. In contrast, in irradiated animals 
there was no difference in tumor volume between CpG oligo and saline treatment. Of note, after 
two weeks of treatment, corresponding to three weeks after irradiation, tumor growth was also 
beginning to be inhibited in the irradiated CpG treatment group, although not to the same extent 
as in the non-irradiated group.
Our fi ndings demonstrate that ablation of the cellular immune system by whole body irradia-
tion suppresses the anti-tumor activity of immune stimulatory CpG oligos in SCID mice. These 
results indicate that the cellular immune system is of critical importance for the anti-tumor 
activity of CpG oligos. Temporal immune ablation in SCID mice by whole body irradiation 
might provide a valuable tool for further elucidating the exact mechanisms of how CpG oligo-
nucleotides elicit their anti-tumoral effect. 
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Apoptotic Cells Accumulate in the Skin of Patients with Cutaneous Lupus Erythematosus after 
UV Irradiation
Kuhn A1, Herrmann M2, Kleber S1, Beckmann M3, Fehsel K4, Martin-Villalba A1, Lehmann P3, 
Ruzicka T3, Kolb-Bachofen V4 and Krammer PH1
1Tumorimmunology Program, Division of Immunogenetics, German Cancer Research Center, 
Heidelberg (Germany)
2Institute for Clinical Immunology, University of Erlangen, Erlangen (Germany)
3Department of Dermatology, University of Düsseldorf, Düsseldorf (Germany)
4Research Group Immunobiology, University of Düsseldorf, Düsseldorf (Germany)
Several reports suggested that the process of apoptosis is abnormal in lupus erythematosus 
(LE) and thus might play an important role in the induction of autoimmunity. It has further 
been described that ultraviolet (UV) irradiation induces clustering of autoantigens in apoptotic 
surface blebs of keratinocytes in vitro. Therefore, we were interested to examine whether apop-
tosis contributes to the pathogenesis of skin lesions in patients with photosensitive cutaneous 
LE (CLE). In situ labelling methods for incorporation of nucleotides into DNA strand breaks 
and anti-caspase 3 antibody were used to detect apoptosis in 85 skin biopsy specimens from 
patients with various subtypes of CLE. In addition to primary lesions, we employed provocative 
phototesting to investigate events occurring secondary to UV irradiation during a very early 
stage of lesion formation. A signifi cant increase of apoptotic nuclei was found in the upper 
epidermal layer of primary and UV-induced skin lesions in CLE compared with controls. Fur-
thermore, in tissue sections taken 24 hours after UV exposure and before lesion formation, a 
slightly higher number of epidermal apoptotic nuclei was present in controls compared with 
CLE. In sections taken 72 hours after irradiation from controls, a signifi cant decrease of the 
apoptotic nuclei count was observed, consistent with a proper clearance of apoptotic cells in 
the period between 24 and 72 hours. In striking contrast, in several patients with CLE apoptotic 
nuclei increased signifi cantly in this period showing no difference with respect to the clinical 
subtypes of the disease. These data support the hypothesis that apoptotic cells accumulate in 
the skin of patients with CLE after UV irradiation before lesion formation possibly due to an 
impaired or delayed clearance, which might contribute to the formation of skin lesions in this 
disease. 
290
Tacrolimus Enhences TGF beta Related Generation of Langerhans Cells
Kwiek B1, Novak N2, Allam JP2, Bieber T2 and Langner A2
1Department of Dermatology, Medical University of Warsaw (Poland)
2Department of Dermatology, University of Bonn (Germany)
Langerhans cells (LC) and infl ammatory dendritic epidermal cells (IDEC) play a key role in the 
pathogenesis of atopic dermatitis (AD). It was shown previously that tacrolimus can decrease 
a number of IDEC during topical treatment of AD restoring physiological domination of LC in 
the epidermis. TGF-β is a crucial cytokine for generation of LC. We wanted to evaluate whether 
tacrolimus can enhance TGF-β dependant LC differentiation and induce the number of LC 
upon tacrolimus treatment of AD.
LC were cultured from monocytes with GMCSF, IL-4 and low dose of TGF-β (1ng/ml) or low 
dose of TGF-beta and tacrolimus or high dose of TGF-β (10ng/ml). Flow cytometry was used for 
cells phenotyping. Additionally, skin biopsies were taken before and after 7 days of tacrolimus 
treatment from AD.
LC cultured with low dose of TGF-β and tacrolimus expressed more langerin, LAG and E-cad-
herin than LC treated with low dose of TGF-β, resembling LC treated with high dose of TGF-β. 
Costimulatory molecules in LC treated with tacrolimus and low dose of TGF-β expressed lower 
amounts of MHC class II, CD80, CD83, CD86 molecules, while the expression of CD40 was 
upregulated when compared to LC with low dose of TGF-β. Further on, tacrolimus inhibited the 
maturation of LC upon TNF-β, reducing an induction of the expression of MHC II, CD80, CD86 
and CD83. The functional signifi cance of these changes has been verifi ed with the help of allo-
genic mixed lymphocyte reactions. According to our in vitro fi ndings we have found tacrolimus 
to increase the number of LC in the skin of topically treated patients with AD.
Together, our data suggest that tacrolimus enhance the number of LC generated with TGF-β, 
which might be of signifi cance for the therapeutic action of this drug in the treatment of AD.
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Dimethylfumarate Inhibits NF-κB-Mediated Cell Activation
Loewe R and Petzelbauer P
Department of Dermatology, Division of General Dermatology, Medical University of Vienna, 
Austria (Austria)
Fumaric acid esters are used to treat psoriasis. We have selected one of these esters, dimeth-
ylfumarate (DMF) and have analyzed the molecular basis of its function. We show that DMF 
reduced NF-κB-mediated gene and protein expression such as e.g., CD62E (E-selectin) or tissue 
factor. We next analyzed effects of DMF on the NF-κB signaling cascade. This revealed that 
IκB proteins were not affected, but nuclear translocation of active NF-κB subunits p50, p65 
and c-Rel was heavily impaired. Activated NF-κB remained in the cytosol and was thus unable 
to bind to DNA. We therefore thus analyzed effects of DMF on the nuclear import machinery. 
Specifi cally, we analyzed effects of DMF on p65 phosphorylation and binding to nuclear im-
port proteins, the importin protein family. Moreover, we tested effects of DMF in in vivo models 
using humanized SCID mice. 
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The Proliferative Activation of Mice Spleen Lymphocytes by Superantigen SEA and its Anti-
B16 Melanoma Cells Activity Mediated by the Replicative-Defi cient Recombinant Adenovirus 
Vector In Vitro
Lu H1, Yu D1, Wang Y1, Mu X1, Yang Z1, Lu B1 and Wu C2
1Department of Dermatology,Affi liated Hospital, Guiyang Medical College (China)
2Department of Micrology,Guiyang Medical College (China)
Staphylococcus enterotoxin A (SEA) is a kind of enterotoxins produced by staphylococcus. In 
these studies, we had used different doses of SEA (from 0.0001 to 10 μg/ml) to stimulate spleen 
lymphocytes of C57BL/6 mice in vitro. It was fond that spleen lymphocytes of C57BL/6 mice 
can be proliferated by even very low dose of SEA (0.0001μg/ml). With the increasing concen-
tration, the rate of lymphocytes proliferation was getting higher until the amount of 0.1μg/ml 
of SEA. After that the spleen lymphocytes of C57BL/6 mice cells proliferated at a signifi cantly 
slower level. SEA gene was transfected into B16 melanoma cells mediated by the replicative-
defi cient recombinant adenovirus vector. And the expression of SEA gene was detected by RT-
PCR and fl ow cytometry (FCM). We observed the expression of SEA gene in the B16 melanoma 
cells after 24h of transfection. Seventy-two hours later, we observed the highest expression of 
SEA gene. From that time, the expression of SEA gene stepped down. Up to 168h we can also 
detect the expression of SEA gene. The spleen lymphocytes of C57BL/6 mice were infected 
with various titers of recombinant adenoviruses carrying SEA gene. The proliferated response 
of lymphocytes of C57BL/6 mice was observed in these groups. Further more, the lymphocytes 
infected by two titers of SEA recombinant adenovirus fi rstly, and then they were isolated and 
inoculated with B16 melanoma cells at three mixture rates of 1/2, 1/5, 1/10(lymphocytes/B16 
cells) respectively for three days.B16 cells were appeared to be killed signifi cantly in those 
experimental groups. And the higher the rate of lymphocytes/target cells was, the stronger 
killing effect was produced. 
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Injection of Anti-CD25 Antibodies into Tumor-Bearing Mice Augments Tumor Growth in a 
B16 Melanoma Model
Schallenberg S1, Suri-Payer E2, Mahnke K1, Schönfeld K1, Storn V1, Ring S1 and Enk AH1
1Department of Dermatology, University of Heidelberg (Germany)
2German Cancer Research Center, Heidelberg (Germany)
CD4+CD25+ T cells represent a T cell subset of natural occurring T regulatory cells (Treg) in 
humans as well as in mice. Their main function is to suppress effector T cells and to prevent 
autoimmune diseases like multiple sclerosis or lupus erythematodes. However, Treg may also 
have adverse effects, since they may impede effective anti-tumor immunity by suppressing 
tumor specifi c T cells. For instance it has been shown in mice that depletion of CD4+CD25+ 
cells before challenge with tumor cells, supports generation of effector T cells and tumor immu-
nity. However, in clinical settings patients with already existing melanoma have to be treated. 
Therefore we set out to investigate in a murine B16 model whether depletion of Treg during 
melanoma therapy supports anti-cancer treatment. Therefore mice were s.c. injected with B16 
melanoma cells followed by injection of the anti-CD25 antibody (clone PC61) at different time 
points. Thereafter depletion of Treg and tumor growth was assessed. Here we show that after 
injection of 300 μg PC61 per mouse CD25+ cells were virtually absent from lymphoid organs 
and blood. But at the same time B16 tumors grew much faster when CD25 depletion was 
performed 1 to 14 days after tumor inoculation. Moreover, successive tumor treatment with 
antigen loaded dendritic cells was also not augmented by the anti-PC61 treatment as compared 
to controls. However, when CD25 cells were depleted before tumor inoculation enhanced 
anti-tumor immunity could be recorded. In summary we conclude that depletion of CD25+ 
cells during tumor growth may also reduce the number and/or effi cacy of effector T cells, which 
would otherwise be able to keep the tumor in check during the fi rst phase of its development. 
Thus, the usage of CD25 depleting reagents is not specifi c for Tregs and has to be carefully 
revisited in individual clinical studies.
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The Role of Np1+/ Foxp3+ Regulatory T-Cells in the Pathogenesis of Insect Venom Allergy
Maier-Simon C, Voelcker V, Scharf M, Anderegg U and Simon JC
Department of Dermatology, University of Leipzig (Germany)
It is unknown so far, why some people develop severe anaphylactic reactions after bee or 
wasp stings, while others show only mild local reactions or do not react at all. We examined, 
whether CD4+/ CD25+ regulatory T-cells (Treg) are relevant for the developement of this im-
munotolerance. Therefore we compared CD4+/CD25+ Treg from patients with anaphylactic 
reactions after insect sting with Treg from patients who developed only local swelling and with 
healthy controls . In proliferation experiments these CD4+/CD25+ Treg showed potent regula-
tory function , i.e. reacted anergic to stimulation and were able to inhibit the proliferation of 
CD4+/CD25- T-cells dose dependently. For further characterisation of these Treg we analysed 
the expression of new possible markers for Treg (Neuropilin/Np1 and Foxp3) per quantitative 
RT-PCR. We could show that Np1 is a highly specifi c marker for CD4+ /CD25+ regulatory T-
cells in human. Furthermore these Treg show a characteristic espression of Foxp3 compared to 
non-regulatory CD4+/CD25- T-cells.
Interestingly CD4 +/CD25 + Treg from allergic and non-allergic individuals differ in the expres-
sion of Foxp3 and Np1. Moreover we detected a specifi c increase of CD4+/CD25+ T-cells in 
non-allergic individuals after in vitro stimulation with bee or wasp venom. These results provide 
fi rst evidence that non-allergic individuals are protected against type-I allergies caused by hy-
menoptera stings by a subset of regulatory T cells. 
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Circulating CLA+ CD3+ and CLA+CD4+ CelIs Inversely Correlate with Disease Severity and 
Extension in Acute Psoriasis but not in Chronic Plaque Psoriasis
Ferran M1, Giménez-Arnau AM1, Bellosillo B2, Pujol RM1 and Santamaria-Babi LF3
1Department of Dermatology, Hospital del Mar-IMAS, Barcelona (Spain)
2Department of Pathology, Hospital del Mar-IMAS, Barcelona (Spain)
3Almirall S.A. Centro de Investigación, Sant Feliu de Llobregat. Barcelona (Spain)
Introduction: Circulating CLA+ T cells represent a leukocyte subset with skin tropism, which is 
involved in different T cell mediated diseases. In psoriasis, the difference in numbers of circu-
lating skin-homing T cells during acute and chronic stages is poorly characterized. The aim of 
the study is to characterize these cells in psoriasis.
Material and methods: Thirty-one adult patients with psoriasis (7 guttate psoriasis, 8 acute 
plaque psoriasis, 16 chronic psoriasis) and 11 healthy subjects were studied. A Psoriasis Area 
Score Index (PASI) and Body Surface Area (BSA) score were calculated. Blood samples were 
obtained and, by fl ow cytometry, the counts of several circulating CLA+ T cell subpopulations 
were analyzed. These results were related with PASI and BSA.
Results: An inverse correlation between the counts of circulating CLA+ CD3+/CD4+ subsets 
and disease severity and extension scores was found in both guttate (r=-0.66 (p=0.004) for 
CLA+CD3+ subset and r=0.-70 (p=0.003) for CLA+CD4+ subset) and acute plaque psoriasis 
(r=-0.64 (p=6x10-4) for CLA+CD3+ subset and r=-0.60 (p=0.001) for CLA+CD4+ subset). In-
terestingly, we also observed that circulating CLA+CD4+CD25+ cells inversely correlated with 
PASI and BSA in guttate patients (r=-0.81 (p=0.01) y r=-0.79 (p=0.002), respectively), which 
had not been shown previously.
Conclusions: These results may also be related to the migration capacity of this subset to skin. 
Further studies are required to clarify the role of CLA+ T cells in psoriasis pathogenesis.
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The IgE-Bearing B-Cell Receptor Repertoire of Atopic Dermatitis Patients Shows Unbiased 
VH-Usage but Patient-Specifi c Clonal Expansions
Mempel M1, Lim A2, Luderschmidt S1, Weidinger A1, Gougeon ML2, Kourilsky P3, Ring J1 and 
Ollert M1
1Department of Dermatology and Allergy, Biederstein, Munich (Germany)
2Antiviral Immunity, Biotherapy and Vaccine Unit, Molecular Medicine Department, Pasteur 
Institute (France)
3Pasteur Institute (France)
We have analyzed the IgE-bearing B-cell receptor repertoire in atopic eczema patients showing 
very high (> 1000 IU/ml) serum levels of IgE by means of FACS analysis, quantitative RT-PCR, 
serum Ig-quantifi cation, CDR-3 spectratyping, and sequence analysis. Our analysis revealed 
that atopic patients used a repertoire of variable segments of the heavy IgE chain highly simi-
lar to their IgM- and IgG- repertoires with a preference of VH3b, VH4, VH3a and VH1. Each 
patient harboured individual expansions within his repertoire, most probably as correlation of 
allergen-specifi c IgE production. Common expansions within the CDR-3 region shared by sev-
eral individuals with similar sensitization patterns were found in spectratyping analysis. How-
ever, these antigen-driven expansions showed differences on the sequence level. In contrast, 
identical rearrangements including the sequences of the hypervariable CDR-3 region were 
found intra-individually for IgE- and IgG-specifi c transcripts supporting the concept of identical 
precursor B-cell clones switching from IgM to IgE and IgG. The quantitative B-cell repertoire 
analysis was further applied to patients undergoing anti-IgE therapy (omalizumab) in which 
the clinical amelioration was paralleled by a clear increase in the ratio of IgG/ IgE transcripts 
as compared to pre-treatment values. The thorough analysis of the B-cell repertoire in highly 
atopic patients thus represents a suitable tool to identify preferential IgE rearrangements and to 
follow immunotherapeutic approaches such as anti-IgE treatment or specifi c immunotherapy.
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Tumor Necrosis Factor-α and Interferon-γ Synergistically Induce Retinoic Acid-inducible 
Gene-I in Cultured Human Keratinocytes
Minakawa S1, Nakano H1, Kimura K1, Kitamura H1, Matsuzaki Y1, Hanada K1, Imaizumi T2 
and Satoh K2
1Department of Dermatology, Hirosaki University School of Medicine (Japan)
2Dept of Vascular Biology, Institute of Brain Science, Hirosaki Univ School of Medicine (Japan)
Retinoic-acid-inducible gene-I (RIG-I) is an essential regulator of virus-induced interferon pro-
duction. Upon viral infection, the protein binds to the viral double stranded RNA and phos-
phorylates the cytoplasmic interferon regulatory factor 3 (IRF3), which then translocates into 
the nucleus where it stimulates interferon-β (IFN-β) and interferon-α1 (IFN-α1) transcription. 
Recently, we have demonstrated that each of tumor necrosis factor-α (TNF-α) and interferon-γ 
(IFN-γ) is capable of inducing the expression of RIG-I at the mRNA and protein levels in cul-
tured human keratinocytes. In the present study, we further investigated the molecular mecha-
nism of RIG-I expression stimulated by TNF-α and IFN-γ in HaCaT keratinocytes. Using a 
protein synthesis inhibitor cycloheximide, we revealed that the accumulation of RIG-I mRNA 
elicited by each cytokine does not require de novo protein synthesis. Half-lives of RIG-I protein 
and mRNA were not altered by the cytokine treatment, demonstrated by western analysis with 
cycloheximide and by semi-quantitative RT-PCR with an RNA synthesis inhibitor actinomycin 
D, respectively. In addition, application of TNF-α and IFN-γ together to HaCaT cells synergisti-
cally increased the steady-state levels of RIG-I mRNA and protein amounts. These fi ndings 
imply that the induction of RIG-I expression by TNF-α and IFN-γ is regulated at the transcrip-
tion level, and that these cytokines utilize the different signaling pathway from each other, 
consequently converging into the enhancement of RIG-I transcription.
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Neuromedin U is the Principal Mediator of Hapten-Induced, TLR2-Dependent Mast Cell 
Activation that can be Inhibited by IgE and Scratching
Mizukawa Y, Yamazaki Y and Shiohara T
Department of Dermatology,Kyorin University School of Medicine (Japan)
The neuropeptide, neuromedin U (NMU), as well as IL-1, is stored in and immediately released 
from keratinocytes upon stimulation. In view of these properties together with its ability to 
directly stimulate mast cells, NMU might be involved in triggering the cascade of intracutane-
ous events. We have recently shown that initial hapten exposure of the site protected from 
scratching results in the development of Toll-like receptor (TLR) 2-dependet, mast cell-medi-
ated, immediate-type hypersensitivity (ITH)-like swelling that needs no memory and can be 
paradoxically inhibited by hapten-specifi c IgE; while the same IgE is essential for the devel-
opment of hapten–specifi c ITH in the site repeatedly exposed to the hapten with scratching. 
The present study examined the in vivo requirements of NMU and IL-1 in mediation of the 
TLR2-dependent and IgE-dependent mast cell activation, respectively. NMU-/- mice as well as 
TLR2-/-and MyD88-/- mice exhibited a marked defect in the TLR2-dependent ITH-like response 
to initial hapten exposure, while IL-1R-/- mice did not. In contrast, these NMU-/-and TLR2-/-mice 
were more susceptible than wild-type (WT) mice to repeated hapten exposure with scratching. 
Importantly, intradermal injection of NMU induced signifi cant ITH-like responses, in WT and 
NMU-/- mice, but not in TLR2-/- mice. These fi ndings indicate that TLR2-dependent mast cell 
activation induced by initial hapten exposure of the site protected from scratching is mediated 
by NMU via the TLR2/MyD88, but not IL-1/MyD88, signaling and that scratching may act to 
direct otherwise TLR2-dependent to IgE-dependent activation: scratching and IgE may have 
evolutionally been strategies to limit the potentially harmful effects of excessive mast cell ac-
tivation by repeated TLR signaling. Thus, NMU would serve a critical function in coordinating 
the nervous and innate immune systems.
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Avocado Sugars are Effective Inducers of Cutaneous Defensive Functions
Bredif S1, Garnier S2, Piccardi N1 and Msika P3
1Department of Biology, Laboratoires Expanscience (France)
2Department of Lipochemistry, Laboratoires Expanscience (France)
3Research and Development Department, Laboratoires Expanscience (France)
The presence of D-manno-heptulose and perseitol as the predominant sugars in avocado fruits 
is of considerable interest for the metabolic growth of the fruit. In this work, we have explored 
the effect of these specifi c sugars on skin defense mechanisms. We have focused our work on 
protective cutaneous functions including structural organization and antimicrobial barrier. For 
the fi rst time, we were able to show the cosmetic relevance of these naturally occurring sugars 
as inducers of the epidermis defensive response. 
Culture of NHK were stimulated with a blend of avocado sugars (40% mannoheptulose/40% per-
seitol), and the cells were maintained for 24 or 48h after stimulation. ELISA tests were performed to 
determine whether anti-microbial peptides, and infl ammatory cytokines were stimulated. Keratinoc-
ytes proliferation (beta-1 integrin) and differentiation (involucrine) as well as desmoglein production 
were also checked. Moreover, using stimulation of NHK with IL-4, we have simulated in vitro atopic 
dermatitis (AD) conditions and we have evaluated anti-microbial peptides (AMPs) production with-
out and with avocado sugars (AV).
AV are able to signifi cantly stimulate the production of hBD-2 by NHK without enhancing pro-
infl ammatory response. This effect is also signifi cant for hBD-3 (+55%). Barrier function of the skin 
is also associated with permeability barrier homeostasis. AV stimulate keratinocytes proliferation 
(+27%), differentiation (+49%) and the production of desmoglein (+38%). 
Decrease expression of h-BD2 following IL-1 beta stimulation was demonstrated in our in vitro model 
of AD (NHK + IL-4). AV treatment is associated with an increase of hBD-2 production in this model. 
This specifi c blend of 7-carbons sugars from avocado may help the skin (normal and patho-
logic) to preserve the equilibrium between the different cutaneous defensive mechanisms by 
enhancing the structural organization of the epidermis as well as the antimicrobial barrier.
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CD158k/KIR3DL2 Allows Molecular Diagnosis of SS in Erythrodermic Skin and Promotes 
Malignant T-Cell Proliferation In Vitro
Ortonne N1, Huet D2, Legouvello S3, Marie-Cardine A2, Bagot M4 and Bensussan A2
1INSERM U659 and Department of Pathology, Henri Mondor hospital, Créteil (France)
2INSERM U659, Créteil (France)
3Department of Immunology, Henri Mondor hospital, Creteil (France)
4INSERM U659 and Department of Dermatology, Henri Mondor hospital, Creteil (France)
We have previously shown that KIR3DL2/CD158k delineates circulating malignant Sézary cells 
(SC). We sought 1) to determine whether CD158k may help to distinguish Sézary syndrome (SS) 
from benign erythroderma (BE) in vivo and 2) to further characterize malignant SC in vitro, by 
analyzing a new long term cultured Sézary cell line (OGU).
Methods: 1) Standard and quantitative RT-PCR for CD3 and CD158k were performed in 8 skin 
specimens from patients with SS and 12 BE. 2) In OGU cell line and ciculating sorted CD4+ 
SC, expression of several killer immunoglobulin like receptors (KIRs) was evaluated at both pro-
tein product and transcript levels. In OGU cell line, proliferation assays upon KIRs engagement 
were followed by analyses of ITIM phosphorylation status and of SHP-1 recruitment. Finally, a 
panel of cytokine was evaluated by quantitative RT-PCR.
Results: 1) Signifi cant levels of CD158k mRNA were found in all SS samples. By contrast, RT-PCR 
supplied negative result in all samples from BE. Interestingly, CD158k mRNA was detected in one 
patient with early SS and in another patient with no detectable circulating SC after alemtuzumab 
treatment. 2) As circulating CD4+ SC, OGU cell line expressed several KIRs, including CD158k, 
CD158a and CD158b. Triggering of these receptors by specifi c antibodies increased the CD3-in-
duced proliferation, without phosphorylation of their ITIM motifs and SHP-1 recruitment. Finally, 
cytokine analyses revealed a IFNgamma-, IL4-, TGFbeta-, IL10+ and FoxP3- regulatory profi le.
Conclusion: Molecular detection of CD158k mRNA in erythrodermic skin allows differential 
diagnosis between SS and BE and represents the fi rst reliable marker of SS in skin samples. 
SC are heterogeneous for KIRs expression but constantly bear CD158k. In vitro engagement 
of KIRs promotes malignant SC proliferation, with a yet undescribed signaling pathway. In 
addition, SC display regulatory functions, which may allow them to escape to the immune 
system in vivo.
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Thrombocytopenia Protects from Graft Rejection
Pfeffer J, Ludwig R, Rubant S, Kaufmann R and Boehncke W
Department of Dermatology and Venerology Uniklinik Frankfurt am Main (Germany)
A close interaction of blood coagulation and infl ammation is being more and more recognised 
– which from an evolutionary point of view is benefi cial, as injury always bears the risk of infec-
tion. However, coagulation, namely activation of platelets can contribute to the pathogenesis 
of diseases. To evaluate the role of platelets in transplant rejection, we investigated the effect of 
thrombocytopenia on rejection of skin allografts. For this purpose skin from BALB/c mice was 
transplanted into C57Bl/6 mice. One group of recipient mice was rendered thrombocytopenic 
by i.p. injection of MWReg30, a monoclonal rat antibody directed to the murine platelet-spe-
cifi c integrin αllbβ3, given 2xday of transplantation in a dose of 60 μg and then every other day 
(30 μg)until the end of the study (D8).
Grafts from thrombocytopenic mice were characterized by substantially better conditions of 
the grafts, mirrored by preservation of graft size, scaliness, blood perfusion, and texture. The 
graft sizes in the treated group changed from 3,04 μm on D5 to 2,09 μm on D6, whereas the 
graft size in the control group changed from 1,96 μm to 1,00 μm at the same time. 
In summary, we here provide evidence, that platelets are critically involved in transplant rejec-
tion. Further studies are currently undertaken to more elucidate the contribution of platelets 
in graft rejection.
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CD8 T Cells do not Prevent Tumor Outgrowth, but Delay Disease Progression in a Spontaneous 
Melanoma Model
Graff-Dubois S1, Lengagne R1, Garcette M1, Kato M2, Nakashima I2, Engelhard V3, Abastado JP1, 
Avril MF1 and Prévost-Blondel A1
1Cochin Département d’Immunologie, INSERM U567, CNRS UMR 8104, Paris (France)
2Department of Immunology, Nagoya University School of Medicine, Nagoya (Japan)
3Carter Immunology Center and Department of Microbiology, University of Virginia School of 
Medicine (USA)
The growth of immunogenic tumors in immunocompetent individuals is one of the major co-
nundrum of tumor immunology. To address this question, we have developed a unique model 
of mice with spontaneous melanoma. The MT-ret/AAD mouse is transgenic for the human RET 
oncogene and the chimeric MHC class I AAD molecule (HLA-A2 related protein). This model 
recapitulates remarkably well the natural history of human melanoma. Tumors were typed 
for antigen expression. Each nodule shares a unique antigenic profi le suggesting the multifo-
cal origin of all nodules naturally occurring in this model. The progressive growth of tumors 
provides the opportunity to study the anti-tumor response all the way through the process of 
oncogenesis. Our data indicate that tumor-specifi c immune response can easily be measured: 
MT-ret/AAD mice develop spontaneous CD8+ T cell responses that are HLA-A2 restricted and 
specifi c for melanoma differentiation antigens (MelanA/Mart1, Tyrosinase and gp100). Tumor 
incidence was similar in animals treated or not with an antibody depleting specifi cally CD8+ 
T cells. In contrast, depleted mice died signifi cantly earlier than control mice. These results 
suggest that CD8 T cells control disease progression and the development of metastasis, but 
have no effect on primary tumors. Interestingly, the relative expression levels of tyrosinase 
and TRP2 transcripts were signifi cantly lower in metastatic organs than in cutaneous tumor 
nodules, suggesting that the antigenic profi le may be selected by the immune response. Finally, 
MT-ret/AAD animals might be of particular interest for studying strategies based on the use of 
HLA-A2 restricted melanoma-associated peptides. Indeed, the growth of melanoma in this 
model does not result from immune ignorance or systemic immune suppression. We believe 
that the tumor microenvironment protects the tumors from immune attacks. A better under-
standing of the interactions that take place within a tumor could facilitate the development of 
novel therapeutic approaches.
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A Novel In Vitro System to Study Reverse Transmigration of Human Dendritic Cells over 
Lymphatic Endothelial Cell Monolayers
Torzicky M, Groeger M, Pehamberger H and Riedl E
1Department of Dermatology, Medical University Vienna (Austria)
Dendritic cells (DC) migrate from peripheral tissues via lymphatic vessels to T cell areas of 
draining lymph nodes. Reverse transmigration of DC over lymphatic endothelial cells (LEC) 
represents a critical step in this process. However the underlying mechanisms of DC-LEC in-
teractions are still poorly understood. We established a novel in vitro system of abluminal-to-
luminal migration of DC over a LEC monolayer using Immortalized human LEC (TERT-LEC). 
TERT-LEC were cultured upside down on collagen-coated transwells for 24 hours and stained 
with antibodies against the LEC marker molecule podoplanin and CD31. Subsequently, TERT-
LEC were stimulated with tumor necrosis factor-α (TNFα), followed by a migration assay using 
monocyte-derived DC. Migration was visualized by confocal laser scan microscopy. Addition-
ally, FACS analysis was applied to further analyze TERT-LEC. Reminiscent of LEC in vivo the ma-
jority of TERT-LEC expressed podoplanin and CD31 (mean±STD: 97.3±5.3% and 97.0±1.57%, 
respectively; n=5). Lower percentages of cells expressed ICAM-1and VCAM-1 (mean±STD: 
15.7±7.3% and 4.7±3.2%, respectively; n=5). Stimulation of TERT-LEC with TNFα for 24 hours 
further upregulated podoplanin expression (mean fl uorescence intensity (MFI) 112.5 versus 
172, respectively; n=5) and increased the expression of ICAM-1 and VCAM-1 by TERT-LEC 
(mean±STD: 97.5±2.5%, and 30.7±13%, respectively; n=5). In contrast CD31 expression was 
down-regulated by TNFα (MFI 248 versus 147, respectively; n=5). This decrease was paral-
leled by the re-distribution of CD31 molecules on TERT-LEC in a luminal to abluminal fashion. 
Stimulation of TERT-LEC with TNFα led to a fourfold increase in the number of migrating DC. 
Interestingly, a considerable proportion of DC interacted with TERT-LEC even in the absence of 
TNFα. This novel in vitro system provides a valuable tool to further study reverse transmigra-
tion of DC.
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Dimethyl Fumarate Blocks T-Cell Adhesion to Selectins In Vitro
Rubant S1, Ludwig RJ1, Diehl S1, Pfeffer J1, Kaufmann R1, Pfeilschifter JM2, Boehncke WH1
1Department of Dermatology, Clinic of the J.W. Goethe University (Germany)
2Pharmazentrum, Clinic of the J.W. Goethe University (Germany)
Esters of the fumaric acid have a long history in the treatment of psoriasis. Currently dimeth-
ylfumarate (DMF) is perceived as the main active substance. However, the molecular mecha-
nisms of DMF action are not completely understood. In this report we focused on effects of 
dimethylfumarate on lymphocyte adhesion molecule expression in vitro and interactions with 
endothelial cells in vivo. DMF dose-dependently reduced the superantigen-induced expres-
sion of CD25, HLA-DR and CLA by 27%, 22% and 48%, respectively, whereas no change in 
expression was observed for CD54 and CD162. DMF dose-dependently enhanced the expres-
sion of CD69 (22%). Investigating the binding to important selectins, DMF-treatment led to 
a strong reduction in binding of human PBMCs to E-selectin (72%) and P-selectin (37%) in 
vitro. Analyzing in vivo interactions of DMF-treated PBMCs along mouse ear vasculature using 
intravital microscopy, DMF resulted in a 1.6-fold reduction of superantigen-induced rolling of 
cells. This is the fi rst report focussing on the effects of DMF on adhesion molecule expression 
and binding. 
Our data support accumulating evidence, that the clinical effects of DMF can be related to 
a multitude of activities acting on key molecules of essential cell processes of the immune 
response, rather than a single specifi c drug interaction.
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Viral Chemokine Antagonist VMIP-Ii Blocks Th1-Cell Migration
Rubant S1, Ludwig RJ1, Pfeffer J1, Schulze-Johann P1, Kaufmann R1, Pfeilschifter JM2, Boehncke 
WH1, Radeke HH2
1Department of Dermatology, Clinic of the J.W. Goethe University (Germany)
2Pharmazentrum, Clinic of the J.W. Goethe University (Germany)
Pro-infl ammatory chemokines and their receptors exhibit elementary functions in cell migra-
tion and in Th1-driven infl ammatory conditions. One therapeutic strategy to prevent accumula-
tion of pro-infl ammatory immune cells is the use of specifi c chemokine receptor antagonists. 
An interesting and promising candidate in this context is the viral antagonist MIP-II (vMIP-II) 
that acts on a broad spectrum of chemokine receptors. To study the in vitro and in vivo effects 
of vMIP-II on pro-infl ammatory chemokine receptor function, we further characterized an oval-
bumin-specifi c murine Th1IF12 clone to be central memory by using the RT-PCR, cDNA array 
and cytometry. Using in vitro chemotaxis assays we show that eukaryotically generated vMIP-
II strongly inhibited migration of CCL2- or CCL5-stimulated Th1 IF12 cells. Using intravital 
microscopy, we observed that CCL5 induced rolling of Th1 cells in ear vasculature of C57Bl/6 
mice. Pre-treatment with vMIP-II signifi cantly reduced CCL5-induced rolling of Th1 cells to ba-
sal levels, indicating, that vMIP-II is also active in vivo (proportion of rolling cells: 19.4±3.8%, 
39.8±2.9% and 26.1±3.2%). In addition, investigating the anti-infl ammatory action of vMIP-II 
in adoptive transfer of immunity and DNFB-induced cutaneous hypersensitivity reaction using 
C57Bl/6 mice, we show a direct inhibitory effect of vMIP-II on the sensitization (∆ ear swelling 
62 and 37 cm x 10-3 for controls and vMIP-II (2.5mk/kg) treated mice , respectively) and effec-
tor phase (∆ ear swelling 14.8 and 3.6 cm x 10-3 for controls and vMIP-II (2.5mk/kg) treated 
mice , respectively) of cutaneous hypersensitivity. These data indicate that vMIP-II is a promis-
ing agent to interfere with chronic infl ammatory (skin) diseases.
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RelA Regulates the Crosstalk between Keratinocytes and Adaptive Immune Cells in an IκBα-
Mediated Model of Psoriasis and is of Relevance in Human Psoriasis
Rupec RA1, Rebholz B1, Haase I2, Eckelt B1, Flaig MJ1, Ghoreschi K3, Debey-Pascher S4,
Schmid RM5, Röcken M3 and Ruzicka T1
1Department of Dermatology, University of Munich (Germany)
2Department of Dermatology, University of Cologne (Germany)
3Department of Dermatology, Eberhard-Karls University Tübingen (Germany)
4Department of Internal Medicine I, University of Cologne (Germany)
5Department of Internal Medicine II, Technical University of Munich (Germany)
Previously we have shown that the development of a psoriasis-like skin disease in IκBα-defi -
cient mice requires simultaneous aberrant NF-κB signalling in the immune cells and epithelial 
cells. Extending the analysis of this model, we found by microarray analysis, that the cytokine 
expression in IκBα-defi cient mice is similar to that described for human psoriasis. Important 
target genes such as S100A8 and S100A9 are found strongly upregulated. Moreover, we show 
by conditional ablation of the genes encoding IκBα and RelA in epidermal keratinocytes and 
in different immune cell populations that initiation and maintenance of a psoriasis like skin dis-
ease depends on RelA mediated interactions between IκBα defi cient epidermal keratinocytes 
and IκBα defi cient lymphocytes. The infl ammatory response is initiated in a RelA dependent 
manner by epidermal keratinocytes, as epidermis-specifi c deletion of RelA in an IκBα-defi cient 
background prevented the development of the psoriasis-like infl ammation which otherwise de-
veloped in IκBα-defi cient mice. As we found a constitutive and concomitant activation of RelA 
in the epidermis and in the invading immunocytes in 14% of patients with active psoriasis, our 
model expands the view on the understanding of the pathogenesis of psoriasis and may lead 
to a novel therapeutic strategy.
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Transcription Factor NF-κB as Mediator of Sulfur Mustard Induced Damage of the Skin
Rebholz B2, Kehe K1, Ruzicka T2 and Rupec RA2
1Bundeswehr Institute of Pharmacology and Toxicology Munich (Germany)
2Department of Dermatology, University of Munich (Germany)
Cutaneous exposure to sulfur mustard [bis(2-chloroethyl) sulfi de] produces a delayed infl am-
matory skin response and severe tissue injury. The NF-κB signal transduction pathway is in-
volved in many cellular processes. It takes part in the immune response, infl ammatory proc-
esses and is placed at the interface between infl ammation and malignancy. NF-κB is a complex 
formed by homo- and heterodimerization of the NF-κB/Rel family members p50 (NF-κB1), 
p52 (NF-κB2), RelA (p65), RelB and c-Rel. Their cytoplasmic receptors are members of the IκB 
family, with IκBα being the most important in the cellular stress response. Activation of cells 
by various stimuli results in serine-phosphorylation of IκBα by the IκB kinase (IKK)-signalosom, 
followed by degradation of IκBα and subsequent translocation of NF-κB to the nucleus. The 
aim of this study was to analyze the function of NF-κB in the infl ammatory skin response to 
sulfur mustard. In mouse keratinocytes we could show, that NF-κB is activated in a biphasic 
response following stimulation by sulfur mustard. The activation was preceded by phosphor-
ylation of IKKβ and IκBα and resulted in a phosphorylation of RelA. The activation of genes 
coding for IL-1β and TNF, two NF-κB regulated genes, proved the functional relevance sulfur 
mustard induced NF-κB activation. These fi ndings strongly support the idea of NF-κB as key 
modulator in the cellular response to sulfur mustard. In addition to NF-κB, we can show that 
the transcription factor AP-1 and the MAP kinase p38α are also activated by sulfur mustard. 
Stimulation of cells with sulfur mustard was followed by phosphorylation of JNK1/2, the AP-1 
subunit c-Jun and p38α.
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High Level IL-12-Producing M-DC8+ Human Blood Dendritic Cells are Controlled by 
Erythrocytes and are Present in Infl ammatory Infi ltrate of Psoriasis Vulgaris and Rheumatoid 
Arthritis
Schäkel K1, von Kietzell M2, Hänsel A2, Haase M3, Semmler C4, Sarfati M5, Barclay N6, Randolph 
GJ7, Meurer M4 and Rieber EP2
1Institute of Immunology, Department of Dermatology, TU Dresden (Germany)
2Institute of Immunology, TU Dresden (Germany)
3Department of Pathology, TU Dresden (Germany)
4Department of Dermatology, TU Dresden (Germany)
5Centre Hospitalier de l’Universite de Montreal, (Canada)
6Sir William Dunn School of Pathology, University of Oxford, Oxford (United Kingdom)
7Department of Gene and Cell Medicine, Mount Sinai Medical School, New York (USA)
IL-12 is essential for the induction of Th1-dominated immune responses. However, the cells 
producing high levels of IL-12 remain poorly defi ned. Here, we identify 6-sulfoLacNAc ex-
pressing dendritic cells (DC) characterized by the mAb M-DC8 as the major source of IL-12 
among human blood leukocytes. Starting with PBMC we noticed that an initial six hour culture 
period prior to stimulation with LPS largely enhanced their capacity to produce IL-12p70. 
Single cell analysis among PBMC and stimulation of purifi ed cell populations revealed that M-
DC8+ DC but not monocytes or CD1c+ DC acquired within six hours the capacity to produce 
the p70 form of IL-12 after stimulation with LPS or CD40-ligand alone. Furthermore, IL-12 
production of PBMC was reduced to 1/9 when PBMC were depleted of M-DC8+ DC prior to 
stimulation. 
The rapid functional maturation of M-DC8+ DC was paralleled by the neoexpression of CD83 
and CD80. Phenotypic changes were absent when coculturing M-DC8+ DC with erythrocytes. 
In addition, erythrocytes also prevented the IL-12 production of M-DC8+ DC. We could iden-
tify that blocking CD47 on erythrocytes with anti-CD47fab-fragments inhibited the capacity of 
the erythrocytes to control for the production of IL-12. Furthermore, by blocking the cognate 
ligand of CD47 on M-DC8+ DC, the signaling regulatory protein alpha (SIRP-α), we could 
also inhibit the regulatory function of erythrocytes on M-DC8+ DC. While tightly controlled in 
blood by erythrocytes, in tissues the high IL-12- and TNF-α-producing capacity of M-DC8+ DC 
may lead to adverse infl ammatory reactions. Accordingly, we identifi ed M-DC8+ DC within 
the Th1-dominated local infl ammation of psoriasis vulgaris and rheumatoid arthritis. Based on 
these data M-DC8+ DC appear as a possible source for the local production of IL-12 in autoim-
mune diseases and chronic forms of the allergic infl ammation.
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Effect of Elastase Inhibitor N-Acetyl-N-[3-(trifl uoromethyl)phenyl]valylglycine) on Langer-
hans Cell Function and Cytokine Generation
Seldon PM1, Gueniche A2, Breton L2 and Chu AC1
1Dermatology, Imperial college (United Kingdom)
2Recherche, L’Oreal (France)
Natural elastase inhibitors are known to have anti-infl ammatory effects both as a result of 
elastase inhibition and by other mechanisms. The effects of N-Acetyl-N-[3-(trifl uoromethyl)phe
nyl]valylglycine) a new elastase inhibitor, on Langerhans cell function and cytokine production 
by keratinocytes were investigated.
Langerhans cell function was assessed using explant skin culture and mixed epidermal lym-
phocyte reaction. Five μl/cm2 of 10% test compound in vehicle or of vehicle were applied on 
human explant skin culture. Explant skin was then exposed to 450 mJ/cm2 UVB delivered by a 
solar simulator. It was shown that Langerhans cell function was dose-dependently suppressed 
by UV-exposure of explants and that the new elastase inhibitor protected Langerhans cell im-
munoreactivity.
In a second step, primary human keratinocytes were pre-incubated with test compound for 24 
hours prior to stimulation with interferon-gamma (IFNγ) and the culture medium was collected 
to measure cytokine production. We found that pre-treatment with test compound inhibited 
TNF-α production but had no effects on IL6 or IL8 levels.
Overall, these fi ndings suggest that N-Acetyl-N-[3-(trifl uoromethyl)phenyl]valylglycine) pro-
tects Langerhans cells function from UV-induced damage and that this protection may involve 
an inhibiting effect on TNFα .
310
Agonists of Proteinase-Activated Receptor-2 (PAR2) Enhance Lipopolysaccharide-Induced 
Effects on Human Neutrophil Functions In Vitro
Shpacovitch V1, Seeliger S2, Huber-Lang M3, Balkow S1, Feld M1, Varga G1, Steinhoff M4 and 
Luger T5
1Dept of Dermatology, Lab of Cell Biology, Univ of Münster (Germany) 2Inst for Experimental 
Dermatology, Univ of Münster (Germany) 3Dept of Surgery, University of Ulm (Germany)
4Dept of Dermatology, Institute of Experimental Dermatology, Univ of Münster (Germany)
5Dept of Dermatology, Univ of Münster (Germany)
Proteinase-activated receptor-2 (PAR2) is a member of a novel subfamily of G protein-coupled 
receptors with 7 transmembrane domains. This subfamily has a unique mechanism of activa-
tion via the proteolytic cleavage by serine proteases thereby unmasking a new N-terminal se-
quence (“tethered ligand”), which further interacts with the same receptor in an intramolecular 
manner. Proteinase-activated receptor-2 (PAR-2) can be activated by tryptase (from mast cells), 
trypsins, and some bacterial serine proteases. PAR2 is expressed by human neutrophils, however 
its functions on these cells remain unclear. Recently, we reported that PAR2 stimulation leads to 
signifi cant changes of neutrophil motility, cytokine production, and cell adhesion molecules ex-
pression. However, the simultaneous actions of pro-infl ammatory stimuli (LPS, for example) and 
PAR2 agonists are still poorly investigated in human cells in vitro and in vivo. Therefore, one of the 
aims of the study was to investigate whether combine application of LPS and PAR2 agonist may 
enhance LPS-induced effects in human neutrophils in vitro. Moreover, we studied whether PAR2 
expression profi le changes during human sepsis. Here, we demonstrate that PAR2 expression in-
creased in septic patients as compared with healthy volunteers. Additionally we show that co-ap-
plication of LPS and PAR2 specifi c activating peptide (tcAP) results in a signifi cant enhancement of 
well-known LPS-induced effects (delayed human neutrophil apoptosis, down-regulation of C5a 
receptor expression) in human neutrophils. Taken together, our in vitro data clearly demonstrate 
that PAR2 activation leads to signifi cant changes of crucial neutrophil functions such as motility, 
cytokine and chemokine secretion, apoptosis, and adhesion molecules expression. Moreover, 
our patient data suggest that PAR2 may play role in the pathology of sepsis in humans.
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Site of Blood Vessel Damage and Relevance of CD18 in a Murine Model of Immune Complex-
Mediated Vasculitis
Sindrilaru A1, Seeliger S2, Ehrchen J3, Peters T1, Roth J2, Scharffetter-Kochanek K1 and 
Sunderkötter C3
1Dept of Dermatology, University of Ulm (Germany) 2Institute for Experimental Dermatology, 
University of Münster (Germany) 3Dept of Dermatology, University of Münster (Germany)
In the scenario of immune complex (IC) vasculitis it is not exactly clear how neutrophils (PMN) 
damage the wall of blood vessels while adhering to endothelial cells since their cytotoxic 
substances could be washed away by the blood stream or neutralized by serum protease inhibi-
tors. We therefore studied if PMN would damage vessels rather from the abluminal site after 
diapedesis. We used the model of reversed passive Arthus reaction in CD18-defi cient mice, as 
in these mice absence of CD18 excludes transmigration of PMN.
We fi rst proved that in vitro CD18 is not required for initial degranulation and oxidative burst 
of murine PMN, thus maintaining their potential toxicity for endothelial cells. When we elic-
ited the Arthus reaction in ears of CD18-/- and wild type (WT) mice we found that deposition 
of IC at and beyond the vessel wall was not suffi cient to recruit PMN into skin and to induce 
IC-mediated vasculitis. By bypassing diapedesis and injecting PMN intradermally into ears of 
CD18-/- mice we could then investigate if PMN located exclusively extravascularly would dam-
age vessels from the abluminal site. We found that injected PMN gathered around perivascular 
IC, but did not cause vessel damage. Only intravenous injection of WT PMN was able to re-
establish the Arthus reaction in CD18-/- mice. Thus PMN cause damage of blood vessels during 
diapedesis from the luminal site, but not from beyond the vessel wall.
Interestingly, in electron-microscopic studies we occasionally found that some PMN degranu-
late at the vessel wall without affecting vascular integrity, while other PMN present a disturbed 
transmigration remaining trapped between endothelium and basement membrane and appar-
ently leading to vessel damage. We therefore assume that vascular damage requires particular 
interactions between PMN, IC and endothelial cells so that granulocytic products exert their 
cytotoxic potential despite being released close to the blood stream.
312
Proinfl ammatory Effects of Bacterial Cell Wall of Pantoea agglomerans: A Possible Explanation 
of Airborne Dermatitis to Bioaerosols
Spiewak R1 and Dutkiewicz J2
1Celimun Biomedical Research Laboratory, Krakow (Poland)
2Institute of Agricultural Medicine, Department of Occupational Biohazards, Lublin (Poland)
Background: Bioaerosol-related airborne dermatitis was reported on e.g. in farmers and sew-
age workers. Bioaerosols consist of Gram-negative bacteria and so-called microvesicles (MV) 
emerging as a result of disruption of the bacteria. The present study was aimed at assessing the 
proinfl ammatory properties of microvesicles in vitro.
Methods: MV were produced through disruption of the bacterial wall of the Gram-negative 
bacterium Pantoea agglomerans (Erwinia herbicola). Peripheral blood mononuclear cells 
(PBMC) of fi ve healthy volunteers were cultured for 6 h, 24 h, 3 days, and 5 days with dilution 
series of MV ranging from 0.48 - 1500 μg/ml. The following variables were observed: secretion 
of IFN-γ and TNF-α (ELISA and ELISPOT assays), intensity of cell proliferation (LPT), expression 
of surface markers CD8, CD14, CD16, CD25, CD69, CD80, CD83, HLA-DR, the apoptosis 
marker Annexin V, and PI permeability (fl ow cytometry).
Results: After 24 hours, a clear dose-dependent response to MV was seen for IFN-γ production 
starting already with the lowest MV concentration of 0.48 μg/ml (p=0.042). As for TNF-α, a 
signifi cant (p=0.05) increase in the production of this cytokine was seen after 3 days at MV 
concentrations of 300 μg/ml or higher. On the LPT, there was a clear and signifi cant dose-
response to MV after 5 days (p=0.001). Regarding expression of cell surface markers, the only 
phenomenon seen in all donors was the decrease in the number of CD14(+)CD83(+) cells with 
increasing MV concentration (probably due to increased MoDC maturation). 
Discussion: We have shown that microvesicles are biologically active in PBMC cultures in a dose-
dependent manner. IFN-γ production was increased already at lowest MV doses tested. These re-
sults explain clinical observations on the proinfl ammatory effect of bioaerosols on the skin.
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Distribution of Protease-Activated Receptors-1 and 2 in Infl ammatory Skin Diseases
Rattenholl A1, Bocheva G2, D’Andrea M3 and Steinhoff M1
1Department of Dermatology, University of Münster (Germany)
2Department of Pharmacology and Toxicology, Sofi a Medical University (Bulgaria)
3Johnson&Johnson, Spring House (USA)
Many cell types which are involved in infl ammatory and immune responses of the skin produce 
proteinase-activated receptor-1 (PAR1) and/or PAR2. PAR1 is activated by matrix metalloprotein-
ase-1 (MMP-1) and thrombin, whereas PAR2 is stimulated by endothelial-derived trypsins, mast 
cell tryptase and stratum corneum tryptic enzyme (SCTE or kallikrein-5). Moreover, tryptase is 
released by mast cells upon stimulation at sites of infl ammation. In many infl ammatory skin 
diseases (e.g psoriasis, atopic dermatitis) the number of mast cells is increased. In previous 
results, we could demonstrate enhanced immunoreactivity for PAR2 in lesional skin of atopic 
dermatitis patients. PAR2 was detected on keratinocytes, as well as on neuronal fi bers that 
were located in the vicinity of mast cells. In this study we wanted to determine whether PAR2 
is up-regulated in other infl ammatory skin diseases, and whether the expression of PAR1 is also 
affected. Using immunohistochemistry we determined the immunoreactivity of PAR1, PAR2 
and the PAR2 agonist mast cell tryptase in six infl ammatory skin diseases – dermatitis (acute 
and chronic stage), psoriasis, prurigo (nodularis and simplex), urticaria, rosacea and leucocyto-
clastic vasculitis. Expression of both receptors was not affected in the epidermis of vasculitis 
patients. However, we found a signifi cant upregulation of PAR1 in the epidermis of rosacea and 
psoriasis patients, and of PAR2 in psoriasis, rosacea, urticaria and prurigo patients, respectively. 
PAR2 expression was also enhanced in the skin of dermatitis patients. No differences could be 
found comparing acute and chronic stages. The expression of PAR1 and PAR2 was also seen in 
vascular endothelial cells and some infl ammatory cells in the dermis. This suggests that both 
receptors play an important role in skin infl ammation. In addition, we may conclude that 
tryptase, as a serine protease, is an important mediator of infl ammation and pruritus in certain 
infl ammatory skin diseases via activation of PAR2. Therefore, serine proteinase inhibitors might 
serve as anti-infl ammatory and anti-pruritic therapeutics.
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TLR Ligation of Epidermal Cells Upregulates Costimulatory Molecule Expression and Hapten-
presenting Function of Murine Langerhans Cells
Sugita K, Kabashima K, Shimauchi T, Kobayashi M and Tokura Y
Department of Dermatology, University of Occupational and Environmental Health (Japan)
We investigated whether TLR ligation of epidermal cells (ECs) enhances the antigen-presenting 
ability of Langerhans cells (LCs) in mice. Freshly isolated EC suspensions were cultured with 
TLR ligands (peptidoglycan, LPS, or CpG oligonucleotide). Ficoll gradient separation (LC-en-
riched ECs; 15-20% LCs) and additional anti-CD11c MACS positive selection (purifi ed LCs; 
70-80% LCs) were performed for enrichment of LCs. The obtained cells were modifi ed with 
TNP hapten and used as stimulators. CD4+ T cells as responders were prepared from draining 
lymph nodes of mice sensitized with TNCB, and incubated with TNP-modifi ed, LC-enriched 
ECs or purifi ed LCs. The cultures were maintained for 3 days in the presence or absence of TLR 
ligands. The ligands were capable of enhancing the hapten-presenting ability of LCs, when 
LC-enriched ECs, but not purifi ed LCs, were used as the LC source, suggesting that bystander 
keratinocytes play a role for the enhancement of LC function in response to TLR ligands. To 
analyze the expression of CD86 molecule on LC, freshly isolated ECs were cultured for 24 h 
in the presence or absence of TLR ligands. We found that TLR ligands increased the frequency 
of CD86-highly expressed (mature) population of LCs. The ligands enhanced the production 
of IL-1α, GM-CSF, and TNF-α by primarily cultured keratinocytes. The addition of a cocktail 
of neutralizing antibodies against these cytokines abrogated the ligand-promoted, antigen-pre-
senting ability of LC-enriched ECs. Moreover, culture supernatants from the ligand-stimulated 
keratinocytes restored the ability of purifi ed LCs. Finally, we found that TLR9 was expressed 
intracytoplasmically in keratinocytes. These results suggest that LC function is upregulated in-
directly by cytokines released via TLR ligation-stimulated keratinocytes. 
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Identifi cation of FOXP3+GITR+CD4+CD25+ Regulatory T Cells in Normal and Diseased 
Skin
Teunissen MB1, Van der Loos CM2, Teeling P2, Van der Wal AC2 and De Boer OJ2
1Department of Dermatology, Academic Medical Center (Netherlands)
2Department of Pathology, Academic Medical Center (Netherlands)
Natural arising regulatory T cells (Treg), generally referred to as CD4+CD25+ Treg because of 
their constitutive high expression of CD25, play a central role in immunologic tolerance. Ab-
normalities in number and function of Treg would disturb this control mechanism of immune 
regulation. Little is known about the presence of Treg in tissues due to the lack of specifi c mark-
ers. In this study we aimed to evaluate the suitability of markers Foxp3 and GITR (both reported 
to be associated to Treg) to identify Treg in skin sections. First we confi rmed the correlation 
of Foxp3 and GITR with the well-defi ned population of peripheral blood CD4+CD25high Treg. 
Next, we tested the coexpression of these markers in normal skin and in diseased skin (e.g. pso-
riasis and lichen planus). Immunohistochemical double stainings of Foxp3 with either GITR, 
CD4, or CD25 and GITR with either CD4 or CD25 revealed that Foxp3 and GITR occurred 
almost exclusively in coexistence in cells that also express CD4 and CD25, indicating that both 
Foxp3 and GITR may be useful markers for the identifi cation of Treg in situ. Granting this we 
determined the frequency of putative Treg in a large series of skin sections from different skin 
disorders: three serial sections were single stained with Foxp3, CD3, and GITR, respectively, 
and the frequency of Foxp3+ and GITR+ cells were expressed as percentage of CD3+ T cells. We 
found a considerable variation, though not signifi cant, in the frequency of Foxp3+ cells (range 
6.5-33%) and GITR+ cells (range of 12-22%) between the different types of skin diseases. Re-
markably, normal human skin also contained Foxp3+ and GITR+ cells (though smaller absolute 
numbers) with a similar frequency range as in diseased skin. In conclusion, no abnormality in 
frequency of Treg was found in several different infl ammatory skin diseases.
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Defective Fas Function and Variation of Perforin Gene in a Patient with Epidermodysplasia 
Verruciformis
Tiberio R1, Pertusi G1, Cappellano G2, Azzimonti B3, Mondini M3, Dell’Oste V3, Colombo E1, 
Dianzani U2, Gariglio M3 and Leigheb G1
1Department of Dermatology, University of Piemonte Orientale, Novara (Italy)
2Laboratory of Immunology, University of Piemonte Orientale, Novara (Italy)
3Lab of Microbiology and Molecular Virology, University of Piemonte Orientale, Novara (Italy)
In this study, we investigated some genetic, virologic and immunological parameters of a 58 
year old female affected by epidermodysplasia verruciformis. Physical examination revealed 
multiple fl at whitish and reddish papular lesions on the hands, and pityriasis versicolor-like 
lesions on the trunk. Surprisingly, she has never developed either cutaneous premalignant or 
malignant lesions even in sun-exposed areas. The diagnosis was confi rmed by typical histologic 
features of EV. HPV detection by PCR analysis from samples collected with swabs from different 
sites of the skin revealed mixed infection with multiple HPV genotypes in both affected and 
unaffected areas. 
The blood immunophenotype, assessed by cytofl uorimetric analysis, displayed normal counts 
of total T cells (CD3+ cells) with decrease of CD4+ T cells and slight increase of CD8+ T cells. 
Intriguingly, she showed expansion (9%) of an atypical T cell population expressing the TCRαβ, 
but not CD4 or CD8 (“double negative” T cells). The notion that double negative T cells are 
typically expanded in the autoimmune lymphoproliferive syndrome (ALPS) caused by inherited 
defects hitting function of the Fas death receptor, prompted our analysis of Fas function and 
the Fas gene in the patients. Results showed that Fas function was defective, but the Fas gene 
was not mutated. By contrast, the patient carried a mutation of the perforin gene (PRF1), that 
is typically mutated in familial hemophagocytic lymphohistiocytosis, but can also concur to 
ALPS. Perforin plays a key role in function of cytotoxic cells (NK and CTL).
Defective function of both Fas and perforin may lead to an unwanted accumulation of lym-
phocytes and favor autoimmunity possibly by impairing switching off of lymphocytes and de-
creasing capacity to clear viral infections. This may play a role in the clinical picture displayed 
by our patient.
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Interactions between Allergens and Dendritic Cells: Relevance for Allergen Screening and 
Implications for Treatment of Skin Diseases
Toebak MJ1, Moed H1, Bruynzeel DP1, Gibbs S1, Scheper RJ2 and Rustemeyer T1
1Department of Dermatology, VU University Medical Center, Amsterdam (Netherlands)
2Department of Pathology, VU University Medical Center, Amsterdam (Netherlands)
Dendritic cell (DC) maturation and polarisation determine the type of cutaneous immune re-
sponses. Allergen exposure stimulates DC activation and, subsequently, T-cell priming of either 
type-1 or type-2 T-cells. In contrast, skin disorders can be treated with various anti-infl amma-
tory drugs which suppress the immune reactions. Here, we investigated the effect of allergens 
on DC maturation and polarisation and subsequently the suppression of anti-infl ammatory 
drugs on allergen-induced DC maturation and polarisation.
Firstly, the effect of contact allergens (nickel sulphate, cobalt chloride, palladium chloride, copper 
sulphate, chrome-(III)-chloride, potassium dichromate, p-phenylenediamine, dinitrochlorobenzene) 
and irritants (sodium dodecyl sulphate, dimethylsulfoxide, benzalkoniumchloride, propane-1-ol) 
on DC maturation was analysed by CD86 expression and CXCL8 production. Secondly, the effect 
of contact and respiratory allergens on DC polarisation was determined by cytokine production 
(DC1: IL-12p70, TNF-α, CXCL10; DC2: IL-10, CCL17). Thirdly, inhibitory effects of anti-infl amma-
tory drugs on allergen-induced DC maturation and polarisation were studied.
All allergens, but not irritants, induced DC maturation, as shown by their CXCL8 production. As 
to DC polarisation, the contact allergens dinitrochlorobenzene and oxazolone induced DC1 cy-
tokines, whereas the respiratory allergens trimellitic anhydride and Dermatophagoides pteronys-
sinus induced DC2 cytokines. The contact allergen nickel sulphate induced, next to DC maturation, 
a combined DC1 and DC2 cytokine profi le. Suppression of dendritic cell maturation could be 
induced by all anti-infl ammatory drugs tested. DC1 polarisation could be suppressed by hydrocor-
tisone, dexamethasone, di-methyl-fumarate, 1-α,25-dihydroxyvitamin D3, whereas diclofenac se-
lectively suppressed DC2 polarisation. Cyclosporine A suppressed both DC1 and DC2 cytokines. 
We demonstrated that allergens directly stimulate maturation of DCs. Contact and respiratory 
allergens have an intrinsic capacity to polarise DC-mediated immune responses, irrespective of 
local factors from cutaneous and mucosal epithelial microenvironments. Ultimately, allergen-
induced DC maturation and polarisation can be differentially suppressed by anti-infl ammatory 
drugs.
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Activated Macrophages Play an Essential Role in a Murine Model for T-Cell dependent Chronic 
Psoriasiform Skin Infl ammation
Wang H1, Peters T1, Kess D1, Sindrilaru A1, Oreshkova T1, Rooijen NV2, Stratis A3, Wlaschek M1, 
Haase I3 and Scharffetter-Kochanek K1
1Department of Dermatology and Allergic Diseases, University of Ulm (Germany)
2Department of Cell Biology, Free University, Amsterdam (Netherlands)
3Department of Dermatology, University of Cologne (Germany)
The CD18 hypomorphic (CD18hypo) PL/J mouse model clinically resembling human psoriasis 
is characterized by reduced expression of the common chain of beta2 integrins (CD11/CD18) 
to only 2–16% of wild type levels. Previously, we found that this chronic psoriasiform skin 
infl ammation also depends on the presence of CD4+ T cells. Herein we investigated the role 
of macrophages in this CD18hypo mouse model. Activated macrophages were signifi cantly in-
creased in lesional skin as well as in infl amed skin draining lymph nodes (DLNs) of affected 
CD18hypo mice and were identifi ed as being an important source of TNF-α in vivo. Both deple-
tion of macrophages and neutralization of TNF-α resulted in a signifi cant alleviation of the 
psoriasiform skin infl ammation. As MCP-1 was enhanced in lesional skin of affected CD18hypo 
mice, we intradermally injected rJE/MCP-1 alone or in combination with TNF-α into the skin 
of healthy CD18hypo mice. Only simultaneous injection of rJE/MCP-1 and rTNF-α, but neither 
substance alone resulted in the induction of psoriasiform skin infl ammation around the injec-
tion sites with recruitment and activation of macrophages. Collectively, our data suggest that 
maintenance of the psoriasiform skin infl ammation critically depends on effi cient recruitment 
and activation of macrophages with suffi cient release of TNF-α.
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Mast Cells Control Dermal Infl ammation and Epidermal Proliferation During Cutaneous 
Wound Healing Responses
Weller K, Zuberbier T and Maurer M
Department of Dermatology and Allergy, Charite - Universitätsmedizin Berlin (Germany)
We and others have recently demonstrated that mast cells (MCs) play a key role in the elicita-
tion of infl ammatory reactions that are benefi cial to the host and it is well established that 
infl ammation is a pivotal event in normal wound repair responses. We have previously shown 
that the closure of skin wounds in mice is critically dependent on the presence of cutaneous 
MCs and that distance-dependent MC activation occurs at wound edges. To explore whether 
MCs also control the early infl ammatory responses in wound repair, we experimentally in-
duced full-thickness back skin wounds in MC-defi cient KitW/KitW-v mice, normal Kit+/+ mice, 
and MC-reconstituted KitW/KitW-v mice using a 6 mm diameter biopsy punch. Subsequently, 
Evans blue-extravasation assays for detection of vasopermeability changes, optimized mye-
loperoxidase assays for the determination of neutrophil infl ux, and staining for Ki67 to ana-
lyze keratinocyte proliferation were performed. Interestingly, KitW/KitW-v mice showed impaired 
Evans blue-extravasation and recruitment of neutrophils to the wounded areas. In addition, 
MC-defi cient mice exhibited a lower rate of proliferating basal keratinocytes at the wound 
edges 24 hours after wounding. Notably, extravasation and neutrophil recruitment were found 
to be normal in MC-reconstituted KitW/KitW-v mice. To better understand how these MC-effects 
are mediated, we studied the impact of the MC-mediators histamine and TNF-alpha on wound 
healing by comparing wound closure between TNF-alpha defi cient and wild type mice as well 
as C57BL/6 mice treated with H1- or H2-antihistamines or placebo. Interestingly, wound closure 
was reduced in dimethindene-treated mice (H1-receptor antagonist) but not after treatment with 
ranitidine (H2-receptor antagonist) or in the absence of TNF-alpha. Taken together, our fi ndings 
indicate that MCs control the early infl ammatory and proliferative events of wound repair re-
sponses and that histamine release is important for normal skin wound healing.
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Immature Mast Cells Show Adherence to Skin Endothelial Cells and Subsequent Transmigration 
in Response to C5a or TNFα
Wetzel A and Maurer M
Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin (Germany)
Skin mast cell (MC) numbers are increased at sites of chronic infl ammation. The underlying 
mechanisms of cutaneous MC hyperplasia, however, remain to be identifi ed and characterized 
in detail. Here, we demonstrate that murine bone marrow derived MCs (BMMCs) adhere to 
skin microvascular endothelial cells (sEND), even without previous stimulation. BMMCs, albeit 
to a lesser extent, also adhered to brain derived endothelial cells (bEND) and fi broblasts, but 
not to the extracellular matrix components fi bronectin and laminin. BMMC adhesion to sEND 
was found to involve several inducible cell adhesion molecules expressed on the surface of 
endothelial cells. As shown by using neutralizing antibodies, both P- and E-selectin, VCAM-1, 
ICAM-1 as well as the junctional adhesion molecules PECAM-1, JAM-B and E-cadherin can 
facilitate BMMC adhesion. BMMC adhesion molecules involved in binding to sEND include 
PSGL-1, VLA-4, and αVβ3, but not ICAM-1 or PECAM-1. Notably, BMMC adhesion to sEND is 
increased by previous stimulation with complement factor C5a. Most interestingly, BMMCs 
were also found to transmigrate across the endothelial barrier in response to C5a or TNFα. Our 
results demonstrate, for the fi rst time, that immature murine MCs can undergo coordinated und 
controlled adhesion to the skin endothelial barrier followed by directed transmigration into the 
dermis. Our ongoing follow-up studies are aimed at characterizing the in vivo relevance of this 
mechanism of MC hyperplasia in settings of chronic cutaneous infl ammation including allergic 
and pathogen-driven infl ammatory responses.
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Epidermal Stem Cells Differ in their Response zo Proinfl ammatory Signals from Other 
Proliferative Keratinocytes
Zeitvogel J, Wang D, Werfel T and Wittmann M
Department of Dermatology, Hannover Medical School (Germany)
The epidermis has a pool of adult stem cells which guarantees a dynamic epithelium with self-
renewal capacity. beta-1-integrin (CD29) is highly expressed on epidermal stem cells which 
allows separation of these cells by beta-1-integrin-ligand mediated adherence. Cells enriched 
by adherence showed a higher Ki67 expression, a slower but sustained proliferative capacity 
and higher CD29 and alpha-6 (CD49f)-integrin expression in comparison to other proliferative 
keratinocytes. Markers such as CD34, transferrin receptor (CD71) downregulation of Hoechst 
dye exclusion were not useful or applicable for discrimination of these cells in our system. 
In this study we analysed the production of the chemokines CCL2, CXCL10, CCL22, of the 
cytokines IL-12, IL-18, IL-10, TGFβ and the surface molecules CD54 and MHC class II in 
unstimulated and IFNγ stimulated cells. We demonstrate that the adherence enriched stem 
cells differed signifi cantly from other proliferating keratinocytes by reduced basal production of 
CCL2, higher medium to IFNγ stimulation indices for CCL22 and a markedly weaker secretion 
of IL-18 upon stimulation with IFNγ. Surface expression of CD54 and MHC class II was found 
increased in adherence enriched stem cells upon IFNγ stimulation. Taken together our data sug-
gest that the skin stem cell compartment might also actively contribute to the immunological 
properties of the skin organ including keratinocyte-T-cells interaction and might contribute to 
skin homeostatis in health and disease. 
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Characterization of Dendritic Cells in Drug-induced Cutaneous Eruptions
Hassan AS, Hunger R, Braathen LR and Yawalkar N
Department of Dermatology, Inselspital, University of Bern, Switzerland (Switzerland)
Increasing evidence indicates that T cells play a pivotal part in the pathogenesis of cutaneous 
drug eruptions. However, the role of dendritic cells (DC), which may activate these T cells, 
has so far been poorly analyzed. The aim of this study was to characterize the DC popula-
tion involved in cutaneous drug eruptions. Skin biopsies were obtained from six patients with 
drug-induced maculopapular eruptions and from healthy controls. Immunohistochemistry us-
ing monoclonal antibodies targeting CD1a, CD207/langerin, CD1c, CD11c, CD123, CD83, 
CD206/mannose receptor, CD208/DC-LAMP, CD209/DC-SIGN and CD68 was performed 
on cryostat sections using the avidin-biotin complex/alkaline phosphatase method. In com-
parison to normal skin, enhanced immunoreactivity for CD11c+DC, CD83+DC, CD206+ DC, 
CD209+DC and for CD68 + macrophages was observed in skin lesions from patients with 
maculopapular drug eruptions. In conclusion, these data indicate that certain DC subpopula-
tions may be involved in the pathogenesis of cutaneous drug eruptions.
323 [014]
Prostaglandin D2 Plays an Essential Role in Chronic Allergic Infl ammation of the Skin via 
CRTH2 Receptor
Satoh T1, Moroi R1, Aritake K2, Urade Y2, Hirai H3, Nagata K3, Yokozeki H1, Nishioka K1 and 
Nakamura M4
1Department of Dermatology, Graduate School, Tokyo Medical and Dental University (Japan)
2Osaka Bioscience Institute (Japan)
3BML Inc. (Japan)
4Human Gene Sciences Center, Tokyo Medical and Dental University (Japan)
Biological activities of prostaglandin D2 (PGD2) are thought to be mediated by the classical 
D P receptor and CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 
cells). Despite increasing knowledge about functions of DP, the roles that CRTH2 plays in 
allergic infl ammation in vivo are not fully understood. In the present study, to examine the 
role of PGD2-CRTH2 interaction in development of allergic infl ammation, we generated mice 
that contain a targeted disruption of the CRTH2 gene. We used these mice to characterize 
chronic cutaneous infl ammatory processes, including IgE-mediated very-late-phase responses 
and chronic contact hypersensitivity induced by repeated hapten application. The present fi nd-
ings indicate that IgE-mediated cutaneous responses are dependent on PGD2. Ear swelling 
responses were suppressed by administration of HQL-79, which is a PGD synthase inhibi-
tor. CRTH2-defi cient mice failed to develop IgE-induced very-late-phase cutaneous responses, 
which are histologically characterized by a decrease in infi ltrative lymphocytes, eosinophils 
and basophils, associated with inhibited production of eotaxin, MDC and RANTES. However, 
local production of IL-4 and IFNγ was not affected by lack of CRTH2. In chronic contact hyper-
sensitivity models, CRTH2 defi ciency also resulted in diminished skin responses and serum IgE 
production. In vivo migration of Langerhans cells and dendritic cells to regional lymph nodes 
was not impaired in CRTH2-defi cient mice. These fi ndings indicate that PGD2 signaling via 
the CRTH2 receptor plays important roles in IgE-mediated cutaneous responses and chronic 
contact hypersensitivity reactions. CRTH2 may represent a novel therapeutic target for the treat-
ment of chronic allergic skin infl ammation, such as atopic dermatitis.
324 [015]
Benefi cial Autoimmunity to Macrophage Migration Inhibitory Factor (MIF) Restrains Atopic 
Dermatitis in Murine Model
Hamasaka A1, Abe R1, Koyama Y2, Sasaki M1, Hirasawa T3, Nishihira J4, Shimizu T5 and
Shimizu H1
1Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
2Dept of Molecular Biochemistry,Hokkaido University Graduate School of Medicine (Japan)
3Discovery Research Laboratories, Shionogi and Co. Ltd (Japan)
4GeneticLab Co. Ltd. (Japan)
5Department of Dermatology, Toyama Medical and Pharmaceutical University (Japan)
Atopic dermatitis (AD) is a chronic infl ammatory skin disease resulting from complex interac-
tions between both genetic and environmental factors. In particular, dysregulation of proin-
fl ammatory cytokine production is important cause of AD. Macrophage migration inhibitory 
factor (MIF), a key proinfl ammatory cytokine, is expressed in various infl ammatory and autoim-
mune disorders including AD. 
We developed a novel plasmid DNA vaccine encoding recombinant MIF molecules, which 
were modifi ed to contain a foreign immunogenetic T-helper epitope. In this study, the MIF-
DNA vaccine was applied to DS-Nh mouse which spontaneously develop dermatitis similar to 
human AD. We assessed whether this vaccine treatment would lead to an improvement in AD 
by downregulating MIF. The effect of MIF-DNA vaccine was evaluated by clinical skin changes, 
histological change, and by serum total IgE level analysis.
MIF-DNA vaccinated mice developed high titers of neutralizing anti-MIF autoantibodies and 
maintained them for at least 6 months. MIF-DNA vaccine also signifi cantly inhibited the de-
velopment of AD skin phenotypes. Furthermore, MIF-DNA vaccine applied to mice which 
had already developed AD, lead to a rapid improvement in clinical skin score. Concurrently, 
there were reduced signs of histological infl ammatory reaction and serum levels of total IgE 
decreased in treated mice. These results demonstrated that MIF-DNA vaccine prevents not only 
the development of AD but also improves symptoms of pre-existing AD. Taken together, induc-
tion of anti-MIF autoantibody production by MIF-DNA vaccination may be a useful approach 
for the treatment of AD.
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IL-1α Suppresses Th2-Mediated Immune Responses
Caucig P1, Dinges S1, Maxeiner J2, Finotto S2 and von Stebut E1
1Department of Dermatology, University of Mainz (Germany)
2Laboratory of Immunology of the Lung, University of Mainz (Germany)
As we and others have previously shown, the quality of resulting Th immune responses is de-
pendent on proinfl ammatory IL-1α/β. In the model of cutaneous leishmaniasis, dendritic cell-
derived IL-1α released during T-cell priming together with IL-12 is responsible for the induction 
of protective, Th1-dependent immunity. To examine the role of IL-1α in other CD4-dependent 
immune responses, we now used the models of OVA-induced allergic asthma and KLH-medi-
ated delayed type hypersensitivity (DTH). To initiate asthma, BALB/c mice were sensitized with 
OVA/Alum complexes. IL-1α was injected on days 0-2 during sensitization. After OVA aerosol 
challenge, we found decreased airway hyperresponsiveness to methacholine in IL-1α -treated 
mice as compared to untreated mice (p≤0.05, n=15). Peribronchial infl ammatory infi ltrates 
in IL-1α-groups were reduced compared to controls (p≤0.05, n=9). IL-1α -treated mice con-
tained fewe eosinophils in the bronchoalveolar lavage fl uid (BALF) in comparison to controls 
(p≤0.002, n=9). In addition, increased amounts of IFNγ and reduced levels of IL-4, IL-5 and 
IL-13 were detected in the BALF of mice treated with IL-1α in contrast to untreated (p≤0.05, 
n=9). Moreover, to assess Th2-associated DTH responses, BALB/c mice were sensitized with 
KLH±Alum with or without co-administration of IL-1α. DTH responses were measured after 
challenge of contralateral footpads. KLH/Alum sensitized, IL-1α-treated mice showed reduced 
footpad swelling as compared to control mice (n=13; 48hrs: p≤0.002; 72hrs: p≤0.05). Popliteal 
lymph node cells were restimulated in the presence of KLH. Signifi cantly higher levels of IFNγ 
were found in IL-1α-treated groups compared to controls (p≤0.05, n=13), whereas no effect 
was observed on IL-4 and IL-10 production. In summary, in these proof-of-principle experi-
ments, we show that IL-1α is able to suppress Th2-mediated immune responses, e.g. allergic 
asthma and DTH responses, by inducing Th1-predominant immunity during sensitization.
326 [026]
Innate Immune Response of Human Keratinocytes to Double-Stranded RNA (dsRNA)
Naderi Kalali B1, Köllisch G1, Bauer S2, Ring J1, Mempel M1 and Ollert M1
1Department of Dermatology and Allergy, Biederstein,TU Munich (Germany)
2Institut of Immunology, University of Marburg (Germany)
As sentinels of host defense, epidermal keratinocytes (KC) respond to viral pathogens by ac-
tivating a broad array of genes mainly promoting immune responses. The pro-infl ammatory 
effect of viral infection can be mimicked by dsRNA which is recognized by Toll-like receptor 
3 (TLR3), protein kinase R (PKR), retinoic-acid-inducible gene 1 (RIG1), and melanoma-dif-
ferentiation-associated gene 5 (MDA5). These receptors are expressed in primary human KC at 
a constitutive and inducible level after stimulation with dsRNA. Accordingly, we observed that 
in human primary KC, polyinosinic acid:cytidylic acid (poly I:C), a synthetic dsRNA, potently 
induced gene expression with a broad pattern of regulated genes, not only pro-infl ammatory 
genes under the control of NF-κB (e.g., IL-8), but also genes which are under transcriptional 
control of IRF3/IRF7 (e.g., IFN-β). In order to dissect the signaling pathways being induced by 
poly I:C through TLR3, PKR, RIG1, and MDA5, we used specifi c inhibitors for receptors or 
their specifi c downstream kinases. While 2-aminopurine (inhibitor of PKR) effi ciently blocked 
both pathways with down-regulation of IL-8 and IFN-β, bafi lomycin A (inhibitor of endosomal 
recruitment of TLR3) blocked up-regulation of IL-8 but not of IFN-β. Inhibition of phosphoi-
nositide 3-Kinase, a downstream kinase for RIG1, or inhibition of TBK1, a key molecule for 
phosphorylation of IRF3, impaired production of IFN-β signifi cantly. Thus, in human KC, TLR3 
seems to be necessary for NF-κB but not IRF3 translocation due to dsRNA stimulation. RIG1 
and MDA5 are involved in IRF3 activation. PKR is essential for the dsRNA response in both 
signaling pathways. Thus, PKR seems to represent the central receptor for KC activation after 
viral infection.
327 [027]
The Bcl10/Malt1 Complex Segregates FcεRI-Mediated NF-kappaB Activation and Cytokine 
Production from Mast Cell Degranulation
Klemm S1, Gutermuth J2, Hültner L3, Sparwasser T4, Behrendt H2, Peschel C1, Mak TW5,
Jakob T2 and Ruland J1
1Third Medical Department, Klinikum rechts der Isar, Technical University Munich (Germany)
2ZAUM-Center for Allergy and Environment, Technical University Munich (Germany)
3Institute of Clinical Molecular Biology and Tumor Genetics, GSF, Munich (Germany)
4Inst for Medical Microbiology, Immunology & Hygiene, Technical Univ Munich (Germany)
5Campbell Family Inst for Breast Cancer & Ontario Cancer Inst, Univ of Toronto (Canada)
Mast cells (MCs) are essential effector cells in IgE-mediated atopic disease. After crosslink-
ing of Fc receptors, histamine and serotonin are released immediately by degranulation and 
proinfl ammatory cytokines and leukotrienes are synthesized de novo. The integration of early 
signalling events after FcεRI aggregation and the control of selected mast cell responses like 
immediate degranulation or delayed cytokine production are major questions. Recently, the 
adaptor proteins B cell lymphoma 10 (Bcl10) and mucosa-associated lymphoid tissue 1 (Malt1) 
were identifi ed as key regulators of T and B cell antigen receptor signalling. In the light of these 
fi ndings, we investigated the role of Bcl10 and Malt1 in FcεRI signalling in vivo and in vitro. 
MC number, morphology and distribution in different body areas of Bcl10- or Malt1-defi cient 
mice were normal compared to wildtype controls, coinciding with regular in vitro develop-
ment of bone marrow-derived MCs (BMMCs). FcεRI-mediated MC degranulation also was not 
altered, as shown by normal in vivo immediate phase passive cutaneous anaphylaxis (PCA) 
reactions and consistently, BMMCs showed normal in vitro leukotriene release. In contrast, 
analysis of late phase PCA by an ear swelling assay exhibited dramatically reduced responses 
in Bcl10- and Malt1-defi cient mice. Accordingly, BMMCs showed severely reduced secretion 
of the proinfl ammatory cytokines TNF- and IL-6. Finally, phosphorylation of FcεRI-proximal 
signalling molecules, MAP kinases and IB- was assessed after stimulation of BMMCs, demon-
strating defective IκB-α degradation and NF-κB activation in MCs lacking Bcl10 or Malt1. In 
summary, Bcl10- and Malt1-defi cient mice displayed defective late phase anaphylactic reac-
tions, while immediate phase reactions appeared normal in vivo and in vitro. Thus, Bcl10 and 
Malt1 are essential positive regulators of FcεRI-dependent mast cell activation, which selec-
tively uncouple NF-κB–induced proinfl ammatory cytokine production from degranulation and 
leukotriene synthesis.
328 [028]
Multiple Roles of Suppressor of Cytokine Signaling (SOCS)1 in Inhibiting the Infl ammatory 
Responses Induced by IFN-γ in Human Keratinocytes
Madonna S, Scarponi C, De Pità O and Albanesi C
Lab of Immunology and Allergology, Istituto Dermopatico dell’Immacolata (IDI)-IRCCS (Italy)
IFN-γ is the most potent activator of the pro-infl ammatory functions of keratinocytes, which relevant-
ly participate in the induction and expression of skin immunity. It signals through the well-known 
Jak1-2/STAT1 pathway, which is in turn negatively regulated by SOCS1 protein to avoid the detrimen-
tal consequences of excessive stimulation. RAS/MAPK/ERK pathway is also involved in the control 
of gene expression in response to IFN-γ, and the abrogation of ERK1/2 activity increased the IFN-
γ-induced chemokine expression in keratinocytes and skin infl ammatory responses in mice. Previous 
studies demonstrated that the expression of many pro-infl ammatory genes, such as CXCL10, CXCL9 
and CCL2 chemokines induced by IFN-γ in human keratinocytes can be abrogated by overexpress-
ing SOCS1, which reduces IFN-γ Rα phosphorylation and, consequently, of STAT1 protein activity. 
In this study, we investigate on the possible role of SOCS1 in regulating RAS/MAPK/ERK pathway 
in human keratinocytes. We found an increased basal ERK1/2 and RAS activity in keratinocytes 
permanently transfected with SOCS1 compared to cells harbouring empty vector. On the contrary, 
the inhibition of SOCS1 expression in IFN-γ-treated keratinocytes resulted in an impaired RAS and 
ERK1/2 activation. These data indicate that SOCS1 is responsible for the induction of RAS and, there-
fore, of ERK1/2 promoted by IFN-γ in human keratinocytes. The enhanced RAS/ERK1/2 pathway in 
SOCS1 clones was in part responsible for their inability to express the chemokines CXCL10 and 
CCL2 in response to IFN-γ, as assessed by treating cells with the inhibitor of the MAPK/ERK signaling 
PD98059. Finally, co-immunoprecipitation experiments revealed that SOCS1 binds the RAS inhibi-
tor protein RasGAP, thus sustaining RAS/ERK1/2 activation. As a whole, our data demonstrate that 
SOCS1 through a direct activation of RAS sustains the MAPK/ERK pathway, which in turn inhibits 
the IFN-γ-induced chemokine expression in keratinocytes. We hypothesize that SOCS1 functions as 
suppressor of IFN-γ signaling not only by repressing STAT1 activation at the IFN-γ R complex but also 
by inducing anti-infl ammatory pathways triggered by RAS molecule.
329 [029]
Role of an Anti-angiogenic Factor, Pigment-epithelium-derived Factor (PEDF) in the 
Pathogenesis of Psoriasis
Abe R1, Sasaki M1, Inokuma D1, Ando S1, Matsui T2, Yamagishi S2, Shimizu T3 and Shimizu H1
1Dept of Dermatology, Hokkaido Univ Grad School of Medicine (Japan) 2Dept of Medicine, Kurume 
Univ School of Medicine (Japan) 3Dept of Dermatology, Faulty of Medicine, Univ of Toyama (Japan)
Psoriasis is a persistent cutaneous disease characterized by skin infl ammation and angiogenesis. 
In general, angiogenesis is regulated by a balance between angiogenic factors, such as vascular 
endothelial growth factor (VEGF) and anti-angiogenic factors whereas the contribution of anti-
angiogenic factors to the pathogenesis in psoriasis is largely unknown. In this study, we have 
investigated pigment epithelium-derived factor (PEDF) in the pathogenesis of psoriasis, one of 
the most potent inhibitors of angiogenesis. PEDF proteins were detected in both epidermis and 
dermis of normal skin, and found to be up-regulated in the epidermal lesions of psoriasis. The se-
cretion of PEDF from cultured keratinocytes was signifi cantly enhanced by the treatment with li-
popolysaccharide in vitro. There was no signifi cant difference in PEDF levels between serum from 
patients with psoriasis and normal controls. In addition, VEGF-induced keratinocyte proliferation 
was completely inhibited by PEDF in a dose dependent manner. Finally, a recombinant PEDF 
was examined for anti-proliferative effects in the human skin-severe combined immunodefi cient 
(SCID) mouse transplant model. Local application of PEDF signifi cantly reduced epidermal thick-
ness of transplanted psoriatic skin and also inhibited the hyperplastic response that developed in 
nonpsoriatic skin after transplantation. These observations suggest that PEDF might be elevated in 
psoriasis lesions as an antagonistic system against the processes of angiogenesis and infl amma-
tion. These data also suggest that an important role for PEDF in psoriatic hyperplasia and suggest 
that inhibition of PEDF activity could be an effi cacious therapeutic strategy for psoriasis. 
330 [030]
Platelet P-Selectin Expression is a Perquisite for Generation of Immunity
Ludwig RJ1, Caucic P2, Stein J3, Henschler R4, Pfeilschifter JM5, von Stebut E2, Radeke HH5, 
Kaufmann R6 and Boehncke WH6
1Dept of Dermatology & Pharmazentrum, Clinic of Johann Wolfgang Goethe Univ (Germany)
2Dept of Dermatology, Johannes Gutenberg Univ (Germany) 3Theodor-Kocher Inst, University 
of Bern (Switzerland) 4Inst of Transfusion Medicine, German Red Cross Blood Donor Serv-
ice, Frankfurt (Germany) 5Pharmazentrum/ZAFES, Clinic of the Johann Wolfgang Goethe Univ 
(Germany) 6Dept of Dermatology, Clinic of the Johann Wolfgang Goethe Univ (Germany)
Cutaneous hypersensitivity reactions depend on a sensitization- and effector phase. During sensitiza-
tion, naïve T-cells home into lymph nodes, where antigen presentation and clonal expansion occur. 
While expression of L-selectin is high on naïve T-cells, effector T-cells have only a small amount of 
this adhesion molecule expressed on the cell surface. Hence, L-selectin has been implied as the 
most important adhesion molecule for entry of lymphocytes into peripheral lymph nodes. We here 
however provide evidence, that P-selectin contributes to an at least similar extend to lymphocyte 
extravasation to lymph nodes. Wild type, L-selectin defi cient (L-sel-/-) or P-selectin defi cient (P-sel-/-) 
mice were sensitized with DNFB. Five days after DNFB-exposure, mice were sacrifi ced and leuko-
cytes were isolated from peripheral lymph nodes and spleens, and i.v. injected into recipient wild 
type mice, which were subsequently exposed to DNFB on the right ear. As previously described, 
L-selectin signifi cantly contributes to sensitization in the model of DNFB-induced cutaneous con-
tact hypersensitivity. However, P-selectin also is critically involved in generating immunity towards 
DNFB. By comparing the relative contribution of L- and P-selectin in this process, the contribution of 
P-selectin seems more detrimental (∆ ear swelling: 40±12, 31±10 and 19±11cmx10-3 for wild type, 
L-sel-/- and P-sel-/- mice, respectively). Decreased ear swelling was accompanied by a reduction of 
infi ltrating CD8+-cells as determined by fl ow cytometry. To further elucidate the relative contribution 
of endothelial vs. platelet P-selectin, using bone-marrow transplantation, we have generated mice 
selectively defi cient in platelet-P-selectin expression. These experiments showed, that generation of 
immunity strongly depends on platelet, not endothelial P-selectin expression (∆ ear swelling: 49±8 
and 11±10 cmx10-3 for irradiated C57Bl/6 mice reconstituted with wild type or P-selectin defi cient 
bone marrow, respectively) . P-selectin may be involved in migration of APC or naïve T-lymphocytes 
to lymph nodes, and/or in antigen presentation. Investigations to further elucidate the role of P-se-
lectin in generating immunity are currently underway. Preliminary results from intravital microscopy 
experiments in lymph nodes of mice exposed to DNFB indicate, that L-selectin independent rolling 
interactions are sustained in these infl amed lymph nodes. In summary, we here provide evidence, 
that platelet P-selectin expression is involved in generating immunity in the model of DNFB induced 
cutaneous hypersensitivity responses. 
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LPS-Induced IL-12 Production by Human Dendritic Cells is Greatly Infl uenced by IL-4
Guenova E, Volz T, Kaessler S and Biedermann T
Department of Dermatology, Eberhard Karls University, Tübingen (Germany)
Interleukin (IL)-4 is known to be the major factor that initiates Th2 cell differentiation. Recently, it 
was demonstrated that IL-4 also potently promotes IL-12 production by dendritic cells consequently 
inducing interferon γ (IFN- γ) producing Th1 cells. These fi ndings are of importance for the under-
standing especially of the regulation of immune responses associated with IL-4 such as in atopic 
dermatitis or allergic asthma. In these diseases, early IL-4 dominated infl ammation is followed by 
IFN- γ expression and the regulation of this process is still not understood. Moreover, human mono-
cyte-derived DC (MoDC) are commonly generated in vitro using IL-4. To elucidate the role of IL-4 in 
humans, the phenotype of activated MoDC was analyzed as a function of IL-4. In all cases CD11c+ 
CD14- HLA-DR+, CD86+/-, CD83- immature MoDC were analyzed and activated with different 
stimuli and cytokines. As expected, HLA-DR and CD86 expression was vigorously upregulated and 
CD83 appeared within 24h upon stimulation with LPS and other stimuli. Pre-culture with different 
doses of IL-4 between 5-50 ng/ml did not signifi cantly infl uence the DC phenotype as detected by 
expression of the indicated surface molecules. However, in contrast to low or intermediate doses of 
IL-4, high concentrations of IL-4 markedly altered the LPS induced cytokine production of human 
DC. High dose IL-4 signifi cantly enhanced IL-12 production in human DC. Investigating the under-
lying mechanisms, we found that enhanced IL-12 production induced by high dose IL-4 depended 
on IL-4 regulated reduction of IL-10 in stimulated DC. In low dose IL-4 treated DC LPS activation 
induced an IL-12/IL-10 ratio < 1, whereas in high dose IL-4 treated DC IL-12 was up- and IL-10 was 
downregulated resulting in an IL-12/IL-10 ratio > 1. Our data clearly show that there is a regulatory 
balance of IL-12 and IL-10 in human DC that is orchestrated by IL-4. This is of clinical relevance in 
regard to the role of IL-4 in atopic diseases and may explain the transition from IL-4 to IFN-γ pre-
dominance in chronic lesions of diseases such as atopic dermatitis or allergic asthma.
332 [032]
Biofi lm-Forming P. aeruginosa Release a Powerful hBD-2 Inducer
Schwichtenberg L, Bartels J, Gerstel U, Harder J and Schroeder JM
Department of Dermatology, University-Hospital SH, Kiel (Germany)
Striking differences in the capacity of bacteria to induce hBD-2 in various epithelia suggest regula-
tion of hBD-2-inducing molecule-production in bacteria. The identifi cation of a biofi lm-derived 
mucoid clinical P. aeruginosa strain as the only at in vivo-relevant bacterial densities hBD-2-induc-
ing strain led to the hypothesis, that biofi lm-formation causes hBD-2-induction.
We therefore analysed supernatants of a P. a. ATCC strain, that was cultured at various conditions 
for hBD-2-induction in keratinocyte cultures. Interestingly, only under iron-starvation at static condi-
tions, but not upon planctonic culture, bacteria released hBD-2-inducing activity. We saw further a 
positive correlation of hBD-2-induction and biofi lm-formation – as revealed by measuring the bio-
fi lm marker N-acetyl-glucosamine, and observed that P.a. mutants incapable of “quorum sensing” 
and biofi lm-formation failed to induce hBD-2. Experiments to purify the bacterial hBD-2-inducer 
revealed, that hBD-2-induction requires at least two components, an hBD-2-inducer and a bacterial 
co-factor. The co-factor we could identify as a mixture of P. a. glycolipid-like “biosurfactants”. These 
“biosurfactants” are known to be under the control of “quorum sensing”. The observation that adding 
these “biosurfactants” to P. a. “quorum sensing”-mutant supernatants did not restore hBD-2-inducing 
activity suggests that hBD-2-inducer production is also under the control of “quorum sensing”. 
Partial purifi cation of the hBD-2-inducer using the P.a. “biosurfactant” in the read-out-system re-
vealed in keratinocytes hBD-2-inducing activity eluting in the void volume of a size-exclusion 
HPLC-column. Interestingly, TNF-alpha was induced in keratinocytes by HPLC fractions eluting 
later, corresponding to a Mr of 60 kDa. 
The conditions of hBD-2-inducer-production only by biofi lm-forming P. aeruginosa and the ab-
sence of proinfl ammatory cytokine-inducing properties suggests a selective induction of hBD-2 by 
a “quorum sensing”-dependent “pathogen-associated molecule, PAM” that is distinct from known 
and rather common PAMs like LPS and which could explain the sometimes seen focal expression 
of antimicrobial peptides in the absence of infl ammation.
333 [033]
Two Stage Model for Induction of Autoimmunity, Loss of Immune Privilege Followed by Expansion 
of Autoreactive T-Cells; SEB Synergizes with Interferon-gamma to Induce Alopecia Areata
Gilhar A1, Kaufman K1, Assy B1 and Kalish RS2
1Skin Research Laboratory (Israel)
2Dept of Dermatology, SUNY at Stony Brook, New York (USA)
It was hypothesized that autoimmune T-cell diseases require two conditions, loss of tolerance 
to induce autoreactive T-cells, and a stimulus, such as superantigen, to expand the autoreac-
tive T-cells. Alopecia areata (AA) is associated with loss of immune privilege in hair follicles. 
We previously demonstrated that interferon-gamma (INF-γ) induces expression of MHC class 
I and II, resulting in loss of immune privilege and induction of AA in genetically susceptible 
female C3H/HeJ mice. It was proposed that treatment with Staphylococcal Enterotoxin B (SEB) 
superantigen would expand autoreactive T-cells and synergize with INF-γ to induce AA. C3H/
He mice 7 wk old were injected IV with murine IFN-γ 2 x 104 U or PBS for three consecutive 
days, followed by injections every 7 days. 30 days following the fi rst injection, the female and 
male mice were divided into three groups: Group 1: (PBS alone) Mice injected with PBS for 30 
days received additional PBS injections IV for 2 consecutive days followed by injections with 
PBS every 7 days. Group 2: (INF-γ alone) Mice treated 30 days with INF-γ were injected IV 
with IFN-γ for two days and followed by every 7 days. Group 3: (INF-γ & SEB) Treated 30 days 
with INF-γ, injected intraperitoneal with SEB (50 μg) for 2 days followed by injections with 
INF-γ every 7 days. Mice were examined for hair loss. Skin was harvested 14 wks after the fi rst 
injection skin and analyzed by histology as well as immunohistochemistry for ICAM-1, and 
MHC class I & II. Clinical rates of AA development on back and abdomen of C3H/He male 
mice; Group 1: PBS alone 5% (1/21), Group 2: INF-γ alone 19% (4/21), Group 3: ING-γ + SEB 
52% (11/21). Differences between SEB + INF-γ and other treatment groups were signifi cant. 
INF-γ plus SEB was superior to INF-γ alone in inducing AA in a susceptible mouse strain. This 
supports the hypothesis of a two stage model for development of autoimmune disease. SEB 
was used as a tool to test the 2 stage hypothesis and there is no evidence that SEB has a role 
in human alopecia areata. The concept of two stage induction of autoimmunity is not specifi c 
for superantigen. epithelium. 
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Activation of the IL-1β-Processing Infl ammasome is Involved in Contact Hypersensitivity
Gaide O1, Watanabe H1, Petrilli V2, Martinon F2, Contassot E1, Roques S1, Tschopp J2 and 
French LE1
1Department of Dermatology and Pathology, University of Geneva (Switzerland)
2Department of Biochemistry, University of Lausanne (Switzerland)
The infl ammasome is a cytosolic protein-complex regulating the activation of caspase-1, which 
cleaves the pro-infl ammatory cytokines interleukin(IL)-1β and IL-18 into their active form. The 
infl ammasome is composed of a NALP family member that acts as a sensor for danger signals 
such as bacterial components and the adaptor protein ASC, which allows the recruitment of 
caspase-1 in the complex. In the skin, exposure to trinitro-1-chlorobenzene (TNCB) causes 
an immune response called contact hypersensitivity (CHS) or eczema. In this delayed-type 
hypersensitivity response, effi cient priming of the adaptive immunity is known to depend on 
the concomitant activation of the innate immune system, including IL-1β / IL-18 activation in 
the skin. To determine if the infl ammasome contributes to CHS, we have analyzed its capacity 
to react to TNCB in vitro and in vivo. We show here that key components of the infl ammasome 
are present in human keratinocytes, and that TNCB induces caspase-1/ASC dependent IL-1β 
and IL-18 processing and secretion. We also show that ASC- and NALP3-defi cient mice display 
an impaired response to TNCB. These fi ndings suggest that TNCB acts as a danger signal that 
activates the infl ammasome in the skin, and reveal a new role of NALP3 and ASC as regulators 
of innate immunity in CHS. 
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Osteopontin is a New Member of Mast Cell-Mediators that Affect IgE-Mediated Degranulation 
and Migration by Mast Cells
Nagasaka A1, Matsue H1, Aoki R1, Kon S2, Uede T2 and Shimada S1
1Department of Dermatology, University of Yamanashi, Yamanashi, Japan (Japan)
2Institute for Genetic Medicine, Hokkaido University, Japan (Japan)
Osteopontin (OPN) was primarily found in bone as an extracellular matrix protein. OPN has 
been also identifi ed in many immune cells (e.g., macrophages, dendritic cells, and activated 
T cells). Its diverse functions in the immune system have been reported. For example, OPN 
serves as a chemotactic factor to immune cells and a Th1 cytokine. Thus, OPN is now known 
to be involved in many aspects of pathogenesis of infl ammatory and immune diseases (e.g., 
infectious diseases and autoimmune diseases). On the other hand, mast cells are also involved 
in many pathological aspects of those diseases by secreting multiple mediators. However, it 
remains determined whether mast cells produce OPN and affect their functions. To test this, we 
used murine fetal skin-derived culture mast cells (FSMC) and bone-marrow-derived mast cells 
(BMMC). FSMC represent connective tissue type mast cells which were originally established 
in our laboratory. We found that OPN was detected only in FSMC but not in BMMC at mRNA 
(RT-PCR) and protein (ELISA) levels and biologically active (chemotaxis assay). In the presence 
of mast cell growth factors (IL-3 and SCF), FSMC were similarly generated from both OPN-de-
fi cient (-/-) and -suffi cient (+/+) mice without signifi cant differences of yield, purity, granularity, 
and viability. Using OPN (-/-) FSMC, we found that recombinant OPN augmented IgE-mediated 
degranulation by FSMC (β-hexosaminidase assay) and attracted FSMC (chemotaxis assay). Both 
effects of OPN were mediated by OPN receptors (i.e., CD44 and αv integrin). These results 
indicate that OPN is a new member of mast cell-mediators, which affects mast cell functions, 
presumably being involved in many pathological settings especially in skin.
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Toll-like Receptor-Mediated Infl ammatory Responses in Keratinocytes: Expression of TSLP 
and IL-31
Bangert C1, Schlehner S1, Mechtcheriakova D2, Stingl G1 and Kopp T1
1Department of Dermatology, Medical University of Vienna (Austria)
2Novartis Institutes for BioMedical Research (Austria)
In atopic dermatitis (AD) bacterial colonization with staphylococcus aureus and recurrent bac-
terial and viral infections are a common phenomenon. Keratinocytes, known to express toll-
like receptor (TLR) 2 and 3, may act as fi rst-line defence against these pathogens by initiating 
innate cutaneous immune responses. Thus we hypothesized that keratinocytes activated by 
microbial stimuli produce factors important for modulating the allergic cutaneous infl amma-
tion in AD. 
To address this issue we analyzed the effect of the TLR3 ligand poly(I:C), a synthetic dsR-
NA, and staphylococcal cell wall components [peptidoglycan (PGN), lipotechoic acid (LTA), 
Pam3CSK4], that act as TLR2 ligands, on the activation profi le of cultured primary normal hu-
man keratinocytes (NHK) by quantitative real time PCR and/or ELISA. In addition, we compared 
the effects mediated by TLR2/3 ligation to those induced by type 1 and type 2 T-cell effector 
cytokines (IFN-γ, IL-4).
Stimulation of NHK with poly(I-C) resulted in strong induction of thymic stromal lymphopoietin 
(TSLP) and IL-6 and, to a lesser extent, of IL-8 and GM-CSF. In addition, we detected IL-8 and 
GM-CSF, but no TSLP and IL-6 secretion upon TLR2 ligation. Comparatively low amounts of 
GM-CSF, IL-8 and TSLP were found in supernatants conditioned by NHK after incubation with 
the Th1/Th2 cytokines IFN-γ and IL-4. Investigation of the newly described cytokine IL-31, 
which is known to be overexpressed in AD skin, revealed an upregulation of IL-31 mRNA 
strictly dependent on LTA or IL-4 activation. 
These results clearly show that keratinocytes are able to provide pathogen-specifi c infl amma-
tory signals, which may have an infl uence on the course of the cutaneous allergic infl ammation 
in AD skin.
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Mass Spectrometric Analysis of Antimicrobial Active Fractionated Psoriatic Scale Extracts
Bartels J, Harder J and Schröder JM
Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel (Germany)
Psoriatic lesions are remarkably free of microbial infections. A number of skin-derived an-
timicrobial peptides have been discovered in the past, some of them were isolated from 
psoriatic scales. We wondered, whether there might be additional skin-derived antimi-
crobial molecules contributing to a broad antimicrobial defense function of the skin.
To address this question we re-analysed fractionated psoriatic scale extracts comparing each 
fractions antimicrobial activity with mass spectrometric profi les and SDS-PAGE analyses. 
HPLC fractionation of heparin-affi nity purifi ed pooled scale extracts and subsequent testing 
for antimicrobial activity revealed high antimicrobial activity against various microorganisms 
in many fractions. The specifi city of antimicrobial activity varied between different HPLC frac-
tions. All major mass signals (revealed by ESI-QTOF mass spectrometric analysis) were found 
in antimicrobial active fractions; they correspond to known heparin-binding antimicrobial pep-
tides/proteins identifi ed as hBD2 (average Mass (Mr)= 4327.27, most intense mass signal), Pso-
riasin (Mr=11364.92), Lysozym (Mr=14691.08), Rnase 7 (Mr=14545.71), HNP-1 (Mr=3441.45) 
and HNP-2 (Mr=3370.51). Closer examination revealed some mass heterogeneity especially 
around major peaks of higher molecular weight indicating the presence of similar molecules 
(e.g. due to modifi cations or polymorphism). A number of less intense mass signals in other 
HPLC fractions displaying antimicrobial activity (together with evidence of not heparin binding 
antimicrobials) indicate the presence of not yet identifi ed antimicrobials in psoriatic scales. 
Future mass mapping experiments after further purifi cation and re-evaluation of antimicrobial 
activity associated with these molecules may provide fi rst clues on their identity.
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IL1β and Tryptase Contribute to Infl ammatory Changes in Spink5-Defi cient Skin Grafts
Briot A1, Bonnart C1, Descargues P1, Robin A1, Deraison C1 and Hovnanian A2
1INSERM U563, Univ Paul-Sabatier, Toulouse (France)
2INSERM U563, Univ Paul-Sabatier, Dept of Medical Genetics, Purpan Hospital, Toulouse 
(France)
Netherton syndrome (NS) is a severe autosomal recessive genodermatosis caused by mutations 
in SPINK5. We generated Spink5-/- mice (KO), which replicate the key features of NS, includ-
ing premature desquamation, impaired keratinization, hair malformation and a profound skin 
barrier defect. As KO mice undergo rapid postnatal lethality, newborn mouse skin was grafted 
on immunodefi cient mice to study phenotypic changes in KO adult skin. KO grafts developed 
alopecic, scaly and erythematous lesions. The KO graft, in contrast to newborn KO mice skin, 
reproduced all major histological and ultrastructural features observed in NS skin. In addition 
to these defects, infl ammatory infi ltrates containing eosinophilic and mast cells were present 
in the epidermis and/or in the dermis of KO grafts. Tryptase, a major factor of infl ammation 
released by mast cells, was markedly increased as shown by immunostaining of KO skin graft. 
Casein zymography analysis of epidermal extracts from the KO graft showed SCTE and SCCE 
hyperactivity, and an additional activity at 34 kDa. Western blot analysis of epidermal extract 
identifi ed this band as being an active form of tryptase monomers. IL1β expression was in-
creased in the epidermis of KO grafts as shown by western blot and immunohistochemistry 
analysis. As a result of the skin barrier defect, we suggest that this cytokine released by kerati-
nocytes contributes to the recruitment of infl ammatory cells. In addition to SCTE and SCCE, 
tryptase is likely to participate in the phenotypical aggravation in adult KO skin. The high simi-
larity between NS skin and Spink5-/- graft demonstrates that skin grafting provides a suitable 
model to study the long-term effects of loss of LEKTI expression in skin. This model will help 
the understanding of the mechanisms by which protease dysregulation and barrier dysfunction 
lead to infl ammatory events.
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Modulation of Leukocyte Recruitment as Therapy in Infl ammatory Skin Diseases
Canavese M1, Proudfoot AE2, Wells T2, Altruda F3 and Ladel CH1
1LCG-RBM Serono Research, Turin (Italy)
2Serono Pharmaceutical Research Insitute, Geneva (Switzerland)
3Universita’ di Torino, Dipartimento di Genetica, Biologia, Biochimica (Italy)
Leukocyte traffi cking from the blood into sites of infl ammation requires interaction between 
circulating leukocytes and vascular endothelial cell barrier. Leukocyte movement and migra-
tion are regulated by chemokines. These molecules are responsible for selective adhesion and 
transmigration and they have been found in the tissues of several skin pathologies character-
ized by distinct leukocyte infi ltrates, including psoriasis and dermatitis.
In this study, using an amino-terminal-modifi ed methionylated form of RANTES, known as Met-
RANTES, we demonstrated the modulation of the immunological profi le in skin disorders.
Irritant Contact Dermatitis (ICD) mouse model that mimics a multifactorial disease, involving 
a combination of endogenous and exogenous factors, resulting from exposure to occupational 
irritants and Contact Hypersensitivity (CHS) as an experimental model for investigation of (Ag)-
specifi c T-cell-mediated immune response, modeling relevant clinic disorders such as psoriasis, 
were used for in vivo evaluation of therapeutic potential of Met-RANTES. 
Our results demonstrated that, according to skin disease type addressed, various soluble factors 
involved are modulated (mainly reduced IL-12p70, MCP-1). In both models a dose dependent 
effect was shown and the maximum percentage of reduction on swelling (edema) was reached 
at 0,5mg/kg. (ICD: 15%, 30%, 37% with 0.05, 0,1, 0,5mg/Kg; CHS: 23%, 24%, 27% with 0.05, 
0.1, 0,5mg/Kg). Signifi cant reduction of PMN recruitment in tissues, based on Myeloperoxidase 
activity, was observed starting at 0,05mg/kg. (ICD: 25%, 22%, 19% with 0.05, 0,1, 0,5mg/Kg; 
CHS: 36%, 51%, 55% with 0.05, 0.1, 0,5mg/Kg).
In conclusion the amino-terminal-modifi ed Met-RANTES showed a pharmacological dose re-
lated effect and it was able to modulate innate immune response (ICD) as well as T-cell driven 
immune responses (CHS) in infl ammatory skin disease models. 
This study has been extremely valuable in determining whether blocking the RANTES 
receptor(s), involved in the recruitment of leukocytes to infl ammatory sites, relieves chronic 
infl ammation.
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Anti-TNF-α Chimeric Antibody (Infl iximab) Inhibits Activation of Psoriatic CD4+ and CD8+ 
T Lymphocytes and Impairs Dendritic Cell Function
Bedini C1, Nasorri F1, Girolomoni G2, De Pità O1 and Cavani A1
1Laboratory of Immunology and Allergology, IDI (Italy)
2Dept of Biomedical & Surgical Sciences, Section of Dermatology, University of Verona (Italy)
Psoriasis is a chronic infl ammatory skin disease characterized by altered differentiation of ke-
ratinocytes paralleled by an infl ammatory infi ltrate which comprise IFN-γ and TNF-α releasing 
T and NK cells. As a consequence, anti-TNF-α treatment is being successfully employed as 
therapeutic regimen for psoriasis. We determined the in vitro effects of Infl iximab, a chimeric 
monoclonal antibody to both soluble and membrane bound TNF-α, on CD4+ and CD8+ T cells 
isolated from psoriatic plaques, and dendritic cells differentiated from the blood of psoriatic 
patients. In vitro activation of psoriatic T cells was strongly impaired by 1-100μg/ml of Inf-
liximab, both in terms of proliferation and IFN-γ release, whereas IL-10 was only marginally 
affected. Maximal effects of Infl iximab were observed in the absence of costimulation, such as 
in the case of CD3 ligation without anti-CD28, or when T cells where activated by immature 
compared to mature dendritic cells. Furthermore, inhibition was more pronounced on psoriatic 
CD8+ than CD4+ T cells, being the fi rst subset much more susceptible of apoptosis induced by 
anti-TNF treatment. Finally, Infl iximab directly affected the differentiation of monocyte-derived 
dendritic cells, by inhibiting the expression of CD1a and CD86, and strongly impaired the 
antigen presenting capacity of immature, and, to a lesser extent, mature dendritic cells. These 
effects may help to explain the long term disease remission obtained with the drug.
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The Expression of the Chemokine Receptor CCR5 in Psoriasis and the Results of a Randomized 
Placebo Controlled Trial with a CCR5 Receptor Inhibitor 
de Groot M1, Teunissen MB1, Picavet DI1, Arreaza MG2, Simon JS2, Kraan M2, Bos JD1 and
de Rie MA1
1Dept of Dermatology, Academic Medical Center, University of Amsterdam (Netherlands)
2Schering-Plough Research Institute, Kenilworth, New Jersey (USA)
In the literature there are several indications that the chemokine receptor CCR5 and its lig-
ands, especially CCL5 (formerly known as RANTES), may play a role in the pathogenesis of 
psoriasis. The purpose of this investigation was to examine the expression of CCR5 and its 
ligands in chronic plaque psoriasis and to evaluate the effect of a CCR5 receptor inhibitor on 
this disease.
Lesional and non-lesional skin biopsies, taken from 9 patients with severe chronic plaque 
psoriasis, were immunohistochemically double-stained for CCR5 and CD3 or CCR5 and 
CD68 and manually quantifi ed with light microscopy. RNA microarray was performed to de-
termine the mRNA expression of CCR5 and ligands (CCL4, CCL5) using quantitative reverse 
transcriptase – polymerase chain reaction (RT-PCR) for confi rmation. Furthermore, 32 patients 
participated in a randomized placebo controlled trial for 28 days with a CCR5 receptor inhibi-
tor (SCH351125). Clinical effi cacy was measured with the Psoriasis Area and Severity Index 
(PASI). Additionally, immunohistochemical single-staining (CD3, CD161, K16, elastase) of le-
sional biopsies taken on baseline and day 28 were analysed with digital image analyser and 
confocal scanning microscopy.
The number of CCR5+CD3+ and CCR5+CD68+ cells showed a signifi cant increase in lesional 
versus non-lesional skin. In contrast, the RNA micro-array and quantitative RT-PCR data did 
not reveal such difference in CCR5 expression. CCL5, but not CCL4, mRNA expression was 
signifi cantly increased in lesional skin. Treatment with SCH351125 did not cause a signifi cant 
difference in PASI or any immunohistochemical marker in comparison to placebo.
We concluded that although CCR5 expression might be increased in psoriatic lesions, this 
receptor does not play a crucial role in the pathogenesis of psoriasis.
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Enhanced Expression Levels of Interleukin-31 Correlate with Interleukin-4 and Interleukin-13 
in Atopic and Allergic Contact Dermatitis
Neis MM1, Peters B2, Dreuw A3, Bieber T4, Krieg T5, Stanzel S6, Heinrich PC3, Merk HF1,
Baron JM1 and Hermanns HM3
1Department of Dermatology and Allergology, University Hospital RWTH Aachen (Germany)
2Miltenyi Biotec GmbH, MACS molecular Business Unit, Cologne (Germany)
3Department of Biochemistry, University Hospital RWTH Aachen (Germany)
4Department of Dermatology, University of Bonn (Germany)
5Department of Dermatology and Venerology, University of Cologne (Germany)
6Institute of Medical Statistics, University Hospital RWTH Aachen (Germany)
Interleukin-31 is a recently identifi ed four helix-bundle cytokine which signals via a receptor 
complex consisting of the specifi c IL-31R and the oncostatin M receptor on keratinocytes. 
Transgenic mice overexpressing IL-31 develop a skin phenotype closely resembling atopic 
dermatitis in human patients. To evaluate the potential importance of this cytokine in the patho-
genesis of human T cell-mediated skin diseases, we analyzed 149 skin biopsies from patients 
with atopic dermatitis, allergic contact dermatitis and psoriasis in comparison to healthy skin. 
Using quantitative real-time PCR the IL-31 mRNA expression was measured and compared to 
the expression profi le of well-known TH1- and TH2-type cytokines. We found statistically el-
evated mRNA levels of IL-31 in biopsies taken from patients with atopic dermatitis and allergic 
contact dermatitis, but not psoriasis. The expression of IL-31 correlated with the TH2-cytokines 
IL-4 and IL-13, but not with the TH1-cytokine interferon-γ. Regarding the atopic dermatitis 
patients, the enhanced expression of IL-31 occured irrespective of the severity of the disease 
or the serum IgE levels, indicating that it may play a role in extrinsic as well as intrinsic atopic 
dermatitis. No signifi cant increase of IL-31 receptor mRNA could be detected in any disease, 
while the second receptor subunit of IL-31, the oncostatin M receptor, was enhanced tran-
scribed in patients with psoriasis.
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A Role for the 5-HT2C Receptor in Murine Contact Allergy
El-Nour H1, Lundeberg L1, Boman A2, Abramowski D3, Holst M4 and Nordlind K1
1Unit of Dermatology & Venereology, Dept of Medicine, Karolinska Univ Hosp, Solna (Sweden)
2Unit of Occupational Dermatology, Dept of Medicine, Norrbacka, Stockholm (Sweden)
3Novartis Pharma AG, S-386.8.16, CH-4002 Basel (Switzerland)
4Dept of Woman & Child Health, Pediatric Endocrinology Unit, Astrid Lindgren Children’s Hosp 
(Sweden)
Serotonin (5-hydroxytryptamine, 5-HT) has been suggested to modulate murine contact hyper-
sensitivity via the action of 5-HT1A/2A receptors (R).
The aim of this study was to investigate the expression of 5-HT2CR in murine contact allergic 
skin and the role of this receptor in modulating the infl ammatory response.
Female BALB/c mice aged 8-10 weeks were sensitized for 2 consecutive days and challenged 
(on day 8) using 3% and 0.1% oxazolone, respectively. Ear biopsies were fi xed in formalin 
and sectioned at 14 μm, and then 5-HT2CR expression was studied using immunohistochem-
istry and a streptavidin-biotin technique. In vitro and in vivo experiments were performed to 
investigate the effect of the 5-HT2CR agonist RO60-0175 on XS52 Langerhans cell-like cells 
regarding their interleukin (IL)-1β secretion, using ELISA, and also the effect of subcutaneous 
administration of the RO60-0175 on the elicitization phase of contact allergy.
5-HT2CR expression was seen on epidermal dendritic cells, which showed an increased 
(p<0.01) number and possessed longer dendrites in the infl amed compared to control skin. The 
majority of these cells were found to be Langerhans cells (I-A positive). Addition of RO60-0175 
at 5x10-5 mol/L to the XS52 cells increased (p<0.03) their IL-1β production. In vivo administra-
tion of RO60-0175 at 0.5 and 1.0 mg/kg, at days 6, 7 and 8 after the fi rst sensitization day, 
enhanced the murine contact eczematous reaction (p<0.05 and p<0.01, respectively). This 
enhanced effect was reversed using the 5-HT2CR antagonist SB 242084 at 3 mg/kg.
Our fi ndings indicate that the 5-HT2C receptor might be important for the maturation of Lang-
erhans cells, and might modulate murine allergic contact dermatitis.
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Keratinocytes Express and Secrete Infl ammasome Proteins and Active Interleukin-1
Feldmeyer L1, Keller M1, Niklaus G1, Hohl D2, Werner S1 and Beer HD1
1Institute of Cell Biology, ETH Zurich (Switzerland)
2Service de Dermatologie, CHUV Lausanne (Switzerland)
The epidermis constitutes a signifi cant reservoir of the proinfl ammatory cytokines interleukin 
(IL)-1alpha and -beta. IL-1 plays an important role in cutaneous infl ammation as well as in 
inherited infl ammatory diseases, like Familial Mediterranean Fever or Muckle-Wells syndrome. 
However, it is not known whether IL-1 secretion by keratinocytes is directly involved in the skin 
phenotype of these diseases. 
Initial synthesis of IL-1alpha and -beta occurs as a precursor, but only proIL-1beta needs 
processing to obtain full activity. The enzyme responsible for this activation is caspase-1. Cas-
pase-1 is also expressed as an inactive precursor and its activation and subsequent processing 
of proIL-1beta is dependent on a multiprotein complex, called the infl ammasome. It has been 
shown that human macrophages need the infl ammasome for the activation and secretion of 
proIL-1alpha and -beta. 
We recently found that infl ammasome components are also expressed in human primary ke-
ratinocytes at the RNA and protein level, and also in vivo in human epidermis. Unstimulated 
keratinocytes are unable to activate and secrete proIL-1. After irradiation with a physiological 
dose of UV-B these cells activate proIL-1beta and they secrete proIL-1alpha, IL-1beta, and in-
fl ammasome proteins, although all these proteins lack a classical signal peptide. The secretion 
is dependent on caspase-1 activity, but not on de novo protein synthesis. 
Recently we showed that EBBP/TRIM16 is a proIL-1beta- binding protein in macrophages 
and its downregulation in keratinocytes resulted in reduced secretion of IL-1beta. Here we 
demonstrate that EBBP/TRIM16 binds also to proIL-1beta in keratinocytes, however, only after 
UV-B irradiation. This suggests that EBBP/TRIM16 is an important regulator of IL-1beta secre-
tion and that the infl ammasome plays also an essential function in the innate immunity of the 
epidermis. 
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CTACK a New Pro-Angiogenic Factor for Dermal Endothelial Cells
Franchi J1, Crola C2, Lardin C2, Marteau C1, Mitterrand M2, Schnebert S1 and Kieda C2
1LVMH Research P&C (France)
2CBM, UPR CNRS, Orléans (France)
The Cutaneous T-cell-Attracting ChemoKine: CTACK supports homing of memory T cells in the 
skin. This chemokine binds to the receptor CCR10 and this interaction participates in the T cells 
recruitment during cutaneous infl ammation. CTACK is constitutively expressed by keratinoc-
ytes but can also be induced upon stimulation by pro-infl ammatory cytokines such as TNF-α 
and IL-1β. Its receptor is expressed by melanocytes, fi broblasts and skin endothelial cells. It has 
been shown that CTACK may be transcytosed and presented on the endothelium. By using a 
human skin microvascular endothelial cell line: HSkMEC, we have demonstrated that CTACK 
induced the HSkMEC growth combined with the induction of vessels formation on the matrigel 
assay by those cells. Moreover, adhesion experiments in fl ow conditions show the selectivity 
of CTACK towards skin endothelial cells in terms of activation and induction of their adhesion 
properties. Understanding of the role of CTACK in the skin, especially at the skin endothelial 
cell level, may be crucial in some skin diseases such as atopic dermatitis or psoriasis.
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AN0128 Inhibits Pro-Infl ammatory Cytokine Production in a Macrophage Cell Line by 
Inhibiting the p38 MAP Kinase Signal Transduction Pathway
Freund Y, Alley M and Bellinger-Kawahara C
Anacor Pharmaceuticals (USA)
AN0128 is a novel anti-infl ammatory borinic acid ester in development for several dermatolog-
ical indications. AN0128 inhibits release of TNF-α, IL-1β, IL-6 and IL-8 from human peripheral 
blood mononuclear cells and the human monocytic THP-1 line challenged with lipopolysac-
charide (LPS). The mechanism of action of AN0128 to inhibit production of TNF-α was inves-
tigated in THP-1 cells. RT-PCR analysis demonstrated that AN0128 did not alter transcription 
of the TNF-α gene; however AN0128 prevented synthesis of TNF-α protein, as demonstrated 
by western analysis. This inhibition was dose-dependent. TNF-α mRNA stability and protein 
synthesis are regulated via phosphorylation through the p38 MAP kinase pathway. The mRNAs 
of TNF-α, IL-1β, IL-6 and IL-8 are all stabilized through binding of trans-acting factors to a com-
mon AU-rich element in the 3’ UTR region. Using western blots and cytometric bead analysis 
with fl ow cytometry, we have demonstrated that AN0128 inhibits phosphorylation of p38 MAP 
kinase in THP-1 cells. This inhibition is likely to be an effect on the pathway upstream of p38 
MAP kinase. Competitive receptor binding assays demonstrate that 10 μM AN0128 inhibits 
agonist binding to the A3 receptor between 60 and 80% with a Ki of 8.8 μM. We are investigat-
ing early downstream events in A3 receptor signaling to determine whether they are affected 
by AN0128 binding to the G-protein-coupled A3 receptor. This binding has been shown to 
inhibit p38 MAP kinase phosphorylation. In conclusion, we have demonstrated that AN0128 
inhibits TNF-α production in macrophages by inhibiting phosphorylation in the p38 MAP ki-
nase pathway, thus destabilizing mRNA and inhibiting protein synthesis. This mechanism is a 
novel action of a boron-containing compound and is likely to also explain inhibition of IL-1β, 
IL-6 and IL-8 production in these cells. 
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CD-3 and ICAM-1: Possible Role in Acne Lesion Initiation
Ghaly N1, Ali B1, Naggar E2 and Sallam F3
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3Department of Pathology, University of Tanta (Egypt)
The aim of the present work is to study CD-3 and ICAM-1 in early acne lesions to detect the role 
of infl ammatory events in acne initiation and to detect wether infl ammatory events occur pre 
or post hyperproliferative changes .Twenty case with early acne vulgaris (less than 6 months) 
were included. Ten subjects matching the patients in age and sex were selected as a control. 
Two biopsies were taken from each patient, one from acne lesion (comedone or papule), the 
other from non lesional skin, apparently normal nearby skin at a distance of 1-10mm from 
the lesion). Specimens were subjected to histopathological examionation and immunohisto-
chemical staining by monoclonal antibodies against ICAM-1 and CD-3. ICAM-1 and CD-3 
showed signifi cant increase in papular acne lesions and non lesional nearby skin in between 
acne lesions than comedonal acne lesions and the controls. As a consequence, ICAM-1 and 
CD-3 expression appears to be associated with the infl ammatory events in acne vulgaris and 
the development of early acne lesions. This can provide a new therapeutic modalities by topi-
cal anti-infl ammatory preparation for the treatment of non lesional skin in acne patients with 
subsequent prevention of acne development. 
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Expression of VEGF& NM23 in Cutaneous Squamous Cell Carcinoma
Ghaly N1, Youssef H2, Nagy H3
1Department of Dermatology, University of Tanta (Egypt)
2Department of Pathology, University of Tanta (Egypt)
3Department of Clinical Pathology, University of Tanta (Egypt)
The aim of this study is to evaluate the expression of vascular endothelial growth factor in tis-
sue specimens in relation to the plasma level, the micro vascular density and the tumor grade. 
moreover, the expression of metastatic gene NM23 expression in skin SCC tissue specimens 
and it’s relation to lymphatic invasion and to found the correlation between the following 
parameters: VEGF expression in tissue specimens, VEGF expression in plasma, micro vascular 
density, NM23 expression, nodal involvement, recurrence history and the grade of the tumor. 
Both primary tumor and lymph node samples were obtained from 31 patients with primary 
skin SCC as well as 10 normal skin biopsies were taken as a control. All the specimens were 
stained by H&E for grading and detection of tumor vascularity, then immunohistochemical 
study were done by immunostaining for VEGF, NM23 and Factor VIII for the primary tumor, the 
associated lymph node biopsy (if present). Blood samples for each patient were taken to study 
plasma level of VEGF by enzyme linked immunossorbent assy method. It has been concluded 
that VEGF level in blood act as a prognostic marker in addition to tumor grade and stage in 
cases of skin SCC. Also it is easy to be performed in clinical practice specially during treat-
ment and to predict the ability of the disease to progress and metastasize. There is an inverse 
relationship between NM23 expression and nodal involvement as well as the ability of the 
tumor to recur, so NM23 can be used as an additional marker to predict the patient outcome 
in cases with skin SCC.
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The Antimicrobial Protein Psoriasin (S100A7) is Signifi cantly Upregulated in the Peripheral 
Blood of Psoriasis Patients
Eisenbeiß D1, Ardebilli S1, Harder J1, Lange H2, Rudolph B1, Schröder J1, Weichenthal M1 and 
Gläser R1
1Department of Dermatology, University of Schleswig-Holstein, Campus Kiel (Germany)
2Dept of Experimental Surgery, University of Schleswig-Holstein, Campus Kiel (Germany)
Recently we identifi ed the S100 protein Psoriasin as well as the ribonuclease RNase7 as potent 
antimicrobial proteins derived from healthy human stratum corneum extracts. The antimicro-
bial activity of Psoriasin is mainly directed against E. coli, whereas RNase 7 exhibits a broad 
spectrum of antimicrobial activity. Both proteins can be isolated in signifi cant higher con-
centrations from psoriatic scale extracts when compared to healthy human stratum corneum 
underlining that Psoriasin and RNase 7 are inducible. This study was initiated to investigate if 
the antimicrobial proteins Psoriasin and RNase 7 can be detected in serum samples of healthy 
controls and patients with psoriasis vulgaris. ELISA systems for the identifi cation of both antimi-
crobial proteins were established and standardized. Serum samples of 50 healthy controls and 
50 patients hospitalized with psoriasis vulgaris were included in the study. 
In the healthy controls a Psoriasin level above the detection limit could be detected in 18/50 
persons, whereas RNase 7 could be measured in 36/50 persons. In the psoriasis group 30/50 
patients had a Psoriasin level above the detection limit, whereas RNase 7 was elevated in 
47/50 patients. Psoriasin serum levels were shown to be signifi cantly upregulated in psoriasis 
patients. A positive correlation between Psoriasin serum levels and psoriasis activity and se-
verity index (PASI) could be demonstrated at admission and Psoriasin serum levels showed a 
signifi cant decline during therapy in parallel to the changes in PASI.
In summary, this study demonstrates for the fi rst time that the antimicrobial proteins Psoriasin 
and RNase 7 are detectable in human peripheral blood and that signifi cantly elevated serum 
levels of Psoriasin can be detected in patients with psoriasis vulgaris. Further investigations 
have to identify the cellular source and biological signifi cance of these serum-derived antimi-
crobial proteins. 
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Nuclear Factor-kappaB Inhibition is Involved in the Nicotinamide Anti-Infl ammatory 
Properties which Downregulates P. acnes-Induced IL-8 Production in Keratinocytes
Grange P1, Raingeaud J2 and Dupin N3
1Hôpital Cochin-Pavillon Tarnier, UPRES-EA 1833 Lab de Recherches en Dermatologie (France)
2INSERM U461, Faculté de Pharmacie, Chatenay-Malabry (France)
3Hôpital Cochin-Pavillon Tarnier, Service de Dermatologie-Vénéréologie, UPRES-EA 1833 (France)
Acne vulgaris is a disease of the pilosebaceous unit that could result in infl ammatory lesions 
in presence of the anaerobic strain Propionibacterium acnes (P. acnes). Nicotinamide is known 
to exhibit inhibitory activity on the proinfl ammatory cytokines production and particularly the 
chemokine IL-8 implicated in the chemotactis of the immune cells, contributing to the infl am-
matory response. Moreover, keratinocytes appear to be the fi rst line of defense and are able 
to produce IL-8 as well. Topical application containing nicotinamide are widely used to treat 
small acne-related lesions. To date, no information are available on the molecular mechanisms 
involved in the nicotinamide action. We used an in vitro test where we stimulated the immor-
talized keratinocyte cell line HaCat by P. acnes in presence of nicotinamide. We have shown 
that HaCat cells stimulated by P. acnes produced a large amount of IL-8 while the level of 
cytokines IL-1α, IL-1β and TNF-α were none detectable by an ELISA test performed on the cell 
culture supernatant. Addition of nicotinamide in the test signifi cantly decreases the IL-8 pro-
duction in a dose-dependent manner. qRT-PCR of IL-8 mRNA indicated a nicotinamide effect 
at the transcriptional or post-transcriptional level. Using a luciferase reporter (plasmid) system 
assay, we demonstrated that nicotinamide inhibits P. acnes-induced IL-8 promoter activation. 
Furthermore, in a NF-κB-dependent promoter luciferase assay, we showed that nicotinamide 
down-regulates NF-κB transcriptional activity. Such effect was confi rmed by the nicotinamide 
ability to interfere with the IκB degradation observed in HaCat cells stimulated by P. acnes. For 
the fi rst time, we have described the action of nicotinamide on the IL-8 production by kerati-
nocyte involving the repression of the IL-8 gene promoter throught the NF-κB pathway. Other 
pathways possibly implicated in this regulation are under study.
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Antibodies Generated by Vaccination with a HMW-MAA Mimotopes Suppress Human 
Melanoma Tumor Growth in SCID Mice
Hafner C1, Wagner S2, Krepler C1, Wiedermann U3, Scheiner O2, Pehamberger H1 and 
Breiteneder H2
1Department of Dermatology, Medical University of Vienna (Austria)
2Department of Pathophysiology; Medical University of Vienna (Austria)
3Dept of Specifi c Prophylaxis and Tropical Medicine, Medical University of Vienna (Austria)
The high resistance of malignant melanoma to chemotherapy and radiotherapy emphasizes 
the need to develop novel therapeutic strategies to prevent melanoma growth. Anticancer 
vaccines formulated with peptide mimics of a conformational epitope that is recognized by 
a monoclonal antibody with antitumor activity represent promising vaccine candidates. We 
have designed such a vaccine consisting of a mimotope of the human high molecular weight 
melanoma-associated antigen (HMW-MAA) coupled to an immunogenic carrier protein. We 
had previously described the immunogenicity and the in vitro biological activity of the induced 
antibodies. Here, we investigated whether the immune response elicited by the mimotope vac-
cine was able to suppress human melanoma tumor growth in SCID mice. Tumors were estab-
lished by subcutaneous injection of the human melanoma cell line 518A2 into SCID mice. On 
the same day, purifi ed antibodies derived from immunization of rabbits with the mimotope vac-
cine were administered intravenously and then in 3 days intervals at 50 μg/injection or at 200 
μg/injection. For control purposes mice were also treated with 200 μg/injection of antibodies 
derived from immunization with the carrier protein alone. Within 23 days following injection 
of the 518A2 cells, tumor growth was reduced by 8% in the group treated with 50 μg/injection 
and by 52% in the group with 200 μg/injection as compared to control mice. Determination of 
tumor weight after this time period revealed a reduction of tumor weight of 32% in the group 
treated with 50 μg/injection and of 49% in the group with 200 μg/injection as compared to 
control mice. The results from our studies indicate that our mimotope vaccine represent a pow-
erful immunotherapeutic agent for the treatment of malignant melanoma.
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Psoriasis Autoantigens in Normal Scalp Skin - Identifi cation Using Expression Cloning
Hagforsen E, Hedstrand H and Michaëlsson G
Department of Medical Sciences, Dermatology, University of Uppsala (Sweden)
Although there is evidence that psoriasis is an autoimmune disease few, if any, autoantigens 
have been defi ned and no psoriasis-specifi c antigen has been found.
The aim with this study was to try to identify auto-antigens in psoriasis by recombinant expres-
sion cloning, a method which comprises expression of proteins from a cDNA library in this 
study, constructed from normal scalp skin and screening of patient sera against these antigens. 
Two sera from patients with different types of psoriasis sera were chosen for library screening 
(widespread, labile psoriasis and stable plaque psoriasis, respectively).
Altogether approximately 2x106 phages from the cDNA library were screened. Twenty-fi ve 
randomly chosen positive clones were purifi ed by repeated screening and, after amplifi cation 
of the phage insert by PCR, sequenced.
Proteins expressed from eight of the sequenced clones were screened with 20 sera from pso-
riasis patients and 20 sera from healthy subjects in a mixed plate assay (positive clones were 
mixed 1:1 with a negative control phage). Patient sera reactivity against the found antigens was 
more frequent than with sera from controls (χ2 test: p=0.05). Nine of the psoriasis sera (43%) 
reacted with at least one of the identifi ed proteins. Three of the sera from healthy controls (15 
%) showed clearly positive reactions with two of the antigens. The screening results showed 
reactivity against different proteins depending on the type of psoriasis.
The results in this study strengthens the idea that psoriasis is an autoimmune disease. Our 
data also suggest that there may be different antigens related to the various clinical subtypes 
of psoriasis.
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TACE/ADAM17 Inhibitor, TAPI-1, Inhibits Skin Sclerosis in a Murine Model of Scleroderma
Murota H, Terao M, Kitaba S and Katayama I
Department of Dermatology, Osaka University (Japan)
Several cytokines are known to be mediated in the mechanism of scleroderma, while differ-
ent types of therapeutic intervention that target these cytokines have been recently attempt-
ed. Increases in the serum concentration of the soluble tumor necrosis factor receptor p55 
(TNFRp55) correlate with the scleroderma severity and inhibit TNF-mediated signaling. How-
ever, there is no direct evidence showing that TNFRp55 mediates the specifi c functions of TNF 
in this disease. To determine the role of TNFRp55-mediated signaling in the pathogenesis of 
scleroderma, we used a murine model of scleroderma that closely resembles systemic sclerosis 
in humans. Wild-type and TNFRp55-/- mice received a subcutaneous injection of bleomycin 
(BLM) each day. TNFRp55-/- mice began to develop severe sclerotic changes of the dermis 
on day 3 after the subcutaneous injections of BLM, while wild-type mice did not. Wild-type 
mice also exhibited skin sclerosis following bleomycin-treatment for 3 weeks. Interestingly, a 
signifi cant elevation of the sTNFRp55 in sera was observed in the BLM-treated wild-type mice. 
The reproducibility of this phenotype among BLM-treated wild-type mice thus indicates that 
the elevation of sTNFRp55 might thus be involved in the pathogenesis of scleroderma. These 
results also indicated that signaling mediated by TNFRp55 and TNFRp55-sheddase, TACE/
AMAD17, plays a key role in both the collagen-degradation process and in this mouse model. 
To investigate the therapeutic effect of TACE-inhibitor in this mice model, TACE-inhibitor, TAPI-
1, was administered orally to BLM-treated wild-type mice. To our surprise, TAPI-1 inhibited 
BLM-induced skin sclerosis. This report might provide a basis for formulating novel therapeutic 
intervention modalities for scleroderma using TACE-inhibitor.
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Interleukin-31: A New Link Between T cells and Pruritus in Atopic Skin Infl ammation
Sonkoly E1, Müller A2, Lauerma A3, Pivarcsi A4, Meller S5, Steinhoff M6, Hoffmann T7,
Ruzicka T8, Zlotnik A9 and Homey B8
1Unit of Dermatology and Venerology CMM L8:02, Karolinska Institute Stockholm (Sweden)
2Department of Radiation Oncology, Heinrich Heine Universität , Düsseldorf (Germany)
3The Finnish Institute of Occupational Health, Helsinki (Finland)
4Clinical Allergy Research Unit, Karolinska University Hospital (Sweden)
5Department of Dermatology, Heinrich Heine Universität, Düsseldorf (Germany)
6Department of Dermatology, University of Münster (Germany)
7Department of Otorhinolaryngology, Heinrich Heine Universität, Düsseldorf (Germany)
8Department of Dermatology, Heinrich Heine University, Düsseldorf (Germany)
9Neurocrine Biosciences Inc., San Diego (USA)
Background: Interleukin-31 is a novel T cell-derived cytokine, which induces severe pruritus 
and dermatitis in transgenic mice, and signals through a heterodimeric receptor composed of 
interleukin-31 receptor A and oncostatin M receptor. 
Objective: To investigate the role of human IL-31 in ‘pruritic’ and ‘non-pruritic’ infl ammatory 
skin diseases.
Methods: The expression of IL-31 and its receptor heterodimer was analyzed by quantitative 
real-time PCR in skin samples of healthy individuals and patients with chronic infl ammatory 
skin diseases. Moreover, IL-31 expression was analyzed in non-lesional skin of atopic der-
matitis patients after allergen or superantigen exposure, as well as in stimulated leukocytes. 
The tissue distribution of the IL-31 receptor heterodimer was investigated by DNA microarray 
analysis. 
Results: IL-31 was signifi cantly overexpressed in ‘pruritic’ atopic compared to ‘non-pruritic’ 
psoriatic skin infl ammation. Highest IL-31 levels were detected in prurigo nodularis, one of the 
most pruritic forms of chronic skin infl ammation. In vivo, staphylococcal superantigen rapidly 
induced IL-31 expression in atopic individuals. In vitro, staphylococcal enterotoxin B but not 
viruses or Th1 and Th2 cytokines induced IL-31 in leukocytes. In atopic dermatitis patients, ac-
tivated leukocytes expressed signifi cantly higher IL-31 levels as compared to control subjects. 
IL-31 receptor A showed most abundant expression in dorsal root ganglia representing the site 
where the cell bodies of cutaneous sensory neurons reside. 
Conclusion: Our fi ndings provide a new link between staphylococcal colonization, subse-
quent T cell recruitment/activation and pruritus induction in atopic dermatitis patients. Taken 
together, IL-31 may represent a novel target for antipruritic drug development. 
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Corticosteroids but not Pimecrolimus Change the Cytokine Profi le of Dendritic Cells Causing 
Enhanced Th2 Cell Differentiation
Kalthoff FS, Fichtinger P, Weishaeupl C and Stuetz A
Novartis Institutes for BioMedical Research (Austria)
The effect of corticosteroids (CS) and pimecrolimus on differentiation, cytokine secretion profi le 
and T cell priming function of committed and semi-mature DC was investigated. Beta-metha-
sone-valerate (β-MSV), hydrocortisone (HC) or the calcineurin inhibitor pimecrolimus were 
added on day 3 during differentiation of human monocytes into DC with GM-CSF+IL-4 and in-
cubated for another 3 days. The maturity and viability of DC was assessed at several time points 
by FACS. On day 6, DC were activated by LPS+IFNγ and the cytokine secretion pattern on day 
7 was determined. Subsequent to wash-out of drugs, non-activated DC were used to prime au-
tologous T cells in the presence of Staphylococcus superantigen for 11 days, after which T cells 
were re-stimulated by anti-CD3+CD28 antibodies to investigate their cytokine pattern. Addi-
tion of CS or pimecrolimus from day 3 to day 6 did not block the differentiation or LPS-induced 
maturation of DC, nor did it reduce their T cell stimulatory function. However, the cytokine 
secretion was modulated by CS but not by pimecrolimus. As compared to untreated control 
cells, CS-treatment of DC from day 3 to 6 of differentiation signifi cantly inhibited the LPS /IFNγ 
-induced secretion of IL-12 and IL-23, but enhanced the secretion of IL-10. Importantly, the 
cytokine response pattern of autologous T cells co-cultured for 11 days with CS-treated DC and 
subsequently stimulated by anti-CD3+CD28 mAb resulted in signifi cantly enhanced produc-
tion of the Th2 cytokines IL-4, IL-5 and IL-10. In contrast, a Th2 cytokine profi le could not be 
demonstrated for T cells co-cultured with DC that were exposed to pimecrolimus instead of CS. 
Conclusion: The results imply that CS but not pimecrolimus incubation of DC modulates their 
cytokine secretion pattern leading to enhanced priming of Th2 cells in vitro.
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Variable Number of Tandem Repeat Polymorphism of Interleukin-1 Receptor Antagonist 
Gene (IL-1RN) in Acne
Koreck A1, Diószegi Cs1, Szegedi K1, Paunescu V2, Cioaca R2, Olariu R3, Morvay M1, Dobozy A4, 
Kemény L1 and Széll M4
1Department of Dermatology and Allergology, University of Szeged (Hungary)
2Department of Immunology, Victor Babes University of Medicine and Pharmacy (Romania)
3Department of Parasitology, Victor Babes University of Medicine and Pharmacy (Romania)
4Derm Research Group of the Hungarian Academy of Sciences, Univ of Szeged (Hungary)
Acne is a common infl ammatory disease of the pilosebaceous glands. The etiology of acne 
is multifactorial including hormonal, microbiological, immunological mechanisms as well as 
hereditary factors. The aim of our study was to investigate whether the variable number of 
tandem repeat (VNTR) polymorphism of the interleukin-1 receptor gene (IL-1RN) contributes 
to susceptibility to acne. A 86-bp tandem repeat sequence in intron 2 of IL-1RN may occur 
in various copy numbers. The most frequent alleles, allele 1, allele 2 and allele 3 contain 
4, 2 and 5 repeats, respectively. Association of allele 2 with infl ammatory and autoimmune 
diseases has been described by several authors. We investigated the allelic distribution of the 
VNTR polymorphism of IL-1RN in patients with acne (n=114) and in a control population 
(n=94). Genomic DNA of patients was used for PCR, and the alleles were detected by gel 
electrophoresis. The frequency of the two-repeat allele of IL-1RN (allele 2) and the number of 
allele 2 homozigotes was slightly increased among acne patients compared to controls. When 
acne patients were subclassifi ed into three groups according to the severity of seborrhoea, the 
frequency of allele 2 showed correlation with the degree of seborrhoea. Our results suggest 
that allele 2 of IL-1RN gene might contribute to the development of acne similarly to other 
infl ammatory diseases.
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Expression and Function of CXCR1 and CXCR2 in Human Epidermal Langerhans Cells
Lippert U1, Peiser M2, Zachmann K1, Ferrari DM3, Knosalla M1, Middel P4 and Neumann Ch1
1Department of Dermatology, University Goettingen (Germany)
2Molecular Biology, Charité, Free University, Berlin (Germany)
3Max-Planck-Institut Enzymology of Protein folding Halle/Saale (Germany)
4Pathology, University Hospital, Goettingen (Germany)
IL-8 is one of the most ubiquitous chemotactic factors and a pleiotropic proinfl ammatory cy-
tokine. It exerts its biological activities in dependence of the specifi c chemokine receptors 
CXCR1 and CXCR2. Langerhans cells (LCs) contribute to infl ammatory and immune responses 
by migrating from skin to lymph nodes, but the expression and possible function of CXCR1/2 
receptors has not been reported so far. We have therefore studied IL-8 receptors in isolated LCs 
and in LCs localized within the epidermis. Using the PCR technique, mRNA expression of both 
receptors was found in isolated LCs. CXCR1 and CXCR2 receptor proteins were detectable by 
FACS analysis in isolated LCs and by double-immunofl uorescence staining in LCs within skin 
sections.Cell cultivation in the presence of IL-8 has no infl uence of CXCR1 or CXCR2 expres-
sion. Activation of LCs by IL-8 induced cell migration whereas cell maturation remains unaf-
fected. These data indicate that IL-8 is able to contribute to the fi rst step of LC migration from 
the epidermis into the dermis that takes place in the context of immunity and infl ammation.
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Specifi c Induction of IL-1F9 by IL-1α in Human Keratinocytes
Mee JB and Groves RW
St John’s Institute of Dermatology, King’s College London (United Kingdom)
The interleukin one (IL-1) family cytokines, IL-1α, IL-1β and IL-18, are well-characterised me-
diators of cutaneous infl ammation. Recently, a further 7 structurally related molecules have 
been identifi ed (IL-1F5 through -F11) but their relevance in cutaneous biology remains to be 
determined. In particular, IL-1F9 and its receptor, IL-1R6, have been shown to be highly ex-
pressed in keratinocytes and IL-1F5 and –F9 have been reported to be up-regulated in psoriatic 
lesions, although no specifi c functions are known.
To assess IL-1F molecule expression and regulation in keratinocytes, transcriptional profi ling 
was performed utilising Affymetrix HG-U133A microarrays and primary human keratinocytes 
stimulated in vitro with either IL-1α (100 ng/ml) or IFN-γ (20 ng/ml) for 24 hours. Constitutive 
expression of IL-1F5 and -F9 was observed with 8 fold up-regulation of IL-1F9 mRNA follow-
ing IL-1α, but not IFN-γ, exposure. IL-1F5 mRNA was not regulated by either cytokine. IL-1F6 
and -F7 expression was not observed and IL-1F8, -F10 and –F11 were absent from the array. 
IL-1α stimulation of IL-1F9 was verifi ed by real-time RT-PCR and shown to be both time and 
dose-dependent with transcriptional increases observed down to 3 ng/ml IL-1α, resulting in an 
up-regulation of 4 fold after 6 hours, rising to 9 fold after 24 hours, relative to vehicle-treated 
control cells. Western blotting of human keratinocyte lysates confi rmed induction of IL-1F9 at 
the protein level by IL-1α but not by IFN-γ.
These data indicate cross coordination between IL-1α and IL-1F9, further increasing the com-
plexity of regulation of the IL-1 family in skin. Although the function of IL-1F9 remains to be 
established, structural homology with IL-1ra may suggest potential down regulatory activities 
during innate immune responses in the skin.
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Induction of Melanocortin-1 Expression on HaCaT Keratinocytes Results in a Reduction of 
UVB-induced TNF-alpha Transcription and an Increase in TNF-alpha-induced Nuclear Factor 
Kappa B Activity
Garcin G1, Le Gallic L1, Stoebner P1, Guesnet J2, Guezennec A2, Martinez J1 and Meunier L1
1CNRS UMR 5810, University of Montpellier (France)
2YSL Beauté Recherche et Développement, Neuilly (France)
Ultraviolet (UV) exposure induces an up-regulation of melanocortin-1 receptor (MC1R) ex-
pression on keratinocytes and stimulates the release of α-melanocyte-stimulating hormone (α-
MSH). The anti-infl ammatory action of α-MSH may be due to its ability to block activation of 
nuclear factor κB (NFκB). The aim of our study was to evaluate on keratinocytes expressing a 
high level of MC1R: 1) the effects of UVB light on TNF-α transcription 2) the effects of TNF-α 
on NFκB activation. For that purpose, HaCaT cells were stably transfected with the wild type 
(wMC1R-HaCaT) and the non functional variant (R151C) of the MC1R gene (vMC1R-HaCaT). 
Functional properties of MC1R expressed in MC1R-HaCaT cells were assessed by radioligand 
binding assays and release of cAMP after α-MSH stimulation. TNF-α transcription was assessed 
by real time PCR and NFκB activity by using a luciferase reporter gene assay. Basal TNF-α 
transcription was similar in non-transfected and in vMC1R-HaCaT cell lines although it was 
strongly repressed in wMC1R-HaCaT cells. Time course studies after UVB exposure (0, 12h, 
24h) demonstrated a strong up-regulation of TNF-α transcription in non-transfected HaCaT 
cells that was abrogated in wMC1R-HaCaT cells (clones 35 and 53). This inhibitory effect was 
enhanced by incubation of wMC1R-HaCaT cells with α-MSH (10-8M) 24h before and immedi-
ately after UVB irradiation. Compared to non-transfected HaCaT cells, TNF-α incubation with 
transiently and stably transfected HaCaT cells with the wild type MC1R gene resulted in a two 
fold and three fold increase of NFκB activity, respectively. In conclusion, forcing the expression 
of MC1R in HaCaT cells affects TNF-α transcription and activation pathways indicating that 
agonist-independent high constitutive activity of this receptor on keratinocytes may play a role 
in cutaneous infl ammation.
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Epidermal Dendritic Cells are the Target for Keratinocyte-derived Interleukin-20
Otkjaer K1, Hasselager E2, Clausen JT2, Iversen L1 and Kragballe K1
1Department of Dermatology, Aarhus University Hospital (Denmark)
2Discovery, Novo Nordisk A/S (Denmark)
Interleukin-20 (IL-20) is a key cytokine in the pathogenesis of psoriasis. Increased levels of IL-
20 mRNA and protein are present in lesional psoriatic skin compared with non-lesional skin. 
In lesional psoriatic skin IL-20 mRNA is distinctly located in basal and suprabasal keratinocytes 
of the suprapapillary epidermis. 
The aim of the present study was to investigate IL-20 expression in non-lesional psoriatic skin 
ex vivo and in vivo. 
3 mm punch biopsies from non-lesional psoriatic skin were collected. Biopsies were trans-
ferred to keratinocyte basal media and incubated at 37 degrees Celsius with IL-1β (10ng/ml) 
for 0, 1, 2, 4, 6, 12 and 24 hours. Furthermore, non-lesional psoriatic skin was irradiated with 
UVB (80 mJ/cm2) and 3 mm punch biopsies were collected after 0, 2, 4, 6 and 24 hours. The 
samples obtained were analyzed by in situ hybridisation, quantitative RT-PCR, immunofl uores-
cent staining and ELISA. 
Incubation with IL-1β or UVB irradiation induced IL-20 mRNA expression in the biopsies. 
ELISA showed increased expression of IL-20 protein in the culture media after 4 hours of stimu-
lation. In situ hybridisation revealed that keratinocytes throughout the epidermis were the cel-
lular source of IL-20 mRNA. Immunofl uorescent staining revealed that no IL-20 protein could 
be detected in keratinocytes, whereas the IL-20 protein and the IL-20 receptor-1 were present 
in epidermal CD1a+ dendritic cells. 
 IL-1β and UVB irradiation induces IL-20 expression and our data demonstrate the keratinocyte 
as the primary cellular source of IL-20 expression in human skin. Interestingly, immunofl uores-
cent staining revealed that IL-20 was below detection level in the keratinocytes but present in 
epidermal CD1a+ cells. Since CD1a+ cells express the IL-20 receptor, these fi ndings indicate 
that IL-20 is released from the keratinocytes and transferred to the epidermal dendritic cells.
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A Study of DCP1 and B2BKR Gene Polymorphism in Cutaneous Vasculitis
Perrinaud A1, Watier H2, Paintaud G3, Esteve E4, Vaillant L1 and Martin L4
1Department of Dermatology, University Hospital of Tours (France)
2Department of Immunology, University Hospital of Tours (France)
3Department of Pharmacology, University Hospital of Tours (France)
4Department of Dermatology, Hospital of Orléans (France)
Vasculitis is characterized by infl ammation around vessel walls, leading to secondary tissue 
damage. The underlying molecular mechanisms remain poorly understood. Recently, activa-
tion of the contact system was suggested to take part into the pathogenesis of vasculitis. Angi-
otensin converting enzyme (ACE) and bradykinin B2 receptor (B2BKR) are both involved in the 
regulation of the contact system cascade. Polymorphisms in ACE ( DCP1) and B2BKR genes 
might therefore predispose to cutaneous vasculitis. 
Fourty consecutive adult patients presenting with cutaneous vasculitis were included .Cutane-
ous vasculitis was confi rmed by an histological examination, and patients were classifi ed in 
2 groups: small-sized vessel disease (group 1, 29 patients), or medium-sized vessel disease 
(group 2, 11 patients). After having obtained informed consent, blood sample was taken for 
DNA extraction. We studied the insertion/deletion (I/D) of 8 pairs of bases in intron 16 of DCP1 
gene and the substitution –58 C/T in B2BKR gene. Allelic frequencies were compared with 
those of 205 healthy controls. 
We did not fi nd any signifi cant differences in polymorphism frequencies between the 2 groups 
or between patients and controls. 
The 2 polymorphisms studied do not appear to be associated with cutaneous vasculitis in adult 
patients. This appears in discrepancy with the fi ndings of Kahn et al. However, their population 
was different since they studied children having a systemic vasculitis, with or without skin in-
volvement. Other polymorphisms in DCP1 and B2BKR genes could also be considered. Finally 
a specifi city of cutaneous involvement in vasculitis is not excluded.
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Gingival Innate Immunity: Induction of β-defensins by Components of Parodontal Bacteria 
through Toll-like Receptors
Peyret-Lacombe A1, Duplan H1, Watts M2, Charveron M1 and Brunel G3
1Pierre Fabre Research Institut, Laboratory of Cell Biology (France)
2Pierre Fabre Oral Care, Pierre Fabre Medicament (France)
3University of Dental Surgery, Laboratory of Oral Physiology and Therapeutics (France)
The role of epithelial cells in oral pathologies is poorly understood. Toll-Like Receptors 2 and 
4 and antimicrobial peptides such human beta-defensins 2 and 3 have been identifi ed as key 
elements in innate immunity against microbial infection.
The aim of this study was to promote a gingival cell line as a functional model, to show the 
implications of the Toll-like receptors in recognition of particular bacterial components and in 
antimicrobial peptides regulation.
Ca9-22 cell line was used, incubated in culture medium alone or with proinfl ammatory cy-
tokines, bacterial components at different time. The expression of the Toll-like receptors 2 and 
4, and human β-defensins 2 and 3 was investigated by immunocytochemical, fl ow cytometry 
analysis and respective messenger RNA level was assayed with quantitative PCR.
Firstly, qualitative immunocytochemistry and quantitative PCR revealed that this cell line Ca9-
22 expressed Toll-like receptors 2 and 4 and human β-defensins 2 and 3 at basal level. Sec-
ondly, these cells were able to respond to pro-infl ammatory cytokines and to different bacterial 
components by inducing or not Toll-like receptors signaling and β-defensins expression. Both 
β-defensins were induced differently according to the bacterial component used. Furthermore, 
the involvement of Toll-like receptors in this induction was supported by neutralizing activity 
of anti-Toll-like receptor antibodies.
The present data demonstrated that Ca9-22 cell line could be used as a functional model 
to study the expression regulation of pattern recognition receptor and antimicrobial peptides 
involved in innate immunity against periodontal infections. Our fi ndings reinforce the notion 
that these receptors and the expression of human β-defensins are linked.
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Induction of C3 and CCL2 by C3a in Keratinocytes: A Novel Autocrine Amplifi cation Loop of 
Infl ammatory Skin Reactions
Purwar R1, Wittmann M1, Zwirner J2, Kracht M3, Breiholz O3, Gutzmer R1 and Werfel T1
1Dept of Dermatology and Allergology,Hannover Medical University, Hannover, (Germany)
2Department of Immunology, Georg-August-University, Göttingen, Germany (Germany)
3Institute of Pharmacology, Hannover Medical University, Hannover, (Germany)
The complement fragment-3a (C3a) acts via a G protein-coupled C3a receptor (C3aR) and is of 
importance in allergic and infl ammatory diseases. Recent studies suggest the presence of com-
plement proteins in the epidermal compartment and synthesis of some of these proteins (C3, 
factor B and factor H) by human keratinocytes (KCs) during infl ammation. However, expression 
of C3aR and its role in human KCs is not elucidated thus far. In this study, we demonstrate the 
expression of C3aR on KCs as detected by real-time PCR and fl ow cytometry. IFNγ and IFNα 
strongly up-regulated the surface expression of C3aR on KCs among all other cytokines tested. 
After up-regulation of C3aR by IFNγ and IFNα, we observed the induction of fi ve genes (CCL2, 
CCL5, CXCL8, CXCL10 and C3) after stimulation of KCs with C3a in microarray analysis. We 
confi rmed the induction of C3 and CCL2 at RNA and protein levels. Furthermore, incubation 
of C3 with skin mast cells tryptase resulted in the generation of C3 fragments with C3a activity. 
In conclusion, our data illustrate that epidermal KCs express functional C3aR. The increases of 
C3 and CCL2 synthesis by C3a and C3 activation by skin mast cell tryptase delineates a novel 
amplifi cation loop of complement activation and infl ammatory responses that may infl uence 
the pathogenesis of allergic/infl ammatory skin diseases.
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Toll-like Receptor Activation of Langerhans Cells Triggers an Antiviral Immune Response
Renn CN1, Sanchez DJ2, Ochoa MT3, Legaspi AJ3, Krutzik SR3, Sieling PA3, Cheng G2,
Merk HF1 and Modlin RL3
1Department of Dermatology, University Clinic Aachen (Germany)
2Microbiol, Immunology & Molecular Genetics, David Geffen School of Med at UCLA (USA)
3Division of Dermatology, David Geffen School of Medicine at UCLA (USA)
Langerhans cells (LC) are a unique subset of dendritic cells (DC), present in the epidermis and 
serving as the fi rst line of defense against pathogens invading the skin. To investigate the role 
of human LCs in innate immune responses, we examined Toll-like receptor (TLR) expression 
and function of LC-like DCs derived from CD34+ progenitor cells and compared them to DCs 
derived from peripheral blood monocytes (Mo-DC).
LC-like DCs and Mo-DCs expressed TLR 1-10 mRNAs at comparable levels. Although many of 
the TLR-induced cytokine patterns were similar between the two cell types, stimulation with 
the TLR3 agonist poly(I:C) triggered signifi cantly higher amounts of the interferon (IFN)-induc-
ible chemokines CXCL9 (MIG) and CXCL11 (I-TAC) in LC-like DCs as compared to Mo-DCs. 
Supernatants from TLR3-activated LC-like DCs reduced intracellular replication of vesicular 
stomatitis virus (VSV) in a type I IFN-dependent manner. Finally, CXCL9 colocalized with LCs 
in skin biopsy specimens from viral infections. Together, our data suggest that LCs exhibit a 
direct antiviral activity that is dependent on type I IFN as part of the innate immune system.
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IL-10 as a Regulator of Immunity at Body Surfaces: Secretion by T Cells but not by B Cells, 
Macrophages or Neutrophils Protects from Infl ammatory Bowel Disease
Siewe L1, Bolatti-Fogolin M2, Greveling M2, Krieg T1, Mueller W2 and Roers A1
1Department of Dermatology, University of Cologne (Germany)
2German Research Center for Biotechnology, Braunschweig (Germany)
Interleukin-10 is an immunomodulatory cytokine secreted by a variety of different cell types, 
which limits innate as well as adaptive immune responses protecting the host from immune-
mediated tissue damage. IL-10-defi cient mice develop exaggerated immune responses and 
suffer from infl ammatory bowel disease as a result of deregulated Th1 responses against lu-
minal bacterial antigen. We recently described that T cell-specifi c IL-10 mutant mice develop 
intestinal infl ammation indistinguishable from the disease observed in IL-10-/- mice. Herein, 
we report that, mice with cell type-specifi c IL-10 defi ciency in B cells or in macrophages and 
neutrophilic granulocytes do not develop intestinal disease. While disease incidence was high 
in IL-10-/- and T cell-specifi c IL-10 mutant mice, we never observed intestinal infl ammation 
macroscopically or by histology in the B cell- or the macrophage/neutrophil-specifi c IL-10 
mutants. An analysis of IL-10 expression by RT-PCR in intestinal tissue of T cell-specifi c mutant 
mice revealed a major reduction of IL-10 transcript levels compared to control mice. Col-
lectively, these data suggest that T cells are the major source of IL-10 in the intestine while B 
cell- or macrophage/neutrophil-derived IL-10 is dispensable for the protection of the intestinal 
mucosa from immunopathology.
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Infl uence of Systemic Photochemotherapy on Regulatory T Cells and Selected Cytokine 
Production in Psoriatic Patients – A Pilot Study
Rotsztejn H1, Zalewska A2, Trznadel-Budzko E3, Lewkowicz P4, Banasik M4 and Tchórzewski H4
1Sec of Dermatology, Research Inst of the Polish Mother’s Memorial Hospital, Lodz (Poland)
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Psoriasis is a chronic autoimmune infl ammatory disease of the skin with strong genetic and 
environmental risk factors and is regarded as a Th1-cell type disease. The aim of our study was 
to evaluate the effect of one month PUVA (Psoralen Ultraviolet A) therapy on regulatory T cells 
subpopulation (CD4+/CD25+) and the production of some cytokines.
The study was performed on the group of 12 patients with severe psoriasis. They were put on 
PUVA therapy for one month. We analyzed the level of regulatory T cells CD4+CD25+ using 
FACSCalibur cytometer and CellQuest Software. The production of IFN-γ (interferon-gamma), 
TNF-α (tumor necrosis factor alfa), IL (interleukin) –10, IL-5, IL-4, IL-2 by lymphocytes was 
estimated using CBA system. The control group consisted of 11 healthy volunteers.
We found that the production of INF-γ, TNF-α, IL-2 and IL-10 in psoriatic patients before 
PUVA application increased signifi cantly when compared with the control group. In patients 
after PUVA therapy we observed decreased production of TNF-α and a decreased number 
of CD4+CD25+ cells in the blood when compared with the same group of patients before 
the treatment. It was demonstrated that systemic PUVA therapy led to marked reduction in 
CD4+CD25+ and a change in cytokine production.
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Antifungal Activity of C3a and C3a-Derived Peptides Against Candida
Sonesson A1, Nordahl E1, Mörgelin M2 and Schmidtchen A1
1Section of Dermatology, Lund University (Sweden)
2Section of Experimental and Clinical Infectious Medicine (Sweden)
Antimicrobial peptides are generated during activation of the complement system. Here 
we show that the anaphylatoxin C3a exerts antimicrobial effects against the yeast Candida. 
Fluorescence microscopy and electron microscopy analysis demonstrated that C3a-derived 
peptides bound to the cell surface of Candida, and induced membrane perturbations and re-
lease of extracellular material. Various Candida isolates were found to induce complement 
degradation, leading to generation of C3a. Arginine residues were found to be critical for the 
antifungal and membrane breaking activity of a C3a-derived antimicrobial peptide, CNY21 
(C3a; Cys57-Arg77). A CNY21 variant with increased positive net charge displayed enhanced 
antifungal activity. Thus, C3a-derived peptides can be utilized as templates in the development 
of peptide-based antifungal therapies.
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Antimicrobial Activities of Peptides Derived from Growth Factors
Malmsten M1, Davoudi M2, Mörgelin M3 and Schmidtchen A2
1Dept. of Pharmacy, Uppsala University (Sweden)
2Section of Dermatology, Lund University (Sweden)
3Section of Experimental and Clinical Infectious Medicine (Sweden)
Growth factors, comprising diverse protein and peptide families, are involved in a multitude of 
developmental processes, including embryogenesis, angiogenesis, and wound healing. Here 
we show that peptides derived from HB-EGF, amphiregulin, hepatocyte growth factor, PDGF-A 
and PDGF-B, as well as various FGFs are antibacterial, demonstrating a previously unknown 
direct antimicrobial effect of growth factor-derived peptides. The peptides killed the Gram-neg-
ative bacteria Eschericia coli, Pseudomonas aeruginosa, and the Gram-positive Staphylococcus 
aureus and Bacillus subtilis as well as the fungus Candida albicans. Analogously, the peptides 
induced membrane leakage of liposomes. Furthermore, no discernible hemolysis was noted. 
Notably, the holoprotein HB-EGF exerted similar antibacterial effects. The fi ndings provide an 
interesting link between the family of growth factors and antimicrobial peptides, both which 
are induced during tissue remodelling and repair.
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The antimicrobial Connection between Horseshoe Crabs and Humans
Pasupuleti M4, Walse B1, Nordahl E4, Mörgelin M2, Malmsten M3 and Schmidtchen A4
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The human anaphylatoxin peptide C3a, generated during complement activation, exerts an-
timicrobial effects. Regions of the ancient C3a from Carcinoscorpius rotundicauda as well as 
corresponding parts of human C3a exhibited helical structures, permeabilised artifi cial lipo-
somes, and were antimicrobial against Gram-negative and Gram-positive bacteria. Phyloge-
netic analysis, paired with sequence analyses and structural modeling studies showed that, in 
particular in vertebrate C3a, crucial structural determinants, governing antimicrobial activity 
have been conserved during evolution. Human C3a and C4a, but not C5a were antimicrobial, 
in concert with the separate evolutionary development of the chemotactic C5a. Thus, the re-
sults demonstrate that, notwithstanding a signifi cant sequence variation, functional and struc-
tural constraints imposed on C3a during evolution have preserved critical features.
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Mice Double-Defi cient For Neprilysin/angiotensin-Converting Enzyme: A Mouse Model to 
Study Dendritic Cell Function in Infl ammatory Skin Disease
Fastrich M, Luger TA and Scholzen TE
Department of Dermatology, University of Münster (Germany)
Neprilysin (NEP; CD10) and angiotensin-converting enzyme (ACE; CD143) are key enzymes 
for metabolizing vasoactive and infl ammatory peptides. Their role in controlling the bioavaila-
bility of bradykinin (BK), angiotensin I and II or substance P (SP) in cardiovascular and renal dis-
ease and in infl ammation is widely appreciated. We have generated NEPxACE double-defi cient 
mice as a model for the simultaneous pharmacologic NEP/ACE (“vasopeptidase”) inhibition, 
which is benefi cial for the treatment of cardiovascular disorders, but bears an increased risk 
of angioedema and uncontrolled infl ammation. In murine cutaneous allergic infl ammation, 
2,-4-dinitro-1-fl uorobenzene (DNFB)-sensitized heterozygous NEP-/-xACE+/- mice displayed in-
creased allergic infl ammation (ear swelling: +96 – +112% over 72 h) in response to challenge 
with DNFB, but not to the unrelated antigen oxazolone in comparison to wild type (wt) mice. 
In the NEPxACE mice, infl ammation could be markedly reduced by systemic treatment with 
receptor antagonists against BK B2 (-34.8 %) or neurokinin 1 (SP) receptors (-9%) before sensiti-
zation. The lack of NEP and ACE promoted functional maturation of bone-marrow derived den-
dritic cells (BmDC) from NEP-/-xACE+/- or NEP-/- mice, as demonstrated by a higher expression of 
surface markers (CD40, CD54, CD80, CD86, MHC II) by CD11c+ DC in comparison to BmDC 
from wt mice, as well as an increased capacity to stimulate allogeneic or antigen-specifi c CD4+ 
or CD8+ T-cell proliferation. Draining lymph nodes (LN) of NEP-/-xACE+/- mice sensitized with 
FITC contained a higher proportion of FITC+/CD207+/CD11c+ DC in comparison to wt animals 
suggesting an enhanced migration of Langerhans cells into regional LN. These data indicate an 
important regulatory role of the vasopeptidases NEP and ACE and their substrates BK and SP for 
DC-initialized adaptive immune responses and establish NEPxACE double-defi cient mice as a 
promising mouse model to study exaggerated cutaneous infl ammation.
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Differential Effects of TNF Blockade on TB-Induced Genes and Cytokines
Wallis R1, Saliu O2, Schwander S2, Wang Q3, Brooks A3, Stein D4 and Sofer C2
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The early risk of reactivation of latent Mycobacterium tuberculosis infection is at least 9 times 
greater with the TNF mAb infl iximab than with the soluble TNF receptor etanercept. We ex-
amined the cellular and molecular basis of this difference using a whole blood culture model, 
in which drugs were tested at peak and trough therapeutic concentrations. Infl iximab and 
adalimumab inhibited TB-induced T cell activation and production IFNγ, a cytokine required 
for host defenses against TB, whereas etanercept did not, even when tested at a supra-thera-
peutic concentration. These effects were accompanied by differential effects on the ability to 
control intracellular TB growth. However, all three drugs blocked production of the regulatory 
cytokine IL-10, and none of the drugs caused apoptosis or necrosis. To better understand the 
apparent specifi city of the effects of TNF blockade, studies were begun to examine effects of 
TNF blockers on 239 TB-induced genes identifi ed by microarray. All three TNF blockers tended 
to inhibit activation of these genes; however, this effect was least apparent with etanercept. The 
differential effects of etanercept compared to the two antibodies were greatest with regard to 
IFNγ and IFNγ-induced genes, and to a lesser extent, on TNF and TNF-induced genes, all of 
which were inhibited more by infl iximab and adalimumab than etanercept. Combined effects 
on TNF and IFNγ may account for the differential TB risks of these drugs. 
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Keratine-14 Promoter-Driven Human VEGF in the Transgenic Mice Results in the Skin Features 
Resembling Human Psoriasis
Yanagihori H1, Oyama N1, Kobayashi K2, Kobayashi K2 and Nakamura K1
1Dept of Dermatology, Fukushima Medical University Graduate School of Medicine (Japan)
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Vascular endothelial growth factor (VEGF) has been implicated in the vascular hyperperme-
ability and angiogenesis of psoriasis skin. In this study, we newly generated transgenic mice 
carrying keratin 14 promoter-driven human VEGF gene to assess the correlations between 
psoriasis and VEGF. The transgenic mice showed the constitutively overproduction of human 
VEGF in the basal layer of skin epidermis, and hypervascularization in the papillary dermis as 
compared with wild type littermates. Moreover, the injured transgenic mice resulted in charac-
teristic histology of psoriasis, such as hyperkeratosis, acanthosis, marked elongation of the rete 
ridge, and perivascular lymphocytic infi ltrates. Immunohistological staining revealed keratin 
6 expression in skin epidermis and infi ltration of CD8+ T cells into the epidermis, whereas 
CD4+ T cells mainly infi ltrated into the dermis. These histological features indicated similarity 
of psoriasis. In serological analysis, the productions of IL-12, IL-1γ, IL-4, IL-5, and MCP-1/CCL2 
were signifi cantly higher in sera from injured transgenic mice compared with those of wild type 
littermates. RT-PCR analysis using lesional skin indicated the overexpressions of IL-12p40, IFNγ 
and TNFα mRNA in the transgenic mice. These trends of the cytokine/chemokine productions 
resemble the cytokine profi les in sera from patients with psoriasis or lesional skin, respectively. 
Therefore, these fi ndings may imply pathogenic importance of the VEGF overexpression in 
skin epidermis of the patients with psoriasis, and let us understand the mechanism to develop 
psoriasis skin lesions.
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New insights into the Mechanism of Action of Bexarotene in Human Cutaneous T-Cell 
Lymphoma
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Bexarotene is the fi rst synthetic nuclear retinoid X receptor-selective retinoid approved by the FDA 
for the treatment of refractory cutaneous T-cell lymphoma (CTCL) in all stages. However, the mecha-
nism of bexarotene action has not been well defi ned. Our purpose was to elucidate the main signal-
ling pathways by which bexarotene exerts its antitumoral effect in vitro in human CTCL. 
Methods: Hut-78, HH and MJ, well-established CTCL cell lines were treated with 10mM bex-
arotene for 24, 48 and 96 hours and viability was measured by colorimetric XTT assay. Cell 
cycle progression and apoptosis were measured by fl ow cytometry using propidium iodide and 
fl uorescein isothiocyanate FITC- labelled Annexin V. Ki-67 levels were also detected by fl ow 
cytometry. For clonogenic survival, methylcellulose assay was used after bexarotene treatment. 
Apoptosis and cell cycle-related proteins were detected by western blot. 
We observed that bexarotene induce in vitro a moderate loss of viability in the three CTCL 
lines studied -Hut-78, HH and MJ- (after 96 hours: 30%, 47.6% and 21,3%, respectively). 
However, the self-renewal capability of such cells were notably affected since clonogenic as-
says performed using treated cells showed in all cases, a strong inhibition of colony formation 
10-15 days after (75%, 80%, 70%). Bexarotene increase apoptotic cells but no enough to 
explain the high inhibition of clonogenic proliferation observed. No detectable changes was 
observed in Bcl-2 expression but a time-dependent decrease of the IAP protein survivin was 
clearly detected. 
We also investigated bexarotene-induced changes in some proliferation-related markers. Dip-
loid Ki-67 positive cells decreased after treatments, which means an increase on G0 resting 
cells and point to the cell cycle arrest. We further examined cycle-related proteins and ob-
served that bexarotene signifi cantly decreased p34(cdc2) levels in Hut-78, but not in HH or 
MJ lines. However, cyclin B1 level was strongly reduced -just after 1 day- in all lines studied, 
suggesting that G2/M checkpoint contributed to the bexarotene-induced cell cycle arrest. In 
the other hand, signifi cant inverse correlation was observed in Hut-78 treated cells, between 
the increase of p21 and the decrease in cyclin D1 levels indicating also the G1/S arrest in such 
cells. In this regard we observed that bexarotene is able to increase p53 phosphorylation in 
the same cells.
In conclusion, we have provided evidences demonstrating that bexarotene induces in vitro 
growth inhibition of CTCL cells by activating an apoptotic pathway and also promoting cell 
cycle arrest at G2/M and G1/S check points.
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Downregulation of NF-κB by the IKK2 Inhibitor AS602868 Induces Apoptosis of Cutaneous 
T Cell Lymphoma
Sors A1, Jean-Louis F1, Dubertret L2, Dreano M3, Parmentier L3, Courtois G1, Bachelez H1 and Michel L1
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The NF-κB signaling pathway is involved in the physiological regulation of apoptosis in many cell 
types, and in the resistance of several malignancies to cell death, thus raising this complex as an 
appealing candidate target in cancer therapy. We previously established that NF-κB is constitutively 
activated in cutaneous T cell lymphoma (CTCL) cells, plays a key role in their survival and chem-
oresistance, and that inhibition of NF-κB nuclear translocation by either a non phosphorylable form 
of IκBα or proteasome inhibitors induces apoptosis in CTCL cells. The aim of the present study was 
to investigate in vitro the effects on CTCL survival and chemoresistance of a pharmalogical inhibi-
tion of the IKK complex at the level of its IκB kinase (IKK) subunit 2 (IKK2) by the anilinopyrimidine 
derivative AS602868. We evaluated the effects of AS602868 (0.1-30 μM) on the viability of CTCL 
cell lines (SeAx, MyLa) lines and circulating tumor cells from patients with Sezary syndrome (SS, 
n=10) according to a dose- and time-dependent experimental protocol. AS602868 was tested either 
alone or in combination with antineoplastic agents such as etoposide (1-10μM), doxorubicin (1μM) 
or vincristine (12.5μM). The modifi cations of NF-κB activity were studied by electrophoretic mobil-
ity shift assay or immunocytochemistry. Results show that in both tumor cells from SS patients and 
in CTCL cell lines, AS602868 down regulates the constitutive nuclear translocation of NF-κB and 
induces a potent apoptotic cell response, associated with annexin V/propidium iodide staining and 
mitochondrial transmembrane potential alterations, as well as procaspase 3 and PARP cleavage. 
Moreover, AS602868 potentiates the apoptotic effects of etoposide, vincristine and doxorubicine. 
Importantly, AS602868 does not signifi cantly alter viability of PBMCs from healthy donors. These 
results indicate that pharmacologic inhibition of the NF-κB pathway by IKK2 inhibitors may be an 
interesting innovating approach for the treatment of CTCL.
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Complete Molecular Identity of Cutaneous and Peripheral Blood Dominant T Cell Clones 
Displaying an Identical Migratory Pattern on Genescan Analysis in Patients with CTCL
Dereure O1, Gubler B2, Marty S2, Eliaou JF2 and Guillot B1
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In patients with Cutaneous T Cell Lymphoma (CTCL), the direct demonstration of the molecular 
identity of skin and blood dominant T cell clones featuring an identical migratory pattern when 
using PCR-based methods of TCR genes analysis has never been accurately reported. However, 
it is usually admitted that an identical migratory pattern is always associated with a complete 
molecular identity and, by extension, of the clones under scope in discriminative methods such 
as DGGE. Nevertheless, direct sequencing of the amplifi ed fragments would be of great interest 
to validate this assumption and it is of clinical interest to demonstrate that the circulating clone 
can indeed correspond to the skin-infi ltrating tumoral clone and not to a reactive population.
To investigate this hypothesis, 8 patients with CTCL (6 men/2 women, mean age 62.5 years old, 
4 Mycosis Fungoides and 4 Sézary Syndrome) and displaying skin and blood dominant T cell 
clones featuring a perfectly identical migratory pattern on Genescan analysis of TCRG-targeted 
amplifi ed fragments were selected. For each patient, a double-step simplex PCR targeting the 
V region used by the rearrangement was performed followed by heteroduplex analysis, exo-
nuclease treatment and direct sequencing of the fragments originating from skin and blood. 
In all cases, this procedure demonstrated a complete homology between these fragments and 
therefore the complete identity of the skin and blood clones. Conversely, another patient dis-
playing skin and blood clones with a slight migratory discrepancy (256 vs 259 bp) proved to 
have completely different clones after sequencing. Accordingly, we demonstrate that the precise 
analysis of migratory patterns obtained from Genescan analysis of TCRG rearrangements is a useful 
method to assess molecular homology of skin and blood-derived dominant T cell clones and that 
the circulating clone corresponds to the tumoral, skin-derived population when it shows an identical 
migratory pattern to this latter one. 
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T Cells Repertoire, Phenotype and Functionality in Drug Hypersensitivity Syndrome
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The drug hypersensitivity syndrome (DHS) is a severe hypersensitivity reaction associated with visceral 
manifestations. The immunological mechanisms involved are still poorly understood. We propose to 
characterize the repertoire, phenotype and the functionality of T cells in DHS. 
40 patients with DHS were included in our study. CD4+ and CD8+ T cells were separated from PBMC 
using positive selection on MACS columns. A T lymphocyte repertoire analysis was performed with the 
immunoscope technique using Vβ and Cβ specifi c primers. Lymphocyte phenotype (activation markers: 
CD25, CD68, CD134, CD45RO, HLA DR; cutaneous homing receptors: CLA, CCR4; apoptosis marker: 
FasL) and cytokine secretion (IL2, IL5, IFNγ, TNFα, IL4, IL8, IL13 and IL10) were analysed by FACS on 
blood samples collected at D0, D30, D90, and D360. Immunoscope analysis permitted to detect rep-
ertoire bias (i.e. non Gaussian distribution) corresponding to expanded lymphocyte population within 
a particular Vβ family; a fl ow cytometry analysis with an anti-Vβ antibody was performed a second 
time to characterize the phenotype and the cytokine secretion profi le of the expanded population. To 
study the modifi cations of gene expression in DHS, we performed a DNA micro-array analysis of 901 
genes expressed in PBMC for 2 patients with DHS induced by carbamazepine and 1 by minocycline. 
Gene expression profi les were compared with PBMC from 3 healthy donors and 4 patients taking 
carbamazepine without hypersensitivity reaction. To show CDR3β homology, we sequenced CDR3β 
region from expanded CD8+ T cells selected from immunoscope technique.T cells presented an acti-
vated phenotype (CD25, CD69,CD38, HLADR), more remarkable within the CD8+ subset. Expression 
of these markers decreases between D0 and D90. CD4+ and CD8+ cells overexpress cutaneous hom-
ing markers at the early stages of the disease. The proportion of CD4+ and CD8+ T cells secreting IFNγ, 
TNFα and IL2 increases between D0 and D90, which may be an explanation for relapses when corti-
cotherapy is decreased in this period. Immunoscope analysis reveals repertoire bias in all the patients, 
preferentially among the CD8+ subset and the analysis of CD8+ expanded populations with anti-Vβ 
antibody showed that these cells express higher levels of activation markers and secrete higher levels 
of IFNγ, TNFα and IL2.
Gene expression analysis with micro-arrays confi rms the results obtained by FACS analysis. A same 
profi le was obtained when two different medications are responsible of DHS. 54 gene transcripts 
are upregulated at D0, playing function in cell activation, signal transduction, apoptosis, cutaneous 
homing and infl ammation. In addition, TNFα Receptor is down regulated at D90. Quantitative PCR 
analysis confi rms these results. Sequencing of CDR3β permitted to reveal CDR3 sequence homology 
with CDR3β T cells specifi c to EBV. Moreover, tetramer technique permitted to confi rm the recogni-
tion of EBV immuno-dominant peptide by CD8+ T cells.
In DHS, the CD8+ T cells secrete TNFα, IFNγ and IL2 and include oligoclonal expansions that 
recognize EBV epitopes.
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The Inhibition of Immunoglobulin E- and Antigen-mediated Signaling by Changing the FcεR1 
Dynamics Due to an Exogenous Cholesterol Overload
Kitaba S, Murota H, Izumi M, Terao M and Katayama I
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Fc epsilon receptor 1 (FcεR1) -bearing cells, such as mast cells, a basophils, Langerhans cells 
and dendritic cells, are known to play a role not only in the intiation of acute phase allergic 
reaction but also in the maintenance of late phase infl ammatory reaction by the interaction of 
allergen and allergen-specifi c IgE. Therefore, the blocking of transmenbrane signaling by IgE-
FcεR1 is thus expected to be a promising approach for the treatment of allergic diseases.
 The plasma membrane contains ordered lipid domains commonly called lipid raft. Lipid raft 
has been believed to affect and most likely regulate the coupling of key cellular signaling pro-
teins. FcεR1 is also known to utilize lipid raft to initiate the downstream signal transduction. 
Since the administration of exogenous cholesterol leads to the instability of lipid raft, a choles-
terol overload is thus considered to inhibit the downstream signaling by IgE-FcεR1. 
 To verify the above hypothesis, monocyte derived dendritic cells (MoDC) from healthy vol-
unteers and patients with AD were treated with cholesterol in vitro. As expected, mite antigen 
and IgE stimulation induced the expression of TARC and the phosphorylation of Syk, an FcεR1-
downstream signal transducer, were reduced following cholesterol-treatment. A confocal mi-
croscopic analysis and sucrose gradient fractionation assay revealed the abnormal localization 
of FcεR1alpha in cholesterol loaded MoDC. Furthermore, the IgE-induced upregulation of cell 
surface FcεR1was not observed in cholesterol-loaded MoDC. These results indicated that cho-
lesterol might therefore inhibit the transmenbrane signal due to the IgE-FcεR1via altered char-
acter of the cellular lipid membrane Taken together, exogenous cholesterol overload might 
thus be a potentially effective novel therapeutic intervention for IgE-related allergic diseases.
378
Differences in Clinical Presentation of Epidermodysplasia Verruciformis Associated with 
EVER2 Gene Mutations
Majewski S1, Favre M2, Orth G2 and Jablonska S1
1Department of Dermatology and Venereology, Warsaw Medical University (Poland)
2Unite des Papillomavirus, Institut Pasteur, Paris (France)
Epidermodysplasia verruciformis (EV) was found to be related to mutations of specifi c genes 
EVER1 or EVER2. The function of EVER1 and EVER2 is unknown, and it is unclear whether their 
mutations are associated with specifi c phenotype. We studied 14 Polish cases of EV, all found 
to have EVER2 mutations but differing by natural history of the disease. The onset of EV in all 
cases was at the ages 6-8 years, and the malignancies started to appear in the third-fourth dec-
ade of life. The morphology and histological picture of skin lesions were typical of epidermo-
dysplasia verruciformis but differed by extent and severity, especially by absence or presence 
of single or multiple premalignant or malignant lesions. Of special interest are familial cases 
which in spite of the same EVER2 mutation, had strikingly different clinical picture and course. 
Of 2 sisters with clinical and histological identical fi ndings, infected with oncogenic HPV5 and 
HPV8, the disease in one was steadily progressive with appearance of multiple malignancies, 
whereas in the other unexpectedly and most unusually the changes regressed spontaneously 
after delivery and did not reappear within 30 years of follow-up. In another family, the sister 
had a stationary changes, and the brother - a widespread progressive disease with numerous 
malignancies. In a family with 3 cases of severe disease, one granddaughter had slight involve-
ment and the lesions regressed after 5 administrations of HPV5 L1 VLPs. The study showed that 
EVER2 mutations, predisposing to EV, are not a decisive factor for clinical presentation and 
course of the disease.
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Protective and Anti-Radical Properties of a Complex Containing Colloidal Gold, Extremophilic 
Seaweed Extract And Ascorbyl Glucoside
Saussay S1, Chastagner A2, Guillou V2, Boussouira B2, NGuyen QL2 and Besné I1
1L’Oréal Recherche, Clichy (France)
2L’Oréal Recherche, Chevilly Larue (France)
Because chronological ageing induces morphological changes and decrease in Langerhans 
Cells (LC) number, we have evaluated in this study the effects of a combination including 
colloidal gold, an extremophilic seaweed extract and ascorbyl glucoside against UV-induced 
damage (direct impact of UV radiation and indirect damaging effects of UV-induced reactive 
oxygen species (ROS)).
The evaluation of the combination was performed by topical application on human skin ex-
plants before and after UVA (15J/cm2) and UVB (1.5J/cm2) radiation. LC were detected using 
immunolabelling with anti-CD31 antibody and cell number was counted on immunolabeled 
section. The anti-oxidant activity was evaluated in tubo by measuring tyrosine photo-oxidation 
(through bi-tyrosine release) induced by UVA radiation (5J/cm2 and 20J/cm2).
In human skin explants, UV radiation induces a signifi cant decrease in LC number (13.1 cells/
mm2 in average versus 82 cells/mm2 in unexposed controls). When 2% or 0.1% of the test 
combination was added to the culture medium, LC number raised to 36.2 cells/mm2 and 31.5 
cells/mm2, respectively. So the protective activity of the combination against UV damage is 
respectively of 28% and 22%. 
In the tyrosine photo-oxidation test method, the test combination reduces by 95% the produc-
tion of bi-tyrosine (an amino acid radical marker) following a 5J/cm2 UVA irradiation (0.007 
UA/μg tyrosine with the added combination versus 0.14 UA/μg tyrosine in control). A protec-
tion of 80% was obtained when UVA irradiation dose is increased to 20J/cm2 (0.22 UA/μg 
tyrosine with the added combination versus 1.10 UA/μg tyrosine in control). 
In conclusion, we show that the test combination protects Langerhans cells against UV dam-
ages by decreasing the cell disappearance and demonstrate an anti-oxidant activity. Better 
protected, Langerhans cells shall give a better immunization to the skin against external aggres-
sions particularly against UV radiation. 
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Dendritic Cells and Macrophages Express Different Cell Surface Proteoglycans
Wegrowski Y1, Kotlarz G1, Perreau C1, Bernard J2, Maquart FX1
1Laboratoire Biochimie Medicale, CNRS UMR 6198, Faculté de Médecine, Reims (France)
2Unité de Therapie Cellulaire, Institute J.Godinot, Reims (France)
It is well known that heparan sulfate modulates the mononuclear cells functions in skin, but the 
characteristic of corresponding proteoglycans was not studied. The expression of cell surface 
proteoglycans, namely syndecans and glypicans was studied in human monocytes, mono-
cyte-derived immature and mature dendritic cells (iDC and mDC) and in monocyte-derived 
macrophages (MF). MF and iDC were obtained from monocytes after stimulation with GM-CSF 
or GM-CSF plus IL-4, respectively. mDC were obtained from iDC by TNFα and PGE2 treatment. 
The cells expressed the typical phenotypes of low level of CD80 and CD86 for iDC and high 
level of surface CD14 and CD16 for MF, respectively. mDC were characterized by increased 
expression of CD83, CD86 and HLA class II. 
The cells were labelled with 35S-sulfate to characterise the synthesis of glycosaminoglycans. The 
expressions of syndecans and glypicans genes were studied by RT-PCR and Western blotting. 
iDC had the highest metabolic activity and the monocytes the lowest metabolic activity for 
the synthesis of cell surface proteoglycans in comparison with mDC and MF. The major part 
of proteoglycans was in phosphatidylinositol-anchored form and was released after treatment 
with phospholipase C, a characteristic for glypicans family. The minor part was released with 
trypsin. Digestion with chondroitinase ABC and mild HNO2 treatment showed that chondroitin 
sulfate represented the major part of cell surface proteoglycans both in phospholipase C and 
trypsin fractions. RT-PCR detected the transcripts of glypicans 1, 3, 4 and 5 and syndecans 1-4. 
iDC expressed a most complex spectrum of glypicans and syndecans, glypican-1 and syndecan 
1 being preferentially expressed by this type of cells. mDC expressed glypican-3, not present 
in others cell subsets. These observations were confi rmed by Western blot studies of isolated 
proteoglycans.
The results indicate that different mononuclear cells actively synthesise cell surface proteogly-
cans with characteristic expression of different syndecans and glypicans genes, depending on 
the degree of cell maturation. The highest metabolic activity of the synthesis of proteoglycans 
by immature dendritic cells corroborate with their role on the survey of skin homeostasis.
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Natural Mutations in IL-12Rb2 and TLR4 Result in Increase or Loss of Chemical-Induced 
Contact Hypersensitivity Responses
Martin SF1, Dudda JC1, Bachtanian E1, Burghard S1, Liller S1, Lembo A2, Galanos C2 and 
Freudenberg MA2
1Clinical Research Group Allergology, Dept of Dermatology, University of Freiburg (Germany)
3Max-Planck-Institute for Immunobiology, Freiburg (Germany)
Contact sensitizers effi ciently activate the innate immune system in the skin by largely un-
known mechanisms. This infl ammatory response is crucial for induction of T cell mediated 
contact hypersensitivity. Similar to pathogen driven innate immune responses, contact sensi-
tizers activate MAP kinases and NF-κB but it was so far unknown whether this also involves 
Toll-like receptors. 
We have now studied mice with natural mutations in genes for the IL-12 receptor β2 chain 
(IL-12Rβ2) and TLR4. Induction of contact hypersensitivity (CHS) revealed two phenotypes: 
defects in IL-12Rβ2 resulted in increased CHS responses, increased skin infi ltration by T cells 
and increased IFN-γ secretion whereas defects in both IL-12Rβ2 and TLR4 resulted in resist-
ance of the mice to CHS induced by TNCB, FITC and oxazolone. Furthermore, the double 
defi cient mice did not develop irritant contact dermatitis to croton oil. We could demonstrate 
that dendritic cells (DC) from double defi cient mice were unable to sensitize wildtype mice for 
CHS whereas wildtype DC effi ciently sensitized double defi cient mice. Abrogation of immune 
regulation restored CHS in the TLR4/IL-12Rβ2 double defi cient mice as did alternative activa-
tion of the double defi cient DC via other TLR.
Our results demonstrate a crucial role for TLR4 and the IL-12/IL-12R system in determining the 
susceptibility to contact hypersensitivity. Dendritic cells are crucially affected by these muta-
tions and lose their capacity to induce sensitization. Further studies will therefore elucidate 
the mechanisms of innate immune activation by contact sensitizers and a potential role for 
infections in allergic responses. 
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Detection of T-cell Mediated Responses to Alpha-Nascent Polypeptide-associated Complex 
(NAC, Hom S2) in Adult Patients with Atopic Dermatitis
Heratizadeh A1, Kienlin P1, Mittermann I2, Valenta R2 and Werfel T1
1Department of Dermatology and Allergology, Hannover Medical University (Germany)
2Division of Immunopathology, Dept of Pathophysiology, Medical Univ of Vienna (Austria)
AD represents a chronic skin manifestation of atopy and it is well established that T cell reactiv-
ity to exogenous allergens represents a prominent feature of AD. These T cells can be found in 
the circulation of AD patients but also home to the skin. In previous studies it has been shown 
that the serum of some patients suffering from AD contains IgE autoantibodies to antigens 
which may be present in infl amed skin. In order to investigate the putative role of “autoallergy” 
for AD we investigated immunological responses to the autoallergen Hom S2, the human tran-
scriptional coactivator alpha-nascent polypeptide-associated complex (NAC), in detail. Sera of 
165 patients with AD were screened for the presence of specifi c IgE antibodies to NAC by an 
enzyme-linked immunosorbent assay. Surprisingly, sensitization to NAC was detected in more 
than 20% of adult patients with chronic moderate to severe AD. rNAC induced proliferation of 
circulating T-cells (detected by fl ow cytometry with CSFE) was similar in patients and control in-
dividuals. However, rHom S2 induced a signifi cantly higher proliferation of CCR4+ (compared 
to CCR4-) and of CLA+ (compared to CLA-) putative “skin-homing” T-cells from the circula-
tion. rNAC-reactive T-cell clones (TCC) which had been generated from the peripheral blood 
were preferentially CD8+ and produced high levels of IFN-gamma. Limiting dilution assays 
performed with cell cultures from lesional skin revealed a high proliferation of skin-infi ltrating 
lymphocytes in the presence of rNAC compared to control cultures. rNAC reactive TCC from 
chronic lesional skin were predominantly CD4+ and produced IFN-gamma as well. In conclu-
sion, NAC appears to be a potent autoantigen in adult patients with AD inducing both humoral 
and cellular responses which may be relevant for cutaneous infl ammation in AD.
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The Th1 Cytokine Osteopontin (OPN) Decisively Contributes to the Chronifi cation of Allergic 
Contact Dermatitis
Renkl AC1, Seier A1, Uebele T1, Liaw L2, Schulz G1, Schlick J1 and Weiss JM1
1Department of Dermatology, University of Ulm (Germany)
2Center for Molecular Medicine, Maine Medical Center Research Institute (USA)
In previous work we demonstrated that during the sensitization phase of CHS Osteopontin 
(OPN) guides skin dendritic cells into lymph nodes and simultaneously instructs them to adopt 
a Th1 inducing phenotype. These fi ndings in part explain the reduced acute CHS response in 
OPN defi cient mice. Because of the described pivotal role of OPN in type-1 immune responses 
we now investigated OPN functions during the chronifi cation of allergic contact dermatitis. 
Immunohistochemistry revealed low OPN expression in normal human skin. In acute aller-
gic contact dermatitis predominantly perivascular leukocytes and endothelial cells stained 
positive for OPN. However, in chronic eczema OPN was highly expressed in the infl amma-
tory infi ltrate and by keratinocytes. Double immunohistochemistry revealed that CD45RO+ 
infi ltrating T cells, antigen presenting cells and microvascular endothelial cells express OPN 
and its receptors CD44v and αvβ3 integrins. This regulated expression correlated with high 
quantitative OPN mRNA expression in contact dermatitis compared to unaffected skin of the 
same donor. To determine OPN secretion by nickel specifi c T cells, CD4+ T cell clones were 
generated from allergic donors and their secretion of IFN-γ, IL-4 and OPN was measured upon 
NiSO4 stimulation. These T-cell clones constitutively secreted OPN, which was not modulated 
by antigen restimulation. However, when comparing the cytokine patterns of different clones, 
IFN-γ high, IL-4 low clones produced little OPN, but IFN-γ low IL-4 high clones secreted four-
fold the amount, indicating, that in antigen specifi c T-cells OPN may function as a redundant 
Th1 cytokine. Because OPN was highly upregulated by keratinocytes in chronic eczema, their 
modulated expression of OPN by infl ammatory cytokines was determined. Among a panel 
of cytokines tested only IFN-γ specifi cally induced high OPN expression. To test the in vivo 
function of OPN for the chronifi cation of CHS, OPN wild type or OPN defi cient mice were 
repetitively challenged over one month. OPN defi cient animals constantly displayed a reduced 
chronic infl ammation measured by ear swelling. In conclusion regulated OPN secretion and 
OPN receptor expression by different cells types is essential in the chronifi cation process of 
allergic contact dermatitis.
* The fi rst two authors contributed equally.
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Analysis of T Cell Responses and Cross-Reactivity in Birch Pollen Allergic Patients with Pollen 
Associated Oral Allergy Syndome to Hazelnut
Adler HS1, Christ S1, Raps C1, Scheurer S2, Vieths S2 and Steinbrink K1
1Department of Dermatology, University of Mainz (Germany)
2Paul-Ehrlich-Institut, Langen (Germany)
The pollen-related food allergy represents the most frequent food allergy in adult individuals 
in Europe. More than 70 % of atopic patients with birch pollen allergy experience allergic 
symptoms after ingestions of birch pollen-related foods resulting in the development of the oral 
allergy syndrome (OAS). The major birch pollen allergen, Bet v 1, belongs to the pathogen-
related protein family 10 (PR-10) and homologous, cross-reactive molecules were isolated in 
various plant families (e.g., Cor a 1.04/hazelnuts, Dau c 1/carrots, Mal d 1/apple, Api g 1/cel-
ery). Former studies depicted cross-reactive IgE in patients suffering from OAS, and allergen-
specifi c responses of in vitro generated T cell clones and T cell lines, but still little is known of 
primary T cell reactivity in OAS. In this study, we analyzed the T-cell responses to recombinant 
Bet v 1 and Cor a 1.04 in a panel of patients (n=8) with proven birch pollen allergy and food 
allergy to hazelnuts (clinical history, skin-prick test, specifi c IgE, EAST) after stimulation with 
autologous mature dendritic cells (DC) loaded with recombinant allergens in vitro. DC were 
generated from peripheral progenitor cells in the presence of IL-4 and GM-CSF and treated 
with IL-1β, IL-6, TNF-α and PGE2 for maturation. The optimal concentration of Bet v 1 and Cor 
a 1.04 for loading of DC and subsequent stimulation of isolated CD4+-T cells was determined 
as 5-20 μg/ml, proved to be non-toxic and did not affect the maturation of DC. In primary 
stimulation of CD4+-T cells with Bet v 1- or Cor a 1.04-loaded DC signifi cant amounts of al-
lergen-specifi c IL-5, IL-13 and IFN-γ were induced indicating a strong TH2 cytokine skewing. 
Notably, we demonstrated a signifi cant T cell proliferation of atopic patients after restimulation 
with both, the identical antigen as in primary stimulation or with the respective cross-reactive 
allergen and could thus identify a group of atopics with T cell cross-reactivity between Bet v1 
and Cor a 1.04. This supports the role of T cell responses in the pathogenesis of pollen-associ-
ated OAS and emphazises the importance to target T cells with novel therapeutic approaches 
like the induction of tolerance using in vitro generated tolerogenic DC.
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MMP-9: A Novel Biomarker for Monitoring Disease Activity in Chronic Urticaria Patients?
Altrichter S, Boodstein N, Peter HJ and Maurer M
Dept of Dermatology and Allergy, Charité - Universitätsmedizin Berlin (Germany)
Matrix metalloproteinase (MMP)-9 is an enzyme that is produced by many cells, including mac-
rophages, T cells, and mast cells and that is thought to contribute to infl ammatory responses and 
subsequent tissue remodelling and repair. Recently, plasma levels of MMP-9 were reported to be 
increased in patients with chronic urticaria (CU), and MMP-9 levels in these patients were claimed 
to positively correlate to disease activity. Here, we have analyzed CU and psoriasis patients and 
healthy controls for plasma levels of total MMP-9 and active MMP-9, as assessed by ELISA. CU ac-
tivity was measured using weekly and daily composite scores calculated from wheal numbers and 
pruritus intensity as documented in patients’ diaries. Signifi cantly increased levels of total MMP-9 
(n = 30; mean = 210 ng/ml) were detected in patients with CU as compared to healthy controls (n 
= 30; mean = 105 ng/ml). However, we did not detect a correlation of disease severity with plasma 
levels of total MMP-9. Interestingly, patients with psoriasis also had clearly elevated plasma levels of 
total MMP-9 (n = 16; mean = 226 ng/ml), indicating that MMP-9 plasma levels do not specifi cally 
refl ect CU-activity. Notably, the analysis of active MMP-9 plasma levels revealed no differences be-
tween CU and psoriasis patients and healthy controls. In all subjects plasma levels of active MMP-9 
were very low, indicating that elevated total MMP-9 levels in CU and psoriasis patients are not due 
to the specifi c release of active MMP-9 by mast cells or other proinfl ammatory cells. Our fi ndings 
strongly discourage the use of MMP-9 as a biomarker for assessing the spontaneous course of CU or 
for monitoring CU activity in patients subjected to treatment in clinical trial settings.
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A Skin-like Cytochrome P450 Cocktail Activates Prohaptens to Contact Allergenic 
Metabolites
Andresen Bergström M1, Ott H2, Carlsson A1, Neis MM2, Zwadlo-Klarwasser G3, Merk HF2, 
Karlberg AT1 and Baron JM2
1Dept of Chemistry, Dermatochemistry and Skin Allergy, Göteborg Univ, Göteborg, (Sweden)
2Dept of Dermatology & Allergology, Univ Hospital RWTH Aachen, (Germany)
3Interdisciplinary Centre for Clin Res (IZKF) BIOMAT, Univ Hosp RWTH Aachen,  (Germany)
The knowledge regarding activation of prohaptens to contact allergens is today limited. Many 
proposed non-animal test methods for prediction of contact allergenic activity do not include 
the possibility of metabolic bioactivation of prohaptens to sensitizers, which could lead to con-
sumer products containing potent allergens being marketed. Thus, alternative methods which 
consider skin metabolism are needed. In this study the metabolic activation of a model diene 
prohapten was studied using a liver-like rhP450 enzyme system, a skin-like rhP450 cocktail, 
the major P450 enzymes present in the skin and liver, liver microsomes, keratinocytes and a 
dendritic cell assay. The skin-like rhP450 cocktail was prepared using cytochrome P450 1A1, 
1B1, 2B6, 2E1 and 3A5 resembling the metabolic properties of human skin cells determined 
by real-time PCR in 18 human skin samples. The diene prohapten was shown to be activated to 
sensitizing epoxides by all microsomal incubations including the skin-like rhP450 cocktail. The 
diene and one of its metabolites were shown to be sensitizers in the dendritic cell assay. The 
results of the metabolic investigations of the diene show the exocyclic epoxide to be the main 
offending agent responsible for the allergenic activity of the diene. The skin-like rhP450 cock-
tail was shown to be as straightforward as conventional microsomal systems used in studies of 
xenobiotic metabolism. The skin-like rhP450 cocktail thus provides the possibility of designing 
new in vitro predictive assays of allergenic activity for prohaptens. 
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Ascertaining Patch Test Concentration in Cutaneous Adverse Drug Reactions to 
Aminopenicillins and Carbamazepine
Gonçalo M, Coelho S and Figueiredo A
Department of Dermatology, University of Coimbra (Portugal)
Background: Aminopenicillins (AP) and carbamazepine (CBZ) are two of the most frequently 
reported causes of cutaneous adverse drug reactions (CADR) in which patch tests are positive. 
Objective: Evaluate patch test reactivity to different concentrations of amoxicillin (AMX), ampi-
cillin (AMP) and CBZ in petrolatum.
Material And Methods: We selected 33 patients (22F/11M) with maculopapular rashes attrib-
uted with a high clinical imputability index (I3 or I4) to amoxicillin or amoxicillin-clavulanate 
and 27 patients (21F/6M) with maculopapular rashes (15), DRESS syndrome (11) or Stevens-
Jonhson’s syndrome (1) attributed to CBZ, who performed patch tests between 1980 and 2005. 
Patch testing was performed with the pure drug diluted at 1% or 5%, 10% and 20% in pet-
rolatum.
Results: Negative results were obtained in 16 patients with CADR to AP (48%) and in 8 cases 
with CADR to CBZ (30%). All the 17 patients reacting to AP reacted both to ampicillin (AMP) 
and AMX at 10% pet. Concentrations of AMP and AMX at 1 and/or 5% and 20%, also tested 
in 13 of these cases, induced the same number of positive results. Of the 19 patients reactive 
to CBZ, concentrations of 1 and 5% were tested in 9 cases and 1, 10 and 20% in 10 cases. 
All patients reacted to all the concentrations tested except for one case with DRESS who was 
positive only with 20%. No adverse reactions were observed.
Conclusions: AP and CBZ at 1 or 5% pet induced the same number of positive patch test reac-
tions as 20%, except for an exceptional case reacting only to the highest concentration of CBZ. 
Therefore we recommend testing with AP and CBZ at 5% pet, eventually using CBZ at 20% pet 
in selected patients with negative reactions at low concentrations.
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Molecular Analysis of Colonization and Sensitization by Malassezia Species in Atopic 
Eczema
Haug S1, Roll A1, Meyer J1, Mempel M2 and Schmid-Grendelmeier P1
1Department of Dermatology, University Hospital (Switzerland)
2Department of Dermatology and Allergy, Biederstein, Technical University (Germany)
Among several contributing factors, cutaneous hyperactivity and inappropriate immune re-
sponse to fungi appear to play important role not only in the underlying pathology but also as 
factor responsible for sustained activity of atopic eczema (AE). There is increasing evidence that 
Malassezia represent a contributing factor in AE. 
Although it is still unknown how, where and why patients suffering from AE become sensitized 
to allergens of this lipophilic yeast, it becomes evident that sensitization to Malassezia particu-
larly M. Sympodialis occurs almost exclusively in AE patients. Also the response to antimycotic 
treatment in patients with AD indicates that Malassezia is involved in the pathogenesis of AD. 
Skin scales from 52 patients with atopic eczema were collected. A portion of the material 
was cultured and microscopically examined and following confi rmation of the presence of 
the yeast cells. Specifi c IgE was measured against Malassezia using commercial kit (m70 and 
m 223). Presence of the various Malassezia species were analysed by a real-time PCR based 
method for testing qualities and quantities of patient skin scales so as to detect directly and 
confi rm the identity of Malassezia species. 
In 33 of 52 patients Malassezia PCR was positive. The presence of Malassezia did not correlate 
with the level of specifi c IgE found against this yeast. Also we did not detect a correlation be-
tween severity of AD and levels of specifi c IgE. However response to systemic antifungals was 
more prone in patients with high levels of specifi c IgE against Malassezia. The presence of M. 
sympodialis, M. globosa, M. restricta, M. obtusa, and M. pachydermatis was highly variable.
We identifi ed various species of Malassezia colonizing the skin and leading to IgE-mediated 
sensitization in atopic eczema. Further analysis of quantitative fungal load will probably help 
to identify AE patients that benefi t from antifungal therapy.
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Does the Intensity of Specifi c IgE-antibody Reactions to Cross-reactive Carbohydrate 
Determinants depend on the In Vitro-Test Method?
Jappe U, Hoffmann M, Huebsch-Mueller C and Enk A
Dept of Dermatology, University of Heidelberg (Germany)
IgE-positivity for both hymenoptera venoms is mostly due to cross-reactive carbohydrate de-
terminants (CCD). This study evaluated whether CCD-IgE-binding intensity depends on the in 
vitro-IgE-detection-method. 32 patients with stinging insect allergy and anti-CCD-sIgE were 
investigated with further CCD-allergens: timothy grass, natural rubber latex (NRL), bromelain 
(BRO), and horse radish peroxidase (HRP) in different test systems: CAP FEIA, based on al-
lergens coupled to a solid ImmunoCAP matrix (Sweden Diagnostics) and Immulite E 2000 
(DPC Biermann), based on liquid phase technology. Additionally, the new CCD-ImmunoCAP, 
a MUXF3-type carbohydrate and ascorbate oxidase (DPC), also a glykan-containing allergen 
were used. The sera were further investigated via hymenoptera venom- as well as NRL-immu-
noblot (DPC). All sera were sIgE-positive to both insect venoms. In CAP FEIA, 19/32 had sIgE to 
NRL, 25/32 to timothy grass, 22/32 to BRO, 25/32 to HRP and 20/32 to CCD-CAP. In Immulite 
E 2000, 10/32 had sIgE to NRL, 16/32 to BRO, 22/32 to HRP, 17/32 to timothy grass, and 21/32 
to ascorbate oxidase. Whereas sIgE-reactions to BRO and HRP were similar in CAP FEIA, they 
differed individually in Immulite E 2000. In immunoblot, all sera reacted with the glycosylated 
allergens. HRP and BRO-derived glycans seem to be suitable CCD-screening allergens in cases 
of IgE-double-positivity in insect venom allergic patients. As in CAP FEIA the IgE-binding to the 
CCD structures was detected in more sera and was comparable with all the tested CCD aller-
gens, it might be assumed that this epitope is equally presented on the different ImmunoCAPs. 
The differences in the IgE-binding to BRO and HRP in the Immulite system might be due to 
different binding sites and/or their presentation in these allergens in liquid phase.
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Increased Sensitizing Potential by Topical Co-Administration of Non-Allergenic Terpenes and 
Haptens in CBA/Ca Mice
Jonsson C, Sandberg E and Karlberg AT
Dermatochemistry and Skin Allergy, University of Göteborg (Sweden)
Chemicals in our daily environment may cause contact allergy. So far, the sensitizing potential 
of different chemicals is defi ned from the chemicals as such. However, usually we are exposed 
to mixtures of chemicals in which the sensitizing effect of a compound can increase or de-
crease depending on the mixture-composition (product).
The aim of the present study was to investigate the impact of adding non-allergenic terpenes (li-
nalool or dihydrocarvone) topically to the contact allergens R-carvone (a terpene) or oxazolone 
to study if the contact allergy inducing potential was affected.
Induction of sensitization was studied using the local lymph node assay. CBA/Ca mice were 
ear-painted with vehicle, R-carvone or R-carvone+non-sensitizer in different concentrations. 
3H-thymidine was injected in the tail, the draining lymph nodes excised, processed, and stimu-
lation indexes (SI) calculated from dpm values. In one carvone/dihydrocarvone experiment 
the lymph node cells were cultured following exposure. In vitro proliferation and supernatant 
levels of cytokines after anti-CD3ε stimulation were investigated. Elicitation was studied using 
the mouse ear swelling test. Oxazolone or oxazolone+non-sensitizer were painted on the back 
of CBA/Ca mice. One week later the ears were challenged with oxazolone. 
R-Carvone+non-sensitzer increased the proliferative response of draining lymph node cells as 
compared to R-carvone. The in vitro proliferative reponse and the cytokine levels increased 
in cultures from mice treated with R-carvone+dihydrocarvone as compared to R-carvone. 
The SI of R-carvone (15%) increased dose-dependently by the addition of dihydrocarvone. 
Oxazolone+non-senstizer increased the ear-swelling response as compared to oxazolone. 
We conclude that topical co-administration at the sensitization phase of non-allergenic ter-
penes increases the response at sensitization and elicitation for both the allergenic terpene R-
carvone and oxazolone. Possible explanations: skewing of the immune response or penetration 
enhancing effects of the non-sensitizers. Penetration studies are planned. 
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Comparison of Clinical & Laboratory Characteristics According to Infection in SJS/TEN 
Patients
Lee JY, Oh MJ and Choi DC
Department of Allergy, University of Sungkyunkwan (Republic of Korea)
Introduction: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-
threatening adverse drug reactions. Early diagnosis with early withdrawal of all potential causa-
tive drugs is essential. In most cases they are accompanied with fever and differencial diagnosis 
of infection is mandatory because sepsis is the major cause of death. But data on clinical and 
laboratory characteristics of SJS/TEN according to infection are rarely reported. 
Objectives: To compare the clinical and laboratory characteristics according to infection and to 
fi nd out useful parameters to suggest infection before culture reports in SJS/TEN.
Methods: From May 2004 to september 2005, all patients with SJS/TEN were enrolled and 
divided into two groups with infection as group A and without infection as group B at Samsung 
Medical Center. The medical records analysis of the etiologies, vital signs and laboratory data 
were carried out. 
Results: (1) Total 14 patients with SJS (n=12)/TEN (n=2) were enrolled. The major causative 
drugs were antibiotics and anticonversants. Thirteen of 14 patients had fever and 70% of them 
over 39℃. Half of 14 patients had combined infections (C-line infection, mucocutaneous in-
fection, pneumonia, cholangitis). Eight of 14 patients had leukocytosis (11960 ~ 33930/mm3). 
All patients had elevated C-reactive protein levels (2.14~29.94 mg/dL) and 8 of them had peak 
C-reactive protein levels over than 10 mg/dL. Thirteen of 14 patients had hyperbilirubinemia 
(1.6~8.9 mg/dL) or abnormal liver enzymes (AST; 46~1104 U/dL, ALT; 44~480 U/dL). But there 
were no differences of peak body temperature, WBC count, total bilirubin, liver enzymes, CRP 
levels between group A (n=7) and B (p=0.142, p=0.338, p=0.700, p=0.565, p=0.949). Two 
patients died of sepsis in group B. 
Conclusion: High fever with leukocytosis was common in the abscence of complicating infec-
tion in SJS/TEN. There were no signifi cant differences of clinical and laboratory data according 
to infection in SJS/TEN. 
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Therapy-Induced Changes in Disease Activity of Acquired Cold Urticaria Patients Correlate 
with Changes in Temperature Thresholds
Mlynek A1, Zalewska-Janowska A2 and Maurer M1
1Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin (Germany)
2Department of Dermatology and Venereology, Medical University, Lodz (Poland)
Acquired cold urticaria (ACU) is a frequent and disabling subform of physical urticaria. ACU 
activity is subject to spontaneous and therapy–induced changes. However, these changes are 
diffi cult to assess because of the current lack of standardized methods for assessing ACU se-
verity. Here, we used TEMPTest©, a novel tool to assess skin temperature thresholds (TTs), to 
study whether changes in disease activity correlate with TT changes in ACU patients subjected 
to treatment. Changes in ACU activity were determined using a patient-based three category 
Likert scale assessing pre- and post-treatment overall disease activity. TTs were determined by 
TEMPTest©–based temperature challenges starting at 4°C with increases of 1°C. Pre-treatment 
TTs in all ACU patients tested were 13.1 ± 7.9°C (n = 22, TT range = 4°C - 26°C). Upon initia-
tion of treatment, 12, 3, and 7 patients experienced reduction, no change, and increase in dis-
ease activity, respectively. Interestingly, we found a very good correlation between TT changes 
(as assessed by TEMPTest©-testing) and changes in disease activity (r=0.92, p<0.001). In fact, 
an opposite trend in TT development was seen in only one of 19 patients exhibiting changes 
in ACU activity. These results indicate that TT changes in ACU patients subjected to treatment 
are strongly correlated with disease course and changes in disease severity. Thus, our fi ndings 
recommend TEMPTest©-based TT measurements in ACU patients for monitoring the effects of 
various treatments including novel therapeutics tested in clinical trial settings.
393
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Features and Proposed 
Score for Validation
Sidoroff A1, Kardaun S2 and RegiSCAR 3
1Department of Dermatology, Medical University of Innsbruck (Austria)
2Department of Dermatology, University of Groningen (Netherlands)
3Studygroup
DRESS is a serious drug-induced skin reaction with eosinophilia and systemic symptoms. Al-
though DRESS has been reported regularly under various names and symptoms since 1950, 
the syndrome is still not clearly defi ned. It can mimic many other diseases and is a diagnosis 
by exclusion. It often goes unrecognised, partly due to the relative long latency and the long 
duration after cessation of the culprit and the variability of symptoms.
In a multinational prospective study of severe cutaneous adverse reactions in Austria, France, 
Germany, Israel, Italy, and the Netherlands from 2002 –2005 (RegiSCAR), cases of DRESS were 
actively retrieved through a hospital network covering about 170 million inhabitants, using 
selected inclusion criteria. Information on reported cases was obtained by local interviewers 
using standardized questionnaires at the active phase of the disease and at follow ups after 8 
weeks and 1 year.
We describe the major clinical and laboratory fi ndings of DRESS, used for case defi nition. Fur-
thermore we propose and explain the scoring system for validation of potential cases, that was 
developed and used by the dermatological review committee (DRC) of RegiSCAR. The score 
was based on a combination of positive, negative and neutral scores, for which the clinical and 
laboratory fi ndings were translated to nominal data. Cases were classifi ed as no case, possible, 
probable and defi nite case, depending on the total score.
Cases were mainly recruited from inpatients of departments of dermatology or internal medi-
cine. Of 102 potential cases up till now 88 were validated using the algorithm, from these 38 
were classifi ed as a probable or defi nite case of DRESS. To prevent bias, the DRC was blinded 
for the drugs that had been used. 
Confrontation of the classifi cation of 30 random cases with an assessment by an expert team 
not using the scoring system demonstrated its level of practicability.
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Drug Intolerance Among Young Poles
Spiewak R1 and Horoch A2
1Institute of Dermatology, Krakow (Poland)
2Medical Academy, Lublin (Poland)
Background: During a nationwide study of vocational students’ health status, history of drug 
intolerance was collected in a random sample of the population tested. 
Methods: 134 Polish vocational students (51 females and 83 males), aged 16-23 (median 19) 
years underwent medical health checks, including skin prick tests with common allergens, 
total IgE measurement and Phadiatop test. The physician-administered questionnaire included 
a question about symptoms of drug intolerance (“Have you ever had adverse reactions after 
taking any medicine?”). In case of a positive answer, the trade name or at least category of the 
causative drug was recorded whenever possible. 
Results: The question about drug intolerance was answered positively by 13 persons, which 
makes 9.7% of the population examined (95%CI: 4.7-14.7%). Among them, 9 persons had 
intolerance reactions to antibiotics (5 to penicillin, 1 to doxycyclin, 1 to cefadroxil and 2 to 
unspecifi ed antibiotics). Four persons complained of ASA-intolerance and 2 persons of intoler-
ance to pyrazolone drugs (metamizole and amimophenazone). There was no signifi cant cor-
relation between drug intolerance in the patients’ history and gender (Fisher’s chi-square exact 
test: p1=0.08 for all drugs and p2 = 0.30 for antibiotics), IgE level (p1=1.00 and p2=1.00 respec-
tively), Phadiatop test result (p1=0.75, p2=0.47), atopy defi ned as combination of IgE, Phadiatop 
and skin prick test results (p1=0.38, p2=0.23), history of dermatitis (p1=0.19, p2=0.27), history of 
allergic rhinitis (p1=0.51, p2=1.00) as well as history of asthma (p1=0.13 and p2=0.07).
Conclusion: 5-15% of young Poles had at least one episode of drug intolerance in their lives. 
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Elevation in the Number of Regulatory T Cells in the Peripheral Blood of Patients with Atopic 
Dermatitis
Baráth S1, Sipka S1, Gál M2, Nagy G2, Hunyadi J2, Szegedi Gy3 and Szegedi A2
13rd Dept of Intern Medicine, Medical & Health Science Center, Univ of Debrecen (Hungary)
2Dept of Dermatology, Medical and Health Science Center, University of Debrecen (Hungary)
3Research Group of Autoimmune Diseases, Hungarian Academy of Sciences (Hungary)
Naturally occurring CD4+CD25bright suppressor and IL-10 producing CD4+ Tr1 regulatory T 
cells can play a key role in the pathogenesis of allergic diseases. 
Our aim was to investigate the differences in the number of regulatory T cells (CD4+CD25bright 
and CD4+IL10+ Tr1) in the peripheral blood of patient with severe atopic dermatitis and in 
healthy controls.Thirthy-one patients with severe atopic dermatitis were investigated in this 
study and 40 healthy volunteers served as controls. Analysis of CD4+CD25bright and Tr1 type 
regulatory T cells was carried out by fl ow cytometry.
Increased percentage of both types of regulatory T cells was detected in the peripheral blood of 
patients with atopic dermatitis compared to the healthy controls, although the differences were 
not signifi cant. However, the absolute number of both CD4+CD25bright and CD4+IL10+ regu-
latory T cells was signifi cantly elevated in AD patients. Our results did not show any signifi cant 
correlation between serum IgE levels or severity of the disease and the percentage or absolute 
number of regulatory T cells. Elevation in the number of regulatory T cells in AD patients sug-
gests that there is a modifi ed immunoregulatory process in atopic dermatitis. However, the 
background of these immunoregulatory alterations is not clear yet. 
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Involvement of Innate Conditioning of Antigen Presenting Cells by Staphylococcus aureus 
Enterotoxin B in Immune Response of Atopic Dermatitis Patients
Mandron M1, Aries MF2, Boralevi F3, Charveron M2, Taieb A3 and Davrinche C1
1Inserm U563, Hôpital Purpan, Toulouse (France)
2CERPER, Centre de Recherche Pierre Fabre, Toulouse (France)
3Service de Dermatologie, CHU Bordeaux (France)
Atopic dermatitis (AD) is dominated by the development of specifi c TH2 responses after ex-
posure of the skin to environmental antigens. This immune deviation may refl ect alterations 
in innate immune mechanisms. Recently, it has become clear that the development of TH1 or 
TH2 subsets is strongly infl uenced by factors produced by antigen presenting cells (APCs) thus 
representing a link between innate and adaptive immunity.
Toll-like receptors (TLRs) are members of pattern recognition receptors family on APCs that are 
activated by specifi c microbial components and some host molecules. They constitute the fi rst 
line of defence against many pathogens and play a crucial role in innate immunity. Further-
more, TLRs were recently demonstrated to take part in the development of adaptive immune 
responses through activation of APCs. We showed in a previous study that Staphylococcal 
aureus enterotoxin B (SEB) could induce activation of monocytes-derived dendritic cells (DCs) 
through toll like receptor 2 signalling and that SEB-pulsed DCs induced priming of naïve T cells 
and their commitment into TH2. To clarify whether APCs from AD patients could play a role in 
TH2 cell polarization, we compared the expression of surface markers and cytokine production 
by monocytes of 30 AD patients (15 adults and 15 children) with those of 15 healthy controls, 
after stimulation with either LPS or SEB. First, we observed that contrary to normal subjects 
atopic dermatitis patients were not able to further modulate TLR 2 and TLR 4 expression after 
in vitro exposition to SEB. Accordingly, cells seemed to be blocked in an activated stage with 
in addition no modulation of HLA-DR and CD54 expression. This feature was supported by 
secretion of large amounts of infl ammatory cytokines (IL-6, IL-10, TNF-α) even in the absence 
of stimulation. Then, we observed that atopic monocytes did not produce bioactive IL-12 (IL-
12p70) in response to LPS contrary to normal subjects but that secretion could persist in some 
of the atopic children. These fi ndings demonstrate that cytokine responses changed markedly 
between normal and atopic persons and provide further evidence of a close relationship be-
tween Th2 skewing and disease progression. Moreover, these data suggest a major role of in-
nate immunity through activation of TLRs on skin APCs in pathogenesis of AD.
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Monocyte-Derived Dendritic Cells from Highly Atopic Patients Show no Impaired Response 
to Toll-Like Receptor Agonists
Terhorst D1, Kalali B1, Rümmler L1, Weidinger S1, Illig T2, Novak N3, Ring J1, Ollert M1 and 
Mempel M1
1Dept of Dermatology and Allergy, Biederstein, Technical University Munich (Germany)
2Inst of Epidemiology, GSF National Research Center for Environment and Health, (Germany)
3Department of Dermatology, Friedrich-Wilhelms-University, Bonn, Germany (Germany)
Toll-like receptor (TLR) agonists such as CpG-DNA and MPLA are used as adjuvants for SIT 
protocols with the idea to deviate TH2-dominated immune responses to a more favourable 
TH1 response. Dendritic cells on the other hand are the sentinels of immune responses act-
ing as gatekeepers for the induction of either TH1- or TH2-dominated immune responses to 
external stimuli. We have analyzed the repertoire of TLRs being expressed on cultured mDCs 
from highly atopic (total IgE > 1000 IU/ml) individuals as compared to healthy controls (total 
IgE < 50 IU/ml). Receptor functionality was further assessed by the up-regulation of a variety 
of DC-maturation-/ activation-markers (CD 40, CD80, CD83, CD86, Mannose receptor, HLA 
A,B,C, HLA DR, CCR3, CXCR4, and FcR epsilon I). Additionally, we tested the reactivity of 
mDCs from highly atopic and control individuals to the known TLR-ligands PGN, poly IC, LPS, 
fl agellin, and CpG-DNA by analyzing TNF alpha and IL12 production. The obtained results 
were correlated to the fi ndings of SNPs in the TLR-genes which might have contributed to a 
particular reaction pattern.
Results: Cultured mDCs of highly atopic patients expressed a highly similar TLR-expression 
profi le as healthy controls. Reactivity of DCs to a panel of known TLR-ligands was not impaired 
in these patients and showed for certain markers even enhanced up-regulation. A distinct set 
of SNPs within the various TLR-genes seemed to have no infl uence on the immunological 
response. Of interest, despite the moderate expression of TLR3 in mDCs, a high reactivity 
towards poly IC could be found which most likely is contributed by a constitutive expression of 
PKR and RIG1, two alternative dsRNA sensing molecules. In addition to LPS-components and 
CpG-DNA, TLR2-ligands such as PGN seem to represent attractive candidates for adjuvants 
in SIT protocols.
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Hydroxyzine, but not Desloratadine, Epinastine, or Fexofenadine, Suppresses Prick Test 
Reactions to Histamine or Allergen in the Majority of Subjects Treated with the Daily 
Recommended Doses
Vieira dos Santos A1, Maurer M1 and Cavalcante Lima H2
1Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin (Germany)
2Department of Clinical Pathology - Universidade Federal do Paraná (Brazil)
Non sedating antihistamines (nsAHs) are recommended as fi rst line therapeutics for the treat-
ment of mast cell driven-disorders including allergic rhinitis and urticaria. However, their su-
periority over fi rst generation antihistamines (fgAHs) has recently been called into question, 
mainly due to the lack of supporting head to head therapeutic studies. Here, we have, in a con-
trolled clinical trial, compared the effects of three modern nsAHs (desloratadine, epinastine, 
and fexofenadine) with those of the fgAH hydroxyzine on histamine- and allergen-induced 
skin reactions. NsAHs given at daily recommended doses prevented the development of posi-
tive prick test reactions to histamine in only 10-20% of all subjects tested (n = 75) as assessed 
by measuring the size of wheal reactions using digital time lapse photography or planimetric 
analyses. In contrast, more than 50% of all hydroxyzine-treated subjects showed negative test 
reactions, i.e. wheals <7 mm2 or <3 mm diameter, to skin prick testing of histamine. Hydox-
yzine was also more effective than nsAHs in preventing histamine-induced erythema develop-
ment. Similar differences, although less pronounced, were detected in a pilot study comparing 
the effects of nsAHs and hydroxyzine on Dermatophagoides pteronyssinus (DP) prick testing 
in a limited number of DP-sensitized patients. These results indicate that hydroxyzine is more 
effective than nsAHs when given as recommended by the manufacturer in suppressing hista-
mine-induced or allergic skin reactions. Our results suggest that higher doses of nsAHs than 
those currently recommended are required to obtain antihistaminic and antiallergic effects that 
are equivalent to those of fgAHs.
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Case Report: Serum Sickness-like Disease on Second Exposure to Bupropion
Zamfi rescu M
Dept of Allergology and Clinical Immunology, Hospital “N. Malaxa”, Bucharest (Romania)
This report describes a case of serum sickness-like disease induced by a 5 days cure of bupro-
pion. 13 days after beginning a treatment with bupropion hydrochloride for quitting smoking, 
a 29 year-old female came to the emergency department with fever, chills, geographical and 
circinate quasi-generalised urticaria, hand oedema, polyarthritis and vomiting. This was the 
second time she took bupropion, the previous treatment (4 months before) being well tolerated. 
Among the laboratory fi ndings, there was an extremely high CRP (180 mg/l) and elevated WBC 
count (18000/μl, with neutrophyllia), no proteinuria. Unfortunately, the C3 and C4 fractions 
of complement could not be dosed in emergency before treatment. Following the administra-
tion of intravenous then oral antihystaminic and corticoids, the clinical fi nding progressively 
resolved in 3 days. The allergology examination concluded in a serum sickness-like disease, 
attributed to bupropion because of the lack of any medication or other possible antigenes 
involved. There was also no evidence of any other possible cause of this unusually high in-
fl ammatory syndrome. The diagnosis of bupropion associated serum sickness-like disease was 
made on the syptoms, time relation to exposure, elimination of the differential diagnosis, slow 
response to antihystaminic and systemic corticotherapy. The literature mentions rarely this kind 
of reaction to bupropion.
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Homo- and Heterotypic Cell-Cell Contacts in Malignant Melanoma Cells: Glycoprotein 
Desmoglein-2 as a Novel Solitary Surface Component
Schmitt CJ1, Franke WW2, Goerdt S1, Bulkescher J1 and Peitsch WK1
1Dept of Dermatology, Medical Center Mannheim, Univ of Heidelberg,(Germany)
2Division of Cell Biology, German Cancer Research Center, Heidelberg (Germany)
During development and progression of melanoma, a crucial role has been attributed to altera-
tions of cell-cell adhesions, specifi cally, to a “cadherin switch” from E- to N-cadherin. This con-
cept is often, but not always concordant with fi ndings on melanoma metastases in situ. There-
fore, we have decided to examine the adhesion of melanoma cells to each other and to other 
cells, including keratinocytes. When we studied different human melanoma cell culture lines 
by protein analyses and immunofl uorescence microscopy, 6 of 8 lines contained N-cadherin 
and 3 of 8 E-cadherin, usually – with one exception – in mutually exclusive arrays, whereas 
other classical cadherins were not detected. Surprisingly, however, 2 of the N-cadherin-positive 
lines, MeWo and C32, additionally synthesized desmoglein-2 (Dsg-2), a desmosomal cadherin 
previously not described in melanoma, while other desmosome-specifi c proteins were absent. 
This unexpected fi nding was confi rmed by immunoprecipitation and MALDI-TOF analysis. 
Double-label confocal and immunoelectron microscopy showed N-cadherin in plaque-bear-
ing junctions, together with α- and β-catenin, plakoglobin and protein p120, whereas, in the 
absence of desmosomes, Dsg-2 was distributed rather diffusely on the cell surface. In co-cul-
tures with HaCat keratinocytes Dsg-2 was found along the periphery of the MeWo and C32 
melanoma cells and in regions of heterotypic cell-cell contacts. Moreover, in situ, a signifi cant 
proportion of melanoma metastases was Dsg-2-positive. Otherwise, the cadherin patterns of 
the metastases were variable, some containing both E- and N-cadherin. Together, we show (1) 
that melanoma cell-cell adhesions are more heterogeneous than expected, and (2) that certain 
cells devoid of desmosomes can still contain Dsg-2 as the only desmosomal component, but in 
an unexpected location and with yet unidentifi ed interaction partners. Future studies will have 
to clarify the diagnostic and prognostic signifi cance of these melanoma subtypes.
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Normal Human Adult Epidermal Melanocytes Dedifferentiate in Chemical-free Culture
Kormos B1, Szabad G1, Pivarcsi A2, Széll M2, Kenderessy Szabó A1, Dobozy A1, Kemény L1 and 
Bata-Csörgo Zs1
1Department of Dermatology and Allergology, University of Szeged (Hungary)
2Derm Research Group of the Hungarian Academy of Sciences, Univ of Szeged (Hungary)
In previous work we found that normal human adult melanocytes can grow without chemical 
mitogens in AIM-V and Keratinocyte-SFM (v:v) supplemented with BPE and FBS. Melanocytes 
in this culture medium grow rapidly, they loose pigmentation after 3-4 weeks in culture and 
their morphology resembles a less differentiated, bipolar phenotype, compared to cells grown 
in the presence of chemical mitogens. In early cultures, cells express the pigmentation related 
TRP-1 protein, c-Kit and EGF receptor. After 3-6 weeks in culture TRP-1 expression disap-
pears and the cells show a uniform bipolar morphology. Addition of chemical mitogens to the 
cultured TRP-1 negative cells induces dendrite formation and TRP-1 expression. Cells grown 
in commercially available PMA containing media for a few weeks show a typical dendritic 
morphology, their TRP-1 and c-Kit expression is very pronounced and a week EGF-R expres-
sion is detectable in the cells. Changing the culture environment to our chemical-free media 
resulted in loss of TRP-1 expression, the appearance of the bipolar cell shape, decrease in c-Kit 
expression, increased cell proliferation and enhanced EGF-R expression. These data indicate 
that in the above described chemical-free culture melanocytes acquire a less differentiated 
phenotype, thus normal human adult melanocytes can reverse their differentiation in the in 
vitro culture. The rapidly growing, less differentiated cultured melanocytes in the chemical-free 
environment can be forced into cell cycle quiescence by contact inhibition and serum with-
drawal. When released from growth inhibition, these cells almost synchronously enter the cell 
cycle, while they express D1, D2 and D3 cyclins. This novel chemical-free culture provides an 
in vitro system in which melanocyte differentiation and pigmentation can be studied.
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Terfenadine Induces Caspase-dependent Apoptosis and Autophagy on Human Melanoma 
Cells
Díaz-Pérez JL1, Jangi SM2, Asumendi A2, Gardeazabal J1, Pérez-Yarza G2, Cañavate ML2, Díaz-
Ramón JL1 and Boyano MD2
1Department of Dermatology. Cruces University Hospital. Baracaldo-Bilbao (Spain)
2Dept of Cell Biology & Histology, Fac of Medicine & Dent University Basque Country (Spain)
Terfenadine induces caspase-dependent apoptosis and autophagy on human melanoma cells.
Apoptosis is a physiological type of cell death controlled by a strictly genetic program. Previ-
ously, it has been thought that apoptosis is the only physiological programmed cell death. 
Recently, other types of physiological programmed cell death have been described like au-
tophagy. Autophagy characterizes by the presence of cytoplasmic vacuoles, which can be 
defi ned morphologically. In our previous works we have found that histamine is a growth 
modulator of melanoma cell proliferation and that treatment with H1 histamine receptor an-
tagonists induces apoptosis in four human melanoma cell lines, but not in normal melanocytes. 
This apoptosis is caspase-2 dependent and involves the mitochondrial pathway. In the present 
work we have demonstrated that terfenadine, a specifi c H1 histamine receptor antagonist, in 
addition to apoptosis, induces autophagic cell death. During our assay for caspase-3 expres-
sion by immunofl uorescence, we observed the presence of various cytoplasmic vacuoles in 
terfenadine-treated melanoma cells. Furthermore, we found that pre-treatment with 3-Methyle 
Adenine (3-MA), an inhibitor of autophagy, prevent terfenadine-induced cell death and in-
creased cell viability by about 40%. In addition, we found that terfenadine increases intracel-
lular accumulation of MonoDansylCadaverine (MDC), a specifi c marker for autophagic vacu-
oles, in the cytoplasm of the treated cells. Lastly, to further confi rm the presence of autophagic 
cell death, we analysed terfenadine treated cells with electron microscopy and we have found 
typical morphological changes of autophagy in the cell cytoplasm. These changes were in the 
form of multiple vacuole formation, of various size and shape surrounded by two or more layer 
membranes and most of them containing cellular organelles debris like mitochondria and en-
doplasmic reticulum. We conclude that terfenadine induces mixed type of caspase-dependent 
cell death including both apoptosis and autophagy. These results may contribute to the elabora-
tion of novel strategies for the treatment of malignant melanoma.
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Functional and Structural Index of Cellular Impairment During Vitiligo
Dell’Anna ML, Ottaviani M and Picardo M
Lab of Cutaneous Physiopathology, San Gallicano Dermatological Institute, Rome (Italy)
The occurrence of an oxidative stress has been described to involve even non epidermal cells 
in subjects with active vitiligo and a mitochondrial impairment has been proposed as possible 
biochemical marker of the oxidative stress as well as biochemical basis for the disappearance 
of melanocytes.
In order to better characterize the site of the possible mitochondrial defect we evaluated, in 
PBMC of 20 patients and healthy subjects, we tested the expression of 10 subunits (15, 30, 39 
kDa of the CxI; 30 kDa of the CxII; 10 kDa and FeS of the CxIII; IV of the CxIV; α, inhibitor 
and OSCP of the CxV) of the mitochondrial ETC complexes (FACS analysis), the pattern of the 
total membrane fatty acids (GC-MS analysis), the degree of membrane lipoperoxidation (FACS 
analysis of C11-BODIPY581/591), and the transmebrane distribution of the cardiolipin (FACS 
analysis of NAO fl uorescence pattern). The peroxidative stimuli were provided by tBOOH (50 
μM for 60’) or frozen/thawen stress.
We report a different transmembrane cardiolipin distribution and an increased expression per 
cell of some ETC subunits (CxII 30 kDa, CxIII 10 kDa) in PBMC from vitiligo patients. The 
membranes of vitiligo PBMC exhibit a high degree of lipoperoxidation (p<0.005) even without 
any signifi cant modifi cation of the fatty acids pattern. The freezing/thawing test given rise to a 
pronounced alteration of these parameters in PBMC from vitiligo patients but not in those from 
normal subjects, whitout any modifi cation of the cell morphology, as indicated by the fl ow cy-
tometric analysis of the physical parameters. In conclusion, an alteration of the lipid envelope 
of the mitochondrial ETC, associated with an increased susceptibility to a mild peroxidative 
stimuli, seems to be a specifi c event occurring in PBMC of vitiligo patients, further suggesting 
a systemic involvement in the disease.
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Oxidative Stress Via Hydrogen Peroxide Inactivates POMC-Peptides in the Human Epidermis
Spencer JD1, Gibbons CJ2, Rokos H3, Peters EM4, Wood JM1 and Schallreuter KU1
1Clinical and Experimental Dermatology/Department of Biomedical Sciences, University of 
Bradford (United Kingdom)
2Institute for Pigmentary Disorders, Greifswald/Germany and Bradford/UK (United Kingdom)
3Institute for Pigmentary Disorders, Greifswald / Germany and Bradford/UK (Germany)
4BMFZ Charite Campus, Berlin (Germany)
Oxidative stress via hydrogen peroxide inactivates POMC-peptides in the human epidermis
It is well established that the human skin holds the capacity for autocrine processing of proo-
piomelanocortin (POMC) derived peptides. Recent data demonstrated the presence of adreno-
corticotropic hormone (ACTH), α- and β-melanocyte stimulating hormone (MSH) as well as 
β-endorphin, demonstrating a functional role in the regulation of skin pigmentation. In patients 
with the pigmentary disorder vitiligo, decreased epidermal POMC-processing and low α-MSH 
levels were documented previously. These patients accumulate hydrogen peroxide (H2O2) in 
the 10-3 M range in their epidermis. Therefore this study was designed to examine the effect of 
H2O2 on POMC-derived peptides as possible targets for direct oxidation by this reactive oxygen 
species (ROS). To address this question we employed immunofl uorescence labelling, dot blot 
analysis, Fourier-Transform Raman spectroscopy and computer simulation of the peptide struc-
tures. We demonstrate H2O2 mediated oxidation of epidermal ACTH, α-MSH and β-endorphin 
in vitiligo in situ and in vitro due to oxidation of methionine residues in the sequence of these 
peptides. These changes are reversible upon reduction of H2O2 levels by a pseudocatalase PC-
KUS. Moreover, we demonstrate that oxidation of the peptide β-endorphin can signifi cantly 
reduce its capacity to stimulate melanin production in cultured human melanocytes. Thus, 
using vitiligo as a model disease, these fi ndings demonstrate that H2O2 can affect pigmentation 
via epidermal POMC peptide redox homeostasis. 
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Experimental Study of Tetramethylpyrazine, Epigallocatechingallate and Ginsenoside Rb1 on 
Ultraviolet B Induced Melanogenesis and Cell Apoptosis of Melanocytes
Zhu JW, Su RJ, Jin SL and Luo D
Dept of Dermatology, The First Affi liated Hospital with Nanjing Medical University (China)
Some traditional Chinese medicine (TCM) are well known to inhibit melanin synthesis of hu-
man normal melanocytes in the skin, while ultraviolet irradiation can induce melanocyte pro-
liferation and melanogenesis, resulting in skin tanning. Here, we investigated in vitro the effect 
of tetramethylpyrazine, epigallocatechingallate and Ginsenoside Rb1, which were extracted 
from relevant TCM respectively, on melanogenesis of melanocytes induced by different dos-
ages of ultraviolet B. A routine culture system of melanocytes was established, cells were irradi-
ated with different dosages of ultraviolet B(30 and 90mJ/cm2 respectively), and then incubated 
with different concentrations of tetramethylpyrazine, epigallocatechingallate and Ginsenoside 
Rb1 for 12h, 24h, 48h and 72h. MTT method, NaOH assay, L-Dopa oxidization reaction and 
fl ow cytometry were employed to determine the cell proliferation, melanin synthesis, tyrosi-
nase activity and apoptosis rate of melanocytes. We found that 30mJ/cm2 ultraviolet B could 
induce the cell proliferation, melanin synthesis and tyrosinase activity of melanocytes, tetram-
ethylpyrazine and epigallocatechingallate could inhibit this effect dose-dependently, but they 
had no effect on cell apoptosis; 90mJ/cm2 ultraviolet B showed toxicity to melanocytes, as the 
cell proliferation, melanin synthesis, tyrosinase activity were all declined, and cell apoptosis 
rate was signifi cantly enhanced. However, all of etramethylpyrazine, epigallocatechingallate 
and Ginsenoside Rb1 could retrieve this effect also in a dose-dependent manner. So, it is con-
cluded that tetramethylpyrazine and epigallocatechingallate can not only inhibit the promoting 
effect on melanocytes induced by low-dosage ultraviolet B irradiation, but also retrieves the 
toxic effect induced by high-dosage ultraviolet B irradiation.
406 [010]
UV Irradiation Activation of EGFR that Drives Photoaging is Mediated by Oxidative Inhibition 
of Receptor Type Protein Tyrosine Phosphatase-Kappa in Human Skin
Xu Y, Shao Y, Voorhees J and Fisher G
Department of Dermatology, University of Michigan (USA)
Ultraviolet irradiation (UV) rapidly increases tyrosine phosphorylation (i.e. activates) of epider-
mal growth factor receptors (EGFR) in human skin. This activation drives signaling pathways 
that induce matrix-metalloproteinases, whose actions fragment extracellular matrix structural 
proteins, thereby leading to premature skin aging (photoaging). We have investigated the 
mechanism by which UV activates EGFR. Prevention of ligand-binding to EGFR, by specifi c 
blocking antibody, did not reduce UV-induced EGFR activation in human keratinocytes. In 
contrast, inhibition of protein tyrosine phosphatase (PTP) activity activated EGFR (5-fold, n=5), 
suggesting that UV may activate EGFR by inhibition of PTP activity. Human keratinocytes were 
found to express 13 of 21 known receptor type PTPs (RPTP). Expression screening, in EGFR-
negative CHO cells, was used to identify which of these RPTPs dephosphorylate EGFR. EGFR 
expressed alone displayed high basal tyrosine phosphorylation. This basal tyrosine phosphor-
ylation was substantially reduced (3.5-fold, n=3) by co-expression with RPTP-κ, but not other 
RPTPs. Exposure of cells to UV inhibited RPTP-κ activity (80%, n=3) and elevated EGFR tyro-
sine phosphorylation (3-fold, n=3). UV inhibition of RPTP-κ was due to oxidation of the active 
site cysteine, as revealed by Western analysis using antibody specifi c to the oxidized form. 
Recombinant RPTP-κ directly dephosphorylatd EGFR in vitro, and this activity was inhibited by 
reactive oxygen (hydrogen peroxide) (80% inhibition at 100μM). In keratinocytes, siRNA-medi-
ated knockdown of endogenous RPTP-κ elevated basal tyrosine phosphorylation (4-fold, n=3), 
and this high basal level was not further increased by UV. RPTP-κ directly dephosphorylates 
EGFR, counteracting EGFR phosphorylation. Oxidative inactivation of RPTP-κ activity by UV 
shifts the balance to favor EGFR activation. These data delineate a novel mechanism of EGFR 
regulation and identify RPTP-κ as a key molecular target for anti-oxidant protection against 
skin photoaging.
407 [012]
AKT Delays UVB-Induced Apoptosis via BAD Phosphorylation and its Subsequent Cytoplasmic 
Sequestration by 14-3-3ζ
Claerhout S1, Decraene D1, Van Laethem A2, Van Kelst S2, Agostinis P3 and Garmyn M1
1Laboratory of Dermatology, University of Leuven (Belgium)
2Div of Biochemistry, Univ of Leuven & Lab of Dermatology, University of Leuven (Belgium)
3Division of Biochemistry, University of Leuven (Belgium)
Upon irradiation with a high dose of UVB, keratinocytes undergo apoptosis as a protective mecha-
nism. Circumventing the apoptotic program is an acquired trait of many tumor cells. In previous 
work, we demonstrated the existence of an early-activated UVB-induced apoptotic pathway in 
growth factor depleted human keratinocytes, which can be substantially delayed by the exclusive 
supplementation of IGF-1. We now show that, in human keratinocytes, IGF-1 inhibits the onset of 
UVB-triggered apoptosis through a transcriptional independent, AKT-mediated mechanism, involv-
ing phosphorylation of BAD on serine 136. Our results show that the early UVB-induced apoptosis 
in growth factor depleted human keratinocytes is exclusively triggered through the mitochondrial 
pathway. It is accompanied by BAX translocation, cytochrome c release and procaspase-9 cleavage, 
but not by procaspase-8 or BID cleavage. In human keratinocytes, IGF-1 supplementation inhibits 
these events in a transcription-independent manner. In addition, we identifi ed the protein kinase re-
sponsible for the delay of UVB-induced apoptosis by IGF-1. Since IGF-1 is a potent activator of AKT, 
we investigated the direct involvement of AKT in this process using a membrane-targeted form of 
AKT (Ad.myrAKT-HA). We show that the effect of IGF-1 in the postponement of early UVB-induced 
apoptosis can be completely mimicked by transduction of keratinocytes with myristoylated AKT. 
Both IGF-1 supplementation and the transduction of a membrane-targeted form of AKT result in a 
shift of the BH3-only protein BAD from the mitochondria to the cytoplasm, paralleled by an increase 
of AKT-specifi c Serine136 phospho-BAD bound to 14-3-3ζ protein. These data indicate that AKT-
induced BAD phosphorylation and its subsequent cytoplasmic sequestration by 14-3-3ζ is a major 
mechanism responsible for the postponement of UVB-induced apoptosis in human keratinocytes.
408 [018]
A MC1R Transgenic MC1R Null Hairless Pigmented and Albino Model Indicates that 
Melanocortin 1 Receptor Genotype Affects In Vivo Responses to UVR through Pigmentary 
and Non-Pigmentary Mechanisms
Robinson S, Dixon S, Friedmann PS and Healy E
Dermatopharmacology, University of Southampton (United Kingdom)
Melanocortin 1 receptor (MC1R) gene variants are associated with red hair and fair skin. Case 
control studies have identifi ed an association between MC1R variants and melanoma and non-
melanoma skin cancer. One possibility is that MC1R variants increase skin cancer risk as a result of 
less photoprotection or greater phototoxicity by phaeomelanin. However, in the case control stud-
ies the skin cancer risk remains elevated after controlling for pigmentation phenotype, suggesting 
that MC1R variants may predispose to skin cancer through non-pigmentary mechanisms. Therefore, 
the exact role and relative importance of MC1R mediated pigmentary and non-pigmentary effects in 
vivo in skin responses to ultraviolet radiation (UVR) and skin cancer susceptibility is unclear.
We have developed a novel MC1R transgenic Mc1r null hairless pigmented and albino mouse line 
to investigate for the presence of and relative contribution of non-pigmentary MC1R effects and the 
role of phaeomelanin (in terms of photoprotection versus phototoxicity) in UVR responses in vivo. 
No signifi cant differences in cyclobutane pyrimidine dimer formation or repair following a single 
UVR exposure were detected in UV-naïve or UV-acclimatised skin between each of the four geno-
type phenotype groups (MC1R+Mc1r-/-pigmented, Mc1r-/-pigmented, MC1R+Mc1r-/-albino and 
Mc1r-/-albino). Conversely, following repetitive UVR exposure signifi cantly fewer epidermal p53 
clones were seen in the MC1R+Mc1r-/-albino than in the Mc1r-/-albino animals (p=0.0256), and 
in the Mc1r-/-pigmented than in the Mc1r-/-albino mice (p=0.0182). Similarly, fewer p53 clones 
were observed in the MC1R+Mc1r-/-pigmented than in the Mc1r-/-pigmented (p=0.0440) and 
MC1R+Mc1r-/-albino groups (p=0.0428). The results show that MC1R genotype infl uences UVR 
responses / skin cancer susceptibility through a combination of pigmentary and non-pigmentary 
mechanisms in vivo. In addition, they suggest that the melanin type (phaeomelanin) in MC1R vari-
ant individuals is photoprotective in vivo.
409 [020]
Serotonin: Systemic Mediator of PUVA-Induced Immune Suppression but not Infl ammation 
or Apoptosis
Wolf P1, Walterscheid JP2, Byrne S2, Nghiem DX2, Ananthaswamy HN2 and Ullrich SE2
1Research Unit for Photodermatology, Dept of Dermatology, Medical Univ Graz (Austria)
2Department of Immunology, The University of Texas MD Anderson Cancer Center (USA)
Psoralen+UVA (PUVA) has immunosuppressive, infl ammatory, and proapoptotic effects, possibly 
playing a role alone or in combination for its therapeutic effi cacy. However, the molecular events 
and mediators by which PUVA leads to its different effects are not well understood. Activation 
of the serotonin (5-hydroxytryptamine, 5-HT) pathway has been suggested to be involved in T 
cell communication, and, therefore, we hypothesized that 5-HT may play a role in PUVA-in-
duced immune suppression and/or other effects. In order to study the effect of PUVA on immune 
function, we used the model of systemic suppression of delayed-type hypersensitivity (DTH) to 
Candida albicans. Six to 8 wk old C3H/HeNCr mice were painted on the their shaved backs 
with 8-methoxypsoralen (100 ug/100 ul ethanol) 30 min before exposure to 50 kJ/m2 UVA (i.e. 
minimal infl ammatory PUVA dose, as determined by skin swelling measurements 48 h after 
exposure). At day 5, the mice were immunized by injecting 2 x 108 formalin-fi xed C. albicans 
into each fl ank, and at day 14 they were challenged by injecting 50 ul of Candida antigen into 
each hind footpad. Infl ammation was monitored by measuring the increase of skin thickness and 
examining microscopically H/E stained skin sections of exposed dorsal skin 48 h after PUVA 
treatment. Apoptosis was quantifi ed by counting sunburn cells in the interfollicular epidermis. 
PUVA exposure resulted in signifi cant immune suppression of up to 80%, infl ammation (i.e., skin 
swelling and mononuclear infi ltration of the dermis as well as subcutaneous fat), and apoptosis of 
epidermal cells. The i.p. injection of the 5-HT2 receptor antagonists ketanserin or cyproheptadine 
(500 nmol each per mouse) or an anti-5-HT antibody (100 ug per mouse) immediately before 
PUVA exposure totally abrogated immune suppression but it had no signifi cant effect on infl am-
mation or apoptosis. Importantly, the i.p. injection of 5-HT (50 to 500 nmol per mouse) led to 
immune suppression in the DTH model in a manner similar to PUVA exposure but 5-HT did not 
induce infl ammation or apoptosis in the skin. Taken together, these results suggest that systemic 
5-HT signaling is crucial for PUVA-induced immune suppression but not for infl ammation or 
apoptosis in situ. 5-HT blockade does specifi cally block PUVA-induced immune suppression, 
which may offer the opportunity to dissect the benefi cial (i.e. therapeutic) from the detrimental 
(i.e. tumorigenic) effects of this clinically highly effective treatment modality.
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410 [035]
The Transcription Factor Nrf2 Controls the Shared Gene Regulation by UVA-1 and UVA-1 
Oxidized Phospholipids
Gruber F1, Mayer H2, Bilban M3, Lengauer B1, Muzik EM3, de Martin R2, Wagner O3,
Leitinger N4 and Tschachler E1
1Department of Dermatology, Medical University of Vienna (Austria)
2Department of Vascular Biology, Medical University of Vienna (Austria)
3KIMCL, Medical University of Vienna (Austria)
4CVRC, University of Virginia Charlottesville (USA)
We have previously shown that the common membrane phospholipid 1-palmitoyl-2-arachido-
noyl-sn-glycero-3-phosphorylcholine (PAPC) is prone to UVA-1 oxidation. One or more of the 
oxidation products can mediate expression of the UVA-1 stress-response gene heme oxygen-
ase-1 in skin fi broblasts and can thus act as mediators of UVA-1 induced gene expression. We 
thus hypothesized that UVA-1 mediated phospholipid oxidation could be responsible for the 
transcriptional regulation of other UVA-1 regulated response genes.
To test this hypothesis, we carried out a comparative microarray chip expression analysis of 
dermal fi broblasts that were either untreated, UVA-1 irradiated or treated with oxidized phos-
pholipids. As much as 10% of the genes that are regulated 4h after UVA-1 treatment are co-
regulated in the cells treated with oxidized phospholipids. Among these co-regulated genes 
are, besides HO-1, also other genes that are regarded as antioxidant response mediators but 
also cytokines. Bioinformatic analysis revealed that many of the known genes contain an anti-
oxidant response element (ARE) in their promoter and are thus prone to regulation with the 
redox sensitive transcription factor Nrf-2. SiRNA mediated knockdown of this transcription 
factor left most of the co-regulated genes less responsive to oxidized PAPC or UVA-1, while 
the genes exclusively regulated by UVA-1 still responded to the stimulus. Our data thus suggest 
that a substantial part of transcriptional regulation upon UVA-1 treatment can be mediated 
by phospholipid oxidation and that the redox sensitive transcription factor Nrf2 is involved 
in this process.
411 [036]
Real-time PCR Analysis of a 3895 bp Mitochondrial DNA Deletion in Non Melanoma Skin 
Cancer and its use as a Quantitative Marker for Sunlight Exposure in Human Skin
Birch-Machin M1 and Harbottle A2
1Department of Dermatology, University of Newcastle, (United Kingdom)
2Genesis Genomics UK, University of Newcastle, (United Kingdom)
Our previous fi ndings have shown that the frequency of occurrence (i.e the simple presence 
or absence) of the 3895 bp mitochondrial DNA deletion is increased with increasing sun-ex-
posure. The present study has signifi cantly extended this work by developing, validating and 
then using a quantitative real time PCR assay to investigate for the fi rst time the actual level (as 
opposed to the frequency of occurrence) of the 3895 bp deletion in human skin from different 
sun-exposed body sites and tumours from non-melanoma skin cancer patients. We investi-
gated the 3895bp deletion in 104 age-matched split human skin samples taken from various 
sun-exposed sites defi ned as usually exposed (n=60) and occasionally exposed (n=44) when 
outdoors. The results clearly show an increased level of the 3895 bp deletion with increasing 
sun-exposure. Specifi cally, there was a signifi cantly higher level of the deletion in the usually 
sun-exposed compared to the occasionally sun-exposed skin (p= 0.0009 for dermis, p=0.008 
for epidermis; two-tailed t test). Our study has also extended previous fi ndings by showing that 
the level of the 3895 bp deletion is signifi cantly higher in the dermis compared with the epider-
mis both in the occasionally sun-exposed samples (p=0.0143) and in the usually sun-exposed 
skin. (p=0.0007). A reliable real time PCR assay for the 3895 bp deletion will provide a means 
of comparing the relative amounts of the 3895 bp and the 4977 bp common mtDNA deletion 
within the same skin sample and help to provide some clues as to the aetiology of the 2 types 
of mtDNA damage in relation to sun exposure. 
412 [037]
In Vitro and In Vivo Evidence for Senescence-Associated Mutations of Mitochondrial (MT) 
DNA as an Early Event in Transformation from Nevi to Malignant Melanoma
Schuller W1, Kamenisch Y1, Wenz J1, Metzler G1, Bauer J1, Neubauer H2, Garbe C1, Röcken M1 
and Berneburg M1
1Department of Dermatology, Eberhard Karls University, Tuebingen, Germany (Germany)
2Department of Gynecology, Eberhard Karls University, Tuebingen, Germany (Germany)
It has recently been reported that senescence-associated growth control represents an impor-
tant protection from tumors including malignant melanoma. We and others have previously 
shown that aging-associated mutations of mtDNA can be induced by ultraviolet (UV)-A-radia-
tion in vitro and in vivo and that these mutations persist or even increase in resting cells while 
they disappear in proliferating cells. However, the question whether UV-A-induced mtDNA 
mutations play a role in the pathogenesis of malignant melanoma has not been addressed. In 
the present study, we could show in vitro by real time PCR that, compared to normal melano-
cytes, melanoma cells are highly susceptible to generation of mtDNA mutations by low dose 
repetitive UV-A-irradiation. These mutations are functionally relevant since they are associated 
with a decrease of mitochondrial oxygen consumption (clark type electrode), mitochondrial 
membrane potential (FACS measured JC-1 fl uorescence) as well as upregulation of matrix met-
alloproteinase (MMP)-1 (real time RT-PCR). Expression of senescence marker ß-galactosidase 
was increased in oxidatively stressed cells, indicating an association of mtDNA mutations with 
senescence. In vivo in laser capture microdissected samples from normal human nevi we de-
tected background levels of mtDNA mutations. However, in samples from nevi showing clini-
cal and histological signs of dysplasia, these mutations were increased 2.5 fold. Interestingly, in 
malignant melanoma, initially high mutation levels later decreased from small to large tumor 
thickness (range 0.25 to 25.0 mm). In addition to known mutations, an unreported mtDNA 
deletion of 4866bp in length was detected (real time PCR, sequence analysis) in tumor samples 
and UV-A-irradiated melanoma cells. These results indicate high susceptibility of melanoma 
cells to the induction of functionally relevant UV-A-mediated mtDNA mutations and this loss 
of senescence associated growth-control may represent an early event in the malignant trans-
formation from inert nevi to proliferative and invasive malignant melanoma.
413 [038]
A Single Sub-erythematous Exposure of Solar-Simulated Radiation on the Elicitation Phase of 
Contact Hypersensitivity Induces IL-10-Producing T Regulatory Cells in Human Skin
Stoebner PE1, Rhamoun M2, Ferrand C3, Meunier L1, Yssel H2 and Pène J2
1CNRS UMR 5810, University of Montpellier (France)
2Inserm U 454, University of Montpellier (France)
3Inserm U 645, University of Besançon (France)
Solar ultraviolet radiation has hazardous effects on human health that, as shown in experimen-
tal animal models are, in part, associated to its immunosuppressive effects via the induction of 
IL-10 production. The objective of our study was to characterize the cytokine production pro-
fi le of human T cell subpopulations that infi ltrate allergic contact dermatitis (ACD) reactions, 
following the application of a single sub-erythematous solar radiation (SSR) prior to antigen 
challenge. Expression of cell surface molecules and cytokine production profi les of cloned 
populations of T cells, generated from single SSR-treated and non-treated biopsies taken from 8 
patients, 48 hours following nickel challenge and propagated for 14 days in the presence of IL-
2, was analyzed by immunofl uorescence and ELISA, respectively. Nickel specifi city of the cells 
was established by analysis of the public T cell receptor Vbeta (TCRVb) repertoire using Im-
munoscope technology. T cells isolated from non-treated ACD reactions were mainly CD4+ and 
produced IL-10, but little IFN-gamma. A single SSR exposure resulted in a clinical attenuation 
of the intensity of ACD reactions which was associated with a signifi cant increase in both the 
magnitude of IL-10 production by skin-infi ltrating T cells, and the frequency of IL-10-producing 
T regulatory type 1 (Tr1) cells. Skin-infi ltrating T cells in both SSR-exposed and non-exposed 
ACD reactions showed a perturbed TCR Vb repertoire, without overexpression of a particular 
TCR Vb gene product, indicating the presence of high frequencies of nickel non-specifi c T cells 
in ACD reactions. These results indicate that cutaneous IL-10-producing Tr1 cells and to a lesser 
extent, Th2 cells are implicated in the SSR-induced inhibition of ACD reaction. 
414 [039]
Ultraviolet A Radiation in Normal Human Keratinocytes Inhibits Gap-Junctional 
Communication by Cx43 Phosphorylation and Degradation
Bellei B, Mastrofrancesco A, Aspite N, Briganti S and Picardo M
San Gallicano Dermatological Institute (Italy)
Cell-cell communication via gap-junction occurs in the epidermal and dermal compartments 
of normal differentiated human skin and appears to participate in epidermal homeostasis. Re-
cent studies have suggested that tumor promotion is associated with reversible inhibition of 
gap junction coupling while tumor progression occurs with stable down-regulation of gap 
junction intercellular communication (GJIC). Regulation of cell-cell comunication by the gap 
junction protein connexin43, can be modulated in response to various stimuli, including UV 
light, ionizing radiation, hydrogen peroxide and heat stress. We studied the mechanism by 
which UVA radiation transiently disrupts GJIC and adhesion propriety in human keratinocytes. 
In keratinocytes irradiated with a dose of 10J/cm2 after 30 minutes, the cell-cell communication 
was reduced to 47% compared to untreated cells, to 42% after 12h and partially recovered to 
70% 24h post-irradiation. Immediately after UVA treatment, phosphorylation of Cx43 appear 
implicated in the regulation of GJIC but following a period of 12h, connexin43 protein level at 
the membrane had decreased, suggesting that degradation of Cx43 is, at this time, the major 
mechanism associated with GJIC down-regulation. Increased phosphorylation of Cx43 seems 
to be related to the activation of mitogen-activated protein (MAP) kinase that occured in kerati-
nocytes immediately after irradiation. In fact, the observed changes in Cx43 phosphorylation 
were specifi c to residues S279 and S282, two residues which are targets of MAPK. Our results 
suggest that at least two mechanisms contribute to the observed fall in GJIC: immediately 
after damage, Cx43 phosphorylation determines a closure of the channel and later connexin 
phosphorylation stimulates gap junction disassembly and degradation. By measuring reactive 
oxygen species (ROS) generation, membrane damage and the expression of adhesion proteins 
we observed more extensive cell damage that persisted several hours after UVA tratment. The 
expression of important adhesion proteins such as β-catenin and E-cadherin were strongly 
reduced 12h after irradiation. 
415 [040]
Nitric Oxide Limits UV Induced Apoptosis and p53 Expression in Human Skin
Tan X1, Mowbray M1, Imko B1, Wheatley P2, Morris R2 and Weller R1
1Department of Dermatology, University of Edinburgh (United Kingdom)
2Department of Chemistry, University of St Andrews (United Kingdom)
Nitric oxide (NO) is synthesised in skin by NO synthases and reduction of sweat nitrate. It is 
stored as protein bound nitrosospecies. Both synthesis and release follow UV irradiation. NO 
can be both pro and anti-infl ammatory and apoptotic. In murine skin we have demonstrated 
that its release following UV irradiation limits keratinocyte apoptosis. Using Zeolite-NO as a 
pure NO donor, we have measured whether NO is similarly anti-apoptotic in human skin.
6 healthy volunteers where irradiated with 2 MEDs of UVB radiation on the volar forearm. Ir-
radiated and unirradiated skin was treated with vehicle control, or with 33%w/v Zeolite NO for 
2 hours before irradiation, and 6 hourly after irradiation. 24 hours after irradiation, 4 mm punch 
biopsies were taken from treated sites. Half of each sample was formalin fi xed for immunohis-
tochemistry, and half stored for quantifi cation of nitrosospecies by chemiluminescence.
Treatment of skin with Zeolite-NO increased bound nitrosospecies from 1.4 +/- 0.8 to 2.7 +/- 
0.6 e-5 mM NO/mg protein. UV induced p53 expression was signifi cantly (p<.01) reduced by 
Zeolite-NO treatment (% p53 positive cells in epidermis: unirradiated, 0; NO, 1.6 +/- 1.4; UV, 
11.5 +/- 2; UV + NO, 2.7 +/- 1.2). UV induced apoptosis, measured by Caspase 3 positive epi-
dermal cells was reduced by Zeolite-NO treatment (unirradiated, 0.6 +/-0.6; NO, 0.7 +/- 0.3; 
UV, 5.3 +/- 1.5; UV + NO, 3.2 +/- 0.6).
Nitric oxide is anti-apoptotic in the human epidermis, and suppresses p53 expression. These 
anti-apoptotic effects may be mediated by scavenging of free radicals, or by direct inhibitory 
effects on caspase activity. Autologously released NO probably serves to limit UV induced 
apoptosis in the human epidermis. 
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416
Applicability of Confocal Microscopy in the Diagnosis of Actinic Keratoses In Vivo
Astner S1, Ulrich M1, Maltusch A1, Rius-Díaz F2, Röwert J1, González S3 and Stockfl eth E1
1Charité University Medicine, Department of Dermatology, Berlin (Germany)
2Department of Medical Statistics, University of Malaga, Spain (Germany)
3Dermatology Service, Memorial Sloan Kettering Cancer Center, New York (USA)
In vivo refl ectance confocal microscopy (RCM) has been used for real-time evaluation of the 
histopathological features of non-melanoma skin cancer. Most authors have reported the appli-
cation of RCM for the non-invasive diagnosis of Basal Cell Carcinoma, however the evaluation 
of Actinic keratoses (AK) has only been the subject of preliminary studies. The goal of this inves-
tigation was to determine the clinical applicability of confocal microscopy in the diagnosis of 
AK, and the optimization of evaluation parameters in correlation with routine histology. 
44 Caucasian subjects (SPT I-III) with a history of extensive actinic damage participated in 
this study. Evaluation inclueded clinical assessment, refl ectance confocal microscopy (RCM) 
and routine histology and a total of 46 AK lesions were included in the fi nal analysis. Ten skin 
sites of healthy, age-matched volunteers were used as controls. RCM evaluation parameters in-
cluded stratum corneum disruption, parakeratosis, architectural disarray and keratinocyte pleo-
morphism/cellular atypia of the spinous, granular and basal layer. Following blinded evaluation 
by two experts in the fi eld, sensitivity and specifi city of individual parameters were determined 
in reference to routine histology and inter-observer concordance was determined. Logistic re-
gression analysis was performed on all signifi cant variables; p-values were determined using 
Chi-square.
Overall, there was high specifi city for RCM features, ranging from 95-100%. Sensitivity of 
individual parameters ranged from 81 % - 99 %. Following logistic regression analysis, the 
presence of stratum corneum disruption and cellular pleomorphism at the level of the spinous 
and granular layer were highly sensitive for diagnosing AK, while theire absence correlated 
well with normal skin. Interobserver concordance for selected paramters was high and a diag-
nostic algorithm may allow the non-invasive detection of AK such that RCM may be a feasable 
alternative to routine histology. 
417
Effect of Ultraviolet Radiation on Murine Chronic Sclerodermatous Graft-versus-Host Disease
Mermet I1, Kleinclauss F2, Marandin A3, Angonin R4, Guerrini JS5, Saas Ph6, Tiberghien P6 and 
Aubin F1
1Dept of Dermatology, University of Besançon, IFR 133 (France)
2Dept of Urology, University of Besançon, IFR 133 (France)
3Inserm U645/EA 2284, Etablissement Français du Sang Bourgogne Franche Comté (France)
4Dept of Pathology, General Hospital, Bourg en Bresse (France)
5Dept of Cell Biology, EA3181 (France)
6Inserm U645/EA 2284, Etablissement Français du Sang Bourgogne Franche Comté, (France)
Effect of ultraviolet radiation on murine chronic sclerodermatous graft-versus-host disease. 
Although graft-versus-host disease (GVHD) is a source of morbidity and mortality in allogeneic 
stem cell transplantation, its mechanisms remain unclear. Previous studies have demonstrated 
the effi cient modulatory effect of ultraviolet radiation, but only the acute form of GVHD has 
been investigated. In our study, we studied the effect of ultraviolet (UV) on the occurrence of 
chronic sclerodermatous (Scl) GVHD in a murine model. Scl GVHD was induced by trans-
planting lethally irradiated BALB/c mice with B10.D2 bone marrow and spleen cells. Donor 
animals, or donor bone marrow and/or spleen cells prior to injection, or recipient animals were 
exposed to UVB radiation or to psoralen plus UVA radiation (PUVA). Histological and clinical 
evaluation of GVHD were performed at day 50 post-BMT, in association with the characteri-
zation of epidermal Langerhans cells (anti-Iad). Scl GvHD was associated with an increase in 
the number of epidermal LC. UVB irradiation of recipients after, or more remarkably, before 
transplantation induced a decrease of Scl GVHD severity with a depletion of host epidermal 
LC. Addition of ex vivo treated (by UVB or PUVA) donor spleen cells also reduced the severity 
of Scl GVHD, but without decreasing the number of recipient epidermal LC. Our results dem-
onstrate that extracorporeal phototherapy of donor cells or corporeal exposure of hosts to UVB 
may provide a means of decreasing debilitated chronic Scl GvHD. The fact that the benefi cial 
effect of phototherapy was not always associated with a decrease in the number of epidermal 
LC suggests that different immunoregulatory mechanisms are involved.
418
Differential Regulation of Hyaluronan Metabolism in the Epidermal and Dermal Compartments 
of Human Skin by UVB Irradiation
Averbeck M1, Gebhardt C1, Voigt S1, Beilharz S1, Anderegg U1, Termeer C1, Sleeman JP2 and 
Simon JC1
1Department of Dermatology, Leipzig University (Germany)
2Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe (Germany)
Hyaluronan, a major component of the cutaneous extracellular-matrix, is involved in tissue re-
pair processes. Human skin is exposed to and damaged by ultraviolet-B (UVB) irradiation. This 
study therefore aimed to investigate the regulation of hyaluronan-metabolism in human skin 
during acute UVB-induced infl ammation. Expression of the three hyaluronan synthesizing en-
zymes - and the three hyaluronan degrading enzymes - was evaluated by qRT-PCR. Expression 
patterns of these genes in response to UVB differed when fi broblasts and HaCat-keratinocytes, 
representative of the major cell types in dermis and epidermis, respectively, were compared. 
Both showed temporally different expression patterns of these genes 3h and 24h post irradia-
tion. This resulted 24h post-irradiation in an increase in HAS gene expression in both fi brob-
lasts and HaCat-keratinocytes, and an increase in HYAL expression only in fi broblasts. This was 
refl ected in human skin 24h post-UVB-irradiation, where an increased expression of HAS and 
HYAL was observed. Hyaluronan production as analyzed by the HA content of conditioned 
medium was reduced in HaCat and fi broblast cultures 3h post-irradiation, while HA increased 
in HaCaT cultures 24h post-irradiation but remained suppressed in fi broblasts. Consistently, 
immunohistochemical staining for hyaluronan in human skin 24h post-irradiation showed in-
creased epidermal hyaluronan, but a decrease in the dermal compartment. Moreover, analysis 
of the HA content of dermal microdialysis fl uid revealed increased accumulation of hyaluronan 
degradation products 24h post-irradiation. These data demonstrate that there is a complex tem-
poral and spatial regulation of HA metabolism in skin in response to UVB irradiation, resulting 
in increased HA synthesis and turnover during regeneration processes.
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Evaluating the Benefi ts of Adding Antioxidants to a Sunscreen Formulation: Effects on Immune 
Protection versus Prevention Of Photoaging
Baron E1, Haneman K2, Miller J2, Scull H2, Matsui M3, Maes D3, Hsia A2 and Cooper K2
1Department of Dermatology, Case Western Reserve University (USA)
2Dermatology, Case Western Reserve University (USA)
3Estee Lauder Research (USA)
Immune suppression and photoaging are detrimental effects of ultraviolet (UV) irradiation. 
UV-induced depletion of CD1a+ epidermal Langerhans cells is one of the steps that result in 
cutaneous immune suppression. MMP1 is the major enzyme implicated in collagen damage 
and photoaging of human skin. This double-blind randomized controlled study was performed 
to evaluate the protective role of sunscreen versus sunscreen plus antioxidants on UV-induced 
CD1a depletion and activation of MMP1. A total of 10 healthy volunteers were included. 
Skin punch biopsies were obtained from simulated solar radiation (SSR) exposed skin treated 
with either a sun protection factor (SPF) 10 sunscreen, or the same sunscreen but with added 
antioxidants. Normal skin and unprotected UV exposed skin were also sampled as controls. 
Individual minimum erythema doses (MEDs) and SPF values were accounted for in delivering 
0.75 MED of SSR for the CD1a study (n=5) and 2 MED of SSR for the MMP1 study (n=5). Im-
munohistochemical staining according to manufacturer’s instructions was performed and the 
percentage of positively (brown)-stained areas in the epidermis (for CD1a) and both epidermis 
and dermis (for MMP1) were calculated using Image-Pro Plus (Media Cybernetics, San Diego, 
CA). Data were compared between control and UV-irradiated skin, as well as product-treated 
skin samples using Student’s t-test. A p-value of <0.05 was considered signifi cant. Both prod-
ucts showed a trend towards preventing UV-induced CD1a depletion, although statistically sig-
nifi cant values were not attained. Addition of antioxidants did not signifi cantly result in greater 
preservation of Langerhans cells. Both products also reduced MMP1 expression relative to un-
protected UV-irradiated controls. Addition of antioxidants resulted in greater protection com-
pared to sunscreen alone. Sunscreen alone decreased the amount of MMP1 per area by a factor 
of 1.75, whereas sunscreen plus antioxidants diminished MMP1 production by a factor of 2.45 
(p=0.05). This study demonstrates that antioxidants and sunscreen can work synergistically 
in vivo. Efforts to improve photoprotection strategies should take into account these results.
420
Inhibition of p16INK4A by shRNA in UVB-Induced Cell Cycle Arrest and DNA Repair
Liboutet M1, Chapelier B1, Michel L2, Douky T3, Lalou C1, Fasseu M4, Khatib AM1 and
Basset-Seguin N1
1Inserm U716, Hôpital Saint-Louis, Paris (France)
2Inserm U696, Hôpital Saint-Louis, Paris (France)
3CEA, Grenoble (France)
4IFR105, Hôpital Saint-Louis, Paris (France)
 
The p16INK4A protein participates in the UVB response in human keratinocyte and HeLa cells 
through G2 arrest. In addition, p16-/- murine fi broblasts were recently reported to be defi cient 
in DNA repair processes following irradiation. To further analyse the role of p16INK4A in UVB 
response during cell cycle and DNA repair events in human cells, we used HeLa cells and 
short hairpin RNA system against p16INK4A.. Using QT-PCR and Western blot analysis we found 
that the maximal inhibition of p16INK4A by shRNA in control and irradiated cells was maximal 
(up to 70%) at 72 h and maintained up to 96 h. Accordingly, inhibition of 16INK4A pathway was 
confi rmed by the hyperphosphorylation of Rb protein. Analysis of the irradiated cells in the 
presence of the specifi c shRNA revealed that the G2/M arrest and photoproduct elimination 
(HPLC quantifi cation) were not affected. These results show that p16INK4A participates but is 
not essential for G2/M arrest and DNA repair following DNA damage suggesting that other 
cell cycle regulators may overcome the inhibition of p16INK4A pathway to protect UVB-induced 
DNA cell damage. 
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No Discernible Pattern of Mitochondrial (mt) DNA Deletions in Basal and Squamous Cell 
Carcinoma Samples Isolated by Laser Capture Microdissection
Kamenisch Y1, Wenz J1, Metzler G1, Bauer J1, Neubauer H2, Garbe C1, Roecken M1 and 
Berneburg M2
1Department of Dermatology, Eberhard Karls University, Tuebingen, (Germany)
2Department of Gynecology, Eberhard Karls University, Tuebingen, (Germany)
Mutations of mitochondrial DNA have been shown to be increased in a number of tumors 
including breast cancer, prostate cancer, colon carcinoma, as well as head and neck cancer. 
We have previously shown that mtDNA mutations are increased in chronically ultraviolet ra-
diation (UV)-exposed skin. Therefore, we employed an established real time PCR technique 
to investigate whether mtDNA deletions are increased in histological samples from patients 
with basal (BCC) and squamous cell carcinoma (SCC) as compared to adjacent non-tumor 
but chronically UV-exposed skin of the same individual. Tumor and non-tumor samples were 
confi rmed by an independent pathologist, hematoxylin eosin stained and then laser capture 
microdissected with a PixCell® IIe Laser Capture Microdissection (LCM2105) System device 
to avoid non-tumor contamination. Subsequently, DNA extraction and real time PCR for the 
4977bp common deletion, considered to be a marker for mtDNA deletions, was carried out in 
24 BCC and 22 SCC. Of these samples 19 showed a decrease, 5 an increase for BCC as well 
as 18 with a decrease and 4 with an increase for SCC with maximum and minimum 2-delta delta 
ct values. These values ranged from 0.013 to 7.396 for BCC and from 0.006 to 6.964 for SCC, 
respectively, where values below one indicate a decrease and values above one an increase 
compared to control samples. Furthermore there was no infl uence of age and gender of the 
investigated patients. Thus, these fi ndings indicate that there is no discernible pattern of large 
mtDNA deletions in basal and squamous cell carcinoma.
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Physiologic Antioxidants Counteract Cell Senescence in PUVA-Treated Fibroblasts: Role of 
Oxidative Stress and Cell Antioxidant Defence
Briganti S1, Hinrichs C2, Wlaschek M2, Bellei B1, Camera E1, Flori E1, Picardo M1 and
Scharffetter-Kochanek K2
1San Gallicano Dermatological Institute, Rome (Italy)
2Department of Dermatology and Allergic Diseases, Ulm University, (Germany)
Exposure of human fi broblasts to 8-methoxypsoralen (8-MOP) plus UVA (PUVA) was found 
to induce growth arrest with morphological and functional changes mimicking cellular se-
nescence. Considering that 8-MOP can act as a strong photosensitizer, we studied the role of 
the intrinsic antioxidant defence system in this model. Senescence-associated changes were 
evaluated without and with the supplementation with the three physiological antioxidants α-
tocopherol (α-Toc), NAC and α-lipoic acid (α-LA). After PUVA treatment, we found an immedi-
ate and progressive generation of intracellular ROS . Photoactivated fi broblasts grown in the 
presence of NAC, α-LA or α-Toc are rescued from PUVA-induced ROS production and typical 
features of cellular senescence, such as cytoplasmic enlargement, increased activity of se-
nescence-associated-β-galactosidase and expression of MMP-1, but no signifi cant modulation 
of the long-term growth arrest was observed. PUVA photoactivation reduced the percentage 
of polyunsaturated fatty acids of membrane phospholipids and determined a time-dependent 
formation of lipid peroxidation end-products, which were reduced in the presence of antioxi-
dants. The cellular antioxidant system showed reduced antioxidative defence in regard to the 
content of GSH and activity of H2O2-detoxifying enzymes, catalase and GSH-Px, whereas a 
relevant induction of Mn-SOD and Cu/Zn-SOD activity was observed. NAC, α-LA and α-Toc 
counteracted these changes and improved the effectiveness of the cellular antioxidant network. 
Photoactivated fi broblasts showed a strong expression of p53 which is signifi cantly reduced 
by α-LA and α-Toc, suggesting a correlation between ROS accumulation and the cell cycle 
block in our model. Our data gives evidence that oxidative stress and the cellular antioxidant 
capacity is causally involved in both the induction and maintenance of the PUVA-induced 
premature senescence phenotype and that physiologic antioxidants can effectively counteract 
this phenomenon. The use of antioxidants may therefore qualify to counteract side effects in 
PUVA-therapy.
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Penetration of Sunscreen Agents Monitored In Vivo by Confocal Raman Spectroscopy
Caspers PJ1, van der Pol A2 and de Sterke J2
1River Diagnostics, Rotterdam; Dept of General Surgery / CODT, Erasmus MC (Netherlands)
2River Diagnostics (Netherlands)
The use of sunscreens is widely promoted as a method to protect the skin from the hazardous 
effects of solar UV radiation, including photo ageing and skin cancer. Sunscreen formulations 
are generally designed to quickly absorb in the stratum corneum (SC) and render it an effective 
UV-A and UV-B blocking fi lter starting shortly after application. However, little is known about 
the in vivo dynamics of sunscreen penetration in the SC. 
The uptake of a widely used UVA absorber, Parsol 1789 (butyl methoxydibenzoylmethane), in 
the stratum corneum was monitored in vivo and in real-time using confocal Raman microspec-
troscopy. Measurements were made using a commercially available Raman skin composition 
analyzer, allowing rapid data acquisition. The high sensitivity and spatial resolution of the 
instrument enabled precise determination of the depth distribution of components within the 
SC as a function of time. Commercial sunscreens were used that contained Parsol 1789. About 
2 mg/cm2 of product was applied on the lower forearm of 3 healthy volunteers between 25 and 
40 years of age. Raman spectra were recorded as a function of depth below the skin surface, 
starting directly after application. The measurements were repeated at recorded time intervals, 
revealing the kinetics of the penetration process. From the Raman spectra the signal of the sun-
screen agents was identifi ed, from which relative concentration profi les (ratio of Parasol 1789 
to keratin) were determined as a function of depth and time. 
Parsol 1789 was found to penetrate very easily into the SC. The agent could be detected deep 
in the SC within minutes after application. To date Raman spectroscopy is unique in its ability 
to monitor these processes in vivo and may help to better understand the protective action of 
sunscreens.
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Artemia Extract Aids in the Restoration of Hsp70 in ATRA-Treated Cells and also Down-
Regulates ATRA-Induced IL-1 after UV Exposure
Bauza E, Cucumel K, Dal Farra C and Domloge N
Vincience Research Center (France)
Heat shock proteins play a central role in the defense mechanisms of organisms from different 
kinds of stress. In the focus of skin protection from UV stress, Hsp70 is of particular importance. 
It is known that retinoids induces a post-transcriptional decrease of constitutive Hsp70 level in 
long-term treatments, and that ATRA-treated skin is particularly susceptible to damage caused 
by UV stress. Our prior studies have shown that Artemia extract (AE) induces Hsp70 in human 
cells and enhances cell protection from UV stress. Consequently, we were interested in observ-
ing the effects of AE on skin undergoing long-term ATRA treatment. We performed immunob-
lotting and ELISA studies on ATRA-treated cells, exposed or not to UV stress. An Hsp70 level 
lower than the control level was observed in cells treated with ATRA 10-7M for 3 to 7 weeks. 
Interestingly, ATRA-treated cells treated with AE exhibited a signifi cantly restored Hsp70 level 
which approached the control constitutive level. To complement the immunoblotting and ELI-
SA studies, IL-1 beta assessments were performed on ATRA-treated human fi broblasts. Fibrob-
lasts were treated with ATRA 10-7M for up to 2 months, and irradiated with 100 mJ/cm2 of UVB. 
The Mann-Whitney test was used to statistically analyze the results and evaluations were made 
at different time points of the study. The results revealed that ATRA-treated cells irradiated with 
UVB exhibited a higher level of IL-1 than control cells (+22.35% increase of AUC over control). 
Interestingly, UV-induced IL-1 signifi cantly decreased in ATRA-treated cells treated with AE 
(AUC -44%). Indeed, Il-1 level in these cells was lower than that of UV control cells. 
These fi ndings suggest that, especially in regard to UV stress, Artemia extract can be of great use 
in treatments aimed at increasing comfort during long-term retinoid therapy.
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A Study of the Protective Effect of a New Dimer Peptide Against UV Oxidative Stress
Plantivaux A, Bauza E, Dal Farra C and Domloge N
Vincience Research Center (France)
UV oxidative stress is a central concern in the fi eld of dermatological research. This stress is 
characterized by free radical formation that damages proteins and causes cross-linking, carbo-
nyl formation, and protein denaturation. Both enzymatic and non-enzymatic antioxidants play 
a role in protecting the skin from oxidative stress. SOD, catalase, glutathion reductase, and 
peroxydase serve as protective enzymatic antioxidant mechanisms in the cell. In addition to 
the important role that catalase plays in protecting the skin from UV-oxidative stress, it is also 
centrally involved in skin aging. Being interested in these properties, we decided to investigat-
ing the effect of a new 1% dimer peptide against UVB and UVA-induced oxidative stress. First, 
we studied the expression of SOD and catalase in peptide-treated cultured human fi broblasts 
after UV irradiation. To supplement these studies, we also evaluated the outcome of peptide ap-
plication on protein carbonylation, DNA damage, and cell viability. SOD gel studies revealed 
that application of the 1% dimer peptide, for 24 h, enhanced SOD expression in UV-stressed 
cells, compared to the controls. In catalase assays, a higher degree of catalase activity was seen 
in UV-exposed cells that were treated with the dimer-peptide, thus corroborating the fi ndings 
of the SOD studies. Moreover, mRNA studies revealed an increase in catalase mRNA level in 
dimer peptide-treated cells. The protective effect of the dimer peptide was confi rmed by protein 
carbonylation studies, which showed a signifi cant decrease in protein carbonylation in dimer 
peptide-treated cells. In addition, a signifi cant decrease in DNA damage was observed in dimer 
peptide-treated cells evaluated in comet assay studies.
These studies demonstrate that, due to the protective effect that it provides against UV-induced 
oxidative stress, the dimer peptide can be of great use in skin care and anti-aging products.
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Topical Nicotinamide (Vitamin B3) Prevents Ultraviolet Radiation-Induced Suppression of 
Mantoux Reactions in Humans
Damian DL, Patterson CR, Yiasemides E, Barnetson RS, Stapelberg M and Halliday GM
Department of Dermatology, University of Sydney (Australia)
Immunosuppression induced by ultraviolet (UV) radiation augments cutaneous carcinogenesis. 
The incidence of skin cancer continues to rise despite increased use of sunscreens, which are 
less effective at preventing immunosuppression than sunburn. Using the Mantoux reaction as 
a model of skin immunity, we tested the ability of topical nicotinamide to protect from solar-
simulated (ss)UV-induced immunosuppression. Twenty healthy, Mantoux-positive volunteers 
(10 men and 10 women) were UV-irradiated on their backs daily for 3 consecutive days, with 
5% nicotinamide or vehicle applied to different sites in a randomised, double-blinded manner 
immediately after each irradiation. Subsequent Mantoux testing (with intradermal tuberculin 
purifi ed protein derivative) at irradiated and adjacent unirradiated sites enabled measure-
ment of UV-induced immunosuppression with and without nicotinamide. Suberythemal ssUV 
caused signifi cant immunosuppression, which was prevented by topical 5% nicotinamide. We 
found that men were immunosuppressed by ssUV doses three times lower than those required 
to immunosuppress women. This gender difference in skin immunity may be an important 
cause of the higher skin cancer incidence and mortality observed in men. In a further group of 
Mantoux-positive volunteers, a range of nicotinamide concentrations (5, 2, 1 and 0.2%) was 
tested, and all concentrations were found to prevent UV-induced immunosuppression. Gene 
chip microarrays were also performed to help elucidate the mechanisms of nicotinamide’s pro-
tective effects. We found a number of genes that were differentially regulated in vehicle-treated 
versus nicotinamide-treated irradiated skin, suggesting alterations in phospholipid metabolism 
and apoptosis as possible mechanisms of nicotinamide’s action. We conclude that nicotina-
mide is a safe and inexpensive compound which could be added to sunscreens or used as after 
sun care to improve protection from immunosuppression and skin cancer. 
427
The Infl uence of Light Fractionation on the Response of Superfi cial Skin Cancer to 
Aminolevulinic-Acid Photodynamic Therapy
de Haas ER1, Sterenborg HJ2, Neumann HA1 and Robinson DJ3
1Dept of Dermatology, University Hospital Rotterdam (Netherlands)
2Dept of Radiation Oncology, University Hospital Rotterdam (Netherlands)
3Dept of Dermatology and Radiation Oncology, University Hospital Rotterdam (Netherlands)
Photodynamic therapy using topical 5-aminolevulinic acid or its methyl ester is an accepted 
treatment modality for superfi cial skin cancer. However a PDT in a single fraction using a light 
fl uence of 75 to 100 J cm-2 yields unsatisfactory long-term results. In several animal models 
and in PDT of superfi cial basal cell carcinoma we have shown that illumination with two light 
fractions two hours apart was considerably more effective. Response is further enhanced if the 
fl uence of the fi rst light fraction is reduced while the cumulative fl uence is maintained. In this 
study our purpose was to determine the response of squamous cell carcinoma in situ to a frac-
tionated illumination scheme. We investigated the response of histological proven squamous 
cell carcinoma in situ to aminolevulinic acid photodynamic therapy using a two-fold illumina-
tion scheme in which two light fractions of 20 and 80 J cm-2 are performed 4 and 6 hours after 
the application of a single dose of 20% ALA. Twenty fi ve lesions of squamous cell carcinoma 
in situ were enrolled. Complete response at a follow up time of 12 months was 88%. In earlier 
work we compared the response of histological proven superfi cial basal cell carcinoma to 
ALA-PDT using a single illumination and a two-fold illumination. The results showed a signifi -
cantly better response to a two fold illumination at 12 months 98 % versus 85% in favour of 
the fractionated scheme (p=0,0003 Fisher’s exact test). These results show the benefi t of using 
a two-fold illumination scheme in PDT to optimise the response rate for a single day treatment 
for superfi cial skin cancer.
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Role of Caspase-14 in Terminal Differentiation of Keratinocytes
Denecker G1, Hoste E1, Gilbert B1, Hochepied T1, Ovaere P1, Lippens S1, VandenBroucke C2, 
D’Herde K3, Vandenabeele P1, Declercq W1
1Department of Molecular and Biomedical Research, University of Ghent (Belgium)
2Department of Pathology, University of Ghent (Belgium)
3Department of Anatomy, Embryology, Histology, Medical Physics, Univ of Ghent (Belgium)
Terminal differentiation of keratinocytes can be considered as a special form of cell death dur-
ing which the dead corpses persist. In the skin caspase-14 activation occurs in the uppermost 
layers of the epidermis and correlates with epidermal cornifi cation. During terminal kerati-
nocyte differentiation the classical apoptotic caspases are not activated. So this skin specifi c 
expression and processing of caspase-14 is intriguing. To unravel the possible role of caspase-
14 in skin differentiation, we have generated caspase-14-defi cient mice. Histological sections 
of the back skin and thymus of newborn wild-type and caspase-14-defi cient mice revealed no 
macroscopic differences. Immunohistochemical analysis of other early and late differentiation 
markers demonstrated a normal expression pattern of K1, K10, K14, loricrin, involucrin and 
fi laggrin. However, the skin of caspase-14-defi cient mice had a more shiny appearance and 
showed a lichenifi cated phenotype. Electron microscopic analysis indicated the presence of 
high numbers of composite keratohyalin granules in the caspase-14-defi cient epidermis. These 
granules are normally used as profi laggrin stores. In accordance, caspase-14 mice show an 
altered profi laggrin-processing pattern when analyzed by western blotting. These data argue 
for a role of caspase-14 in the terminal differentiation of keratinocytes. We will report on phe-
notypes, which are related with the improper functioning of the stratum corneum as barrier in 
caspase-14 defi cient mice.
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Heat Shock and UVA-Induced Cell Death: Tissue Dependence
Der-Petrossian M, Klosner G, Grabner R, Kokesch C, Hofstätter E, Hönigsmann H and 
Trautinger F
Department of Dermatology, Medical Universitiy of Vienna (Austria)
In previous studies we have shown that heat shock protects the human squamous cell carci-
noma cell line A431 from UVA-induced cell death. The mechanism seemed not related to an 
antioxidative effect. In the present study we were interested whether this protection occurs also 
in other tissues, and if so which mechanisms were underlying this effect.
Normal human keratinocytes (NHEK), A431, normal human dermal fi broblasts (NHDF), XPA- 
and XPV-fi broblasts, the human fi brosarcoma cell line HT1080, peripheral blood mononuclear 
cells (PBMC), EBV-transformed lymphocytes, XPA- and XPV-lymphocytes, the human leukae-
mia cell lines Jurkat and U937 were exposed to heat shock (3h, 42°C) and subsequently to 
UVA from a metal halide source (315-390 nm). Cell viability was measured by an MTT assay. 
The levels of the 72kDa heat shock protein (Hsp72) and heme oxygenase-1 (HO-1) were deter-
mined by enzyme-linked immunosorbent assay. Oxidative stress was determined by measure-
ment of TBARS and glutathione. 
In addition to A431, heat pretreatment increased the survival rate after UVA in PBMC, EBV-
lymphocytes, XPA-lymphocytes and Jurkat compared to controls. However, no induction of 
Hsp72 could be found in these cells after heat exposure. Furthermore, UVA-induced TBARS 
formation and glutathione depletion did not differ between heat treated and control cells. 
On the other hand, PBMC, XPA- and EBV-lymphocytes showed a baseline and heat-inducible 
expression of HO-1. 
These results show that heat shock inhibits UVA-induced cell death depending on the tissue 
type with protection mainly in lymphoid cells. In contrast to UVB-induced cell death Hsp72 
seemed not to play a role in this protective effect. The mechanism is not due to an antioxidative 
effect of heat shock, but might be related to HO-1 expression. 
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Effect of Neonatal Phototherapy on Melanocytic Nevi Count Inchildren
Matichard E1, Le Hénanff A2, Sanders A3, Leguyadec J4 and Descamps V1
1Dept of Dermatology, Bichat Claude Bernard Hosp, (France)
2Dept of Epidemiology, Biostatistics & Clin Research, Bichat Claude Bernard Hosp, (France)
3Dept of Neonatalogy, Saint-Antoine Hospital, Assitance Publique-Hôpitaux de Paris (France)
4Department of Scholar Medicine, Malakoff Public School, France (France) 
The aim of the study was to assess the role of blue light neonatal phototherapy used for hyper-
bilirubinemia in nevus acquisition in childhood.
An exposed, non-exposed study was performed. A total of 58 children were included in this 
study. Selection criteria were: 8-9 years old, skin type <IV (Fitzpatrick classifi cation).The patient 
group consisted of 18 children exposed to neonatal phototherapy (mostly intensive photo-
therapy) retrospectively found by a review of consecutive neonatal records at Saint-Antoine 
hospital. The control group was composed of 40 non-exposed children consecutively recruited 
from a public school in the same geographic area. 
Total body nevus count in children, phenotypic characteristics, solar exposure, and demo-
graphic data were assessed by the same dermatologist. 
A comparison of both groups showed that >2 mm nevus count was signifi cantly higher in 
the exposed group. The mean mole count was 3.5 per child in the exposed group (SD : 3.05) 
(median : 3), compared to 1.45 (SD : 1.99) (median : 1) in the-non-exposed group (p mean 
= 0.0154 and p median = 0.0101, respectively). Multivariate analysis confi rmed these results 
with a statistically signifi cant correlation with nevus count, especially to nevus sized 2 to 5 
mm.. The association between neonatal phototherapy and nevus count was not signifi cant 
for nevus < 2 mm or those > 5 mm. Solar exposure, especially during holidays was strongly 
associated with the total nevus count and with all of the groups (nevus sized 2 to 5 mm, ≥2 
mm and >5 mm). 
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Neurotrophin Modulate Melanogenesis in Human Melanocytes
Lazou C1, Marconi A2, Marteau C1, Bonnet-Duquennoy M1, Kurfurst R1, Dumas M1, Bonté F1 
and Pincelli C1
1LVMH Recherche, Saint Jean de Braye (France)
2Dept of Medicine, Institue of Dermatology, University of Modena and Reggio Emilia (Italy)
Melanocytes are neural crest-derived cells that migrate to the epidermis early in embryonic life 
and subsequently synthesize and distribute melanin through dendritic processes to surrounding 
keratinocytes. Basal skin color largely results from its melanin content and distribution. Expo-
sure to ultraviolet (UV) irradiation stimulates increased pigmentation or tanning as a protection 
against further photodamage. 
The aim of the present study was to evaluate the expression of the neurotrophin (NT) family 
members and their receptor in human melanocyte under basic conditions and upon UV irra-
diation. In addition, we intend to analyze the role of NT in melanogenesis in human melano-
cytes. Melanocytes express all NTs, as shown by ELISA and RT-PCR. Whereas NGF and brain-
derived neurotrophic factor (BDNF) are detected in low picogram amounts, NT-3 and NT-4 are 
expressed in nanogram amounts/cell lysate. Moreover, melanocytes release NT-3 and NT-4 in 
culture supernate, while they don’t release NGF and BDNF. UVB irradiation up-regulates the 
release of NT-3, while it down-regulates the release of NT-4. TPA differentiated melanocytes 
express TrkA and TrkC, but not TrkB. In an attempt to evaluate possible NT functions in human 
melanocytes, NTs were added to the cultures. NTs failed to exert any effect on the prolifera-
tion of melanocytes treated either with TPA or endothelin-1, as shown by MTT assay. NT-3 and 
NT-4 enhance tyrosinase and TRP-1 mRNA levels, as shown by RT-PCR and stimulate melanin 
synthesis in human melanocytes treated with endothelin-1. These results suggest a close cor-
relation between melanocyte and the epidermal NT network. This may result in the modulation 
of several melanocyte functions in skin.
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Ultraviolet Radiation Induces Premature Regression and Massive Apoptosis, Reduces Viability, 
and Inhibits Hair Shaft Elongation of Organ-Cultured Human Scalp Hair Follicles
Lu Z1, Hasse S1, Fischer TW1, Funk W2, Krengel S1 and Paus R1
1Department of Dermatology (Germany)
2Klinik Dr. Kozlowski and Dr. Funk (Germany)
Ultraviolet radiation (UVR) is a predominantly harmful environmental factor causing e.g. aging 
and photocarcinogenesis in the skin. However, the direct impact of UVR on skin append-
ages remains to be systematically investigated. Therefore, we have studied the direct effects of 
monochromatic UVB (280 nm; 50mJ/cm²) irradiation on organ-cultured human scalp hair fol-
licles in anagen VI, focussing on the assessment of hair shaft elongation, hair follicle regression 
(catagen), follicle viability, growth and apoptosis. This was quantitatively assessed by hair cycle 
histomorphometry, measurement of hair shaft length and of LDH-activity in the culture super-
natant, and by immunohistochemistry for Ki-67 and fragmented apoptotic DNA (TUNEL). 
Microdissected, UVB-irradiated human anagen hair follicles prematurely entered catagen by 
day 6 of organ culture, accompanied by signifi cantly reduced hair shaft elongation compared 
to non-irradiated control follicles (p<0.001). Correspondingly, LDH-activity increased signifi -
cantly in supernatants of UVB-irradiated follicles as early as day 5 (p<0.05) with increasing 
signifi cance at later time points (day 7 and day 9; p<0.001). Ki-67 was positive in 22% of cells 
in a defi ned area of the bulb region in non-irradiated follicles vs. 1% in irradiated hair follicles. 
Cells were positive for TUNEL in 2.5% per defi ned reference area of non-irradiated follicles vs. 
57% in UV-exposed follicles (p<0.001). 
This is the fi rst study to directly show that UVR is harmful to human hair follicles and that, at 
least in vitro, high dose-UVB radiation is a potent hair growth inhibitor. This identifi es the hair 
follicle as a direct target of UV-induced damage, whose underlying molecular mechanisms 
remain to be dissected. We also show that human hair follicles can serve as a novel, highly 
instructive, physiologically relevant general model for studying the molecular and cellular pa-
thology of UV-induced damage in a complex, prototypic epithelial-mesenchymal interaction 
unit.
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Protective Effects of the Flavonoid Luteolin on UVB-Induced Response in Human 
Keratinocytes
Verschooten L1, Smaers K1, Claerhout S1, Declercq L2, Maes D3, Agostinis P4 and Garmyn M1
1Laboratory of Dermatology, University of Leuven (Belgium)
2Estee Lauder Companies, Oevel (Belgium)
3Estee Lauder Companies, Melville, NY (USA)
4Division of Biochemistry, University of Leuven (Belgium)
Flavonoids, like luteolin, are plant polyphenols which have antioxidant, anti-infl ammatory 
and even anticancer effects. We tested the effect of increasing concentrations of luteolin on 
the response of primary human keratinocytes (NHK) to UVB. We show that NHKs, grown in 
medium with luteolin (1 and 10 μM) for 24 hours were less sensitive to UVB induced cell 
death than those grown in normal medium and this effect is dose dependent as we saw a 
more pronounced effect with an increasing dose of luteolin. MTT cell viability experiments 
showed a higher percentage of viable cells in luteolin treated conditions, compared to control, 
24 hours after an apoptotic UVB-dose. This increased survival is paralleled by a delay and 
reduction of apoptosis as we demonstrated by western blot analysis (Parp cleavage and cas-
pase 3 activation), FACS analysis (Sytox Green, preG1) and Hoechst 33342 staining. Possible 
underlying mechanisms of this photoprotective effect were further tested. In basal conditions 
only the highest concentration of luteolin tested (10 μM), demonstrated a reversible inhibition 
of cell growth, as indicated by an increase of the population doubling time, which returned to 
normal levels 48 hours after transient luteolin treatment. In basal conditions, luteolin treatment 
elevates the levels of p53, a key player in the endogenous protective response of keratinocytes 
to UV light. FACS analysis with the use of DCF-DA dye confi rmed the antioxidant effect of 
luteolin for basal as well as UVB-induced ROS levels, which might explain at least partially the 
protective effect of luteolin. These results encourage further research to the potential functions 
of luteolin as a photoprotective agent.
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UVB Induces Melanoma Cell Motility Via Induction of IL-8
Gebhardt C, Averbeck M, Viertel A, Kauer F, Saalbach A, Anderegg U and Simon JC
Department of Dermatology, Leipzig University (Germany)
Ultraviolet radiation (UVR) is known to be a factor involved in the initiation and pathogenesis 
of malignant melanoma. Many studies have focused on the initiation of melanoma, but less 
is known about the effect of UVR on tumor cells. Here we show that after UV-B irradiation, 
melanoma cells are able to secrete autocrine factors that enhance their motility. Time series 
of UV-B radiated melanoma cells showed an initial decrease in cell motility one hour after 
irradiation, with subsequent increase 24 hours after UV-B treatment, suggesting a newly syn-
thesized soluble factor. Since interleukin 8 (IL-8) is known to be up-regulated by different cell 
types after UVB irradiation, we investigated IL-8 expression after UV-B exposure. Quantitative 
rt-PCR and ELISA demonstrated an induction of IL-8 by UV-B and addition of recombinant IL-8 
to cell cultures was able to enhance cell motility comparable to the UV-B mediated effect. In 
addition, blocking IL-8 activity by anti IL-8 antibody inhibited the up-regulation of cell motility 
after UV-B treatment, showing that indeed IL-8 is responsible for the increased cell motility of 
malignant melanoma cells after UV-B exposure. We conclude that UV-B is not only involved in 
the initiation of melanoma, but also appears to be important in the local progression.
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The Relationship Between Plasma Antioxidant Levels and Photoaging
Ghaderi R1 and Zarban A2
1Department of Dermatology, Birjand University of Medical Sciences (Iran)
2Department of Biochemistry, Birjand University of Medical Sciences (Iran)
Background: Photoaging is signifi cantly different from chronological aging in both clinical and 
histological appearance. It has been suggested that oxidative stress, generated by ultraviolet ra-
diation (UVR), leads to photoaging over a long period. This study was conducted to determine 
the relationship between plasma antioxidant levels and Photoaging in clinic of Dermatology at 
Vali asr hospital, city of Birjand, Iran.
Methods: In this case-control study, 33 cases of patients with Photoaging and 33 controls 
(matched age and gender) were recruited. They were recruited after obtaining a verbal consent 
to participate in the study and after confi rmation of the diagnosis by a dermatologist. Plasma 
total antioxidant levels, lipids peroxidation and tiol groups (as stress oxidative index) were 
measured by The ferric reducing ability of plasma (FRAP), ELMANS and Thiobarbituric acid 
Reactive substances (TBARS) in case and control groups.
The collected data were analyzed using SPSS (ver.12) software and chi-square Test of signifi -
cance were carried out at 5% level of signifi cance.
Results: Mean of malondialdehyde (MDA) in case group was higher than control group and 
this difference was signifi cant but mean of Plasma total antioxidant capacity (by FRAP) in case 
group was not signifi cantly higher than control group. Also, mean of lipids peroxidation in case 
group was not signifi cantly higher than control group.
Conclusion: The results of this study suggest that a relationship exists between plasma antioxi-
dant levels and Photoaging.
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UVB-Induced Caspase-3 Expression and Loss of CD1a+ Langerhans’ Cells in Human Skin are 
Independently Correlated with Erythemal Sensivity
Tye J, Blackburn A, Winhoven SM, Brownrigg M, Rhodes LE and Gibbs NK
Dermatological Sciences, The University of Manchester Medical School, (United Kingdom)
Photoimmunosuppression is associated with loss of Langerhans’ cells (LC) after UVB exposure. 
We have previously reported reduced CD1a+ LC 24h, but not at 1 or 4h, after UVB irradiation 
(200mJ/cm2 TL-12) of human skin which correlated with individual erythemal sensitivity. We 
now investigate the relationship between erythemal sensitivity and activation of the apoptotic 
effector caspase, caspase-3, in epidermal cells and in particular, CD1a+ LC.
8 healthy volunteers (aged 33-51; 5 female) were irradiated on buttock skin with a series (21-
200mJ/cm2) of broad-band (TL-12) UVB. 1, 4 and 24h later, punch biopsies were taken from the 
200mJ/cm2 site and a non-irradiated site. Diastron® erythema meter readings were taken at 24h 
on all irradiated and control sites. Refl ectance data yielded D0.025 as an objective measure of 
individual erythemal sensitivity. Biopsies were cryosectioned and double stained with antibod-
ies against CD1a+ and activated caspase-3.
There was marginal caspase-3 staining in non-irradiated skin (mean cells/mm epidermis ± se 
= 0.12 ± 0.09) which did not increase 1h or 4h after irradiation (0.33 ± 0.36 and 0.05 ± 0.05 
respectively; p>0.45). By 24h, caspase-3+ staining was signifi cantly higher (18.67 ± 3.73 p 
<0.001) and showed a strong negative correlation with individual D0.025 (R
2 = 0.73). None of 
the 563 caspase-3+ cells observed expressed CD1a.
This data demonstrates that 24h after exposure to 200mJ/cm2 UVB there is an increase in ac-
tive caspase-3+ epidermal cells that correlates with individual erythemal sensitivity. Although 
CD1a+ LC loss is also negatively correlated with D0.025 (R
2 = 0.65; previous data) the lack of 
co-localisation of CD1a and caspase-3 indicates that this loss is not via caspase-3 mediated 
apoptosis.
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Abnormal IL-4 and IL-12p70 Secretion in Stimulated Peripheral Blood Mononuclear 
Cells (PBMC) from Patients with Polymorphic Light Eruption (PLE) is Unaffected by TL-01 
Phototherapy
Blackburn A, Winhoven S, Brownrigg M, Rhodes LE and Gibbs NK
Dermatological Sciences, The University of Manchester Medical School, (United Kingdom)
The pathogenesis of PLE may involve an abnormal T-cell response to a ‘photoallergen’ gen-
erated following skin exposure to solar ultraviolet radiation (UVR). To examine whether this 
putative ‘photo-autoimmunity’ is associated with a systemic Th1/Th2 imbalance we have in-
vestigated the cytokine secretion profi le of phytohaemagglutinin (PHA) stimulated PBMC from 
normal (n=10) and PLE subjects before (n=10) and after (n=7) a successful course of TL-01 
‘photohardening’ therapy. PBMC were isolated from whole blood by Lymphopaque centrifuga-
tion and cultured in sextuplicate in 96-well plates +/- 10μg/ml phytohaemagglutinin (PHA). 
PBMC proliferation was assessed at 72-80h by measurement of 3H-thymidine incorporation. 
The supernatants from further duplicate PBMC cultures were analysed for IL-1β, IL-4, IL-6, IL-8, 
IL-10, IL-12p70, IL-17, GM-CSF, IFNγ, MIP-1β and TNFα using a Biorad multiplex kit read on a 
Luminex analyser 4, 24 and 48h following PHA stimulation. 
 PBMC proliferation following PHA stimulation was similar in normal and PLE subjects (p=0.7) 
and phototherapy did not signifi cantly alter the proliferative responses of PBMC from PLE sub-
jects (p=0.5). With the exception of IL-8 and MIP-1β, cytokine secretion without PHA stim-
ulation was low at all times points. PHA stimulated equivalent secretion of the majority of 
cytokines from PLE (pre-phototherapy) and normal subjects at 24h and 48h. However, there 
was signifi cantly higher secretion of IL-4 (p≤0.03) and IL-12p70 (p≤0.02) at 24h and 48h from 
PBMC taken from PLE patients prior to phototherapy. A standard course of TL-01 phototherapy 
did not alter these raised levels of IL-4 (p>0.2) and IL-12 (p>0.3). 
These fi ndings suggest that both IL-12p70 driven Th-1 responses and IL-4 dependent Th-2 re-
sponses may be exaggerated in PLE but do not indicate an overt Th-1/Th-2 imbalance in this 
condition.
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The Triplet Properties of the Photocarcinogenic Fluoroquinolone Antibiotic, Lomefl oxacin, 
are not Consistent with an Energy Transfer Mechanism for Photosensitised Thymine Dimer 
Formation
Clarke K1, Truscott TG1, McGarvey DJ1 and Gibbs NK2
1School of Physical & Geographical Sciences, Keele University (United Kingdom)
2Dermatological Sciences, The University of Manchester, (United Kingdom)
The fl uoroquinolone antibiotic lomefl oxacin (LOM) photosensitizes human skin, is photog-
enotoxic and is highly photocarcinogenic in mouse skin. We have demonstrated that LOM 
photosensitizes mutagenic thymine dimer (T^T) formation in vitro and it has been recently 
reported that mice lacking DNA excision repair of T^T (XP-A) are exquisitely sensitive to LOM 
photocarcinogenesis. The classic mechanism for photosensitized T^T formation is via energy 
transfer from the triplet excited state of the photosensitiser (3LOM*) to a thymine molecule (T) 
which forms 3T* which can then dimerise with an adjacent T:
3LOM* + T →LOM + 3T* →3T* + T → T^T
An absolute requirement for this reaction is that the triplet state energy (ET) of 
3LOM* exceeds 
that of 3T* (308 kJ.mol-1). 
We used the time-resolved technique of laser fl ash photolysis (LFP) to study the properties of 
3LOM*. LOM triplets could not be directly observed using LFP, which concurs with previous 
reports of short 3LOM* lifetimes. We therefore investigated whether LOM could receive trans-
ferred energy, and hence quench, LFP-generated triplets of biphenyl (3BIP*, ET=274 kJ.mol
-1) 
or naphthalene (3NAP*, ET=253 kJ.mol
-1). LOM was not able to quench 3NAP* suggesting that 
3LOM* has an ET > 253 kJ.mol
-1. Conversely, LOM was able to quench 3BIP* suggesting that 
3LOM* has an ET < 274 kJ.mol
-1. 
These results indicate that the 3LOM* ET is in the range 253-274 kJ.mol
-1 and well below the 
ET for 
3T* (308 kJ.mol-1). This fi nding makes energy transfer from 3LOM* to T an energetically 
unfeasible route for T^T formation. We are currently exploring other mechanisms by which 
LOM photosensitizes T^T formation including possible triplet energy transfer from LOM pho-
toproducts. 
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Oral Skin Probiotic Facilitate Early Recovery of Cutaneous Homeostasis after UV Exposure 
in Humans
Peguet Navarro J1, Dezutter-Dambuyant C1, Buetler TM2, Leclaire J3, Smola H4, Blum S2, Breton L3 
and Gueniche A2
1EA 37-32 Hopital Ed Herriot, University Claude Bernard Lyon I, Lyon (France)
2Nestle Research Center, Lausanne (Switzerland)
3L’OREAL Centre Charles Zviak, Paris (France)
4Dept of Dermatology, University of Cologne, (Germany)
There is now strong evidence that probiotic bacteria can modulate immune responses in many 
infectious and infl ammatory conditions. In the present study, we analyzed whether oral supple-
mentation with Lactobacillus johnsonii (Skin Probiotic) could interfere with down-regulation and/or 
recovery of normal skin immune status after UV exposure. The probiotic bacterial strain L. johnsonii 
was tested in a randomized, double-blind, placebo controlled clinical trial with 54 healthy vol-
unteers. Half the volunteers received Skin Probiotic the other half a placebo during 6 weeks prior 
to exposure to solar-simulated UV irradiation (2 x 1.5 MED). Blister roofs and skin biopsies were 
recovered 1, 4 and 10 days after UV exposure from unirradiated and irradiated skin sites and used 
for mixed epidermal cell lymphocyte reaction (MECLR) and immunohistochemical analysis.
Skin Probiotic supplementation did not prevent UV-induced phenotypic alterations and matu-
ration of Langerhans cells (LCs) or the decrease in allostimulatory function in irradiated skin 
samples 18 hrs post-UV exposure. Interestingly, 4 days post UV exposure the allostimulatory 
capacity of epidermal cells was totally recovered in the Skin Probiotic group correlating with 
normalization of CD1a expression within epidermis. In contrast, MECLR was still decreased in 
the placebo group with paralleled reduction in the CD1a LC marker in irradiated epidermis at 4 
and 10 days after UV. Moreover CD36+ monocytic cells colonized epidermis as soon as 18 hrs 
post irradiation and disappeared faster in the Skin Probiotic supplemented group.
For the fi rst time, our results provide evidence that ingested probiotic bacteria accelerate the 
recovery of cutaneous immune homeostasis after UV exposure.
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The UV Fingerprint Dominates the Patched Gene Mutation Spectrum of Basal Cell Carcinoma 
from Different Groups, Including Patients with Early-Onset and Multiple Lesions
Heitzer E1, Lassacher A1, Kerl H2 and Wolf P1
1Research Unit for Photodermatology, Dept of Dermatology, Medical Univ Graz (Austria)
2Department of Dermatology, Medical University Graz (Austria)
Basal cell carcinoma (BCC) is the most common cancer in humans. While UV radiation of 
sunlight is thought to be the main risk factor in the etiology of BCC, more recent research has 
also focused on genetic factors leading to BCC. A striking characteristic of BCC is the extent of 
inter-patient variation in tumor accrual. We have identifi ed at our institution more than 16,000 
BCC patients with more than 32,000 lesions within 10.5 years. Among those BCC patients 
there were 166 subjects with early-onset BCC (as defi ned by having developed the fi rst BCC 
before the age of 35 years) (group A) and 245 subjects with multiple BCCs (as defi ned by hav-
ing had 10 or more BCCs) (group B). Patched (PTCH) tumor suppressor gene mutations are 
found very frequently not only in BCC from patients with nevoid basal carcinoma syndrome 
(NBCCS) but also in BCC from patients of the general population. In this study we searched 
for specifi c fi ngerprint PTCH mutations, associated with carcinogen exposure (e.g. UV-A or -B 
radiation and/or benzo[a]pyrene), to determine whether there are differences in the mutation 
spectrum and possibly causing agents among different groups of patients. DNA was extracted 
from paraffi n-embedded BCC tissue of a total of sixty (20 per group) randomly selected patients 
from the different groups, including early-onset patients (median age, 32.5 years; range 21 to 
34; median number of BCC, 1; range, 1 to 18), multiple BCC patients (median age, 67 years; 
range 26 to 90; median number of BCC, 15; range, 10 to 36), and regular BCC patients (group 
C) (median age, 69 years; range 45 to 77; median number of BCC, 1; range, 1 to 6). PCR and 
subsequent direct automated sequencing of the PTCH gene (exon 2 to 23) revealed the pres-
ence of PTCH mutations in 11 (55%), 5 (25%), and 10 (50%) of the cases of group A, B, and 
C, respectively (Fisher exact test, n.s.). Interestingly, we were able to detect exclusively point 
mutations (and no deletions) in contrast to previous reports. In all 3 groups of patients, the UV 
fi ngerprint dominated the mutation spectrum, suggesting a similar pathogenic role for UV. 
These results furthermore suggest that the occurrence of PTCH mutations is not the decisive 
factor for the early onset and/or multiple appearance type of BCC. 
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Ultraviolet-B Irradiation Induces Vascular Hyperpermeability in the Skin of SKH1 Mice
Huegel R1, Schwarz A1, Tuexen N1, Velasco P2, Lange-Asschenfeldt B2 and Schwarz T1
1Department of Dermatology, University of Kiel (Germany)
2National Institutes of Health, Bethesda (USA)
The vascular response to ultraviolet (UV) radiation is characterized by vasodilation, edema 
formation and enhanced leukocyte adhesion and transmigration. Recent studies have revealed 
that UVB radiation induces an up-regulation of the proangiogenic factor vascular endothelial 
growth factor-A (VEGF-A) in human and murine skin. Since edema formation is a striking 
feature of acute photodamage and VEGF-A is known to play a key role in enhancing vascular 
leakage, we investigated the vascular permeabilizing effect of UVB radiation using a modifi ed 
Miles permeability assay. For this purpose hairless SKH1 mice were exposed to a single dose 
of UVB radiation (120 mJ/cm2). Twenty-four hours thereafter Evans Blue dye was injected into 
the retroorbital venous plexus and the induction of vascular permeability was measured by 
evaluating the exudation of the dye in the UV-irradiated back skin. Control mice were treated 
identically but not exposed to UVB radiation. Evaluation of exuded dye was performed 30 
minutes after intravenous injection of the dye. We observed a strong bluish colouration in the 
skin that was exposed to UVB radiation, while non-irradiated mice did not reveal any bluing. 
This provides evidence that UVB irradiation of murine skin in vivo induces a strong increase 
in vascular permeability. Our results suggest that therapeutic approaches aimed at maintaining 
endothelial integrity could prove benefi cial in the treatment and prevention of acute photo-
damage. In addition, this model represents a useful tool to screen drugs which might interfere 
in this process.
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Dose-Response Effects of Ultraviolet A Irradiation on Oxidative Stress and Molecular Markers 
of Antioxidant Status in Human Keratinocytes and Fibroblasts
Saguet T1, Robin S1, Binda D1, Lascombe I2, Fauconnet S2, Viennet C1, Nicod L3 and Humbert P1
1LIBC, Université de Franche-Comté, IFR133 (France)
2Laboratoire de Carcinogénèse Epithéliale, Université de Franche-Comté, IFR133 (France)
3Lab de Sciences Séparatives & Biopharma, Univ de Franche-Comté, IFR133 (France)
Human skin is easily and constantly exposed to solar radiation and mainly ultraviolet radiation 
A (UVA) which are responsible of photoaging associated to oxidative/antioxidative imbalance. 
Clarifying the comprehension of these disorders requires an in vitro mechanistic approach of 
the alteration of antioxidant markers in the major epidermal and dermal cells: keratinocytes 
and fi broblasts.
Human primary cultures were exposed to 1 and 3 J/cm². Basal levels of lipid peroxidation 
and superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities were equivalent 
in both cell populations, while reduced glutathione (GSH) level was two times higher in ke-
ratinocytes. 
The UVA doses used didn’t lead to signifi cative mortality. Lipid peroxidation and SOD activity 
were increased in fi broblasts 2h after irradiation. They returned to basal levels 24h after ir-
radiation. The responses of these markers were more moderate in keratinocytes. Moreover the 
glutathione system (GSH, GPx, Glutathione reductase) of both fi broblasts and keratinocytes 
increased 2h after a 3 J/cm² irradiation and decreased 24h after irradiation. A molecular ap-
proach of antioxidant enzymes (Western blot) could delve into implicated mechanisms. 
Keratinocytes and fi broblasts populations react similarly to UVA irradiation in vitro but cellular 
density in vivo is lower in the dermis which could explain why the effects of photoaging are 
more visible in this cutaneous sublayer.
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Gene and Protein Expression Profi les in COP1 Silenced Human Keratinocytes after UVB 
Irradiation
Kinyó Á1, László Zs2, Nagy F3, Polyánka H4, Széll M4, Dobozy A1 and Kemény L1
1Department of Dermatology and Allergology, University of Szeged (Hungary)
2Department of Medical Genetics, University of Szeged (Hungary)
3Inst of Plant Biology, Biological Res Center of the Hungarian Acad of Sciences (Hungary)
4Derm Research Group of the Hungarian Academy of Sciences, Univ of Szeged (Hungary)
UVB irradiation has been indicated to trigger the broadest range of gene expression responses 
in human cells. However, factors governing these events are still not well understood. Human 
COP1 has been shown as a tumor-suppressor p53 interacting protein increasing p53 turnover 
in an ubiquitin–dependent fashion. Moreover, COP1 serves as an E3 ubiquitin ligase for p53 
and inhibits p53 dependent transcription and apoptosis. The aim of our work was to elucidate 
whether COP1 protein has any function(s) in UVB response of human keratinocytes. For that 
we used a vector-based RNA silencing approach. Two silencing constructs were made for the 
COP1 (siCOP1A and siCOP1B) and one silencing construct (sip53) was made for the p53 tran-
script. These constructs were transfected to human keratinocytes by nucleofection. Real-time 
RT-PCR experiments revealed successful COP1 and p53 gene specifi c silencing and by using 
Western blot we could demonstrate a substantial p53 protein up-regulation upon COP1 silenc-
ing. Transfected cells were than irradiated with increasing doses of UVB and gene expression 
changes were followed. UVB down-regulated COP1 expression in all of the irradiated cells, 
however, this down-regulation was 20-fold in the COP1-silenced cells compared to the mock-
transfected ones. Moreover, the level of COP1 mRNA showed a 150-fold decrease in the p53 
silenced keratinocytes after UVB irradiation indicating that p53 is an inevitable regulator of 
COP1 expression. These results indicate that gene expression of p53 and COP1 are mutually 
regulated.
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Variable Pulsed Light (VPL) Reduces Treatment Induced Pain in Patients Undergoing 
Photodynamic Therapy For Actinic Keratosis
Szeimies RM1, Banilas P1, Hummel S1, Koller M2 and Knobler R3
1Department of Dermatology, Regensburg University Hospital (Germany)
2Center for Clinical trials, Regensburg University Hospital (Germany)
3Department of Dermatology, Medical University of Vienna (Austria)
Photodynamic therapy (PDT) is meanwhile established worldwide for the treatment of epithe-
lial skin cancer like basal cell carcinoma and actinic keratoses (AK). PDT utilizes the selec-
tive tissue necrosis upon illumination with red light due to the induction of reactive oxygen 
species upon activation of synthesized porphyrins. Unfortunately, free nerve endings are also 
stimulated during this process thus inducing pain which sometimes leads to stop of treatment. 
Therefore, a modifi cation of the illumination process using a variable pulse light source (VPL, 
Energist Ultra, Energist, U.K.) with spectral characteristics matching the absorption spectrum of 
the photosensitizer, was studied in a randomized parallel-group trial, by including 25 patients 
(8 f, 17 m, mean age 73 yrs) with an overall of 238 AK on face and scalp. Patient received me-
thyl aminolevulinate (MAL, Metvix, Galderma, France) for 3 hrs, afterwards one side received 
an illumination with a LED light source (37 J/cm², duration 12 min), and the contra lateral side 
received 80 J/cm² with the VPL, with a pulse train of 15 impulses each with duration of 5 ms.
Therapeutic outcome was judged using a lesion score after 2 weeks and 3 months, pain assess-
ment after each treatment side was made with the use of a visual analog scale.
After two weeks and three months, there was no signifi cant difference between the therapeuti-
cal outcomes using the different illumination systems. However, pain assessment immediately 
after PDT revealed a signifi cant lower pain level (4.3 vs. 6.4) for the treatment with the VPL.
The use of short pulsed light is therefore an effi cient and useful alternative in the photodynamic 
treatment of AK in case development of pain is a limiting factor for the performance of PDT.
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Effects of E2F-1 Over-Expression Upon Proliferation and DNA Repair  in UVA-Irradiated 
SCC9 Cell Lines
Kwong RA1,2,3 Corlette TH3, Musgrove EA3,  Sutherland RL3, Barnetson RS1,2 and Halliday GM1
1Dermatology Research Laboratories, Blackburn Building, University of Sydney, NSW [R.A.K., 
R.S.B. and G.M.H.]; 2Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, 
NSW [R.A.K. and R.S.B.] and 3Cancer Research Program, Garvan Institute of Medical Research 
[R.A.K., T.H.C., E.A.M. and R.L.S.,], Darlinghurst, N.S.W. Australia.
p53 modulation by CP-31398 enhances its mitochondrial translocation leading to induction of 
apoptosis and blockade of the growth of UVB-induced squamous cell carcinoma
Mutations in the tumor suppressor gene p53 are detectable in more than 50% of all human 
malignancies including those affecting skin. CP-31398, a small molecular weight styrylquina-
zoline is known to restore tumor suppressor functions of mutant p53 protein in tumor cells 
carrying mutant p53 under certain in vitro conditions. We recently showed that this agent is 
effective in restoring mutant p53 function and inhibits carcinogenesis in UVB-irradiated murine 
skin. We also showed that CP-31398 treatment was only effective in inducing p53-dependent 
expression of down-stream target proteins and apoptosis in UVB-irradiated wild-type mice but 
not in p53-/- littermates. To probe the molecular mechanism underlying these effects and to 
demonstrate whether this agent is equally effective in arresting growth of human SCC cells, we 
employed human epidermoid carcinoma cells, A431 cells, which carry mutant p53. CP-31398 
caused G1 arrest and a dose-dependent induction of p21, mdm2 and Bax and diminution of 
cyclin D1 expression, which was followed by cytochrome C release, caspase 3 activation and 
apoptosis. We employed a mitochondria-specifi c fl uorescent dye to show that p53 is localized 
in mitochondria of CP-31398-treated A431 cells and that p53 co-immunoprecipitates with 
the mitochondrial protein Mn-SOD. This is followed by changes in mitochondrial membrane 
potential, opening of permeability transition pore (MTP), release of cytochrome c, and SMAC/
Diablo and apoptosis. These data indicate that CP-31398 acts by translocating p53 to mito-
chondria resulting in the induction of apoptosis and consequent abrogation of UVB-induced 
skin cancer development.
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No Major Role for p53, RAS, BRAF, INK4a-ARF, and c-kit in Merkel Cell Carcinomas
Lassacher A1, Heitzer E1, Kerl H2 and Wolf P1
1Research Unit for Photobiology, Department of Dermatology, Medical University of Graz 
(Austria)
2Department of Dermatology, Medical University of Graz (Austria)
Merkel cell carcinoma (MCC) is a rare but very aggressive skin tumor that occurs predomi-
nantly in elderly people on sun-exposed body sites. MCC has a poor prognosis, with an overall 
5-year survival rate ranging between 25 and 75%, depending on stage. MCC is assumed to 
arise most likely from Merkel cells, which are neuroendocrine cells with mechanoreceptor 
function in the skin, and/or stem cells. The exact causes and molecular mechanism of MCC 
formation are not known at present. Although UV radiation is thought to be one of the main 
causing factors of MCC, it is not clear how UV radiation does lead to MCC formation. Molecu-
lar epidemiology has elucidated the importance of interactions between environmental factors 
(such as UV radiation, tar, X-ray and chemical agents) and individual susceptibility factors of 
cancer. We hypothesized that similar than in other cancers complex mutational profi les of sev-
eral genes might be responsible for tumor initiation and progression of MCC. In this study, we 
analysed MCCs from 23 patients (20 females; 3 males) by direct sequence analysis of certain 
exons of interest in p53 (exon4-8), Ras (exon1+2), BRAF (exon15), INK4a-ARF locus (encoding 
for p14/p16) (exon1+2), and c-Kit (exon11), tumor suppressor genes and oncogenes, which are 
known to be mutated most often in other forms of skin cancers. Our analysis confi rmed p53 
mutations (codon 224, 229, 234, 294) in 4 (17%) and p16 mutations (codon6) in 1 (4%) of the 
23 MCCs. No mutations were detected in Ha-, Ki-, and N-Ras and, c-kit, BRAF, and p14. These 
results suggest that these genes do not play a major role in the formation of MCC and that other 
factors/genes are involved in the development of MCC.
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HPV5 E6 and E7 Oncoproteins Modulate Glutathione Content and UV Sensitivity of Human 
Keratinocytes
Mouret S1, Favre M2, Favier A3, Beani JC1 and Leccia MT1
1ORSOX, Université Joseph Fourier (France)
2Institut Pasteur (France)
3CEA Grenoble (France)
In Epidermodysplasia verruciformis and some immunocompromised patients, such as organ 
transplant recipients, cooperative effects of human papillomavirus (HPV) and ultraviolet (UV) 
radiation have been postulated in the development of non-melanoma skin cancers. E6 and E7 
oncoproteins of high risk HPV are able to alter cell cycle and DNA repair that may allow cell 
survival of UV-damaged cells. In a recent paper we demonstrated that SKv cell lines which 
present different levels of E6*, a truncated form of E6, but similar levels of E6 and E7, have dif-
ferent sensitivity to UV and oxidative stress which are related to different glutathione levels and 
glutathione peroxidase activities. The aim of our study was to develop keratinocyte transfection 
with E6 and/or E7 of HPV5 and HPV16 in order to determine viral oncoprotein infl uence on 
antioxidant status in relation with UV sensitivity. For this, we used the NCTC 2544 cell line and 
expression vector were produced with the pcDNA3.1/NT-GFP-TOPO for each oncoprotein. 
Firstly, we showed E6 an E7 RNA expression in NCTC 2544 cell line after transfection by RT-
PCR. Interestingly, keratinocytes transfected with HPV5 E6 and E7 had total GSH levels 2.5 fold 
higher than control cells. Moreover, this high GSH level was associated with a higher resist-
ance to solar simulated radiation. No effect of transfection was shown with HPV16 E6 and/or 
E7 which is concordant with an essential role played by E6* during this process as previously 
demonstrated in our recent work. In conclusion, our results suggest that GSH pathway seems 
to be an antioxidant mechanism of fi rst importance in HPV5-infected keratinocyte survival and 
HPV-associated carcinogenic process.
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Photodynamic Therapy (PDT) with Fractionated Versus Unfractionated Illumination: A Half-
Side Comparison in Patients with Actinic Keratoses
Legat FJ1, Holzer A1, Wackernagel A1, Hofer A1, Quehenberger F2, Kerl H1 and Wolf P1
1Department of Dermatology, Medical University of Graz (Austria)
2Dept of Medical Informatics, Statistics and Documentation, Medical Univ of Graz (Austria)
Certain previous reports suggested an increased effi cacy of PDT with fractionated compared to 
unfractionated illumination. In a half-side comparison we assessed the therapeutic effi cacy of 
PDT with fractionated versus unfractionated illumination of multiple actinic keratoses (AK) (mean 
number 47, range 17-89) on the bald head of 22 male patients (median age 75y, range 59-84). 
Three hours after application of Metvix® cream (methyl aminolevulinate) to the involved skin of the 
head, the area was half-side illuminated with visible red light (Aktilite®, peak emission at 635nm). 
Contralateral halves were randomly assigned to PDT with fractionated (two doses of 18.5J/cm2 
divided by a dark interval of 15 min) or unfractionated (one single dose of 37J/cm2) illumination.
Two patients prematurely terminated PDT because of intense pain. Fourteen patients completed PDT 
with half-side illumination according to the protocol and were available for per-protocol-analysis. 
PDT with fractionated as well as unfractionated illumination signifi cantly (p<0.005) reduced the 
number of AK. At 4, 12, and 24 weeks, the mean number of AK was reduced by 56, 53, and 50% af-
ter PDT with fractionated illumination and by 65, 60, and 48% after PDT with unfractionated illumi-
nation, respectively (difference not signifi cant). PDT-induced pain, the most important adverse event 
during PDT, however, was signifi cantly (p=0.018) less intense for PDT with fractionated (6.0±0.5 
[mean ± SEM], on a visual analogue scale from 0 to 10) compared to PDT with unfractionated 
(6.7±0.5) illumination (n=14). In the remaining six patients unfractionated illumination could not 
be applied because they reported about intense pain already after the fi rst dose of 18.5J/cm² on the 
fractionated illumination side. Thus, these patients received standard fractionated illumination (i.e., 
2 doses of 18.5J/cm² divided by a dark interval of 5 min) on one half and PDT with an alternative 
fractionated illumination (i.e., 3 doses of 12.3J/cm² interrupted by 2 dark intervals of 5 min each) 
on the contralateral half instead of unfractionated illumination. In these six patients, the clinical 
response rate to PDT with the alternative fractionated illumination was similar to PDT with standard 
fractionated and unfractionated illumination, and there was no signifi cant difference in the pain 
score between the two types of fractionated illuminations (8.15±0.3 vs. 8.0±0.7, respectively). 
In summary, PDT with fractionated and unfractionated illumination were similarly effective in re-
ducing actinic keratoses. However, pain sensation during PDT was signifi cantly less intense with 
standard fractionated compared to unfractionated illumination. 
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Low Doses of Solar Simulated Radiation may Induce mRNA Expression of IL-1beta, IL-6 and 
IL-10
Lesiak A1, Sysa-Jedrzejowska A1, Cierniewska-Cieslak A2 and Narbutt J1
1Department of Dermatology Medical University of Lodz (Poland)
2Department of Medical and Molecular Biophysics, Medical University of Lodz (Poland)
Ultraviolet radiation affects immune skin system, alters gene expression and contributes skin 
tumors development. To date, various mechanisms of UVR-mediated infl ammatory and im-
munosuppressive responses in the skin have been described, however most studies were con-
ducted in mice or in vitro, and usually erythematogenic doses of UVR were used.The aim of our 
study was to examine the infl uence of low and repeated exposure to solar simulated radiation 
(SSR) on expression of IL-1 beta IL-6, IL-10 mRNAs in healthy human volunteers. Our study 
included 30 subjects who were irradiated with SSR: 15 subjects (whole-body, low doses of SSR 
for 10 days with subsequent local irradiation with 3 MED UVB), 15 subjects (whole-body, low 
doses of SSR for 30 days). Skin samples were taken twice or three times before and 24 h after 
fi nal exposure. IL-1 beta IL-6, IL-10 mRNAs were determined in each specimen by relative 
quantitative RT PCR. Concentrations of mRNAs for tested cytokines were normalized in each 
sample in relation to beta actin mRNA. The obtained results were statistically analysed. Expres-
sion of IL-1 beta IL-6, IL-10 mRNAs was statistically signifi cantly higher after irradiation than 
before exposure begun (p<0.01 for all comparisons). After additional irradiation with 3 MED 
UVB expression of mRNAs was signifi cantly lower than in 10-day and 30 day group (p<0.05). 
The obtained results indicate that SSR enhances mRNA expression of the examined cytokines 
and modulates skin immunity. 
450
Cell Surface Expression of Melanocortin-1 Receptor on HaCaT keratinocytes and α-
Melanocortin Stimulation do not Affect the Formation and Repair of UVB-induced DNA 
Photoproducts
Garcin G1, Douki T2, Stoebner P1, Guesnet J3, Guezennec A3, Martinez J1, Cadet J2 and Meunier L1
1CNRS UMR 5810, University of Montpellier (France)
2Laboratoire lésions des acides nucleiques, CEA Grenoble (France)
3YSL beauté Recherche et Développement, Neuilly (France)
Ultraviolet (UV) exposure induces an up-regulation of melanocortin-1 receptor (MC1R) ex-
pression in human skin and the α-melanocyte-stimulating hormone (α-MSH) may reduce 
UVB-induced DNA damage in normal human melanocytes. Using high-performance liquid 
chromatography coupled to tandem mass spectrometry, we investigated the formation and 
repair of DNA lesions in UVB-irradiated HaCaT cells stably transfected with the wild type 
MC1R gene (MC1R-HaCaT). Functional properties of MC1R expressed in MC1R-HaCaT cells 
were assessed by radioligand binding assays and the cellular cAMP content of transfected cells 
after α-MSH stimulation was measured with a radio-immunoassay kit. Similar levels of 8 bipy-
rimidine photoproducts including cyclobutane pyrimidine dimers (CPDs) (TT-CPDs, TC-CPDs, 
CT-CPDs), (6-4) photoproducts (64 PPs) (TT-64PPs, TC-64PPs) and their Dewar valence isomers 
together with 8-oxo-7,8-dihydroguanine (8-oxoGua) were found to be generated in both non-
transfected and MC1-R-HaCaT cells after UVB irradiations corresponding to 50, 150 and 300 
mJ.cm2. Time-course studies of DNA photoproduct yields after UVB irradiation (0h, 1h, 4h, 8h, 
24h) and exposure doses (5 and 50 mJ.cm2) indicated that the DNA repair ability depended 
upon radiation doses. It was shown that 64 PPs were removed from the DNA of UVB-irradiated 
cells much more effi ciently than CPDs. The repair effi ciency of 8-oxoGua, CPDs and 64 PPs 
was relatively similar in both cell lines and was not modifi ed by incubation with α-MSH (10-6M 
and 10-9M) 24h before and immediately after UVB irradiation. There was no difference in cell 
viability between non-transfected and MC1R-HaCaT cell lines 24h after UVB treatment (50 
mJ.cm2). In conclusion, cell surface-enforced expression on HaCaT keratinocytes and α-MSH 
stimulation do not affect the formation and repair of DNA photoproducts that occur upon 
UVB exposure.
451
Decreased Human Epidermal Antigen-presenting Cell Activity after UVA Exposure: Dose 
Response Effects and Protection by Sunscreens
Stoebner P2, Poosti R2, Djoukelfi t K1, Martinez J2 and Meunier L2
1Epidaure CRLC, Montpellier (France)
2CNRS UMR 5810, University of Montpellier (France)
Ultraviolet A exposure of human skin causes immunosuppression that may contribute to skin 
cancer growth. The purpose of our study was to fi nd a dose-response effect of UVA exposure 
on human epidermal antigen-presenting cell (eAPC) activity and to evaluate the in vivo protec-
tive capacity of two sunscreen formulations (UVA-PF=3 and UVA-PF=7, respectively) against 
an acute and high UVA exposure. We compared these immune protective capacities to those 
afforded by the same sunscreen formulations against clinical changes such as UVA-induced 
redness and pigmentation. In each volunteer (n=16) keratotomes were obtained from normal 
and UVA-irradiated skin (3 days after 15, 30 and 60 J.cm-2 UVA doses) and the eAPC activity 
was assessed by incubating freshly isolated epidermal cells with highly purifi ed allogeneic 
CD4+ T cells. Skin redness and pigmentation were assessed by chromametry 24 h after UVA 
irradiations. In vivo UVA exposure resulted in a dose-dependent decrease of T cell prolifera-
tion that was statistically signifi cant at suberythemal UVA doses (15 J.cm2). The UVA-induced 
decrease of the eAPC activity exhibited a plateau-response curve between 30 and 60 J.cm-2. 
There was no correlation between the decreased eAPC activity and the intensity of UVA-in-
duced erythema and pigmentation. Both sunscreen formulations strongly protected against the 
UVA-induced (90 J/cm²) reduction of the eAPC activity as well as the UVA-induced erythema 
and pigmentation. Our results demonstrate that a single suberythemal UVA exposure of human 
skin impairs the eAPC capacity and indicate that erythema and immunosuppression may have 
different dose-response curves in the UVA spectrum. They also indicate that the two tested sun-
screen formulations afforded a signifi cant protection against the decrease of the eAPC activity 
and the induction of erythema/pigmentation induced by an acute and high UVA-exposure. 
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Cutaneous Photochemoprotection with Topical Application of Low Dose Green Tea Extract 
(OM24®) in Humans - A Placebo-Controlled Trial
Mnich CD1, Hoek KS1, Urosevic M1, Farkas A1, Dudli C1, Laine E1, Holzgang-Schneiter HE2 
and Dummer R1
1Department of Dermatology, University Hospital Zurich (Switzerland)
2Omnimedica AG, Schlieren (Switzerland)
Background: Preclinically, green tea extracts (GTEs) have shown reduction of UVB-induced 
(i) erythema, (ii) DNA damage, (iii) formation of radical oxygen species and (iv) upregulation 
of numerous factors related to apoptosis, infl ammation, differentiation and carcinogenesis. In 
humans, topical GTEs have only been tested in limited studies, with very high concentrations 
and over short periods of time. Here, the utility of topical GTEs as everyday photochemopre-
ventive agents was tested.
Probands and Methods: 18 Probands applied over 34 days on UV-protected skin verum (= 
W/O cream with 0.4% GTE, OM24®) and placebo. 24h after irradiation with 100mJ/cm2 UVB, 
biopsies were taken on day 6 and 34; (A) non-irradiated; (B) placebo+UVB; (C) GTE+UVB. On 
paraffi n sections, thymidine dimers, p53, and apoptosis (sunburn cells and TUNEL assay) were 
histochemically assessed and AffymetrixTM DNA microarrays were perfomed.
Results: Tolerability was excellent. Comparing biopsy C with B, p53- positive keratinocytes 
were reduced in C, by 31.9% (p= 0.002) on day 6) and by 36.3% (p= 0.001) on day 34. As 
was apoptosis [TUNEL-Assay, 66.3% reduction (p= 0.027) on day 6; and 38.5% reduction (p= 
0.097) on day 34; sunburn cells, 38.9% reduction (p= 0.02) on day 6]. Thymidine dimer-posi-
tive keratinocytes, erythema response and gene expression profi les were unchanged between 
biopsies C and B.
Conclusions: Already at low, cosmetically usable, non-erythema-reducing concentrations 
(0.4%), topically applied GTE (OM24®) signifi cantly reduces UVB- mediated induction of p53 
and apoptosis without tachyphylaxis over fi ve weeks, suggesting GTEs as suitable everyday 
photochemopreventive agents.
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Sun Protection by Red Wine?
Moehrle M1, Dietrich H2, Patz CD2 and Haefner HM3
1Dept of Dermatology, University of Bordeaux (F) and University of Tuebingen (D) (France)
2Res Inst Geisenheim, Dept of Wine Analysis & Beverage Research, Geissenheim (Germany)
3Department of Dermatology, University Hospital Tuebingen (Germany)
There is increasing evidence that polyphenols, antioxidants from plants such as green tea or 
grapes may impair the UV-induced erythema reaction as well as carcinogenesis and metastasis 
of melanoma and epithelial skin cancer. The UVB-protective potential of wine polyphenols 
have not been studied so far in humans.
In this study we investigate the infl uence of local and systemic application of three red wines, 
which had different polyphenol contents, on the minimal erythema dose (MED/UVB, i.e. sun-
burn threshold) of 15 healthy male physicians. To examine the local effect ultraviolet irradiation 
was carried out prior to and immediately following 20 minutes of occlusive local wine resp. 
ethanol 12% application to the back. The systemic effect of red wines was tested by ultraviolet 
irradiation which was administered immediately prior to the oral intake of red wine (6 ml of 
wine/kg body weight, e.g. 500 ml / 83 kg; over about 40 min.).
With respect to MED/UVB we did not see any effect of topical red wine.
There was no signifi cant change of MED after oral intake of wine A (p=0.75). The oral intake 
of wine B was almost associated with a signifi cant rise of MED (p=0.063). Drinking of wine 
C, which had the highest polyphenol content, resulted in a statistically signifi cant higher MED 
(p=0.031).
“Wine baths“ probably will not have sun protective properties. A signifi cant rise of the MED/
UVB following an oral intake of the red wine with the highest polyphenol content tested here 
might have been the result of sun protective properties of red wine polyphenols. 
Here, further research is needed to clarify the role of polyphenol content, dose and duration 
of wine consumption.
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Occupational Skin Cancer in Mountain Guides
Moehrle M1, Dennenmoser B2, Schlagenhauff B3, Haefner HM2, Garbe C2
1Dept of Dermatology, University of Bordeaux (F) and University of Tuebingen (D) (France)
2Department of Dermatology, University of Tuebingen (Germany)
3Dermacenter Kuessnacht (Switzerland)
There is little knowledge about the impact of occupational sun exposure on the development 
of skin cancer. Due to the outdoor workplace, altitude-related UV-increase, and refl ection from 
snow-covered surfaces mountain guides (MG) are exposed to extreme UV-radiation.
283 male MG (21-93y, median 41y) from Austria, Switzerland and Germany had a standardised 
interview and were examined on professionally sun-exposed skin areas (head, neck, arms). As 
controls traumatology patients and healthy men (18-91y, median 41y) were evaluated.
Precancerous lesions such as solar keratosis (SK) (25% vs. 7%) and solar cheilitis (53% vs. 
12%) were signifi cantly more frequent in MG. Basal cell carcinoma (BCC) was diagnosed in 
19 MG (7%), squamous cell carcinoma in 3 MG (1%). In the MG group one melanoma was 
confi rmed histologically: For 10 lesions, which were highly suspicious for melanoma, excision 
was strongly recommended.
Risks factors for SK were profession (MG vs. control), age, severe sunburns and skin pigmen-
tation. Within the MG group age, lifetime working days as a guide, severe sunburns during 
lifetime, sunburns during the last year, and the skin type were independent risk factors for 
SK. Severe lifetime sunburns were the only signifi cant risk factor for BCC. However for MGs 
lifetime working days as a guide was a signifi cant risk factor for BCC.
The present study demonstrates a correlation between high occupational UV-exposure and an 
increased prevalence of precancerous skin lesions and skin cancer. MGs may be considered 
as a model for other outdoor professions. Skin cancer in outdoor workers is likely to be an oc-
cupational disease. Primary and secondary prevention in highly UV-exposed outdoor workers 
should be reinforced.
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UVA1(340-400nm) Induces Apoptosis in Malignant B Cells and Plasma Cells Depending On 
The Level of Caspase 3 Availability
Kobayashi K, Yasuda Y, Shintani Y and Morita A
Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate 
School of Med (Japan)
Ultraviolet A1 radiation, that is radiation the range of in the range of 340-400nm, is effective 
for the treatment of cutaneous T cell lymphoma (CTCL). We have found that malignant T-cells 
are more sensitive to UVA-1 irradiation-induced apoptosis as compared with normal T-cells. 
Phototherapy is often used for the treatment of Sezary syndrome. However, the leukemic trans-
formation is refractory to the phototherapy because the malignant cells are mostly located in 
the blood. Extracorporeal photochemotherapy (ECP), consisting of extracorporeal irradiation of 
blood fractions in the presence of 8-MOP, has been used for the palliative treatment of erythro-
dermic CTCL. However, one concern in ECP is that 8-MOP is returned to the circulation of the 
patient, which may cause phototoxic effect, liver dysfunction and cataract. If the light source of 
UVA1 is used, UVA1-ECP would prevent this adverse effect induced by ECP. Therefore, UVA1-
ECP would have a great advantage in the quality of life of the patients. In order to develop, we 
investigated whether UVA1 radiation would induce apoptosis in malignant B cells and plasma 
cells as well as malignant T cells. Cells from different malignat B cell and multiple myeloma 
cell (plasma cell) lines were employed. 24 hours after UVA1 irradiation, cells were harvested 
and subjected to FACS analysis by using Annexin V method. The positive apoptosis was shown 
as 10-60% in maligant B cell lines and 20-50% in multiple myeloma cell lines at the dose of 
30J/cm2 of UVA1. From these observations, UVA1 readily induces apoptosis in malignant B 
cells and plasma cells as well as malignant T cells, although the rates of apoptosis were variable 
each cell line. Moreover, the sensitivity of B cell and plasma cell lines towards UVA-1 radia-
tion-induced apoptosis was defi ned at the level of caspase 3 availability.
456
Evidence for a Major Role for Cyclobutane Dimers in UVA Genotoxicity in Whole Human 
Skin
Mouret S1, Baudouin C2, Charveron M2, Favier A1, Cadet J1 and Douki T1
1CEA Grenoble (France)
2Institut de Recherche Pierre Fabre (France)
Solar ultraviolet (UV) radiation is the most important environmental factor involved in the 
pathogenesis of skin cancers. While the genotoxic properties of UVB radiation are now well 
established, the contribution of less energetic but much more abundant UVA radiation has 
recently emerged as a matter of concern and remains poorly understood in skin. Using a highly 
accurate and quantitative high-performance liquid chromatography coupled to tandem mass 
spectrometry assay, we investigated the formation and distribution of DNA damage in whole 
human skin exposed to UVB or UVA radiation. We presently report that cyclobutane pyrimi-
dine dimers, a typical UVB-induced DNA damage, are produced in signifi cant yield in whole 
human skin exposed to UVA. In contrast to a widely accepted hypothesis, we found that the 
latter class of photoproducts is produced in larger amount than oxidative DNA damage in hu-
man skin. Interestingly, we also found that the level of unrepaired UVA–induced cyclobutane 
pyrimidine dimers was higher than after UVB irradiation. We also compared the yields of DNA 
damage in whole skin with those determined in primary cultures of keratinocytes isolated from 
the same donors. Finally, this approach allowed us to establish that human skin effi ciently 
protects against UVB-induced DNA lesions by a factor of 22, while very weak protection is 
afforded against UVA. The corresponding value is 1.5 for UVA. These observations emphasize 
the likely role played by UVA in skin carcinogenesis and should have consequences upon 
photoprotection strategies.
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Effect of Natural Peptides (ZR101) Patented on Melanogenesis
Naaimi D1, Bredif S1, Bernard FX2, Juchaux F2 and Msika P3
1Department of Biology, Laboratoires Expanscience (France)
2BioAlternatives (France)
3R&D Center, Laboratoires Expanscience (France)
Skin reacts to ultraviolet exposure by tanning. Sunlight stimulates the melanocytes to increase 
melanin production, and also increases the transfer of melanosomes to keratinocytes. We have 
studied in vitro and ex vivo the effi cacy of natural peptides (ZR101) on skin natural pigmenta-
tion. Different pigmentation parameters including melanin synthesis, morphological modifi ca-
tions of melanocytes were analysed.
The fi rst assay was designed to precisely evaluate to level of melanin synthesis in coculture of 
normal human melanocytes and keratinocytes (240H incubation, with or without exposure to 
UV (UVA+UVB), spectrophotometry analysis). 
The potential effects of dendricity after 72H incubation and labeling with a fl uorescent probe 
specifi c of melanosome (Mel-5), was investigated (computer-image analysis) .
Finally, the study was completed by functional ex vivo assay using human skin explants (wom-
en age 31, phototype III) and analysing photography after 6 days.
IBMX (3-isobutyl-1-methyl xanthine) was used as positive control in the tests. 
ZR101 is able to signifi cantly stimulate the production of melanin, with and without UV (re-
spectively 11%, 29%, p<0.01). Under these two conditions, this stimulation was correlated 
with an increase of the protein contents and metabolic activity.
ZR101 is also able to change the morphology of melanocytes by increasing the extension and 
the number of the dendrites (respectively 67%, 27%). These data suggest the ability of ZR101 
to enhance the transfer melanosomes into neighboring keratinocytes.
Finally the study on ex vivo human skin explants demonstrated that ZR101 has cutaneous 
pigmentation accelerator effect in agreement with other tests.
Future studies will aim to investigate the mechanism by which ZR101 activates melanogenesis.
ZR101, natural peptides are enhanced the cutaneous innate and photoprotective pigmentation. 
The topical application of these specifi c peptides could allow in vivo faster tanning and thus 
could protect the skin from the stress induced by UV.
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The Infl uence of Repeated UVB Irradiation on Apoptosis of Peripheral Blood Mononuclear 
Cells
Narbutt J1, Lesiak A1, Robak T2, Sysa-Jedrzejowska A1, Wozniacka A1, Smolewski P2
1Department of Dermatology, Medical University of Lodz (Poland)
2Department of Haematology, Medical University of Lodz (Poland)
UVB-induced apoptosis is a complex process involving extrinsic (by triggering of death recep-
tors) and intrinsic (by DNA damage and reactive oxygen species formation) pathways. The aim 
of the study was to assess apoptotic index in population of PBMC after 10-day irradiation of 
human volunteers with suberythemal doses of UVB and after high UVB dose (3 MED) applied 
on a small body area. The study included 60 healthy volunteers: 30 subjects were whole-body 
irradiated with 0.7 MED UVB for 10 days; 30 individuals were exposed to 3 MED UVB (left 
buttock skin, 10x10 cm). Blood samples were taken before and 24 h after fi nal irradiation. Ap-
optosis was assessed by DNA fragmentation detection using DNA content analysis with stain-
ing with the mixture propydium iodide (PI) and RNA-se, and confi rmed by other methods, such 
as TUNEL and Annexin-V/PI assays. The percentage of apoptotic, hypoploid sub-G1 fraction 
was calculated and demonstrated as an apoptotic index (AI). We found statistically signifi cant 
higher apoptotic index after 10-day irradiation with suberythemal doses of UVB (p=0.02) while 
application of acute dose of UVB on small body area did not cause signifi cant alteration in AI 
of PBMC. The obtained results indicate that repeated suberythemal doses of UVB are suffi cient 
to induce PBMC apoptosis in healthy volunteers.
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Treatment of Severe Psoriasis with PUVA and 308 nm Excimer Laser Outreaches PUVA 
Monotherapy
Gerber W, Trott J and Ockenfels HM
Klinikum Stadt Hanau (Germany)
Objectives: Therapeutive strategies to clear up psoriasis consist of UV-light radiation using nar-
row-band ultraviolett B (NUVB) or 8-methoxypsoralen plus UVA (PUVA). Normally, these two 
PUVA and UVB-radiation procedures cannot be combined on account of phototherapeutic 
side-effects on unaffected skin. The combination of a PUVA bath with NUVB were unsuccess-
full as described by Orthel (1993) or Arnold (2001).
In contrast to common NUVB 311 nm the modern UVB excimer laser technology (308 nm) 
could offer the possibility to combine UVB 308 nm with PUVA radiation synergistically.
Methods: To analyze if the combination of the phototherapies is more effective than PUVA 
monotherapy, a prospective study was performed: 256 patients (170 men and 105 women, 
mean age 50 years) with severe psoriasis where included in the study. 113 patients were treated 
with PUVA, during the second group with 143 patients were treated with the combination of 
PUVA and up to four sessions with 308 nm excimer Laser only on the affected skin. The cure 
was documented by PASI over a time period of 4 months.
Results: Patients treated with the combination method went into complete remission in half the 
treatment time (15 ± 6 versus 27 ± 7 days, p< 0,05). The UVB dosage was approximately 4.07 ± 
3.29 and the cumulative UV A dosage could be dramatically decreased from 53.2 J/cm² ± 26.3 
to 22.9 J/cm² ± 5,8 J/cm² (p<0,01), whereas the response rate of complete or partial remission 
was not increased in the combination therapy compared to PUVA alone.
Conclusion: Skin heals considerably quicker when treated with a combination of photoche-
motherapy and a short course of UVB 308 nm laser treatment applied directly to the affected 
skin, resulting in a shorter hospital stay and quicker rehabilitation of patients with moderate-
severe psoriasis.
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DNA Repair Biochip: An In Vitro Miniaturized and Parallelized Assay for the Determination 
of DNA Repair Capacities in Skin Cells
Millau JF1, Oddos T2, Von stetten O3, Favier A4 and Sauvaigo S4
1CEA Grenoble, LCIB (UMR-E3 CEA-UJF), DRFMC, (France)
2Johnson & Johnson Consumer R&D (France)
3Johnson & Johnson Consumer R&D (Germany)
4CEA Grenoble, LCIB (UMR-E3 CEA-UJF), DRFMC (France)
DNA repair as a major defence against damage to cells is present in all living organisms. Ab-
normalities in DNA repair have been implicated in cancer and aging. Therefore the detection 
of the functionality of DNA repair enzymes in skin is of the utmost interest as skin cells are 
exposed to environmental challenges, e.g. solar light known to damage DNA through either 
the direct absorption of UV light by nucleotide bases or the generation of reactive oxygen 
species. 
Most in vitro repair assays assess the ability of cell-free extracts to correct DNA damage intro-
duced into plasmid DNA. Briefl y, repair enzymes incise the DNA near the site of the lesion, re-
move one or several nucleotides and then copy the intact DNA strand incorporating radioactive 
dNTP. Usually these assays are performed in solution and are followed by the electrophoretic 
separation of the plasmid and quantifi cation of the incorporated radioactivity. 
We have devised a miniaturized tool to characterize the repair capacities of different lesion 
types of a given cell extract better, allowing the simultaneous quantifi cation of different repair 
systems. For this purpose, DNA plasmids containing each a specifi c lesion such as UV-induced 
damage, oxidative damage, alkylated bases, psoralen and cisplatin adducts were spotted onto a 
glass-slide (Biochip). Repair reactions were then performed in situ by adding cell extracts in the 
presence of a fl uorescent dNTP. The use of the biochip technology results in a gain of sensitivity 
and in a drastic reduction of the biological material required for the repair assay. 
Specifi c repair profi les were obtained for the different cell types tested, demonstrating that the 
capacity to repair specifi c lesions may vary from one tissue to another. We also observed that 
UV light modulates DNA repair capacity in reconstituted epidermis suggesting that environ-
mental factors could not only damage DNA but also modulate repair capacity of skin cells.
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Prostaglandin E Synthases (PGES) in Epidermis are Upregulated by Ultraviolet Light (UVR) 
Exposure
Pentland A, Chung K, VanBuskirk J and Ryan J
Department of Dermatology, University of Rochester (USA)
Recent work has shown that prostaglandin(PG) E2 enhances progression of squamous cell 
cancers in skin. Treatment with drugs to inhibit PGE2 synthesis target cyclooxygenase (COX), 
but the side effects of these drugs may increase the risk of heart disease or ulcers. Recent efforts 
have focused on targeting the isomerases that act on the cyclooxygease product PGH2 to form 
PGE2. One of these, mPGEs-1, is tightly linked to COX-2 activity, and is inducible by infl amma-
tory mediators, suggesting it might be an ideal target. The other isomerases are generally con-
stitutive. We examined the regulation of all three PGE2 isomerases(mPGES-1, mPGES-2 and 
cPGES-1) in hairless mice exposed to UVR. Light was administered using a bank of UVAsun 
lamps emitting UVR between 290 and 340 nm. Animals were exposed to 90, 180, 270, or 360 
mj/cm2 UVR, and euthanized 24 h later. Solubilised curettings of snap frozen epidermis were 
then analyzed by western blot. These experiments revealed that all three isoforms of PGES were 
upregulated 2 to 3 fold. A time course studying enzyme induction 2, 6, 24, 48, or 72 h post 
UVR was then done. These experiments showed the microsomal forms of PGES were induced 
by 6h and remained elevated at 72h, while the cytosolic form thought to be linked to COX-1 
was induced by 2 hours, and returned to baseline by 72h. These data suggest that targeted in-
hibition of the mPGES-1 PGE isomerase would not be effective for prevention of squamous cell 
carcinoma in skin, since enhanced PGE2 synthesis is likely to still occur through the activity of 
the other isomerase isoforms. 
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Specifi c Suppression of Contact Hypersensitivity in Mice by Photolysis Products of Psoralens
Kyagova A1, Moshnina Z2, Kozir L1, Glazunova O1, Moshnin M2 and Potapenko A1
1Russian State Medical University (Russian Federation)
2Psoriasis Centre (Russian Federation)
Psoralens (PS) plus UVA radiation (PUVA-therapy and photopheresis) is widely used for the 
treatment of a variety of skin and autoimmune diseases associated with hyperreactivity of T-cell 
immunity. Some of the benefi cial effect of PUVA-therapy and photopheresis may be due to 
their immunosuppressive properties. Photolysis of psoralens occurs during PUVA or photo-
pheresis treatment. The role of PS photoproducts in immunosuppression is still not clear. We 
assessed effect of photolysis products of psoralen (Ps), 8-methoxypsoralen (8-MOP) and 5-
methoxypsoralen (5-MOP) on contact hypersensitivity (CSH) in mice, the experimental model 
of human contact dermatitis. It was found that orally administered photolysis products of Ps, 
8-MOP and 5-MOP induced suppression of the CHS to haptens 2,4-dinitrofl uorobenzene and 
oxazolone. The CHS suppression induced by photolysis products of PS was fl uence dependent. 
Immunosuppressive effi cacy of PS photoproducts was different: 5-MOP=8-MOP>Ps. Suppres-
sive effects of PS photoproducts on the CHS were compared with those of PUVA-treatment 
with 8-MOP or 5-MOP (orally applied 8-MOP or 5-MOP plus UVA-irradiation of the skin). We 
found that PUVA-treatment with 8-MOP or 5-MOP suppresses not only the afferent but also the 
effector phase of the CHS. Suppression of the CHS induced by PUVA-treatment with 5-MOP or 
8-MOP was fl uence dependent. Immunosuppressive effi cacy of PUVA with 5-MOP was higher 
than that for 8-MOP. Suppression of the CHS induced by PS photolysis products was found to 
be adoptively transferable and antigen-specifi c suggesting the generation of cells with suppres-
sive functions. Our results indicate that induction of systemic suppression by PUVA-therapy 
may be the result of production of PS photoproducts.
463
A Comparative Study on the Effects of the 585 nm Pulsed Dye Laser and Narrow-Band UVB 
in Plaque-Type Psoriasis
Racz E, De Leeuw J, Van Lingen R, Van Tuyll A, Both H, Prens E and Van der Fits L
Department of Dermatology, Erasmus University Rotterdam (Netherlands)
In a clinical and immunohistochemical study we compared two treatments for chronic plaque-
type psoriasis that have different modes of action, i.e. pulsed-dye laser (PDL) that mainly causes 
selective destruction of dilated papillary vessels, and narrow-band UVB that predominantly 
acts on epidermal T-cells and keratinocytes. Furthermore, a possible synergistic effect of the 
two therapies was analysed. Immunohistochemistry was applied to test whether the differences 
in the mode of action of the treatments can be visualized.
In each patient (n=27), 4 psoriatic plaques were selected and locally treated for 12 weeks 
according standard protocols with PDL, UVB, both PDL+UVB, or left untreated. Clinical im-
provement was assessed using the Physician’s Global Assessment (PGA) score for each selected 
plaque. Biopsies were taken before treatment and 2 weeks after the last treatment. Cryosec-
tions of the biopsies were analyzed for expression of transglutaminase K (TGK), CD3, von 
Willebrand factor (vWF), E-selectin and ICAM-1. 
About 50% of the patients showed clinical improvement of at least 50%. The majority of these 
responders responded to both PDL and UVB-treatment. The combined application of both 
therapies resulted in slightly but not signifi cantly more decrease in the PGA score.
In biopsies of the responders, TGK, ICAM-1 and dermal CD3 expression decreased upon all 
treatments, whereas epidermal CD3 did not show substantial changes. Expression of the en-
dothelial markers vWF and E-selectin were signifi cantly decreased in the UVB-treated plaques 
but not in the PDL-treated ones. No differences in marker expression were observed in the bi-
opsies taken before treatment between the responders versus the non-responders, demonstrat-
ing that the parameters analyzed do not have any prognostic value about therapy effi cacy.
In conclusion, PDL and UVB show similar clinical effectiveness, whereas immunohistochemi-
cal analysis of biopsies taken after treatment mainly correlate with clinical improvement, and 
do not refl ect the mechanism of action of treatment modalities.
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Surface Alterations Detected by Atomic Force Microscopy in Ultraviolet B Irradiated 
Keratinocytes
Reich A1, Lehmann B2, Knuschke P2, Muller DJ3, Meurer M2
1Dept of Dermatology, Venereology and Allergology, Wroclaw Medical University (Poland)
2Dept of Dermatology, Carl Gustav Carus Med Fac, Univ of Technology, Dresden (Germany)
3Biotechnological Center, University of Technology, Dresden (Germany)
We applied atomic force microscopy (AFM) to visualize on the single-cell level changes in 
keratinocytes morphology after UVB irradiation. Immortalised human keratinocytes (HaCaT 
cell line) were cultured under standard conditions for 24h. Cells were irradiated with nar-
row band UVB (NB-UVB) light with 50, 100, 200, 400 and 800 mJ/cm2 or left unirradiated 
for control. Irradiated and control cells were fi xed 2, 24, or 48h after irradiation and then 
imaged by AFM (NanoWizard, JPK Instruments) mounted on an inverted optical microscope. 
Topographical cell surface features were analysed by Image Processing software using the 
cross section function. NB-UVB provoked dose-dependent alterations of the keratinocyte mor-
phology. Surface of control cells showed multiple, dense and evenly distributed and shaped, 
crest-like protrusions having mean width of 0.61±0.16 micrometers and height 0.16±0.05 mi-
crometers (n=50). In contrast, cells irradiated with 800 mJ/cm2 demonstrated smaller, more 
rounded protrusions, concentrated mainly around the nucleus whereas diminished at the cell 
edge (width 0.55±0.16 micrometers, and height 0.14±0.06 micrometers, n=68), and larger, 
bleb-like protrusions, which were in smaller number and irregularly distributed on the cell 
surface (width 3.57±0.78 micrometers, height 0.95±0.29 micrometers, n=100). In addition, 
irradiated cells were signifi cantly larger than control cells (79.1±29.2x58.2±26.3 micrometers, 
n=47, vs. 41.6±10.4x27.8±9.4 micrometers, n=79; p<0.0001) and showed reduced contact 
with adjacent keratinocytes and detachment from the glass surface. About 30-40% of irradi-
ated cells had also long villi (length 8.28±5.35 micrometers, n=258) compared to control cells, 
which only sporadically had shorter villi (length 3.88±1.79 micrometers, n=100, p<0.0001). In 
conclusion, we for the fi rst time applied AFM to assess ultrastructural changes of cells irradiated 
with UVB light and were able to demonstrate pronounced alterations including changes of cell 
size, formation of bleb-like protrusions and long villi, loss of cell-cell contacts and detachment 
of the cell from the supporting surface following irradiation. We hypothesised that these mem-
brane alterations may refl ect ongoing apoptosis in UVB treated cells. 
465
Protective Effects of Catalase Overexpression on UVB-Induced Apoptosis in Normal Human 
Keratinocytes
Rezvani HR, Cario-Andre M, Pain C, Ged C, de verneuil H and Taieb A
Inserm 0217, University of Bordeaux2 (France)
UV-induced apoptosis in keratinocytes is a highly complex process in which various molecular 
pathways are involved. These include the extrinsic pathway via triggering of death receptors 
and the intrinsic pathway via DNA damage and reactive oxygen species (ROS) formation.
In this study we investigated the effect of catalase and Cu/ZnSOD overexpression on apoptosis 
induced by UVB exposure at room temperature or 4°C on normal human keratinocytes. Ir-
radiation at low temperature reduced UV-induced apoptosis by 40% in normal keratinocytes 
independently of any change in p53 and with a decrease in caspase-8 activation. Catalase 
overexpression decreased apoptosis by 40% with a reduction of caspase-9 activation accom-
panied by a decrease in p53. Keeping cells at low temperature and catalase overexpression 
had additive effects. Cu/ZnSOD overexpression had no signifi cant effect on UVB-induced ap-
optosis. UVB induced an increase in ROS levels at two distinct stages; immediately following 
irradiation and around 3 hours after irradiation. Catalase overexpression inhibited only the late 
increase in ROS levels. 
 We conclude that catalase overexpression has a protective role against UVB irradiation by 
preventing DNA damage mediated by the late ROS increase. This approach might be a promis-
ing tool against deleterious effects of UV irradiation such skin cancer especially in monogenic/
polygenic photosensitive disorders characterized by ROS accumulation. 
466
Role of Memory Effector T Lymphocytes in the Early Phase of Photosensitive Psoriasis
Cotterell LF, Rutter K, Brenn T, Chalmers RJ, Griffi ths CE, Watson RE and Rhodes LE
Dermatological Sciences, University of Manchester (United Kingdom)
A minority of patients demonstrate severely photosensitive psoriasis (PP), but the underlying 
pathomechanism is poorly understood. We examined the early histological response to pho-
toprovocation in PP (n=10) vs. non-photosensitive psoriasis (NP; n=10) and healthy volunteers 
(C; n=12).
Low dose broadband UVA (20J/cm2, 320-400 nm) was given to healthy ventral forearm skin 
on 3 consecutive days. Skin biopsies were taken 6h, 24h and 7d post-provocation, and from 
unchallenged healthy skin of the contralateral forearm. Samples were assessed immunohis-
tochemically for CD4+, CD8+ and CD45RO+ T-lymphocyte subsets, and epidermal thickness 
quantifi ed by image analysis. Photoprovocation produced a clinical response in the majority of 
PP patients, while no visible change occurred in NP or controls. Histological changes of lym-
phocytic infi ltration and epidermal thickening occurred in 4/10 PP patients, but in no subjects 
in the other groups. This PP subgroup (PPH; n=4) was analysed separately from those with no 
histological change (PPN; n=6). Epidermal thickening occurred at 7d (mean ± SE μm, C: 53.4 
± 2.6; NP: 64.4 ± 3.6; PPN: 54.3 ± 5.5; PPH: 72.3 ± 9.0, p<0.05 for PPH vs. C). Whilst CD4+ 
cells were unchanged, CD8+ cells (cytotoxic T cells) were increased in the PPH sub-group com-
pared to other groups and maximal 24h post-UVA provocation (mean ± SE cells/hpf, baseline, 
12.1 ± 4.8; +6h, 9.0 ± 4; +24h, 18.2 ± 4.7; +7d, 13.2 ± 3.0; p<0.001 for PPH vs. C). CD45RO+ 
cell (memory effector T cell) expression mirrored CD8+ (baseline, 9.1 ± 2.4; +6h, 11.3 ± 4.1; 
+24h, 20.3 ± 11.8; +7d, 8.3 ±1.3; p<0.001 for PPH vs. C). 
Histological features consistent with psoriasis are rapidly photoprovoked in a subgroup of pa-
tients with severely photosensitive psoriasis; memory effector T cells may play a role in the 
early phase.
467
Plasma Membrane Derived, but not Mitochondrial Reactive Oxygen Species are Involved in 
UVA Radiation Damage
Schauen M1, Hornig-Do H1, Schomberg S1, Herrmann G2, Wiesner RJ1
1Institute of Vegetative Physiology, University of Köln (Germany)
2Department of Dermatology, University of Köln (Germany)
Ultraviolet A (UVA), the long wavelength part of the sun’s ultraviolet radiation, elicits its harm-
ful effects through production of reactive oxygen species. In this study, we have tested the 
hypothesis that the mitochondrial electron transport chain, the main source of ROS in most 
cells, importantly contributes to UVA-induced cell damage. We irradiated cells with UVA1 and 
determined viability 24 h later. Model cell lines completely lacking a mitochondrial electron 
transport chain (ρ0-cells) were not protected against UVA-induced cell death. Also, primary 
human fi broblasts and keratinocytes with induced depletion of electron transport chain activity 
were not better protected against UVA-induced cell death. On the contrary, diphenyleneiodo-
nium and resiniferatoxin, inhibitors of plasma membrane oxidases, protected primary human 
fi broblasts against UVA, as potently as the lipid peroxidation chain breaker Trolox. These data 
indicate that plasma membrane electron transport systems, but not the mitochondrial electron 
transport chain, play a major role in UVA-induced cell death.
468
Further Characterisation of UV-Induced Regulatory T cells
Maeda A, Schwarz T and Schwarz A
Department of Dermatology, University Kiel (Germany)
Painting of contact allergens onto UV-exposed skin results in immunotolerance. This is mediated 
via regulatory T cells (Treg) expressing CD4 and CD25. In contrast to the classical CD4+CD25+ 
Treg which act contact-dependent, UV-induced Treg (UV-Treg) suppress via releasing IL-10, 
indicating that they may represent a distinct subtype of Treg. This study was performed to further 
characterize UV-Treg. Transfer of UV-Treg generated by sensitization with dinitrofl uorobencene 
(DNFB) through UV-exposed skin into naive mice inhibited the sensitization against DNFB. 
Upon depletion with antibodies against the glucocorticoid inducible TNF family-related recep-
tor (GITR) or the surface molecule neuropilin, transfer of suppression was lost. Furthermore, 
UV-Treg express FoxP3. UV-Treg act antigen-specifi c since injection of DNFB-specifi c Treg 
into the ears of oxazolone (OXA)-sensitized mice does not affect the OXA challenge. However, 
OXA challenge is suppressed when DNFB-specifi c Treg are activated before OXA challenge 
with DNFB. Hence, activation of UV-Treg is antigen-specifi c, however, once activated their 
suppressive activity is non-specifi c (bystander suppression). Thus speculations exist about the 
therapeutic potential of Treg generated in response to antigens that are not necessarily the 
precise antigen driving the pathogenic process. Thus, we asked whether multiple injections of 
DNFB-specifi c Treg into ears of naive mice followed by multiple DNFB challenges fi nally result 
in sensitization against DNFB. DNFB-specifi c Treg were injected once per week into the left 
ears of naïve mice and DNFB challenge performed 24 h later. After 3 injections a challenging 
dose of DNFB was applied on the right ear. This resulted in pronounced ear swelling, indicat-
ing that subsequent boosting of Treg had caused sensitization. These data demonstrate that 
UV-Treg express GITR, neuropilin as well as FoxP3 and that they act via bystander suppression. 
However, constant boosting of Treg with antigen doses in the challenging range results in sen-
sitization which may limit their therapeutic potential. 
469
Green Tea Polyphenols Reduce UV-Induced Apoptosis of Human Keratinocytes via an IL-12-
dependent Mechanism
Matsui M1, Mammone T1, Schwarz A2 and Schwarz T2
1The Estee Lauder Companies, Melville, NY (USA)
2Department of Dermatology, University Kiel (Germany)
Green tea chemoprevention has been a focus of recent research, as epigallocatechin gallate 
(EGCG) isolated from green tea has been suggested to prevent UV-induced skin cancer. Re-
cently, it was demonstrated that application of EGCG reduced the risk to develop skin cancer 
in a murine photocarcinogenesis model. This was accompanied by a signifi cant reduction in 
UV-induced DNA damage. The authors provided evidence that these effects were mediated via 
IL-12, which was previously shown to induce DNA repair and thereby prevent UV-induced 
immunosuppression in mice. Therefore, we studied whether a similar effect of EGCG can be 
observed in human cells. The human epidermoid carcinoma cell line KB and normal human 
keratinocytes were exposed to EGCG either 5 hours before and immediately after, or only im-
mediately after UVB irradiation (250 J/m²). UVB-induced apoptosis, which is primarily driven 
by the severity of DNA damage, was reduced in UVB-exposed cells treated with EGCG under 
both conditions. The fact that apoptosis was also reduced when EGCG were applied after 
UVB excluded a UVB-fi ltering effect of EGCG. To study whether EGCG induced IL-12, we 
used human blood monocytes which are a potent source for IL-12. Monocytes were exposed 
to EGCG and 24 hours later the amount of IL-12 released was measured. EGCG signifi cantly 
induced the secretion of IL-12. Finally, to determine whether the reduction of UV-induced 
apoptosis by EGCG is mediated via IL-12, KB cells were exposed to UVB in the absence or 
presence of EGCG. To one group of samples a neutralizing anti-IL-12-antibody was added. 
EGCG signifi cantly reduced UVB-induced cell death, an effect almost completely reversed 
upon addition of the IL-12-antibody, indicating that the reduction of UV-induced cell death 
of human cells by EGCG is mediated via IL-12. Hence the previously reported UV-protective 
effects of EGCG in human cells appear to be mediated via IL-12, presumably through its ability 
to induce DNA repair. 
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Keratinocyte Growth Factor has an Anti-Apoptotic Effect on UVB-Irradiated Normal Human 
Keratinocytes
Shirakata Y, Wang X, Yang L, Tohyama M, Tokumaru S, Sayama K and Hashimoto K
Department of Dermatology, Ehime University School of Medicine (Japan)
Ultraviolet (UV) is considered as the most prevalent environmental carcinogen for skin cancer. 
UV irradiation causes apoptosis of epidermal keratinocytes. Keratinocyte growth factor (KGF) 
also called as fi broblast growth factor 7 (FGF7) is a potent and specifi c mitogen for different 
types of epithelial cells. KGF stimulates epidermal keratinocyte proliferation. Recently it has 
been reported that KGF has an anti-apoptotic effect. Therefore, we investigated whether KGF 
could inhibit apoptosis of keratinocytes and protect DNA damage induced by ultraviolet B 
(UVB) irradiation. Keratinocytes were cultured under serum free condition. KGF was added 
to the medium and 24 h later UVB (60 mJ/cm2) was irradiated. Cell lysates were harvested at 
different time points for Western Blot. Pre-treatment of KGF suppressed cleaved-PARP, cleaved-
caspase-3 and cleaved-caspase-9, indicating that KGF suppresses apoptosis induced by UVB. 
Next we investigated annexin V expression, which is an early apoptotic marker, in keratino-
cytes by FACS analysis. Six hours after UVB irradiation, annexin V positive cells were 25% 
in non-treated cells, whereas they were 15% in KGF-pretreated cells. These results indicate 
that KGF has an anti-apoptotic effect on UVB-irradiated keratinocytes. We further investigated 
the modulation of upstream molecule involved in UVB induced DNA damage. KGF down-
regulated the expression of phospho-ATR/ATM, phospho-p53 and proapoptotic molecule Bax 
confi rmed by western blot analysis. In conclusion, these fi ndings indicate that KGF has an 
anti-apoptotic effect on UVB-irradiated keratinocytes.
471
TACE(ADAM17) Activator, 4-aminophenylmercuric acetate (APMA) Inhibits Photoaging in 
the Mouse Model
Terao M, Murota H and Katayama I
Graduate School of Medicine Osaka university (Japan)
TNFRp55 signaling is assumed to play an important role in the photoaging pathway because of 
the previous two fi ndings; (1) TNF derived from UV irradiated keratinocyte induced the expres-
sion of collagenase, (2) UV activates downstream signaling via TNFR in a ligand-independent 
manner. 
In this study, we focused on the TNF activating converting enzyme (TACE/ADAM17), which is 
a sheddase of TNFRp55. The activation of TACE form soluble TNFRp55 (sTNFRp55) which is 
known to neutralize the effect of TNF. It also reduces the cell surface TNFR and it is therefore 
expected to decrease signaling via TNFR. As TACE is known to be activated by 4-aminophe-
nylmercuric acetate (APMA), we addressed whether APMA might therefore be a potentially 
effective anti-photoaging agent. To evaluate the anti-photoaging effect of APMA, we used an 
immortalized keratinocyte cell line, HaCaT, and a photoaging model mouse (SKH mouse ex-
posed to UVB at a dose of 180mJ/cm2 every other day for 12 days).
The application of APMA to HaCaT cells increased sTNFRp55 in the culture supernatant and 
suppressed the UVB induced phosphorylation of JNK pathway in vitro. In a mouse photoaging 
model, the decrease of procollagen type1 formation and wrinkle formation by UVB irradia-
tion were prevented with topical APMA application. Taken together, these results indicate that 
APMA might therefore be a one of a potentially effective anti-photoaging agent.
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Solar Elastosis: A Key Feature in the Pathogenesis of Melasma
Torres-Alvarez B1, Moncada B1, Castanedo-Cázares JP1, Oros-Ovalle C2 and
Hernández-Barrera NR1
1Department of Dermatology, Hospital Central, University of San Luis Potosí, S.L.P. (Mexico)
4Department of Pathology, Hospital Central, University of San Luis Potosí, S.L.P. (Mexico)
Melasma is an acquired symmetrical hypermelanosis characterized by light to dark brown 
maculae on sun exposed areas of the face. Their pathogenesis has not been clearly exposed. 
The aim of this study was to evaluate the light microscopic and the histochemical features 
(Giemsa, Verhoeff-Van Giesson, Fontana Masson) on melasma lesions to be compared with 
non lesional skin and evaluated the characteristic features of photoaged skin. Moreover, we 
quantifi ed melanocytes, dermal elastosis and mast cells and evaluated the characteristic fea-
tures of photoaged skin.
Skin samples were obtained from lesional and non lesional facial skin of 30 Mexican women 
with melasma. Data on the number of melanocytes and mast cells as well as melanin contents 
of the epidermis and dermis were analyzed by a computer-assisted image analysis program. 
A computerized image analysis method was also used to determine the total area of elastic 
fi bres. In some patients we found an increased pigmentation confi ned to the epidermis, oth-
ers demonstrated increased deposits of melanin in both the epidermis and dermis compared 
with non lesional skin. Although not statistically signifi cant, data trends suggest an increase in 
dermal melanophages in the affected skin. However the most outstanding feature was the solar 
elastosis both in lesional and non involved skin, although less prominent in the latter. The mean 
quantifi cation of elastotic material was correlated with the amount of sun exposure before the 
age of 18, and with the most frequent clinical characteristics of photoageing. An increased 
number of mast cells were found in both lesional and non lesional skin. These histological 
features are seen in chronic skin infl ammation. The increased solar elastosis in melasma may 
suggest an activation of fi broblasts generating an increased amount of melanogenic cytokines 
such as steam cell factor and hepatocyte growth factor, which may activate melanocytes in the 
overlying epidermis.
473
Human Keratinocytes Undergo Mitochondrial Apoptosis through the Ask-1-p38MAPK 
Cascade in UVB Induced Sunburn Cell Formation
Van Laethem A1, Agostinis P2 and Garmyn M3
1Department of Dermatology and Biochemsitry, University of Leuven (Belgium)
2Department of Biochemistry, University of Leuven (Belgium)
3Department of Dermatology, University of Leuven (Belgium)
The UVB fraction of solar radiation is a ubiquitous stress to human skin. To escape the car-
cinogenic potency of UVB, keratinocytes dispose of the nucleotide excision repair system. 
When repair of DNA is insuffi cient, however, apoptosis occurs, eliminating the potentially 
mutagenic keratinocyte in a process called sunburn cell formation. Insight into the molecular 
mediators triggering this process and the disturbed pathways underlying the sunburn resistant, 
carcinogenic phenotype, is a requisite to fi nd effective anticancer therapeutics. We showed 
that p38MAPK mediates a strong pro-apoptotic death route for UVB irradiated keratinocytes, 
as it controls critical pre-mitochondrial events leading to cytosolic cytochrome c release and 
keratinocyte apoptosis. The upstream mediators of the p38MAPK mediated stress signal are not 
completely defi ned. The present study shows that the reactive oxygen species (ROS), gener-
ated after UVB irradiation in human keratinocytes, lead to activation of the Apoptosis Signal 
Regulating Kinase-1 (Ask-1), a redox-sensitive mitogen activated protein kinase kinase kinase 
which in turn regulates p38MAPK and JNK cascades. Inhibition of the NADPH oxidase pre-
vents UVB induced ROS, activation of the Ask-1-p38MAPK stress pathway and apoptosis. On 
the other hand the stable overexpression of Ask-1, sensitizes keratinocytes to mitochondrial 
cell death following UVB. If the p38MAPK activity is blocked by a pharmacological inhibitor 
or by using p38α-/- murine embryonic fi broblasts, the killing effect of Ask-1 after UVB is also 
reverted proving p38MAPK and not JNK, to be the main target of Ask-1. Altogether these re-
sults argue that UVB induced ROS deliver the death message to the keratinocytes through the 
mitochondrial Ask-1–p38MAPK pathway, thereby preventing the pass through of potentially 
mutagenic keratinocytes.
474
Presence of Herpes Simplex Virus DNA in Erythema Multiforme but not Polymorphous Light 
Eruption
Wackernagel A, Zöchling N, Bäck B, Kerl H and Wolf P
Department of Dermatology, Medical University Graz (Austria)
Erythema multiforme (EM), a frequently recurring (muco)cutaneous syndrome characterized by 
distinctive target skin lesions, and polymorphous light eruption (PLE), the most common idi-
opathic photodermatosis, share some similarities. The skin lesion distribution patterns in both 
conditions can resemble each other and a type of PLE morphologically resembles EM. Two in-
frequently noted but long recognized hallmarks of EM are photodistribution and photosensitiv-
ity. Both EM and PLE are suspected to have an etiology involving cell-mediated (auto)immune 
reactivity. Whereas in EM this reactivity most commonly manifests itself against pertinent anti-
gens like HSV, the PLE the antigen is as yet unidentifi ed. Reports of PLE patients, who became 
totally free of PLE symptoms while taking acyclovir, and of cases in which episodes of PLE were 
followed by recurrent EM, led us to search for the presence of HSV DNA in PLE skin lesions. 
Paraffi n-embedded blocks of skin biopsies from 31 EM patients (m, 20; f, 11; mean age, 38 y) 
and 24 PLE patients (m, 7; f, 17; mean age, 39 y) were used for PCR and Southern blot hybridi-
zation techniques. To amplify HSV DNA using PCR, a standard pair of primers defi ning a 92-bp 
segment of the DNA polymerase gene was used. Southern blot hybridization was performed 
with an internal 32P-labeled HSV-specifi c oligonucleotide probe and evaluated on x-ray fi lm. 
All 24 PLE specimens examined were negative for HSV DNA by PCR analysis and subsequent 
Southern blot hybridization. In contrast, 10 of 31 EM specimens (32%) were positive for HSV 
DNA (p = 0.003; Fisher exact test). Our inability to fi nd HSV DNA presenting in any PLE skin 
samples contradicts the hypothesis that a direct immune response to HSV in the skin is involved 
in the pathogenesis of PLE. 
475
Mycobacterium Marinum Infection Cured by Photodynamic Therapy
Wiegell SR, Kongshoj B and Wulf HC
Department of Dermatology, Bispebjerg Hospital, University of Copenhagen (Denmark)
Mycobacterium marinum is the cause of swimming-pool granuloma, commonly occuring in 
patients exposed to fi sh. 
M. marinum contains porphyrins, which are activated by appropriate wavelengths of light lead-
ing to development of various cytotoxic compounds damaging cellular components. We report 
a case of M. marinum infection treated with blue light, red light, and photodynamic therapy 
(PDT).
A 59-year old woman had a 1½-year history of erythematous granuloma on the dorsal part of 
her left fi fth fi nger and regularly contact with fi sh tanks. 
Skin biopsy showed granulomatous infl ammation and culture grew M. marinum. The patient 
was treated with doxycycline after 1½-months treatment was stopped without lesional im-
provement. 
Inspired by Finsens light treatment of skin tuberculosis the lesion was treated with blue light 
once weekly for 10 weeks. The blue light treatment resulted in resolution of the thin part of the 
lesion. The lacking effect in the thicker part of the lesion could be due to poor light penetra-
tion. 
Porphyrins are also activated by red light to a lesser extent than by blue light but penetrates 
deeper into the lesion. The thicker part of the lesion was treated with red light once weekly for 
7 weeks. After 7 treatments the lesion had improved but not resolved, and a new lesion had de-
veloped in the border of the old lesion. M. marinum might need time to accumulate suffi cient 
amounts of porphyrins to be cleared by the phototoxic effect.
In vitro incubation of M. marinum with ALA showed an accumulation of protoporphyrin IX 
after 3 hours. We therefore treated the rest-lesion with PDT once a week for 3 weeks using red 
light. The lesion cleared after PDT and no recurrence was seen 7 months post-treatment. 
The lesion was cured after light treatment and PDT and no side effect was seen indicating that 
PDT may be an effi cient treatment of swimming-pool granuloma. 
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UVB Induces a Biphasic Response of HIF-1α in Cultured Human Keratinocytes
Wikonkal NM1, Paragh G1, Wunderlich L2, Banhegyi G2 and Mandl J2
1Department of Dermatology, Semmelweis University, Budapest (Hungary)
2Department of Medical Chemistry, Semmelweis University, Budapest (Hungary)
Hypoxia in the skin is important in various events, such as chronic degenerative dermo-epi-
dermal changes, infl ammation, photoaging and carcinogenesis. In these processes, vascular 
endothelial growth factor (VEGF) plays a crucial role and is known to be affected by ultraviolet 
radiation (UV). 
Hypoxia inducible factor-1 (HIF-1) closely regulates the expression of VEGF in several experi-
mental settings. 
We set out to study the impact of acute UVB irradiation on the level of HIF-1 as a major regula-
tor of hypoxia-inducible genes. 
Effects of UVB exposure on HIF-1α expression were investigated in HaCaT cells, at several time 
points after a single irradiation by Western blots. Downstream target gene expressions were 
measured by a quantitative real-time PCR method. 
UVB treatment resulted in an initial depression in HIF-1α that was followed by a subsequent 
prolonged increase. If cells were exposed to additional UVB irradiation, another decrease in 
HIF-1α was provoked, similar to the original effect. These changes followed a strict timeline 
and were dose-dependent.
The potential role of the PI3K/AKT pathway was examined to explore the mechanism underly-
ing the upregulation of HIF-1α upon UVB irradiation. No change was observed in the total 
level of AKT after UVB treatment, however, its phosphorylation level was found to be markedly 
higher. In accordance with these observations, wortmannin, an inhibitor of PI3-kinase effec-
tively blocked the increase in HIF-1α. In agreement with previous fi ndings, UVB irradiation 
increased VEGF and HO-1 mRNA levels determined by quantitative real time PCR. 
It is concluded that changes in HIF-1α expression underlie the alterations in expression of 
VEGF upon UVB irradiation. It is supposed that UVB effects are mediated by the PI3K/AKT 
pathway.
477
Photo-Protective and Immunoregulative Effects of (–)-epigallocatechin-3-gallate on BALB/c 
Mouse Skin Damaged by Chronic Ultraviolet B Irradiation
Xu LX, Luo D, Lin XF, Ji X and Zhu J
Dept of Dermatology, the First Affi liated Hospital of Nanjing Medical University (China)
Objective: To investigate the pathological changes, p53 protein expression and the mRNA ex-
pression of three cytokines (IFN-γ, IL-10 and TNF-α) in the skin of BALB/c mouse irradiated by 
chronic UVB and to clarify the possible mechanisms of photoprotective and immunoregulation 
effects of EGCG on the skin damaged by UVB. Methods: BALB/c mice were pretreated with 
topical application of EGCG for 30 min, then different dosages of UVB were delivered at each 
exposure daily for 30 consecutive days. The skin samples were obtained after one month and 
were conserved in frozen liquid nitrogen. The mouse skin samples were made into hematoxy-
lin-eosin-stained specimens and light microscope was used to observe the histopathological 
changes; Immunohistochemical method was performed to examine p53 protein expression; 
Reverse transcription (RT)-PCR was conducted to detect three cytokines (IFN-γ, IL-10 and TNF-
α). Results: After chronic UVB irradiation, there were obvious pathological changes in the skin 
of BALB/c mouse, such as hyperkeratosis, acanthosis, sponge like edematization, sunburn cells 
occurring in the epidermis, edema in the papillary layer of dermis, telangiectasis, infl ammatory 
cell infi ltrating and so on. The intervention of EGCG could reduce such changes induced by 
UVB irradiation; The up-regulation of p53 protein expression in the mouse skin was increased 
in dose-dependent pattern in UVB irradiation groups compared to the control group. The inter-
vention of EGCG could down regulate p53 protein expression induced by UVB irradiation; The 
chronic UVB exposure to mouse skin resulted in a reduction in IFN-γ mRNA expression and 
an increase for IL-10 and TNF-α mRNA expressions after UVB irradiation. Pretreatment with 
EGCG could obviously inverse the change of the mRNA expression levels of the three cytokines 
caused by UVB irradiation. Conclusion: For UVB exposed BALB/c mouse skin, chronic UVB 
irradiation causes noticeable pathological changes and p53 protein expression and topical 
application of EGCG can protect the irradiated skin from UVB injury and reduce UVB induced 
p53 expression. EGCG also shows a potential regulation effect on UVB induced local cytokine 
mRNA expressions, which may play a crucial role in its immunoregulation mechanisms.
478
Infl uence of UVB and EGCG on Dendritic Cells Functions
Zhou BR, Luo D and Ji X
The First Affi liated Hospital of Nanjing Medical University (China)
Objective: To investigate The protection effect of epigallocatechingallate (EGCG) on The im-
mune function of dendritic cells (DCs) after UVB irradiation and its underlying manchanisms. 
Methods The monocytes were isolated from peripheral blood and cultivated into DCs wiTh 
cytokines such as GM-CSF and IL-4. DCs were harvested after culture for 7days and irradiated 
by different dose of UVB.200μg /ml EGCG was added in certain groups immediately after UVB 
irradiation. T lymphocytes were co-cultured wiTh DCs which were irradiated only by UVB or 
treated by boTh UVB irradiation and EGCG. MTT assay was used to detect The ability of DCs 
stimulating lymphocytes to proliferate. CD80, CD86,HLA-DR and CD40 surface markers on 
DCs were detected by fl ow cytometry . The level of IL-10 and IL-12 secreted by DCs 24 hours 
after culture was measured by ELISE.
Results: UVB irradiation inhibited The ability of DCs stimulating lymphocyte proliferation and 
CD80,CD86,HLA-DR and CD40 expression in a dose-dependence manner way.The inhibition 
rate of DCs was improved to some degree, respectively after treated wiTh 200μg/mL EGCG. 
When EGCG concentration was higher Than 100μg/mL, CD80,CD86,HLA-DR and CD40 ex-
pressions on DCs were protected by EGCG in a dose-dependence manner.UVB showed no 
signifi cant infl uence on IL-12 and IL-10 secretions from DCs ,while EGCG could downregulate 
IL-12 and upregulate IL-10 secretion level.
Conclusion: EGCG can regulate infl uenced cellular immune function of DCs induced by UVB 
irradiation.This function has some relationship wiTh its protecting effect of co-stimulate mol-
ecule expression of DCs and The IL-10 and IL-12 secretion level. 
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The Infl uence of (-)-epigallocatechin-3-gallate in Different Formation on the Apoptosis of 
Epidermal Cells of BALB/C Mice Irradiated by Ultraviolet B
Xu J, Luo D, Zhou Br, Hao Xj, Ma Qh, Zhang Xj and Yu Ml
The First Affi liated Hospital of Nanjing Medical University (China)
The study was to investigate the infl uence of (-)-epigallocatechin-3-gallate (EGCG) in different 
formation on the apoptosis of epidermal cells of BALB/C mice irradiated by chronic UVB. Dor-
sal skin of BLAB/C mice were treated with EGCG in different formation (solution, cream and 
liposome) and then irradiated with UVB in the dosage of 30mJ/cm2 once a day for 30 days. The 
apoptotic cells were detected by TUNEL. EGCG in different formation all showed to promote 
apoptosis, the effect of EGCG cream and liposome were better than solution（P<0.05）；and 
there was no statistic signifi cance between EGCG cream and liposome groups（P>0.05）. 
EGCG showed to promote apoptosis of epidermal cells of BALB/C mice after chronic UVB 
radiation in low dosage; the effect of EGCG cream and liposome were better than solution.
480 [002]
Stable Overexpression of Smad7 in Human Melanoma Cells Inhibits Bone Metastasis In Vivo
Javelaud D1, Mohammad KS2, McKenna CR2, Niewolna M2, André J1, Delmas V3, Larue L3, 
Guise TA2 and Mauviel A1
1INSERM U697, Paris (France)
2University of Virginia (USA)
3Institut Curie, Orsay (France)
Melanoma has a propensity to metastasize to bone, where it is exposed to high concentrations 
of TGF-β. Because TGF-β promotes bone metastases from other solid tumors such as breast 
cancer, we tested the role of TGF-β in melanoma metastases to bone. 1205Lu melanoma cells 
which stably overexpress Smad7 were studied in an experimental model of bone metastasis 
whereby tumor cells are inoculated into the left cardiac ventricle of nude mice. All mice (n=6) 
bearing parental 1205Lu cells and 4/6 mice bearing mock-transfected 1205Lu cells developed 
osteolytic bone metastases 5-10 weeks post tumor inoculation, as well as metastases to ad-
renal glands and kidney. Only 1/14 mice bearing Smad7-transfected 1205Lu cells (2 clones) 
had osteolytic bone lesions on radiographs 10 weeks post tumor inoculation and only 5/14 
were sacrifi cied after 15 weeks. The mice bearing these 1205Lu-Smad7 tumors had therefore 
signifi cantly longer survival compared to parental and mock-tranfected 1205Lu mice. To de-
termine if the reduced bone metastases observed in mice bearing 1205Lu-Smad7 clones was 
due to reduced expression of TGF-β target genes known to enhance metastases to bone from 
breast cancer cells, we analyzed gene expression of osteolytic factors, PTHrP and IL-11, the 
chemotactic factor, CXCR4, as well as CTGF and osteopontin, in Lu1205. Quantitative RT-PCR 
analysis indicated that PTHrP, IL-11, CXCR4, and osteopontin mRNA steady-state levels were 
robustly increased in response to TGF-β, and that Smad7, and the TβRI small molecule inhibi-
tor, SB431542, prevented such induction. These data suggest that TGF-β promotes osteolytic 
bone metastases due to melanoma by stimulating the expression of prometastatic factors via 
the Smad pathway. Blockade of TGF-β signaling may be effective treatment for melanoma 
metastatis to bone.
481 [041]
Oncogenic CDK4 Mutation Promotes Rapid Growth of Invasive Metastatic Melanoma in 
Carcinogen-Treated HGF/SF-Transgenic Mice
Tormo D1, Ferrer A1, Gaffal E1, Steitz J1, Wenzel J1, Heukamp L2, Malumbres M3, Barbacid M3, 
Merlino G4 and Tuting T1
1Laboratory of Experimental Dermatology, Uniklinik Bonn (Germany)
2Institute of Pathology, Uniklinik Bonn (Germany)
3CNIO, Madrid (Spain)
4Lab of Cell Regulation and Carcinogenesis, NCI (USA)
Currently, novel mouse models of melanoma are being generated which recapitulate the his-
topathology and molecular pathogenesis observed in the human disease. Deregulated receptor 
tyrosine kinase signaling and impaired cell cycle control are hallmarks of both familial and spo-
radic melanoma. Here we investigated whether a germline mutation in the cyclin-dependent 
kinase 4 (CDK4R24C) would synergize with overexpression of hepatocyte growth factor (HGF) in 
melanomagenesis. C57BL/6 mice overexpressing HGF/SF in combination with wildtype CDK4 
or mutant CDK4 mutant CDK4 were treated with 0,2 mg DMBA at day 4 after birth followed 
by twice weekly application of TPA from week 3 to 8. Carcinogen treatment signifi cantly pro-
moted the development of melanomas in HGF/SF mice. The simultaneous expression of mutant 
CDK4 had a dramatic effect on the number and the growth kinetics of melanocytic neoplams. 
HGF/SF mice homozygous for mutant CDK4 had to be sacrifi ced with around 50 rapidly grow-
ing melanomas at the early age of about 12 weeks. HGF/SF mice with wildtype CDK4 survived 
more than 30 weeks with an average of 10 slowly growing melanocytic neoplasms. Mutant 
CDK4 also promoted growth of metastatic melanoma in the lymph nodes and the lungs of 
HGF/SF mice. Apart from very few skin papillomas, we did not observe tumors of other histol-
ogy in CDK4R24C x HGF/SF mice at the time of sacrifi ce. Our results show that overexpression 
of HGF/SF and mutant CDK4 synergistically promote the rapid development of wide-spread 
carcinogen-induced melanomas in the skin of C57BL/6 mice which spontaneously metastasize 
in lymph nodes and lung. This new experimental mouse model can now be exploited to further 
study the biology of melanoma and evaluate new treatment modalities.
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Variations of the MC1R and the GSTM1 and T1 Genes in Cutaneous Malignant Melanoma
Mössner R1, Anders N1, König IR2, Krüger U1, Berking C3, Ziegler A2, Volkenandt M3, Kaiser R4, 
Westphal G5 and Reich K1
1Department of Dermatology, Georg-August-University, Göttingen (Germany)
2Institute of Medical Biometry and Statistics, University of Lübeck (Germany)
3Department of Dermatology, Ludwig-Maximilians-University, Munich (Germany)
4Department of Clinical Pharmacology, Georg-August-University, Göttingen (Germany)
5Department of Occupational Health, Georg-August-University, Göttingen (Germany)
Variations in the melanocortin-1 receptor gene (MC1R) and in the glutathion-S transferase 
genes mu1 (GSTM1) and theta 1 (GSTT1) have been reported to infl uence UV-sensitivity and to 
be associated with melanoma risk. MC1R is one of the major genes that determine skin pigmen-
tation because the melanocortin-1 receptor regulates eumelanin synthesis. GSTT1 and GSTM1 
are enzymes expressed in the skin that detoxify products of oxidative stress reactions occurring 
in response to UV-irradiation. In this study, we investigated whether variations in MC1R, and 
homozygous deletions in GSTM1 and GSTT1 are associated with melanoma and assessed the 
relation of these variations with phenotypic risk factors of cutaneous malignant melanoma. The 
region of the MC1R gene containing the majority of genetic variations was sequenced and the 
D294H polymorphism analyzed by RFLP in 347 healthy controls and 322 melanoma patients 
recruited in Germany. GSTM1 and GSTT1 null genotypes were analyzed by multiplex PCR. In 
addition, phenotypic characteristics of the study participants were recorded. 
Of the recorded phenotypic characteristics, fair skin type, high nevus count and high age were 
independently associated with melanoma (p < 0.001). We found an association of melanoma risk 
with carriage of the rare alleles of the MC1R D84E and R151C variants (odds ratio = 4.96, 95% CI 
[1.06 – 23.13], p = 0.0315, and odds ratio = 1.69, 95% CI [1.12 – 2.55], p = 0.0130, respectively). 
Melanoma risk signifi cantly increased with the total number of non-synonymous MC1R variants 
(p = 0.0030). In our study population only the D84E polymorphism infl uenced melanoma risk 
independent of phenotypic risk factors (p = 0.0468). There was no association of GST null variants 
with overall melanoma risk. In contrast to earlier results, there was also no signifi cant effect of the 
GSTM1 null variant on melanoma risk in the subgroup of individuals with reddish or fair hair. 
483 [043]
Upregulation of ASK/DBF4 and Tpr Expression in Human Cutaneous Melanomas: Two Novel 
Discriminators of Melanoma Identifi ed by Comparative Microarray Analysis
Nambiar S1, Mirmohammadsadegh A1, Hassan M1, Marini A1, Alaoui A1, Hegemann JH2 and 
Hengge UR1
1Dept of Dermatology, Heinrich-Heine-University of Duesseldorf (Germany)
2Institute of Functional Genomics for Microorganisms, Heinrich-Heine-University (Germany)
The molecular and genetic events that contribute to the development and progression of cutane-
ous malignant melanoma involve multiple molecular events orchestrated by the neoplastic cell 
and its microenvironment. With the aim to identify novel determinants describing the tumor 
progression of cutaneous melanoma, we performed oligonucleotide microarray (GeneChip HG-
U133A) based comparison of gene expression profi les of a series of nevi (n=11), primary cutane-
ous melanomas (n=10), cutaneous melanoma metastases (n=11) and melanoma cell lines (n=5) 
with normal human melanocytes (NHM) as baseline. Multiclass signifi cance analysis identifi ed 
several differentially regulated genes between nevi, primary cutaneous melanomas, and cutane-
ous melanoma metastases. Four candidate genes, activator of S-phase kinase (ASK/DBF4), trans-
located promoter region (Tpr), melanoma cell adhesion molecule (MCAM/MUC18), hepatocyte 
growth factor receptor (c-MET) were identifi ed and confi rmed in 51 additional samples by quanti-
tative real-time reverse transcriptase-polymerase chain reaction (qReal-time-PCR). We report two 
novel discriminators in development of cutaneous melanoma namely, ASK/DBF4 and Tpr. We 
also demonstrate that a signature of ASK/DBF4 and Tpr in combination with MCAM/MUC18 and 
c-MET can distinguish benign and malignant states during cutaneous melanomagenesis. In addi-
tion, immunohistochemistry showed strong ASK/DBF4 and Tpr staining in cutaneous melanoma 
and metastasis specimens. Further, as trans-acting factor binding preference for specifi c transcrip-
tional regulation in cell types are fundamental to the understanding of the resulting gene expres-
sion signatures and to uncover molecular hierarchies, we investigated if ASK/DBF4 is a transcrip-
tional target of E2F1 in melanoma. As evidenced by gel shift assays performed on nuclear extracts 
from various melanoma cell lines (SK-MEL-28, MV3, M13, A375 and BLM) in the presence of an 
anti-E2F1 antibody E2F1 binding to the ASK minimal promoter (MP) was conserved. In addition, 
cisplatin mediated abrogation of E2F1 binding to the ASK minimal MP in BLM cells also resulted 
in a transcriptional decrease of ASK/DBF4. Our data demonstrate that transcriptional activation 
of ASK/DBF4 and Tpr are two important and novel molecular discriminators in the development 
of cutaneous melanoma.
484 [044]
p53 Modulation by CP-31398 Enhances its Mitochondrial Translocation Leading to Induction 
of Apoptosis and Blockade of the Growth of UVB-Induced Squamous Cell Carcinoma
Tang X1, Kim A1, Zhu Y1, Han L1, Kopelovich L2, Bickers D1, Athar M1
1Department of Dermatology, Columbia University NY,  (USA)
2Cancer Cheoprevention Division, NCI, Bethesda, MD (USA)
Mutations in the tumor suppressor gene p53 are detectable in more than 50% of all human 
malignancies including those affecting skin. CP-31398, a small molecular weight styrylquina-
zoline is known to restore tumor suppressor functions of mutant p53 protein in tumor cells 
carrying mutant p53 under certain in vitro conditions. We recently showed that this agent is 
effective in restoring mutant p53 function and inhibits carcinogenesis in UVB-irradiated murine 
skin. We also showed that CP-31398 treatment was only effective in inducing p53-dependent 
expression of down-stream target proteins and apoptosis in UVB-irradiated wild-type mice but 
not in p53-/- littermates. To probe the molecular mechanism underlying these effects and to 
demonstrate whether this agent is equally effective in arresting growth of human SCC cells, we 
employed human epidermoid carcinoma cells, A431 cells, which carry mutant p53. CP-31398 
caused G1 arrest and a dose-dependent induction of p21, mdm2 and Bax and diminution of 
cyclin D1 expression, which was followed by cytochrome C release, caspase 3 activation and 
apoptosis. We employed a mitochondria-specifi c fl uorescent dye to show that p53 is localized 
in mitochondria of CP-31398-treated A431 cells and that p53 co-immunoprecipitates with 
the mitochondrial protein Mn-SOD. This is followed by changes in mitochondrial membrane 
potential, opening of permeability transition pore (MTP), release of cytochrome c, and SMAC/
Diablo and apoptosis. These data indicate that CP-31398 acts by translocating p53 to mito-
chondria resulting in the induction of apoptosis and consequent abrogation of UVB-induced 
skin cancer development.
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Association of a TLR9 Polymorphism with Atopic Eczema and High IgE Serum Levels
Novak N1, Bussmann C2, Maintz L2, Diaz-Lacava A3, Baurecht HJ4, Klopp N5, Wagenpfeil S6, 
Ring J7, Illig T5, Weidinger S7
1Dept of Dermatology, Univ of Bonn & GSF-National Res Center, Neuherberg (Germany)
2Dept of Dermatology, University of Bonn, (Germany)
3Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn (Germany)
4Inst of Medical Statistics and Epidemiology, TU Munich (Germany)
5Inst of Epidemiology, GSF-National-Res Center for Environ & Health, Neuherberg (Germany)
6Insitut for Medical Statsistic and Epidemiology, TU Munich (Germany)
7Dept of Dermatology & Allergy, TU Munich, GSF-National Res Ctr & ZAUM Center (Germany)
Toll-like receptors (TLR) play a pivotal role in the induction of fi rst-line defence mechanisms 
of the innate immune system and trigger adaptive immune responses to microbial pathogens. 
Defi ciencies on the level of immunity receptors such as pathogen-recognition receptors are 
suspected to affect the maturation of our immune system and to avail thereby the high preva-
lence of atopic diseases. TLR9 detects microbial DNA via CpG motifs and is expressed by plas-
macytoid dendritic cells and B-cells. CpG mediated TLR9 activation on B-cells induces B-cell 
activation and proliferation and directs the class-switch of immunoglobulins.
We evaluated TLR9 haplotype-tagging Single-Nucleotide-Polymorphisms (htSNPs) for asso-
ciation with Atopic Eczema (AE) and related phenotypes in a well characterized, large-sized 
sample of 275 families. In addition, we functionally analysed the infl uence of a polymorphism 
of the TLR9 promoter region on the TLR9 protein expression, proliferation and IgE production 
of B-cells, enriched from the peripheral blood of AE patients in relation to genetic variations 
at the TLR9 gene region. Assays for SNP genotyping were developed for all TLR9 SNPs and 
genotyping analyses were carried out by using the MassARRAY system. We observed a signifi -
cant allelic association between the rs5743836 T allele and AE (p=0.001). For the same allele 
preferential transmission was seen to elevated IgE levels (p=0.003) and allergic sensitization 
(p=0.009). We conclude that TLR9 might represent a major susceptibility locus for AE and sug-
gest an important role of TLR9 in directing the balance between Th1 and Th2 immune response 
and the modulation of the IgE synthesis. Further on, genetic variations of the TLR9 gene com-
bined with functional defi ciencies of pattern recognition receptors might promote the develop-
ment of sensitizations to microbial antigens and the paradoxical induction of Th2 dominated 
immune responses instead of Th1 directed immune responses after microbial challenge in AE.
486
p38alpha and p38delta Regulate Invasion and Growth of Head and Neck Squamous 
Carcinoma Cells
Ala-aho R1, Junttila M2, Jokilehto T2, Peltonen J3, Kallajoki M4, Grenman R5, Jaakkola P2, West-
ermarck J2 and Kähäri VM1
1MediCity Research Laboratory and Deparment of Dermatology, University of Turku (Finland)
2Centre for Biotechnology, University of Turku and Åbo Akademi University (Finland)
3Department of Anatomy, University of Turku (Finland)
4Department of Pathology, University of Turku (Finland)
5Dept of Otorhinolaryngology-Head & Neck Surgery, Turku Univ Central Hospital (Finland)
Recent studies indicate that the specifi city of p38 mitogen-activated protein kinase (MAPK)-
mediated cellular stress responses is determined by the expression pattern of the distinct p38 
isoforms. In this study, we have analyzed the function of distinct p38 isoforms in the growth and 
invasion of head and neck squamous cell carcinomas (HNSCC). Activation of p38 MAPK by 
arsenite resulted in inactivation of ERK1,2 signaling pathway by dephosphorylation of MEK1,2 
in primary human epidermal keratinocytes (HEKs), whereas this p38-mediated inhibition of the 
ERK1,2 pathway was absent in HNSCC cells. Quantitation of p38 pathway component mRNA 
expression in HNSCC cell lines compared to HEKs revealed that p38alpha and p38delta iso-
forms are predominantly expressed in both cell types and that MKK3 is the primary upstream 
activator expressed. Inhibition of endogenous p38alpha or p38delta activity by adenoviral 
delivery of corresponding dominant negative p38 isoforms potently reduced collagenase-1 
(MMP-1) and collagenase-3 (MMP-13) expression, and suppressed the invasion of HNSCC 
cells through collagen. Additionally, dominant negative p38alpha and p38delta inhibited SCC 
cell proliferation and inhibition of p38alpha activity also promoted apoptosis in SCC cells. 
p38alpha and p38delta were predominantly expressed in HNSCCs and non-neoplastic epi-
thelium in vivo, with MKK3 being the primary upstream activator. In addition, activation and 
expression of p38alpha and p38delta by tumor cells was detected in HNSCCs in vivo. Our 
results indicate that p38alpha and p38delta specifi cally promote the malignant phenotype of 
SCC cells by regulating cell survival, proliferation, and invasion, suggesting these p38 MAPK 
isoforms as potential therapeutic targets in SCCs of the head and neck.
487
Recent Quantitative Real Time RT-PCR Multimarker Technology for Detection of Circulating 
Melanoma Cells in Blood
Arenberger P, Arenbergerova M, Gkalpakiotis S, Lippert J, Kremen J and Stribrna J
Department of Dermatology, Charles University Prague (Czech Republic)
Interferon alpha is a standard treatment in patients with malignant melanoma belonging to 
stage II and III. However, it is essential to be able to detect the therapeutic response of adjuvant 
immunotherapy and to investigate if the disease is showing regression or progression in clini-
cally tumor-free patients. The best candidate for such examination seems to be the quantitative 
detection of tumor associated antigens. In the past, different authors discussed the relevance of 
such detection due to the result inconsistency. However, the main problem was a methodologi-
cal difference among various studies. The majority of the previous studies has been carried out 
with a single marker, detected by conventional or semiquantitative RT-PCR.
In our study, we introduced a quantitative multimarker real-time RT-PCR. This method detects 
the expression of tyrosinase, MART-1, MIA, MAGE-3 and gp 100 genes exhibiting high spe-
cifi city for melanoma cells. Fifty melanoma patients at stage II and III were regularly examined 
within one year. In our preliminary results, down-regulation of different markers after the onset 
of the immunotherapy with interferon-alpha was observed. Furthermore, a strong correlation 
between the up-regulation of different melanoma–associated marker expression level and de-
velopment of distant metastases was seen. The best candidate for this purpose seems to be 
MAGE-3 which became positive in 85 % of examined patients developing distant metastasis.
The results provide us with information on the frequency of melanoma-associated gene tran-
scripts and help us to determine which patients are in a risk of developing distant metastases 
and how we should proceed with the immunotherapy. The fi nal aim of our study is the routine 
usage of this method for rapid screening in melanoma risk patients.
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Mast Cell Distribution and Action in Cutaneous Tumors
Artuc M, Guhl S, Babina M and Zuberbier T
Department of Dermatology, Universitätsmedizin Berlin Charite CCM (Germany)
Mast cells (MCs) are increased in number in the vicinity of tumors. There is evidence that the 
number of peri-tumorous MCs is positively correlated with the probability of metastasis and 
with poor prognosis. Since MCs express a number of cytokines and growth factors, they may 
have an impact on tumor growth and neovascularisation. Still, little is known about MC actions 
on tumor homeostasis.
To address this question, human melanomas, spinaliomas and basaliomas of various stages 
were cut into sections of 5 μm after therapeutical excision. MCs were localised and charac-
terised by immunohistochemical double-stainings using antibodies directed against chymase, 
tryptase and c-kit. In addition, a MC-tumor co-culture system was established using primary 
human MCs combined with melanoma cells (S+, S-, SKMEL-28, Mel-1 and Mel2) or the sq-
uamous cell carcinoma cell line SCL-2 in varying MC: tumor cell ratios (1:250, 1:50, 1:10, 
1:5, 1:1). Furthermore, this panel was expanded by the use of pre-activated MCs (activated by 
crosslinking of the FCER I receptor). As an indicator for tumor cell proliferation and metabolic 
activity, WST-1 assays were performed after 48h of co-cultivation. 
In melanomas and spinaliomas, no increase in MC numbers was observed for tumors “in-situ”. 
However, as soon as the tumors began to grow invasively, an increase in surrounding fi brous 
tissue coinciding with an increase in MCs was observed. In basaliomas, an increase in MCs 
within the surrounding tissue could be observed in all cases examined.
The in vitro experiments revealed that MCs have a stimulatory effect on tumor metabolic activ-
ity, and that this effect is dependent on MC number.
We conclude that mast cells are increased in the tumor-vicinity as soon as the tumor gets 
invasive. Tumor metabolic activity is stimulated by surrounding MCs and this is positively cor-
related to mast cell number.
489
TGFβ1 Pathway Proteins in Human Non-Melanoma Skin Cancers (NMSC): Implications for 
Epithelial-Mesenchymal Transition and Metastatic Potential 
Bickers DR, Herman S, Kim AL and Athar M
Department of Dermatology, Columbia University (USA)
NMSC are the most common types of human malignancy and include basal cell carcinoma 
(BCC) and squamous cell carcinoma (SCC). Transforming growth factor-beta1 (TGFβ1) and its 
receptors have been implicated in the growth and progression of NMSC. TGFβ1 negatively 
regulates growth in normal epidermis and functions as a tumor suppressor early in tumorigen-
esis. However, its overexpression often leads to epithelial-mesenchymal transition (EMT) and a 
more aggressive phenotype. These effects are primarily mediated by Smad-dependent signal-
ing. The involvement of TGFβ1 signaling in the development of human NMSC, particularly 
BCCs, is poorly understood. In this study we tested whether the differential growth patterns of 
human BCCs and SCCs could be related to this pathway. We assessed the expression of proteins 
regulating EMT/metastasis (including TGFβ1, TGFβRII, p-Smad2, Smad4, E-cadherin, and MMP-
2) in human BCCs and SCCs and their surrounding tumor stroma using immunohistochemical 
tissue-specifi c localization of these molecules in formalin-fi xed, paraffi n-embedded samples. 
Decreased expression of TGFβ1, pSmad2, and MMP-2 was observed in BCCs whereas SCCs 
showed overexpression of TGFβ1, Smad proteins and MMP-2 as well as decreased expression 
of TGFβRII and E-cadherin. However, expression of TGFβRII and E-cadherin was seen in BCCs 
and was comparable to that observed in normal epidermis. Our data suggest that the TGFβ1 
pathway is down-regulated in BCCs, and that loss of TGFβRII expression in SCCs may correlate 
with their more aggressive growth pattern as compared to BCCs. Furthermore, the expression 
of proteins involved with invasive behavior and loss of cell adherence can be correlated with 
tumor phenotype. Our data suggest differential regulation of the TGFβ1 pathway may drive the 
unique characteristic behaviors of human BCCs and SCCs. 
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Regulation of Melanoma Cells Invasion and Migration by the Proprotein Convertases
Lalou C, Scamuffa N, Calvo F, Basset-Seguin N and Khatib AM
Inserm, U716, Hôpital Saint-Louis, Paris (France)
To date 7 members constitute the family of the proprotein convertases (PCs), namely Furin, 
PC1, PC2, PC4, PC5, PACE4 and PC7. These serine proteases were found to be involved in 
the activation of a wide range of protein precursors crucial for tumor cell malignant pheno-
types such as growth factors, receptors, MMPs, and adhesion molecules. While the latter were 
reported to be actively involved in melanomas, we postulated the implication of the PCs in 
this disease. Thus we investigated the expression and role of PCs in the processes of invasion 
and migration of melanoma cells. Using several human melanoma cells and RT-PCR analysis 
we found that all the convertases analysed were present in these cells. While there was no 
difference in furin and PC7 expression in melanoma cells, PACE4 and PC5 were found to be 
overexpressed when compared to normal melanocytes. To investigate the role of the proprotein 
convertases in the invasiveness and migration of melanoma cells we stably transfected these 
cells with the general convertases inhibitor αI-PDX. Inhibition of the PCs by this inhibitor 
reduced their ability to migrate and to invade by up to 87% and 72%, respectively. These data 
highlights the role of the proprotein convertases in melanoma cells invasion and migration and 
suggest the potential use of PCs inhibition as new promising therapeutic strategy.
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Induction of Cellular Senescence Offers a Novel Approach for Growth Arrest, 
Chemoprevention and Treatment of Squamous Cell Carcinoma of the Skin
Kim AL, Zhu Y, Athar M and Bickers DR
Department of Dermatology, Columbia University (USA)
Cellular senescence is a state of irreversible terminal growth arrest emerging as an attractive 
cancer treatment strategy. Chk2 is a key DNA damage signal transducer and is known to co-
operate with p53 signaling. DNA damage pathway dysregulation is often associated with tu-
mor development, and Chk2 mutations predispose to various human and murine epithelial 
cancers. In this study, we show that resveratrol, a phytoalexin derived from grapes and other 
fruits, induces cellular senescence in various human and murine skin carcinoma cell lines, 
including squamous cell (A431 and SCC13) and basal cell (AZ001) carcinomas. In A431 cells, 
resveratrol-induced senescence is associated with phosphorylation-dependent Chk2 activa-
tion, upregulation of p21CIP1 and p27KIP1, hypophosphorylation of pRb, and downregulation 
of cyclin D1. This resveratrol-mediated p21CIP1 induction is p53-independent, as A431 cells 
carry mutant p53. Furthermore, resveratrol treatment accompanied reorganization of chro-
matin structure in A431 cells. Transcriptionally silent, senescence-associated heterochromatin 
foci (SAHF) are known to be dependent on the pRb tumor suppressor pathway and may repress 
proliferation-promoting genes. We observed accumulation of heterochromatic structures in 
resveratrol-induced senescent A431 cells that included increases in heterochromatin protein 
1 (HP1), histone variant (macroH2A1), and PML (promyelocytic leukemia) nuclear bodies, 
known to contain PML and other proteins implicated in senescence induction. We also show 
that resveratrol induces p53-independent senescence in epidermal keratinocytes derived from 
UVB-irradiated p53-/- SKH-1 hairless mice, but not in non-irradiated mice, indicating that res-
veratrol-induced senescence induction in the skin requires DNA damage pathway activation. 
Our data suggest that induction of cancer cell senescence by resveratrol could be a potentially 
useful novel strategy for the treatment and prevention of human non-melanoma skin cancer.
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Matriptase, Proteinase-activated Receptor-2 and Hepatocyte Growth Factor Activator 
Inhibitor-1 in Skin Carcinoma Development and Progression
Bocheva G1, Rattenholl A2, Lin CY3, Steinhoff M2
1Department of Pharmacology, Sofi a Medical University (Bulgaria)
2Department of Dermatology, University of Muenster (Germany)
3Vincent T. Lombardi Cancer Center, Georgetown University Medical Center (USA)
Matriptase, also known as membrane-type serine proteinase-1 (MT-SP1), is a trypsin-like serine 
proteinase that functions as an activator for certain proteinases, proteinase-activated receptor-2 
(PAR2) and latent growth factors. In the skin, MT-SP1 is required for the formation of a func-
tional stratum corneum and for the establishment of epidermal barrier function. We could show 
previously that PAR2 plays a protective role in epidermal tumor formation and progression. 
In contrast, MT-SP1 is highly expressed in many epithelium derived tumors including breast, 
stomach, lung, kidney, prostate, and uterus carcinomas. Interestingly, both proteinase and its 
inhibitor, hepatocyte growth factor activator inhibitor-1 (HAI-1) are markedly co-expressed in 
breast cancers. This proteinase system may activate stromal-derived proteinases such as uroki-
nase-type plasmin activator (uPA), and growth/motility factors such as hepatocyte growth fac-
tor/scatter factor (HGF/SF), on the surface of breast cancer cells, enhancing their growth and 
invasive properties. Nevertheless, the expression and possible role of MT-SP1, HAI-1 and PAR2 
in skin carcinogenesis is still not established. Therefore, the aim of this study was to determine 
the expression of MT-SP1/HAI-1 and their possible co-localization with PAR2 in human basal 
(BCCs) and squamous cell carcinomas (SCCs) of different histological grades by immunohisto-
chemistry. Interestingly, staining for MT-SP1 was upregulated in some nodular BCCs compared 
to superfi cial and metatypic BCCs, respectively. In contrast, expression was high in both well 
and poorly differentiated SCCs. The expression pattern of MT-SP1 in skin carcinomas was con-
fi rmed at the protein level (70kDa) by western blot analysis. Immunoreactivity for HAI-1 was 
moderate to strong in all types of BCCs and SCCs examined. To test a possible co-localization 
between PAR2 and MT-SP1, we performed double immunofl uorescence staining. We found a 
co-localization of PAR2 with the proteinase in normal human skin but not in poorly differenti-
ated SCCs. This is in agreement with our previous results demonstrating a down-regulation of 
PAR2 in poorly differentiated SCCs, suggesting a tumor-protective role for PAR2 in epidermal-
derived skin tumors.
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ATM and p53 Gene Expression Involved in the Pathogenesis of Human Melanoma
Boyano MD1, Alonso S2, Ortega I1, Arroyo J1, Izaguirre N2, Gardeazabal J3, Asumendi A1, Peréz-
Yarza G1, Díaz-Ramón JL3, Jangi SM1
1Dept of Cell Biol & Histology, Fac of Medicine & Dentist, Univ of the Basque Country (Spain)
2Dept of Genetics, Faculty of Science and Technology, Univ of the Basque Country (Spain)
3Dermatology Service, Cruces Hospital, Barakaldo, Bizkaia (Spain)
To understand the molecular changes involved in the pathogenesis of melanoma, we com-
pared the gene expression profi les of a series of nevi and primary melanomas. Normal human 
melanocytes and melanoma cell lines were obtained in our laboratory from biopsies of three 
independent nevi and four independent primary melanomas. RNA from these specimens were 
analysed by microarray technology (Affymetrix U133A). After normalization of the data the 
resulting data table was imported into the Signifi cance Analysis of Microarrays (SAM) soft-
ware package and Onto-Express. An overexpression of p53 and repression of ATM (Ataxia-
Telangectasia- Mutated kinase) genes in melanoma cell lines were the most robust biomarkers 
identifi ed. These results have been validated by qRT-PCR. We investigated if this observation 
could be associated to any sequence polymorphism in the coding region of TP53. A muta-
tion at codon 72 responsible for a Pro -> Arg aminoacid change was found in the melanoma 
cDNAs sequenced. However, a population analysis by ARMS-PCR showed that this is a com-
mon polymorphism. This suggests that the increase of TP53 expression is not related to TP53 
coding sequence variants. Phosphorylation of ATM and p53 protein has been also studied in 
the total protein lysates from normal melanocytes and melanoma cell lines and we have found 
signifi cantly less phosphorylated ATM and p53 protein on melanoma cells than in normal 
melanocytes. As ATM is an upstream kinase of p53 involved in DNA damage and in the stabil-
ity of p53 we conclude that ATM might be involved in the pathogenesis of melanoma. Thus, 
despite of the overexpression of p53 found in melanoma cells, inactivation of ATM inhibits p53 
activity suppressing apoptosis and favouring tumorigenesis.
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The p63 and IKKalpha Regulate Keratinocyte Proliferation in SCC
Marinari B1, Giustizieri ML1, Maranke K2, Ballarò C3, Allemà S3, Roop D2 and Costanzo A1
1Department of Dermatology University of Rome “Tor Vergata” (Italy)
2Department of Molecular and Cellular Biology, Baylor College, Houston Texas (USA)
3Istituto di Biologia Cellulare, CNR, Rome (Italy)
The P63 gene belongs to the p53 gene family of tumor suppressor genes and encodes for se-
quence specifi c transcription factors. The DNp63 protein, lacking the canonical transactivation 
domain, has been proposed to identify the epidermal stem cells and to regulate their survival 
and self renewal. In an attempt to identify new potential p63 targets, we have found that the 
epidermal morphogenesis modulator IKKalpha is tightly regulated at the transcriptional level by 
different isoforms of p63. We have observed that IKKa mRNA expression increases at the onset 
of the stratifi cation program. The selective downregulation of DNp63 by siRNA in primary 
keratinocytes abolishes IKKa activation and the onset of terminal differentiation and increases 
keratinocyte proliferation rate. This is consistent with transcriptional assay data performed with 
an IKKa-promoter reporter gene showing a strong activation of IKKa transcription by DNp63 
isoforms and a low activity of TAp63 isoforms. On the other hand, the downregulation of IKKa 
in primary keratinocytes hampers the ability of differentiating cells to exit the cell cycle induc-
ing the formation of a K1 expressing proliferative layer that is reminiscent of the embryonic in-
termediate layer and of squamous cell carcinoma. The IKKa and p63 expression was evaluated 
in 49 squamous cell carcinomas and in 10 normal skin biopsies by immunohistochemistry. 
IKKa expression was found to be downregulated in the vast majority of SCCs while was strongly 
expressed in normal epidermis. Interestingly, we could also observe a strong difference in the 
nucleo-cytoplasmic distribution of IKKa in SCC (mainly cytoplasmic) vs normal skin (strong nu-
clear staining) that is consistent with the presence of K1 positive proliferating cells in SCC. Our 
results indicate IKKa as an important p63 target potentially involved in the control of epidermal 
stem cells proliferation in skin development and in cell transformation.
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Constitutive Transcription Factor Activities in Cutaneous Squamous Cell Carcinoma (SCC)
Döbbeling U, Dummer R and Häffner AC
Department of Dermatology, University Hospital Zurich (Switzerland)
Cancer cells contain constitutively active transcription factors that are normally tightly regu-
lated. Prototypes of such transcription factors are the members of the NFkB and STAT gene 
families. We checked therefore keratinocyte and SCC cell lines for the presence of these fac-
tors. We also analyzed the presence of activin and inhibin proteins, which regulate the smad 
pathway and play a role in wound healing.
Analyzing keratinocyte and SCC cell lines for NFkB and STAT proteins, we found constitutive 
activities if the p50, p52, and p65 NFkB proteins, but no STAT activities. Immunohistochemical 
stainings of normal skin showed no signs of the presence of p50 or p65 in normal keratino-
cytes. Only p52 was strongly expressed in the basal layer. Immunohistochemical stainings 
of cutaneous SCC lesions showed the presence of activin in SCC cells just neighbouring the 
normal tissue. 
We conclude that cutaneous SCC cells have a pattern of NFkB activities that differs from nor-
mal keratinocytes. In contrast to cells of SCCs of the head and neck cutaneous SCC cells 
contain no constitutive STAT factors. The presence of activin in SCC cells neighbouring the 
normal tissue, indicate that activin may be involved in the invasion of cutaneous SCCs into the 
surrounding normal tissue.
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Knock-Down of Microphthalmia-Associated Transcription Factor Increases Melanoma 
Metastatic Potential
Eichhoff O1, Schlegel N1, Saydam O2, Fraefel C2, Dummer R1 and Hoek K2
1Department of Dermatology, University Hospital of Zürich (Switzerland)
2Institute of Virology, University of Zürich (Switzerland)
Our group has used DNA microarrays to establish a molecular taxonomy of melanoma gene 
expression which describes changes between states of metastatic potential.
Our data suggested that transcriptional changes in Wnt signal targets correlate with changes in 
melanoma metastatic potential. Resistance to TGFβ growth inhibition is a marker for increased 
metastatic potential and we used this to assess the effects of changing levels in microphthalmia-
associated transcription factor (Mitf), an important target of Wnt signalling which is crucial to 
processes of neural crest differentiation, proliferation and survival. Primary melanoma cell lines 
expressing Mitf mRNA and protein were infected with Herpes Simplex Virus particles carrying 
a plasmid which expresses siRNA against Mitf mRNA. Knock down was monitored using West-
ern and RT-PCR analyses. Changes in metastatic potential of the cells were monitored through 
proliferation studies using TGFβ. We fi nd increased resistance to TGFβ growth inhibition upon 
Mitf knock-down in melanoma cells formerly expressing this factor. The experiments suggest 
that Mitf (a Wnt signal target expressed by melanomas of low metastatic potential) is involved 
in mediating susceptibility to growth inhibition by TGFβ (a marker for low metastatic poten-
tial). While further work must be performed, this data supports the thesis that Wnt signalling is 
important to maintaining a low metastatic potential in melanoma. 
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FOXP1 is not Translocated But Shows Multiple Copies in Primary Cutaneous Large B Cell 
Lymphomas
Espinet B1, Gallardo F2, Baro C1, Servitje O3, Salido M1, Salgado R1, García M1, Serrano S1, 
Pujol RM2 and Solé F1
1Department of Pathology, Hospital del Mar-IMAS, Barcelona (Spain)
2Department of Dermatology, Hospital del Mar-IMAS, Barcelona (Spain)
3Dept of Dermatology, Ciutat Universitària de Bellvitge, L’Hospitalet, Barcelona (Spain)
High expression of Forkhead box protein P1 (FOXP1) seems to be related to an unfavora-
ble prognosis in diffuse large B-cell lymphoma (DLBCL). Translocations and amplifi cations of 
FOXP1 gene, mapped to chromosome 3p13, have been described in nodal DLBCL, splenic and 
nodal marginal zone B-cell lymphoma. So far, little is known regarding mechanisms underly-
ing overexpression of FOXP1 observed in up to 40% of cutaneous large B-cell lymphomas 
(PCLBCL). The aim of this study was to investigate the presence of translocations or amplifi ca-
tions of FOXP1 gene in PCBCL.
FISH technique using a FOXP1 (3p13) dual color break apart non-commercial translocation 
probe was performed in 24 patients diagnosed of PCLBCL: 10 PCLBCL-leg type, 8 follicle-cent-
er cell lymphoma (PCFCCL) and 6 secondary cutaneous DLBCL (SLBCL). The probe consisted 
in two BACs: BAC RP11-79P21 labelled and located at 5’ of the gene and BAC RP11-713J7 
labelled and located at 3’ of the gene. All the previously described breakpoints of FOXP1 are 
located at 90Kb downstream of the gene, so that, the dual color designed probe could detect 
translocations of FOXP1. FISH was analyzed in parallel sections from those studies for mor-
phology and immunohistochemistry. In addition, four peripheral blood samples from healthy 
donors were tested as controls.
FISH technique was successful in all samples. FOXP1 translocations were not detected in any 
of the analyzed cases. However, in 14/24 samples (58.3%), 3 or 4 copies of FOXP1 were found: 
9/11 PCLBCL-leg type , 3/7 PCFCCL and 2/6 SLBCL.
Amplifi cations of FOXP1 gene but absence of translocations seems to be present in a high 
percentage of PCLBCL. It seems to be particularly frequent in PCLBCL-leg type supporting the 
hypothesis that PCLBCL-leg type are related to an activated B-cell profi le.
498
Squamous Cell Carcinoma Induced by Ultraviolet Radiation Originate from Cells of the Hair 
Follicle in Mice
Faurschou A1, Haedersdal M1, Poulsen T2, Wulf HC1
1Department of Dermatology, University of Copenhagen, Bispebjerg Hospital (Denmark)
2Department of Pathology, Sønderborg Sygehus (Denmark)
UVB is the most carcinogenic part of the ultraviolet spectrum. The target cells of skin cancer are 
considered to be the bulge stem cells of the hair follicle and/or their progenitors, the transit-am-
plifying cells that migrate into the epidermis. However, the amount of UVB penetrating epider-
mis is reported to be only around 10% with even less reaching the bulge cells, which questions 
whether these cells obtain suffi cient DNA damage and subsequent mutations to transform into 
cancer stem cells. We therefore performed this study to determine whether UV induced squa-
mous cell carcinomas originate from epidermis or hair follicles in mice. 
Hairless mice had their epidermis removed at different levels using a CO2 laser. Simulated solar 
irradiations were administrated to induce and promote carcinogenesis either preoperatively (in 
total 7 weeks) or pre and postoperatively (in total 30 weeks). Control groups included mice that 
were untreated or either submitted only to UV irradiation or laser treatment. Blinded clinical 
assessments of skin tumors were performed weekly during 12 months observation. 
Only mice irradiated with UVR for 30 weeks developed tumors. Median time to development 
of fi rst, second, and third tumor ranged from 19-20.5 weeks and was not signifi cantly different 
between non-laser and laser treated groups (p>0.05). No tumors appeared in groups of mice 
exposed only to preoperative UVR, treated solely with laser, or left untreated. 
In conclusion, the tumor response was similar in UV exposed mice whether they had their 
epidermis removed or not. Hence, UV induced squamous cell carcinomas of mice originate 
from cells located in the hair follicle, presumably the bulge stem cells. This indicates that the 
amount of ultraviolet radiation penetrating epidermis is suffi cient to cause irreversible DNA 
damage in cells located beneath the epidermis.
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Dermal Fibroblasts Isolated from Cancer Prone Xeroderma Pigmentosum Group C Patients 
Overexpress Matrix Metalloproteinase 1
Fréchet M1, Sarasin A1, Bernerd F2, Magnaldo T1
1Institut Gustave Roussy (France)
2L’OREAL Recherche (France)
Xeroderma pigmentosum (XP) is a rare, recessive genodermatosis prone to skin cancer and 
photoaging. XP results from defective nucleotide excision repair of ultraviolet-induced DNA 
lesions. Previous results obtained by reconstruction of XP-C skin in vitro strongly suggested 
the active contribution of patients dermal fi broblasts to epidermal cancer through a peculiar 
phenotype connected to remodelling of the extracellular matrix. Here, we aimed at docu-
menting in XP-C dermal fi broblasts the expression of matrix metalloproteinases involved in 
skin aging and cancer. Dermal equivalents were constructed in vitro using primary WT and 
XP-C fi broblasts (n=7) to compare their contractile properties and morphology. MMP1, 2 & 
3 expressions were analysed by ELISA, Western-blot, zymography and immunostaining, and 
real time quantitative PCR for mRNAs. MMP-1 gene trancription was analysed in both WT and 
XP-C primary fi broblasts using promoter-reporter constructs. Results showed that young XP-C 
fi broblasts exhibit aged-like features attested by elongated and dendritic morphology. MMP1 
amount and activity were signifi cantly overexpressed in XP-C compared to WT fi broblasts and 
confi rmed in situ by staining of patient skin sections. Molecular analyses revealed increased 
MMP1 transcriptional activity associated with constitutive activation in XP-C fi broblasts of the 
stress-associated AP-1 complex, a major regulatory pathway of MMP1 transcription. Constitu-
tive MMP1 increase in XP-C dermal fi broblasts may contribute to skin aging and exacerbated 
epidermal carcinogenesis and underscore the role of fi broblasts in epidermal cancers. Our 
fi ndings could be taken into account for prevention and care of XP-C patients.
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T- and B-Cell Clonality Evaluation In Primary Cutaneous Lymphomas Using The Standardized 
BIOMED-2 PCR Protocols
Gallardo F1, Parera E1, Costa C2, Estrach T3, Servitje O4, Garcia-Muret MP5, Serrano S2, Pujol 
RM1 and Bellosillo B2
1Department of Dermatology, Hospital del Mar, Barcelona (Spain)
2Department of Pathology, Hospital del Mar, Barcelona (Spain)
3Department of Dermatology, Hospital Clinic, Barcelona (Spain)
4Department of Dermatology, Hospital de Bellvitge, Barcelona (Spain)
5Department of Dermatology, Hospital de Sant Pau, Barcelona (Spain)
The aim of this study was to determine the usefulness in clonality detection of the BIOMED-2 
Concerted Action BMH4-CT98-3936 PCR protocols in paraffi n-embedded samples in a series 
of primary cutaneous lymphomas (CTCL/CBCL).
One hundred and seventy samples were evaluated: 105 CTCL (51 patch/plaque mycosis fun-
goides (MF), 3 tumor MF, 3 Sézary syndrome (SS), 29 lymphomatoid papulosis (LyP), 6 CD30+ 
CTCL, 13 non-MF CTCL) and 29 large-plaque parapsoriasis (PP). 37 cases of CBCL (27 mar-
ginal zone (MZL), 10 cutaneous large B-cell lymphomas (LBCL)) were also included. In addi-
tion, 30 samples of psoriasis/eccema and 18 lymphoid reactive hyperplasia (LRH)s were also 
analyzed. A dominant T-cell clone was demonstrated in 63% of CTCL cases: 34/51 (66%) 
patch/plaque stage MF, 2/3 (66%) tumor MF, 2/3 (66%) SS, 1/29 (3%) of PP and 0/30 of benign 
chronic infl ammatory diseases. T-cell clonality was identifi ed in 15 out of 29 (52%) skin biop-
sies of LyP lesions, in 4/6 (66%) of CD30+ lymphoma cases and 9/13 (69%) of non-MF CTCL. 
B-cell monoclonality was demonstrated in 73% of CBCL cases (18/27 (67%) MZL and 9/10 
(90%) of LBCL) using a combined approach of FR1, FR2 and FR3 primers. In contrast when 
analizing exclusively FR3 IgH rearrangements, in only 43 % of MZL cases a B-cell monoclonal 
population was identifi ed. None of LRH samples disclosed a dominant clone.
Our study shows that BIOMED-2 mutiple PCR approach appeared to be a highly informative 
strategy in the diagnostic process of patients with a suspiscion for primary CTCL/CBCL when 
analyzing paraffi nized material. It seems to be particularly informative and specifi c for the 
distinction of early MF and infl ammatory dermatoses. False negative detection rate of B-cell 
clonality can be reduced using additional VH primers to FR2 and FR1.
501
Epigenetic Silencing of the PTEN Gene in Melanoma
Mirmohammadsadegh A1, Marini A1, Nambiar S1, Hassan M1, Tannapfel A2 and Hengge UR1
1Department of Dermatology, Heinrich-Heine-University (Germany)
2Institute of Pathology, Ruhr-University of Bochum (Germany)
Phosphatase and tensin homologue deleted from chromosome 10 (PTEN) seems to be an im-
portant tumor suppressor gene (TSG) in melanoma. As it is only infrequently deleted or mutated 
and as the PTEN protein is low to absent in a signifi cant number of melanoma, we investigated 
alternative methods of epigenetic silencing. We performed positional methylation analyses in 
sera from patients with melanoma in addition to assessing the methylation status in both, cor-
responding sera and frozen melanoma specimens in 21 patients by pyrosequencing and Taq-
Man® RT-PCR, respectively. We report signifi cant PTEN methylation in sera of patients with 
melanoma and melanoma metastases. The percentage of methylation of a selected CpG island 
in blood showed a detectable, but weak correlation with methylation levels in corresponding 
melanoma tissue. In corresponding frozen melanoma specimens and corresponding patients 
sera, the rate of methylation correlated with PTEN expression. Using the demethylation agent 
5-Aza-2’-deoxycytidine (5-Aza) reduced methylation and a corresponding increase in PTEN 
protein were observed in BLM melanoma cells, leading reduced AKT activity in an in vitro 
kinase assay. In summary, epigenetic PTEN silencing seems to be a relevant mechanism of in-
activating this important TSG in melanoma patients that may promote melanoma development 
by de-repression of the AKT pathway. Analyzing positional methylation of circulating DNA of 
TSG may hold diagnostic promise for monitoring the course of melanoma.
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Novel CYLD mutations Spiegler-Brooke Syndrome: Identifi cation of Aspartic Acid 681 as 
Crucial Amino Acid for Enzymatic Function
Almeida S, Maillard C, Hohl D and Huber M
Department of Dermatology, CHUV, Lausanne (Switzerland)
Spiegler-Brooke syndrome (SBS), an autosomal dominantly inherited genetic predisposition 
for benign tumors of skin appendages, is caused by mutations in the CYLD gene localised on 
chromosome 16q12-13. The encoded protein functions as ubiquitin specifi c protease (UBP) to 
negatively regulate the NF-κB and JNK signalling pathways. We investigated fi ve SBS families 
whose patients all showed heterozygous germline mutations in CYLD. All mutations led to 
premature stop codons except for one missense mutation (D681G) in a family presenting only 
with trichoepithelioma and spiradenoma. This mutation, which does not affect amino acids of 
the CYLD catalytic triad (Cys601, His871, Asp889), was introduced into CYLD cDNA (CYLDD681G) 
to study its effects on NF-κB and JNK signalling pathways compared to wild type CYLD and 
CYLDC601A. The results of either luciferase-based assays measuring NF-κB activation mediated 
by TRAF2 or TRAF6, or kinase-based assays evaluating JNK activity after TNFα treatment dem-
onstrated that the mutation D681G reduced the enzymatic activity to a level comparable to 
the one of the active site mutant C601A. These fi ndings emphasize the crucial role of aspartic 
acid 681 for CYLD activity which is highly conserved in CYLD orthologues and other members 
of the UBP family. The homologous residue D295 of UBP7 (HAUSP) is important to make 
hydrogen bond to the C-terminal end of the ubiquitin substrate. Mutation of the D295 residue 
in UBP7 abolished the enzymatic activity. In summary, these experiments support the notion 
that D681 in CYLD has a critical role in binding the ubiquitin substrate and might be involved 
in determining the specifi city towards K63-linked polyubiquitin chains. 
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Protease Expression Profi ling of Head and Neck Squamous Carcinomas
Joutsa J1, Ala-Aho R1, Stokes A2, Pennington C2, Grenman R3, Peltonen J4, Edwards D2 and 
Kähäri VM1
1MediCity Research Laboratory and Department of Dermatology, University of Turku (Finland)
2Department of Cell Biology, University of East Anglia (United Kingdom)
3Department of Otorhinolaryngology, Turku University Central Hospital (Finland)
4Department of Anatomy, University of Turku (Finland)
Squamous cell carcinomas (SCCs) of the head and neck are malignant tumors with high abil-
ity to invade locally and metastasize to lymph nodes. To determine new candidates for the 
targeted therapy of SCCs we analyzed head and neck SCC tumors and cell lines by quantitative 
real-time RT-PCR (Taqman). Expression levels of mRNAs for different matrix metalloproteinases 
(MMPs), metalloproteinases with a disintegring domain (ADAMs), ADAMs with thrombospon-
din domains (ADAM-TSs), and tissue inhibitors of metalloproteinases (TIMPs) were analyzed 
from 41 head and neck SCC cell lines and compared to the expression levels in normal human 
epidermal keratinocytes. The expression levels of MMP-7, MMP-11, MMP-13, MMP-14, MMP-
16, MMP-24 and ADAM-28 were clearly enhanced in SCC cell lines compared to normal 
keratinocytes. The expression of MMP-19, ADAMTS-1 and TIMP-1 mRNAs were most clearly 
reduced in SCC cell lines as compared to normal keratinocytes. The mRNA levels for metal-
loproteases and TIMPs were also analyzed from 57 head and neck SCC tumor samples and 
compared to expression levels in tumor adjacent tissue samples. The expression of MMP-12, 
MMP-13, MMP-14 and ADAMTS-8 was most potently upregulated in SCC tumors as com-
pared to adjacent tissues samples. The levels of mRNAs for MMP-24, MMP-27, ADAMTS-5, 
ADAMTS-9 and all TIMPs were downregulated in SCC tumors. These observations warrant 
further evaluation of these genes as potential prognostic markers and therapeutic targets in 
head and neck cancer.
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Epilysin (MMP-28) Induces TGF-beta Mediated Epithelial to Mesenchymal Transition in Lung 
Carcinoma Cells
Illman SA, Lehti K, Lohi J and Keski-Oja J
Departments of Pathology and Virology, University of Helsinki (Finland)
Epilysin (MMP-28) is the newest member of the matrix metalloproteinase (MMP) family. Al-
though it is expressed in a number of tissues, no biological substrates or functions for this 
enzyme have been identifi ed yet. We have expressed recombinant epilysin in A549 lung ad-
enocarcinoma cells and found that this resulted in stable and irreversible epithelial to mesen-
chymal transition (EMT) accompanied by loss of cell surface E-cadherin, proteolytic processing 
of latent TGF-β-complexes and increased levels of active TGF-β. The cascade of events leading 
to the onset of EMT could be prevented by the MMP inhibitor GM6001 or antibodies neutral-
izing the bioactivity of TGF-β. Once EMT had occurred the cell phenotype could not, how-
ever, be reversed by the MMP-inhibitor. Importantly, the expression of epilysin also resulted 
in upregulation of MT1-MMP and gelatinase-B (MMP-9) and in the collagen invasive activity 
of A549 cells. Further, we found that epilysin and the recombinant hemopexin domain were 
targeted to the surface of epithelial cells. This cell surface interaction was lost upon EMT, and 
was sensitive to the proteolytic activity of MT1-MMP. Current results indicate that epilysin 
can induce EMT and cell invasion through a TGF-β dependent mechanism suggesting novel 
biological roles for this enzyme in the regulation of epithelial cell function and in the induction 
of carcinogenesis.
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Presence of Fetal Endothelial Cells in Melanomas During Pregnancy
Nguyen Huu S1, Aractingi S2, Oster M1, Boitier F3, Mortier L4, Avril MF3 and Khosrotehrani K2
1EA4053, Université Pierre et Marie Curie, Paris 6 (France)
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3AP-HP, Hôpital Cochin, Service de Dermatologie, Paris (France)
4CHRU Lille, Hôpital Claude Huriez, Service de Dermatologie (France)
Purpose: Chimeric cells are able to develop tumors in recipients. Since fetal cells invade the 
maternal circulation during pregnancy and may adopt various tissue phenotypes, we studied 
the presence and the phenotype of such fetal cells in maternal melanomas occurring during 
pregnancy.
Methods: Formalin-fi xed, paraffi n-embedded archival specimens of 17 melanomas, 4 benign 
naevi and one basal cell carcinoma obtained from women bearing a male fetus or who had 
given birth to a male child six month prior to the surgery were collected. Fetal cells were detect-
ed by fl uorescence in situ hybridisation (FISH) with specifi c probes to X and Y chromosomes. 
FISH was performed at least twice on each patient. The phenotype of fetal cells was identifi ed 
by combination of FISH and immunolabelling. 
Results: Patients were 25 to 40 years old.. Fetal cells were detected in 11/17 melanomas, 
almost exclusively in the dermis. No fetal cell was detected in 4 naevi and one basal cell 
carcinoma sample (p=0.004). Fetal cells expressed endothelial cell markers such as CD31 (20 
positive cells out of 28 tested: 20/28), or CD34 (1/12). Interestingly, fetal CD31+ cells were 
clustered, displaying the morphology of a blood vessel in one case. Fetal CD45+ cells were 
found in only one case. Fetal S100A1 expressing cells were found in 227/302 studied slides, 
without HMB45 nor cytokeratin expression. 
Conclusion: melanomas developing during or immediately after pregnancy display signifi -
cant presence of fetal cells. These may adopt various phenotypes, most usually endothelial 
cells, sometimes leading to fetal angiogenesis. Such engraftement may theoretically infl uence 
the disease evolution.
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The Resveratrol Analogue M8 (3,3’,4,4’,5,5’-hexahydroxystilbene) is a Potent Inhibitor of 
Melanoma Growth In Vitro and In Vivo
Paulitschke V1, Holzweber A1, Szekeres T2, Scheiner O3, Pehamberger H1 and Kunstfeld R1
1Department of Dermatology, Medical University Vienna (Austria)
2Clinical Institute for Medical and Chemical Laboratory Diagnostics (Austria)
3Pathophysiology, Medical University Vienn (Austria)
Resveratrol (3,5,4’ trihydroxystilbene) , a polyphenolic compound derived from various plants 
including grapes, displays benefi cial effects on a variety of tumor cells. In an attempt to in-
crease the anti-tumor effect of resveratrol, we have generated the higher hydroxylated stilbene 
analogue 3,3’,4,4’,5,5’-hexahydroxystilbene termed M8. In vitro, M8 dramatically inhibited 
the proliferation of melanoma cells including the highly metastatic human melanoma cell line 
M24met. Interestingly, in non-metastatic melanoma cells the anti-prolifertive effect of M8 was 
only moderate. The anti-tumor effects of M8 were signifi cantly more pronounced in M8 treated 
cells compared to resveratrol. To evaluate the underlying mechanisms we perform proteomic 
analyses on different melanoma cell lines in vitro. We demonstrate that M8 exerted cell line 
specifi c modulations of proteins, which are involved in the regulation of oxidative stress. Cru-
cial oncogenic stimuli such as Ras and Akt were analyzed by western blotting to evaluate the 
therapeutic impact of this new agent. 
In our recently established human melanoma SCID mouse model we demonstrate that M8 
signifi cantly impairs tumor progression. In conclusion, M8 exerts its antiproliferative effects 
via blockade of oncogenic stimuli such as Ras and Akt, involvement in cellular regulations of 
oxidative stress and impairment of tumor growth in vivo. M8 appears to represent an innovative 
and potent approach for the treatment of melanoma.
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Multiple Primary Melanoma in a Patient Receiving Levodopatherapy and Presenting a 
CDKN2A Germline Mutation and Two MC1R Moderate Risk Variants
Charles J1, Templier I1, Bressac de Pailleret B2, Leroux D3, Richard MJ4, Sarasin A5 and Leccia MT1
1Dermatologie, Département Pluridisciplinaire de Médecine, CHU de Grenoble (France)
2Service de Génétique, Institut Gustave Roussy Villejuif (France)
3Département d’Oncogénétique, CHU de Grenoble (France)
4Unité Mixte de Thérapie Tissulaire et Cellulaire, CHU de Grenoble (France)
5CNRS UPR 2169 Institut Gustave Roussy Villejuif (France)
A 58-year old male patient presented a fi rst melanoma in the three years that followed the intro-
duction of levodopa for a Parkinson’s disease. In the 4 next years he presented 21 other cutane-
ous melanoma (confi rmed by a referent anatomopathologist for pigmented tumor). This patient 
was of phototype II and had an history of high sun exposure. Because of multiple melanoma 
and of a possible role of levodopa in melanoma development and progression (levodopa and 
melanin sharing a common metabolic pathway in pigmented cells), we aimed at exploring the 
genetic background and also enzymatic pathways for DNA repair and antioxidant defences 
of this patient. The study of two high-risk genes for melanoma, CDKN2A and CDK4, showed 
that our patient was carrier of a tandem germline mutation of CDKN2A leading to a signifi -
cant loss of function of p16INK4A. We found no mutation of CDK4. MC1R, the type 1 Receptor 
for the Melanocortin, that is expressed on melanocytes surface and regulates the balance of 
eumelanime and phaeomelanine synthesis in this cells, was also studied and two variants of 
the MC1R gene associated with increased melanoma risk were identifi ed in our patient. DNA 
repair analysis was performed including analysis of nucleotide excision repair and analysis of 
UV sensitivity in the presence of caffeine. We identifi ed neither XP syndrome nor XP variant 
syndrome. Investigations focussing on anti-oxidant defences are in progress. Melanin photo-
sensitized oxidant production could actually be implicated in melanoma induction.
The concomitance of levodopa therapy on a strong genetic predisposition in this fair skin patient 
may explain the occurrence of numerous melanoma. The role of levodopa in melanoma devel-
opment should be reconsidered especially in patients with high risk genetic background.
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Protein S100β and Melanoma Inhibitory Activity: Prospective Study of their Clinical Value for 
the Early Detection of Metastasis in Malignant Melanoma
Loppin M1, Adamski H2, Quillien V3, Chevrant-Breton J2 and Ollivier I2
1Department of Dermatology, CH Saint Brieuc (France)
2Department of Dermatology, CHU Rennes (France)
3CRLCC, CHU Rennes (France)
Introduction: We have studied whether the serum values of proteins S100B and MIA would 
allow early and reliable screening of a metastatic growth in melanoma.
Patients and methods: We realised a prospective study from 1998 to 2005 about patients affect-
ed by non-metastatic melanomas, whose Breslow’s ratings were above 0.75mm. Four PS00B 
and MIA measurements per patient were regularly administered within 1 or 2 years. Blood 
samples were analysed for PS100B and MIA by an ELISA assay. 
Results: 50 patients were subsequently analysed. Maximum time difference between two sam-
ples was 8 months. A metastatic evolution happened for 15 patients. When melanoma evolved 
to Stage III, the sensitivity was 33.3% for PS100B and 25% for MIA. When it evolved to Stage 
IV, the sensitivity was 70% for PS100B and 30% for MIA. In 3 cases, elevation of the PS100B 
value happened before the discovery of metastasis. The specifi city of the dosage was 100% for 
PS100B and 91.4% for MIA. 
Discussion: We found that sensitivity and specifi city were higher for PS100B than for MIA for 
the spotting of metastasis during the follow up of thick melanomas. The technique ELISA used 
for this research seems to increase the specifi city of the dosage, but not its sensitivity, compared 
to the other techniques used previously. Therefore we can confi rm the benefi ts of the dosage of 
the PS100B for early spotting of metastasis in melanomas. However this biological surveillance 
can not substitute a regular clinical follow up, due to its low sensitivity.
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Type VII Collagen Regulates Squamous Cell Carcinoma Cell Migration and Proteinase 
Expression
Martins VL1, Vyas JJ1, Purdie KJ1, Chen M2, McGrath JA3, Storey A1, South AP1 and O’Toole EA1
1Centre for Cutaneous Research, ICMS, Queen Mary, University of London (United Kingdom)
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Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited blistering skin disorder due 
to mutations in the gene encoding for type VII collagen, COL7A1. In RDEB patients, anchor-
ing fi brils can be morphologically abnormal, reduced in number or completely absent. SCC 
is the major cause of morbidity and mortality in RDEB, with over 55% of patients dying from 
SCC by the age of 40. Because reduction in collagen VII expression is a hallmark of RDEB, we 
investigated whether collagen VII levels affected proteinase expression or cell migration, factors 
involved in tumour progression/invasion. SCC cell lines derived from patients with and with-
out RDEB, as well as COL7A1-transduced SCC RDEB cell lines were established. A retroviral 
pSUPER RNAi system was used to stably down-regulate collagen VII expression in a SCC non-
RDEB cell line. Levels of metalloproteinases (MMPs) and serine proteinases expression were 
measured in the different cell lines, and scratch and colloidal gold assays were performed to 
assess cell migration. A SCC RDEB cell line with absent expression of collagen VII showed re-
duced levels of the metalloproteinase, MMP-2, and the serine proteinase PAI-1, and increased 
levels of the metalloproteinase inhibitor TIMP-1, when transduced with COL7A1. We observed 
higher migration rates in SCC non-RDEB when compared to SCC RDEB cells, and COL7A1-
transduction of a type VII collagen null SCC RDEB cell line led to a 1.5-1.7 fold increase in cell 
migration. Preliminary experiments demonstrated that down-regulation of collagen VII in SCC 
non-RDEB cells by RNAi resulted in decreased cell migration. Our data suggest that collagen 
VII directly modulates proteinase activity and increases cell migration, which might be relevant 
for tumour invasion in both non-RDEB and RDEB SCC. 
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Signalling Mechanisms in Squamous Cell Carcinoma Migration and Invasion
Vyas JJ2, Green J2, Proby CM1, Storey A1 and O’Toole EA2
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2Centre for Cutaneous Research, ICMS, Queen Mary, University of London (United Kingdom)
Invasion and migration play a fundamental role in squamous cell carcinoma (SCC) metastasis. 
In this study, we used a series of cutaneous SCC cell lines representing different stages of 
epidermal carcinogenesis to examine the biological events during SCC invasion in vitro. Cells 
were derived from histologically dysplastic forehead skin (PM1) and SCC cell lines were from 
a primary cutaneous tumour (MET1), a local recurrence (MET2) and a distant lymph node 
metastasis (MET4) from the same patient. Migration was examined using the colloidal gold and 
scratch assays in response to EGF, 10 nm, and Western blotting was performed for signalling 
molecules known to be involved in migration. SCC lines displayed increased adhesion on type 
1 collagen and fi bronectin, and hypermotility and increased invasion compared to PM1 cells 
(MET2>MET4>MET1>PM1). MET2 and MET4 did not respond to the pro-motility effect of EGF 
(p<0.001), compared to PM1 or MET1 keratinocytes. Migration in the presence of EGF was 
blocked by an EGFR neutralising antibody in PM1 and MET1, but not MET2 and MET4, sug-
gesting that metastatic cells were EGF-independent. ERK1/2 and JNK were induced in response 
to EGF in PM1 and MET1, but not in MET2 and MET4. P38 MAPK was induced in PM1 only. 
Signifi cantly, NFκB p50/105 expression was increased in MET1/2/4 with a reciprocal decrease 
in IκBα. Immuno-fl uorescence staining showed increased staining of NFκB p50 and NFκB 
p65 nuclear staining in MET1/2 cells. Data mining of Affymmetrix chip data on these cell lines 
revealed increased IL-8 expression in MET1>MET4 compared to PM1 and increased gro-beta 
and gro-gamma expression in MET2/4 (metastases). As IL-8 and gro-beta/gamma are regulated 
by the ERK1/2 MAP Kinase and NFκB pathways, respectively, these data further delineate the 
sequence of events in SCC invasion.
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Allelic Imbalances and Chromosome 9p Microdeletion Demonstrated in Cutaneous Squamous 
Cell Carcinomas Using Single Nucleotide Polymorphism Microarray Analysis
Purdie K1, Lambert S1, Harwood C2, Teh T3, Kelsell D2, Young B4, Leigh I2 and Proby C2
1Cancer Research UK Skin Tumour Laboratory (United Kingdom)
2Centre for Cutaneous Res, Queen Mary’s School of Med, Univ of London (United Kingdom)
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Cutaneous squamous cell carcinomas (SCC) are the second most commonly diagnosed can-
cers in white-skinned populations yet the genetic mechanisms involved in SCC tumorigenesis 
remain poorly understood. We have employed single nucleotide polymorphism (SNP) microar-
ray analysis to examine genome-wide allelic imbalance in 16 primary and 2 metastatic SCC 
against corresponding non-tumour samples. The most frequent genetic change was loss of het-
erozygosity (LOH) on chromosome 9p, observed in 13 of 16 primary SCC. Other recurrent 
events include LOH on chromosomes 3p, 8p and 13 (observed in 10, 8 and 7 primary tumours 
respectively) as well as allelic gain on chromosomes 3q and 8q (each in 6 primary SCC). Copy 
number analysis demonstrated that most LOH was due to deletion. However, 3 of 7 samples 
with chromosome 13 LOH and 3 of 13 samples with 9p LOH did not show copy number loss, 
implying that LOH was due to somatic recombination leading to acquired uniparental disomy 
(UPD), an event not previously demonstrated in SCC. As well as identifying recurrent patterns 
of gross chromosomal changes, SNP microarray analysis revealed a microdeletion on chromo-
some 9p23 within the protein tyrosine phosphatase receptor type D (PTPRD) locus. This event 
was observed in 3 primary SCC, 2 of which had demonstrated metastatic potential. Our data 
validates SNP microarray analysis as an accurate and sensitive method for evaluating the global 
genetic changes underlying SCC tumorigenesis. 
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Genomic Aberrations in Morphologically Malignant Cells of Subcutaneous Panniculitis Like 
T-Cell Lymphoma
Hahtola S1, Burghart E2, Karenko L1, Jeskanen L1, Polzer B2, Wolf M3, Pettersson T4, Monni O5, 
Klein C2 and Ranki A1
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4Department of Internal Medicine, University of Helsinki (Finland)
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of Helsinki (Finland)
Subcutaneous panniculitis-like T-cell lymphomas (SPTL) represent a rare subtype of cutaneous 
T-cell lymphomas (CTCL), and are diffi cult to diagnose. To study the molecular pathogenesis 
of CTCL, we collected morphologically malignant cells of seven SPTL patients by laser micro-
dissection, isolated and amplifi ed genomic DNA with a reliable whole genome amplifi cation 
method. Chromosomal comparative genomic hybridization (CGH) as well as CGH on cDNA 
microarrays were performed to identify DNA copy number aberrations characterizing SPTL. 
CGH revealed large numbers of DNA copy number changes, the most common of which were 
losses of chromosomes 1pter, 2pter, 10qter, 11qter, 12qter, 16, 19, 20, and 22, and gains of 
chromosomes 2q, and 4q. CGH microarray narrowed some of these areas, and genes possibly 
having a role in SPTL pathogenesis could, thus, be identifi ed. For instance, DNA copy number 
losses were demonstrable on eight adjacent genes in the region 19p13.2-p13.1. Among these 
deleted genes are e.g. IL27 receptor alpha, essential to the initiation of Th1 response in T-helper 
cells, and the EGF-TM7 family membrane antigen CD97. The DNA copy number aberrations 
identifi ed in this study overlap to some extent to those characteristic to the most common 
subtypes of CTCL, e.g. mycosis fungoides and Sezary syndrome, but differences predominate. 
Our fi ndings thus support the WHO-EORTC classifi cation of SPTL being a separate CTCL sub-
group, and identify new chromosomal aberrations and candidate genes for the development of 
specifi c diagnostic tools and targeted therapy.
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Expression Profi ling of the NAV3 Protein, Deleted/Translocated in Common Forms of 
Cutaneous T-Cell Lymphomas
Carlsson E1, Häyry V2, Zhou Y3, Karenko L1, Virtanen I4, Krohn K3 and Ranki A1
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We recently reported that deletion/translocation of the Nav3 gene in 12q21 is a common aber-
ration in cutaneous T-cell lymphoma (CTCL). Nav3 is a potential haploinsuffi cient tumor sup-
pressor gene, but nothing is known about its function in neuronal or lymphoid tissue. To mimic 
the in vivo gene deletion, we designed a lentiviral siRNA construct to silence the Nav3 gene. 
The siRNA construct was cloned into the lentiviral vector pLL3.7, and the derivative (a 23-nt 
sequence from exon 19) with most effi cient inhibition was used. To study the expression and 
function of Nav3 in neuronal and lymphoid cells in parallel, we used human neuronal stem 
cells (HNSC, self-renewing cells from the subventricular zone of human fetal brain), induc-
ible to differentiate into astrocytes, neurons and oligodendrocytes, and glioblastoma cell lines 
A172 and U118 MG. As lymphoid cells, the Jurkat cells and fresh PBL were used. In confocal 
microscopy, Nav3 was detected with a polyclonal anti-Nav3 peptide antibody, neurons were 
identifi ed with Tuj-1 (class III β-tubulin), and stem cell markers Nanog, Nestin, BMI-1 and 
Oct4 were identifi ed with respective antibodies. The differentiated HNSC and glioblastoma 
cell lines showed high levels of Nav3 by western blot, immunocytochemistry and RT PCR. The 
siRNA construct decreases the level of Nav3 expression by 88%, and Nav3-silenced cells show 
increased levels of apoptosis (TUNEL) but also cell proliferation (BrdU). Although Nav3 has po-
tential actin-binding domains, no co-localization with actin was found. Instead, in the glioblas-
toma cells, preliminary results indicate co-localization of the embryonic stem cell transcription 
factor Nanog and Nav3. Nanog is a transcription factor, essential for the pluripotent phenotype 
and the self-renewal of human embryonic stem cells. It is not expressed in adult tissues, except 
for various cancers, and has been shown to accelerate cell proliferation. Thus, our fi ndings, 
although preliminary, provide new insight to the basic mechanisms of Nav3 function. 
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Gene Expression Analysis of Papillomas from Proteinase-Activated Receptor-2-Defi cient and 
Wild-Type Mice
Rattenholl A1, Seeliger S2, Buddenkotte J1, Ehrchen J1, Schön MP3, Schön M3, Ständer S1 and 
Steinhoff M1
1Department of Dermatology, University of Münster (Germany)
2Department of Pediatrics, University of Münster (Germany)
3Rudolf Virchow Center, University of Würzburg (Germany)
Proteinase-activated receptors (PARs) play an important role in the tumorigenesis of various 
tissues. PAR2 is a G protein-coupled receptor which can be activated by specifi c proteolytic 
cleavage of the extracellular N-terminus. The truncated N-terminus then interacts with the sec-
ond extracellular loop of the receptor, leading to receptor activation. PAR2 is strongly expressed 
in epidermal keratinocytes and is known to inhibit keratinocyte proliferation in vitro. Moreover, 
PAR2 formation is downregulated in dedifferentiated epidermal skin tumors. We could show 
that in a chemically induced skin tumor model, PAR2-defi cient mice developed fi vefold more 
papillomas as compared to the wild-type. However, no differences regarding keratinocyte dif-
ferentiation and apoptosis could be observed in these papillomas. To further analyze potential 
reasons for the facilitated tumor growth in PAR2-defi cient animals, differences in papilloma 
gene expression of both groups were studied by gene array analysis and qRT-PCR. We found 
that the expression of Ym2, a chitinase-like protein, was upregulated in PAR2-defi cient mouse 
papillomas. Ym2 is produced by mast cells and is known to be upregulated during infl am-
mation. It binds glycosaminoglycans and might play a role in hematopoiesis, tissue remodel-
ling and immune response. This leads to the conclusion that in PAR2-defi cient mice, immune 
defense mechanisms of the skin, i.e. against papilloma viruses or transformed cells might be 
impaired, thus facilitating epidermal tumor formation and progression.
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SPARC Represses E-cadherin and Induces Mesenchymal Transition During Melanoma 
Development
Robert G1, Gaggioli C1, Bailet O1, Chavey C2, Abbe P1, Aberdam E3, Cano A4, Garcia de Her-
reros A5, Ballotti R1 and Tartare-Deckert S1
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During progression of melanoma, loss of the cell-cell adhesion molecule E-cadherin contrib-
utes to uncontrolled growth and invasive behavior of transformed melanocytes. Secreted Pro-
tein Acidic and Rich in cysteine (SPARC) is a nonstructural matricellular protein that regulates 
cell-matrix interactions leading to alterations in cell adhesion and proliferation. Overexpres-
sion of SPARC has been associated with progression of various cancers including melanoma, 
however its role in primary tumor development is not well defi ned. Primary human melano-
cytes overexpressing SPARC using adenoviral transduction adopted a fi broblast-like morphol-
ogy, concomitant with loss of E-cadherin and P-cadherin expression, and increased expres-
sion of mesenchymal markers. Concurrent with theses changes, SPARC expression stimulates 
melanocyte motility and melanoma cell invasion. Expression of SPARC results in transcrip-
tional downregulation of E-cadherin that correlates with induction of Snail, a repressor of E-
cadherin. Conversely, SPARC depletion by siRNA leads to upregulation of E-cadherin, reduces 
Snail levels and SPARC-null cells exhibit a marked change in their mesenchymal phenotype. Fi-
nally, analysis of SPARC, Snail and E-cadherin levels in melanocytes and malignant melanoma 
cell lines further supports the functional relationship between these proteins during melanoma 
progression. Our fi ndings provide evidence for the role of SPARC in early transformation of 
melanocytes and identify a novel mechanism whereby tumor-derived SPARC promotes tumori-
genesis by mediating Snail induction and E-cadherin suppression. 
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Raf Kinase Inhibitor Protein is not Involved in the Metastatic Progression of Squamous Cell 
Carcinoma of the Skin: Lack of Classical MAP Kinase Activation
Rokunohe D1, Nakano H1, Kaneko T1, Aizu T1, Nakajima K1, Ikenaga S1, Ohashi S1
Hanada K1 andTsuchida S2
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The Raf kinase inhibitor protein (RKIP) exerts an inhibitory effect on the Ras/Raf/MEK/ERK in-
tracellular signaling pathway by binding to either Raf or MEK, resulting in the interference with 
the activation of MEK by Raf. Recently, the decreased expression of RKIP has been demon-
strated to be associated with the metastatic nature of some tumors such as prostate cancer and 
malignant melanoma. To elucidate the role of RKIP in relation with the Ras/Raf/MEK/ERK path-
way in the development of squamous cell carcinoma (SCC) of the skin, we performed immuno-
histochemical analysis using 35 individual SCC samples for detection of the expression of RKIP 
and phosphorylated ERK. Most of the proliferating SCC cells in 35 samples showed moderately 
positive staining of RKIP; the intensity of staining was higher than that in malignant melanoma 
cells, in which RKIP was negative or slightly positive. On the other hand, the differentiating 
(keratinizing) cells in moderately- or well-differentiated SCC were strongly positive for RKIP, 
consistent with our previous observation that the RKIP protein amount was increased by high 
concentration calcium treatment in cultured normal human keratinocytes. The RKIP expression 
in metastatic lesions of SCC was not declined as compared to that in primary lesions. We next 
investigated the activation status of the Ras/Raf/MEK/ERK pathway by immunohistochemistry 
for detecting the phosphorylated ERK (pERK) in SCCs. Only a faint staining of pERK was dem-
onstrated in more than 90% of SCC samples, while the parallel staining of melanoma sections 
resulted in a strong positivity. Furthermore, no differences of pERK expression were evident be-
tween primary or metastatic SCC lesions. These data suggest that in SCC the Ras/Raf/MEK/ERK 
signal transduction pathway is not highly active as demonstrated in melanoma cells. RKIP may 
be involved not in the metastatic progression of SCC, but in the keratinization of the tumor cells 
of SCC subtypes retaining the differentiation process of normal keratinocytes.
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Do Langerhans Cells Play a Role in Vulvar Epithelium Resistance to Squamous Cell 
Carcinoma?
Rotsztejn H1, Trznadel-Budzko E2 and Jesionek-Kupnicka D3
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Langerhans cells (LC) are a very important part of the skin immune system (SIS). 
We estimated skin biopsies taken from 13 women after removing vulvar squamous cell carci-
noma (SCC). The control group consisted of 12 women who underwent a plastic surgery op-
eration of the vulva region. Immunohistochemical staining was performed on formalin-fi xed, 
paraffi n-embedded tissues samples, using antihuman CD1a antibody (NCL-CD1a-235, NO-
VOCASTRA).
Our work has shown a large decrease of LC in vulvar SCC. 
We postulate that the reduction in a number of LC may be one of the reasons for a higher ten-
dency of carcinogenesis in the vulvar region. Their role as a main element of the skin immune 
system in the initiation of this process needs further investigation. It is possible that research 
on LC in the skin will cast a new light on their role and even contribute to the prophylaxis and 
treatment of skin and mucosa carcinomas.
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High Resolution Cytogenetic Analysis Using 10K Affymetrix SnPs in a Group of Patients with 
Sezary Syndrome
Caprini E, Narducci MG, Citterich-Helmer M, Picchio MC, Tocco V, Cristofoletti C, Frontani M, 
Arcelli D, Baliva G and Russo G
Ist Dermopatico dell’ Immacolata - Ist Ricovero e Cura a Carattere Scientifi co, Rome (Italy)
Sezary Syndrome (SS) is a form of Cutaneous T-Cell Lymphoma characterised by a distinct 
metastatic pattern mainly involving skin and blood. Exact pathogenesis of this disease is un-
known and no characteristic genetic lesion is really associated. 
High-density single nucleotide polymorphism (SNP) arrays enable high-resolution and ge-
nome-wide detection of loss of heterozygosity (LOH) and copy number (CN) abnormalities. We 
used Affymetrix 10K-SNP mapping array to investigate genetic aberrations of 13 individuals SS. 
Genomic DNA from SS tumour samples, consisting of sorted CD4 population from peripheral 
blood, and paired normal from granulocyte fraction, were genotyped using GeneChip Hu-
man Mapping 10K Array (Affymetrix) containing 11,560 tiled SNPs. LOH involve the follow-
ing chromosomal regions: 9p21.2p21.1(31%), 9q21.2q21.32(31%), 10p12.1p11.21 (38%), 
10p11.21q11.21(31%), 10q21.1q21.3(31%), 10q23.1q25.3(46%), 17p13.3-17q11.1(62%). 
Gains were most frequent at chromosome 17q(54%) and chromosome 8. This latter one results 
in entirely duplicated in 3 out of 13 patients, while smaller common amplifi cations encompass 
regions 8q12.3q13.3(46%)and 8q21.3q22.3(46%).
Almost all individuals showing loss of the 17parm have also gain of the 17q, suggesting the 
presence of the isochromosome 17q, a frequently reported abnormality in SS. Furthermore, 
we characterised the chromosome LOH pattern identifying seven regions of signifi cant loss 
shared by multiple tumours. Sample clustering based on signifi cant LOH regions identifi ed two 
groups of patients: one consisting of 4 patients with a lower rate of chromosomal losses, other 
containing 9 patients mainly characterised by the co-occurrence of LOH at chromosome17 
and 10. These results are in agreement with previously reported results using conventional 
techniques, demonstrating the feasibility of the 10K-SNP system to assess allelic imbalance. 
However this technique allows identifi cation of a larger number of LOH regions. Even though 
no signifi cant statistical association can be observed due to the low number of cases available, 
we observed a lower overall survival in the group of 9 patients showing simultaneous LOH 
events at chromosome 17 and 10.
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Introduction: Cutaneous squamous cell carcinoma (CSCC) derivates from transformed epithe-
lial keratinocytes frequently developing on sun-exposed areas with occasional local invasion 
and metastasic potential. The aim of this study was to analyze chromosomal abnormalities by 
array-CGH and evaluate the signifi cance of the detected genetic aberrations in relation to the 
clinical and histological features. Methods: Nine patients (8 males/1 female; mean age 75) with 
CSCC were included in the study. DNA was extracted from frozen tissue. Forward and reverse 
hybridizations were performed in test and control samples using the Spectral Chip 2600ΤΜ 
(Spectral Genomics), an array consisting on 2,621 BAC clones at an average of 1-2 Mbp resolu-
tion, according the manufacturer’s specifi cations. Fluorescent images were obtained using an 
Agilent G2565BA scanner and quantifi ed using GenePix 6.0 software (Axon, Molecular De-
vices) using the irregular feature fi nding option. Extracted raw data was fi ltered and normalized 
using Bacanal and an in house web server implementation of the Limma package developed 
within the Bioconductor project in the R statistical programming environment. Results: All 
cases showed genetic alterations, predominantly gains. Gains were observed in decreasing 
order in 5p15.2, 9q31.3-q33.2, 13q, 18q22, 1p21-p22, 1q24-q25, 3p13, 4q33-q34 (HMGB2, 
SAP30), 20p12.2 (JAG1), 21q21.1, Xq21.33. A recurrent loss was only observed in 9p13.1-
p13.3 region. No correlation between gains or losses and clinicopathological features was 
observed. Conclusions: The use of the CGH-array tecnique has rarely been reported in CSCC. 
The fi nding of gains in 5p, previously described with other tecniques, indicates the presence 
of recurrent aberrations. The detection of abnormalities in small regions in chromosome 1 il-
lustrates the capacity of this technique to detect small alterations. Larger numbers of tumours 
should be analyzed with CGH-array to better understand the genetic aberrations implicated in 
the tumorigenesis of this disorder.
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Inhibitor of DNA Binding/Differentiation 2 and Transforming Growth Factor beta’s Growth 
Inhibitory Effect on Melanoma
Schlegel NC, Dummer R and Hoek KS
Department of Dermatology, University Hospital Zürich (Switzerland)
Resistance to the growth-inhibitory effects of TGFβ is a hallmark of aggressively metastatic 
melanomas, however nothing is known about the mechanism of this resistance. By contrast, re-
sistance to Activin A, a TGFβ-like molecule with similar signalling properties, is common even 
in weakly metastatic melanomas. Using melanomas differentially susceptible to the growth 
inhibition effects of TGFβ and Activin A, we sought to identify genes involved in melanoma’s 
response to these factors. After screening a number of melanoma cell cultures and characteris-
ing their susceptibility or resistance to TGFβ and Activin A, we used gene expression profi ling 
to characterise their differential responses to theses factors. We identifi ed the gene Id2, a mem-
ber of the Inhibitors of DNA binding/differentiation (Id) group, as being potentially involved 
in mediating the cytostatic effect of TGFβ. Id2’s twofold role in the regulation of the cell cycle 
is particularly interesting. Id2 is a dominant negative inhibitor of differentiation-specifi c basic 
helix-loop-helix transcription factors. Furthermore, unlike other Ids, it also binds and regulates 
the activity of the pRb family of proteins. A marked downregulation of Id2 RNA after incuba-
tion with TGFβ in susceptible cells was not observed in resistant cells. Protein levels were also 
shown to be decreased by western blotting. Id2’s known role in the regulation of the cell cycle 
and the modulation of its expression by TGFβ in susceptible cells suggest the involvement of 
this gene in melanoma growth and proliferation.
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Functional Analysis of Chemokine Receptors CXCR3, CCR4, CCR7 and CCR10 on Circulating 
T Cells of Sezary Syndrome Patients – A Preliminary Study
Sokolowska-Wojdylo M1, Gaffal E2, Basner - Tschakarjan E2, Speuser P2, Buechs S2, Sobjanek 
M1, Roszkiewicz J1 and Tueting T2
1Department of Dermatology, Medical University of Gdansk (Poland)
2Department of Dermatology, Medical University of Bonn (Germany)
INTRODUCTION: The migratory properties of T lymphocytes is determined by adhesion mol-
ecules and chemokine receptors on their cell surface. Both CLA and CCR4 are expressed on 
circulating CD4+ T cells in Cutaneous T Cell Lymphomas (CTCL). We reported that circulating 
CD4+ T cells in Sézary syndrome (SS) express CCR7 as well as CCR10 and may represent a 
malignant expansion of cutaneous central memory T cells. There is no explanation why those 
T cells stay in blood in SS and late stages of CTCL in spite of migration to skin or/ and lymph 
nodes according to their chemokines’ phenotype. To further analyze the migratory properties 
of Sézary T cells, we decided to establish cell lines for future experiments.
MATERIAL AND METHODS: (1) T cells were isolated from heparin blood of CTCL patients (11 
experiments) and healthy voluntiers (3 experiments) in gradient of Lymphoprep® (2) Chemok-
ine Migration Assays were performed with chemokines: IP-10 (CXCR3 ligand), TARC (CCR4), 
MIP-3β (CCR7) and CTACK (CCR10). (3) Migrated cells were analyzed by three (3)-color fl ow 
cytometry (anti-CLA FITC, anti-CD 4PE, anti-CD3 PerCP antibodies) using the TruCount Tubes® 
system. (4) T cells and dendritic cells were cultured with IL-2, IL-4, IL-7 and GM-CSF (6 experi-
ments), with IL-2 and IL-7, or with IL-7 alone. (5) T cells in culture were analyzed with three 
(3)-color fl ow cytometry and antibodies specifi c for monoclonal TCRVβ.
RESULTS AND CONCLUSIONS: CD4+CLA+ T cells from SS patients are able to migrate 
(chemotactic index >1) in response to the chemokines MIP-3β, TARC and CTACK. No migra-
tion was observed in response to IP-10 in spite of the high expression of this chemokine in 
the skin of CTCL patients. Migration to MIP-3β, CTACK and TARC, but not to IP-10 was also 
observed in circulating T cells of healthy voluntiers. The chemotactic indices with MIP-3β and 
TARC were signifi cantly higher in SS than in heathy voluntiers. 
Immature dendritic cells (DC) supported the culture of Sézary cells in vitro. With increased 
maturation of DC in culture, the population of Sézary cells decreased signifi cantly. Maturation 
of DC could be exploited for the treatment of CTCL in the future.
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High Frequency of BRAFV600E Mutation in Acquired Nevi and Small Congenital Nevi, but Low 
Frequency of Mutation in Medium-Sized Congenital Nevi
Takata M, Ichii-Nakato N, Takayanagi S, Murata H, Lin J and Saida T
Department of Dermatology, Shinshu University (Japan)
To investigate whether the frequency of the BRAFV600E in melanocytic nevi is associated with 
sun exposure patterns, we examined the mutation in 120 acquired melanocytic nevi excised 
from various anatomic sites including glabrous skin, as well as in 62 congenital nevi. We used a 
new mutation detection system based on the shifted termination assay, called Mutector, which 
was able to detect only 5% of heterozygous mutant cells within the samples. We detected the 
mutation in 105/120 (87.5%) acquired nevi and 43/62 (69.4%) congenital nevi. Notably, we 
found the mutation in 35/43 (81.4%) acquired nevi excised from glabrous skin and genitalia. 
These results strongly suggest that ultraviolet light is not necessarily required for the acquisition 
of the BRAFV600E mutation, and suggest that non-mutagenic effects of ultraviolet light to melano-
cytes may be more important in the nevogenesis. Additionally, we showed heterogenous dis-
tribution of BRAF-mutated cells within the lesions of small congenital nevi by a combination 
of laser microdissection and direct sequencing. Finally, we found low frequency of BRAFV600E 
mutation (6/20, 30.0%) in medium-sized congenital nevi. Most of these nevi with wild-type 
BRAF had NRAS mutations (9/14, 64.3%), suggesting different pathogenesis of medium-sized 
congenital nevi from acquired nevi and small congenital nevi.
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Melanocytic Expression of Organic Anion Transporting Polypeptides and Modifi cations of the 
Vasculogenic Mimicry Displayed by Aggressive Melanoma Cells
Parriaux D1, Verine A1, Lombardo D1 and Verrando P2
1INSERM U777, University of the Mediterranean (France)
2INSERM U777 and LIMP, University of the Mediterranean (France)
Transport proteins of the ATP-binding cassette family can mediate high drug resistance in 
melanoma. To our knowledge, outside-in transporters and subsequent signaling that could im-
balance such resistance have not been truly considered. This initial study looked for the pres-
ence of members of the recently identifi ed human superfamily of organic anion transporting 
polypeptides (OATP) in melanocytic cells and their possible interactions with aggressiveness 
in melanoma cells. For this purpose, we carried out RT-PCR on normal human melanocyte 
cultures and on two highly- and poorly-aggressive human cell lines derived from cutaneous 
and metastatic uveal melanoma tumors. Protein expression was ascertained by immunofl uores-
cence technique. Several OATP substrates were used to record phenotypical changes that they 
could induce with regard to vasculogenic mimicry. This phenomenon is unique to aggressive 
cells and correlates to poor clinical outcome in patients.
Normal melanocytes display transcripts for 6 out of the 9 known human OATP, with differences 
in abundance. In transformed cells, except for 2 OATP members that were expressed in either 
cell lines, other OATP discriminates according to the aggressive status. Exposure of aggressive 
cells to OATP substrates (cholate, taurocholate, Rifampicin, Rifamycin), or to either TNFα or 
Phenobarbital, did not result in main changes in transcript amounts but, importantly, in modi-
fi cations of vasculogenic mimicry. Focusing on OATP1B3 present only in aggressive cells, we 
found that its organic anion substrates induced modifi cations/disorganization of the vasculo-
genic mimicry, in a dose-dependent manner. A Monoclonal antibody against OATP1B3 and 
OATP1B1 located these transporters exclusively to vasculogenic tubular structures. Conclu-
sively, this study shows OATP occurrence in melanocytes and melanoma cells with discrimina-
tion according to melanoma cell aggressiveness, and gives evidence for possible modulation of 
vasculogenic mimicry linked to aggressiveness by OATP organic anions substrates. 
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Early Response Transcription Factors Promote Cell Death and DNA Repair of UV-Irradiated 
Epidermal Cells
Aberdam E1, Turchi L1, Kitajima S2, Wicking C3, Aberdam D1 and Virolle T1
1INSERM U634 (France)
2Department of Biochemical Genetics (Japan)
3Institute for Molecular Bioscience (Australia)
UV light is one of the major cause of genomic instability. During such a stress, normal epider-
mal cells orientate their physiological response toward DNA repair or, if the extent of dam-
ages is too important, undergo apoptosis. This process, deleterious for cell survival, is crucial 
because it leads to the destruction of cells that bear the risk to become tumorigenic. Here we 
show that repression of early response transcription factors such as Egr-1 or ATF/CREB family 
members promotes survival following UV mediated genotoxic stress and in addition impairs 
the DNA repair process. We provide further evidences that these transcription factors are im-
portant players belonging to a signaling cascade dependent on p38, JNK and NF-κB pathway. 
We then observed that Egr-1 contributes to the regulation of Gadd45a and Gadd45b genes, that 
are involved in the control of cell cycle, DNA repair and apoptosis, by direct binding to their 
promoter. Therefore, our study demonstrate that early response transcription factors are major 
player of a crucial signaling cascade leading to the control of DNA repair and cell death of 
genotoxic stressed epidermal cells. Impairement of such a pathway is likely to promote onco-
genesis by allowing accumulation of survival cells that bear severe chromosomic alterations.
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Loss of p16 Overcomes GLI Induced Hypermitogenic Arrest in Immortalised Keratinocytes
Williams T, Philpott M and Neill G
Center for Cutaneous Research, QMUL (United Kingdom)
Hedgehog (Hh) signaling is associated with the development of several neoplasms including 
basal cell carcinoma (BCC) which is linked to mutational inactivation of Ptch1 and the sub-
sequent activation of the GLI (Gli1 and Gli2) transcription factors. Interestingly, despite high 
levels of GLI transcript, BCC’s are slow growing and rarely metastasise.
Here we detail the characterisation of N/Tert-1 cells overexpressing Gli1 and Gli2. We de-
termined by MTT analysis that retroviral expression of the EGFP- Gli1 and EGFP-Gli2 fusion 
proteins inhibited the proliferation of immortalised keratinocytes (N/Tert-1) even in the pres-
ence of exogenous growth factors and that these cells do not passage successfully. This was also 
associated with marked reduction in cell size and enhanced cell-cell adhesion as demonstrated 
by redistribution of E-cadherin and β-catenin to the cell membrane. FACS analysis revealed a 
notable increase in the number of cells arrested in the G1 phase of the cell cycle that correlated 
with an increase in expression of the cell cycle inhibitors p16 and p27 but not p53. However, 
the concomitant increase in Cyclin D1 expression suggests that GLI cells are subject to a phe-
nomenon termed ‘hypermitogenic arrest’ (senescence) that is characterised by simultaneous 
pro- and anti-proliferative signals. Accordingly, GLI cells stained positive for the senescence-
associated β-Gal marker. When expressed in a comparable keratinocyte cell line (OKF6/Tert-2) 
that is p16 null, GLI again induced colony formation but the number of cells arrested in G1 was 
decreased and the cells were successfully passaged. 
We propose that, paradoxically, increased GLI expression in BCC may account for its slow 
growth and poor metastatic potential and that further genetic events are required to overcome 
this anti-proliferative modality. Reduced p16 expression has been observed previously in the 
most proliferative areas of BCC. As such, we propose that reduced epidermal p16 expression 
may co-operate with GLI to promote BCC formation through loss of a major proliferative block 
that is usually associated with more aggressive epithelial tumours.
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Molecular Mechanisms of As-Induced G2/M Cell Cycle Arrest in Kerationcytes
Yu HS1 and Liao WT2
1Department of Dermatology, National Taiwan University College of Medicine (Taiwan)
2Div of Environmental Health & Occupational Med, National Health Research Insts (Taiwan)
Long-term exposure to arsenic has been documented to induce cancers in multiple organs 
including skin. Arsenic-induced Bowen’s disease (As-BD, a carcinoma in situ) is the most com-
monly encountered arsenic skin cancer. Abnormal proliferation, dysplasia and apoptosis are 
observed in the epidermal lesions of As-BD. To elucidate the molecular mechanisms of these 
characteristic pathological features in As-BD, we investigated the effects of arsenic on cell cycle 
regulation of keratinocytes. Among the 15 As-BD specimens, G2/M arrest and aneuploid DNA 
distribution were observed in 10 patients and 3 patients, respectively. To confi rm the mecha-
nisms associated with arsenic-induced G2/M cell cycle arrest, a DNA micro-array analysis in 
cultured keratinocytes was performed. Our results revealed that the major effects of arsenic on 
keratinocytes were in cell cycle regulation genes. Our in vitro studies further confi rmed that As 
triggered the p53-related cell cycle arrest at G2/M phase. Decreased levels of M phase-specifi c 
cyclin B1/CDK1 were associated with increased levels of cell cycle inhibitory proteins, such as 
p21waf1/cip1 and 14-3-3. These results of arsenic-induced G2/M phase arrest were compatible 
with the fi ndings observed in the lesions of As-BD. The p53-related regulation in G2/M arrest 
will be helpful to understanding the patho-mechanisms of As-induced Bowen’s disease.
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Amplifi cation of Sonic Hedgehog Signaling by TGF-β: Smad3-Dependent Activation of Gli 
Transcription Factors
Dennler S1, André J1, Alexaki I1, Javelaud D1, Li A2, Wang XJ2, Verrecchia F1 and Mauviel A1
1INSERM U697, Paris (France) 2OHSU (USA)
Hedgehog and TGF-β family members are involved in numerous overlapping processes during 
embryonic development, hair cycle and cancer. In this study, we demonstrate that TGF-β modu-
lates the expression of Hh signaling molecules in various skin cell types, including fi broblasts, ke-
ratinocytes, and melanocytes, Specifi cally, we demonstrate that TGF-β induces a rapid induction 
of Gli2 mRNA which does not require de novo protein synthesis. Gli2 activation preceeds that of 
Gli1, whose activation by TGF-β is blocked by cycloheximide. We demonstrate that SB431542, 
a small molecule inhibitor of TβRI/ALK5, blocks TGF-β-induced modulation of Gli2 expression 
while pharmacologic inhibition of the ERK, JNK and p38 MAPKs, PKA or PI3K is without ef-
fect. Furthermore, we demonstrate that Smad3 knock-down with specifi c siRNA oligonucleotides 
blocks Gli2 induction by TGF-β. Using tagged Gli expression vectors, we demonstrate that TGF-β 
induces Gli nuclear translocation. In addition, EMSA experiments indicate that TGF-β promotes 
Gli binding to cognate DNA sequences. Using either recombinant Shh or a transfected Shh ex-
pression vector, we demonstrate that Gli2 activation is specifi c achieved by TGF-β, and that 
TGF-β and Shh have additive effects on Gli1 activation. Also, in various melanoma cell lines that 
exhibit high constitutive TGF-β signaling, we observed constitutive Gli2 and Gli1 expression, 
which could be downregulated by pharmacologic inhibitors of the Smad pathway. Interestingly, 
we found that Gli1 and Gli2 expression is 3-6x higher in the hyperproliferative epidermis of K5-
TGFβ1 transgenic mice as compared to that of wild-type mice. Together, these results indicate 
that TGF-β is able to activate the intracellular events of the Hh pathway in the absence of Shh, and 
to bolster Shh activity. Work is in progress to identify specifi c cellular functions are affected by 
Gli2 induction by TGF-β and to determine the specifi c contribution of TGF-β to processes initially 
thought to be exclusively dependent upon Shh signaling.
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Keratinocytes Co-Express TRANCE and its Receptor TRANCE-R: A Key Role in KC Proliferation 
and Survival
Barbaroux JB1, Beleut M2, Brisken C2, Mueller C3 and Groves R1
1St John’s Institute of Dermatology, King’s College London (United Kingdom)
2Swiss Institute for Experimental Cancer Research (Switzerland)
3UPR 9021 Immunologie et Chime Therapeutiques, CNRS Strasbourg (France)
The TNF superfamily members TRANCE, TRANCE receptor (TRANCE-R) and a decoy receptor os-
teoprotegerin (OPG), have been associated with numerous activities including regulation of lymph 
node and mammary gland organogenesis, dendritic cell longevity and osteoclast function. We pre-
viously defi ned expression and function of TRANCE-R on Langerhans cells and were interested to 
defi ne expression and function of molecules of the TRANCE system in epidermis. RT-PCR demon-
strated mRNA for TRANCE, TRANCE-R and OPG in normal human skin (n=3) and primary human 
keratinocyte cultures (n=3). Ligand and receptor were detected in vivo by immunofl uorescence 
on paraffi n embedded sections of human skin. In cultures, TRANCE was evident in cytoplasmic 
vesicles and fl ow cytometry indicated that TRANCE-R was present on the cell membrane of kerati-
nocytes. OPG was secreted into the supernatant of cultured keratinocytes as assessed by ELISA. To 
explore the functional signifi cance of these fi ndings we fi rst assessed the proliferative response of 
KC to TRANCE. Stimulation of HaCaT KC with rhTRANCE resulted in a 25% increase in total cell 
numbers following 6 days of culture (n=12;P=0.018). Additionally, BrdU incorporation studies re-
vealed a 60% defi cit in KC proliferation in situ in TRANCE KO mice compared to wild type controls 
(n=5;P=0.008). Finally, TRANCE had a major effect on TRAIL induced KC apoptosis. HaCaT KC 
pre-incubated with TRANCE for 24 hours prior to TRAIL stimulation showed decreased sensitivity 
to TRAIL and displayed a 15% decrease in total cell death compared to control pre-treated cultures 
(n=3;P=0.0032). These data indicate that TRANCE and TRANCE-R are co-expressed by keratinoc-
ytes, forming a functional autocrine system involved in KC proliferation and apoptosis both in vitro 
and in vivo. We hypothesise that TRANCE signalling plays a key role in epidermis homeostasis, 
regulating KC growth and response to apoptotic signals.
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Targeted Disruption of Smad3 Affects Skin Immune Responses in a Mouse Model of Atopic 
Dermatitis
Anthoni M1, Wang G1, Lauerma A2, Wolff H3 and Alenius H1
1Ctr of Excellence in Immunotoxicology, Finnish Institute of Occupational Health (Finland)
2Control of Hypersensitivity Diseases, Finnish Institute of Occupational Health (Finland)
3Biological Mechanisms & Prevention of Diseases, Finnish Inst of Occupat Health (Finland)
Atopic dermatitis is a common chronic infl ammatory skin disease characterized by itchy, dry and 
thickened skin. Pathophysiology of atopic dermatitis involves a series of interactions between 
resident and infi ltrating cells directed by proinfl ammatory cytokines and chemokines. Under-
standing the mechanisms of TGF-β signalling is important in the development of new treatments 
for atopic dermatitis or other diseases in which TGF-β signalling is involved. This study examines 
the role of TGF-β - Smad -signalling using Smad3 -defi cient mice in a murine model of atopic 
dermatitis. Dermatitis was induced in mice by the technique of epicutaneous application of oval-
bumin applied in a patch to tape-stripped skin. The mice were sacrifi ced and blood and skin 
biopsies were collected. OVA-specifi c IgE, IgG1 and IgG2a serum levels were measured by ELISA 
method. Skin biopsies from treated skin areas were used for RNA isolation, histology and immu-
nohistochemical examination. The thickness of dermis and epidermis was signifi cantly increased 
in OVA-sensitized WT mice compared to saline group of the WT mice. Instead, OVA-sensitized 
smad-/- mice didn’t show the thickening of dermis. The amount of eosinophils was increased in 
the skin of OVA-sensitized mice. Interestingly, mast cells were signifi cantly increased in OVA-
sensitized smad-/- mice compared to OVA-sensitized WT mice. OVA-specifi c IgE, IgG1 and IgG2a 
levels were comparably increased in smad-/- and WT mice sensitized with OVA.  The levels of 
IL-4, IFN-γ and TNF-α mRNA were signifi cantly higher in OVA-sensitized animals compared to 
saline treated animals, but not signifi cant difference between smad-/- and WT mice was detected. 
However, the mRNA levels of IL-6 and IL-1β in the skin were drastically decreased in OVA-sen-
sitized smad-/- mice compared to OVA-sensitized WT mice. 
We demonstrate that smad3 -defi ciency affects the thickness of dermis, immunological status of 
the skin through pro-infl ammatory cytokines and mast cell infi ltration after epicutaneous OVA 
sensitization in this experimental model of atopic dermatitis. 
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Interferon alpha Signalling and its Relevance for the Upregulatory Effect of Transporter 
Proteins Associated with Antigen Processing in Patients with Malignant Melanoma
Benesova T1, Dreuw A2, Heise R1, Joussen S1, Neis MM1, Abuzahra F1, Hermanns HM2, Merk 
HF1 and Baron JM1
1Department of Dermatology and Allergology, University Hospital RWTH Aachen (Germany)
2Department of Biochemistry, University Hospital RWTH Aachen (Germany)
IFNα is widely used in adjuvant therapy of malignant melanoma due to its broad immunmodula-
tory and antiproliferative effects. However, the molecular mechanisms of its antitumor effects in 
adjuvant therapy are still not clarifi ed. We examined the expression of transporter proteins as-
sociated with antigen processing (TAP1 and TAP2) in peripheral blood mononuclear cells isolated 
from patients receiving intermediate high dose IFNα-treatment (10 million IU/m2). Depending on 
the patient analyzed, 2- to 5-fold upregulation of TAP1 mRNA expression could be detected by 
Real time-PCR. To evaluate whether the upregulatory effect of IFNα on TAP1 expression depends 
on the well-known activation of STAT1 we used the monocytic cell lines THP1 and TUR as model 
cell lines. High concentrations up to 200 U/ml IFNα led to the activation of STAT1, STAT3, Erk1/2 
and Akt, whereas lower concentrations of 10 U/ml IFNα resulted only in the phosphorylation of 
STAT1. Time course experiments revealed that the concentration of 10 U/ml was still suffi cient to 
upregulate the expression of TAP1. Pretreatment of THP1 cells with JAK inhibitor I 45 min before 
stimulation with IFNα inhibited upregulation of TAP1/2. Similarly, the mutation of the STAT1 or 
the interferon regulatory factor binding site in the TAP1 promoter signifi cantly decreased the 
expression of the luciferase reporter gene. For the IFNα-sensitive melanoma cell line A375 we ob-
tained similar results. The fi nding that IFNα activates STAT1 and stimulates the cytotoxic effector 
functions of antigen presenting cells by upregulating TAP1 could be one important mechanism to 
explain the effi cacy of IFNα in the treatment of malignant melanoma.
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Opioid Receptors in Skin – Link Between Stress and Skin Disease?
Gaveriaux-Ruff C1, Baumann T2 and Bigliardi PL2
1IGBMC, Illkirch, Cedex (France)
2Department of Dermatology, University of Lausanne (Switzerland)
Opioid peptides and its receptors are highly conserved and crucial for survival in stress situa-
tions. Besides their well-known role in antinociception, they control cell differentiation, pro-
liferation and infl uence apoptosis in various tissues. We are fi rst to discover their presence in 
skin and established their functions in modulation of chronic itch and wound healing. μ-Opiate 
receptor is a key player in induction of chronic itch. This could be confi rmed using μ-opiate re-
ceptor knockout mice experiments and clinical studies on patients with chronic itch. We have 
induced a dry skin dermatitis as a model for chronic itching on knockout and wild type mice. 
μ-Opiate receptor knockout mice revealed signifi cant less scratching behavior, less epidermal 
hypertrophy and different density and quality of epidermal nerve endings compared to the 
wild type mice. Several fi ndings suggest that the δ-opiate receptor and its endogenous ligands 
(enkephalins) are important in cell differentiation and proliferation. We proved the existence of 
a functional active δ-opiate receptor in different skin cells using RT-PCR, western blot analysis 
and migration assays. In addition, δ-opiate receptor knockout mice revealed a phenotype of 
thinner epidermis and higher expression of cell differentiation marker cytokeratin 10 (CK 10) 
compared to wild type mice. In a burn wound model δ-opiate receptor knockout mice showed 
signifi cant wound healing delay and a severe epidermal hypertrophy at the wound margin. 
This can be explained by a change of cell differentiation and migration due to the absence 
of a functional active δ-opiate receptor. In summary, these experiments proved that the skin 
and the nerve system interact with each other in a bi-directional way, i.e. nerve system release 
neuropeptides in stress situations affecting skin homeostasis and sensations and vice versa. 
Therefore, the opioid receptor system is an excellent model to study the connection between 
psychological stress and aggravation of different skin diseases. 
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IKKalpha in Psoriasis: Regulation of Keratinocyte Proliferation and Infl ammation
Giustizieri ML1, Maranke K2, Marinari B1, Papoutsaki M1, Chimenti S1, Karin M3, Roop D2 and 
Costanzo A1
1Department of Dermatology University of Rome “Tor Vergata” (Italy)
2Dept of Molecular & Cellular Biology & Dermatology, Baylor College, Houston Texas (USA)
3Department of Pharmacology, UCSD, La Jolla CA (USA)
The rate of epidermal cell replication in psoriasis is markedly increased as suggested by the higher 
number of basal and suprabasal mitotic fi gures. The source of cycling cells in suprabasal layers 
is not yet well defi ned. It could be expanded population of basal keratinocytes or could be cells 
committed to terminal differentiation that already express markers of the spinous layer but still 
undergo rounds of amplifying divisions above basal layer. We have confi rmed that suprabasal 
cycling cells in psoriasis express the keratin marker of the spinous layer K1. This K1 positive 
proliferating layer is reminiscent of the embryonic intermediate layer, which transiently appears 
between the basal layer and the periderm at early stages of embryogenesis and contains K1 posi-
tive proliferating cells, presumably to accommodate the rapidly growing embryo. Interestingly 
the epidermis of IKKalpha knock-out mice is composed of a basal layer and suprabasal layers 
composed by proliferating K1 positive cells that fail to exit the cell cycle and to form a spinous 
layer. Aim of our study was to evaluate the potential involvement of the epidermis development 
regulator IKKalpha in the formation of the K1 positive proliferating layer in Psoriasis. Therefore, 
we have IKKalpha expression by immunohistochemistry in 5 biopsies from normal skin and 15 
biopsies from psoriasis plaques. We have observed a strong down-regulation of IKKalpha expres-
sion in all psoriasis biopsies examined. IKKalpha downregulation occured at the transcriptional 
level as detected by RT-PCR assays being the total amount of IKKα mRNA approximately one 
third of the amount detected in wild type skin. We also observed that IKKa expression is delo-
calized in psoriatic plaques, being ligthly nuclear in the basal layers and mainly cytoplasmic in 
upper layers, this correlates with a strong nuclear localization of the active form of the NFκB 
subunit p65/RelA in the nuclei of psoriatic keratinocytes. This is in agreement with the recently 
identifi ed role of IKKα as responsible for the turnover of p65/RelA in infl ammation. Therefore 
we propose a model in which, in analogy to IKKα knock out mice, the low amount of IKKα in 
psoriatic epidermis may delay the exit from the cell cycle of K1 positive cells thus contributing to 
Psoriasis hyperkeratosis, in addition its delocalization may contribute to the mantainance and the 
amplifi cation of the infl ammatory response in keratinocytes.
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In Melanoma RAS Mutations are Accompanied by Switching Signalling from BRAF to CRAF 
and Disrupted cAMP Signalling
Dumaz N1, Bensussan A1 and Marais R2
1INSERM U659, Fac de Medecine de Creteil (France)
2Institute of Cancer Research, London (United Kingdom)
Melanocytes require the RAS/RAF/MEK/ERK and the cAMP signalling pathways to maintain the 
fi ne balance between proliferation and differentiation. We have investigated how cross-talk 
between these pathways affects melanoma progression. We show that cAMP suppresses CRAF 
activity in melanocytes and that this is essential to suppress the oncogenic potential of CRAF 
in these cells. As a consequence, BRAF alone is responsible for signalling to MEK. However, 
when RAS is mutated in melanoma, the cells switch their signalling from BRAF to CRAF. This 
switch is accompanied by dysregulated cAMP signalling, a step that is necessary to allow 
CRAF to signal to MEK. Thus, a fundamental switch in RAF isoform usage occurs when RAS 
is mutated in melanoma and this occurs in the context of disrupted cAMP signalling. These 
data have important implications for the development of therapeutic strategies to treat this life 
threatening disease.
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Mitogen- and Stress-activated Protein Kinase 2 is Activated in Lesional Psoriatic Skin
Funding AT, Johansen C, Kragballe K and Iversen L
Department of Dermatology, Aarhus University Hospital (Denmark)
Mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 are down stream targets of 
both the p38 and ERK1/2 mitogen-activated protein kinases (MAPKs). MSK1 and MSK2 stimu-
late transcription of pro-infl ammatory genes through activation of transcription factors including 
cAMP-response element-binding protein (CREB).We have previously reported that the activity of 
p38, ERK1/2, and MSK1 are increased in lesional psoriatic skin. 
The purpose of this study was to investigate the expression and activation of the MSK1 related 
protein kinase MSK2 and CREB in cultured human keratinocytes and in lesional psoriatic skin.
Keratome and punch biopsies were taken from patients with plaque-type psoriasis. Normal 
human keratinocytes were cultured and stimulated by interleukin-1β (IL-1β) or the p38 MAPK 
activator, anisomycin. The p38 MAPK, MSK1, MSK2 and CREB expression and phosphorylation 
were determined by Western blotting.
Western blotting analysis revealed a consistent and highly signifi cant increase in phosphorylat-
ed p38, MSK1, MSK2 and CREB in lesional psoriatic skin compared with non-lesional psoriatic 
skin. Immunofl ouroscense staining of the phosphorylated CREB showed a strong activation 
in lesional psoriatic skin compared with non-lesional psoriatic skin. Cultured normal human 
keratinocytes stimulated with IL-1β or anisomycin showed a signifi cant and time dependent 
phosphorylation of the p38 MAPK, MSK1, MSK2 and CREB. This activation was inhibited by 
pre-incubation with a p38 inhibitor.
These results demonstrate that MSK1, MSK2, and CREB are expressed in human epidermis and 
in human keratinocytes. A pro-infl ammatory in vitro stimulation leads to the activation of the 
p38-MSK1/2-CREB signalling pathway and in lesional psoriatic skin an activation of the p38 
MAPK MSK1, MSK2 and CREB signalling cascade was also seen. This indicates that the MSK1 
and MSK2 might play a role in the pathogenesis of psoriasis. 
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Adenosine Stimulates FGF-7 Expression in Human Hair Follicle Dermal Papilla Cells
Iino M1, Iwabuchi T1, Nakazawa Y1, Ehama R1, Kishimoto J1, Tajima M1 and Arase S2
1SHISEIDO Research Center (Japan)
2School of Med, Univ of Tokushima (Japan)
One of the purinergic compounds, adenosine, stimulates FGF-7 expression in human hair fol-
licle dermal papilla (DP) cells that is a key player in hair cycle regulation. It has been shown 
that the upregulation was mediated by intracellular cAMP generated via adenosine receptor 
A2b (AdoR A2b, classifi ed as stimulatory G protein) activation by adenosine in human DP cells. 
In this study, we have examined whether other purinergic compounds (ATP, ADP and AMP) 
stimulate FGF-7 expression in immortalized human DP cells. After addition of the purinergic 
compounds and/or inhibitor (2 hours), mRNA was isolated from the cells. FGF-7 expression 
level was determined by real time PCR. The 10 μM of adenosine strongly stimulated FGF-7 ex-
pression, but ATP, ADP, and AMP at the same concentration did not show the stimulation. ATP, 
ADP, and AMP stimulated FGF-7 expression at prominently higher concentration (over than 
100 μM), and these stimulations were inhibited by the specifi c antagonist of AdoR A2b (8 μM 
of alloxazine). On the other hand, antagonists of P2X/Ys (100 μM of suramin or 50 μM TNP) 
did not affect these expressions. These results suggest that high concentration of ATP, ADP and 
AMP stimulate FGF-7 expression mainly via AdoR A2b, not their major receptor P2X/Ys. Taken 
together, adenosine is considered as the most direct stimulator of FGF-7 in human DP cells, 
and AdoR A2b plays an important role in hair growth via FGF-7 signaling.
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Transforming Growth Factor-β/Smad Signaling is Functional in Human Eosinophis
Kanzaki M1, Shibagaki N2, Mitsui H2, Inozume T2, Okamoto A1, Dobashi Y3, Ogawa H4, 
Shimada S2 and Nakao A1
1Department of Immunology, Faculty of Medicine, University of Yamanashi (Japan)
2Department of Dermatology, Faculty of Medicine, University of Yamanashi (Japan)
3Department of Pathology, Faculty of Medicine, University of Yamanashi (Japan)
4Atopy Reseach Center, Juntendo University School of Medicine (Japan)
Objective. There is a paradoxical fi nding that eosinophils are frequently accumulated at the 
sites of allergic infl ammation where transforming growth (TGF-β), a negative regulator of 
eosinophil survival, is upregulated, however, eosinophil accumulation is persistent. We thus 
hypothesized that eosinophils might have aberrant TGF-β signaling and be unresponsive to 
TGF-β. To test the hypothesis, we examined the expression and function of Smad proteins, 
which are central mediators for TGF-β signaling, in human eosinophils. Methods. Eosinophis 
were isolated from the peripheral blood of normal donors and the expression and activation of 
endogenous Smad proteins were examined by RT-PCR and Western blotting. The Smad func-
tion in the transcription of a major TGF-β target gene Smad7 was investigated using a dominant 
negative form of Smad3. The effect of TGF-β on eosinophil survival was evaluated by a cell 
viability assay. Results. Human eosinophils expressed mRNAs and proteins of TGF-β type I and 
type II receptors, Smad2, Smad3 and Smad4. TGF-β induced the phosphorylation of Smad2 in 
eosinophils, which was blocked by SB431542, an inhibitor of TGF-β type I receptor kinase. A 
cell membrane-permeable form of mutant Smad3 protein, that has a dominant negative effect 
on Smad3, suppressed TGF-β-induced Smad7 mRNA expression in eosinophils. Finally, we de-
tected the expression of TGF-β1 and TGF-β2 mRNA in eosinophils, which was enhanced upon 
stimulation with TGF-β. However, the expression of TGF-β mRNAs did not appear to function 
in an autocrine manner because SB431542 did not affect the GM-CSF-mediated prevention of 
eosinophil apoptosis. Conclusion. Human eosinophils have an intact Smad signaling pathway 
leading to a major TGF-β target gene expression.
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Normal Human Keratinocytes Can Secrete Precursor Nerve Growth Factor (proNGF). 
Cutaneous Neuropeptides Increase Both proNGF Production and NGF secretion in Cultured 
Human Keratinocytes
Kiss M, Dallos A, Polyánka H, Dobozy A, Kemény L and Husz S
Department of Dermatology and Allergology, University of Szeged (Hungary)
Nerve growth factor (NGF) acts on different cells types of the skin to promote cell survival and 
cell proliferation. In contrast, its precursor molecule, proNGF is a high affi nity, functional ligand 
for the pro-apoptotic p75NTR receptor. The aim of our study was a systematic investigation of the 
effects of cutaneous neuropeptides substance P (SP), calcitonin gene-related peptide (CGRP), 
vasoactive intestinal polypeptide (VIP) and galanin (GAL) on the production and secretion 
proNGF and mature NGF. Cultures of normal human keratinocytes were treated with 10-8 M SP, 
CGRP, VIP or GAL for 30 min. After different time intervals, cells were harvested for total RNA 
isolations, in addition cell lysates and cell culture supernatants were collected. The effects of 
the neuropeptides on the mRNA expressions of proNGF/NGF were investigated by Q-RT-PCR 
and the protein levels were studied by means of ELISA assays and Western blotting. We dem-
onstrated that all four neuropeptides can increase the proNGF/NGF mRNA expression, though 
to different extents. In the cell lysates of neuropeptide-treated keratinocytes, only proNGF can 
be detected, in a concentration about 2-fold that in the time-matched controls. Both the control 
cultures and the neuropeptide-treated cultures can secrete proNGF and mature NGF, but the 
neuropeptide-treated cell cultures produce markedly higher (3-7-fold) amounts of NGF-like 
immunoreactive materials. The exact proNGF/NGF ratio in the supernatants of cultured human 
keratinocytes treated with different neuropeptides is not known at present. This question neces-
sitates further investigations.The results demonstrated that neuropeptides released from cutane-
ous nerves after an injurious stimulus are able to infl uence the expression of proNGF/NGF and 
their secretion from the keratinocytes. These fi ndings may contribute towards an understanding 
of the neural infl uence on skin health and disease.
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Increased Activity of Mnk1 and Eukaryotic Initiation Factor 4E in Psoriasis
Kjellerup R, Johansen C, Iversen L and Kragballe K
Department of Dermatology, Aarhus University Hospital (Denmark)
Mnk1 is a kinase known to be activated by the MAP-kinases p38 MAPK and ERK1/2, which 
are kinases recognized to display increased activity in chronic psoriatic plaque lesions as com-
pared with non-psoriatic lesions. Events downstream to Mnk1 include phosphorylation of the 
eukaryotic initiation factor 4E (eIF4E) which is known to play a key role in the translation of 
mRNA. Previous studies have demonstrated the importance of Mnk1 and eIF4E in the induc-
tion of pro-infl ammatory cytokines such as TNF-α and IL-1β. Therefore, the purpose of this 
study was to elucidate whether Mnk1 and eIF4E showed increased activity in psoriasis. We 
demonstrated for the fi rst time increased activation/phosphorylation of both Mnk1 and eIF4E 
in lesional psoriatic skin compared with non-lesional psoriatic skin from patient suffering from 
chronic plaque psoriasis, as determined by western blotting. In contrast, the expression level 
of Mnk1 and eIF4E was unchanged between lesional and non-lesional psoriatic skin. To further 
characterize the regulation of Mnk1 and eIF4E, we stimulated cultured human primary kerati-
nocytes with either IL-1β or the p38 MAPK activator anisomycin. These in vitro studies revealed 
that both IL-1β and anisomycin induced the phosphorylation of Mnk1 and eIF4E in keratinoc-
ytes in a time-dependent manner. The anisomycin-and IL-1β-induced phosphorylation of both 
Mnk1 and eIF4E was maximal after 1 hour of stimulation. Thus, it is possible that the aberra-
tions in the phosphorylation status of Mnk1 and eIF4E seen in psoriasis may contribute to the 
infl ammatory processes occurring in psoriasis.
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Untangling the Role of Heparin Binding-EGF in the Stress Response of Normal Human 
Keratinocytes
Mathay C, Giltaire S, Bera E, Hérin M and Poumay Y
Department of Medecine, University of Namur (Belgium)
Epidermal wound healing requires common cellular mechanisms such as growth factor signal-
ling, migration and proliferation in order to achieve re-epithelialization. In this study, we are 
exploring Heparin-Binding EGF (HB-EGF) synthesis, signalling and function in human epi-
dermal keratinocytes. Immunohistolabeling confi rms that HB-EGF is expressed in the plasma 
membrane of keratinocytes located at wound margins as well as in skin organ culture, espe-
cially when biopsies are cut into smaller fragments, enhancing thereby the length of epider-
mal margins. Since HB-EGF is upregulated in healing keratinocytes, we investigated several 
features of this cell type subjected to recombinant HB-EGF treatments. Scratch assays as well 
as phagokinetic tracking experiments demonstrate that the keratinocyte’s mobility is enhanced 
by HB-EGF. Moreover, HB-EGF produces EGF-like alterations of differentiation marker levels 
and increases mRNA levels of HB-EGF itself most likely due to its positive feed-back loop on 
HB-EGF expression. Since HB-EGF favours epidermal wound healing, we reasoned that its ex-
pression should be induced by stressing conditions, like oxidative stress, but also phorbol ester 
treatment or cholesterol depletion, treatments known to activate p38MAPK in keratinocytes. 
Consecutive to these treatments, we indeed detected increased amounts of the pro-HB-EGF 
precursor protein. The utilization of a p38 inhibitor confi rms the role of this kinase in the 
stimulation of HB-EGF production after stresses. Collecting our data, we suggest a mechanism 
in which stresses applied to keratinocytes induce expression of HB-EGF at RNA and protein 
levels. The membrane-bound pro-HB-EGF will be cleaved into soluble HB-EGF which will 
then exert its effects on neighbouring keratinocytes, probably in order to anticipate the repair 
of epidermal tissue.
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Immunohistochemical Analysis of EGFR and HER-2 Expression in Patients with Tumors of 
Cutaneous Appendages
Maubec E1, Duvillard P2 Crickx B3 and Avril MF3
1Department of Dermatology, Hospital Bichat, Paris VII-Denis Diderot University (France)
2Department of Pathology, Institut Gustave Roussy, Villejuif (France)
3Department of Dermatology, Hospital Cochin, Paris V René Descartes University (France)
Effi cient treatments are needed for patients with locally recurrent or distant metastatic unresect-
able tumours of cutaneous appendages.
Since EGFR is strongly expressed in squamous cell carcinoma of the skin, we studied the 
expression of EGFR and HER-2 in a series of various tumours of cutaneous appendages. Thirty 
specimen from 23 patients were reviewed and studied by immunochemistry. Medical records 
were analysed. 
The patients were twelve men and 11 females with a mean age of 60 years at the time of di-
agnosis of the primary tumour. The studied samples consisted of 21 primary tumours, 2 local 
recurrences, 3 lymph nodes metastasis and 4 distant metastasis. Primary lesions were located 
to the head and neck (n=17), the trunk (n=7), and limbs (n=3). Eight tumours were benign and 
22 tumours were malignant. Mean follow-up was 50 months.
EGFR was expressed moderately or strongly in 24 out of 30 specimen. EGFR was constantly 
expressed in sebaceous tumours (4/4), hair follicle tumours (2/2), adenoid cystic carcinoma 
(2/2), hydradenoma carcinoma (1/1), and most eccrine tumours [microcystic adnexal carci-
noma (8/8), cylindroma (3/3), porocarcinoma (2/2)]. EGFR was not expressed in 4/5 eccrine 
carcinoma, 1 myoepithelioma and 1 apocrine carcinoma. HER-2 was expressed in one third of 
tumours with a level ≥2+ in 3/5 sebaceous tumours in most differentiated areas, in 2/5 eccrine 
carcinoma and in 1/8 microcystic adnexial carcinoma. 
Results show an expression of EGFR and HER-2 in respectively 80 % and 30% of tumours 
of cutaneous appendages. A positive expression of HER-2 has already been reported in 3/21 
cases of eccrine carcinoma whereas discordant results have been published in two studies of 
sebaceous tumours. According to the present fi ndings, anti-EGFR and HER-2 targeted therapies 
might be therapeutic options for inoperable tumours.
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Histone Deacetylase Inhibitors may Interfere with Angiogenesis by Decreasing Endothelial 
VEGFR2 Protein Half-life in Part Via a CBL Dependant Manner
Meissner M, Hrgovic I, Stein M, Kaufmann R and Gille J
Department of Dermatology,University Frankfurt (Germany)
Recent evidence suggests that histone deacetylase (HDAC) inhibitors may mediate part of their 
antitumor effects by interfering with tumor angiogenesis. As signaling via the vascular endothe-
lial growth factor receptor-2 (VEGFR2) pathway is critical for angiogenic responses during tu-
mor progression, we explored whether established antitumor effects of HDAC inhibitors are 
mediated in part through diminished VEGFR2 expression. We therefore examined the potential 
impact of three different HDAC inhibitors, trichostatin A (TSA), sodium butyrate (NaB) and val-
proic acid (VPA), on both mRNA and protein VEGFR2 expression. In contrast to VAP, TSA and 
NaB are shown to signifi cantly inhibit VEGFR2 protein expression in a time- and concentration-
dependent manner, whereas no such effect is demonstrated at the level of mRNA expression. 
Pertinent to these data, VEGFR2 protein half-life is shown to be decreased in response to TSA 
and NaB. First experimental evidence indicates that reduction of protein half-life is mediated 
in part via HDAC inhibitor-induced expression of the ubiquitin 3 ligase Cbl. The inhibition of 
Cbl via a siRNA technique reveals a recovery of VEGFR2 expression. To further distinguish as to 
which of the eight different histone deacetylases are responsible for the regulation of VEGFR2 
protein half-life, specifi c HDAC genes were silenced by transfecting respective siRNAs. These 
studies revealed that HDACs 1 and 4 are preferentially involved in VEGFR2 expression, provid-
ing fi rst evidence for the regulation of a tyrosine kinase receptor protein half-life by distinct 
HDACs. This regulating is in part mediated via a Cbl dependant increase in mono-ubiquitinila-
tion of the VEGFR2. Together, VEGFR2 protein expression may represent an important target of 
HDAC inhibitors in mediating antitumor effects by suppressing angiogenesis.
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Cross Talk Between Kinase Activation/Oxidative Stress in Human Dendritic Cell Maturation 
Induced by Contact Sensitizers
Migdal C1, Trompezinski S1, Arab K2, Steghens JP2 and Serres M3
1EA37-32, Univ Claude Bernard Lyon 1 (UCBL1), Pav R, Hospital E. Herriot, Lyon (France)
2EA30-90 UCBL1, Biochemistry Federation, Hospital E. Herriot, Lyon (France)
3Pavillon R, Hospital E. Herriot, Lyon (France)
Although the maturation of dendritic cells (DC) induced by contact sensitizers is well charac-
terized by a change in phenotype and cytokine production, earlier events involved this process 
required to be more specifi ed. Recently, only few studies were reported demonstrating the 
role of oxidative stress and p38 kinase activation in DC maturation. The cross talk between 
kinase activation/oxidative stress induced by allergens have to be clarifi ed for a new approach 
to discriminate sensitizers from irritants. To address this purpose, the role of oxidative stress 
and cell signaling induced by allergens was evaluated on the maturation of DC derived from 
human monocytes cell lines (THP1 and U937) which similarly respond to allergens as mono-
DC, and prevent from inter-individual variations. Kinase activation was assessed using specifi c 
inhibitors and intracellular phosphoprotein analysis by fl ow cytometry and Face method. The 
role of kinases upstream and downstream p38 MAPK, respectively ASK1 and HSP27, will be 
investigated as well as PKCδ which plays an essential role in DC maturation. To confi rm their 
specifi c role, RNAi specifi c for these kinaseswill be investigated. Oxidative stress was detected 
by fl ow cytometry using a H2DCF-DA fl uoroprobe for ROS and DSSA for glutathione measure-
ment in addition to HPLC-MS. Preliminary data showed that an oxidative stress was induced 
essentially by 2,4-dinitrochlorobenzene and thimerosal but not by nickel sulfate, in correlation 
with a specifi c activation of p38 MAPK and ASK1. In contrast, nickel activated more specifi -
cally JNK and Erk pathways. These studies will allow to better manipulate DC in infl ammatory 
diseases and for their use in cancer vaccinology.
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Essential Role of MAPK Signaling Pathways and Oxidative Stress in Human Dendritic Cells 
Maturation Induced by Contact Sensitizers
Trompezinski S1, Migdal C1, Arab K2, Courtellemont P3, Le Varlet B3, Steghens JP2 and Serres M2
1EA37-32 University Claude Bernard Lyon 1 (France)
2EA30-90 University Claude Bernard Lyon 1 (France)
3LVMH research, St Jean de Braye (France)
Dendritic cells (DC) play an essential role in the initiation of allergic reaction by primary ac-
tivation of naïve T cells. DC maturation induced by allergens is well characterized by over-
expression of CD86 and CD54 and cytokine production. However, in this process the early 
events induced by allergen treatments were not fully understood. To address this, the role of 
oxidative stress and cell signaling induced by allergens were evaluated on the maturation of 
DC derived from human monocytes or monocytes cell lines. Oxidative stress was detected by 
fl ow cytometry using a H2DCF-DA fl uoroprobe and gluthathion measurement by HPLC-MS. 
The kinase activation was assessed using specifi c inhibitors and by intracellular phophoprotein 
analysis. Preliminary data showed that an oxidative stress was induced essentially by 2,4-dini-
trochlorobenzene and thimerosal but not by nickel sulfate (Ni), in correlation with a specifi c 
activation of p38 MAPK. In contrast, JNK and Erk pathways were mainly activated by Ni in 
correlation with DC maturation characterized by CD86 and CD54 overexpression. The cross 
talk between oxidative stress, cell signaling and DC maturation will be discussed. These studies 
will be extended to other allergens and irritants in perspective to develop alternative methods 
for contact dermatitis prediction.
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The Activation of Caspase-1 is Increased in Lesional Psoriatic Skin
Moeller K, Johansen C, Kragballe K and Iversen L
Department of Dermatology, University of Aarhus (Denmark)
Caspase-1 is known to play a key role in infl ammatory processes and is responsible for the 
proteolytic cleavage of pro-IL-18, given rise to the mature cytokine. IL-18 is a pro-infl ammatory 
cytokine and its expression has been demonstrated to be elevated in psoriasis.
The purpose of this study was to investigate the expression and activation of caspase-1 in 
lesional psoriatic skin, and the role of caspase-1 in the signalling pathways regulating the pro-
infl ammatory cytokine IL-18 in cultured normal human keratinocytes.
In this study, we demonstrated for the fi rst time increased activation of caspase-1 in lesional 
psoriatic skin compared with non-lesional psoriatic skin, as measured by western blotting. 
In vitro experiments on cultured human keratinocytes stimulated with anisomycin showed a 
rapid and signifi cant time dependent activation of IL-18 as determined by ELISA. The anisomy-
cin-induced IL-18 activation was maximal after 4 hours of stimulation. This is in contrast to 
the anisomycin-induced IL-18 mRNA expression which reached a maximum after 12 hours of 
stimulation. Furthermore, we demonstrated that IL-18 activation was mediated by a p38 MAPK 
and caspase-1 dependent mechanism because the anisomycin-induced IL-18 activation was 
signifi cantly down-regulated by pre-incubating the keratinocytes with a p38 MAPK inhibitor, 
as well as a caspase-1 inhibitor. In addition, experiments revealed that caspase-1 could be acti-
vated by anisomycin in human keratinocytes. This activation was seen after 2 hours of stimula-
tion and was inhibited by pre-incubating the keratinocytes with a p38 MAPK inhibitor.
Taken together we have shown an increased activation of caspase-1 in lesional psoriatic skin 
and by in vitro experiments we have demonstrated that the anisomycin-induced IL-18 protein 
level is mediated by a p38 MAPK/caspase-1 dependent mechanism in human keratinocytes. 
These fi ndings identify caspase-1 as a potential target in the treatment of psoriasis.
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Nickel Triggers a Unique Infl ammatory and Proangiogenic Gene Expression Pattern Via 
Activation of NF-κB and HIF-1α
Mueller V1, Viemann D2, Schmidt M1, Tenbrock K2, Schmid S1, Klimmek K2, Ludwig S3, Roth J2 
and Goebeler M1
1Dept of Dermatology, University Medical Center Mannheim, Univ of Heidelberg (Germany)
2Institute of Experimental Dermatology, University of Münster (Germany)
3Institute of Molecular Virology, University of Münster (Germany)
Nickel compounds are important carcinogens and prime inducers of contact allergy in humans. 
To elucidate the signaling pathways mediating the cellular responses to nickel we performed 
Affymetrix gene profi ling using human primary endothelial cells, which strongly respond to 
nickel stimulation. Overall, we found 258 signifi cantly modulated transcripts, comprising 140 
up-regulated and 118 down-regulated genes. The bulk of those genes represent targets of two 
distinct signaling cascades, the proinfl ammatory IKK2/NF-κB pathway and a proangiogenic 
pathway mediated by HIF-1α, which becomes posttranslationally stabilized by nickel. Using 
dominant-interfering mutants we demonstrate that both pathways act independently to modu-
late expression of non-overlapping gene pools. While NF-κB activation mediates most of the 
proinfl ammatory responses to nickel, nickel-dependent HIF-1α stabilization modulates expres-
sion of genes involved in proliferation, survival, metabolism and signaling. Transactivation of 
both transcription factors is partially dependent on p38 MAPK activation that contributes to the 
intensity of target gene expression. Our data provide fi rst mechanistic insight into the complex 
network of nickel-induced processes and identify IKK2/NF-κB and HIF-1α as essential path-
ways in the pathogenesis of nickel-mediated diseases.
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Fibroblast Growth Factor Receptor 2 Gene in the Pathogenesis of Venous Leg Ulcer
Nagy N1, Bata-Csörgo Zs1, Szolnoky Gy1, Szabad G1, Dobozy A1, Kemény L1 and Széll M2
1Department of Dermatology and Allergology, University of Szeged (Hungary)
2Derm Research Group of the Hungarian Academy of Sciences, Univ of Szeged (Hungary)
Fibroblast growth factor receptor 2 gene (FGFR2) codes for tirosine kinase receptors: kerati-
nocyte growth factor receptor (KGFR = FGFR2-IIIb), mainly expressed by keratinocytes and 
bacterially expressed kinase (BEK = FGFR2-IIIc), expressed by mesenchimal and endothelial 
cells. Both isoforms play pivotal roles in wound healing. The aim of our study was to identify 
single nucleotide polymorphisms (SNPs) of the FGFR2 gene, which may play a role in the 
pathomechanism of prolonged wound healing in patients with leg ulcer and to investigate the 
expression pattern of FGFR2-IIIb in keratinocytes of patients with venous leg ulcer. SNP analy-
sis was performed with mutation specifi c TaqMan probes and quantitative real-time RT-PCR 
was used for mRNA expression studies. Comparing the SNP data of leg ulcer patients (n=82) 
with healthy individuals (n=82) we found an SNP located in the 3’ untranslated region (UTR) of 
FGFR2 (2451A®G; 900 bp downstream from the ORF), which showed a signifi cant difference 
in the allelic distribution between leg ulcer patients and healthy individuals (p=0.0103). We 
could also demonstrate that the mRNA expression level of FGFR2-IIIb in cultured keratinoc-
ytes isolated from the epidermis of leg ulcer patients (n=8) was approximately 4 times lower 
compared to healthy individuals (n=10). We hypothetise that the abnormal functioning of the 
FGFR2 gene in leg ulcer contributes to the pathogenesis of the disease: the 3’ UTR SNP might 
alter the stability of the mRNA, resulting in decreased amount of FGFR2 protein and receptor 
disfunction.
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Neurotrophins (NT) Modulate Survival and Chemotaxis in Metastatic and Primary Melanoma 
Cell Lines through their High-Affi nity Receptors Trk
Truzzi F1, Marconi A1, Lotti R1, Dallaglio K1, Pignatti M1, French L2 and Pincelli C1
1Department of Dermatology, University of Modena and Reggio Emilia (Italy)
2Department of Dermatology, Geneva University Hospital, Geneva (Switzerland)
NT are a family of structurally and functionally related molecules including nerve growth fac-
tor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and NT-4. NT act 
through two receptors, the low-affi nity receptor p75 (p75NTR) and the high-affi nity receptor 
Trk. It has been shown that NGF and NT-3 are important in the progression of melanoma to 
the brain-metastatic phenotype. In this study, we evaluated the expression and function of 
NT in metastatic and primary melanoma cell lines. Metastatic and primary melanoma cell 
lines A375, Mewo, Me272, WM115, WM266-4 and SK-MEL-28 express all NT. In particular, 
melanoma cell lines secrete very high levels of NT-3, high levels of NT-4 but low levels of NGF 
and BDNF. Melanoma cell lines also express the low affi nity NT receptor p75NTR at different 
levels. Moreover, metastatic and primary melanoma cell lines also express the high-affi nity NT 
receptors (Trks), as shown by RT-PCR. No effect of NT on melanoma cell growth was observed. 
On the contrary, addition of K252a, a phosphorylation inhibitor of Trks, blocked cell line pro-
liferation. Moreover, using NT specifi c blockers (TrKA, TrkB, TrkC/Fc chimera), deprivation of 
NT3 arrests proliferation of all cell lines. The deprivation of NGF arrests proliferation of both 
WM115 and Skmel28, while deprivation of NT-4/BDNF arrests proliferation of WM115 only. 
Finally, all NT induced the chemotaxis of Skmel28, while NT4 and BDNF stimulated the chem-
otaxis of WM266-4. These results seem to suggest that NT and their receptors may be involved 
in the growth, invasion of melanoma cells thus contributing to melanoma progression.
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Identifi cation of the Molecular Events Involved in Cell Cycle Entry and Exit During Dermal 
Fibroblast Wound Healing
Chassot A1, Turchi L2, Fitsialos G2, Fisher D3, Meneguzzi G2, Busca R2, Dulic V4 and Ponzio G2
1INSERM U636, Centre de Biochimie, Université de Nice. Nice (France)
2INSERM U634, Faculté de Médecine Nice (France)
3IGH-CNRS UPR 1142, Montpellier, France (France)
4CRBM-CNRS FRE 2593, Montpellier (France)
Skin wound healing involves multiple cellular processes (migration, proliferation, differentia-
tion…) allowing the reconstruction of skin lesions. Many genetic or acquired defects can per-
turb the normal wound healing process leading to skin pathologies characterized by abnormal 
fi broblasts proliferative properties (hypertrophic scars, keloids or ulcers). Today the molecu-
lar anomalies responsible for these pathologies are unknown notably because the classical 
wounding models do not allow a molecular exploration of the healing process. To circumvent 
this hurdle we have developed an original device enabling the detection of a wide range of 
molecular events activated during wound healing. Using this model we show that injury, per-
formed within confl uent human dermal fi broblast cultures provokes a synchronous cell cycle 
entry followed by a cell cycle exit after a unique round of proliferation. We demonstrate that 
the mRNA of p27kip1, a cyclin dependent kinase inhibitor, which classically exerts a negative 
control of proliferation, is rapidly and transiently down-regulated after injury. We identifi ed Id3, 
a bHLH transcriptional repressor, as a candidate responsible for p27 mRNA down regulation. 
Id3-siRNA impairs the injury mediated p27 suppression and blocks the cell cycle progression, 
demonstrating that Id3 is involved in the trancriptional repression of p27 and is required for 
cell proliferation after wounding. When the wound is healed, the proliferation stops due to 
cell confl uence. We demonstrate that the cell cycle exit is preceded by the down regulation of 
cyclin D1 in S/G2 as well as the inhibition of pRb and p130 phosphorylation. We demonstrated 
that the overexpression of cyclin D1 in S/G2 increases the phosphorylation of the “Pocket 
Proteins” (pRb, p130), and allows cells to enter into the next cycle. In conclusion our data al-
lows to gain interesting new information concerning the molecular signals responsible for both 
dermal fi broblasts cell cycle entry and exit during wound healing.
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CTACK/CCL27 Expression is Regulated by both IKKβ and p38 MAPK Signalling Pathways
Riis JL, Johansen C, Vestergaard C, Funding AT and Iversen L
Department of Dermatology, University Hospital of Aarhus (Denmark)
CTACK/CCL27 is a skin-specifi c CC-chemokine continuously expressed by keratinocytes. It 
is highly upregulated in infl ammatory skin diseases such as atopic dermatitis and psoriasis. 
CTACK binds to the chemokine receptor CCR10 and mediates lymphocyte migration into the 
skin. This chemokine is inducible in cultured keratinocytes by TNFα and IL-1β. Very little is 
known about the signalling pathways regulating CTACK expression. Non-specifi c NF-κB-inhib-
itors have been shown to repress TNFα-induced CTACK production. The purpose of our study 
was to investigate the role of the NF-κB and p38 MAPK signalling pathways in the regulation of 
CTACK expression. Cultured normal human keratinocytes were incubated with either an IKKβ 
inhibitor (SC-514) or a p38 MAPK inhibitor (SB202190) prior to stimulation with TNFα or IL-
1β. CTACK mRNA was measured by quantitative PCR after a stimulation period of 6 hours. The 
CTACK protein level was detected by ELISA after 24 hours of stimulation. Duration of stimula-
tion periods was based on time studies of maximal CTACK mRNA and protein expression. 
Interestingly, a pronounced and statistically signifi cant reduction in CTACK mRNA (up to 71%) 
as well as protein levels (up to 76%) was found following incubation with both inhibitors. To 
further characterize the role of p38 MAPK down stream kinases keratinocytes were transfected 
with siRNA against MSK1 and MSK2. Surprisingly, a knock down of MSK2 protein lead to a 
statistically signifi cant increase of CTACK mRNA expression (p-value 0,011). No regulation was 
detected when MSK1 was knocked down. Our work indicates that CTACK is regulated by both 
the IKKβ and the p38 MAPK signalling pathways. Furthermore, MSK2 knock down results in 
an increased CTACK expression and this is the fi rst time MSK2 has been shown to regulate the 
expression of a specifi c chemokine or cytokine. 
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Regulation of Calcium Entry in Keratinocytes by Calcium-Independent PLA2 and STIM1
Ross K and Reynolds NJ
Dermatological Sciences, University of Newcastle upon Tyne (United Kingdom)
Sustained calcium entry is essential for activation of numerous cellular processes. The mecha-
nisms linking depletion of intracellular calcium stores with Ca2+ entry through cell surface 
Ca2+ channels are not fully understood. Extracellular nucleotides have been shown to promote 
keratinocyte proliferation, but their relationship to Ca2+ entry has not been established. In this 
study we therefore investigated the mechanism of ATP and UTP-induced calcium entry. Us-
ing single cell fl uorescence confocal microscopy we found that stimulation of normal human 
epidermal keratinocytes with extracellular nucleotides trigger Ca2+ release. However this was 
not followed by sustained Ca2+ entry when external Ca2+ was low (70μM). Enhancement of the 
driving force for Ca2+ entry by elevation of extracellular Ca2+ to 1.2mM facilitated Ca2+ entry. 
This Ca2+ infl ux was dependent on calcium-independent phospholipase A (iPLA2) activity, as 
it was impaired by treatment of the cells with bromoenol lactone, a specifi c pharmacologi-
cal inhibitor of iPLA2. Similar inhibition of ATP-induced Ca
2+ entry was observed in cultured 
non-lesional psoriatic keratinocytes. In contrast, lysophosphatidic acid, a bioactive lipid that 
also induces keratinocyte proliferation, only a short-lived Ca2+ transient was detectable under 
our experimental conditions, regardless of the extracellular Ca2+ concentration. Similar results 
were obtained in HaCaT keratinocytes. Interestingly, LPA and UTP promoted translocation of 
STIM1 in these cells. STIM1 is a transmembrane protein that appears to function as a sensor 
Ca2+ levels in the endoplasmic reticulum. However, the dynamics of STIM1 translocation were 
markedly different, with the bulk of STIM1 remaining associated with the plasma membrane 
for signifi cantly longer following UTP stimulation compared to LPA stimulation. Taken together, 
our results demonstrate for the fi rst time an important role for iPLA2 and STIM1 in regulating 
Ca2+ entry in human keratinocytes.
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Transforming Growth Factor β Potentiates Interleukin-1β/p38-mitogen-activated Protein 
Kinase Signaling Pathways: Consequence for c-fos and Metalloproteinase 2 and 9 Expression
Schiller M1, Mauviel A2, Luger TA1 and Böhm M1
1Department of Dermatology, University Hospital Münster (Germany)
2INSERM U697, Molecular Bases of Skin Homeostasis, Hôpital Saint-Louis (France)
The transcription factor c-fos is involved in the regulation of numerous AP-1-dependent genes, 
i.e., cytokine-induced metalloproteinase gene expression. Aberrant expression of these ex-
tracellular matrix-degrading enzymes has important effects on connective tissue integrity in 
infl ammatory disorders, and is also critical to convey the invasive phenotype of tumor cells. 
However, the precise mechanism how proinfl ammatory cytokines, i.e., interleukin-1β (IL-1β), 
and profi brotic cytokines, i.e., transforming growth factor β (TGF-β), orchestrate the balance 
between extracellular matrix destruction and neosynthesis remains unclear. Using human 
HaCaT keratinocytes we determined that TGF-β enhances IL-1β-induced, mitogen-activated 
protein kinase-mediated (MAPK) c-fos gene transcription as revealed by Northern blotting and 
quantitative real time PCR. We further provide evidence that TGF-β potentiated IL-1β induced 
p38-MAPK phosphorylation by inhibiting MAPK phosphatase-1 (MKP1) expression at the 
mRNA and protein level. By contrast, IL-1β prevented TGF-β-induced SMAD-specifi c gene 
transactivation, while TGF-β-mediated SMAD phosphorylation and nuclear translocation re-
mained unaffected. In addition, the inductive activity of IL-1β on the expression and secretion 
of metalloproteinase-2 and -9 was signifi cantly enhanced by TGF-β as evidenced by zymogra-
phy, Western blotting, and real-time PCR. To further assess the physiological relevance of these 
fi ndings, an in vitro migration assay model was employed. IL-1β mediated migration of HaCaT 
keratinocytes was signifi cantly augmented by TGF-β. Together these results identify TGF-β as a 
potent regulator of IL-1β mediated gene expression in keratinocytes critical for cellular proc-
esses such extracellular matrix degradation and epithelial tumor-cell invasion. 
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Impact of Fibroblast Growth Factor-2 on Mitogenic and Motogenic Activities of Epithelioid 
Sarcoma Cells
Takahashi T and Otsuka F
Department of Dermatology, University of Tsukuba (Japan)
Epithelioid sarcoma (ES), a rare malignant neoplasm of uncertain origin, is characterized by 
positively staining for not only fi brosarcoma antigens but also epithelial membrane antigen. 
Although this tumor shows an aggressive progression in vivo, the malignant behavior of ES cells 
has hardly been evaluated in vitro presumably due to its rare opportunity of cell line establish-
ment. As tumor cells generally are affected by many cytokines, a small number of investigations 
have shown that ES cells might be modulated by epidermal growth factor (EGF), transforming 
growth factor-alpha (TGF-alpha), platelet-derived growth factor (PDGF), fi broblast growth fac-
tor (FGF)-1 and FGF-2. Modifi ed Boyden chamber elucidated the strongest effect of FGF-2 and 
the slight effect of hepatocyte growth factor/scatter factor (HGF/SF) on the invasion of ES cells 
into Matrigel while EGF, TGF-alpha, PDGF-A, FGF-1, FGF-5, FGF-6, FGF-7 and insulin-like 
growth factor (IGF) failed to augment the ES cells invasion activity. FGF-2 enhanced the expres-
sion level of integrin alpha3, the adhesion of ES cells to type 1 collagen and type 3 collagen, 
and also activated their focal adhesion kinase signaling. Furethermore, FGF-2 also served as the 
more effective mitogen compared with other cytokines. Collectively, FGF-2 has much higher 
effect on ES progression via proliferation and invasion of ES cells, possibly refl ecting to the 
in vivo state. ES cells used expressed FGF receptor (FGFR)-1 IIIb and FGFR-2 IIIb. The FGFR 
neutralizing monoclonal antibody inhibited the FGF-2 effects on ES cells. The results imply the 
major contribution of FGF-2 to ES progression and the poor prognosis via enhancing both the 
mitogenic and motogenic potentials of ES cells, even though there may be other contributory 
candidates not tested in the present study. 
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Tumor Necrosis Factor Alpha Augments the Proliferation of Human Neurofi broma Cells
Nakamura Y, Takahashi T, Xuezhu X, Kawachi Y and Otsuka F
Department of Dermatology, University of Tsukuba (Japan)
Tumor necrosis factor (TNF) alpha is a multifunctional cytokine mediating infl ammation, ap-
optosis, cell differentiation and proliferation in the immune system or tumor progression. Al-
though the function of TNF alpha varies among the cell type, it has not yet been elucidated why 
TNF alpha selectively acts as an apoptotic agent or a mitogenic factor for some cell types but 
not for other types. In the nervous system, TNF alpha is responsible for neuropathic pain, neu-
ronal apoptosis and degeneration. Schwann cells are also led to apoptosis by TNF alpha. In this 
study, we investigated the function of tumor necrosis factor (TNF) alpha on neurofi broma (NF) 
cells derived from neurofi bromatosis type 1 patients. TNF alpha apparently accelerated the pro-
liferation of NF cells in dose- and time-dependent manners, which was confi rmed by an MTT 
[3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide] colorimetric bioassay and cell 
cycle analysis. The mitogenic effect was attenuated by anti-TNF-R1 neutralizing monoclonal 
antibody. On the other hand, other cytokines including insulin-like growth factor 1, fi broblast 
growth factor-2 and nerve growth factor did not serve as the mitogen. Additionally, TNF alpha 
failed to induce the apoptotic signals but rather activated AKT and MEK/ERK cascades. The 
results suggest a contribution of TNF alpha to NF growth. NF multiply arises, continuously 
grows, and often causes neuropathic pain in neurofi bromatosis patients, in whom the surgical 
removal of NF is presently the sole effective treatment although the repeated or newly recur-
rence is observed. Our results suggest the possible effi cacy of anti-TNF alpha treatment as the 
main or adjuvant therapy leading to suppression of NF growth.
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Fibroblast Growth Factor-7 Elicits the Proliferation of Human Epithelioid Sarcoma Cells 
without Inhibition of Fibroblast Growth Factor-2 Effect
Sato H1, Takahashi T1, Fujisawa Y1, Nakamura Y1, Kawachi Y1, Otsuka F1
Department of Dermatology, University of Tsukuba (Japan)
Fibroblast growth factor (FGF)-7 is a member of the FGF family initially purifi ed in conditioned 
medium of human embryonic lung fi broblasts. Its action is unique in being produced predomi-
nantly in stoma and targeting the epithelial cells. Like other FGF members, FGF-7 works as a 
potent mitogen for a range of cell types mainly through FGFR2 IIIb, high affi nity FGF-7 recep-
tor. The present study was designed to determine the impact of FGF-7 in human epithelioid 
sarcoma (ES) cells. ES, which is a variant of fi brosarcoma possessing both epithelial and mes-
enchimal features, actively grows, frequently recurs after the complete resection, and shows a 
high metastasis rate. The in vivo aggressive progression of ES suggests the possible involvement 
of plural growth factors. It was notably of interest whether FGF-7, which did not generally target 
the cells of mesenchimal origin, could have a mitogenic effect on ES cells. Analyses of cell pro-
liferation and cell cycle distribution showed the mitogenic effect of FGF-7 on human ES cells. 
The effect of FGF-7 was higher than those of EGF dan TGF-alpha, but relatively weaker than 
that of FGF-2 and did not signifi cantly interfere with FGF-2 effect which acts mainly via FGFR1 
IIIb, high affi nity FGF-2 receptor. The results imply that FGF-7 and FGF-2 may independently 
participate in ES cell proliferation. 
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Differential Regulation of Karyopherin alpha 2 Expression by TGF-beta 1 and IFN-gamma 
in normal Human Epidermal Keratinocytes: Evident Contribution of KPNA2 for Nuclear 
Translocation of IRF-1
Umegaki N1, Tamai K2, Nakano H2, Moritsugu R2, Yamazaki T2, Kaneda Y2, Hanada K2 and 
Katayama I1
1Department of Dermatology, Osaka University Graduate School of Medicine (Japan)
2Department of Dermatology, Hirosaki University School of Medicine (Japan)
Despite a number of studies on signal transduction in epidermal keratinocytes, very little is 
known about how the signals move from the cytosole to the nucleus during the course of 
keratinocyte proliferation and differentiation. To investigate the regulation of nuclear transport 
in keratinocytes, we compared the expression patterns of the karyopherin α (KPNA) subtypes 
in normal human epidermal keratinocytes (NHEKs) and normal human dermal fi broblasts (NH-
DFs). In terms of mRNA expression, KPNA2, KPNA3, and KPNA4 were the major subtypes, 
whereas KPNA 1 and KPNA5 were expressed at lower levels. Stimulation with both TGF-β1 
and IFN-γ for 24 hours resulted in the specifi c down-regulation of KPNA2 expression in NHEK 
cells at both the mRNA and protein levels. Interestingly, IFN-γ specifi cally upregulated KPNA2 
expression within 12 hours, suggesting the dual regulation of KPNA2 expression by IFN-γ. The 
addition of cycloheximide antagonized the effects of both TGF-β1 and IFN-γ on KPNA2 expres-
sion, indicating the requirement of on-going protein synthesis. We further demonstrated that 
KPNA2 binds and imports interferon regulatory factor-1 (IRF-1), a transcription factor induced 
by IFN-γ that mediates IFN-γ-dependent signals in NHEKs. Microarray expression analysis also 
suggested that KPNA2 mediates the nuclear translocation of the signals for keratinocyte dif-
ferentiation. Our data suggest that KPNA2 may play important roles in the signal transduction 
pathways that regulate epidermal proliferation and differentiation.
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The Melanocortin 1 Receptor Effects on Objective Ultraviolet-Induced Tanning and Erythema 
are Modest
Wong TH and Rees JL
Department of Dermatology, University of Edinburgh, Edinburgh (United Kingdom)
In order to investigate the facultative pigmentary (tanning) response, we have characterised the 
phenotype and melanocortin 1 receptor (MC1R) genotype of 98 individuals and also irradiated 
them with a custom-made UVB source with 10 increasing UVB doses (1.0, 1.3, 1.6, 2.0, 2.6, 
3.2, 4.1, 5.2, 6.5 and 8.2 standard erythemal doses (SEDs)) on photoexposed and photopro-
tected skin sites: mid back and buttock respectively. MC1R genotype status was determined by 
sequencing from venous blood using fl uorescent primer extension on ABI3100 electrophoresis 
systems.
The tanning response in the absence of blood fl ow (post noradrenaline iontophoresis), ex-
pressed in colorimetric L* score, was measured. Erythemal responses were measured with an 
erythema meter and a contact laser doppler. All measurements were taken in triplicate.
As expected there was a dose dependent increase in the tanning responses on both the back 
and the buttock. The back tans 6.35±0.33 L* units in response to 8.2 SEDs of UVB; whereas the 
buttock tans 4.01±0.32 L* units [n=98]. The differences between back and buttock are formally 
signifi cant (with p<0.01), with the back tanning signifi cantly more than the buttock. The aver-
age gradient of tanning response for the mid back was higher than that of the buttock.
Classifying by MC1R genotype status (using R and r classifi cation) showed no obvious differ-
ence between groups for tanning and erythemal responses. The erythemal response on the 
buttock for individuals homozygous for MC1R genotype was 615±219 compared to hetero-
zygous (406.3±36.0) and wild type (321.9±30.7). Unexpectedly, the pigmentary response on 
the buttock for individuals that are homozygous for MC1R genotype (4.35±2.68) compared to 
heterozygous (4.38±0.55) and wild type (3.75±0.40) showed no apparent difference.
These results suggest that the effect of MC1R on skin phenotype is less than that on hair.
557 [061]
Complete Loss of Langerhans Cells in the Lesional Skin in Acrodermatitis Enteropathica with 
Novel SLC39A4 Mutation
Kawamura T, Furuhashi M, Nakano H, Hanada K and Shimada S
Department of Dermatology, University of Yamanashi (Japan)
Acrodermatitis enteropathica (AE) is a rare autosomal recessive disease that manifests with low 
serum zinc levels, acral dermatitis and dysfunction of cellular immunity. Recently, it has been 
revealed that the human gene SLC39A4 encodes a protein with features characteristic of a ZIP 
zinc transporter and several SLC39A4 mutations have been demonstrated in AE patients. In 
this study, we identifi ed a novel premature termination codon mutation in SLC39A4 gene in a 
case of AE. Sequencing of PCR products spanning exon 9 revealed a homozygous 1438 G to 
T, designated E480X. To date, the pathogenesis of immune dysfunction in AE remains largely 
unknown. It has been previously reported that rats with dietary zinc defi ciency exhibited de-
creased number of epidermal LC, and we hypothesized that Langerhans cells (LC) undergo ex-
tensive apoptosis in AE lesions. To justify this hypothesis, we examined specimens of AE lesions 
by immunohistochemistry. We found that 1) Langerin antigens on LC were completely absent 
in the epidermis of AE lesion, but not in controls. 2) HLA-DR antigens on LC were also absent 
in AE specimens, but were present on the surface of dermal mononuclear cells. 3) cleaved 
caspase-3 positive dendritic cells were detected in the epidermis of AE lesion, but not in con-
trols. 4) TGFβ expression levels were severely decreased in the epidermis of AE lesion, when 
compared to controls. Taken together, these results indicate that LC destruction in AE occurs as 
a result of apoptosis presumably due to the absence of TGFβ. We have noted the absence of LC 
in lesional skin in AE, thus providing evidence that this defect may be an important mechanism 
involved in AE -related immune dysfunction.
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Polymorphisms in Methotrexate Effl ux Transporters have the Potential to Predict Clinical 
Response to Methotrexate Therapy in Psoriasis
Warren RB1, Camapalani E2, Smith R3, Barker JN2, Smith CH2, Worthington J3 and Griffi ths CE1
1The Dermatology Centre, University of Manchester (United Kingdom)
2Skin Therapy Research Unit, St John’s Institute of Dermatology (United Kingdom)
3ARC Epidemiology Unit, University of Manchester (United Kingdom)
Methotrexate remains a fi rst-line systemic therapy for moderate-to-severe psoriasis but unpre-
dictable effi cacy and toxicity limits its use. Previous methotrexate pharmacogenetic studies 
have focused on isolated single nucleotide polymorphisms (SNPs), within the folate and purine 
pathways. Effl ux of methotrexate from cells has the potential to reduce effi cacy, therefore we 
hypothesised that in psoriasis patients SNPs in the ATP-binding cassette (ABC) family of effl ux 
transporters, ABCC1 and ABCG2, are associated with clinical response to methotrexate. DNA 
was collected from 374 psoriasis patients defi ned as either responder or non-responder to 
methotrexate therapy. Haplotype tagging SNPs (r2 >0.8) for ABCC1 (n=42) and ABCG2 (n=12) 
with a minor allele frequency of >5% were selected from the HAPMAP phase II data, giving 
73.3% and 74.1% gene coverage respectively. Genotyping was undertaken using the MassAr-
ray spectrometry (Sequenom®). SNP rs17731538 (ABCG1) was signifi cantly (p=0.02) associ-
ated with response to methotrexate and development of any adverse event (p=0.01); carriage 
of the major allele confers an OR = 1.84 (95%CI 0.98 –3.4, p=0.02) and 1.2 (95%CI 0.7-2.1, 
p=0.2) respectively. This SNP had a strong (p=0.0005) association with development of sig-
nifi cant gastrointestinal adverse events. SNP rs2238476 (ABCC1) was signifi cantly (p=0.02) 
associated with response to methotrexate and development of an adverse event (p=0.01); car-
riage of the major allele confers an OR =2 (95%CI 0.79-4.9,p=0.07) and 2.16 (95%CI 0.9-5.3 
p=0.03) respectively. Two further SNPs rs246240 (ABCC1) and rs3784862 (ABCC1) were also 
associated with the development of an adverse event, p= 0.01 and p=0.005; conferring an 
OR=1.6 (95%CI 0.97-2.8, p=0.03) and 1.8 (95%CI 1.1-3.2, p=0.01) respectively. These data 
indicate that SNPs in the ABC family of effl ux transporters may prove important when iden-
tifying psoriasis patients suitable for methotrexate therapy and this should be validated in a 
prospective trial.
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Drug-Induced Hypersensitivity Syndrome is a Manifestation of Newly Observed Immune 
Reconstitution Infl ammatory Syndrome
Asano Y, Kano Y and Shiohara T
Department of Dermatology, Kyorin University School of Medicne (Japan)
Drug-induced hypersensitivity syndrome (DIHS) is a severe drug eruption associated with re-
activation of human herpesvirus 6 (HHV-6). Recent articles demonstrated various herpesvirus 
reactivations and multi-organ failures including encephalitis, pneumonia and cutaneous cy-
tomegalovirus (CMV) disease during the course of DIHS. However, it remains unknown why 
these herpesviruses reactivate coincident with the development of multi-organ failures long 
after withdrawal of the causative drug. Considering immunosuppressive potentials of the causa-
tive drugs and paradoxical worsening of clinical symptoms and laboratory parameters after 
withdrawal of these drugs, protracted administration of these drugs would itself lead to some 
degree of immune suppression before onset of DIHS that can be reversible upon withdrawal of 
the drug; and rapid restoration of cellular and humoral immune responses would be respon-
sible for clinical manifestation of DIHS. In this study, we sequentially analyzed lymphocytes 
subsets in the peripheral blood during the course of DIHS. Our results showed that signifi cant 
increases in CD4+ and/or CD8+ T cells were observed following discontinuation of the causa-
tive drug; clinical manifestations such as erythematous rashes and liver dysfunction developed 
coincident with the signifi cant rises in CD4+ and/or CD8+ T cells, a fi nding typically observed 
in immune reconstitution infl ammatory syndrome (IRIS). In view of clinical similarities be-
tween IRIS and DIHS developing upon discontinuation of immunosuppressive agents, we sug-
gest to expand the spectrum of IRIS to include DIHS. Recovery of immune responses against 
previously unrecognized viruses reduces viral loads on the on hand but causes tissue damage 
at sites of subclinical infection on the other, leading to the development of clinical manifesta-
tions of DIHS. Thus, patients with DIHS are at a greater risk of subsequently developing the 
wide spectrum of IRIS ranging from CMV disease to autoimmune disease.
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T-plastin Expression in Cutaneous T Cell Lymphoinfi ltrative Disorders
Michel L1, Pellet C2, Bégué E2, Jean-Louis F2, Dubertret L3, Courtois G2 and Bachelez H2
1Inserm U697, Hopital Saint-Louis, Paris (France)
2Inserm U697 (France)
3Dermatology 1 Department, Hopital Saint-Louis, Paris (France)
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of non-Hodgkin ex-
tra-nodal T cell lymphomas, from which mycosis fungoides (MF) and Sézary syndrome (SS) 
are the two major clinical variants. In the past few years, transcriptome analysis, allowed the 
identifi cation of T-plastin as an upregualted gene in CTCL cells from SS patients, while this lat-
ter plastin isoform is not expressed by normal T lymphocytes. We investigated herein T-plastin 
expression in patients with a wide range of cutaneous T-cell lymphoinfi ltrative disorders, in 
order to approach the value of this feature in the diagnostic of CTCL.
Peripheral blood lymphocytes (PBL) were isolated from circulating blood of patients with CTCL 
(n=34), MF (n=12), unidentifi ed erythroderma (n=10), hypereosinophilic syndrome (n=8) and 
healthy donors (n=6). The expression levels of T-plastin and L-plastin was quantifi ed by quan-
titative real-time polymerase chain reaction assay and immunoblotting in PBLs and CTCL cell 
lines (SeAx, MyLa) lines as well as in control leukemic Jurkat cells. Our results show that T-plas-
tin mRNA were detected in 80% of SS patients, while no exprssion was detectable in patients 
with MF (n=12), idiopathic erythroderma (n=10), hypereosinophilic syndrome with clonal T-
cell subset (n=8), and healthy donors. Although Hut-78 cell line does constitutively express 
T-plastin, SeAx cells and MyLa cells derived from one SS and one MF patient, respectively, do 
express T-plastin only after stimulation with PMA (10ng/ml) + ionomycine (1μM). Immunoblot-
ting analysis confi rms mRNA expression results. 
Altogether, our results suggest that T-plastin expression is restricted to Sézary syndrome and 
might be considered as a useful molecular marker in diagnostic procedures. They also reveal 
that transcriptional expression might be unrepressed following stimulation, emphasizing the 
existence of regulatory mechanisms at the promoter level.
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Susceptibility of Furunculosis-Derived Staphylococcus aureus to LL-37 and Antibiotics
Baranska-Rybak W1, Sonesson A2, Nowicki R1 and Schmidtchen A2
1Department of Dermatology, Venereology and Allergology, University of Gdansk (Poland)
2Dermatology & Venereology, Department of Clinical Medicine, University of Lund (Sweden)
During infection, various bacteria may exhibit various resistance mechanisms against en-
dogenous antimicrobial peptides, such as human cathelicidin LL-37. Recurrent furunculosis 
caused by Staphylococcus aureus (SA) presents a diffi cult clinical problem and causes signifi -
cant morbidity. Antibiotic treatment does not seem to eradicate the infection totally and may 
induce antibiotic resistance and allergy. Here we investigated the susceptibility of SA isolates 
to LL-37 alone or in combination with other antimicrobials.
The aim of study: 1. To analyse the susceptibility of SA strains isolated from patients with recur-
rent furunculosis to conventional antibiotics (erythromycin, doxycyclin and clindamycin) as 
well as the human antimicrobial peptide LL-37. 
2. To investigate possible synergistic interactions between LL-37 and antibiotics. Susceptibility 
of SA to antibiotics was performed according to NCCLS. ADSRRS-fi ngerprinting was used for 
identifi cation of SA strains. Radial diffusion assay was performed to analyse bactericidal activ-
ity of LL-37 as well as potential synergistic effect of combinations of LL-37 and antibiotics.
 Among investigated SA strains we found 89% to be resistant to penicillin and 20.6%, 19.5%, 
and 6.5% were resistant to erythromycin, clindamycin and doxycyclin respectively. ADSRRs-
fi ngerprinting patterns for 70 SA isolates yielded 31 unique profi les. All strains were suscepti-
ble, although to a variable extent, to 50 μM LL-37. In the presence of antibiotics, only erythro-
mycin potentiated the activity of LL-37.
 LL-37 exerts antibacterial activity against the investigated strains of SA. No correlation be-
tween genotype and sensitivity to LL-37 was observed. A signifi cant synergy between LL-37 
and erythromycin was demonstrated.
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Stem Cell Therapy with Human Mesenchymal Stem Cells for Mouse Skin Radiation Damage
Bensidhoum M1, Gobin S1, Chapel A2, François S2, Le Minter P1, Bouet S3, Gidrol X1
Thierry D2 and Martin M1
1CEA/DSV/DRR/SGF, Evry (France)
2IRSN, Fontenay aux Roses (France)
3INRA, Jouy en Josas (France)
Normal tissues are inevitably exposed to ionising radiation during radiotherapy, which can 
result in organ failure and hence limits the dose delivered to the tumour. The skin is a radiosen-
sitive tissue, where both early and late complications can occur. 
Our present goal is to test whether skin radiation-induced damage can be reduced through 
stem cell therapy. We isolated human MSCs and tested their capability to engraft in a damaged 
skin tissue. We assessed this potential in NOD/SCID mice, which received 30 Gy locally on 
the thigh and 3.2 Gy globally. This dose resulted in local skin necrosis within 3 weeks which 
was repaired within 8 weeks. hMSCs have been i.v. injected in irradiated mice 24 hours after 
irradiation. Establishment of a clinical scoring throughout 6 weeks gave indications that hMSCs 
positively infl uenced the development of radiation-induced damage, as the extent of damage 
was reduced and the wound healing process was accelerated in grafted mice. Mice were sacri-
fi ced 6 weeks after irradiation and the skin was removed. Using qPCR for the human b-globin 
gene we could detect hMSCs-derived cells that had homed to the damaged skin. Histological 
studies confi rmed the presence of these cells into skin epidermis. Using an antibody against the 
human b2 microglobulin protein, we found that hMSCs were located as clusters in the healing 
epidermis. Moreover, the hMSCs exhibited an epithelial morphology. We are currently assess-
ing the mechanisms of the contribution of hMSC, from trans-differentiation, dedifferentiation, 
to fusion with resident cells.
In this study, we demonstrate that human transplanted MSC can improve the clinical outcome 
of irradiated mice and engraft to injured skin epidermis to promote wound healing by prolifera-
tion and differentiation. A successful replacement of stem cells and subsequent amelioration 
of radiation-induced complications may open the road to new strategies in radiotherapy and 
help combating cancer. 
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Multiple Solar Lentigines on the Upper Back and Shoulders: A Potential Causality Link 
Between Past Severe Sunburns and Melanoma
Reguiai Z1, Jovenin N2, Derancourt C1 and Bernard P1
1Department of Dermatology, University Hospital Robert Debré, Reims (France)
2Department of Medical Proceedings, University Hospital Robert Debré, Reims (France)
The presence of pigmented lesions suggestive of past excessive sun exposure might be used 
to identify individuals with an increased risk of cutaneous melanoma. Among these lesions, 
multiple solar lentigines of the upper back and shoulders (MSLBS) have been individualized 
as large brown-colored macules induced by excessive UV-B exposure. A recent case-control 
study found a strong and independent association between MSLBS and past severe sunburns.
To determine whether MSLBS might represent a clinical marker of an increased risk of develop-
ing melanoma, we conducted a prospective study to estimate their prevalence among patients 
with melanoma and to compare constitutional and behavioral characteristics of these patients 
with and without MSLBS. From October 2003 to November 2004, 125 adult patients (67 men 
and 58 women; mean age 58 ± 13.9 years) followed up for melanoma in our department of 
dermatology (northern France) were included. MSLBS were observed in 37.6% of patients 
with melanoma. In multivariate analysis, the presence of more than 10 naevi on the back, 
extensive common freckles on the arms, propensity to burn in the sun were more frequent in 
patients with MSLBS. MSLBS were signifi cantly and independently associated with melanoma 
on the back (adjusted odds ratio (OR) = 4.3; 95% confi dence interval (CI) = 1.5- 12.3) and with 
recalled episode(s) of severe sunburn(s) before the age of 28 (OR = 3.4; 95% CI = 1.3-9.4). 
Large irregularly-shaped MSLBS were frequently seen in adults with melanoma and associ-
ated with melanoma on the back, suggesting a causality link between past severe sunburn(s) 
and melanoma. Patients presenting MSLBS should therefore be followed up more closely and 
strongly encouraged to avoid excessive sun exposure.
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What About Education to Apply Sun Care Product?
Bertin C, Nkengne A, Robert C and Issachar N
R&D J&J Consumer France (France)
The deleterious effects of sun exposures are well known and this is why a vast majority of 
the people use sun care products to protect their skin. But it is crucial to apply the products 
correctly, both in terms of quantity applied and uniformity of spreading without any exposed 
zones forgotten. The objective of this study was to set up guidelines to help consumers to use 
sun care products adequately thanks to a detailed protocol of applications. Height healthy 
volunteers were recruited in this study. First, the subjects applied the product the way they 
usually do on the beach on all the zones of their face and body possibly exposed to sun. 
Photos under Ultra Violet (UV) light were taken. Then, they were provided with a protocol of 
application and photos under UV light were taken again. A grading of the quality of application 
was done by 3 graders on the UV photos following the two types of application to evaluate if 
the protocol recommended allowed to obtain optimal suncare product application or if it has 
to be amended. The quantity of cream was graded from 0 (No product applied) to 3 (enough 
product applied) and the uniformity was graded from 0% (not uniform at all) to 100% (totally 
uniform). The results obtained showed that this protocol improved a lot both quantity and 
quality of suncare product application. A better protection of the face was noticed (+ 22,9% in 
quantity, + 21,7% in spreading) and of the body (+27,5 % in quantity, + 20,2% in spreading). 
No signifi cant improvement was observed on the legs because people are already good on that 
part. In conclusion, the results obtained during this study confi rm that we can improve the way 
by which the consumers apply their sun care products if we educate them. 
565
Interim Results of a Multi-Center Study to Evaluate the Safety and Effi cacy of Topically Applied 
AN2690 5.0% and 7.5% Solution for the Treatment of Onychomycosis of the Great Toenail
Beutner K1, Toledo-Bahena M2, Barbosa Alanis H3, Hernandez-Garcia A4, Reyes-Santana E4, 
Mata-Lara M5, López-Tello Santill A6, Ocampo-Candiani J7 and Barba-Gomez J8
1Anacor Pharmaceuticals (USA)
2Instituto Mexicano de Investigación Clinica (Mexico)
3Monterrey Internatinal Research Center (MIRC/OCA Hospital) (Mexico)
4Unidad de Investigación en Salud de Chihuahua S.C. (Mexico)
5Hospital “Dr. Ángel Leaño” (Mexico)
6Instituto de Seguridad Social del Estado de México y Municipios (Mexico)
7Hospital Universitario”Jose E. Gonzalez” (Mexico)
8Instituto Dermatologico de Jalisco (Mexico)
AN2690 is a novel antifungal which penetrates through the nail plate and blocks fungal protein 
synthesis. This trial enrolled 60 subjects with mild to moderate, KOH positive, distal subungual 
onychomycosis. Subjects are being treated with either AN2690 5.0% or 7.5% once daily for a 
6 month treatment period followed by a 6 month treatment-free follow-up period. Effi cacy is 
being monitored by evaluating KOH, fungal culture, and length of clear nail growth as meas-
ured from serial digital images. This interim analysis presents the mycology results on all 60 
subjects through day 60 of treatment and on clear nail growth on 49 subjects (24 on AN2690 
5.0% and 25 on AN2690 7.5%) whose day 90 images were available. All subjects were KOH 
positive at baseline, and at days 14, 30, and 60 the KOH positive rates were 63%, 81%, and 
41%, respectively. At baseline, 50% (31/60) were culture positive for a dermatophyte; at days 
14 and 60, the culture positive rates were 3% (2/60). Overall 67% (33/49) of subjects had at 
least 1 mm of clear nail growth at day 90 and were considered “responders” with an average 
growth of 3.5 mm, and 16% (8/49) achieved > 5 mm of growth. Treatment was well tolerated 
by 84% of the subjects. Of 10 subjects that required a drug holiday, 9 completely recovered, 
1 is recovering, and 8 of the 9 who recovered are tolerating dosing three times weekly. These 
early mycologic and clinical responses suggest that AN2690 may represent a signifi cant new 
therapy for onychomycosis.
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An Open-Label, Multiple-Dose Study of the Absorption and Systemic Pharmacokinetics of 
AN2690 Applied as a 7.5% Solution to All Toenails of Adult Patients with Moderate to Severe 
Onychomycosis
Beutner K2, Jones T1 and Sanders V2
1J & S Studies (USA)
2Anacor Pharmaceuticals (USA)
AN2690 is a new novel antifungal being developed for the treatment of onychomycosis. 
AN2690 has demonstrated excellent nail plate penetration in ex vivo studies as well as favora-
ble early clinical effi cacy results. In pre-clinical studies, the plasma half life of AN2690 in rats 
was 11 minutes following intravenous dosing. Systemic exposure in the minipig was very low 
following a topical dose of 8.59 ± 0.34 mg/kg (10% solution applied to 5% body surface area). 
A Cmax of 184 ± 110 ng/mL was observed at 2 h. At the ten-fold lower dose of 0.859 ± 0.034 
mg/kg, all plasma concentrations were below the limit of quantitation. The purpose of this study 
was to defi ne the extent of human systemic exposure when AN2690 solution, at 7.5%, was 
applied to all 10 toenails of subjects with moderate to severe onychomycosis. 15 subjects with 
a body mass index between 19-35, onychomycosis involving greater than 80% of both great 
nails, a combined thickness of the nail plate and nail bed > 3 mm, and at least 6 additional 
onychomycotic nails were enrolled to be treated daily for 28 days. A total dose of 0.25 ml was 
distributed over the subjects’ 10 toenails daily for 28 days at the study site. Plasma samples for 
quantitation of AN2690 were collected prior to and 0.25, 0.5, 1, 2, 3, 4, 6, 8 hours after test 
agent application on days 1, 14, and 28. Samples were analyzed for AN2690 by a LC/MS/MS 
method with a lower limit of quantitation of 100 ng per ml. Only a very low level of 2690 was 
detected indicating minimal systemic exposure. 
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A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Safety 
and Effi cacy of Topically Applied AN0128 1% Cream for the Treatment of Mild to Moderate 
Atopic Dermatitis
Beutner K1, Bucko A1, Jones T2, Loss R3, Matheson R4, Jarratt M3, Fowler J5, Rich P6, Stough D7
1Academic Dermatology (USA) 2J & S Studies (USA) 3 (USA) 4Oregon Medical Research (USA) 
5Dermatology Specialists (USA) 6Northwest Cutaneous (USA) 7Burke (USA)
AN0128 is a novel topical anti-infl ammatory drug which blocks pro-infl ammatory cytokines in 
vitro and in pre clinical studies demonstrates an excellent topical and systemic safety profi le. 
As the fi rst clinical trial of this new therapy in the treatment of atopic dermatitis, this trial was 
considered exploratory in nature and thus there were no formal power calculations. Eight cent-
ers enrolled 103 subjects over 18 years of age with mild to moderate atopic dermatitis (AD) and 
a body surface area of 3-10% to be randomized 2:1 to twice daily treatment for 4 weeks with 
either AN0128 Cream 1% or the vehicle cream. At baseline 67% of subjects were evaluated 
as moderate in severity. An intent to treat analysis of all subjects randomized, at the end of the 
treatment period showed that 51% (30/59) of the AN0128 treated subjects vs. 37 % (13/35) of 
the vehicle treated group reached a level of clear or almost clear (p=0.19) based on a 5 point 
(clear, almost clear, mild, moderate, severe) investigator static global assessment (ISGA). In a 
modifi ed intend to treat population of only those subjects who were of moderate severity at 
baseline 47%, (18/38) of the A0128 treated group and 29% (7/24) of the vehicle group reached 
at least a two grade improvement in their ISGA (p=0.15). Both treatments were well tolerated 
with only rare application site reactions and no serious adverse events report. The results of this 
study would indicate that AN0128 represents a potential new therapy for AD and this study 
provides the necessary data to power future trials.
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Prediction of CD11a as a Putative Relevant Treatment Target in Atopic Dermatitis by Ex Vivo 
MELK Analysis
Bonnekoh B1, Pommer AJ2, Böckelmann R1, Schubert W3, Philipsen L4 and Gollnick H1
1Clinics for Dermatology & Venereology, Otto-von-Guericke-Univer Magdeburg (Germany)
2SkinSysTec GmbH, ZENIT Technology Park, Magdeburg (Germany)
3Institute for Medical Neurobiology, Otto-von-Guericke-University Magdeburg (Germany)
4MelTec GmbH & Co. KG, Magdeburg (Germany)
CD11a is a subunit of LFA-1 representing a critical epitope for lymphocyte adhesion and co-
stimulation. During the last years biological drugs alike efalizumab targeting CD11a have been 
successfully introduced as a new treatment for psoriasis. Given the fact, that certain treatment 
modalities (e.g. ciclosporin) are equally effective in psoriasis and atopic dermatitis we ad-
dressed the question whether CD11a could also be of major pathogenetic relevance in atopic 
dermatitis.
Therefore we compared the expression of CD11a, together with more than 40 other epitopes, 
in skin biopsies from involved skin of atopic dermatitis, psoriasis and normal skin (n = 10 in-
dividuals each) by means of Multi Epitope Ligand Kartography (MELK) Robot Technology. This 
high-dimensional fl uorescence microscopy is based upon a repeated cycling of a skin tissue 
section through i) incubation with a fl urophore-labeled antibody, ii) fl uorescence imaging and 
iii) soft bleaching. Resulting fl uorescence images are point-precisely overlaid allowing to de-
termine the sub-cellular co-location of the epitopes in terms of topo-proteomics. Combinatorial 
data were quantifi ed with regard to 1) topographic micro units (corresponding to single pixels 
and a specimen area of 450 nm x 450 nm, 20x objective), 2) adequate binarization related to 
external and internal biological as well as technical standards, and 3) the newly defi ned dimen-
sion “pixel events normalized to a horizontal skin width of 100 μm".
Under these conditions the dual co-location of CD11a with the lymphocyte markers CD2, 
CD3, CD4, CD8, CD45R0, CD45 RA and CLA, each, was found to be signifi cantly up-regu-
lated in atopic dermatitis and psoriasis as compared to control (p < 0.05), with no difference 
between both diseases. This may allow the prediction that CD11a-targeting treatment modali-
ties like the antipsoriatic efalizumab might be also of therapeutic effi cacy in atopic dermatitis.
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Anti-Wrinkle and Antioxidant Properties of Date Palm Kernel Extract Demonstrated in In 
Vitro and In Vivo Studies
Oberto G1 Berghi A, Dal Farra C and Domloge N
Vincience Research Center (France)
Recently, increasing scientifi c attention has been devoted to anti-aging active ingredients ex-
tracted from plants. This development has taken place alongside a dramatic increase in interest 
in natural products as a whole. In this area, we developed Date Palm Kernel Extract (DPK), 
and investigated its antioxidative and anti-wrinkle properties. 1% DPK extract was applied to 
human fi broblasts, for 24 h, in SOD gel studies. These studies showed that DPK application 
enhanced SOD Mn expression in UVA-stressed human fi broblasts, compared to the control. 
Catalase assays revealed that DPK extract-treated cells exhibited a higher level of catalase 
activity in response to UVA stress, and this result was confi rmed by mRNA studies. Protein 
carbonylation studies showed a signifi cant decrease in protein carbonylation in treated cells, 
confi rming the protective properties of DPK extract. Immunoblotting studies on DPK extract-
treated cells added further evidence of the extract’s protective role. These studies demonstrated 
that, despite UVA exposure, extract administration enhanced collagen I synthesis in treated 
cells, compared to the control. In addition, an in vivo study on DPK extract was performed on 
10 healthy women volunteers. Volunteers applied a cream formula with 5% DPK-extract, or 
placebo, on the eye zone area twice a day for 4 weeks. Silicon replica studies showed a 27.6% 
(p=0.038) reduction in the total surface of wrinkles when DPK extract was topically applied to 
the skin. A 3.52% (p= 0.0231) reduction in the depth of wrinkles was also observed. The fi nd-
ings of these studies were statistically signifi cant and were confi rmed both clinically and by the 
impressions of volunteers which indicated a visual improvement of 60%. 
These studies demonstrate that the antioxidant and anti-wrinkle properties of Date Palm Kernel 
Extract are signifi cant and can be of great use in natural anti-aging skin care products.
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Acute Generalized Exanthematous Pustulosis (AGEP) Following a Spider Bite - Report of 3 
Cases
Davidovici B1, Dyachenko P2, Cagnano E3, Rozenman D2 and Halevy S1
1Department of Dermatology, Ben-Gurion University of the Negev, Beer-Sheva (Israel)
2Department of Dermatology, Haemek Hospital, Afula (Israel)
3Institute of Pathology, Soroka Univ Medical Center, Ben-Gurion Univ of the Negev (Israel)
Acute generalized exanthematous pustulosis (AGEP) is a rare severe cutaneous adverse reac-
tion. In addition to drugs, which are the most common causative agents, viral infections and 
hypersensitivity to mercury have been implicated as possible triggers. We hereby present an 
additional trigger for AGEP that has not been reported before. We reviewed 22 AGEP cases 
from Israel that were diagnosed during the years 1997-2005 and included in two prospec-
tive European studies of severe cutaneous adverse reactions. Three out of the 22 AGEP cases 
(13.6%) occurred 24-48 hours following a spider bite. The diagnosis of a spider bite was based 
in our case series on the presence of typical dermonecrotic skin lesions associated with ery-
thema and edema in an endemic country (Israel). All patients manifested the typical clinical 
and histopathological fi ndings of AGEP and according to a standardized scoring system were 
diagnosed as defi nite AGEP cases. In view of the short latent period reported for the appearance 
of AGEP (usually 2-3 days) and based on time-relationship data recorded in the present case 
series, a spider bite was suspected to be a possible trigger factor. The mechanism responsible 
for the induction of AGEP may involve stimulated release of various cytokines by the spider 
venom, including large amounts of IL-8 and GM-CSF that play a role in the etio-pathogenesis of 
AGEP. In conclusion, we suggest that a spider bite is a possible trigger for AGEP. 
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SWISDOM (http://www.swisdom.org)- A Case- Based Medical E-Learning Platform, 
Exemplifi ed by the SWISDOM- Based Dermatological E-Learning Resource “DOIT- 
Dermatology Online with Interactive Technology”
Dummer R1, Djamei V1, Mnich C1, Rufl i T2, Itin P2, Braathen L3, Pannizon R4, Lautenschlager S5, 
Elsner P6 and Burg G1
1Dept of Dermatology, Univ of Zurich (Switzerland) 2Dept of Dermatology, Univ of Basel (Swit-
zerland) 3Dept of Dermatology, Univer of Bern (Switzerland) 4Dept of Dermatology, Univ of 
Lausanne (Switzerland) 5Dermatologisches Ambulatorium, Stadtspital Triemli,Zurich (Switzer-
land) 6Dept of Dermatology, Univ of Jena (Germany)
Purpose: To present SWISDOM, a new e-learning platform for medical education, whose fea-
tures and functions are exemplifi ed by the SWISDOM-based e-learning resource “DOIT- Der-
matology Online with Interactive Technology”. DOIT is an e-learning environment for under- 
and postgraduate students in dermatology.
Methods and Results: DOIT has been developed primarily by the Swiss university dermatology 
departments in Zurich, Bern, Basel and Lausanne with the support of the Swiss Virtual Campus 
program (http://www.swissvirtualcampus.ch), the E-learning Center Zurich and the university 
dermatology department in Jena, Germany. DOIT is used in these institutions, in a blended 
learning approach, for medical student training in dermatology, as well as by more than 30 
other universities worldwide. DOIT is currently available in English, French, German and Por-
tuguese, with further translations (Spanish, Italian, Chinese and Japanese) in progress. The main 
modules are: (1) Cyberlecture; a lecture text and atlas; (2) Cybertrainer; an interactive training 
program including multiple-choice questions; and (3) Cyberforum, a discussion forum with 
users and tutors. Additional functions are: an authoring tool, a personalized notepad, a PDF 
print function, a contextual help function, and a search engine. DOIT enjoys high usage rates 
and very positive user feedback. DOIT was a fi nalist in two recent e-learning competitions: 
“European Academic Software Award 2004” and “MEDIDAPRIX 2005”. Working with these 
modules and functions allows the students to proceed at their own pace to study the basics 
of dermatology with a problem-based learning approach. The usage of the Swiss Catalogue of 
Learning Objectives (SLO, http://www.smifk.ch) as a basis for the DOIT content helps unify 
medical teaching among the Swiss universities.Conclusions: SWISDOM is an established and 
expandable platform which is ideally suited to realize multi-media based teaching concepts 
for visually-based specialties like dermatology. Interdisciplinary and world-wide collaboration 
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Reliability of Psoriasis Assessment on Photographs: A Pilot Study
Farhi D1, Dupuy A2 and Falissard B3
1Department of Dermatology and Venereology, Tarnier Hospital (France)
2Department of Dermatology, Saint Louis Hospital (France)
3INSERM, Cochin hospital (France)
Reliable assessment of severity in psoriasis is essential to document treatment response in clini-
cal trials. Psoriasis global assessment (PGA) and Psoriasis area and severity score (PASI) are the 
most frequently used evaluation scales for psoriasis. The reliability of available measures of pso-
riasis severity is uncertain.To quantify reliability of psoriasis severity measure on photographs 
with PGA 30 adult patients, with a wide range of plaque psoriasis severity, were evaluated 
twice at a 30 days interval. At each session, 9 standardized numeric photographs were made, 
covering more than 95% of the body surface area. These photographs were independently eval-
uated by 11 dermatologists (5 seniors, and 6 residents), using PGA. Each dermatologists gave 2 
evaluations of all photographs at a one month intervall (test – retest). Inter-rater agreement and 
intra-rater consistency were assessed with the intra-class coeffi cient (ICC). Reliability among 
senior dermatologists was compared with reliability among resident dermatologists. Correla-
tion of dynamic PGA and PASI variation was assessed. Inter-rater agreement was good for 
dynamic (ICC=0.70) and static (ICC=0.72) PGA, and was not better for senior than for residents 
dermatologists. Intra-rater consistency was good for dynamic (ICC>0.8) and static (ICC>0.8) 
PGA, and was not better for senior than for residents dermatologists. Correlation between PASI 
(psoriasis area and severity score) variation and dynamic PGA was excellent (ρ=0.87).
The good metrologic performances of dynamic and static PGA on photographs provide reliable 
evaluation of psoriasis severity in clinical trials. Furthermore, photography allows evaluation 
of a single patient by several dermatologits (which enhance generalisability of the severity as-
sessment), favorizes respect of blindness and of independence of phsycian’s judgement during 
clinical trials (avoiding communication between patients and physicians), and provides a con-
trolable evidence of treatment effect (that can be re-assessed by peers subsequently).
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Effects of Adenosine 5’-monophosphate on Epidermal Turnover
Furukawa F1, Harano F2, Shinohara S2, Kamimura J2, Kawabata S2, Igarashi S2, Kawamura M2, 
Kanehara S3, Yamamoto Y1 and Miyachi Y4
1Department of Dermatology, Wakayama Medical University (Japan)
2Otsu Lab for Skin Care Science, Rejuvenate Division, Otsuka Pharmaceutical Co.,Ltd (Japan)
3Department of Dermatology, Rinku General Medical Center (Japan)
4Department of Dermatology, Graduate School of Medicine, Kyoto University (Japan)
Background Structure and function of epidermis is maintained by cell renewal based on epi-
dermal turnover. The epidermal turnover delays by aging, and the delay is related to the en-
ergy metabolism of epidermal basal cells. It is reported that adenosine 5’-triphosphate (ATP) is 
needed for the cell renewal: cell division, and adenosine 5’-monophosphate (AMP) increases a 
quantity of intracellular ATP. These fi ndings suggest that AMP accelerates the epidermal turno-
ver delayed by aging. Objectives To examine whether AMP (including the salts: adenosine 5’-
monophosphate disodium salt (AMP2Na)) can accelerate the epidermal turnover or not. 
Method An effect of AMP2Na on cell proliferation was examine by our counting keratinocytes. 
An effect of AMP2Na on cell cycle was examined by our counting basal cells in DNA synthetic 
period of hairless rats. Effects of AMP2Na (or AMP) on the epidermal turnover were examined 
by our measuring stratum corneum transit time by use of guinea pigs, and by our measuring 
stratum corneum surface area by use of hairless rats and in a clinical pharmacological study.
Results In a case of culture for 74 hours, AMP2Na of 0.00001% and 0.00005% induced cell 
growth, but AMP2Na of 0.001% and 0.01% inhibited it. The number of basal cells in DNA 
synthetic period of 3 and 10% AMP2Na treated groups were signifi cantly higher about 1% 
than that of vehicle treated group. Corneocyte surface area of 2% AMP treated group was sig-
nifi cantly smaller than that of vehicle treated group (hairless rats). Stratum corneum transit time 
of 1, 3 and 10% AMP2Na treated group was signifi cantly shorter than that of vehicle treated 
group (guinea pigs). Corneocyte surface area of emulsion containing 3 % AMP2Na treated 
group was signifi cantly smaller than that of vehicle treated group (human volunteers).
Conclusion We conclude that AMP (including the salts) promotes the cell cycle progression of 
the epidermal basal cells and accelerates the epidermal turnover safely. We also think that AMP 
(including the salts) is useful for skin rejuvenation in dermatology or aesthetic dermatology.
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Evaluation of Alexandrite Laser, ND:YAG Laser and Intense Pulsed Light for Axillary Hair 
Removal: A Prospective Randomized Controlled Trial
Ghaly N
Department of Dermatology, University of Tanta (Egypt)
The aim of this work is to conduct a prospective randomized controlled study addressing the 
practical interest of comparing effi cacy, safety and tolerability of Alexandrite laser, ND:YAG 
laser and IPL, with different wavelength for axillary hair removal in different skin types. 120 
female subjects were randomly classifi ed into 3 equal groups; group A, B and C treated with 
alexandrite laser, ND:YAG laser and IPL respectively. Patients scored according to Fitzpatrick 
skin type, 22 patients had skin type III, 67 patients had skin type IV and 31 patients had skin 
type V. Four sessions were carried out at 4-6 weeks intervals. Follow up, clinical evaluation; 
photographs and hair reduction ratio were evaluated before each session and 6 months after 
last session. Subjects completed questionnaires assessing tolerability and satisfaction at the last 
follow up. All systems were almost equally tolerable. Subjects expressed satisfaction earlier 
with alexandrite laser than ND:YAG and IPL. A decreased rate of satisfaction was noted with 
darker skin types. The greatest hair reduction was seen with alexandrite laser (83.11 ± 7.9) and 
signifi cantly different from ND:YAG and IPL. There was no signifi cant difference between ND:
YAG (60.63±13.82) and IPL (55.70±13.05) in hair reduction ratio. Side effects including pain 
and hyperpigmentation observed more with alexandrite laser and darker skin types. Thus, Al-
exandrite laser can achieve excellent long term hair removal with more effi cacy than ND:YAG 
and IPL. Meanwhile, it is still safe and tolerable even in dark skin types where ND:YAG and IPL 
show less side effects. The increased side effects in darker skin type can be avoided by careful 
adjustment of the laser parameters. More frequent sessions are needed by ND:YAG and IPL for 
long term hair reduction with acceptable effi cacy.
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Custom Designed Autologous Skin and Mucosa Substitutes for Wound Healing
Gibbs S1, van den Hoogenband HM1, de Boer EM1, Vriens AP1, Waaijman T1, Breetveld M1, 
Kirtschig G1 and Scheper RJ2
1Department of Dermatology, VU University Medical Center, Amsterdam (Netherlands)
2Department of Pathology, VU University Medical Center, Amsterdam (Netherlands)
Advanced wound healing therapies are entering into the area of tissue engineering. Ideally, a 
full thickness autologous skin substitute is required that can replace the use of the full thickness 
or meshed autograft in the treatment of therapy resistant ulcers, surgical excision wounds, deep 
burns, wounds on exposed bone and receding gum correction. Currently, there is no insight as 
to whether a single skin/mucosa substitute is suitable or whether custom built constructs should 
be developed which take into account body location, size of wound, condition of the wound 
bed (inert/granulating/highly infl amed) and the quality of the scar required.
Over the last three years we have developed full thickness autologous skin and mucosa sub-
stitutes suitable for transplantation. These skin/mucosal substitutes consist of reconstructed 
epithelia on fi broblast populated human donor dermis. The full thickness constructs maintain 
many of the phenotypic and histological characteristics of the tissue from which they were 
derived.
Application of the skin substitute to therapy resistant ulcers resulted in complete healing after 
only a single application (16 / 19 ulcers). Also, application of the mucosal substitute to tooth 
extraction wounds (n=4) resulted in an improved and increased rate of healing. However, ap-
plication of the skin substitute to surgical excision wounds resulted in hypergranulation and 
retarded healing (n=3). Comparison of the skin substitute with a full thickness autograft using a 
protein array showed that the skin substitute secreted more angiogenic and granulation stimu-
lating factors than the autograft and in general showed characteristic markers which closely 
resemble those found in wounded epidermis.
These results indicate that custom designed skin/mucosa substitutes should be developed spe-
cifi cally for the type of wound to be treated. In order to do this, the different wound beds, cell-
cell interactions within the constructs and culture medium effects should be investigated.
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Plasma Homocysteine and Folate Levels in Patients with Chronic Plaque Psoriasis
Gisondi P1, Malerba M2, Radaeli A2, Sala R3, Calzavara Pinton PG3 and Girolomoni G1
1Dept of Biomedical & Surgical Science, Section of Dermatology University of Verona, (Italy)
2Department of Internal Medicine, First Medical Division, Spedali Civili, Brescia (Italy)
3Sect of Dermatology, Dept of Medical & Surgical Science, Univ of Brescia, Spedali C (Italy)
Hyperhomocysteinemia is a well-known risk factor for cardiovascular diseases. Patients with 
severe chronic plaque psoriasis have a higher risk of death due to arterial and/or venous 
thrombosis. The objective of the study was to investigate the relationship among plasma homo-
cysteine and folate levels and severity of chronic plaque psoriasis in a selected cohort of pso-
riatic patients without known risk factors for acquired hyperhomocysteinemia. We performed 
a case-control study on 40 patients with chronic plaque psoriasis and 30 age and sex matched 
healthy controls. Cases and controls were selected excluding individuals with conditions or 
diseases associated with acquired hyperhomocysteinemia, and were also asked to stop alcohol 
and coffee consumption for one week before drawing. The plasma levels of homocysteine and 
folic acid were measured and correlated with the severity of psoriasis. The result of the study 
showed that psoriatic patients had plasma homocysteine levels higher than controls (16 ± 5.6 
μmol/L vs 10.4 ± 4.7 μmol/L; p <0.001). Conversely, folic acid levels were lower in psoriatic 
patients compared to controls (3.6 ± 1.7 μmol/L vs 6.5 ± 1.7 μmol/L; p <0.001). Plasma ho-
mocysteine in psoriatic patients correlated directly with disease severity (PASI) and inversely 
with folic acid levels. Plasma folic acid levels inversely correlated with the PASI. No alterations 
of plasma vitamin B6 and B12 were measured. Patients with psoriasis may have a tendency to 
hyperhomocysteinemia, which may predispose to higher cardiovascular risk. Dietary modifi ca-
tion of this risk factor appear relevant to the global management of patients with moderate to 
severe psoriasis.
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Prevalence of Metabolic Syndrome in Patients with Psoriasis
Gisondi P1, Tessari G1, Conti A2, Piaserico S3, Peserico A3, Giannetti A2, Cotena C1 and 
Girolomoni G1
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Psoriasis is a chronic infl ammatory skin disease that affects 3% of the population and can be 
associated with other diseases, which may have a major impact on patients. The more com-
mon co-morbidities include psoriatic arthritis, Crohn’s disease and ansiety/depression disor-
ders. Moreover, it has been documented an increased mortality from cardiovascular diseases in 
patients with severe psoriasis. The presence of metabolic syndrome is a signifi cant predictor of 
cardiovascular events and diabetes mellitus. We performed a case control study to investigate 
the prevalence of metabolic syndrome in a cohort of psoriatic patients and in age and sex 
matched controls. Metabolic syndrome was diagnosed in the presence of three or more criteria 
of the National Cholesterol Education Program’s Adult Panel III: waist circumference >102 cm 
in male or 88 in female; hypertriglyceridaemia >1.7 mmol/L; HDL cholesterol <1.0 mmol/L in 
male or <1.3 mmol/L in female; blood pressure >135/85 mmHg; fasting plasma glucose >6.1 
moml/L. We classifi ed as cases patients with a clinical diagnosis of psoriasis, and as controls 
patients with skin diseases or conditions other than psoriasis. We included in the study 584 
patients: 330 cases and 254 controls. Metabolic syndrome was detected in 30% of cases and 
in 22% of controls p=0.02. We found a mean waist circumference of 101 cm in cases and 96 
cm in controls (p<0.05); hypertriglyceridaemia was present in 28.7% of cases and in 25.6% 
of controls (p<0.05); hypertension in 42.7% of cases and 37.4% of controls (p=0.11); fasting 
plasma glucose >6.1 moml/L in 21.2% of cases and in 20.6% of controls (p=0.96). In logistic 
regression model, psoriasis, age at visit older than 50 and female sex were independent risk 
factors for metabolic syndrome. No correlation was found between psoriasis severity (four 
patients categories: PASI 1-10 and PASI 11-72; BSA 1-10% and 11-100%) and prevalence of 
metabolic syndrome. This study shows that metabolic syndrome is signifi cantly associated with 
psoriasis possibly favouring cardiovascular events in such patients.
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Vitreoscilla Filiformis Bacterium Extract Improves Seborrheic Dermatitis
Guéniche A1, Cathelineau A2, Bastien P3, Martin R4, Queille Roussel C2 and Breton L1
1L’OREAL Recherche, Clichy (France) 2Centre de Pharmacol Clinique Appliquée à la Derma-
tologie, Hôp l’Archet 2, Nice (France) 3L’OREAL Recherche, Aulnay sous bois (France)
4C/O CRN, L’OREAL, Notre Dame d’OE (France)
Seborrheic dermatitis is a chronic cutaneous infl ammatory condition, marked by frequent exacer-
bations affecting areas of skin in which sebaceous glands have a dense distribution and are highly 
active. It may occur on the face as well as on the scalp. Lesions are erythematous and scaly and 
may be associated with intense pruritus and a burning sensation in the involved areas. Treatments 
of seborrheic dermatitis of the scalp have been based on the use of antifungal shampoos and topi-
cal antifungal or anti-infl ammatory agents. However, appropriate non pharmacological treatment 
strategies and the daily use of safe effective shampoos and lotions should be the fi rst line approach 
to reduce scalp erythema, scaling and pruritus. These products may also be able to restore to some 
extent scalp homeostasis and thus improve symptoms.There are very few lotions specifi cally formu-
lated for seborrheic dermatitis of the scalp. In order to address the question, we tested the effi cacy of 
LRP-Biomass extract from a fi lamentous micro-organism (naturally found in oligotrophic lakes and 
also in sodium rich spa water) which had been cultured in a medium prepared with La Roche Posay 
spa (LRP) water. This water is rich in selenium and strontium, and has long been used as a ‘thermal 
cure’ for dermatologic infl ammatory disorders. For this purpose 66 patients with moderate scalp 
seborrheic dermatitis were included in a randomised, double-blind, vehicle-controlled and parallel 
group comparison study. The total clinical score (sum of erythema and scaling sub-scores) showed 
a signifi cant improvement (62.7% decrease) in the group treated with the test lotion (5% LRP-Bio-
mass lotion) once daily for 4 weeks compared to vehicle treated group (26.1% decrease only), the 
between groups comparison being highly signifi cant (Chi-Square, p<0.0001). In parallel, the level 
of pruritus self-assessed by the subjects showed a signifi cant decrease (73.4%) in the 5% LRP-Bio-
mass lotion treated group at Day 28 versus 49.4% decrease (t-test, p=0.01) in vehicle treated group. 
Moreover the total clinical score remained almost unchanged in the test lotion treated group one 
week after daily treatment was stopped indicating a persistent effect of the 5% LRP-Biomass lotion. 
Overall, this study showed that LRP-Biomass lotion was effective in improving SD symptoms and 
may be valuable when used between conventional drug treatments. Lotions containing LRP-Bio-
mass may also improve SD and prevent relapses. More generally, the active extract used at lower 
concentration should prove benefi cial when incorporated into cosmetic products, such as dandruff 
shampoos, designed to reduce scalp scaling.
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Social Support and General Health in Psoriatic Patients
Haduch I1, Miniszewska J2, Chodkiewicz J2, Juczynski Z2, Janusz I1 and Zalewska A1
1Department of Dermatology, University of Lodz (Poland)
2Department of Health Psychology, University of Lodz (Poland)
Social support belongs to the best studied resources of resistance to stress observed also in somatic 
disease, including psoriasis. The purpose of this research was to set connections between social 
support and general health in psoriatic patients. 
The study included 32 people with psoriasis who were treated at the Department of Dermatology, 
Medical University of Lodz. The Social Support Questionaire (Frydrych, polish adaption of Juczyn-
ski), General Health Questionaire – GHQ-28 (Goldberg) and the PASI scale were used. Age, sex, 
occupation, diesease duration, pruritus severity were evaluated. Patients got high scores in all scales 
of GHQ-28 (the higher the score the worse general health) i.e. somatic symptoms, anxiety and 
sleeplessness, functioning disturbances and depression symptoms. The worst evaluation was con-
nected with depression symptoms. We observed correlations between general health, social sup-
port and age. It demonstrates that among others practical help in daily problems as well as having 
friends are connected with better evaluation of one’s health condition. However, the evaluation of 
health condition is getting worse with age. What is interesting the severity of psoriatic lesions, pruri-
tus as well as disease duration seem not to correlate with the studied variables. What is more in the 
researched group women present less severe depression symptoms. The stepwise analysis allowed 
to emerge 2 predictors of general health, which together explain 40% of variable scores – this is the 
social integration and disease severity. The obtained results point out at an urgent need for support 
group organisation in order to allow for better social functioning in this group of patients.
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Low Basal Serum Cortisol in Severe Atopic Dermatitis Patients: Potent Topical Corticosteroids 
Wrongfully Accused
Haeck IM1, Timmer-de Mik L1, Lentjes E2, Buskens E3, Hijnen DJ1, Guikers C1, Bruijnzeel-
Koomen CA1 and de Bruin-Weller MS1
1Department of Dermatology & Allercology, University Medical Center Utrecht (Netherlands)
2Department of Clinical Chemistry and Hematology (Netherlands)
3Julius Center for Health Sciences and Primary Care (Netherlands)
Topical corticosteroids are used extensively to treat infl ammatory skin disorders including at-
opic dermatitis (AD). Several studies have described temporary reversible suppression of hy-
pothalamic-pituitary-adrenal (HPA) function. However, sound evidence of permanent distur-
bance of adrenal gland function is lacking. Aim of this study is to relate basal cortisol levels to 
prior use of topical steroids and disease activity in patients with moderate to severe AD and to 
investigate the effect of topical steroid treatment during hospital admission on the basal serum 
cortisol levels. Two groups of AD patients were evaluated: 25 inpatients with severe AD who 
required hospitalization (group 1) and 28 outpatients with moderate AD (group 2). In group 
1 basal serum cortisol levels were measured twice, at admission and at discharge, in group 2 
once. Use of topical corticosteroids 3 months prior to the cortisol measurement was recorded 
and disease activity was monitored using the SASSAD and serum TARC levels. 
On admission, basal cortisol levels in group 1 were signifi cantly (p<0.001) decreased in 80% 
of the patients. In group 2, in all but three patients the basal cortisol levels were normal. Com-
paring the two groups: group 1 on admission had a signifi cantly lower cortisol level than group 
2 (p<0.001). Disease activity in group 1 on admission was signifi cantly higher than in group 2 
(p<0.001). There was no difference (p=0.8) in use of topical steroids in the 3 months before cor-
tisol measurement. At discharge in group 1 there was a signifi cant increase (p<0.001) of basal 
cortisol levels and a signifi cant (p<0.001) decrease in disease activity refl ected by the decrease 
in serum TARC levels and SASSAD. Disease activity, rather than the use of topical steroids are 
responsible for the low basal cortisol values in patients with severe AD.
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Anxiety and Depression in Psoriatic Patients
Hawro T1, Chodkiewicz J2, Miniszewska J2, Juczynski Z2, Sysa-Jedrzejowska A3 and Zalewska A3
1Dept of Dermatology, Department of Medical Genetics, Medical University of Lodz (Poland)
2Department of Health Psychology, University of Lodz (Poland)
3Department of Dermatology, Medical University of Lodz (Poland)
Many dermatological patients present mental disturbances, behavioural problems or diffi cul-
ties in social functioning. The prevalence of mental problems among dermatological patients 
is much higher than in general population, with anxiety and affective disturbances being the 
most frequently encountered. The aim of the study was to examine a correlation between anxi-
ety, depressive disorders, and social support, disease severity, pruritus and positive psoriatic 
family history.
The study comprised 32 psoriatic patients treated at the Department of Dermatology, Medical 
University of Lodz. The following questionnaires were employed: The Hospital Anxiety and 
Depression Scale HADS (Zigmunt and Snaith, Polish adaptation by Majkowicz et al.), Social 
Support Questionnaire (Frydrych et al., polish adaptation by Juczynski). Severity of disease was 
obtained by Psoriasis Area Scoring Index (PASI).
There was a negative correlation between anxiety level and social integrity together with gen-
eral social support level. Moreover the more severe pruritus and the older patient, the higher 
anxiety level was observed. There was a negative correlation between depression and general 
social support and social integrity (the higher score on social support and integrity scale, the 
lower score on depressive symptoms scale) and positive correlation with age and pruritus (the 
more intensive pruritus and the older patient, the higher score on a depressive symptoms scale). 
Disease severity expressed as PASI score did not correlate with anxiety and depression in the 
examined group. Gender was not a differentiating factor for anxiety and depression level. Pa-
tients with positive psoriatic family history demonstrate lower depression level.
The obtained results point out at necessity of support groups organization, especially for psori-
atic patients of older age and negative psoriatic family history.
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The expression of Angiogenesis and Lymphangiogenesis Markers is Higher in Normal Skin of 
Psoriatic Patients than in Healthy Volunteer Skin
Henno A1, Lapière CM2, de la Brassinne M3 and Nusgens BV2
1Laboratory of Connective Tissues Biology, Dept of Dermatology, Univ of Liege (Belgium)
2Laboratory of Connective Tissues Biology, University of Liege (Belgium)
3Dermatology Department, University of Liege (Belgium)
Our data show that several vascular growth factors and receptors are not equally expressed 
in non lesional psoriatic skin compared to healthy volunteer skin. Thirteen patients suffering 
from untreated plaque-type psoriasis underwent punch biopsies in the lesional skin (LSP) and 
uninvolved skin (NIP). Fifteen healthy volunteers (HVS) were biopsied. Total RNA was extracted 
and RT-PCR performed for ribosomal 28S, keratins (K) 10, 14, 16, vimentin, collagen I and IV, 
GAPDH, PCNA, VEGF-R1, -R2, -R3, VEGF-A, -C, -D, MMP9, NRP-1, the two soluble forms 
of NRP1 (NRPs)-11&-12 and Semaphorin3A. Results were expressed per unit amount of 28S. 
Statistical analysis was performed by using the Student’s t test for unpaired and paired data. 
For information, GAPDH (p<0,01), K14 (p<0,025), K16 (p<0,05), PCNA (p<0,01), collagen IV 
(p<0,05) and MMP9 (p<0,005) mRNA expression was increased in LSP compared to NIP and 
HVS. Furthermore, the mRNA of VEGFA total (p<0,01), 121 (p<0,01) and 189 (p<0,05) as well 
as VEGFR2 (p<0,05) and NRPs11&12 (p<0,01) was increased in LSP compared to HVS. VEGFD 
(p<0,005), vimentin (p<0,05), NRP1 (p<0,05) and sema3A (p<0,01) mRNA was reduced in 
LPS compared to NIP. The expression of vimentin, K10, K16, PCNA, collagen I and IV mRNA 
did not differ between HVS and NIP, supporting comparable epidermal and dermal prolif-
erative and biosynthetic activity. The expression of GAPDH (p<0,001), K14 (p<0,01), VEGF 
121 (p<0,01), VEGFR2 (p<0,05), NRPs11 (p<0,01) and NRPs12 (p<0,05), but not VEGFR1 and 
NRP1, was signifi cantly increased in NIP compared to HVS. No difference existed for VEGF-C 
but a signifi cant overexpression of VEGFR3 was detected in NIP (p<0,001) as in LPS (p<0,05) 
compared to HVS. Our data suggest that the uninvolved skin in psoriatic patients displays signs 
of altered angiogenesis and lymphangiogenesis. 
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A therapeutic Effect of STAT6 Decoy Oligodeoxynucleotites Ointment in Atopic Dermatitis
Igawa K1, Yahara H1, Kanai Y1, Sumi K1, Satoh T1, Nishioka K2 and Yokozeki H1
1Department of Dermatology, Tokyo Medical and Dental University (Japan)
2Yokohama Minato Red Cross Hospital (Japan)
Signal transducers and activators of transcription 6 (STAT6) play a crucial role in the transac-
tivation of IL-4 and IL-13, which are involved in the pathogenesis of atopic dermatitis (AD). 
We have reported that the topical application of STAT6 decoy oligodeoxynucleotides (ODNs) 
inhibited skin infl ammation of several mouse models of AD. In this study, we evaluated the 
clinical effect of topical STAT6 decoy ODNs ointment in human AD patients.
With the approval of local ethical committee of our university, informed consent was obtained 
from adult AD patients who were enrolled in this study (n=8, age: 32±5.7) . The ointment con-
taining 2% STAT6 decoy ODNs was applied to lesions (erythema on the face or the trunk) twice 
daily. Clinical effect was evaluated at 2 and 4 weeks. Skin conditions were evaluated by the 
clinical score using Eczema Area and Severity Index (EASI) and photography. A visual analogue 
scale (VAS) was examined for the evaluation of pruritus. Eosinophil counts in peripheral blood 
and serum IgE levels were also examined. 
In seven cases except one who dropped out at the third week, clinical scores of the lesion 
were improved at the fourth week (mean clinical score: 7.57 and 3.75, before and after the 
treatment, respectively). Moreover, in all cases, remarkable improvement of VAS was observed 
(mean VAS score: 52 and 14, before and after the treatment, respectively). Neither eosinophil 
counts nor serum IgE levels were improved. 
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Arrhythmias in Psoriatic Patients
Janusz I1, Bissinger I2, Markuszewski L2, Narbutt J1, Sysa-Jedrzejowska A1, Zalewska A1
1Department of Dermatology, Lodz (Poland)
2Dept of Interventional Cardiology, Cardiodiabetology and Cardiac Rehabilitation (Poland)
Psoriasis is regarded by many researches as a systemic disease. Many cardio-vascular abnor-
malities have been described in psoriatic patients, however, there is scarcity of data on heart 
rate and conduction abnormalities in this group of patients. So, the aim of this study was to 
evaluate 24 hour echocardiographic recordings in psoriasis patients.
The study comprised 32 patients with chronic psoriasis vulgaris and negative personal his-
tory of heart problems. Severity of the disease was evaluated by Psoriasis Area and Severity 
Index (PASI). 24-hour continuous electrocardiographic monitoring (24-hour Holter ECG) was 
performed in all the patients.
Heart rate was signifi cantly higher, both during the day and at night, in psoriasis vulgaris pa-
tients than in the control group (p=0.001). There was a positive correlation between the in-
creased heat rate, both during the day and at night, in psoriatic patients and severity of the 
disease expressed as PASI. Single supraventricular beats were signifi cantly more frequently 
observed in psoriatic patients versus the control group (p<0.01). 
An active infl ammatory process observed in psoriasis seems to exert its infl uence on increased 
heart rate and supraventricular arrhythmia development in psoriatic patients. However, to con-
fi rm or reject the above fi ndings, further studies on larger groups of psoriatic patients, present-
ing different types of the disease are required.
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The Importance of the Timing of the Lymphocyte Transformation Test Performed During the 
Evolution of the Disease
Kano Y, Hirahara K, Sakuma K and Shiohara T
Department of Dermatology, Kyorin University School of Medicine (Japan)
Although both patch tests and the lymphocyte transformation test (LTT) have been frequently 
used for the diagnostic assessment of drug-specifi c T cell responses in clinical settings, the LTT 
offers numerous advantages over patch tests. Nevertheless, a number of practical concerns re-
lated to the time of testing and the infl uence of therapy continue to limit their frequent applica-
tion to clinical diagnosis. In this study, the LTT was sequentially performed during the evolution 
of the disease in patients with various types of drug reactions to the same drugs and repeated 
several months to 1 year later. In the majority of patients with maculopapular rashes (MP) and 
Stevens-Johnson syndrome (SJS), positive LTT reactions were obtained when the test was per-
formed within 1 week after onset of rashes, regardless of whether the patients were treated with 
systemic prednisolone. In contrast, negative results were constantly observed in patients with 
drug-induced hypersensitivity syndrome (DIHS), when the test was performed within 1 week 
after onset. At the 5-7 week measurement, most of the patients with SJS and MP did not show 
positive reactions while the majority of patients with DIHS exhibited positive reactions. Even 
at the 1-year measurement, the level of LTT remained high in patients with DIHS. Lymphocyte 
proliferation in response to PHA was generally parallel to the LTT in patients with MP and SJS 
at any time point. By contrast, in patients with DIHS, there were inverse correlations between 
the LTT and PHA-induced proliferation: PHA-induced lymphocyte proliferation was increased 
in the acute stage but became decreased afterward. Our results indicate that the diagnostic 
sensitivity and specifi city of the LTT would be much more promising than previously believed 
only when the test is performed at the right timing.
586
Functional Status Improvement In Infl iximab-Treated Psoriatic Arthritis Patients Regardless of 
Baseline Radiographic Damage: IMPACT 2
Kavanaugh A1, Krueger GG2, de Vlam K3, Birbara C4, Beutler A5, Dooley LT5, Guzzo C5, Bala 
M5, Kirkham B6 and Antoni C7
1University of California San Diego (USA) 2University of Utah Health Sciences Center (USA)
3University Hospital Leuven (USA) 4University of Massachusetts School of Medicine (USA)
5Centocor Research & Development, Inc. (USA) 6Guy’s & St. Thomas Hospital Trust (United 
Kingdom) 7Friedrich-Alexander-University (Germany)
PURPOSE: To determine the effect of baseline radiographic damage on improvement in physi-
cal function in psoriatic arthritis.
METHODS: In IMPACT 2, 200 patients with psoriatic arthritis received infl iximab 5mg/kg or 
placebo. Concomitant methotrexate was permitted (45% placebo, 47% infl iximab). Placebo 
patients could enter early escape at week16 (n=47/100); other placebo patients received inf-
liximab at week 24. Infl iximab patients could dose escalate at week 38 and 46 to 10 mg/wk 
(n=15/100). The proportion of patients achieving a >0.3 unit decrease in HAQ at weeks 24 
and 54 within subgroups defi ned by quartiles of baseline radiographic scores (baseline quar-
tiles of total modifi ed vdHS scores were > 0 and <1 [Group 1]; > 1 and < 5.3 [Group 2]; > 
5.3 and < 31.5 [Group 3]; > 31.5 [Group 4]) were analyzed post-hoc. RESULTS: At week 24, 
signifi cant HAQ improvements were observed in all groups except in those patients with the 
greatest baseline radiographic damage (Group 1 57.1% vs 25.0%, p=0.036; Group 2 64.0% 
vs 22.2%, p=0.002; Group 3 65.4% vs. 22.7%, p=0.005; Group 4 32.0% vs. 20.8% p=0.396, 
for the infl iximab vs placebo groups, respectively). In Group 4, the proportion of patients with 
clinically meaningful improvement in HAQ in the combined infl iximab group continued to 
increase with treatment from 32.0% (8 of 25) at week 24 to 48.0% (12 of 25) at week 54. 
Patients with less severe radiographic damage maintained improvement in physical function 
or continued to improve.
CONCLUSIONS: Infl iximab improved physical function in PsA regardless of baseline dam-
age. Patients with most severe disease improve with further treatment. This data suggests early 
intervention to limit accrual of joint damage.
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Acute Social Stress Modulates Cutaneous Calcitonin Gene-Related Peptide
Kleyn CE1, Saraceno R2, Richards HL1, Smith C1, Terenghi G2 and Griffi ths CE1
1Dermatological Sciences Research Group, The University of Manchester (United Kingdom)
2Plastic & Reconstructive Surgery Research Group, The Univ of Manchester (United Kingdom)
It is known that psychological stress may impact negatively on several infl ammatory skin dis-
eases but the underlying mechanisms are poorly understood. We investigated the response 
of cutaneous innervation [protein gene product (PGP 9.5)] and the neuropeptide, calcitonin 
gene-related peptide (CGRP) to social stress (modifi ed Trier paradigm).
On day 1, a 6mm punch biopsy was taken from buttock skin of all participants, n=34 (19 male, 
15 female; mean age: 23, range 18-45yrs). The second biopsy was taken from the contralateral 
buttock 4hrs (n=5) or 24hrs (n=13) after the social stressor. Controls (n=16) had biopsies taken 
24 hours apart. Sensory nerve fi bres and CGRP were evaluated by immunolocalisation (CGRP- 
and PGP 9.5-antibodies), immunofl uorescent microscopy and the Image Pro-Plus package®. 
CGRP+ fi bres were observed predominantly at the dermo-epidermal junction and in the papil-
lary dermis, whilst PGP 9.5+ fi bres were expressed in the epidermis and dermis. We observed 
a 101% increase in PGP 9.5 fi bre density and a 35% decrease of CGRP fi bre density from 
baseline after 4 hrs. After 24hrs, there was a 36% increase of PGP 9.5 fi bre density and a 40% 
decrease of CGRP fi bres from baseline. By contrast, non-stress controls showed a modest de-
crease in PGP 9.5 (14%) and no evidence of change of CGRP fi bre density. At 24hrs there was 
signifi cant difference between the control and Trier groups in terms of increase in PGP from 
baseline (p=0.045); however, the reduction of CGRP did not reach signifi cance (p= 0.068). Co-
localization of CGRP+ fi bres and LC was observed at the dermo-epidermal junction.
Our results suggest that acute social stress could modulate the release of neuropeptides. This 
may be important for our understanding of how stress may exacerbate infl ammatory skin dis-
ease and provides further support for the ‘brain-skin’ axis. 
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Short-Term Doxorubicin for Advanced AIDS Related Kaposi’s Sarcoma in Patients on HAART
Kohrgruber N, Tschachler E and Rieger A
Department of Dermatology, Vienna Medical School (Austria)
Objective: Despite the widespread use of pegylated-liposomal Doxorubicin (PLD) for advanced 
AIDS related Kaposi sarcoma (KS), it is still unclear as to when PLD should be discontinued 
in patients on HAART. Here we evaluate a strategy of PLD + HAART induction followed by 
HAART maintenance therapy. 
Patients: Between 1995 and 2005, 2 female and 16 male patients with biopsy confi rmed ad-
vanced KS were treated at our department and thus were included in this analysis. 16 patients 
had visceral or multiorgan KS. 2 patient had KS confi ned to the skin with >25 lesions. 15 ART 
naive patients started HAART simultaneously with PLD treatment.
Results: All patients received 20mg/m2 PLD in 3 week intervals. A mean number of 7,3 (±3,5; 
3-16) cycles of PLD was administered. The mean follow up time was 50,5 months (±40,7; 9-
122). 13 complete remissions and 5 partial remissions occurred, with mean follow up periods 
of 65,7 (± 38) and 11 (± 1,9) months, respectively. In all patients with a follow up time of >24 
months complete KS remission was observed. 
In 14/18 patients KS regressed further after discontinuation of PLD. They received a mean of 
6,3 (±2,7; 3-12) PLD cycles. 
In contrast, 4 patients had a relapse of KS after withdrawal of PLD, following a mean of 4,5 
(±0,5; 4-5) cycles. In all those cases of relapse, KS responded promptly to reinitiation of PLD 
therapy. Notably, all patients with a relapse after PLD withdrawal exhibited a signifi cant rise 
CD4+ T cells during the PLD + HAART induction phase. In contrast, among the 14 patients with 
continuous decrease of the KS after PLD withdrawal, only 3 had rising CD4+ T cells during the 
induction period, whereas stable or even decreasing CD4 counts were observed in the remain-
ing subjects. In respect of side effects, only moderate neutropenia and anaemia, or grade 1 
deviation of the liver function parameters occurred. 
Conclusions: The strategy of PLD + HAART induction followed by HAART maintenance is 
effi cient in most cases and very well tolerated. Relapse after PLD discontinuation occurred in 
a subgroup of patients with a pronounced gain of CD4+ T cells. All patients with KS relapse 
responded to reinitiation of PLD.
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T Cells - The Only Targets of Efalizumab-Treated Psoriatic Patients?
Koszik F, Selenko-Gebauer N, Duschek N and Stingl G
Department of Dermatology, DIAID, Medical University of Vienna (Austria)
Efalizumab (E) is a new and often effective treatment regimen in therapy-resistent psoriasis. Its 
activity is mediated by blocking the binding site of the α-chain (CD11a) of lymphocyte func-
tion-associated molecule 1 (LFA-1). It is generally assumed, but not proven that E exerts its ef-
fects mainly, if not solely, by targeting T lymphocytes. To address this issue, we performed FACS 
analyses of the expression levels of CD11a in the peripheral blood and enumerated leukocyte 
subpopulations of E- and non-E-treated individuals. CD11a was found to be present on all leu-
kocytes and the expression levels of psoriatic patients and healthy persons were essentially the 
same. However, substantial differences were encountered in the anti-CD11a reactivity of dif-
ferent leukocyte subpopulations. Highest levels were encountered on dendritic cells (DC) and 
natural killer (NK) cells, followed - in decreasing order - by T cells, monocytes, granulocytes 
and B cells. In agreement with previous observations, numbers of CD3+ T cells, CD56+ NK cells 
and CD19+ B cells were found to be signifi cantly enhanced in E- compared to non-E-treated 
individuals. In sharp contrast, E treatment did not affect the numbers of either myeloid or plas-
macytoid circulating DC. These fi ndings indicate that the gradual reduction of DC in lesional 
skin of E-treated psoriatic patients may be due to a preferential overall depletion of these cells, 
perhaps by antibody-induced apoptosis. In contrast, the E-induced reduction of pathogenic T 
cells in psoriatic skin appears to be rather the result of inhibition of their extravasation and, 
possibly, of an impaired activation and expansion of these cells in the immunological synapse. 
Support for the latter assumption comes from our additional fi nding that E induces downregula-
tion of CD11a on T cells but not on DC.
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Investigation on the Biophysical Properties of Striae Distensae
Bertin C, Lopes A, Stamatas G, Rossi A and Issachar N
Johnson & Johnson R&D (France)
Striae distensae (SD) are linear dermal scars accompanied by epidermal atrophy that occur 
after tissue tearing due to rapid growth or over-stretching. A common condition in pregnant 
women and adolescents, it can be of cosmetic concern and psychological distress. Our objec-
tive in this study is to investigate the characteristics of SD relating to skin biophysical proper-
ties compared to normal uninvolved skin. A population of 26 women and 3 men with SD 
were examined after giving written informed consent. Following clinical grading, non-invasive 
measurements were conducted to characterize skin moisture (Corneometer), barrier function 
(Tewameter), coloration (Chromameter and diffuse refl ectance spectrometer), and biomechani-
cal properties (cutometer and reviscometer). No signifi cant difference was found between nor-
mal and involved skin in terms of skin barrier function and skin moisturization (with a trend 
of SD having higher values, p=0.078). Spectroscopic analysis showed that the color difference 
between SD and control skin sites is primarily due to reduced apparent melanin concentration 
and reduced optical scattering index, whereas oxy-hemoglobin and deoxy-hemoglobin values 
were found to be similar. The melanin and scattering values varied independent of each other 
indicating that differences in scattering arise from dermal rather than epidermal sources (e.g. 
collagen structures). Skin elasticity and deformation appear to be decreased for the SD sites, 
while mechanical anisotropy appears to be increased compared to control skin. In conclusion, 
SD sites differ signifi cantly from control skin in their biomechanical properties, the apparent 
concentration of melanin, and the optical scattering arising from dermal structures.
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A Clinical Research of Facial Corticosteroid Addictive Dermatitis in Outpatient Clinical in 
China
Lu H1, Dong D1, Lu B1, Lu Q2, Luo H3, Wang Y1, Yu D1, Jing Y1 and Yang L1
1Department of Dermatology,Affi liated Hospital, Guiyang Medical College (China)
2Derzhou Hospital, Shandong (China)
3Department of Dermatology, University of Shichun (China)
The facial corticosteroid addictive dermatitis has become a common skin disease in the outpa-
tient clinical in China.It is listed daily at four or fi ve in all skin disease patients in our outpatient 
clinical in the recent years. To investigate the causes, clinical manifestation and type of facial 
corticos teroid addictive dermatitis for proposing diagnostic code of the disease. Summarize 
and analyze the data of 312 examples of facial corticosteroid addictive dermatitis which in-
cluding patient history, clinical feature, the results of patch test and other aided breadboard 
detection. All patients used glucocorticoid repeatedly and lastingly on face with the result 
that whose facial skin begin to depend on glucocorticoid. The reason of initial use included 
to treat the primarily disease of skin or to make pretty skin; Patients obtained the medication 
mainly from hospital, drugstore or beauty parlor. However, most patients used glucocorticoid 
that know little about it and do not know its component and adverse reaction. Using gluco-
corticoid at the beginning can lessen the skin rash, but stop using it will make the state of the 
illness recurrence and more serious. The appearance of skin rash include erythema, papule, 
infl ammatory edema , peeling , skin humble, telangiectasis and hyperpigmentation etc .Most 
common symptom of the disease are scorching hot，burning pain and dry, taut instead of 
itching. The diagnosis is relative easily made by long-term topical use of corticosteroid history 
and the clinical features and symptoms. The patients who suspected the disease carried out the 
patch test with glucocorticoid cream to make differential diagnosis as corticosteroid contact 
hypersensitivity.
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Generalized Cutaneous Eruotion with Neutrophilic Spongiosis Induced by Erlotinib 
(Tarceva®)
Lübbe J1, Dietrich PY2 and Massouyé I1
1Department of Dermatology, Geneva University Hospital (Switzerland)
2Department of Oncology, Geneva University Hospital (Switzerland)
Erlotinib is a small molecule tyrosine kinase inhibitor that is used as an anticancer agent. A 
characteristic facial eruption consisting of infl ammatory papules and pustules with a seborrheic 
distribution appears within 1 week of treatment in up to 75% of treated patients. We describe a 
patient with metastatic renal cell carcinoma treated with erlotinib and bevacizumab. After hav-
ing experienced an ephemeral facial eruption within the fi rst week of treatment, she developed 
widespread erythemato-squamous lesions with focal erosions in the 8th week of therapy. Histo-
logic analysis revealed neutrophilic spongiosis with subcorneal pustules and erosions. A search 
for bullous autoimmune skin disease and infection was negative. The lesions quickly regressed 
after discontinuation of erlotinib while bevacizumab treatment was maintained. Cutaneous 
symptoms associated with erlotinib are poorly characterized. Side effects such as facial acute 
folliculitis, perionychial abscesses and pyogenic granulomas have been observed in several 
drugs that interfere with EGFR signalling, suggesting that neutrophilic infl ammation may be a 
class effect. Investigation of these side effects may hold clues for both management of future 
cases, and better understanding of the mechanisms of neutrophilic dermatoses. 
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Management of Cutaneous Heparin Hypersensitivity Reactions
Ludwig RJ1, Schindewolf M2, Utikal J3, Lindhoff-Last E2, Kaufmann R4 and Boehncke WH4
1Dept of Dermatology & pharmazentrum, Clinic of Johann Wolfgang Goethe Univ (Germany)
2Dept of Internal Medicine (Div of Vascular Medicine), Clinc of JW Goethe Univ (Germany)
3Dept of Dermatology, Venerology & Allergology, Univ Medical Center Mannheim (Germany)
4Department of Dermatology, Clinic of the Johann Wolfgang Goethe University (Germany)
Cutaneous hypersensitivity reactions to heparin have been fi rst noticed in 1952. Yet, the in-
cidence of these reactions remains uncertain at the time. However, in the last 10 years an 
increasing number of patients are being reported, leading to the assumption, that cutaneous 
hypersensitivity reactions towards heparin are underreported. Clinically patients present with 
itching, sometimes infi ltrated, and blistering erythemas at the injection sites of heparins. The 
diagnosis of cutaneous heparin allergy may on one hand lead to delay of required medical or 
surgical treatment. On the other hand, delayed initiation of treatment may lead to a general-
ized eczematous reaction. Hence, from review of 223 cases of patients with cutaneous hyper-
sensitivity reactions to heparin, we here summarize the clinical picture of cutaneous type IV 
allergic reactions, defi ne risk factors on both the patient- and drug-side, and give an overview 
of principle therapeutic alternatives, as well as recommendations for treatment options for 
emergency and elective patients.
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Treatment of Melanoma Bearing Individuals with ONTAK® Depletes Regulatory T Cells 
Resulting in an Augmented Immune Response Following Vaccination
Schönfeld K, Mahnke K, Schallenberg S, Storn V, Ring S and Enk AH
Department of Dermatology, University Heidelberg (Germany)
Regulatory T cells (Tregs) suppress proliferation of effector T cells in vitro and in vivo. In healthy 
individuals this function is responsible for controlling immune responses and to suppress au-
toimmunity. However, these suppressive functions may prevent induction of effective immune 
reactions during cancer treatment. We therefore aimed at removing Tregs in vivo by ONTAK® 
(a fusion protein of IL-2 and diphtheria toxin) and to evaluate its effects on immunization of 
melanoma bearing individuals. When patients were injected with a dose of 5 μg/Kg bodyweight 
ONTAK®, we noticed a reduction of CD25+/FoxP3+ Tregs in peripheral blood over a period 
of 2 weeks after application. However, numbers of Tregs reached normal levels thereafter. A 
second group of patients was treated with a dose of 18 μg/Kg bodyweight ONTAK®. Here no 
substantial reduction of Treg numbers was recorded as compared to the low dose treatment. 
During treatment with ONTAK®, all patients were vaccinated 3 times with MelanA/gp100 pep-
tides injected into an area of skin that had been painted with the contact sensitizer DCP. After 
every vaccination blood samples were taken and analyzed for the presence of MelanA/gp100 
specifi c T lymphocytes by tetramer staining and IFNγ ELISPOT. Here we could show that during 
vaccination the population of MelanA/gp100 specifi c T lymphocytes increased in all patients. 
Furthermore we noticed that individuals that were resistant to DCP-induced hypersensitivity 
reactions before ONTAK® treatment, developed vast eczemas and generated DCP-specifi c T 
cells after the ONTAK® application.
Thus, in summary our data indicate that low dose treatment with ONTAK® causes a depletion 
of Tregs in melanoma patients, which may lead to a better vaccination response.
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Palmoplantar Pustulosis and Gluten Sensitivity – A Study of Serum Antibodies Against Gliadin 
and Tissue Transglutaminase, the Duodenal Mucosa and Effects of Gluten-Free Diet
Michaëlsson G, Kristjánsson G, Pihl I and Hagforsen E
Dep Medical Sciences/Dermatology, University Hospital Uppsala (Sweden)
Palmoplantar pustulosis (PPP) is characterized by intense infl ammation in and around the sweat 
duct and marked endothelial proliferation. Although 18% also have psoriasis PPP is genetically 
different from psoriasis vulgaris. Autoimmune thyroid disease, abnormal calcium homeostasis 
and diabetes are common in patients with PPP.
The aim was to fi nd out the prevalence of antibodies against gliadin (AGA) and tissue 
transglutaminase(tTG) in a large group of PPP patients, to study the lymphocyte infi ltration in 
the duodenal mucosa and to evaluate effects of gluten-free diet (GFD) on PPP. 
Out of 123 PPP patients 18.7% had IgA antibodies against gliadin and 10% against tTG – (in 
population surveys <1%). Three percent had tTG antibodies without AGA. Coeliac disease with 
villous atrophy was found in 5.7% of the patients but with immunohistochemistry an increased 
number of lymphocytes was also present in specimens from patients with AGA and/or tTG anti-
bodies but not in those without these antibodies. With the exception for specimens with villous 
atrophy routine stained specimens offered minor information about increase in lymphocytes. 
Routine stained specimens from antibody negative PPP patients were evaluated as normal. 
Thirteen patients with antibodies were asked to adhere to GFD regardless of the fi ndings in 
the duodenal mucosa. Nine with antibodies adhered to GFD and had a total or nearly total 
clearance of their PPP and normalization of the levels of gliadin and tTG antibodies. Four who 
did not adhere to GFD had unchanged PPP and antibody levels. Three PPP patients without 
antibodies also adhered to GFD but with no effect. 
The conclusion is that gluten sensitivity is common in PPP and that PPP patients with AGA and 
tTG can be much improved on GFD. 
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Topical Nitric Oxide Causes a Moderate CD4 Positive T-Cell Dermal Infi ltrate
Mowbray M1, Tan X1, Wheatley PS2, Morris RE2 and Weller R1
1Department of Dermatology, University of Edinburgh (United Kingdom)
2School of Chemistry, University of St. Andrews (United Kingdom)
Nitric oxide (NO) biology is complex, and although inducible NO synthase is elevated in a 
number of infl ammatory dermatoses, it remains unclear whether NO is predominantly pro or 
anti-infl ammatory in human skin. In 1999 Ormerod et al demonstrated marked infl ammation 
after application of the NO donor acidifi ed nitrite, concluding that NO is a potent infl amma-
tory mediator in human skin. Acidifi ed nitrite releases other radicals than just NO however. 
Using Zeolite-NO compounds, which release pure gaseous NO from an inert chemical matrix, 
we have been able to quantify and compare the effects of pure NO on normal human skin with 
those of acidifi ed nitrite. Six healthy volunteers were treated three times daily, for 48hours, with 
5% acidifi ed nitrite (ascorbate and sodium nitrite) or a dose of a Zeolite-NO which released 
an equimolar quantity of NO, together with ascorbate and Zeolite controls. Biopsies were 
embedded in paraffi n and sections processed for H & E and immunohistochemical infl amma-
tory cell staining.
Acidifi ed nitrite treated skin showed a distinct dermatitis reaction, with an infi ltration of neu-
trophils and macrophages into the epidermis (p<0.05) and absence of Langerhans’ in the epi-
dermis, compared with zeolite-NO and controls. Both acidifi ed nitrite and Zeolite-NO treated 
skin showed CD4 positive T helper cell invasion into the dermis compared to control skin 
(p<0.05). The availability of novel NO donors has enabled us to demonstrate that NO per se 
is not as potent an infl ammatory molecule, in human skin, as was previously suggested, but 
does cause a moderate and specifi c dermal infi ltration of CD4 positive T helper cells. The avail-
ability of a pure NO donor will allow us to specifi cally determine the roles of this multi-faceted 
biological messenger. 
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Quantifi cation of Enzyme Independent Stores of Nitric Oxide in Human Skin
Mowbray M, Lomatschinsky N, Jones S and Weller R
Department of Dermatology, The University of Edinburgh (United Kingdom)
Quantifi cation of enzyme independent stores of Nitric Oxide in human skin
Nitric oxide (NO) plays an important role in ultraviolet radiation (UVR) induced erythema and 
prevention of apoptosis following UVR. NO is formed in the skin by 3 NO synthase enzymes 
(NOS). NO can also be stored in human skin in the form of nitrosospecies, providing a non-
enzymatic source of NO, these can be found the skin itself and in sweat.
Cutaneous nitrosospecies include: Nitrate (NO3), Nitrite (NO2), Nitrosothiols (RSNOs) and N-
nitrosocompounds (RNNOs). Enzymatic NO production is maximal 8-10hrs post UVR, but 
nitrosospecies can be photolysed by UVA to release NO within 20 minutes. It has been hy-
pothesised that this rapid NO release from nitrosospecies post UVR is important as it ‘bridges 
the gap’ between UV challenge and maximal iNOS upregulation. 
We have developed methods of quantifying nitrosospecies in human epidermis and sweat. 
Epidermal suction blisters from 5 healthy human volunteers, and in a further 8 subjects simul-
taneous samples of sweat, saliva and serum, were analysed for nitrosospecies content. 
Healthy human epidermis contains 0.017± 0.009 μMols/mg protein of total nitrosospecies, the 
majority is made up of NO3 0.013 μMols/mg the remainder being NO2 0.004±0.001μMols/mg, 
no RSNOs were detected. We found that there is inter-individual variation in skin nitrosospe-
cies content, a fi nding which has been reported in other tissues. Sweat on the skin surface con-
tains 21.97±2.95μM total NO-species; 13.13±1.78μM NO3, 8.66±1.48μM NO2, 0.19±0.02μM 
RSNOs. Sweat nitrosospecies correlate with plasma nitrite levels.
We have shown that important enzyme independent NO stores in human skin can be found 
in skin itself and in sweat. We propose that these cutaneous NO stores provide an instantly 
available bioactive reservoir which is depleted by photolysis following UV, allowing for protec-
tion against keratinocyte apoptosis following UVR. These stores are then replenished by iNOS 
upregulation, maximal at 8-10hrs post UV.
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New Natural PPAR-α Agonist for childhood Atopic Dermatitis: Dermocorticoid-Sparing and 
Quality of Life Improvement
Msika P1, de Belilovsky C2, Chadoutaud B3 and Nicolas JF4
1Research and Development Department, Laboratoires Expanscience (France)
2Dermatologist, Institut Alfred Fournier (France)
3Clinical Consultant, ClinReal Online (France)
4Immunologist, Inserm 503 (France)
Atopic dermatitis (AD) is associated with major lipids metabolism dysfunctions. Dermo-corti-
costeroids (DC) are used for AD fl ares but have potential side effects. 
PPAR-α (Peroxysome-Proliferative-Activated Receptors) are transcription factors involved in the 
regulation of epidermal homeostasis.
A new emollient, containing a patented Sunfl ower Oleodistillate, has been formulated for AD. 
Sunfl ower Oleodistillate: * activates of PPAR-α in CV1 cells * induces the synthesis of key 
epidermal lipids (e.g. ceramides x 3, cholesterol x 2) in human skin explants * reduces TPA-
induced infl ammation (oedema and cytokines mRNA production).
We have investigated the potential role of this new patented PPAR-α agonist emollient on DC 
sparing and quality of life (QoL) of young atopic children and their family. Eighty-six patients, 
(4-48 months), were randomised into 5 treatment groups : DC (desonide 0,05%) 2X/D, 1X/D 
with or without PPAR-α agonist and DC 1D/2 with PPAR-α agonist for 21 days. Evaluations of 
SCORAD and QoL (DFI = Dermatitis Family Impact and IDQLI = Infant’s Dermatitis Quality of 
Life Index) were performed at D7 and D21.
At D7, all groups had a statistical improvement of their SCORAD (>60%, p<0,001) without 
differences between them (p=0,715). This illustrates rapid action of steroids. At D21, the 5 
groups were also statistically improved (p<0,001) but with better results in the 3 PPAR-α ago-
nist groups (mean improvement 73,7%) than in the 2 other groups (mean 60,5%). PPAR-α ago-
nist impact was noticed mostly on lichenifi cation, excoriation and dryness. Global evaluation 
of QoL at D21 revealed that PPAR-α agonist+DC offers a better improvement (73%, p<0,001) 
than DC alone (52%, p<0,01). 
A twice daily application of new PPAR-α agonist emollient permits a corticoid sparing of 50 to 
75% and a higher quality of life improvement for children and parents.
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An Objective Measure of Itch in Atopic Dermatitis: Tuning into the Right Frequency
Murray CS1, Pye SD2, McBride K2, Schofi eld O3 and Rees JL1
1Department of Dermatology, University of Edinburgh, Edinburgh (United Kingdom)
2Dept of Medical Physics, NHS Lothian Univ Hospitals Division, Edinburgh (United Kingdom)
3Dept of Dermatology, NHS Lothian Univ Hospitals Division, Edinburgh (United Kingdom)
A major goal of research into atopic dermatitis is to fi nd an objective measure of disease activi-
ty. We and others have previously tried to use nocturnal scratch as a bioassay for such activity. A 
major technical issue is how to distinguish scratch related movements from those due to other 
activities (e.g. turning–over), without having to resort to time consuming and intrusive infrared 
videoing. In the present study we have evaluated DigiTrac accelerometers that contain three-di-
mensional piezoelectric sensors that record acceleration 40 times/second. This raw data is then 
processed by Fast Fourier Transforms (FFT) to provide frequency components. First, itch-related 
movements, scratch and rub (rhythmical,) and adjusting position movements were compared. 
Eight children with atopic dermatitis were videoed under infrared illumination at night in their 
own bedrooms. On replay, movements were timed using a stop-watch and frequency calcu-
lated. The means were formally different but there was overlap: generalised movement 0.48Hz; 
rub 0.98Hz and scratch 1.85Hz, one way ANOVA F2:21=56, p<0.0001. In a second study, on 
9 subjects and 12 controls, FFT were compared with infrared video observations to character-
ise frequency and acceleration scores associated with different movements. The sum of FFT 
for the spectrum 0.5-2.5Hz enabled the largest separation: patients, 16749Gs±1318; controls 
12875Gs±1109 (mean± s.e.; p=0.036). The sum of FFT 100-400Gs most often represented 
‘scratch.’ Third, an algorithm to enrich further for itch-related movement was applied to group 
2 recordings and the separation was increased: sum of FFT 0.5-2.5Hz, 100-400Gs, patients 
5128Gs±967; controls 1328Gs±214 (mean± s.e; p=0.0046). Our results show that whilst there 
is overlap in the spectral characteristics of scratch and non-scratch movements it is possible to 
enrich for scratch based on spectral characteristics.
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Clinical Response of Severe Mechanobullous Epidermolysis Bullosa Acquisita to Combined 
Treatment with Immunoadsorption and Rituximab (anti-CD20 monoclonal antibodies)
Niedermeier A1, Eming R1, Pfütze M1, Neumann CR2, Happel C1, Reich K3 and Hertl M1
1Department of Dermatology and Allergy, Philipps-University, Marburg (Germany)
2Department of Dermatology, Georg-August-University, Göttingen (Germany)
3Dept of Dermatology, Georg-August-Univ, Göttingen & Dermatologikum Hamburg (Germany)
Epidermolysis bullosa acquisita (EBA) is a chronic subepidermal blistering disease with muco-
cutaneous involvement and remarkable skin fragility and tendency to scarring. It is associated 
with humoral autoimmunity to type VII collagen, an integral part of anchoring fi brils that are 
important components of the dermal-epidermal junction. The mechanobullous form of EBA 
has a chronic relapsing course and is known to be refractory to many immunosuppressive 
treatments.
Two patients with mechanobullous EBA were treated with immunoadsorption (IA) in conjunc-
tion with rituximab. IA was done on 4 consecutive days using Globaffi n® absorbers, repre-
senting 1 treatment cycle. Each cycle was followed by a second cycle after a 4-week interval. 
During the entire IA treatment, patients continued receiving an immunosuppressive medication 
consisting of glucocorticosteroids, and mycophenolate mofetil 3 x 1 g/day. After IA, rituximab 
was administered intravenously at a dosage of 375 mg of m2 body surface over 4 to 6 hours 
once weekly on 4 consecutive weeks.
Treatment resulted in an almost complete clinical remission in one patient and a partial re-
sponse in another patient. In the responding patient, prolonged B cell depletion and clinical 
improvement with disappearance of cutaneous erosions paralleled the decline in titers of cir-
culating anti-basement membrane zone autoantibodies. In the other patient immunoadsorp-
tion and rituximab reduced the de novo appearance of blisters but did not lead to signifi cant 
improvement of the gingivitis despite the depletion of B cells for six months and a reduction 
of autoantibody titers. 
This preliminary clinical observation suggests that IA combined with rituximab may be a valu-
able adjuvant treatment regimen for severe mechanobullous EBA, which is in line with recently 
observed benefi cial effects of rituximab in the clinical variant, infl ammatory EBA.
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Evaluation of Facial Wrinkles using a Scale Built Upon Parallel Polarization Imaging
Nkengne A1, Fertil B2, Giron A2, Bertin C1, Stamatas G1, Rossi AB1 and Issachar N1
1Johnson & Johnson Consumer France (France)
2INSERM UMR S678. Laboratoire d’Imagerie Fonctionnelle (France)
Photonumeric scales are widely used to assess the effi cacy of anti-aging treatments. Although 
some scales have been proposed to evaluate the wrinkles on women faces, they have not ad-
dressed the problems of sensitivity and reproducibility of image acquisition. 
In this study, we present a new photonumeric scale based on calibrated digital parallel polari-
zation imaging of the face. Parallel polarization is used to remove glares (better say: specular 
refl ections) and to enhance the appearance of skin features such as wrinkles and furrows.
A photonumeric scale is built separately for each part of the face. One group of trained observ-
ers and another of untrained have scored pictures from 30 volunteers twice and the inter and 
intra observer agreement is measured using the kappa test. The sensitivity of the given scale to 
detect changes is tested in a study involving 40 people who have used an anti-wrinkle product 
containing 0.1% of retinol during 3 months.
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Lactic Acid Application to the Skin Alters Thermal Perception Thresholds
Porcheron A1, Latreille J1, Morizot F1 and Tschachler E2
1CE.R.I.E.S (France)
2Department of Dermatology, University of Vienna Medical School (Austria)
The description of the “sensitive skin” comprises visible transient reactions in response to en-
vironmental, chemical or physical stimuli as well as sensorial perceptions. One way to identify 
individuals with “sensitive skin” is the application of 10% lactic acid to the nasolabial fold and 
assessment of a “stinging” response i.e. whether or not the person reports a stinging sensation 
at the application site (“stinger” vs “non-stinger”). The objective of the present study was to 
explore the effect of this test on the skin sensorial nervous system by investigating the conse-
quences of lactic acid application on thermal perception thresholds.
Twenty Caucasian women, with healthy apparent skin, aged between 25 and 35, were in-
cluded in the study. Cold and warm perception thresholds were determined on the nasolabial 
fold using the Thermo Sensory Analyser® (TSA 2001, Medoc) before and after application of 
10% lactic acid in accordance with the “stinging Test” protocol.
No signifi cant difference in perception thresholds values was found between “stingers” and 
“non stingers”. In both, cold perception thresholds were signifi cantly increased after applica-
tion of lactic acid, and warm perception thresholds were decreased. Our results demonstrate 
that the effect of topical application of lactic acid on thermal perception is independent of a 
“stinging” response. Since it has been previously shown in vitro that a reduction of pH en-
hances the response of a cutaneous warm receptor (TRPV1) while inhibiting the response of 
cutaneous cold receptor (TRPM8), the modulation of these receptors by reduction of skin sur-
face pH by lactic acid is the most likely explanation for our results.
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Topical Methimazole as a New Treatment for Hyperpigmentary Disorders: From Cell Culture 
to Human
Kasraee B1, Handjani F2, Omrani GH2, Sorg O1 and Saurat JH1
1Geneva University Hospital (Switzerland)
2Shiraz University of Medical Sciences (Iran)
Methimazole (1-methyl-2-mercaptoimidazole : MMI), a potent inhibitor of mammalian peroxi-
dases, has been long utilized as an oral agent for the treatment of hyperthyroidism in human. In 
2002, we showed for the fi rst time that the topical application of MMI on brown guinea pig skin 
produces a signifi cant reduction of epidermal melanin, resulting in visually recognizable skin 
depigmentation. In vitro studies concerning the melanocytotoxic vs. melanogenesis inhibiting 
effects of MMI showed a signifi cantly lower cytotoxicity and a higher melanogenesis inhibiting 
effect for MMI in comparison with hydroquinone, kojic acid and arbutin. In addition, MMI is 
confi rmed to be a non-mutagenic molecule through several experimental trials. Our human 
studies concerning the transdermal absorption of MMI as well as the long-term effect of topical 
MMI on thyroid function show that MMI is not detected in serum following its topical applica-
tion to the face skin in healthy female subjects and does not induce any signifi cant changes 
in the level of serum free-T4, free-T3 and TSH, following 6 weeks of continuous application 
in melasma patients. Topical MMI was found to be signifi cantly more effective than its vehicle 
alone for the treatment of epidermal melasma in a double blind randomized clinical trial. This 
agent was previously shown to have recognizable therapeutic effect against post-infl ammatory 
hyperpigmen tation in sporadic cases. Topical MMI may serve as a non-melanocytotoxic non-
mutagenic agent for the treatment of skin hyperpigmentary disorders in near future.
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In Vivo Documentation of Cutaneous Infl ammation using Spectral Imaging
Stamatas GN1 and Kollias N2
1Scientifi c Affairs, Johnson & Johnson Consumer Products France (France)
2Methods & Models Development, Johnson & Johnson Consumer Products Worldwide (USA)
Skin infl ammation is often accompanied by edema and erythema. While erythema is the result 
of capillary dilation and local increase of oxygenated hemoglobin (oxy-Hb) concentration, 
edema is characterized by an increase in extracellular fl uid in the dermis leading to local tissue 
swelling. Edema and erythema are typically graded visually. In this work we tested the potential 
of spectral imaging as a non-invasive method for quantitative documentation of both the ery-
thema and the edema reactions. As examples of dermatological conditions that exhibit skin in-
fl ammation we imaged patients suffering from acne, herpes zoster, and poison ivy rashes using 
a hyperspectral-imaging camera. Spectral images were acquired in the visible and near infrared 
part of the spectrum, where oxy-Hb and water demonstrate absorption bands. The values of 
apparent concentrations of oxy-Hb and water were calculated based on an algorithm that takes 
into account spectral contributions of deoxy-hemoglobin, melanin, and scattering. In each 
case examined concentration maps of oxy-Hb and water can be constructed that represent 
quantitative visualizations of the intensity and extent of erythema and edema correspondingly. 
In summary, we demonstrate that spectral imaging can be used in dermatology to quantitatively 
document parameters relating to skin infl ammation. Applications may include monitoring of 
disease progression as well as effi cacy of treatments.
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Are Polymorphisms of Corticotropin Releasing Hormone Relevant for Psoriasis Vulgaris?
Reichelt A1, Baerwald C2 and Wetzig T3
1Department of Dermatology, University of Leipzig (Germany)
2Department of Internal Medicine/Rheumatology , University of Leipzig (Germany)
3Department of Dermatology, University of Leipzig (Grenada)
Glucocorticoids are well appreciated in the treatment of psoriasis as well as other chronic 
infl ammatory disorders. Consequently, endocrine dysbalance among hypothalamus, pituitary 
gland and adrenal cortex have been speculated upon in the past to play a pathogenic role. 
Data from both experimental animal models as well as rheumatoid arthritis (RA) support this 
concept. Polymorphisms of the 5’ regulatory region of the corticotropin releasing hormone 
(CRH) gene have been described for RA. Their relevance has been examined in patients with 
psoriasis vulgaris (n=82) and psoriasis arthritis (n=14). The data were compared to 125 pa-
tients with rheumatoid arthritis and 82 healthy controls. Restriction fragment polymorphism 
was studied on DNA extracted from peripheral blood amplifi ed by polymerase chain reaction. 
Alleles A1/B1 were found in similar frequencies of 87 to 90 % in all three study groups as were 
alleles A2/B1 and A2B2 in 4-7 % and 5-9 % respectively. No statistically signifi cant differences 
could be found among the three groups and three allele combinations. Based on these data, 
this polymorphism seems of limited pathogenetic relevance in the context of psoriasis and 
psoriasis arthritis.
606
Report on a Workshop on Clinical Assessment of Vitiligo Patients
Taïeb A1, Pelicciotta M2, Gauthier Y1, Leone G2 and Picardo M2
1Dept of Dermatology, CHU de Bordeaux (France)
2San Gallicano Derm Institute, Roma (Italy)
Background: The Vitiligo European Task Force (VETF) was created design tools for clinical re-
search in vitiligo. 3 previous workshops allowed to design a common evaluation form which 
includes 3 items for assessing extent (based on the rule of nines), staging (0-4 from normal 
pigmentation to complete depigmentation plus hair whitening), and spreading (-1 to +1), le 
two last assessments being made on the largest patch in each area (head and neck, trunk, arms, 
legs, excluding hands and feet scored separately)
Methods: 10 dermatologists of the VETF evaluated blindly13 patients. For each patient a patch 
to be assessed was chosen by the organising team in order to reduce the duration of the session. 
130 evaluations of the 3 scoring items were collected and analysed vs standardized colour and 
black and white UV photographs. The patient’s opinion about disease/patch progression was 
recorded separately and did not infl uence the investigators.
Results: Except for some discrepancies which have been addressed in the discussion using 
photographs as references, inter-observer agreement was acceptable for the three items. Con-
cordance, evaluated versus an “ideal investigator” , a virtual participant defi ned by the choices 
made by the majority of the workshop participants, was good for spreading (K=0.395) and 
staging (K=0.380) and excellent for extent. For spreading, it was more diffi cult to defi ne stability 
than to defi ne progression/regression. More specifi cally noted in segmental vitiligo, selected 
patches were not homogeneous in colour. Investigators staged generally according to the worst 
stage. Conclusions: This workshop has allowed to test a simple clinical assessment system of 
vitiligo, which can be easily handled in clinical practice and during clinical trials. Further steps 
are envisaged, namely (1) build a global index including staging and spreading for the initial 
assessment of vitiligo patients, usable as a guidance for therapeutic indications and prognosis; 
(2) implement large-scale tests necessary for clinical trials (to check reproducibility and sen-
sitivity); (3) studies of automated devices to assess extent more precisely; (4) set up a teaching 
tool for scoring vitiligo, which could be posted on a web site and (5) set up an international 
conference on classifying, staging and scoring vitiligo.
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Surgical Skin Staplers, Which Types are Better Adapted to Wound Closure and Which to Skin 
Grafting
Yuji T, Tatsuo H, Kiyoshi N and Younosuke A
Department of Orthopaedic Surgery, Kaetsu Hospital (Japan)
Background: Surgical staplers are useful devices for wound closure and skin grafting. When 
used for wound closure, the top of the steel staples are required to not be in such close contact 
as to cause swelling of the skin surface, so that blood circulation is maintained and an unsightly 
scar can be prevented. On the other hand, when used for skin grafting, the staples are required 
to be in close contract in order to achieve maintain union between the transplanted skin and 
the graft bed. 
Methods: The devices considered for the study consisted of 9 products of 7 manufacturers, 
which account for about 80% of the total domestic sales for such products in our country. We 
measured the exposure length of the staple before use, the distance the anvil from the skin 
surface, the turning radius of the staple, and the internal dimensions of the staple after use. 
We calculated the insertion depth of the staple and the fl oating length from the skin surface. 
In addition, we measured the actual insertion depth of the staple and the fl oating length using 
urethane foam as a substitute for human skin. 
Results: Devices which had an insertion depth of less than 1 mm and a fl oating length of more 
than 1.8 mm (3 of the products examined) were better suited for wound closure, and devices 
(3 of the products examined) which had an insertion depth of more than 2 mm and a fl oating 
length of less than 1 mm were better suited for skin grafting. 
Conclusions: Some products may allow local pressure on the skin wound, but have too large a 
fl oating length to be suitable for skin grafting. 
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608
Common HLA Allele Presented in the Case of Stevens-Johnson Syndrome and Drug-Induced 
Hypersensitivity Syndrome by Allopurinol
Dainichi T, Moroi Y and Furue M
Department of Dermatology, Kyushu University (Japan)
It has been reported that a strong association of HLA-B*5801 in 51 patients with allopurinol-
induced severe cutaneous adverse reactions, which included 21 cases of Stevens-Johnson syn-
drome (SJS) and/or toxic epidermal necrosis (TEN) and 30 cases of hypersensitivity syndrome 
(HSS). This HLA allele is present in 20% of general population in Taiwan. 
The aim of the study is to determine whether the HLA-B*5801 allele is present in the patient 
with allopurinol-induced SJS and DIHS in Japan, in which the frequency of the allele in general 
population is 0.6%.
Case 1. A 57-year-old man developed fever, conjuncutival injection and bleeding from oral 
mucosa on day 8 after the start of allopurinol inoculation. We diagnosed him as allopurinol-
induced SJS. Case 2. A 77-year-old man developed fever, edema and itchy erythroderma on 4-
week after the start of allopurinol inoculation. The patient’s serum transaminase level elevated 
and anti-human herpesvirus 6 IgG titers of paired sera showed 128-fold increase in 3-week. We 
diagnosed him as allopurinol-induced DIHS.
The patient in case 1 presented HLA-A31, A33, B51 and B58. The patient in case 2 presented 
HLA-A31, A33, B39 and B58.
Among the patients who had common HLA allele, B*5801, one could be induced SJS and 
another could be induced DIHS by the same drug, allopurinol. The fact should be considered 
for investigation of the pathogenesis of SJS and DIHS. 
609
NY-ESO-1 Protein-Based Immunotherapy for Malignant Melanoma: Tumor Antigen-Specifi c T 
Cell Responses and Suppressive Phenomenon
Tsuji K1, Hamada T1, Asagoe K1, Wada H2, Kawabata R2, Aji T3, Uenaka A3, Shiku H4
Nakayama E3 and Iwatsuki K1
1Department of Dermatology, University of Okayama (Japan)
2Department of Surgery, University of Osaka (Japan)
3Department of Immunology, University of Okayama (Japan)
4Department of Immunology, University of Mie (Japan)
Hydrophobized polysaccharide, pullulan (CHP) is a novel, simple protein delivery system, 
which is designed to form complexes with soluble protein molecules. The truncated protein 
is processed by dendritic cells through a pathway similar to that for endogenous proteins. The 
NY-ESO-1 human tumor antigen is a ‘‘cancer-testis’’ antigen expressed by various neoplasms, 
including melanoma. We report a case of malignant melanoma treated with the NY-ESO-1 
protein formulated in CHP (CHP/ESO), according to Code of Ethics. A 50-year-old man with 
stage IV (T4N3M1c) malignant melanoma was challenged by s.c. injections of CHP/ESO vac-
cine every 2 weeks. A month after treatment, multiple blister formation was observed on the 
metastatic lesions almost at the same time. Histological examination confi rmed the death of 
NY-ESO-1+ melanoma cells by TUNEL assay. CHP/ESO vaccine induced a gradual increase 
of NY-ESO-1-specifi c IgG1 in serum and a high CD8/CD4 T cell ratio in serum and skin le-
sion. Using IFN-γ secretion assays with synthetic overlapping peptides as monitors of T cell 
responses, we found increase in the number of NY-ESO-1-specifi c CD4+ T cells and CD8+ T 
cells in circulation after vaccination. Despite having received a cancer vaccine, tumors con-
tinued to grow and the patient died of pulmonary failure due to multiple metastasis. Analysis 
of postvaccine lesions prom patient showed an increased number of CD25+FOXP3+ cells and 
tumor-associated macrophages, and an increased amount of IL-4 and IL-10 secretion in the 
blister fl uid. Our observations indicate the occurrence of NY-ESO-1-specifi c immune response 
and immune suppression simultaneously, which may result in tumor progression and immune 
escape phenomenon.
610
Acupuncture Reduces the Number of Cutaneous Nerve Fibers
Wallengren J and Carlsson C
Department of Clinical Sciences, Lund University (Sweden)
The effect of acupuncture on nociceptive pain is well documented, but effects on nociceptive 
itch have been contradictory. The aim of this study was to evaluate possible effects of acupunc-
ture on the occurrence, distribution and function of sensory nerve fi bres in human skin. 
Methods: Ten subjects were treated by inserting ten acupuncture needles subcutaneously in 
the upper-lateral aspect of one buttock during the twice-weekly 25-minute sessions over fi ve 
weeks. Skin biopsies, diameter 3mm, were taken before and 3 to 6 days after local acupunc-
ture. Antibodies against a pan-neuronal marker PGP 9.5, calcitonin gene-ralated peptide CGRP, 
and vanilloid receptor VR1 (capsaicinreceptor) were employed to study sensory unmyelinated 
nerve fi bres that transmit nociceptive pain and itch. 
Results: The number of CGRP nerve fi bres/ biopsy was reduced from 36.0+3.3 to 21.3+4.0 
(p=0.05) after the treatment. The PGP 9.5-immunoreactive nerve fi bres/ biposy were found 
both in the epidermis and in subpapillary dermis. The total number of PGP 9.5 immunore-
active nerve fi bres 249.8+16.7 to 211.8+12.0 (p=0.03). The PGP 9.5 immunoreactive nerve 
fi bres occurring in the dermis appeared more fragmented after the acupuncture compared to 
pre-treatment. The VR 1 immunoreactivity was found both in the free nerve fi bres and in kite-
like formations, possibly mast cells, throughout the dermis, sometimes occurring around hair 
follicles. The number of VR1 immunoreactive elements was not signifi cantly infl uenced by the 
acupuncture, 33.5+4.6 vs 43.0+4.4 (p=0.09).
Conclusions: Our fi ndings support the opinion that the pain-relieving effects of acupuncture 
partly depend on its effect on the peripheral innervation.
611
Cognitive Skills Involved in ‘Diagnostic Snap’
Waterston K, Bisset Y and Rees JL
Department of Dermatology, University of Edinburgh (United Kingdom)
The goal of medical artifi cial intelligence (AI) is to simulate and support clinical behaviour. 
The impact of AI approaches on dermatological practice has been modest. In part this may be 
because we have little cognitive insight into the skills used by clinicians in making a diagnosis. 
Our interest is focussed on the abilities of experts and non-experts to match index cases with 
a reference image. We report two studies. In the fi rst 12 subjects, comprising 6 experts, and 6 
non-experts, were shown an index image (of a lesion rather than a rash) and asked to match 
the index card with one of 108 references cards representing a variety of cognate lesions (but 
including 1 card identical to the index). This was repeated with 2 further cards. The time taken 
was measured and errors recorded. In subsequent trials the reference cards were modifi ed by 
either using black+white images, inverted B+W, inverted colour, or degraded images. Subjects 
were able to match images with mean times of 8.2, 12.8, 20.8, 23.3 and 44.0 seconds for 
the respective groups. Errors increased alongside time. These differences in time are formally 
signifi cant (p<0.01). In the second experiment, subjects were asked to search and match two 
images that were identical within 54 images. The time taken to achieve a match was the out-
come. The mean time was 229.6 seconds. Since there are over 1400 combinations this suggests 
a processing of ~0.3 seconds per image if the correct second image was indentifi ed after half 
the search space had been examined. These studies show that even non-experts are extremely 
good at matching and that such processes occur at high speeds. At face value, time taken and 
errors seem to refl ect the amount of processing required.
612
Psoriasis Palmoplantaris Pustuolosa is not Inevitably Associated with Antigliadine-antibodies
Weisenseel P, Kuznetsov A, Rucizka T and Prinz J
Department of Dermatology, Ludwig Maximilians-University of Munich (Germany)
Psoriasis palmoplantaris pustulosa (PPP) is one of the most disabling and challenging Psoriasis 
variants. The pathogenesis is still enigmatic. Earlier studies have implied an association of PPP 
with celiac sprue by the detection of elevated Antigliadine-antibodies (AGA) in up to 25 % 
of the PPP patients. Accordingly some PPP patients with elevated AGA could benefi t from a 
glutene free diet regarding disease activity. We wondered how high the incidence of elevated 
IgA AGA levels was in German PPP patients compared to patients with chronic plaque type 
psoriasis and whether the incidence differed from earlier studies. Patients: 19 Patients (13 w, 
6 m, mean age 54 y) with a history of PPP ≥1 y and as a control group of 30 patients with 
chronic plaque-type psoriasis (13 w, 17m, mean age 43 y) were included in the study. None 
of the patients had a history of celiac sprue or chronic sprue-like symptoms. IgA AGA were 
assessed by indirect immunofl uorescent examination. Results: None of the PPP patients was 
tested seropositive for elevated IgA AGA levels. One of the patients with chronic plaque-type 
psoriasis showed an elevated IgA AGA level.
Conclusions: In this study no association between PPP the detection of elevated Antigliadine-
antibodies could be found. This fi nding is in contrast to earlier studies. This contrast might be 
based upon ethnical/latitudinal differences and should be evaluated in a larger epidemiologi-
cal effort.
613
Thermographic Methods In Psoriatic Lesion Evaluation
Zalewska A1, Gralewicz G2, Owczarek G2, Wiecek B3 and Sysa-Jedrzejowska A1
1Department of Dermatology, Medical University of Lodz (Poland)
2Central Institute for Labour Protection-National Research Institute, Warsaw (Poland)
3Inst of Electronics, Computer Thermography Group, Technical University of Lodz (Poland)
Thermography is more and more frequently used in evaluation of infl ammatory diseases. The 
aim of the present study was to assess usefulness of thermography in psoriatic lesion regres-
sion.
Twenty psoriasis vulgaris in-patients were included in the study. ThermaCam INFRAMETRICS 
290E thermocamera with temperature resolution of 0.1 oC was used. Both visual and thermal 
images, derived from four body regions i.e. chest, back, upper and lower limbs of lesional and 
lesion-free areas were recorded and subsequently analyzed.
A signifi cant decrease in temperature measurement was observed along with regression of skin 
lesions both over lesional skin and lesion-free areas. There was also a signifi cant decrease in 
erythema severity in all the examined areas. A negative correlation was noted between temper-
ature and desquamation on the chest and between temperature and infi ltration on the back. 
It is conceivable to speculate that temperature measurement could serve as a marker of psori-
atic lesion regression. It should be pointed out that, lesion-free skin in psoriatic patients seems 
to be involved in psoriatic pathology thus suggesting systemic involvement in psoriasis pro-
gression. 
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614 [058]
Beta-human-papillomavirus Infection and Squamous-Cell Carcinoma in Organ-Transplant 
Recipients
Bouwes Bavinck JN1 and EPI-HPV-UV-CA2
1Department of Dermatology, Leiden University Medical Center, Leiden (Netherlands)
2Study Group
Organ-transplant recipients (OTR) have an increased risk of warts and skin cancer. The risk of 
beta-papillomavirus (beta-PV) infection on the development of squamous cell carcinoma (SCC) 
was studied in 5 transplantation clinics in 219 OTR with and 550 without a history of SCC. All 
OTR were physically examined and keratotic skin lesions were counted. DNA of beta-PV types 
was tested in plucked eyebrow hairs by a newly developed PCR and reverse-hybridization 
assay (RHA) allowing the simultaneous detection of 25 beta-PV types. Serological responses 
against 28 late antigens (L1) of which 15 beta-PV types were measured by glutathione-S trans-
ferase (GST) ELISA using multiple bead serology (Luminex).
The number of keratotic skin lesions was strongly associated with a history of SCC. The per-
centage of OTR with keratotic skin lesions was 88.3% in recipients with compared to 52.1% 
in those without SCC: OR (odds ratio with 95% confi dence interval) 6.9 (4.5;10.8). The age 
of the OTR, the time period after transplantation and the study center were important factors 
associated with beta-PV infection.
The prevalence of one or more beta-PV types in eyebrow hairs of OTR with SCC was 95.9% 
compared to 88.6% in the OTR without SCC: OR 3.0 (1.5;6.2). Adjustment for age, sex, time 
after transplantation and study center resulted in an OR of 1.7 (0.78;3.8). Using forward step-
wise regression with all 25 beta-PV types tested, HPV 8, 14, 24, 25, 38 and 92 were specifi cally 
associated with an increased risk of SCC. The prevalence of a serological response against 
beta-PV types was 60.2% in OTR with compared to 54.8% in the OTR without SCC: OR 1.2 
(0.91;1.7). After adjustment the OR was 1.2 (0.83;1.7). Infection with specifi c beta-HPV types 
appears to be associated with the development of SCC in OTR.
615 [059]
Improving Sun Protection Behaviour in Children: Results of a Cluster-Randomized Trial in 
Italian Elementary Schools. The “SoleSi SoleNo GISED” Project
Chatenoud L1, Naldi L2, Bertuccio P1, Scotti L1, Zinetti C2 and La Vecchia C1
1Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan (Italy)
2Centro Studi Gised, Bergamo (Italy)
History of sunburns in early life nearly doubles the risk of developing malignant melanoma in 
adulthood. From 2001 to 2004, we undertook a cluster randomized study in order to evalu-
ate the effectiveness of an educational intervention to improve sun protection behaviour in 
schoolchildren. We randomized 122 Italian primary schools (II and III class) to receive (or 
not) an educational intervention conducted by trained teachers. Attitudes toward sun exposure 
and behaviour while in the sun, were assessed at baseline and one year after the educational 
intervention. Of the 11,230 children enrolled, 8,611 completed the study. A total of 1,547 
children (14%) reported a history of sunburns in the year preceding the study. Within-child 
changes in sun exposure and sun protective behaviour (difference: baseline-follow-up) were 
reported in terms of unchanged situation, worsened or improved one. No difference for any 
of the study variables was documented between the two groups. Proportions of worsened and 
improved behaviours were similar between groups (8% for both, sun burns and intense sun 
exposure experience). In this study, there was no signifi cant impact of an educational program 
on sun protection evaluated after one year from the intervention. This may be partly attributed 
to the high level of awareness of the studied population, concerning not only the correct sun 
exposure, but also proper protection behaviours. New educational prevention programs may 
be targeted for those population groups that were less sensitive to their health rather than to 
the whole population. 
616
Development and evaluation of the Family Dermatology Life Quality Index (FDLQI)
Basra MK and Finlay AY
Dept of Dermatology, Cardiff Univ, Wales College of Medicine, Cardiff (United Kingdom)
Skin diseases impact not only on the quality of life of the patients but also on their families. The 
aim of this study was to develop and validate a dermatology-specifi c instrument to measure the 
QoL of the family members of dermatological patients. Qualitative interviews were conducted 
with 50 family members of patients to identify different aspects of QoL affected. An initial 
draft version of the questionnaire based on the main topic areas revealed was pilot tested to 
assess the face and content validity. Psychometric evaluation of the fi nal 10-item questionnaire 
was conducted on a new cohort of family members (n=132) accompanying patients to a der-
matology out-patient clinic; family members completed the FDLQI and the patients (n=109) 
completed the DLQI.  Each of the 10 FDLQI questions has a 4-point response format. The total 
score (0-30) is generated by summing the individual item scores; higher scores indicate greater 
QoL impairment. Factor analysis identifi ed 2 main factors which explained 60% of the total 
variance. The FDLQI demonstrated high internal consistency (Cronbach’s α = 0.88) and test-
retest (ICC=0.94, n=64) reliabilities. The responsiveness to change was shown by change in 
the family members’ FDLQI scores (mean change= 1.37, SD=8.3, n=27) 3-6 months after the 
fi rst administration. Construct validity was assessed by testing a number of a priori hypotheses; 
a strong correlation between the families’ FDLQI score and patients’ DLQI scores (r=0.69), 
a higher FDLQI score for infl ammatory dermatoses (mean=10.0, n=90) compared with non-
infl ammatory/isolated lesions (mean=3.8, n=32, p<0.0001), a high correlation between the 
families’ FDLQI scores and patients’ disease severity (r=0.49) and the instrument’s ability to 
discriminate between the affected families and control population (n=25, p<0.0001). 
The FDLQI has the potential to be used as an additional outcome measure, supported by the 
initial results of its reliability, responsiveness to change and validity.
617
The Naevus Count on the Arms as a Predictor of the Number of Melanocytic Naevi on the 
Whole Body in an Italian Survey on Children
Gallus S1, Naldi L2 and La Vecchia C1
1Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan (Italy)
2Centro Studi GISED, Bergamo (Italy)
Scanty information is available on the relationship between naevus count on a specifi c ana-
tomical site and on the whole body surface, particularly in children. We analysed the issue 
using data from a uniquely large study on children from Italy.
In 1997 we conducted a survey among schoolchildren aged 13-14 years in 14 cities from the 
North, Centre and South of Italy. The parents of 3,406 children (1,746 boys and 1,660 girls) 
consented to the study, and fi lled a structure questionnaire with information about their child’s 
sun exposure and lifetime history of sunburns. Children were also examined by trained derma-
tologists examined to assess pigmentary traits and to make a count of melanocytic naevi on 19 
different anatomical areas. 
Overall the mean number of naevi was 17.2 (18.6 in males and 15.8 in females). It was 2.1 on 
the head and neck, 3.8 on the upper and 3.0 on the lower limbs, 3.3 on the anterior and 5.1 
on the posterior trunk. The Spearman correlation coeffi cients (r) with number of naevi on the 
whole body were 0.72 for head and neck, 0.88 for upper and 0.79 for lower limbs, 0.83 for 
anterior and 0.86 for posterior trunk. With reference to single anatomical areas, the best predic-
tors of the count of naevi on the whole body were the medial (r=0.77) and the lateral aspect of 
the arms (r=0.79), the chest (r=0.78) and the back (r=0.74).
This large study provides defi nite evidence that posterior trunk and upper limbs might be suit-
able for predicting total naevus count in children.
618
Assessment of Psoriasis Lesions by Digital Image Analysis
Cazzaniga S1, Martinelli M1 and Naldi G2
1Centro Studi Gised, Bergamo (Italy)
2Dipartimento di Matematica, Università degli Studi di Milano (Italy)
Our work was oriented to provide an algorithm to assess the severity of psoriasis lesions on 
image analysis. Image analysis was performed into three steps. Firstly, we segmented the image 
into skin area and lesion area, with automated computer vision algorithms. In the second step, 
we analysed isolated areas in order to identify signifi cant parameters. According to statistical 
correlation tests between parameters and severity, in a group of 18 lesions, fi ve parameters 
were identifi ed as possibly predictive of severity: texture, estimated by local standard deviation; 
exfoliation index, that was the percentage of scale inside lesion and was determined studying 
red and green channels ratio; contrast with skin, measured, in the colour space, by chromatic 
distance between lesion and skin; internal redness, valuated by chromatic difference between 
red and green channels inside lesion; modal intensity value of green channel, a general vari-
able that had great correlation with severity. Finally, in the last step we developed a summary 
index of clinical severity, by using a statistical regression based model. Compared with judge-
ment by a dermatologist, on a scale from zero to ten, the accuracy of the index, with an error of 
5%, was 87%. According to our results, our algorithm for digital image analysis may represent 
an helpful tool to assess psoriasis lesions.
619
Reproducibilty of a Questionnaire on Contact Allergy: The EDEN International Study on the 
Prevalence Of Contact Allergy to Fragrances
Rossi M6, Coenraads PJ1, Diepgen T2, Elsner P3, Api AM4, Svensson A5, Naldi L6
1Environmental Dermatology Unit, University Hospital, Groningen (Netherlands)
2Dept. of Clinical Social Medicine, University of Heidelberg (Germany)
3Dept of Dermatology, Friedrich-Schiller-University, Jena (Germany)
4The Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ (USA)
5Department of Dermatology, University of Malmo (Sweden)
6Centro Studi Gised, Bergamo (Italy)
This study was undertaken to estimate reproducibility of a questionnaire developed to record 
demographic aspects, clinical history and product exposure in a multinational project, “The 
EDEN Fragrance Study”, aimed to assess the prevalence and severity of contact dermatitis and 
the rate of sensitisation to fragrances, in a general population of fi ve European regions. We 
compared the results concerning 60 items from the questionnaire administered twice at an 
interval of 1-8 weeks (median = 1 week) to 94 volunteers (31 males and 64 females, median 
age = 40 years) from three European regions in Italy (Bergamo, 40 subjects), The Netherlands 
(Groningen, 34 subjects) and Sweden (Malmo, 21 subjects). In each country, a face-to-face 
interview was performed by trained interviewers, using own language questionnaire (obtained 
from the English version by translation/back-translation technique). Data showed high agree-
ment for the questions relating to demographic issue (0.85 to 1 in agreement). The Kappa value 
of the clinical section was lower,: around 0.70, for the questions referring to skin problems, 
previous clinical examinations, allergic tests performed, dry skin and sensitive skin. The data 
on the history of skin diseases were unbalanced to calculate the Kappa statistic, while the 
agreement of the questions concerning to itchy skin rash, were low (around 0.30), although 
the results restricted to the subjects interviewed using a more detailed code book, were higher 
(around 0.70). The weighted Kappa statistic for the questions concerning exposure frequencies 
to selected products containing fragrances, ranged from 0.54 (“Shampoos”) to 0.91 (“Cosmetic 
product”); with the majority of items obtaining Kappa values higher than 0.70. 
In conclusion, in spite of some limitations mainly due to differences with collecting data, the 
present study showed a good level of reproducibility for the questionnaire.
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Comparison of the Dynamics and Correlates of Transmission of Herpes Simplex Virus-1 
(HSV-1) and Varicella Zoster Virus (VZV) in a Sample of the Israeli Population
Davidovici B1, Balicer RD2, Klement E2, Green M3, Smetana Z4 and Cohen D1
1Dept of Epidemiology & Preventive Medicine, Sackler Fac of Medicine,Tel Aviv Univ (Israel)
2Med Corps, Israel Defense Force; Epidemiology Dept, Ben-Gurion Univ, Beer-Sheva (Israel)
3Israel Ctr for Disease Control, Min of Health, Gertner Inst, Chaim Sheba Med Center (Israel)
4Central Virological Laboratory, Public Health Services,Ministry of Health,Chaim Sheba Medical 
Center (Israel)
HSV-1 and VZV are both alpha herpes viruses that share many characteristics including the 
ability to establish latent infection of the ganglia and recurrent disease at the innervated der-
matome. In this study we compare the dynamics and correlates of transmission of these two 
viruses in the same population.
In 2000-2001, 1,642 sera collected from an age-stratifi ed general population sample were test-
ed using commercial ELISA kits to measure type-specifi c HSV-1 and varicella IgG antibodies.
The VZV seroprevalence increased rapidly with age reaching almost 50% seropositivity by the 
age of 3 years, while HSV-1 reached 50% seropositivity at the age of 14 years. The highest VZV 
force of infection was in the 3.5–5.5 year age group (0.7 per susceptible year) followed by the 
5.5–10.5 years age group, while for HSV-1 the age specifi c force of infection was substantially 
lower and stable over the various age groups. Multivariate analysis revealed that HSV-1 sero-
prevalence was signifi cantly associated with age, country of birth, country of origin, ethnicity, 
socio-economic status and VZV serostatus. Ethnicity (non-Jewish origin) was the strongest pre-
dictor of HSV-1 seropositivity. Only age, country of origin and HSV-1 serostatus were found to 
be associated with VZV seropositivity. Country of origin (Eastern) was the strongest predictor of 
VZV infection. Furthermore, each year of age had a 4% contribution to the increase in overall 
HSV-1 seropositivity and a 17% contribution to the increase in VZV seropositivity. 
We conclude that in developed countries such as Israel the transmission of VZV is much quick-
er and less dependent on socioeconomic status as compared with HSV-1.
621
A Systematic Review of Randomised Controlled Trials of Treatments for Inherited Forms of 
epidermolysis bullosa
Langan SM and Williams HC
Centre of Evidence-based Dermatology, University of Nottingham (United Kingdom)
The inherited forms of epidermolysis bullosa (EB) are associated with signifi cant morbidity. 
Many interventions are described, but it is unclear which are benefi cial.
We sought to systematically review the trial evidence in order to inform clinical practice and 
to highlight research gaps
A systematic review of CENTRAL (The Cochrane Central Register of Controlled Trials) and 
Medline was carried out. Our primary outcomes were healing and/ or prevention of new le-
sions. Only results of randomized controlled trials (RCTs) were included in the fi nal analysis.
88 papers were identifi ed, of which only 5 were RCTs (n=102). Heterogeneity of studies pre-
vented meta-analysis. Study quality was poor. Most were under-powered and results were in-
adequately reported. All were randomised double-blind placebo-controlled crossover studies. 
Two assessed oral tetracyclines in EB Simplex (EBS). In the fi rst study (n=12), 4/6 improved 
and 2/6 deteriorated with 1500mg of tetracycline daily; placebo results were not given and 
only 2 patients completed the full study. In the second study (n=21), 6/18 and 7/18 improved 
in tetracycline and placebo groups respectively. Two RCTs on topical interventions for EBS 
were found. The fi rst study of aluminium chloride (n=23) showed no difference in mean lesion 
counts between active and placebo sides. A study of 5% bufexamac (n=8) showed a non-sig-
nifi cant mean difference in lesion count between active and placebo of 3.44 (95% CI -11.88 to 
18.76). In recessive dystrophic EB an RCT of phenytoin failed to show any difference in mean 
lesion counts= 0 (95% CI -11 to 4). No RCTs were found in junctional EB.
Despite the impact of EB and the many treatments, there is currently no conclusive RCT evi-
dence to support therapeutic interventions. This research gap needs to be addressed by col-
laborative international multi-centre RCTs. 
622
Erythema Exsudativum Multiforme Majus Versus Stevens-Johnson Syndrome: Differences in 
Clinical Pattern and Etiology
Liss Y1 and Mockenhaupt M1, for the RegiSCAR2
1Department of Dermatology, University Clinic, Freiburg (Germany)
2study group
Based on the original publications Stevens-Johnson syndrome (SJS) and Erythema exsudati-
vum multiforme majus (EEMM; EEM with mucosal involvement) are two different entities. SJS 
presents with widespread pupuric macules or fl at atypical targets with blister formation mainly 
on the trunk, whereas EEMM appears with target lesions especially on the limbs (typical EEMM) 
and sometimes with single lesions disseminated in other parts of the body (atypical EEMM). 
Since 1990 all hospitalized cases of EEMM, SJS and toxic epidermal necrolysis (TEN) are as-
certained by the population-based registry for severe skin reactions in Germany. All cases are 
reviewed by an independent expert committee using a consensus defi nition. Thereby a huge 
variety in clinical appearance of atypical EEMM was observed. Giant targets could be found, 
affecting mostly small children. When appearing periocular and perioral, they give the patient 
an almost “clown-like” look. 
A total of 1226 cases of EEMM (n=486; typical 269, atypical 217) and SJS (n=663) were vali-
dated as probable and defi nite; 77 cases could not be classifi ed, since they presented with 
features of both conditions. 197 of all EEMM-patients were ≤18 years of age, 88 with typical 
EEMM, 109 with atypical EEMM, compared to 68 of SJS-patients. 
Besides the difference in age distribution there are differences in the etiology. Whereas herpes 
simplex is the major risk factor of typical EEMM, mycoplasma pneumonia, other upper respira-
tory tract infections and infl uenza or infl uenza –like illness could be identifi ed as causes of 
atypical EEMM. In contrast, drugs also known to induce TEN are the major risk factor of SJS. 
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Sequelae and Impairment after Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Mockenhaupt M1 and Sekula P1, for the RegiSCAR2
1Institute of Medical Biometry and Medical Informatics, University Clinic, Freiburg (Germany)
2Study Group
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe skin reac-
tions with a high mortality and morbidity. Long-lasting sequelae are frequently reported in 
survivors.
In order to assess prognostic factors as well as sequelae and quality of life after severe cuta-
neous adverse reactions (SCAR), a large cohort of patients with SCAR was constituted in the 
RegiSCAR-study (European Registry on SCAR to drugs and collection of biological samples). 
Follow-up information was obtained 8+/-2 weeks and one year after the case ascertainment. 
360/508 potential cases of SJS and TEN were validated as probable and defi nite, 327 consented 
to the cohort. 8 +/-2 week follow-up information could be obtained in 304 cases. Among 
216 survivors 159 reported hyper-pigmentation, whereas hypo-pigmentation and hypertrophic 
scars were less frequent. Nail loss was experienced by half of the patients, hair loss by ap-
proximately one third.
More dangerous for the patients are sequelae after eye-involvement. The most frequent com-
plain is dryness (58) followed by photophobia (54), loss of eyelashes (48), redness (46), pain 
(40), watering (35), trichiasis (26), corneal erosions (21) and synechia (20). Sequelae of other 
mucous membranes include oral dryness, impairment of taste as well as oral and genital syn-
echia.
One year after the adverse event many cutaneous and mucosal sequelae, impairment and 
disability are still present and the quality of life is substantially reduced in a large number of 
patients.
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PRISM (Pictorial Representation of Illness and Self Measure) is a Reliable and Valid Method to 
Measure Perception of the Impact of Illness in Dermatological Hospitalised Patients
Muehleisen B1, Schmidhauser S1, Buechi S2, Dummer R1 and Hofbauer G1
1Department of Dermatology, University Hospital Zurich, Switzerland (Switzerland)
2Department of Psychiatry, University Hospital Zurich, Switzerland (Switzerland)
Perception of the burden of illness in hospitalised patients is diffi cult to assess and is thought 
to be an important measure in order to provide and improve individual therapy. There is no 
‘gold standard measure’ for suffering. Recently PRISM gained attention as a reliable and valid 
non-verbal method to measure burden of illness. Tested mainly in non-dermatological subjects, 
our aim was to validate PRISM for hospitalised dermatological patients. 171 dermatological 
patients performed the PRISM task at the beginning of hospitalisation and later every week 
until demission. At the same occasions patients were asked to fi ll out two standardised health 
quality of life questionnaires (DLQI (Dermatology Life Quality Index) and skindex-29). PRISM 
showed good correlation with DLQI and skindex-29 (Spearman’s rho = 0.42, 0.43 respectively, 
p< 0.005). PRISM scores correlated also well with changes in skin status during hospitalisa-
tion. We conclude that PRISM is a valid method to measure perception of the impact of illness 
in hospitalised dermatological patients. It is very acceptable to patients and takes less than 5 
minutes to complete.
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Little Change in Global Psoriasis Severity in the Last 20 Years: A Prospective Study
Nijsten T1, Looman C2 and Stern RS3
1Dept Dermatology, Erasmus MC (Netherlands)
2Dept Biostatistics, Erasmus MC (Netherlands)
3Dept Dermatology, Beth Israel Deaconeess Medical Center (USA)
Objective: To study the change of psoriasis severity in time. Design: The data was derived 
from a prospective cohort study of 1,380 psoriasis patients that started in 1976 (The PUVA 
Follow Up Study). Setting: A 16 center US study. Participants: Patients with psoriasis resistant 
to topicals and/or moderate to severe disease treated with PUVA. The analysis was restricted 
to those who had at least two of the four standardized clinical examinations between 1985 
and 2005. Outcome measurement: A four-point physician global assessment (PGA) by der-
matologists independent of seeking medical care. Results: Of the 979 participating patients 
in 1985, 815 (83.2%) were examined twice or more in the last 20 years. The distribution 
of the four PGA levels did not change signifi cantly, except that in 2005 more patients had 
no psoriasis compared to prior examinations (9.6% vs <5.1%, p<0.001). The vast majority of 
patients remained within one level of its baseline PGA in 1986 at later examinations. Transi-
tion rate analysis demonstrated that patients had a likelihood of about 50% to remain at the 
same PGA level at their next examination about fi ve years apart. Of patients with mild disease, 
60.1% (95%CI=58.2, 63.5) remained mild and more than 80% of those with severe psoriasis 
continued to have moderate to severe psoriasis. Conclusion: Although global psoriasis severity 
may vary, psoriasis is a relatively stable condition. For about half the patients who presented 
in 1985, either current treatments controlled the disease or their psoriasis became less active 
over a long period of time. 
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Evaluation of Quality of Life in Patients with Cutaneous Lymphoma
Sampogna F, Frontani M, Baliva G, Lombardo G, Di Pietro C, Alvetreti G, Tabolli S, Abeni D 
and Russo G
Ist Dermopatico dell’ Immacolata - Istit. Ricovero e Cura a Carattere Scientifi co, Roma (Italy)
Cutaneous lymphoma(CL) is a cutaneous malignancy, which especially in the more severe 
forms may have a profound effect on patients lives. The aim of this study was to evaluate quality 
of life (QoL), psychological distress, and alexithymia in patients with CL referring to our derma-
tological hospital, and to correlate these results with clinical parameters. QoL was evaluated 
with the Skindex-29, that measures QoL in skin conditions on three scale (symptoms, emo-
tions, and functioning), and the EORTC QLQ-C30, that assesses the QoL of cancer patients. 
Presence of minor non-psychotic disorders was assessed using the GHQ-12, defi ning as case 
patients scoring 4 or more; alexithymia was evaluated using the TAS-20 questionnaire.
 In our ongoing study, we analysed data from the fi rst 66 patients. Of them, 67% were men, the 
mean age was 58 years (range:26-85y), and there were 15 patients (23%) with cutaneous-B-cell 
lymphoma (CTBL), and 51 with T-cell-lymphoma (CTCL), 6 of them with Sézary Syndrome. In 
our population, 31.3% of patients were GHQ-cases, 18.6% had alexithymia, and another 22% 
possible alexithymia. Dermatology-specifi c QoL was particularly impaired in the symptoms 
and the emotions scales. QoL was always signifi cantly more impaired in patients with CTCL 
than in those with CBCL. Also, the prevalence of GHQ-cases was higher (35% in CTCL vs 13% 
in CBCL), as well as the prevalence of people with alexithymia (48% vs 20%).
Skindex-29 and TAS-20 scores signifi cantly correlated with the T stage of lymphoma (i.e., the 
higher the stage, the lower the QoL and the higher the prevalence of alexithymia). The evalu-
ation of quality of life and psychological problems in patients with CL may help clinicians to 
better manage the disease and its burden on patients life. Also, the relation between quality 
of life impairment and clinical variables may give important information on the course of the 
disease as well as the possible effect of treatment.
627
Increased Urinary Levels of Nitrotyrosine, a Marker for Peroxynitrite Production, in Yusho 
Victims 35 Years after Accidental Poisoning with Polychlorinated Biphenyls in Nagasaki, Japan
Shimizu K, Ogawa F, Bae S and Sato S
Dept of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, (Japan)
Yusho is a food poisoning, which was caused by the contamination of rice oil with PCB and 
polychlorinated dibenzofuran in western Japan in 1968. More than thirty-fi ve years have 
passed since the accidental poisoning, yet high and signifi cant concentrations of PCB are still 
detected in the serum of Yusho victims, in whom severe skin symptoms are not recognized 
such as acneiform eruptions and pigmentation. Previous studies reported that PCB causes the 
release of superoxide, suggesting that Yusho victims have been exposed to oxidative stress for 
more than 35 years. Meanwhile, nitric oxide (NO) is a gaseous radical and the role of NO has 
been clarifi ed in many diseases. NO reacts with superoxide and immediately produces perox-
ynitrite (ONOO-), which can cause severe cytotoxicity. ONOO- causes nitration of tyrosine and 
produces nitrotyrosine (NT) as an end-product. Recently, some antibodies have been produced 
against NT and utilized to examine the effects of ONOO-. We have already recognized high 
concentrations of urinary nitrite, a stable metabolite of NO, in Yusho victims. Therefore, we 
conducted here to examine urinary concentrations of NT in Yusho victims. The study protocol 
was approved by Japanese government and a signed consent form was obtained from each sub-
ject before enrolment. Early-morning void urine samples were collected and kept at -80C until 
analysis. Urinary level of NT was measured in 41 Yusho victims and 45 age-matched healthy 
individuals. A specifi c Enzyme-linked immunosorbent assay kit (HK501, Hycult, biotechnol-
ogy. The Netherlands) was used to measure the concentrations of urinary NT. Statistical analy-
ses were performed using Mann-Whitney’s U-test and the relationship between parameters was 
statistically examined by Spearman’s rank test. The mean ages of Yusho victims and the controls 
were not signifi cantly different and the mean urinary concentration of NT was signifi cantly 
higher in the victims than in the controls.
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Drug safety, Pharmacoepidemiology, and Risk Management: What does it all Mean?
Sobel R
Epidemiology/Safety and Risk Management, Pfi zer Inc. (USA)
In the wake of some recent global drug withdrawals, drug safety has become a topic of intense 
interest to clinicians, researchers, and the general public. The processes pharmaceutical com-
panies utilize to assess drug safety and manage pharmaceutical risks, and the regulatory frame-
work under which they are guided, are often unknown to those outside the fi eld. The objectives 
of this presentation will be to a) explain the concept and importance of Risk Management, 
including evolving regulatory perspectives such as the recently issued European Medicines 
Evaluation Agency’s (EMEA) Guidelines on Risk Management; b) describe the tactics and strate-
gies needed for effective risk evaluation and management, incorporating how pharmacoepide-
miology (the intersection between pharmacology and epidemiology) plays a essential role in 
risk assessment and management; and c) illustrate how a pharmaceutical company achieves 
effective risk management, employing some recent examples. Risk management in the phar-
maceutical industry is often characterized as a comprehensive and multidisciplinary method 
for the quantifi cation of potential drug reactions and the implementation of strategies to reduce 
these risks when identifi ed. Methods used to identify and quantify possible risks include passive 
and active surveillance mechanisms, formal epidemiologic/observational studies, registries, or 
clinical trials, each of which has benefi ts and substantial pitfalls. Once a potential risk is identi-
fi ed, strategies for risk minimization may incorporate physician/patient education, reminder 
systems, or restricted distribution. In summary, comprehensive strategies must be continuously 
utilized to adequately assess and manage drug safety.
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Risk Factors for Work-Related Dermatoses Among Farming Students
Spiewak R
Inst of Public Health, Fac of Health Care, Jagiellonian Univ Medical College, Krakow (Poland)
Background: Farmers are at highest risk of occupational skin diseases. Ideally, the prevention 
should start at the earliest phase of vocational training. In order to identify risk factors for farm 
work-related skin diseases, a nationwide study of Polish farming students was carried out in 
2001 and 2002. Study group: 304 random students of 11 agricultural schools consented to 
participate in the study (participation rate 98%). The schools were at least 100 km from each 
another. The participants were 160 men and 144 women, aged from 17 - 21 years. 
Methods: The examinations included questionnaire, skin prick tests, patch tests, total IgE, farm-
animal specifi c IgE and Phadiatop. For each of 144 variables, odds ratios were calculated 
(Mantel-Haenszel). Logistic regression model was used for the determination main determin-
ing factors. Results: Work-related dermatoses were identifi ed in 18 of 304 study participants. 
Contact dermatitis was diagnosed in 10 students, contact urticaria in 4, and both dermatitis 
and urticaria in remaining 4 students. Main risk factors for work-related dermatitis were: history 
of atopic dermatitis before entering school (OR=7.64; 95%CI: 1.84-31.72; p=0.005), history 
of contact dermatitis before entering school (OR=5.20; 1.63-16.59; p=0.005), and history of 
respiratory allergy before entering school (OR=3.80; 1.21-11.95; p=0.022). Main risk factors 
for work-related urticaria were: positive skin prick tests to farm allergens (OR = 6.56; 1.52-
28.20; p=0.012), history of contact dermatitis before entering school (OR=5.32; 1.21-23.38; 
p=0.027), and positive Phadiatop test (OR=5.00; 1.17-21.43; p=0.030).
Discussion: 5.9% farming students have developed occupational skin disease before fi nishing 
their vocational training. Asking simple questions at the initial health check would be suffi cient 
for identifying students at risk for work-related dermatitis, whereas simple allergy tests would 
be suffi cient for identifying those at risk for work-related urticaria.
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Nocturnal Wrist Movements as an Objective Outcome Measure for Clinical Trial in Eczema
Thomas KS1, Lawton S2 and Armstrong SJ1
1University of Nottingham (United Kingdom)
2Queen’s Medical Centre, Nottingham (United Kingdom)
This study aimed to: i) assess the feasibility of using scratch accelerometers to record nocturnal 
scratching in children with eczema, and ii) to record the views of those using the devices in 
terms of their suitability for use in a clinical trial setting. Eleven children were observed in a 
prospective observational study. All children had a minimum eczema severity score (SASSAD) 
of at least 10 points and were aged between 6 months and 14 years. Nocturnal scratch scores 
(measured using Actiwatch units, Cambridge Neurotechnology, Cambridge, UK) were corre-
lated with eczema severity (SASSAD); self-reported scratching behaviour; self-reported global 
assessment of eczema severity; the Patient Oriented Eczema Measure - POEM; application of 
topical steroids; and quality of life for the family and the child. Assessments were conducted at 
baseline, 2 weeks and 4 weeks. The primary outcome was the correlation between nocturnal 
wrist movement and eczema severity (SASSAD) since these are both objective measures of 
disease activity, suitable for use in a clinical trial setting. Other associations were examined 
as secondary outcomes. It was not possible to achieve our target recruitment of 24 children in 
time for this abstract submission deadline. We therefore present preliminary results at this time. 
Correlating the disease severity score (SASSAD) at 2 weeks with the nocturnal scratch score 
for the previous night, we found no correlation between the two (Spearman’s rank correlation 
coeffi cient = 0.26, 95% CI -0.40 to 0.74, P=0.44). Similarly, the correlation between SASSAD 
and a summary of the previous 7 days scores for nocturnal scratching was also non-signifi cant 
(-0.14, 95% CI -0.68 to 0.50, P = 0.68). Participants found the watches simple to use and were 
generally well-tolerated by children and their families. 
These preliminary results are based on a small sample size and confi dence intervals are wide, 
making conclusions diffi cult. Nevertheless, the watches were well tolerated - even in children 
who were very young and who had relatively severe eczema. This suggests that their use as an 
outcome measure in a clinical trial may be appropriate. Further work is still required in order 
to establish their responsiveness to change.
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Amifostine, a New Drug With High Risk of Inducing Stevens-Johnson Syndrome and Toxic 
Epidermal Necrolysis
Valeyrie-Allanore L1, Poulhalion N1, Fagot JP1, Hellmer A2, Davidovici B3, Sidoroff A4,
Roujeau JC1 and Mockenhaupt M2
1Dept of Dermatology, Univ Paris XII, Creteil (France) 2Dept of Dermatology, Univ Freiburg 
(Germany) 3Soroka Medical Center (Israel) 4Dept of Dermatology, Univ of Innsbruck (Austria)
Amifostine is a cytoprotective organic thiophosphate prodrug that provides a selective cytoprotec-
tion against the toxic effects of radiotherapy and chemotherapy. It recently received approval for re-
duction of xerostomia in patients undergoing fractioned radiotherapy in head and neck cancer. We 
report seven cases of Stevens Johnson Syndrome (SJS) and Toxic epidermal necrolysis (TEN) during 
amifostine treatment. In a European prospective epidemiological study of SJS/TEN, conducted be-
tween March 1998 and November 2005, eight cases induced by amifostine were reported. Seven 
were validated as probable or defi nite by the expert comity.
All patients received amifostine for radioprotection of head or neck cancer in association with 
chemotherapy in 3 of them. Most of cases occurred at least 26 days after the initial dose. The 
mean SCORTEN at the fi rst day of hospitalisation was 2.5 (range 1 to 4). The skin involvement 
predominated on radiation-exposed sites. Mucous membranes were systematically involved. A 
skin biopsy was systematically performed, consistent with the diagnosis of SJS/TEN. Complica-
tions were represented by sepsis, transient liver enzymes elevation, and delayed lingual healing. 
Treatment was mainly symptomatic. All patients rapidly improved and were discharged with 
a mean delay of 13 days. Amifostine corresponds to a cytoprotective agent for normal tissues 
against chemotherapy and radiotherapy toxicities. The most common adverse effect events with 
amifostine administration include hypotension, nausea/vomiting and skin rash. Boccia et al. re-
cently reported cases of severe skin reactions with amifostine, according to the review of post-
marketing worldwide reports of skin reactions. The results of our study could confi rm that ami-
fostine is associated with a high incidence of severe and even life-threatening adverse cutaneous 
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Cardiovascular Risk Factors and Comorbidities among Psoriasis Patients – A Review of 
Evidence from Multiple Analyses
Wu Y, Robinson D and Bala M
Centocor Research and Development, Inc. (USA)
Introduction: Previous studies suggest an increase in cardiovascular risk factors/ comorbidities 
among psoriasis patients. We analyzed data from four sources (three large US claims databases, 
A, B, and C, and one large-scale US survey of psoriasis patients, D) to further explore this as-
sociation. 
Methods: Adult patients continuously enrolled between 2001-2002 and with at least 1 medical 
service claim during the period were included in datasets A and B. Adult patients continuously 
enrolled from 1997-2005 were included in dataset C. ICD-9 codes were used to identify pso-
riasis patients and cardiovascular risk factors/comorbidities: type 2 diabetes (DM2), hyperten-
sion (HTN), and dyslipidemia. Patients without psoriasis were extracted from these datasets and 
matched 4:1 to cases. Likewise patients who reported a diagnosis of psoriasis were extracted 
from dataset D, a large national survey conducted in 2004. Patients without psoriasis were 
matched 1:1 to cases. Odds ratio (OR) and 95% confi dence interval (CI) were derived to assess 
the association.
Results: Numbers of psoriasis patients analyzed in these four datasets were 23,897 (A), 
30,558(B), 1,911(C), and 1,127 (D). Across studies, cardiovascular risk factors/ comorbidities 
were increased among psoriasis patients compared to controls: the ORs (CI)s of HTN in the 
four datasets were 1.12(1.08-1.15), 1.18(1.15-1.21), 1.18(1.07-1.31), and 1.49(1.23-1.80), 
respectively. The OR(CI)s of DM2 were 1.17(1.12-1.23), 1.22(1.17-1.28), 1.37(1.21-1.56), 
and 1.42(1.10-1.84), respectively. The ORs (CI)s of dyslipidemia in datasets C and D were 
1.19(1.08-1.32), and 1.35 (1.11-1.63), respectively.
Conclusions: In keeping with earlier data, increased cardiovascular risk factors/ comorbidities 
were found among psoriasis patients. This increased risk was consistently observed across mul-
tiple datasets. More research is needed to further understand the underlying mechanism. 
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Cutaneous HPV Early Genes Target Epidermal AKT Activity, Altering Heat-Shock Protein 
Regulation of Cornifi cation
O’Shaughnessy R1, Welti J1, Pfi ster H2, Harwood C3 and Byrne C3
1Centre of Cutaneous Res, Inst of Cell & Molec Science, Queen Mary Univ (United Kingdom)
2Institute of Virology, University of Cologne (Germany)
3Cancer Research UK Skin Tumour Laboratory, Queen Mary University (United Kingdom)
We show complex, biphasic AKT activities in epidermis. A major epidermal granular layer 
activity regulates cornifi ed envelope formation, needed for skin barrier function, while activity 
in the lower strata regulates epidermal differentiation. HSP27 is one important granular AKT 
target. HSP27 phosphorylation causes transient interaction with fi laggrin, regulating the com-
plex processing of this essential cornifi ed envelope protein. Cutaneous human papilloma virus 
(HPV) early gene expression changes epidermal AKT activities, upregulating lower strata AKT 
levels in an isoform-specifi c manner but downregulating granular layer AKT activity, altering 
the association between fi laggrin and HSP27, and causing cornifi ed envelope defects. AKT 
expression was similarly altered in a panel of human warts, with dysplastic papillomas showing 
focal increases in AKT expression. We propose that HPV targets the AKT-induced interaction 
of HSP27 with fi laggrin to induce HPV virion release from the tough epidermal cornifi ed enve-
lope. Further these AKT changes could be prerequisite for, or predispose to dysplasia.
634 [056]
APOBEC3g Mediates Innate Resistance of Dendritic Cells to HIV-1 Infection
Pion M, Stalder R and Piguet V
Dept of Dermatology & Venereology, Univ Hospital & Med School of Geneva (Switzerland)
During HIV sexual transmission, Dendritic Cells (DC) are likely to be the fi rst targets of HIV. 
HIV-1 infects DC both in vivo and in vitro although very ineffi ciently compared to CD4+ T cells. 
However, HIV-1-infected DC are capable of transmitting infection to neighboring mucosal 
CD4+ T cells, constituting thereby a so-called “founder” population of infected cells suffi cient 
to promote infection in the host. Understanding the cellular determinants of DC resistance to 
HIV infection may provide new opportunities to control HIV infection at a vulnerable step for 
the virus. 
We analyzed whether the relatively ineffi cient viral replication in immature DC (iDC) could 
be attributed to specifi c cellular restrictions during the viral life cycle. We identifi ed an Env-
independent restriction to HIV-1 infection in human iDC using single round infection assays 
with viral particles pseudotyped with VSV-G. This restriction was dominant but not saturable. 
This block to HIV infection of DC was released by Arsenic treatment. siRNA-mediated deple-
tion of TRIM-5 alpha in human DC did not release this restriction which demonstrated that this 
Arsenic sensitive block is independent of TRIM-5 alpha. However, siRNA-mediated depletion 
of human APOBEC3g enhanced HIV-1 infection of iDC, indication that this restriction was at 
least in part mediated by APOBEC3g.
In conclusion, our study highlights an unexpected role for APOBEC3g in restriction of HIV-1 
infection in DC. We propose that the low levels of HIV-1 replication in iDC result from an 
APOBEC3g-mediated intrinsic resistance of these cells to HIV infection, thereby possibly slow-
ing down the fi rst steps of HIV infection at its mucosal point of entry. 
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The Extent and Differentiation Phenotype of HHV8-Specifi c CD8 T Cells are Associated with 
Spontaneous Control of Infection and Absence of Kaposi sarcoma
lambert M1, Gannage M1, Karras A2, Legendre C2, Abel M1, Kerob D3, Agabalika F3, Girard P4, 
Lebbe C3 and Caillat-Zucman S1
1AVENIR Team INSERM U561, Hôpital St-Vincent de Paul, Paris, France (France)
2Hopital Necker (France) 3Hopital Saint Louis, Paris (France) 4Hopital Saint Antoine (France)
The role of specifi c immune response in the control ofhuman herpes virus 8 (HHV8 or Ka-
posi’s sarcoma-associated herpesvirus- KSHV) replication and in the progression of Kaposi’ 
sarcoma (KS) remains unclear. We compared CD8 T cell responses to HHV8 latent (K12) and 
lytic(glycoprotein B, ORF6, ORF61, ORF65) antigens in patients who spontaneously control-
ledthe infection and in patients with post-transplant, AIDS-related or classical KS. We found 
that anti-HHV8 responses were frequent, diverse and strongly differentiated towards an effector 
phenotype in patients who controlled the infection. By contrast HHV8-specifi c CD8 cellswere 
very rare in patients who progressed to KS. Finally HHV8-specifi c CD8 T cells were observed 
in a seronegative recipient of HHV8-infected graft who remained persistently aviremic and 
antibody-negative, suggesting that specifi c CTL may provide protection from persistent HHV8 
infection. These results support the crucial role of cellular immune responses in controlling 
HHV8 replication, in preventing malignancies in latently infected subjects, and in conferring 
genuine resistance to persistent infection. They may also have important implications for the 
design of prophylactic and therapeutic HHV8 vaccines, and for adoptive immunotherapy of 
KS.
636
Behaviour of Venous Leg Ulcer Fibroblasts Compared with Normal Fibroblasts in Contact 
with an absorbent Dressing in a Model of Dermal Equivalent Infected by Pseudomonas 
aeruginosa
Courderot-Masuyer C1, Robin S1, Bertrand X2, Tholon N3 and Humbert P4
1Bioexigence, Espace Lafayette, Besançon (France)
2Service d’Hygiène Hospitalière et d’Epidémiologie moléculaire, CHU Besançon (France)
3Laboratoire Paul Hartmann, Arcueil (France)
4Engineering and cutaneous Biology Laboratory, CHU Saint Jacques, Besançon (France)
Fibroblasts and myofi broblasts are the key cells in granulation tissue formation and wound 
contraction. In the present study, fi broblasts were obtained from explants from wound bed and 
normal dermis of a patient with venous leg ulcer (woman 75-year-old). The fi broblasts were 
embedded in a tense collagen lattice allowing myofi broblast differentiation. Absorbent dressing 
(Hydroclean active) and Pseudomonas aeruginosa (106 CFU/ml) were placed on tense collagen 
lattices at the same time. Viability of fi broblasts and actin organisation were evaluated and 
the amount of Pseudomonas aeruginosa was investigated in the culture medium. A signifi cant 
decrease in the quantity of Pseudomonas aeruginosa was noted in presence of the absorbent 
dressing and many fi broblasts were still alive in contact with Pseudomonas aeruginosa and the 
absorbent dressing. Moreover myofi broblast differentiation was not modifi ed when a dressing 
and Pseudomonas aeruginosa were present. Since fi broblasts from leg ulcers are more sensi-
tive to environment stress, the comparative analysis versus normal fi broblasts was of interest. 
Indeed, in the presence of Pseudomonas aeruginosa, the number of fi broblasts from leg ulcers 
still alive was lower than in normal fi broblasts. The use of an absorbent dressing protected 
venous leg fi broblasts against Pseudomonas aeruginosa. This new model of infected dermal 
equivalent enables to know whether the use of a dressing preserve the viability of fi broblasts. 
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Multiplex Assay for the Detection of Antibodies to Human Papillomaviruses 16, 18, 31 and 33
Dang Q1, Ludvíková V2, Tachezy R2, Hamšíková E2 and Arenberger P1
1Department of Dermatology, University of Charles (Czech Republic)
2Institute of Hematology and Blood Transfusion (Czech Republic)
Objective: High risk human papillomaviruses (HR HPV) are etiologically associated with cervi-
cal cancer (CC) and their role in the development of other anogenital cancers as well as in a 
portion of head and neck tumors has also been established. For large seroepidemiological stud-
ies ELISA is the most frequently used technique. The major drawback of this technique is the 
volume of sample required, which is proportional to the number of antigens used. Therefore, 
other methods for the detection of HPV-specifi c antibodies are being developed. In this study 
we show our preliminary data of the comparison of the ELISA and Luminex-based multiplex 
assay.
Materials and Methods: Luminex microspheres were coated with virus-like particles (VLP) 
mimicking HR HPV types 16, 18, 31 and 33, prepared in baculovirus expression system. Sera 
known to be positive in ELISA to VLP16, 18, 31 or 33, as well as sera from healthy individuals 
known to be HPV seronegative to all antigens tested were scanned in multiplex assay to opti-
mize the conditions of the test. Antibodies bound were detected by biotin-labeled anti-human 
Ig and streptavidine-phycoerythrine conjugate using Luminex 100 device. The prevalence of 
antibodies in the group of patients with CC, HSIL, vulvar lesions and in the group of healthy 
controls was determined using multiplex assay and the results were compared with ELISA 
results.
Results: The conditions for multiplex assay were elaborated to possess reproducible results and 
to minimalize the cross-reactions. Results of both methods showed good concordance.
Conclusion: Luminex-based multiplex assay allows simultaneous analysis of large numbers of 
samples in minimal amount of sera. Disadvantage of this method is relatively high cost of the 
supplies needed.
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Characterization of Skin Microbiota in Patients with Atopic Dermatitis and Normal Subjects 
Using 16S rRNA Gene-based Comprehensive Analysis
Dekio I1, Sakamoto M2, Hayashi H2, Tanikawa A1, Sakuraoka K1, Ebihara T1, Amagai M1, 
Suematsu M3 and Benno Y2
1Department of Dermatology, School of Medicine, Keio University (Japan)
2Microbe Division / Japan Collection of Microorganisms, RIKEN BioResource Center (Japan)
3Dept of Biochemistry & Integrative Medical Biology, School of Medicine, Keio Univ (Japan)
Previous study using DNA-profi ling method revealed that the microbiota in the healthy human 
skin include uncultured microorganisms, although those in the skin exposed to disease conditions 
remain to be examined. To compare profi les of skin microbiota in patients with atopic dermatitis 
(AD) and healthy controls, we applied a terminal restriction fragment length polymorphism (T-
RFLP) analysis of bacterial 16S rRNA gene to twenty-three swab-scrubbed samples from facial 
skin of thirteen patients and ten controls. The culture-independent analysis successfully visual-
ized the complex bacterial components of microbiota as peak patterns of capillary electrophore-
sis of terminal restriction fragments (T-RFs). A T-RF peak refl ects each consisting microorganisms 
and the assignment for each peak can be predicted by computer simulation of T-RF length using 
the sequence data of well-known bacteria in the nucleotide database and the others in our previ-
ous study. Among eighteen assigned species, Stenotrophomonas maltophilia and phylotype B 
were detected primarily in AD patients, which were observed in fi ve and three patients, respec-
tively, although their contribution to the skin conditions is unknown. The dendrogram analysis of 
the polymorphism patterns categorized the participants into fi ve clusters A1, A2, B1, B2 and C, 
and key features of clusters B1 and B2 were predicted to be determined by uncultured bacteria. 
Difference was seen in patients with AD and healthy controls; patients belonged to clusters A2, 
B1, B2 and C, while controls belonged to clusters A1 and A2. The microbiota were presumed to 
include uncultured bacteria in major population of patients with AD, and further study should be 
undertaken to investigate the role of the major microorganisms in AD.
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Human Herpesvirus 6 Infection is Responsible for Visceral Manifestations in Drug Reaction 
with Eosinophilia and Systemic Symptoms (DRESS): A Demonstrative Case of Fulminant 
Hepatitis in salazopyrine Induced DRESS
Descamps V1, Musette P2 and Rabnger-Rogez S3
1Dept of Dermatology, Bichat Claude Bernard Hosp, Assis Publique-Hôp de Paris (France)
2Department of Dermatology, Charles Nicolles Hospital, Rouen (France)
3Department of Virology, CHU, Limoges (France)
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug-induced 
reaction. We and others demonstrated frequent reactivation of human herpesviruses (especially 
HHV-6) during this syndrome. The role of viral reactivation in this syndrome is debated. We 
demonstrated in this case the responsibility of HHV-6 infection and immune response against 
HHV-6 in the development of visceral involvement.
A 30-year old young woman had ankylosing spondylytis. She began taking sulfasalazine. She 
stopped the treatment after 3 weeks when the fi rst manifestations of DRESS developed. The patient 
was hospitalised one week later with a typical DRESS (high fever, facial edema, erythroderma, 
diffuse lymphadenopathy, hypereosinophilia, atypical circulating lymphocytes). Liver aminotrans-
ferases rapidly increased from 2 to 185 times normal values. A liver transplantation was done 6 days 
after admission. Liver histology showed massive centrolobular necrosis and dense infl ammatory 
infi ltrates containing lymphocytes and eosinophilis. Virological tests demonstrated by a real time 
PCR procedure HHV-6 viremia (with very high viral load) in a serum sample one day before liver 
transplantation. HHV-6 genome was strongly detected by PCR in liver specimen. Serum samples 
confi rmed that it was a reactivation: anti-HHV-6 IgG antibodies were detected in previous serum 
samples. After an initial favourable outcome a fl are of the DRESS occurred 44 days after transplan-
tation (amine transferases 5 times normal values). At this time anti-HHV-6 IgM antibodies were 
detected in serum samples with an increase in the titres of HHV-6 IgG antibodies. CD8 + T cell 
lymphocyte analysis by immunoscope technique demonstrated at the time of transplantation (1) a 
bias of repertoire, (2) the same population was detected in the blood and in the liver. This case report 
confi rms HHV-6 reactivation in DRESS. It demonstrates that HHV-6 infection is responsible for vis-
ceral manifestation by two ways (1) viral infection, (2) host immune response against viral infection. 
Treatment of DRESS must combine antiviral and immunosuppressive drugs.
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Real-Time Quantitative PCR of Staphylococcus Species and Staphylococcus aureus from Skin 
Microfl ora
Ingrassia I1, Duplan H2, Maitre Boube M1, Charveron M2 and Roques C1
1University of Pharmaceutical Sciences, Laboratory of Industrial Microbiology (France)
2Pierre Fabre Research Institut, Laboratory of Cell Biology (France)
Many of staphylococci that inhabit normal human skin do not cause skin disease. However, Sta-
phylococcus aureus occurs frequently in skin infections as atopic dermatitis. Rapid and accurate 
quantitative detection of staphylococci fl ora and especially S. aureus is important for predicting 
microbial pathology or treatment effi ciency. Staphylococcus genus-specifi c PCR primers were de-
signed, targeting the tuf gene encoding elongation factor Tu. S. aureus primers targeted variable 
region of species-specifi c 442 bp gene fragment previously described in literature, named Sa442. 
These two set of primers were initially tested by a conventional PCR and evaluated for their specifi -
city in preliminary assays on 50 strains isolated from skin microfl ora, identifi ed by phenotypic and 
biochemical analysis. For the 50 strains tested, correlation was obtained between conventional PCR 
detection and phenotypic and biochemical identifi cations. We then adapted assays to real-time 
quantitative PCR for the discriminating detection of Staphylococcus genus and S. aureus. A prereq-
uisite for assessment of this sensitive method from skin microfl ora samples is to isolate and recover 
small amounts of bacterial DNA. Forearm skin fl ora samples from 10 subjects were analyzed by 
culture isolation and identifi cation of Staphylococcus strains and molecular detection by real-time 
quantitative PCR. Optimisation of DNA extraction from skin samples were obtained using bacterial 
mechanical lysis followed by DNA extraction-purifi cation with commercial kit. By culture, only 
3 subjects presented Staphylococcus species in their skin microfl ora, whereas by real-time PCR 7 
subjects were positively detected for Staphylococcus species. This sensitive method could detect 
specifi cally fewer than 100 Staphylococcus or S. aureus, a detection level that could not be reached 
by culture. Such a tool represents a powerful method for routine diagnostic in skin infections, pri-
marily considering the ratio S. aureus/Staphylococci.
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The effect of laurate Butyl Glucoside on Cutaneous Microorganisms In Vitro: Direct or 
Indirect Antimicrobial and Anti-Adhesive Activities
Duplan H, Ceruti I and Charveron M
Pierre Fabre Research Institut, Laboratory of Cell Biology (France)
The skin ecosystem is composed of three closely interacting components : epidermal host cells, 
nutrients and microfl ora. The normal microfl ora usually co-exists peacefully with the host. 
For various reasons, this balance can be disturbed and results in a colonizing microfl ora be-
coming pathogens. Here we studied the direct antimicrobial and anti-adhesive activities of 
Laurate Butyl Glucoside (LBG) on several cutaneous microorganisms and assayed its indirect 
regulation by the induction of innate immunity. Minimal inhibition tests in the presence of 
preparations of LBG were performed on Corynebacterium xerosis, Staphylococcus aureus, Sta-
phylococcus epidermidis, Propionibacterium acnes and Candida albicans. The micro-organism 
survival curves were also investigated. Our results showed a high microbicidal activity of LBG 
especially against C.xerosis and P.acnes at low concentrations (MIC of 40 and 2.5 μg/ml, re-
spectively), confi rmed by a signifi cant growth delay in both cases. Microbicidal activity of LBG 
against S.aureus and S.epidermidis was lower, characterized by higher MICs (6 and 12 mg/ml, 
respectively), and undetectable against C.albicans. In order to evaluate the direct action of LBG 
on microbial adhesion we also carried out adhesion assay on a human keratinocyte cell line 
with radio-labelled C.xerosis and C.albicans. A signifi cant and dose-dependant inhibitory effect 
was especially observed on C.albicans adhesion. Among cutaneous microorganisms studied, 
C.xerosis is one of the bacteria living on the axillary skin, responsible for perspiration break-
down and body odor. By controlling C.xerosis colonization of skin, LBG would represent an ac-
tive principle of choice for deodorant. Furthermore, we investigated in vitro the complementary 
role of sub-microbicidal concentrations of LBG as a regulator of epithelial innate immunity. We 
demonstrated that LBG was able to stimulate endogenous expression of beta-defensins 2 and 
3 at mRNA and protein level in keratinocytes and skin tissue. Together these data showed that 
LBG could interact directly and indirectly on the balance of the cutaneous ecosystem.
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Sequencing and Analysis of a Propionibacterium Acnes Bacteriophage – A Potential Tool for 
Genetic Manipulation of P. acnes and Phage Therapy of Acne Vulgaris
Farrar MD1, Howson KM1, West D2, Bojar RA1 and Holland KT1
1Insitute of Moecluar & Celluar Biology, University of Leeds (United Kingdom)
2Sarum Biosciences Ltd (United Kingdom)
The human skin commensal Propionibacterium acnes is associated with infl ammatory acne 
vulgaris has been implicated in a wide range of opportunistic infections. The study of P. acnes 
at the genetic level has been hindered by the lack of systems for genetic manipulation and 
antibacterial therapy for acne can be complicated by the development of antibiotic resistance. 
A P. acnes bacteriophage, PA6, was isolated from the skin of a volunteer and its genome se-
quenced. The PA6 genome was 29,739 bp in length and was predicted to encode 48 proteins. 
PA6 showed a high degree of similarity to the mycobacteriophages both morphologically and 
genetically. The overall genome organisation of PA6 resembled that of the temperate mycobac-
teriophage Bxb1with structural genes clustered on the left arm and genes involved in replica-
tion of phage DNA on the right arm. PA6 produced clear plaques with turbid centres but lacked 
any obvious genes for lysogeny. Attempts to isolate stable lysogens of PA6 were unsuccessful. 
PA6 was able to infect all (32) of the strains of P. acnes tested, including those with resistance 
to antibiotics commonly used to treat acne. PA6 did not infect other species of propionibacteria 
or other skin commensals. Sequencing of the PA6 genome makes an important contribution 
to the study of phage evolution and represents an initial step in the development of a genetic 
transfer system for P. acnes. The ability to manipulate P. acnes genetically will greatly enhance 
our understanding of this organism and its role in acne.
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A Novel, Noninvasive Diagnostic Probe for Hydroa Vacciniforme and Related Disorders: 
Detection of Latency-Associated EB Virus Transcripts in the Crusts
Iwatsuki K, Yamamoto T, Tsuji K, Suzuki D and Morizane S
Department of Dermatology, Okayama University (Japan)
Skin biopsy is usually required to confi rm the latent EBV infections in cutaneous lesions of 
EBV-associated NK/T-cell lymphoproliferative disorders, including hydroa vacciniforme (HV) 
and hypersensitivity to mosquito bites (HMB). We have devised a novel, noninvasive method 
to detect EBV-encoded small RNA (EBER), BamHI A rightward transcripts (BARTs) in the skin 
crusts and scales of such patients. Six patients with EBV-associated cutaneous lesions were 
enrolled in the present study, including three patients with HV, one with HV-like eruptions and 
chronic active EBV infection, and two with EBV-associated cutaneous lymphoma. RNA was 
extracted from the crusts obtained from the cutaneous lesions by forceps, converted to cDNA, 
and processed for polymerase chain reaction (PCR) amplifi cation with a specifi c set of primers. 
The PCR products were assayed by a DNA sequencer and RFLP. Intact RNAs were successfully 
extracted from the crusts as well as control materials. EBER1 and BARTs RNAs were detected in 
all 7 crusts, and in 6 of 7 crusts of EBV-associated cutaneous diseases, respectively. One of 23 
crusts from non EBV-associated diseases was positive for EBER1 RNA. The sensitivity and spe-
cifi city of our assay for latent EBV infection was 100% and 95.8% for EBER1 RNA, and 85.7% 
and 100% for BARTs mRNA, respectively. The correct DNA sequence for EBER1 and BARTs 
was confi rmed in the PCR products by a direct sequencing method and RFLP. Our procedure 
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The Antimicrobial Protein Psoriasin (S100A7) is Up-regulated in Lesional Skin of Atopic 
Dermatitis Patients
Meyer-Hoffert U1, Harder J1, Lange H2, Blunck A1, Fölster-Holst R1, Schröder JM1, Schwarz T1 
and Gläser R1
1Department of Dermatology, University of Kiel (Germany)
2Department of Immunology, University of Kiel (Germany)
Keratinocyte-derived antimicrobial peptides and proteins (AMP) protect healthy skin from sur-
rounding microorganisms and may contribute to the composition of the normal fl ora. Patients 
suffering from atopic dermatitis (AD) are often affected by lesional bacterial infections pre-
dominantly caused by Staphylococcus aureus but rarely by Escherichia coli. Recently, dimin-
ished expression of the infl ammation-induced AMPs cathelicidin LL-37 and of the human beta 
defensins (hBD)-2 and -3 was found in lesional skin of these patients. Since the preferentially 
E. coli killing S100-protein psoriasin was identifi ed as principle, focally expressed and se-
creted AMP in healthy human skin, we aimed to analyse whether psoriasin-production in both, 
non-lesional and lesional AD skin is similarly altered as observed for LL-37, hBD-2 and -3. 
Therefore we investigated the in vivo expression and secretion of psoriasin in lesional and non-
lesional skin of untreated AD patients and healthy controls. Skin biopsy samples derived from 
AD patients (n=4) were investigated by immunohistochemistry using a monoclonal antibody 
directed against natural skin-derived psoriasin. To determine the active secretion of psoriasin, 
standardised areas of the skin of AD patients (n=10) and controls (n=10) were rinsed and the 
psoriasin concentration in the washing fl uids was measured by ELISA. Psoriasin expression and 
in vivo secretion was found to be up-regulated in the lesional skin of AD patients. Interestingly, 
even in non-lesional skin of AD patients levels of psoriasin were increased compared to healthy 
controls. Our results indicate a different regulation of psoriasin compared to other AMPs like 
LL-37, hBD-2 and -3. This might also explain why patients with AD, in contrast to an increased 
frequency and severity of impetiginization with Staph. aureus, do not suffer from enhanced 
superinfections of the skin caused by E. coli.
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Effects of a Patented Natural Sugar on M.furfur Pathogenicity and HBD2 Expression
Buommino E1, Donnarumma G1, Orlando M1, Auricchio L1, De Filippis A1, Piccardi N2
Msika P3 and Tufano MA1
1Department of Experimental Medicine, Microbiologic section, Université Naples (Italy)
2Department of Biology, Laboratoires Expanscience, Epernon (France)
3R&D Center, Laboratoires Expanscience, Epernon (France)
AV119 is a patented natural sugar, able to induce the HBD-2 production by human keratino-
cytes. We analyzed the effect of AV119 on growth and invasiveness ability of M.furfur and the 
modulation of proinfl ammatory and immunomodulatory cytokines expression in human kerati-
nocytes. For the evaluation on growth and invasiveness ability, keratinocytes were pre-treated 
with 0.1% AV119 for 24 hours and successively incubated with M.furfur (yeast/keratinocytes 
ratio 30:1) for 24 and 48 hours. At the end of each incubation, the plates were washed and 
stained by May-Grumwald Giemsa and observed under a light microscope to assess the yeast 
cells penetration. The total RNA was extracted to analyze the gene production of HBD-2, IL-1α, 
IL-6, IL-8, TGFβ-1. AV119 is able to modulate the HBD-2 response (max after 48 hours).When 
AV119 pre-treated keratinocytes were stimulated by M.furfur, we observed a strong increase of 
proinfl ammatories cytokines gene expression and a decrease of TGFβ-1. In contrast, when the 
keratinocytes were treated only with the yeast, IL-1α was down-regulated, whereas TGFβ-1 was 
up-regulated. Further, AV119 did not modify the gene expression of the analyzed cytokines, 
versus control. Microbiologic assay demonstrated that AV119 induced aggregation of the yeast 
cells and inhibits the invasiveness and the pathogenicity of M. furfur, without infl uencing the 
growth. In addition, it has been demonstrated that the culture medium derived from AV119 
treated keratinocytes is able to inhibits the yeast growth. Such effect could be related to the 
release in the culture medium of HBD-2 induced by AV119.
Thanks to its potential to induce the recovery of a normal proinfl ammatory response to yeast in 
human keratinocyte and its ability to aggregate and inhibit the penetration of M.furfur, AV119 
could be an innovative pathway in the future management of skin disease complicated by re-
current infections of skin lesions by fungal pathogens with an original mechanism of action .
646
Schistosome Cercarial Interactions with Human Keratinocytes and Langerhans Cells
Nanayakkara GR1, Bartlett A1, Whitfi eld PJ1, Brown MB2 and Groves R3
1Department of Biochemistry, King’s College London (United Kingdom)
2Department of Pharmacy, King’s College London (United Kingdom)
3St. John’s Institute of Dermatology, King’s College London (United Kingdom)
The human parasite, Schistosoma mansoni is known to modulate host immune responses in 
order to promote its own survival. However, studies investigating the interaction between the 
skin-invading cercarial stage and cells of the epidermis and immune system are limited and 
largely based on animal models. Here, cultured human skin cells and human skin explants 
were used to gain further insight into the immunobiology of cercarial/skin interactions. . 
HaCaT keratinocytes (n = 3) were exposed to S. mansoni cercarial lysate for 4 and 24 hours. 
Supernatants were analysed by ELISA for the presence of infl ammatory/immunomodulatory 
mediators. After 4 hours, signifi cant (P < 0.05) increases were observed in the levels of inter-
leukin (IL)-1α (12.17 ± 0.85 pg/ml; mean ± s.d.), IL-10 (23.38 ± 2.17 pg/ml) and IL-1 receptor 
antagonist (IL-1ra) (271.27 ± 20.38 pg/ml). At 24 hours, only IL-1α (17.51 ± 1.12 pg/ml) and 
IL-10 (22.44 ± 2.15 pg/ml) concentrations remained signifi cantly above those of controls (P < 
0.05). Levels of IL-1β were consistently below the level of detection. Epidermal Langerhans 
cell (LC) migration in response to cercarial penetration was assessed using a Franz cell system. 
Epidermal sheets (n = 11) prepared from full thickness skin exposed to cercariae for 2 hours 
showed a small reduction in the number of remaining LC (625 ± 58 LC/mm2; mean ± s.d.; 
control skin 693 ± 58 LC/mm2, P < 0.05). This number, however, was signifi cantly (P < 0.05) 
greater than in skin treated for 2 hours with 1% oxazolone (545 ± 78 LC/mm2), a potent contact 
sensitizer. 
These data suggest a complex cutaneous immunological response to cercariae, which may 
have the ability to down-regulate local immune responses by inducing anti-infl ammatory cy-
tokines (IL-1ra and IL-10) and interfere with cercarial antigen presentation by migrating LC. 
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Ultraviolet-B Radiation Induces the Expression of Antimicrobial Peptides in Human 
Keratinocytes
Holtmeier C, Gläser R, Schwarz A and Schwarz T
Department of Dermatology, University Kiel (Germany)
Ultraviolet-B radiation (UVB) suppresses the immune system. This effect certainly plays an 
important role in photocarcinogenesis. Exacerbation of skin infections is suggested as a further 
biological consequence of UV-induced immunosuppression. However, this may only apply to 
certain viral infections like herpes simplex but not to bacterial infections also due to the fact 
hat impetiginized dermatoses can improve upon UVB-exposure without antibiotic or antisep-
tic treatment. There is evidence that for the bacterial defense the innate immune response is 
much more relevant than the adaptive immune response. Keratinocytes exhibit the capacity to 
release various antimicrobial peptides (AMP), including human beta defensins (HBD), RNase 7 
and psoriasin. Therefore, we asked whether UVB induces the release of AMP. Normal human 
keratinocytes and HaCaT cells were exposed to various UVB doses. FACS analysis and RT-PCR 
revealed a dose-dependent increase of HBD-2, -3, RNase7 and psoriasin. Doses exceeding 
150 J/m² caused a decrease which was associated with the initiation of apoptotic cell death as 
shown by annexin-V staining. Patients suffering from atopic dermatitis show decreased levels 
of AMP which may be due to an over-expression of interleukin-10 (IL-10). Accordingly, incuba-
tion of cells with IL-10 caused a decrease of the constitutive expression of AMP. UVB was able 
to revert the inhibitory effect of IL-10 on the expression of AMP. The in vivo relevance of these 
fi ndings was supported by preliminary in vivo experiments, demonstrating induced secretion 
of AMP after repeated UVB irradiation as determined by ELISA from skin derived rinsing fl uids 
Together, these data demonstrate that UVB is able to induce the expression of AMP, thereby ex-
plaining the rare frequency of bacterial superinfections upon UVB exposure. This also indicates 
that UVB exerts diverse effects on the immune system, suppressing the adaptive but inducing 
the innate immune response. 
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Evaluation of Wound Healing Activity of Topical Versus Systemic Therapy with Teicoplanin in 
Experimental Model
Simonetti O1, Goteri G2, Cirioni O3, Giacometti A3, Orlando F4 and Offi dani A1
1Department of Dermatology, Università Politecnica delle Marche, Ancona (Italy)
2Institute of Pathology, Università Politecnica delle Marche, Ancona (Italy)
3Inst of Infect Diseases & Public Health, Università Politecnica delle Marche, Ancona (Italy)
4Experimental Animal Models for Aging Units, Research Dept, INRCA IRRCS, Ancona (Italy)
We used a rat model to compare the effects of drug-free and teicoplanin-soaked hydrocellular 
foam (Allevyn) with respect to parenteral teicoplanin in surgical wound infection caused by 
methicillin-resistant Staphylococcus aureus. 
A full thickness wound was established through the panniculus carnosus on the back subcu-
taneous tissue of adult male Wistar rats. A small gauze was placed over each wound and then 
inoculated with 5×107 colony-forming units of S. aureus. The study included a control group 
that did not receive any treatment and fi ve contaminated groups treated, respectively, with: a) 
drug-free Allevyn, b) teicoplanin-soaked Allevyn, c) daily intraperitoneal teicoplanin (7 mg/Kg), 
d) drug-free Allevyn and daily intraperitoneal teicoplanin (7 mg/Kg) and, fi nally, e) teicoplanin-
soaked Allevyn and daily intraperitoneal teicoplanin (7 mg/Kg). 
Main outcome measures were: quantitative bacterial culture, assessment of vascular endothe-
lial growth factor (VEGF) plasma levels, histological examination with assessment of micro 
vessel density and of VEGF expression in tissue sections. 
Data analysis showed that strong inhibition of bacterial growth was achieved in any group 
treated with intraperitoneal teicoplanin. However, the highest inhibition of bacterial growth 
was obtained in the group that received teicoplanin-soaked Allevyn and intraperitoneal te-
icoplanin.
Histological examination revealed that each treatment modality was able to reduce the delay in 
wound repair. The most effective treatment appeared to be the local application of teicoplanin-
soaked hydro gel foam. The tissue effects were associated with an increase in neovasculariza-
tion and VEGF expression by endothelial cells and fi broblasts in the granulation tissue. Bacte-
rial colonies were also reduced, especially when teicoplanin was given parenterally.
In conclusion our in vivo study demonstrated that the use of antibiotic-soaked allevyn with an 
antistaphylococcal agents such as teicoplanin may be useful in the management of infected 
wound through a signifi cant bacterial growth inhibition and in its accelerated repair process. 
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Observation of Viral-like Particles in Patients with Eruptive Pseudoangiomatosis
Tran A1, Misery L2, Le Grand MC1, Baron R3, Le Ru Y2, Karam A2, Le Goupil D2, Sassolas B2, 
Gobin E4 and Payan C1
1Departement de Microbiologie, CHU Brest (France)
2Service de Dermatologie, CHU Brest (France)
3Service d’hygiene hospitaliere et sante publique, CHU Brest (France)
4Laboratoire d’Anatomo-pathologie, CHU Brest (France)
Eruptive pseudoangiomatosis (EPA) is a benign and spontaneously regressive dermatosis occur-
ring generally in children. Recently, some sporadic cases have also been reported in adults.
In December 2003, we noted an outbreak of eruptive pseudoangiomatosis in an old people’s 
home. Clinical examination revealed angioma-like macules and papules, surrounded by a 
white halo. The lesions were mainly localized on the trunk and the abdomen. No prodromal 
phase was noted. Histological examination showed dilated small blood vessels with plump 
endothelial cells in the superfi cial dermis.
Considering the epidemic trend of the disease, a viral etiology was suspected. Throat, stool 
and urine samples were collected from 35 patients. Molecular detection of Enteroviruses was 
negative. Cell cultures using Vero cells, MRC-5 and Buffalo Green Monkey Kidney (BGMK) 
cells did not allow any viral proliferation. Nevertheless, a cytopathic effect was observed on 
Rhabdomyosarcoma (RD) cells and Human Rectal Tumor (HRT) cells. 
Transmission electron microscopy was performed to observe the morphological changes of 
the infected and uninfected cells. Viral-like particles of approximately 45 nm diameter were 
detected.
Hence, EPA could be linked to a viral infection. Particles’ identifi cation and studies on skin 
lesions are in progress. 
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Antibacterial Action of an Apple Extract
Wille J and Toronyi R
Cell Biology, Bioderm Technologies, Inc. (USA)
Recent interest has shifted to the use of safer and natural botanical ingredients to preserve 
personal care products and or to kill pathogenic bacteria in dermatological preparations. For 
this purpose, a gram-negative bacterial culture of Pseudomonas aeruginosa and a non-patho-
genic gram-positive bacterial culture of Staphylococcus epidermis were employed to test the 
bactericidal activity of a apple extract powder enriched in proanthocyanidins and catechins 
(ApplephenonSH, Ashi Breweries, Tokyo, JP). Stock solutions of the powder prepared either in 
sterile distilled water or ethanol (50% v/v) were diluted further to assess the minimal bacteri-
cidal concentration (MBC). 
Stock solutions directly diluted in to a bacterial culture medium (Beef Heart Infusion, BHI) at 
a fi nal concentration of 0.25% were sterile even though they were not prefi ltered for sterility, 
a property labeled self-sterility.. Sterile saline prepared in spring water were used to assess the 
MBC by serial dilution from the stock solutions. The bacterial stocks in BHI were diluted in BHI 
to realize a fi nal count of 105 cells in the challenge assays. The MBC against S. epidermis was 
determined to be below 0.05% and for P. aeruginosa it was below 0.125%. The absence of any 
bacterial growth in the post-challenge test assures that the extract has killed 100% of the added 
S. epidermis and P. aeruginosa in the challenge assay. These results indicate that polyphenolic-
enriched apple extract contains an active antibacterial agent(s). Determination of the specifi c 
polyphenolic compound(s) responsible is under current investigation
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A delta Opioid Receptor Agonist Downregulates CXCR4 Responses and Reduces Pulmonary 
Metastasis Induced by B16 Melanoma Cells
Ludwig R1, Muniz-Pello O2, Gomez L2, Boenhcke WH1, Gille J1, Martinez C2 and Duthey B1
1Department of Dermatology, Frankfurt Medical University (Germany)
2CSIC (Spain)
The chemokine receptor CXCR4 has recently been shown to play a key role in metastasis for-
mation by promoting the migration and adhesion of tumor cells from a primary tumor to other 
organs where its ligand, eg CXCL12, is overexpressed such as lymph nodes, lungs and liver. In 
this work we show that a selective delta opioid receptor agonist, [D-Pen2, D-Pen5] enkephalin 
(DPDPE), known for its analgesic properties, downregulates CXCR4 responses in the murine 
B16 melanoma cells. DPDPE suppressed coupling of CXCR4 to Gαi without affecting internali-
zation of the receptor. As a consequence of this, adhesion and migration of B16 cells towards 
CXCL12 gradients were markedly reduced in a dose dependant manner. This effect was also 
observed in vivo, as shown with the intravital microscopy. In this assay, DPDPE pretreatment 
of cells signifi cantly reduced the rolling of cells to the vascular endothelium of mice enriched 
with CXCL12. Rolling and adhesion are known to be previous steps to metastasis establish-
ment, therefore we investigated if DPDPE could have an impact in metastasis formation. In 
agreement with our hypothesis, DPDPE treatment of mice signifi cantly reduced pulmonary 
metastasis induced by the syngenic B16 melanoma cells in both C57BL/6 and immunocompro-
mised beige SCID mice. Our data brings evidence of the importance of the cross talks between 
opioid and chemokine receptors in vivo but also opens new perspectives in cancer therapy. 
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Retinoic Acid Increases Aquaporin 3 (AQP3) Expression in Skin
Bellemere G1, Oddos T1 and Von stetten O2
1Department of Pharmacology. J&J R&D EAME (France)
2J&J Consumer R&D EAME (Germany)
Topical application of retinoids on skin is known to induce dryness. In order to ascertain 
whether AQP3, a membrane protein involved in water transport, may mediate retinoid-in-
duced skin dryness, we have investigated the effects of retinoic acid (RA) on AQP3 expression 
and function in cultured normal human epidermal keratinocytes (NHEK) and skin explants. 
Treatment of NHEK with RA for 3 h and 24 h markedly increased the concentration of AQP3 
transcripts and protein as assessed by real time PCR and western blotting procedures. Using 
selective agonists of retinoic acid receptor (RAR) subtypes expressed in the skin we have dem-
onstrated that RARγ is predominantly mediating RA effect. RA stimulated also glycerol infl ux in 
NHEK, suggesting that the increase in AQP3 gene and protein expression is accompanied by 
an enhancement of its biological activity. When RA was topically applied onto skin explants 
for 24 h a strong increase in the concentration of AQP3 transcripts was noted in the epidermis. 
Concurrently, an accumulation of AQP3 was visualized by immunohistochemistry mainly in 
the epidermal basal layers. Taken together the present results show that RA increased AQP3 
expression and enhanced its biological activity. Skin dryness induced by topical retinoids may 
be due to a disorganisation of stratum corneum structure together with an increase in water 
transport through the epidermis following AQP3 stimulation. 
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Drug-induced Angioedema: Co-factors and Course
Bork K and Theiss K
Department of Dermatology, University of Mainz (Germany)
Drugs belong to the most common precipitating factors in recurrent angioedema including 
angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARB), and 
estrogens (oral anticonceptives, estrogen replacement therapy). ACE inhibitors have long been 
recognized to cause angioedema. It can start years after beginning the treatment and may recur 
inconstantly while the drug is continued. We retrospectively analysed a series of 66 patients 
with angioedema due to ACE inhibitors. The angioedema attacks occurred in the mean after 
17 months (range 0-240 months) after onset of ACE inhibitor medication. Most commonly, the 
face was involved (49 patients) followed by the tongue (37 patients), extremities (16 patients), 
uvula (13 patients), and bowel (7 patients). Laryngeal edema with dyspnea and fear of asphyxi-
ation occurred in 29 patients. The time interval between onset of angioedema and diagnosis 
was 11 months in the mean (range 0-168 months). Seven patients with hereditary angioedema 
due to C1 inhibitor defi ciency and six patients with hereditary angioedema with normal C1 
inhibitor (HAE type III) experienced an exacerbation of their disease following the intake of 
ACE inhibitors or ARB. All patients with hereditary and acquired forms of angioedema should 
be questioned for the intake of ACE inhibitors since cases of asphyxiation due to ACE inhibitors 
have been reported.
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Anti-Psoriasis Action of Basic Esters of Fatty Alcohols in Human Skin Graft SCID Mouse 
System
Gilhar A1, Kam Y1, Kaufman G1, Assy B1, Landau M1, Kalish RS2 and Cohen IR3
1Skin Research Laboratory, Fleiman Medical Center, Haifa (Israel)
2Dept of Dermatology, SUNY at Stony Brook, New York (USA)
3Department of Immunology, Weizmann Institute of Science (Israel)
Basic esters of long chain fatty alcohols were found to be active in a DTH model. Two such 
agents, piperazin-1-yl-acetic acid octadec-(Z)-9-enyl ester bitartrate (TV-3809, Teva) and ami-
nophenylacetic acid octadec-(Z)-9-enyl ester HCL (TV-3813, Teva) were tested for their ability 
to treat psoriasis in the human skin graft / SCID mouse transfer system. Skin grafts obtained 
from normal skin (non-psoriasis) were grafted onto beige-SCID mice. 4 mice were grafted from 
each donor to generate 4 groups (N=6 mice per group). IL-2 activated NK-cells from psoriasis 
donors were injected into the grafts 4 weeks later. Two wks later the grafts were treated daily 
for 14 days by topical application of test compounds to the grafts in 40μl of PBS. Test com-
pounds were coded and the investigators were blinded. Group 1: non-treated control, Group 
2: Dexamethasone (50mg/ml), as positive control, Group 3: Test compound 0.5mg, Group 4: 
Test compound 4mg. After 14 days of topical treatment grafts were harvested and analyzed by 
histology and immunohistochemistry. TV-3813 had the greatest activity with signifi cant reduc-
tions in epidermal thickness (771 vs. 1204) and proliferation index (8.8 vs. 24.9) at 0.5mg per 
application (p<0.05). Application of 4mg of TV-3813 demonstrated a dose response with fur-
ther reduction of thickness (527), and proliferation index (7.8) (p<0.01 vs. untreated). TV-3809 
demonstrated reduced potency with signifi cant reductions in thickness and proliferation index 
only at the 4mg dose (p<0.05). Histology demonstrated resolution of psoriasiform features 
which was often complete at the higher doses. Thus, basic esters of long chain fatty alcohols 
represent a promising new class of immune-modulating drug with activity against psoriasis in 
the human / SCID model. 
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A New Method for Assessing Drug Causality in SJS or TEN
Haddad C1, Sassolas B1, Hellner A2, Bouwes-Bavinck JN3, Halevy S4, Naldi L5, Sidoroff A6, 
Mockenhaupt M7, Roujeau JC1 and Le Louet H1
1Université Paris XII, Créteil (France) 2IMBI Freiburg University (Germany) 3Dept of Dermatol-
ogy, Leiden University (Netherlands) 4Ben Gurion University, Beer Sheva (Israel) 5University of 
Milano (Italy) 6Insbruck University (Austria) 7dZh, Freiburg University (Germany)
Whatever the adverse drug reaction, the same method for causality assessment is currently 
used in most countries. The aim of this study was to compare a new algorithm designed spe-
cifi cally for Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), with the 
widely use but non-specifi c French one. Both algorithms use the same items, but the new one 
defi nes more precisely cut off values, based on prior experience with the diseases and data on 
elimination half-life. We evaluated retrospectively with both algorithms all 526 drugs taken by 
100 cases included in a case control study of SJS and TEN and compared these results to those 
of the case control analysis. With the specifi c method, a single drug was suspected as the cause 
in 79 % of cases, versus 43% with the non specifi c method. No drug has been determined as 
“suspected” for 21% of patients, with specifi c method, while 57% were considered “doubt-
ful” with the other method. Discrepancies between the results of these two algorithms were 
statistically signifi cant (p<0.0001). The ranking of most frequently suspected drugs was similar 
with the two methods and in good adequation with the results of case-control analysis. Among 
the 36 drugs suspected with the new algorithm, 25 had been signifi cantly associated with 
the disease in case-control analysis. We also evaluated 29 exposures to 3 drugs of common 
use that were not associated in case-control analysis. The new algorithm considered causality 
“unlikely” 5 times and “excluded” 24 times, when the traditional method evaluated them as 
“doubtful”. Indeed, compared to the case-control analysis, the new algorithm appeared to 
be more discriminant than the French method, permitting to make the difference between a 
suspected drug and an excluded one. 
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Therapeutic Effects of Cutaneous Wound Healing by Ozonated Olive Oil 
Kwon HJ, Kim HS, Noh SU, Lee YJ, Kang YS, Kim MY, Kim HO and Park YM
Department of Dermatology, College of Medicine, The Catholic University of Korea (Korea)
A long duration of exposure to ozone(O3) has defi nitive deleterious effects, but transitory 
exposure at low and precisely controlled O3 concentrations can have useful effects, which 
was demonstrated through the acceleration of cutaneous wound healing by ozone in young 
mice. This study was undertaken to evaluate the in vivo effect of topical ozonated olive oil on 
wound healing in guinea pigs and to elucidate its mechanism. After creating a full-thickness 
skin wound on a guinea pig by using a 6 mm skin punch biopsy, we examined the wound heal-
ing effect of daily topically applied ozonated olive oil (OZOO, Aurora Inc.) compared to the 
control groups(pure olive oil treatment, non-treatment) and observed the difference between 
the ozonated olive oil group and the controls by routine hematoxylin-eosin stains and immu-
nohistochemical stains for fi broblast growth factor, transforming growth factor-β, vascular en-
dothelial growth factors (VEGF), and platelet derived growth factors closely associated with the 
mechanism of wound healing. Wound size and residual wound area (present wound size/initial 
wound size) was measured 3, 5, 7, and 11 days after injury using photographic image analysis. 
The experimental group, with wounds treated with ozonated olive oil, recovered faster than 
the control groups and was observed to have a smaller wound area at 3, 5, 7, 11 days after 
wounding. Moreover, the residual wound area treated with ozonated olive oil was decreased 
signifi cantly in size at 5 and 7 days after wounding (P<0.05). Immunohistochemical stain also 
demonstrated the upregulation of VEGF expression at the edge of the wounded area treated 
with ozonated olive oil at 7 days as compared with the controls. In conclusion, application 
of low and precisely controlled topical form O3 as an oxidant, ozonated olive oil accelerated 
cutaneous wound repair in a guinea pig.
657
A Novel Metallothionein Inducer, Zinc (II) Glycine Complex: Its Effect on Reduction of 
Intracellular Oxidative Stress in Keratinocytes
Masaki H1, Ochiai Y1, Obayashi K1, Okano Y1 and Sakurai H2
1Cosmos Technical Center Co., Ltd. (Japan)
2Dept of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University (Japan)
Background: The harmful effects of UVB are mediated in part by reactive oxygen species (ROS). 
At present, the contribution of ROS to aging, in particular skin aging, has been established as 
one important theory. In this study, we focused on the antioxidant function of metallothionein 
(MT) to remove ROS. The purpose of the study was to establish an effective inducer of MT to 
remove oxidative stress. We evaluated zinc (II) amino acid complexes as candidates of a MT 
inducer. 
Methods: MT inductions and incorporation of zinc(II) in HaCaT cells which were treated with 
zinc (II) amino acid complexes, were measured with RT-PCR and ELISA, comparing to ZnCl2. 
Responses of zinc (II) amino acid complexes-treated cells against oxidative stress involving 
UVB, and ROS (H2O2, t-butyl hydroperoxide) were examined at following points; DNA dam-
age, viability and intracellular peroxidation.
Results: A zinc (II) glycine complex, Zn(Gly)2, showed a superior capability for MT induction, 
and also gave well-incorporation of zinc(II) compared with ZnCl2. Regarding reduction of 
oxidative stress, Zn(Gly)2 exhibited following results; Suppression of both DNA damage and 
intracellular peroxides elevated by UVB exposure, and also increases of tolerance against cell 
death by exposure to UVB or ROS such as H2O2 and t-butyl hydroperoxide. 
Conclusions: In this study, we fi gured out a new MT-inducer, Zn(Gly)2 which effectively in-
creased tolerance against various oxidative stress. The effects are probably realized by increase 
of intracellular redox potential by MT.
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Thioguanine Nucleotide Levels Correlate with Clinical Response in Atopic Eczema Patients 
Treated with Azathioprine
Reynolds NJ1, Anderson H2, Taylor G2, Hall AG2 and Hogarth LA2
1Dermatological Sciences, University of Newcastle upon Tyne (United Kingdom)
2Northern Institute for Cancer Research, Univ of Newcastle upon Tyne (United Kingdom)
We have previously demonstrated in a randomised, controlled trial the effi cacy of azathioprine 
for moderate-to-severe atopic eczema, but ~1/3 to 1/2 of patients fail to respond. Thioguanine 
nucleotides (TGNs) are active metabolites of azathioprine and in other infl ammatory diseases 
(e.g. Crohn’s disease) erythrocyte TGN levels correlate with clinical response. Therefore, we 
investigated whether erythrocyte TGNs are related to azathioprine effi cacy in atopic eczema, 
and aimed to establish a therapeutic range. 
We fi rst developed a liquid chromatography mass spectrometry method to quantify total eryth-
rocyte TGN levels. These were then measured monthly in 38 patients with moderate-to-severe 
atopic eczema treated with azathioprine for 12 weeks. Patients were dosed with azathioprine 
according to the activity of the enzyme thiopurine methyltransferase, in order to minimise the 
potential for myelotoxicity. Changes in disease activity were assessed using serial SASSAD 
score measurements.
A signifi cant correlation was found between improvement in disease activity and mean patient 
(4, 8 & 12 week) erythrocyte TGN levels (r=0.44, p=0.006). Clinically important response was 
pre-specifi ed as a 30% (10 unit) change in disease activity from baseline, and on this basis pa-
tients were partitioned into: responders (n=23) and non-responders (n=15). We demonstrated 
a clear threshold erythrocyte TGN level above which response was seen in all but one patient, 
and defi ned the therapeutic range for TGNs in atopic eczema as 175 to 450 pmol/8x108 eryth-
rocytes. Interestingly, 3 responders had low TGN levels, suggesting that in a few patients other 
azathioprine metabolites may be therapeutically important.
In conclusion, failure to reach threshold TGN levels accounts for poor azathioprine effi cacy 
in approximately 40% of patients, and the establishment of a therapeutic range now raises the 
possibility that serial TGN measurement could be used for therapeutic drug monitoring in a 
clinical setting.
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A New Lipophilic Pro-vitamin C, Tetra-Isopalmitoyl Ascorbic Acid (VC-IP), Prevents UV-
Induced Skin Pigmentation through its Anti-Oxidative Properties
Okano Y, Ochiai Y, Obayashi K, Kaburagi S, Ujiie N, Hashimoto S and Masaki H
Cosmos Technical Center Co., Ltd (Japan)
Vitamin C, which is a strong anti-oxidant, plays an important role in maintaining physiological 
states. In dermatology, vitamin C (VC) is used for treatment of various skin problems such as 
acne vulgaris and for de-pigmentation of hyper-pigmented spots. However, it is well known 
that VC has limited stability and permeability, and development of a VC derivative with im-
proved properties is needed. Some VC derivatives such as phosphoryl ascorbate salt (VC-PMg, 
VC-PNa) and VC 2-glucoside had been synthesized, however they are insuffi cient to realize 
effi cient skin penetration because of hydrophilicity. Then, we synthesized a lipophilic VC de-
rivative, tetra-isopalmitoyl ascorbic acid (VC-IP) to minimize the disadvantages of VC and its 
derivatives.
In this study, we elucidated the effect of VC-IP on UV-induced skin pigmentation and its mecha-
nisms focusing on its potential of pro-VC.
As the fi rst step, we confi rmed whether VC-IP worked as pro-VC by measuring a release of 
VC. The release of VC from VC-IP was examined using a reconstructed skin model following 
topical application of VC-IP for 48 h. VC-IP released VC in physiological conditions. Further, 
we confi rmed that VC-IP acted as anti-oxidant after converting to VC. We found that VC-IP 
suppressed the elevation of intracellular peroxide after UVB irradiation, and enhanced cellular 
tolerance against UVB and ROS such as H2O2 and t-BHP. Furthermore, VC-IP reduced the 
production of IL-1α and PGE2 in UVB-irradiated keratinocytes and suppressed melanocyte 
proliferation in conditioned culture medium prepared from UVB-irradiated keratinocytes. Fi-
nally, in a clinical study, topical application of a 3 % VC-IP formulated cream for three weeks 
showed the suppression of UVB-induced pigmentation. These results demonstrate that VC-IP is 
a precursor of VC, and effectively suppresses UVB-induced skin pigmentation, possibly through 
its anti-oxidative activity.
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Effects of a Potent MEK Inhibitor in Two In Vivo Contact Hypersensitivity Models
Pheneger J1, Wallace E1, Yang HW1, Seo J1, Lyssikatos J1, Koch K1, Bendele A2 and Lee P1
1Array BioPharma (USA)
2Bolder BioPath (USA)
The mitogen-activated protein kinase (MEK) pathway is activated in infl ammation. Present stud-
ies evaluate the activity of a topically-applied, selective MEK inhibitor, ARRY-358, in two in 
vivo contact delayed-type hypersensitivity (DTH) models. Methods: Rat oxazolone-induced 
DTH: Seven days post-sensitization, treatment (0.1, 0.5 or 1% ARRY-358) was applied topically 
to both ears 30’ before and 3h post-oxazolone challenge (repeated on day 8). Ear cores were 
taken (both ears) on day 9 and weighed. Swine DNFB-induced DTH: Swine were sensitized 
topically with DNFB on four different sites on day 0. Animals were sensitized again on day 
7 on two sites. Challenge reactions were elicited on day 12 (0.6% DNFB solution) on a grid 
(3 x 8) on the back of the animals. ARRY-358 was applied topically (0.5, 1 or 2%) 2-hr pre-
challenge and post-challenge on days 12 and 13. On Days 13 and 14, challenge sites were 
scored for: erythema intensity/ extent, induration, lesion area . On day 14 , skin was collected 
and processed for histopathology. Results: Rat DTH: ARRY-358 showed dose-related inhibition 
of ear core weights (ED50 = 0.23%). Inhibition ARRY-358 (1% dose) was similar to positive 
control Elidel® (76 vs 82%). Swine DTH: ARRY-358 produced 36-50% inhibition of erythema 
intensity/extent and ~80% inhibition of induration. Microscopic scoring showed inhibition of 
epidermal (61-93%) and dermal (27-48%) infl ammation. The 1% dose was slightly better than 
the 2% dose in microscopic histopathology in swine. DTH inhibition with ARRY-358 was: simi-
lar to Elidel® and FK506(0.5%) on in-life scores (all doses);superior to Elidel® and equivalent 
to FK506 on microscopic scores. Conclusions: We have shown that topical administration of a 
potent, selective MEK inhibitor (ARRY-358) inhibits the DTH response in both rats and swine; 
confi rming the therapeutic potential for treatment of dermal infl ammatory conditions.
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The Efalizumab Binding Site in Psoriatic Skin Tissue as Analysed by a Novel Biological Drug 
Binding Biochip Assay using the MELK Robot Technology
Pommer AJ1, Böckelmann R2, Malykh Y3, Philipsen L3, Gollnick H2 and Bonnekoh B2
1SkinSysTec GmbH, Magdeburg (Germany)
2Clinics for Dermatology & Venereology, Otto-von-Guericke-Univ Magdeburg (Germany)
3MelTec GmbH & Co. KG (Germany)
MELK (multi epitope ligand kartography) robot technology allows to analyze in situ the sub-cel-
lular point-precise co-location of large numbers of epitopes giving insight into topo-proteom-
ics. Thereby, a given skin tissue section is processed through successive cycles of 1) labelling 
with FITC- or phycoerythrin-tagged antibodies, 2) fl uorescence imaging and 3) soft bleaching. 
Post-processing and pixel-precise overlay of images provides multi-dimensional combinatorial 
co-location data.
As a contribution to clarify the mode of action of efalizumab as an anti-psoriatic biological 
drug, the compound was labelled with FITC and integrated into a MELK library of more than 40 
antibodies primarily selected for detection of various infl ammatory cell types.
Efalizumab bound to CD11a in affected psoriatic skin by a factor 15x and 32x higher than in 
unaffected psoriatic skin and normal control skin, respectively (n=6 individuals, each). CD11a 
and the efalizumab binding site were primarily expressed in the extravascular dermis, whereas 
CD54 (ICAM-1) as its ligand was most prevalent in the dermal vessels. T-lymphocytes (as iden-
tifi ed by CD3, CD8, CD4, and CD45R0) were the major cellular targets of efalizumab. In 
contrast, NK cells were only a minor target of efalizumab.
Our study indicates that efalizumab represents a treatment for psoriasis that is primarily di-
rected to memory CD4+ and CD8+ T-cells and has a high specifi city for psoriatic disease activ-
ity. Moreover, we hereby introduce the novel principle of a biological drug binding biochip 
assay. It may be especially useful for this new class of medication with regard to i) preclinical 
ex vivo predictive testing and ii) clinical treatment-related monitoring of skin lesions, thereby 
contributing to an increase of drug safety.
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Topical 4-oxoretinal and 4-oxoretinol Exert Biological Activities in Mouse Skin, although they 
are not Converted to Retinoic Acid
Sorg O1, Tran C1, Carraux P1, Bordat P2, Derguini F3 and Saurat JH1
1Geneva University Hospital (Switzerland)
2Research Centre Pierre Fabre Dermo-Cosmétique, Castanet-Tolosan (France)
3Research Institut Pierre Fabre, Ramonville (France)
According to the classical biochemical pathway of vitamin A (retinol), retinoic acid mediates 
the biological action of vitamin A. Retinoic acid is a therapeutical agent prescribed in various 
cancers and dermatological diseases; it is oxidised by the monooxygenase CYP26 to 4-ox-
oretinoic acid, usually considered as an inactive catabolite of retinoic acid. This gave rise to the 
RAMBA concept (i.e. Retinoic Acid Metabolism Blocking Agents), according to which CYP26 
inhibitors would sustain the biological action of retinoic acid. On the other hand, some studies 
reported the presence of 4-oxoretinal or 4-oxoretinol as the predominant retinoids during mor-
phogenesis. We thus wondered whether 4-oxoretinal and 4-oxoretinol might exert a biological 
action in mouse skin by themselves, i.e., independently of their bioconversion to retinoic acid. 
In the model of mouse tail aimed at assessing retinoid-like activity, topical 4-oxoretinal, and to 
a lesser extent 4-oxoretinol, promoted a strong retinoid-like response, as assessed by epidermal 
hyperplasia and metaplasia. 4-Oxoretinal induced a lower epidermal infl ammatory response, 
compared to retinal, as measured by myeloperoxidasse activity, whereas neither 4-oxoretinal 
nor 4-oxoretinol prevented menadione-induced epidermal lipid peroxidation, unlike to retinal 
and retinol. Following topical application, both 4-oxoretinoids loaded the epidermis with siz-
able amounts of 4-oxoretinol, 4-oxoretinal and 4-oxoretinoic acid, whereas no retinoic acid 
was found. Interestingly, unlike to topical retinal and retinol, which load the epidermis with 
high amounts of retinyl esters, no 4-oxoretinyl esters were found following topical 4-oxoretin-
oids. We conclude that 4-oxoretinal, and to a lesser extend 4-oxoretinol, exert a moderate 
direct retinoid-like activity in mouse skin following topical application, thus confi rming previ-
ous in vitro studies showing 4-oxometabolites of vitamin A as bioactive agents rather than 
inactive catabolites.
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IP10/CXCL10 Expression Links Type I IFN Signaling and Recruitment of CXCR3+ Cytotoxic 
Lymphocytes in Imiquimod Treated Skin Tumors
Gaffal E, Wiechert A, Bieber T, Tüting T and Wenzel J
Department of Dermatology, University of Bonn (Germany)
Background: The TLR7 agonist imiquimod is effective in the topical treatment of superfi cial 
skin tumors such as actinic keratosis, basal cell carcinoma and skin metastasis of malignant 
melanoma. Imiquimod induces the production of several pro-infl ammatory cytokines, includ-
ing IFN-alpha and stimulates an antitumor immune response. Tumor specifi c cytotoxic T lym-
phocytes (CTL) are supposed to play an important role in the imiquimod induced antitumor 
effect, but the mechanisms involved in the recruitment of these cells are not clear. Based on 
earlier observations in regressive melanoma, we hypothesized that the interaction between the 
chemokine IP10/CXCL10 and the corresponding receptor CXCR3, expressed on CTL, might 
play a role in Imiquimod induced lymphocyte recruitment. 
Patients and methods: 27 skin biopsies of patients suffering from different malignant skin tu-
mors and healthy controls were included. Analyses were performed by immunohistochemistry 
using monoclonal antibodies against the antiviral protein MxA, which is specifi cally induced 
by type I IFNs, the interferon inducible protein IP10/CXCL10 and its receptor CXCR3 and 
against the cytotoxic molecule granzyme B. 
Results: Our investigations revealed a strong expression of MxA in imiquimod treated skin 
which was accompanied by a pronounced expression of IP10. The IP10 expression was 
closely associated with the recruitment of cytotoxic lymphocytes expressing the IP10 receptor 
CXCR3. 
Discussion: Our analyses confi rm earlier studies which highlight the role of type I IFNs in imi-
quimod treated skin. We hypothesize that the lesional type I IFN production is involved in the 
recruitment of CXCR3+ CTL via IP10 and enhances their cytotoxic capacity in the skin. 
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Differential Expression of Tumor Necrosis Factor Receptor-Associated Factor 1 (TRAF1) 
in Cutaneous CD30+ Lymphoproliferations Distinguishes Lymphomatoid Papulosis from 
Cutaneous Anaplastic Large Cell
Assaf C1, Hirsch B2, Wagner F2, Lucka L3, Grünbaum M2, Gellrich S1, Lukowsky A1, Sterry W1, 
Stein H2 and Dürkop H2
1Department of Dermatology, Charité (Germany)
2Institute of Pathology, Charité (Germany)
3Institute of Biochemistry,Charité (Germany)
Lymphomatoid papulosis (LyP), primary cutaneous anaplastic large cell lymphoma (cALCL), 
and cutaneous infi ltrates of systemic anaplastic large cell lymphoma (sALCL) are CD30+ lym-
phoproliferative disorders of the skin that overlap clinically, histopathologically, immunophe-
notypically, and genetically but differ considerably in their prognosis. In particular, lesions of 
LyP regress spontaneously, while those of cALCL and sALCL persist and often progress with a 
devastating clinical outcome. In contrast to patients with cALCL, LyP patients do not benefi t 
from an aggressive radio- and/or chemotherapeutic approach. We generated a novel TRAF1 
antibody that recognizes a formalin-resistant epitope (Ber-Traf1A) and investigated the expres-
sion of TRAF1 (tumor necrosis factor receptor (TNFR)-associated factor 1), an intracellular com-
ponent of TNFR signaling, in LyP and ALCL. We could show a strong TRAF1 expression in the 
tumor cells of most LyP cases (42/49, 84%). In contrast, tumor cells of primary and secondary 
cALCL revealed no or weak TRAF1 expression in almost all cases (38/41, 93%) as shown 
for sALCL without skin manifestation. The data indicate that TRAF1 expression reliably distin-
guishes LyP from primary or secondary cALCL. This is of crucial diagnostic importance and has 
a strong impact on early decision-making in the treatment of patients with cALCL or LyP.
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Absence of Prognostic Value of Dermal Infi ltrate in Stevens-Johnson and Toxic Epidermal 
Necrolysis
Valeyrie-Allanore L1, Bastugi-Garin S2, Guegan S1, Wolkenstein P1, Revuz J1, Roujeau JC1 and 
Wechsler J1
1Department of Dermatology, University Paris XII, Creteil (France)
2Department of Public Health, University Paris XII, Creteil (France)
Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are rare, life-threatening, 
drug-induced skin reaction, with clinical spectrum. SJS/TEN pathology classically shows necro-
sis of full-thickness epidermis, with a mild lymphocytic infi ltrate of superfi cial dermis, which 
has recently been suggested as potential prognostic factor in patient outcome. The purpose of 
the study was to evaluate the prognostic value of dermal mononuclear infi ltrate in SJS/TEN.
We retrospectively included all consecutive patients admitted in our department from January 
1993 to October 2003 for SJS/TEN, receiving no specifi c treatment. A skin biopsy was obtained 
in 103 cases. Medical charts were reviewed and a histopathological analysis of skin biopsies 
was performed blinded to clinical data on haematoxylin-eosin-stained sections. Dermal mono-
nuclear infi ltrate was evaluated according to a semi-quantitative analysis, and graded as sparse, 
moderate and extensive (+ to +++). 
One hundred and three patients were eligible, including 40 SJS, 34 SJS/TEN, 29 TEN. Forty 
eight percent of them (n=50) had a body surface area (BSA) involvement up to 10% at the day 
of arrival. Among them, 21 (20.3%) deceased. The mononuclear infi ltrate was graded to sparse 
(n=33), moderate (n=51), extensive (n=19). The mortality associated with the type of infi ltrate 
was respectively of 9 patients for sparse, 8 for moderate and 4 for extensive infi ltrate. There 
was no signifi cant association between the density of the infi ltrate and the mortality (p=0.435). 
There was no correlation between the density of the infi ltrate and the percentage of BSA in-
volved at arrival. (BSA<10%: p=0.372; 10-30: p=0.475, >30%: p=0.29).
Our study demonstrates that the dermal infl ammation can not be considered as predictive fac-
tor of patient outcome. This result was confi rmed whatever the infi ltrate density, BSA involve-
ment in patients receiving the same symptomatic supportive care.
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Optical Biopsies in Dermatology by Optical Coherent Tomography (OCT)
Aschoff R, Pizara P, Meurer M and Knuschke P
Department of Dermatology, University Dresden (Germany)
Background: Optical coherence tomography (OCT) is a non-invasive technique generating 
cross-sectional images of the epidermis and upper dermis. The image resolution is about 10 
to 20 fold higher compared to conventional 20-MHz-ultrasonic techniques. The penetration 
depth of this optical method into tissue is up to 0.5 mm. OCT imaging does not require prepa-
rations (e.g. gel application) and can be carried out in skin sections of 5mm length as rapid 
measurement.
The aim of this investigation was to obtain reference data in healthy individuals (n = 60) on 
epidermal thickness depending on body area, age and gender.
Methods: OCT imaging was performed in parallel (left/right) in 5 different body areas of Cau-
casian individuals (back of the hand/ volar forearm/ back/ forehead/ cheek). To look for in-
traindividual variations, in 3 volunteers the OCT measurements were repeated 5 times per 
day over 5 days.
Results: The epidermal thickness as determined by OCT imaging in vivo shows a considerable 
degree of site-dependent variation with mean values ranging from 58 μm (cheek), 73 μm (fore-
head), 81 μm (volar forearm) 86μm (back) to 105 μm (back of the hand). The dependencies 
on age or gender were less pronounced or absent, respectively: There was small variations in 
epidermal thickness between adults younger than 60 years and between men and women. 
In volunteers above 60 years the epidermal thickness decreased by about 15 %. In contrast, 
the thickness of the epidermis was highest (+ 10...20%) in all measured skin areas of children 
younger than 7 years ( n= 6 ). Intraindividual OCT variations were less than the current ac-
curacy of the method (± 7 μm).
In conclusion, taking optical biopsies by cutaneous OCT imaging is a promising new proce-
dure for investigative and possibly clinical dermatology. 
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Imatinib Mesylate (Gleevec®) Inhibits the Proliferation of Scleroderma Dermal Fibroblasts
Soria A1, Cario-André M1, Pain C1, Schaeverbeke T2, Mahon FX1 and Taïeb A3
1INSERM E217, University V Segalen, Bordeaux (France)
2Dpt of Rhumatology, Bordeaux (France)
3INSERM E217, pt of Dermatology and Pediatric Dermatology, Bordeaux (France)
Background: In systemic and cutaneous forms of scleroderma, cutaneous fi brosis is character-
ized by an increased number of dermal fi broblasts and exaggerated deposits of normal col-
lagen. In systemic sclerosis, the PDGF-β receptor is overexpressed on dermal fi broblasts. The 
tyrosine kinase activity of these receptors make them a candidate target for tyrosine kinase 
inhibitors such as imatinib mesylate (IM), which inhibits Bcr-Abl, ARG protein, PDGF receptor 
(PDGF-R) and c-Kit.
Methods: This study tested the effect of IM on fourteen strains of dermal fi broblasts grown 
from patients with scleroderma (mean: 47 years), mostly systemic sclerosis. Skin biopsies were 
obtained in sclerotic and non sclerotic skin, and control fi broblasts (N=13) were obtained from 
age-matched plastic surgery specimen. To test the proliferation and phosphorylation of PDGF-
R, fi broblasts were exposed to 1 μmol.L-1 of IM and/or to 30 ng.mL-1 of PDFG. In parallel, since 
keratinocytes produce PDGF and interact with dermal fi broblasts, skin equivalent have been 
reconstructed using SS fi broblasts and healthy keratinocytes.
Results: IM inhibited signifi cantly (p<0.01). the proliferation of scleroderma and control fi -
broblasts, and a part of the decreased proliferation was due to a cellular toxic effect (30 %). 
PDGF stimulated fi broblasts proliferation without any signifi cant difference between SS and 
normal fi broblasts. IM inhibition of fi broblasts growth was more important in the presence of 
PDGF as compared to IM alone. Using western-blot, IM inhibited the phosphorylation of a 110 
KDa protein. In skin models, scleroderma fi broblasts secreted neocollagen whereas normal 
fi broblasts did not.
Conclusion: This study suggests that IM can serve as potential drug to stop dermal fi broblast 
proliferation in scleroderma at least partially via the inhibition of PDGF-R.
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Usefulness of Direct Microscopic Examination of Skin Scraping for Correct Assessment of the 
Clinically Complicated Prolonged Scabies
Chomicz L1, Wozniak K2 and Kowalewski C2
1Department of Medical Biology, Medical University of Warsaw (Poland)
2Department of Dermatology, Medical University of Warsaw (Poland)
Highly contagious infection of the human skin, the scabies, is caused by microscopic mite Sar-
coptes scabiei var. hominis. The clinical symptoms of the infection are variable and depend on 
different factors. In this paper we report a mentally retarded young woman clinically presenting 
extensive xerosis accompanied with intense itching. The clinical picture of this dermatosis was 
complicated diagnostically because of occurrence of numerous diffuse hyperkeratotic plaques 
resembled ichthyosis. Moreover epidermal burrows characteristic for scabies were not clear 
visible. The horny layer scraping after exposition to 10% KOH, was directly, without staining, 
examined microscopically; permanent slides were also prepared from the material for verifi ca-
tion of assessment. In each of the ten samples examined, numerous mites were revealed; they 
were identifi ed as adult males and females, gravid females with eggs inside their bodies as well 
as free eggs and larvae of S. scabiei. Proper treatment was included with success. Concluding, 
in a case of severe prolonged itching not clear in origin, the direct microscopic examination of 
skin scraping and looking for developmental forms of S. scabiei is useful for correct assessment 
and treatment in course of dermatosis complicated clinically.
669
Sensitivity and Specifi city of Confocal Laser Scanning Microscopy for In Vivo Diagnosis of 
Malignant Skin Tumors
Gerger A1, Kerl H2, Samonigg H1, Langsenlehner U1, Krippl P1 and Smolle J3
1Department of Internal Medicine, Medical University Graz (Austria)
2Department of Dermatology, Medical University Graz (Austria)
3Inst for Medical Informatics, Statistics and Documentation, Medical University Graz (Austria)
Melanoma and non-melanoma skin cancer are far the most frequent malignant tumors in Cau-
casians. At present, early diagnosis is the most effi cient method in preventing fatal outcome. 
In vivo confocal laser scanning microscopy (CLSM) represents a novel diagnostic imaging tool 
that allows the examination of skin morphology in vivo and in real-time at a resolution equal 
to that of conventional microscopes.
The aim of the study was to test the applicability of CLSM to the diagnostic discrimination of 
malignant skin tumors.
4 independent observers without previous experience in CLSM received a standardized instruc-
tion about diagnostic CLSM features. Subsequently, 117 melanocytic and 45 non-melanocytic 
skin lesions (90 benign nevi, 27 melanomas, 15 basal cell carcinomas, and 30 seborrheic kera-
toses), imaged using a confocal laser scanning microscope, were evaluated by each observer. 
All of the experimenters were blinded as to the clinical and conventional surface microscopic 
or histopathologic diagnosis of the tumours.
Differentiation between melanoma and all other lesions based solely on CLSM examination 
was achieved with a positive predictive value of 94.22 %. Malignant lesions (melanoma and 
basal cell carcinoma) as a group were diagnosed with a positive predictive value of 96.34 %. 
Assessment of distinct CLSM features showed a strong interobserver correlation (kappa > 0.80 
in 11 of 13 criteria). Classifi cation and regression tree analysis yielded a 3-step algorithm based 
on only three criteria, facilitating a correct classifi cation in 96.30% of melanoma, 98.89% of 
benign nevi and 100% of basal cell carcinoma and seborrheic keratosis. 
In vivo CLSM examination seems to be a promising method for the non-invasive assessment 
of melanoma and non-melanoma skin tumors. The results of the present study underline that 
CLSM merits application for use as a screening tool in skin oncology.
670
Diagnostic Virtual Histopathology of Untreated Fresh Specimens from Squamous Cell 
Carcinoma Using Confocal Laser-Scanning Microscopy
Gerger A, Horn M, Samonigg H, Langsenlehner U, Krippl P, Kerl H and Smolle J
Department of Internal Medicine, Division of Oncology, Medical University Graz (Austria)
Fast confocal laser scanning microscopy offers the opportunity to examine fresh and untreated 
skin excisions from squamous cell carcinoma during microscopy guided surgery without histo-
technical processing. Since vertical sections are prepared, morphologic features according to 
standard criteria used in conventional histopathology can be assessed.
In this study we validate the diagnostic confocal examination of squamous cell carcinoma in 
microscopy guided surgery.
4 independent observers received a standardized instruction about diagnostic confocal mi-
croscopy features of squamous cell carcinoma. Subsequently, 120 confocal images of fresh 
excisions from squamous cell carcinoma or normal skin, imaged using a commercially avail-
able, near-infrared, refl ectance confocal laser-scanning microscope, were evaluated by each 
observer. All of the experimenters were blinded as to the clinical and histopathologic diagnosis 
of the confocal images.
Approximately 5 minutes are required to prepare confocal examination of surgical excisions. 
General morphology, such as location, size and shape of the cancer area could be visualized 
by the imaging system. Furthermore, densely packed and irregularly organized nuclei and 
nuclear atypia could be delineated. Overall, sensitivity of 95% and specifi city of 96.25% could 
be achieved by the 4 observers (ppv 96.25%, npv 95.23%). 
This study provides a set of well-described morphologic criteria with obvious diagnostic im-
pact. In the future, confocal laser-scanning microscopy may guide microsurgery of any skin 
cancer.
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Histopathology of the Skin in Acute Generalized Exanthematous Pustulosis (AGEP) – A Study 
of 102 cases
Halevy S1, Kardaun S2, Davidovici B1 and Wechsler J3
1Dept of Dermatology, Soroka Univ Medical Center, Ben-Gurion Univ of the Negev (Israel)
2Dept of Dermatology, Univ Medical Center Groningen (Netherlands)
3Dept of Pathology, Henri Mondor Univ Hospital, Faculty of Medicine, Paris (France)
The present study was aimed to characterize the detailed histopathology of the skin in AGEP, 
a rare severe cutaneous adverse reaction (SCAR) caused mostly by drugs. AGEP cases were 
actively detected in two multinational prospective studies of SCAR: the EuroSCAR study (1997-
2001) and the RegiSCAR study (2002-2005).
The validation of the diagnosis AGEP was based on a standardized scoring system, which al-
lowed classifi cation of AGEP as defi nite, probable, possible or no AGEP. In the present study we 
included cases with a defi nite or a probable diagnosis of AGEP. Four investigators conducted 
the histopathological evaluation based on a special reviewing system. The study comprised of 
102 cases of which at least 14% had a psoriatic background. Pustules of different size were 
observed in all cases. The location of the pustules was corneal (50% of cases, mainly non-
spongiform) and/or epidermal (50%, mainly spongiform). Contrary to previous reports, follicu-
lar pustules were observed in 20% of the cases. The presence of Munro abscess was recorded 
in 17.6% of the cases. However, other “classical” histopathological features of plaque-type 
psoriasis were absent in the majority of the cases (the granular layer was preserved; supra 
papillary plate thinning and tortuous blood vessels were absent). Other features consisted of 
high prevalence of necrotic keratinocytes (70%), papillary edema (85%), superfi cial infi ltrate 
(100%) and presence of dermal neutrophils (75%), which have been previously reported in 
AGEP. Remarkable dermal features observed in the present study were the high prevalence of 
deep (97%) and interstitial (95%) infi ltrates, dermal eosinophils (80%) and absence of vasculitis 
in the vast majority of cases (99%). In conclusion, the present study conducted in a large series 
of AGEP cases with a validated diagnosis, disclosed a spectrum of histopathological features, 
which may contribute to the differentiation of AGEP from other similar conditions. 
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The New Effect of Roxithromycin on Hair Elongation of Murine Vibrissa
Ito T1, Ito N1, Hashizume H1, Paus R2 and Takigawa M1
1Department of Dermatology, Hamamatsu University School of Medicine (Japan)
2Department of Dermatology, University Hospital Hamburg-Eppendorf (Germany)
Roxithromycin (RXM) is a macrolide antibiotics that has not only antibacterial action but 
also immunomodulatory or anti-infl ammatory potency such as inhibition of T cell responses 
to mitogens, RXM inhibits the antigen-presenting ability of LC for T cells and production of 
cytokines, IL-1β, IL-2 and IL-5. In this study, we tried to fi nd the new effect of roxithromycin 
on murine hair follicles because there are still not enough topical hair restoration drugs for 
alopecia, especially androgenetic alopecia. Murine vibrissa taken from 4 week-old BALB/c 
mice were cultured in William’s medium E with PBS (control), IFN-γ 50 IU/ml, RXM 5μM, 
IFN-γ 50 IU/ml+RXM10μM, clarithromycin (CLM) 5μM, CLM 10μM, erythromycin (EM) 5μM, 
EM 10μM followed by Philpott’s model for 6 days. RXM treatment only showed signifi cant hair 
elongation than control. In addition, RXM inhibited IFN-γ induced catagen induction and hair 
cycle score (anagen IV anagen VI = 0; early catagen = 1; mid catagen = 2; late catagen = 3) 
was signifi cantly lower in RXM+IFN-γ treatment group compared to IFN-γ treatment group. 
Furthermore, the number of apoptotic cells was signifi cantly decreased by RXM treatment in 
hair follicles. These results implicate that RXM can be new candidate of hair restoration drug 
for androgenetic alopecia.
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Sweet-like Bullous Skin Infi ltrations in a CML Patient Treated with Tyrosine Kinase Inhibitors
Kaune KM1, Baumgart M2, Gesk S3, Chapuy B4, Baesecke J4, Glaß B4, Siebert R3, Ghadimi BM2, 
Neumann C and Emmert S1
1Department of Dermatology, University of Goettingen (Germany)
2Department of Surgery, University of Goettingen (Germany)
3Institute of Human Genetics, University of Schleswig-Holstein, Campus Kiel (Germany)
4Department of Hemato-Oncology, University of Goettingen (Germany)
The occurrence of sweet-like cutaneous lesions with chronic myeloic leucemia (CML) has been 
recently observed especially in patients treated with tyrosine kinase inhibitors. We present a 
67y old patient with a 6 year history of Philadelphia- translocation t(9;22)(q34;q11)-positive 
CML. AMN 107 tyrosine kinase inhibitor treatment kept the patient in the chronic phase of 
CML over the last months at the cost of neutro- and thrombozytopenia. Under this treatment he 
developed a pneumonia and sepsis with temperatures up to 40°C. After one week bullous skin 
infi ltrations on both upper arms occurred as well as a monstrous and painful bullous swelling 
of the right neck with loss of contours. Serology revealed no indication of a viral infection 
(VZV, HSV, EBV, CMV, HAV), blood cultures were negative, and lesional skin biopsy cultures 
revealed no viral, bacterial, or fungal pathogen. Histology of a skin biopsy from the right neck 
showed massive infi ltrations of the whole dermis with neutrophile granulozytes as well as with 
monozytoid histiozytic cells also spreading into the spongiotic destroyed epidermis. In addi-
tion, atypical monozytoid and binuclear cells usually not found in classical sweet syndrome 
were present. FISH analysis of paraffi n embedded lesional tissue sections revealed a BCR-ABL-
fusion indicating t(9;22)(q34;q11) in a signifi cant number of infi ltrating cells. After cessation 
of AMN 107 and initiation of an Augmentan/Avalox antibiotic treatment the addition of pred-
nisolone 1 mg/kg qd led to rapid resolution of the sweet-like cutaneous bullous infi ltrations. We 
conclude that the development of sweet-like bullous dermatoses in septic CML patients may be 
precipitated by tyrosine kinase inhibitors.
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Primary Cutaneous Large B-cell Lymphomas. Clinicopathologic Study in a Large Series of 
Patients
Kodama K1, Massone C2, Chott A3, Metze D4, Kerl H2 and Cerroni L2
1Department of Dermatology, Hokkaido University Graduate School of Medicine (Japan)
2Department of Dermatology, Medical University of Graz (Austria)
3Department of Pathology, Medical University of Vienna (Austria)
4Department of Dermatology, University of Münster (Germany)
In the new World Health Organization/European Organization for Research and Treatment of 
Cancer (WHO/EORTC) classifi cation of cutaneous lymphomas, large B-cell lymphomas (LB-
CLs) are divided into 3 groups: LBCL, leg-type (LBCLLT); follicle center lymphoma, diffuse type 
(FCLDT); LBCL, others (LBCLO). We studied a large number of primary cutaneous LBCLs in or-
der to test the validity of the classifi cation, and to identify prognostic factors for these patients. 
Ninety-three cases of primary cutaneous LBCL were analyzed for clinicopathologic features, 
expression of several markers including Bcl-2, Bcl-6 (a marker for germinal center B-cell), 
MUM-1 and FOX-P1 (Both are markers for activated B-cell), in-situ-hybridization for Epstein-
Barr virus, and molecular analyses of IgH gene rearrangement and of Borrelia burgdorferi and 
Human herpesvirus 8 DNA. Patients were classifi ed into the following categories: FCLDT: 44 
cases; LBCLLT: 40 cases. LBCLO: 9 cases. Statistical analyses showed that the groups of LBCLLT 
and FCLDT were clearly distinct in terms of clinicopathologic features and survival. The group 
of LBCLO had features in-between those of LBCLLT and FCLDT. Our study shows that accurate 
morphologic and phenotypic analyses allow stratifying most patients into the prognostically 
different categories of LBCLLT and FCLDT. The defi nition of a third category of LBCLO requires 
further studies to clarify whether these cases show indeed distinct clinicopathologic features. 
We also identifi ed six adverse prognostic markers including location on the leg, age over 70, 
round cell morphology, Bcl-2 expression, MUM-1 expression, and FOX-P1 expression. We 
could fi nd only one case of LBCLLT positive for human herpesvirus 8, suggesting that Epstein-
Barr virus, Borrelia burgdorferi and Human herpesvirus 8 are not implicated in the pathogen-
esis of these lymphomas.
675
Human Nail Study Using Acoustic Microscopy
Maeva A1, Khramtsova E2, Denisova L2, Maev RG1 and Shum D3
1University of Windsor, Ontario (Canada)
2Emanuel’s Institute for Biochemical Physics, RAS, Moscow (Russian Federation)
3Hotel-Dieu Grace Clinic, Windsor, Ontario (Canada)
Acoustic microscopy provides unique opportunities for the micro anatomical investigation of 
human skin and its derivations. Numerous papers have focused upon the ultrasound charac-
terization of skin but only a few (contradictory) paprers have been dedicated to the ultrasound 
characterization of the human nail. The aim of the present study is to evaluate the analytical 
validity of acoustic microscopy with regard to human nail. 
In the fi rst part of the study amputated fi ngers and toes were obtained from the Hotel-Dieu 
Grace Clinic (Windsor). A non-invasive study of the fi nger- and toenails was performed with 
a scanning acoustic microscope, the Tessonics-1103 (frequency 25 and 50 MHz). Afterwards 
each nail was sectioned longitudinally and direct measurements taken of nail plate thickness. 
In the second part of the study fi ngernails of 112 healthy volunteers (18 years old) were non-
invasively evaluated using a portable handheld ultrasonic device, the Tessonics-AM 1163 (fre-
quency 15 MHz).
Acoustic and light microscopes were used to comparatively analyze the nail plate, nail bed, 
matrix and other structural images obtained by the study. Artifacts and distortions of ultrasound 
imaging and measurements were investigated. No correlation was found between nail plate 
thickness and ultrasound velocity values. There were no signifi cant differences in ultrasound 
thickness and velocity between the volunteers representing different ethnic groups (White, 
Afro-American, Oriental, Indian, Middle Eastern). The average value of the sound velocity in 
the centre of the forefi nger nail plate was 2400±470 m/c; no differences in either sex or ethnic 
group were revealed. However, in each distinct ethnic group nail plate thickness was 20% 
higher in men than in women. A specialized non-invasive technique was developed to evaluate 
nail plate ultrasound velocity and thickness. The results obtained were used as a base for the 
design of a new ultrasound device non-invasive characterization of human nails.
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Elastofi broma: Immunohistochemical Characterization and Pathophysiologic Hypothesis
Naouri M1, Michenet P2, Maruani A1, Nseir A1, Viala J3, Maître F2, Chassaing N4 and Martin L1
1Dept of Dermatology, CHR d’Orléans (France) 2Dept of Pathology, CHR d’Orléans (France)
3Dept of Radiology, CHR d’Orléans (France) 4Dept of Genetics, CHU Purpan, Toulouse 
(France)
Introduction: Elastofi broma (EF) is a pseudotumor characterized histologically by the associa-
tion of dystrophic elastic fi bers, bundles of collagen, mature adipose tissue and spindle-shaped 
cells. We carried out an immunohistochemical study of EFs to further describe the proteic 
content of EF fi bers and cells. Material and Methods: We studied 4 EF from 3 unrelated pa-
tients. The lesions were stained by HES, orcein and von Kossa stainings. Immunolabelings were 
performed on EF and control skins without or with elastic dystrophy (pseudoxanthoma elas-
ticum (PXE), elastosis) for the following antigens: actin, desmin, vimentin, elastin, fi brillin 1, 
vitronectin, fi bronectin, bone sialoprotein and osteonectin. All patients gave informed content 
for blood sampling and search for mutations in ABCC6 (the PXE gene).
Discussion: Spindle-shaped cells expressed vimentin, but not desmin or actin, what allows us to 
rule out the myofi broblastic feature suspected in the litterature. The expression of bone sialoprotein 
and vitronectin rather suggests an osteoblastic differenciation of those cells. Dystrophic elastic 
fi bers of EF and PXE express vitronectin and bone sialoprotein which are glycoproteins known for 
their affi nity for calcium. We propose an original pathophysiological hypothesis for the histogen-
esis of EF. Indeed, as in PXE, a stage of neoelastogenesis including incorporation of proteins with 
affi nity for calcium could fi rst occur. The latter glycoproteinst could secondarily be responsible for 
the mineralisation of the elastic fi bers, and for the progressive dystrophy. The difference in miner-
alisation between EF and PXE could be explained by the younger age of EF fi bers in comparison 
with the congenital PXE fi bers. A genetic predisposition to the development of EF is suspected. 
Our study has excluded the implication of germinal mutations of ABCC6. It would be interesting 
to seek for acquired somatic changes within the EF cells.
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Immunohistochemical Characterization of Infl ammatory Infi ltrate of Intraepidermal and 
Invasive Squamous Cell Carcinoma of the Skin in Immunocompetent Patients and Organ 
Transplant Recipients
Muehleisen B1, Petrov I1, Gaechter T1, Kurrer M2, Schaerer L1, Dummer R1 and Hofbauer G1
1Department of Dermatology, University Hospital Zurich (Switzerland)
2Department of Pathology, University Hospital Zurich (Switzerland)
Incidence of epithelial skin cancer is increasing. Organ transplant recipients (OTRs) are at a 
much higher risk than immunocompetent patients to develop squamous cell carcinoma of the 
skin. Histologically, peritumoral infl ammatory infi ltrate is a frequent feature and is believed 
to be a correlate of antitumoral immune response. Our aim was to characterize peritumoral 
infl ammatory infi ltrate in intraepidermal (actinic keratosis or Bowen’s disease) and subsequent 
invasive squamous cell carcinoma in the same patient in organ transplant recipients (n = 42) 
and immunocompetent patients (n = 43). Thus, in 170 formalin fi xed, paraffi n-embedded tissue 
samples peritumoral infl ammatory infi ltrate was characterized by its extent, density, localisa-
tion in the dermis and by its composition focusing on immunohistochemical expression of 
the T-cell markers CD3, CD4, CD8 and FOXP3. Maximum diameter of infi ltrate was larger 
in invasive lesions than in their intraepidermal precursor lesions (p < 0.005) but did not differ 
between immunocompetent patients and OTRs (p = 0.22). Infl ammatory infi ltrate in immuno-
competent patients was more dense than in OTRs (p = 0.041) and more dense in invasive than 
in intraepidermal lesions (p = 0.005). Immunocompetent subjects showed higher rates of CD3 
(p = 0.015) and CD8 (p = 0.038) immunoexpression across all lesions but comparable CD4 
immunoreactivity (p = 0.169) to OTRs. In invasive lesions, immunocompetent patients showed 
higher levels of FOXP3 immunoexpression than OTRs (p = 0.049). In conclusion peritumoral 
infl ammatory infi ltrate was more pronounced as measured by density, CD3, CD8 and FOXP3 
expression in immunocompetent patients than in OTRs and grew larger and more dense on the 
course from intraepidermal to invasive squamous cell carcinoma. 
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Characterization of CXCL13+ Neoplastic T-Cells in Cutaneous Lesions of Angioimmunoblastic 
T-Cell Lymphoma (AITL)
Ortonne N1, Wechsler J1, Plonquet A2, Dupuis J3, Martin N4, Bagot M5, Delfau-Larue N5 and 
Gaulard P1
1Department of Pathology, Henri Mondor hospital, Creteil (France)
2Department of Immunology, Henri Mondor hospital, Creteil (France)
3Department of Hematology, Henri Mondor hospital, Creteil (France)
4Pathology, Henri Mondor hospital, Creteil (France)
5Department of Dermatology, Henri Mondor hospital, Creteil (France)
Purpose. Skin manifestations of angioimmunoblastic T-cell lymphoma (AITL) are frequent and may 
reveal the disease, but in the absence of a specifi c marker for neoplastic cells, diagnosis of AITL in 
skin biopsy is diffi cult. CD10 and CXCL13 have been recently recognized as characteristic markers 
of AITL, but have not been yet investigated in the skin. 
Methods. We analyzed 14 skin biopsies from 7 patients with AITL having skin manifestations and 
compared them to 14 skin biopsies from patients with various cutaneous lymphocytic infi ltrates, 
including primary cutaneous T-cell lymphomas. Immunohistochemical analyses were performed 
on paraffi n embedded sections with specifi c monoclonal antibodies to CD10 and CXCL13 and 
a panel of B and T-cell markers. Molecular studies included in situ hybridization for Epstein Barr 
virus mRNA, B-cell and T-cell clonality studies. Results. CXCL13+ cells were identifi ed in most AITL 
cutaneous biopsies (11/14, 78%), whereas absent in all samples from control cases. Interestingly, 
cutaneous CXCL13+ cells were found in one patient without lymph node involvement, allowing 
diagnosis of AITL, and in cases showing non specifi c infi ltrates. Among 11 biopsies with CXCL13+ 
cells, cutaneous localization of AITL was suspected in only 4 on the basis of light microscopic 
and classical phenotypic studies, mostly with knowledge of systemic AITL. By contrast, only few 
CD10+ lymphocytes were found in only 2 samples of the AITL group. In addition, the identifi cation 
of CD10+ lymphocytes was impaired in both AITL and control cases by the presence of a dermal 
CD10+ cells population with dendritic features, which remains to be further characterized.
Conclusion. This study shows that neoplastic AITL CXCL13+ T cells localize in the skin and that ac-
curate diagnosis of AITL can be done in skin specimens using CXCL13 immunostaining on paraffi n 
embedded tissues.
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Analysis of the Subepidermal Nerve Plexus and Terminal Schwann Cells in Skin of Diabetic 
Patients Compared to Non-Diabetic Controls
Reinisch CM1, Traxler H2, Piringer S2, Tangl S3, Nader A4, Tschachler E1 and Tschachler E5
1Department of Dermatology, Medical University of Vienna (Austria)
2Center of Anatomy and Cell Biology, Medical University of Vienna (Austria)
3Department of Oral Surgery, Dental School Medical University of Vienna (Austria)
4Institute of Pathology, Hanuschkrankenhaus, Vienna (Austria)
5Centre de Recherches et d’Investigations Épidermiques et Sensorielles, Neuilly (France)
Diabetic neuropathy is one of the most common peripheral neuropathies. Morphological changes 
associated therewith, as for example a tremendous reduction of epidermal nerve fi bers at distal 
body sites, have already successfully been evaluated using skin biopsies. We hypothesized that 
the subepidermal nerve plexus and terminal Schwann cells, that are ensheating all nerve fi bers, 
might be affected in diabetic polyneuropathy as well. To visualize the subepidermal nerve plexus 
in its entirety, we used dermal sheet preparations of forefoot skin from diabetic patients and control 
individuals and did immunostainings for the neural cell adhesion molecule (NCAM/CD56). The 
subepidermal nerve plexus was quantifi ed by the use of computerised image-analysis. Whereas 
dermal sheets of control individuals showed a dense, highly ramifi ed subepidermal nerve network, 
in diabetic subjects only a diminished nerve plexus could be found. Within the diabetic group, 
we detected an average length of the subepidermal nerve plexus of 6,724 mm ± 1,261 mm / mm2 
(mean ± standard deviation) compared to 12,999 mm ± 2,905 mm / mm2 in the control group. 
Moreover, in diabetic individuals, the length correlated inversely with the level of blood glucose. In 
both groups, neither age nor sex was correlated with the length of the subepidermal nerve plexus. 
Equally, the number of terminal Schwann cells was reduced in the diabetic group. In conclusion, 
the subepidermal nerve network containing terminal Schwann cells was strongly diminished in skin 
of diabetic patients. If this reduction in terminal Schwann cells is just a consequence of the nerve 
fi ber loss or is directly caused by metabolic changes in diabetes deserves further investigations. 
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Three-dimensional Analysis of Human Facial Skin In Vivo by Swept Source Optical Coherence 
Tomography
Sakai S1, Hori Y2, Matsumoto M3, Sugawara T1, Yasuno Y2, Makita S2, Yamanari M2, D.Madjarova 
V2, Itoh M2 and Yatagai T2
1Basic Research Laboratory, Kanebo COSMETICS INC. (Japan)
2Computational Optics Group in University of Tsukuba (Japan)
3Cosmetics Laboratory, Kanebo Cosmetics Inc. (Japan)
In dermatology, it is very important to investigate the relationships between surface morpholo-
gies and the internal structures of the skin. Time-domain optical coherence tomography (TD-
OCT) using a safe infra-red light source has so far been useful for non-invasive histological 
observations of the internal structures. However, the considerable time required to take meas-
urements by three-dimensional scanning prevents investigators from feasibly applying TD-OCT 
for three-dimensional morphological analyses. As a possible solution, several groups have 
proposed the application of swept-source OCT (SS-OCT), a Fourier domain OCT which can 
remarkably shorten measurement times by detecting the wavelength resolutions of backscatter-
ing light. In this study we present a set of practical algorithms for three-dimensional analysis of 
skin in vivo using SS-OCT. The forehead areas (4 mm x 4 mm) of fi ve males (age: 22~44) were 
scanned by a 1.3μm SS-OCT in two seconds. Sequential image fi elds of 1024 (A-scan)×200 (B-
scan)×200 (C-scan) pixels were layered to reconstruct a three-dimensional OCT image. Once 
the image was complete, we applied an algorithm to extract characteristic parameters and 
morphological structures of infundibulum based on volume. Our algorithm provided param-
eters such as the mean epidermal thickness, infundibulum density, and dermal attenuation 
coeffi cient. The values obtained were almost the same as those reported in earlier studies. 
Moreover, the algorithm segmented the epidermal layer and infundibulum of the sebaceous 
follicle three-dimensionally, thereby allowing us to examine the relationship between the sur-
face morphology and distribution of the infundibulum. The algorithm with SS-OCT will be 
practically suitable for three-dimensional analyses of the skin. This method will serve important 
purposes not only in dermatology, but also cosmetic science and cosmetic surgery.
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Reclassifi cation of 299 Primary Cutaneous B-cell Lymphoma According to the New WHO-EORTC 
Classifi cation for Cutaneous Lymphomas and Characterization of Prognostic Parameters
Senff NJ1, Vermeer MH1, Hoefnagel JJ1, Jansen PM2, Meijer CJ3 and Willemze R1
1Department of Dermatology, Leiden University Medical Center (Netherlands)
2Department of Pathology, Leiden University Medical Center (Netherlands)
3Department of Pathology, Vrije Universiteit Medical Center (Netherlands)
Purpose: To assess the percentage of primary cutaneous B-cell lymphoma (CBCL) patients for-
merly classifi ed according to either the EORTC or WHO classifi cation assigned to a differ-
ent prognostic category according to the WHO-EORTC classifi cation and establish prognostic 
parameters for different types of CBCL. Methods: 299 Dutch CBCL patients were reclassifi ed 
according to the criteria of the new WHO-EORTC classifi cation. Within subgroups the prog-
nostic signifi cance of clinical, histological and immunophenotypical (Bcl-2, Mum-1, FoxP1) 
parameters were analyzed by multivariate analysis using a Cox regression model with overall 
survival (OS) and disease specifi c survival (DSS) as end points.
Results: After reclassifi cation according to the criteria of the WHO-EORTC classifi cation the 
study group included 71 primary cutaneous marginal-zone B-cell lymphomas, 168 primary 
cutaneous follicle center lymphomas (PCFCL) and 60 primary cutaneous diffuse large B-cell 
lymphoma, leg type (PCLBCL, LT). The 5-year DSS was 98%, 95% and 51%, respectively; the 
5-year OS 91%, 88% and 37%, illustrating the clinical signifi cance of this new classifi cation. 
Comparison with classifi cation according to the former EORTC and WHO schemes showed 
that 5.7% and 35.8% of CBCL were reclassifi ed into another prognostic category. Multivari-
ate analysis of PCFCL cases showed that only age, site of presentation (leg) and expression of 
FoxP1, but not Bcl-2 or Mum-1 expression, were independent prognostic parameters for both 
OS and DSS. In the PCLBCL, LT group only age and the presence of multifocal skin lesions 
were adverse prognostic parameters for OS. Conclusion: Using the WHO-EORTC classifi cation 
a small percentage of patients formerly classifi ed according to the EORTC classifi cation, but 
a considerable proportion of CBCL formerly classifi ed according to the WHO classifi cation 
will be reclassifi ed into a different prognostic group. This observation may have important 
therapeutic consequences. 
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Reduced and Abnormal Proteolysis of Corneodesmosomal proteins in Psoriatic Skin
Simon M1, Tazi-Ahnini R2, Jonca N1, Cork MJ2 and Serre G1
1UMR5165, CNRS-University of Toulouse III (France)
2Division of Genomic Medicine, University of Sheffi eld (United Kingdom)
Desquamation occurs after degradation of corneodesmosomes paralleled by the proteolysis of 
their constituent proteins, desmocollin 1 (Dsc1), desmoglein 1 (Dsg1), corneodesmosin (CDSN) 
and plakoglobin. The serine protease SCCE is likely to be involved in this process. Persistence of 
corneodesmosomes in the upper stratum corneum is one of the features of psoriatic hyperkera-
totic skin. Particular allelic variants of the CDSN gene are strongly associated with familial or 
type 1 psoriasis, some of the associated SNPs potentially modifying protease cleavage sites on 
the encoded protein. We tested whether the proteolysis of corneodesmosomal components and 
the expression of SCCE are reduced in psoriasis. Total protein extracts of tape-strippings from 
nonlesional (NL) and lesional (L) skin were obtained from seven type 1 and four type 2 psoriasis 
patients. They were immunodetected with antibodies specifi c for either Dsg1, Dsc1, plakoglobin, 
various domains of CDSN, or for the protease. Results were quantifi ed and compared. In the L 
skin extracts, a quasi-entire form of CDSN and high molecular weight fragments were detected 
by the antibodies specifi c for the most amino- and carboxy-terminal domains of the protein. They 
were not or only slightly detected in the NL skin extracts. They are never detected in normal 
skin extracts. Increasing amounts of plakoglobin and Dsg1 (both the entire proteins and derived 
fragments) were detected in L as compared to NL skin extracts. In most L skin extracts (7/11), in-
creasing amounts of Dsc1 fragments were observed. However, similar or higher amounts of both 
pro-SCCE and SCCE were detected in L compared with NL skin extracts. Our results evidence 
a reduced and abnormal proteolysis of corneodesmosome proteins in psoriasis lesions but no 
reduction in the expression of SCCE. They warrant further investigations on the relative role of 
CDSN and serine proteases in the molecular pathogenesis of the disease.
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IP10/CXCL10–CXCR3 Interaction: A Potential Self Recruiting Mechanism for Cytotoxic 
Lymphocytes in Lichen Sclerosus Et Atrophicus
Wenzel J, Wiechert A, Bieber T and Tüting T
Department of Dermatology, University of Bonn (Germany)
Background: Lichen sclerosus et atrophicus (LSA) is a chronic infl ammatory skin disease with 
unknown etiology. Recent studies provided evidence that autoimmune mechanisms might be 
involved in the pathogenesis of this disease and suggested a role for autoreactive cytotoxic T 
lymphocytes (CTL) in this disorder. Based on recent observations in lupus erythematosus and li-
chen planus we hypothesized now that a type I interferon driven recruitment of CTL via CXCR3 
/ IP10 interactions might be involved in the pathogenesis of LSA skin lesions.
Patients and Methods: Lesional skin biopsies taken from 9 patients with LSA and 12 controls 
were analyzed by immunohistochemistry using monoclonal antibodies against the cell surface 
markers CD3, CD4, CD8, CD68 and CD123, the cytotoxic molecules Tia1 and Granzyme 
B, the specifi c type I interferon marker MxA, the interferon inducible protein IP10/CXCL10 
and the corresponding receptor CXCR3. Sequential double staining was performed to analyze 
coexpression of Tia1 and CXCR3. 
Results: Our investigations confi rmed earlier studies which reported numerous CTL to be in-
volved in the dermal and junctional infl ammation of LSA. Signifi cant expression of MxA was 
found in all LSA skin lesions, indicating type I IFN production. This expression was closely 
associated with the expression of the interferon inducible protein IP10 and the recruitment of 
CXCR3+ CTL. Plasmacytoid dendritic cells appeared to be a major source of type I IFN in LSA. 
Interestingly, several infi ltrating lymphocytes contained IP10 in their granules.
Discussion: This is the fi rst study providing evidence that a type I IFN associated recruitment of 
CXCR3+ CTL via IP10 is involved in the pathogenesis of LSA. Infi ltrating lymphocytes, contain-
ing IP10 in their granules, could provide an important self perpetuating mechanism. They might 
be in part responsible for the chronic infl ammation that is characteristic for LSA.
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Type I IFN Signature Distinguishes Lichen Planus from Atopic Dermatitis and Psoriasis
Wenzel J2, Küsters D1, Bieber T2, Tüting T2, Baron JM3, Merk HF3, Mauch C4, Krieg T4, Bosio 
A1 and Peters B1
1Miltenyi Biotec GmbH, MACSmolecular Business Unit (Germany)
2Department of Dermatology, University of Bonn (Germany)
3Department of Dermatology and Allergology, University Hospital RWTH Aachen (Germany)
4Department of Dermatology and Venerology, University of Cologne (Germany)
Background: Lichen planus is an infl ammatory disorder of the skin and mucous membranes, 
characterized histologically by a T cellular interface dermatitis. This infl ammation is supposed 
to represent a cytotoxic response to epidermal antigens. LP is associated with type I IFN medi-
ated diseases such as hepatitis C and herpes infection and may exacerbate during IFN alpha 
therapy. Therefore, type I IFN dependent proinfl ammatory mechanisms have been discussed to 
play am pathogenic role. Now we present detailed data, based on gene expression profi ling, in 
situ hybridisation and immunohistochemistry in a large patient cohort, supporting the impor-
tance of IFN associated infl ammation in this condition. 
Patients and methods: Lesional skin biopsies of altogether 321 donors (atopic dermatitis (AD, 
n=45), psoriasis (Pso, n=157), lichen planus (LP, n=34), healthy controls (HC, n=85) were in-
cluded. First, SAGE™ analyses were performed to generate complete gene expression profi les 
of healthy and diseased skin, followed by PIQOR™ microarray analyses including 1544 genes. 
In situ hybridisation was done to confi rm and to localize the expression of mRNA coding 
for IFNs and several chemokines in formalin fi xed skin biopsies. Additionally, immunohistol-
ogy using monoclonal antibodies against CD3, CD4, CD8, CD20, GranzymeB, Tia1, CXCR3, 
CXCL9, 10, and 11, as well as the type I IFN marker MxA, was performed to characterize the 
lesional infl ammation and to confi rm our data on the protein level. 
Results: Our analyses revealed about 200 genes whose expression was upregulated in one 
or more skin disorders. Genes highly expressed in all infl ammatory skin diseases encode 
for keratinocyte proteins and proinfl ammatory factors, and refl ecting the common histologi-
cal features of these disorders such as epidermal acanthosis and lymphocytic infl ammation. 
However, a strong type I interferon signature as well as CXCR3-associated chemokines were 
almost exclusively found in lichen planus and distinguished this disorder clearly from atopic 
dermatitis and psoriasis. The CXCR3 ligand CXCL9 was the most signifi cant marker for LP in 
all analyses. Results of microarray analyses were confi rmed by in situ hybridization and im-
munohistochemistry. 
Discussion: Our results underline the importance of type I IFN dependent infl ammation in LP. A 
strong expression of the IFN inducible chemokines CXCL9, 10 and 11 was observed in almost 
all investigated LP skin lesions. CXCR3+ cytotoxic T cells appeared to be the main effector 
cells. We hypothesize that lesional type I IFN signaling drives the lesional infl ammation by 
CXCR3 <-> ligand interaction and enhances the cytotoxic capacity of infi ltrating CD8+ T cells. 
CXCR3+ pDCs and CTLs, carrying CXCL10 in their cytotoxic granules, might play an important 
role to amplify the lesional infl ammation.
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